data_2do8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2do8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 121.593 0.711 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 91.8 mt -82.25 -3.03 54.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.153 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.588 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -65.1 135.65 55.79 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.88 12.82 83.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.961 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 43.2 mmtm -112.8 163.4 14.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -140.28 150.45 44.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.04 0.448 . . . . 0.0 110.382 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.51 HD13 HG13 ' A' ' 40' ' ' ILE . 8.4 pt -116.06 129.14 72.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.851 -177.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.711 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.0 mp -86.37 103.83 13.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.8 -54.37 3.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.426 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.86 -178.163 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 121.708 0.766 . . . . 0.0 112.593 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 t -140.45 110.89 6.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.391 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.56 HG11 HG22 ' A' ' 40' ' ' ILE . 90.2 t 73.55 140.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 122.844 0.458 . . . . 0.0 110.918 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.54 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.3 tp -135.19 -58.42 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.54 ' HD1' HG13 ' A' ' 26' ' ' ILE . 20.4 p90 -168.05 171.44 9.62 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.647 0.658 . . . . 0.0 112.134 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.4 mp -98.68 133.75 40.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.195 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.8 m -75.97 -52.6 9.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.03 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.588 ' HA ' ' HB2' ' A' ' 6' ' ' GLN . 13.7 pt-20 -161.1 169.91 21.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.131 0.491 . . . . 0.0 111.752 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 37.6 t-80 -134.16 111.03 9.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.636 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -128.25 170.16 13.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.495 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.33 -31.97 73.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.133 0.492 . . . . 0.0 110.85 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -74.57 -18.11 60.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.857 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.31 -177.52 30.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.659 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.0 m -113.27 117.62 32.35 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.639 HG13 HG23 ' A' ' 133' ' ' THR . 3.9 mp -96.28 124.85 49.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.44 164.73 34.65 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.037 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.38 81.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.443 0.64 . . . . 0.0 110.355 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.56 HG22 HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -133.97 6.65 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.431 -176.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.9 tp -70.59 -35.9 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 120.506 0.193 . . . . 0.0 111.247 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 63.97 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.182 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 74' ' ' ASN . 4.1 t -161.34 91.52 1.49 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 121.714 0.768 . . . . 0.0 110.062 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.521 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 58.6 Cg_endo -72.85 154.56 53.63 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.719 2.279 . . . . 0.0 112.058 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.1 p -114.95 167.98 10.31 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.46 -0.63 47.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 0.0 111.595 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.634 HD22 ' HB3' ' A' ' 52' ' ' LEU . 35.1 tp -92.4 152.38 19.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.9 0.381 . . . . 0.0 110.143 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.712 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 12.8 m -109.08 154.48 22.2 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 7.4 p -61.28 -45.56 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.237 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.588 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 90.3 mt -75.67 -25.82 57.12 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.407 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.712 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.5 OUTLIER -57.36 -53.47 57.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.097 178.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.634 ' HB3' HD22 ' A' ' 47' ' ' LEU . 3.8 pp -66.66 -36.52 82.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.04 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.69 -51.63 64.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.779 0.323 . . . . 0.0 111.105 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.7 p -72.49 -29.46 63.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.057 0.456 . . . . 0.0 111.186 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -69.61 -37.2 76.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.584 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' A' ' 52' ' ' LEU . 65.2 mtt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.928 0.394 . . . . 0.0 111.918 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.588 ' OD2' ' HB2' ' A' ' 50' ' ' LEU . 6.0 t0 . . . . . 0 C--O 1.233 0.233 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -118.34 137.11 53.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 23.3 mmt -81.93 140.44 34.04 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.353 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.427 HG21 HG13 ' A' ' 127' ' ' VAL . 14.2 p -93.94 137.71 22.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.012 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.1 mp -106.48 155.11 19.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.513 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.459 ' HB2' HG22 ' A' ' 43' ' ' THR . 44.2 m-20 -89.42 127.72 35.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.52 -15.0 69.5 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.178 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.22 175.12 29.8 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.66 -12.19 20.27 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.651 2.234 . . . . 0.0 112.719 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.95 145.38 9.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.514 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 64.9 30.7 11.92 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.504 0.321 . . . . 0.0 111.618 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.629 ' HA ' HE21 ' A' ' 80' ' ' GLN . 0.0 OUTLIER -65.78 -9.19 26.18 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.045 0.45 . . . . 0.0 111.314 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.1 -19.99 60.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.303 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -134.77 143.16 46.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 111.413 -171.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.14 122.6 7.28 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.537 ' HB3' HD13 ' A' ' 106' ' ' LEU . 92.9 m-85 -96.97 126.12 41.88 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.631 0.253 . . . . 0.0 110.426 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.474 ' HB ' HG12 ' A' ' 112' ' ' VAL . 3.6 mp -111.35 115.16 49.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.189 0.518 . . . . 0.0 110.479 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.446 HG23 HD11 ' A' ' 106' ' ' LEU . 31.2 t -94.24 124.42 46.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.309 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -139.51 166.84 23.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.882 0.373 . . . . 0.0 111.195 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.3 p -93.16 174.12 7.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.064 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.529 ' HG3' ' OD1' ' A' ' 103' ' ' ASP . 21.7 mmtp -57.6 134.81 56.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 172.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.628 ' OG1' ' HA ' ' A' ' 122' ' ' PRO . 81.9 m -155.05 114.68 3.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.663 173.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.3 t70 59.68 -147.89 0.47 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.993 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -126.65 36.25 4.5 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.86 -0.525 . . . . 0.0 112.378 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 94' ' ' PHE . 40.2 mm-40 -90.52 161.0 15.69 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.348 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 27.0 t80 167.59 102.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.789 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.4 m -121.26 -55.05 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.974 0.416 . . . . 0.0 110.913 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.715 ' HB2' ' HB2' ' A' ' 111' ' ' ASP . 9.6 m-70 -127.08 70.98 1.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.418 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.4 m -128.51 139.51 52.28 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.111 0.482 . . . . 0.0 111.036 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -102.91 133.35 48.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.548 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -76.31 113.49 13.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.111 0.481 . . . . 0.0 111.943 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.54 -53.73 9.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 166.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.757 HG23 ' HB ' ' A' ' 104' ' ' ILE . 6.3 t -142.72 -164.05 1.75 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.442 ' O ' ' HE3' ' A' ' 89' ' ' LYS . 10.5 t70 -67.42 -53.29 30.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.572 0.623 . . . . 0.0 111.272 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.529 ' OD1' ' HG3' ' A' ' 89' ' ' LYS . 91.8 m-20 -84.18 -34.26 24.01 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.757 ' HB ' HG23 ' A' ' 101' ' ' THR . 46.8 mm -81.48 121.64 35.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.097 0.475 . . . . 0.0 110.226 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.14 128.96 50.03 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.749 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.537 HD13 ' HB3' ' A' ' 84' ' ' PHE . 54.8 tp -96.87 112.43 24.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.242 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.596 ' CG2' ' HB3' ' A' ' 111' ' ' ASP . 10.8 m -118.69 128.43 54.5 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -132.91 -29.67 1.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 t -112.37 104.71 12.87 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.459 -0.497 . . . . 0.0 112.024 -172.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.88 -53.4 2.93 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.715 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 15.4 t0 -56.3 -34.48 66.54 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.89 0.476 . . . . 0.0 112.201 -170.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.52 HG21 HD21 ' A' ' 113' ' ' LEU . 3.7 m -59.2 -34.9 55.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.52 HD21 HG21 ' A' ' 112' ' ' VAL . 2.7 mm? -70.64 -27.29 63.94 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.437 0.637 . . . . 0.0 110.24 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.2 -33.54 56.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.288 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.407 ' HB3' ' HD3' ' A' ' 122' ' ' PRO . 20.2 m -60.82 -67.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.967 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.466 ' HA ' ' HB1' ' A' ' 121' ' ' ALA . 8.4 p90 -79.45 140.18 37.43 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.006 0.431 . . . . 0.0 111.055 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.74 -17.71 9.35 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 t -131.89 178.87 6.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -77.66 1.68 19.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -174.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.6 p -99.8 14.55 29.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.451 0.643 . . . . 0.0 110.828 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 116' ' ' PHE . . . -71.52 130.93 86.8 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.473 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.628 ' HA ' ' OG1' ' A' ' 90' ' ' THR . 17.4 Cg_exo -63.95 140.09 71.06 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.542 2.161 . . . . 0.0 111.985 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -55.12 -51.35 66.71 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.152 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.527 ' HB2' ' HE2' ' A' ' 159' ' ' PHE . 67.2 mmtt -128.06 138.22 52.47 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.607 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -154.04 144.33 22.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.492 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 28.8 pt -122.27 144.45 31.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.004 177.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.427 HG13 HG21 ' A' ' 72' ' ' VAL . 7.4 p -119.39 134.29 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.154 0.502 . . . . 0.0 111.197 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 70.2 m -139.11 131.91 29.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.376 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.6 116.77 23.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.188 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.98 -177.33 50.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.388 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 64.1 m -150.41 169.39 21.55 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.168 0.587 . . . . 0.0 109.434 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.6 m -106.88 139.67 40.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.65 0.262 . . . . 0.0 110.502 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.639 HG23 HG13 ' A' ' 37' ' ' ILE . 27.5 p -117.55 114.22 23.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.037 0.446 . . . . 0.0 110.668 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -83.67 156.2 22.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.263 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -58.57 141.47 84.04 Favored Pre-proline 0 C--O 1.237 0.441 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.355 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.97 119.89 7.44 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.746 2.297 . . . . 0.0 112.319 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.468 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 58.4 t60 74.83 -9.19 1.39 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.262 174.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -66.68 -51.01 60.99 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.158 -0.339 . . . . 0.0 111.29 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.45 ' O ' HG13 ' A' ' 143' ' ' ILE . 47.7 tp -54.41 -35.93 63.43 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.468 ' OE2' ' HA ' ' A' ' 137' ' ' HIS . 45.3 mt-10 -57.8 -43.26 85.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.061 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 8.5 mt-30 -72.39 -38.1 68.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.478 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.64 -40.56 97.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.583 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 139' ' ' LEU . 76.1 mt -65.77 -33.01 60.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.249 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.07 64.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.059 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 75.2 mt-30 -75.97 -8.17 56.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.389 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 65.65 30.67 10.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.078 -173.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -87.74 -18.29 29.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.592 0.711 . . . . 0.0 109.477 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -125.62 137.49 53.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.474 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.711 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 58.0 mt -92.37 108.31 19.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.071 0.462 . . . . 0.0 109.9 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.0 tp -91.45 134.05 34.96 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.927 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.0 t -149.7 148.0 28.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.544 ' HG3' ' HD2' ' A' ' 8' ' ' LYS . 1.7 mp0 -85.5 152.62 23.04 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.928 0.394 . . . . 0.0 110.178 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.35 104.15 13.21 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -80.29 77.01 7.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.8 t30 49.97 -83.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.275 0.985 . . . . 0.0 112.889 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.06 -35.58 80.73 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.545 0.212 . . . . 0.0 110.772 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.0 m -58.58 -30.3 67.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.858 0.361 . . . . 0.0 111.385 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 tt -67.0 -50.23 62.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.985 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.618 ' HB2' HD13 ' A' ' 104' ' ' ILE . 2.4 t80 -112.08 -27.67 8.3 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -169.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -105.44 -54.87 2.41 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.493 -176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.468 0.465 0 O-C-N 124.46 1.1 . . . . 0.0 111.863 -172.236 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 168' ' ' VAL . 17.0 t . . . . . 0 CA--C 1.539 0.519 0 CA-C-O 122.429 1.109 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -60.63 -36.3 78.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.48 -178.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.92 -36.16 80.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.049 0.452 . . . . 0.0 111.096 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.404 ' HB3' HG11 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -79.84 -28.36 40.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.739 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.29 -26.38 38.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.361 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -53.94 -33.77 57.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.273 0.559 . . . . 0.0 111.077 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.99 -39.13 14.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.971 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.232 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.139 179.03 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.7 p30 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.452 0.644 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 6' ' ' GLN . 95.8 mt -130.0 -152.12 0.5 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.965 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.448 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 50.8 tt0 67.98 119.25 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.215 0.531 . . . . 0.0 110.792 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.18 19.7 27.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.758 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -134.96 169.79 16.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.494 ' CZ ' ' HG3' ' A' ' 173' ' ' MET . 29.4 p90 -143.85 162.41 36.16 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 175.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 3.3 pt -133.02 128.46 56.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.507 -174.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 4.9 mp -96.24 140.05 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.575 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.32 168.68 19.51 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.827 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 N--CA 1.469 0.477 0 O-C-N 124.136 0.898 . . . . 0.0 113.044 177.295 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.689 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 1.4 mmp_? . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 120.917 0.389 . . . . 0.0 112.023 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.1 p -146.34 158.71 43.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t 68.24 100.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 O-C-N 123.897 0.748 . . . . 0.0 111.13 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.666 HG13 ' HD1' ' A' ' 27' ' ' TYR . 10.6 tp -129.67 -142.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.32 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.666 ' HD1' HG13 ' A' ' 26' ' ' ILE . 37.1 p90 -117.64 174.55 6.1 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.476 1.034 . . . . 0.0 112.259 -165.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -92.98 125.73 45.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.326 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.3 m -73.0 -59.03 2.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.064 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -145.89 164.21 32.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.409 0.623 . . . . 0.0 111.223 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -118.27 118.87 32.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -114.64 -176.87 3.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.326 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -66.51 -28.84 68.88 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.261 0.553 . . . . 0.0 110.438 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.82 9.52 43.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.835 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.09 -143.63 15.34 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.567 -1.302 . . . . 0.0 113.185 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 133' ' ' THR . 12.4 m -123.97 129.11 50.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.499 0.19 . . . . 0.0 110.94 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.701 HG13 HG22 ' A' ' 133' ' ' THR . 3.5 mp -103.74 114.78 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.272 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -145.82 165.72 28.0 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.534 HG22 ' CG2' ' A' ' 26' ' ' ILE . 3.5 m -113.37 68.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.628 0.728 . . . . 0.0 110.787 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.43 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -115.37 15.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.956 -173.498 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.35 -29.38 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.739 0.304 . . . . 0.0 110.737 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 62.99 85.88 0.12 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.093 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.1 t -179.1 123.11 0.24 Allowed Pre-proline 0 C--O 1.235 0.315 0 CA-C-O 121.358 0.599 . . . . 0.0 111.514 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.625 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 71.9 Cg_endo -81.67 155.73 18.33 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.503 2.136 . . . . 0.0 110.733 170.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 p -112.2 161.75 16.22 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.022 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.05 -20.42 63.24 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.467 ' O ' HG13 ' A' ' 72' ' ' VAL . 57.5 tp -67.44 145.07 55.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.609 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 17.9 m -101.06 153.33 19.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.16 -176.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.1 p -69.65 -33.97 59.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.0 mt -73.68 -26.84 60.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.514 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.3 OUTLIER -71.45 -40.24 70.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.091 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.5 pp -74.03 -32.34 63.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.013 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 94.9 mt -65.4 -51.28 61.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.328 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.7 p -67.07 -28.47 68.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.339 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -55.72 -39.52 71.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.158 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 46.2 mtt . . . . . 0 C--N 1.326 -0.413 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.043 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.531 ' CG ' ' HB3' ' A' ' 48' ' ' SER . 25.3 t70 . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -126.86 14.46 7.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.836 -175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.2 mtt 63.06 165.89 0.12 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.626 -174.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.474 HG22 HD21 ' A' ' 129' ' ' LEU . 11.7 p -116.0 144.16 24.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.785 172.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.625 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.2 mp -103.8 158.12 16.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.972 0.415 . . . . 0.0 110.355 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.43 127.44 53.29 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.52 ' HA3' HG13 ' A' ' 39' ' ' VAL . . . -87.79 -10.06 70.4 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.316 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' A' ' 131' ' ' CYS . . . 160.2 176.74 32.62 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.483 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 1.7 Cg_endo -85.41 -2.3 9.25 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.131 2.554 . . . . 0.0 113.322 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.415 HG13 HD21 ' A' ' 79' ' ' ASN . 19.7 t -103.3 128.39 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.785 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.415 HD21 HG13 ' A' ' 78' ' ' VAL . 45.7 m-80 62.59 39.18 11.7 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.111 0.564 . . . . 0.0 111.809 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 77' ' ' PRO . 96.2 mt-30 -68.58 -10.37 55.46 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.201 0.524 . . . . 0.0 110.582 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -71.92 -17.61 62.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.292 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 82' ' ' ARG . 41.2 mtt180 -110.07 129.28 55.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.409 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 108' ' ' THR . . . -90.6 112.97 4.17 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.472 ' HB3' HD11 ' A' ' 106' ' ' LEU . 85.9 m-85 -93.53 125.04 37.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.646 0.223 . . . . 0.0 110.553 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.459 HG22 HG13 ' A' ' 112' ' ' VAL . 4.7 mp -123.34 105.56 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.975 0.417 . . . . 0.0 110.091 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 66.0 t -88.14 122.03 39.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.37 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -133.01 163.44 29.23 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.834 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 122' ' ' PRO . 4.9 m -64.33 158.67 22.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.66 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.74 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 1.5 tmtp? -66.48 118.22 9.8 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.944 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.428 ' HB ' ' OG1' ' A' ' 120' ' ' THR . 1.5 p -126.3 -169.3 1.99 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.456 173.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -116.27 155.92 27.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.245 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 75.53 165.94 0.27 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.644 0.59 . . . . 0.0 110.253 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.523 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 0.3 OUTLIER 69.41 169.29 0.3 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.349 0.66 . . . . 0.0 111.875 -176.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 93' ' ' GLU . 21.3 p90 157.46 117.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 113.98 -1.463 . . . . 0.0 109.307 -173.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.2 m -146.71 -71.19 0.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.394 0.616 . . . . 0.0 109.822 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -120.45 37.39 4.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.0 m -74.26 104.78 5.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.684 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -101.97 118.44 36.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.215 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.495 ' HD3' ' HA ' ' A' ' 102' ' ' ASP . 95.6 mttt -100.0 112.0 24.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.877 0.37 . . . . 0.0 110.814 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.06 -53.67 44.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.1 t -133.26 169.67 16.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 166.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.495 ' HA ' ' HD3' ' A' ' 99' ' ' LYS . 38.7 t70 -61.16 -36.59 80.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 118.872 0.76 . . . . 0.0 111.358 -174.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.74 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 4.1 m-20 -77.26 -7.9 56.71 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.2 mm -121.06 122.37 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.959 0.409 . . . . 0.0 110.027 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 m -121.47 113.74 20.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.422 0.63 . . . . 0.0 111.498 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 84' ' ' PHE . 54.1 tp -94.07 137.7 32.98 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.971 174.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.661 HG21 ' HB3' ' A' ' 111' ' ' ASP . 16.2 m -145.98 137.78 25.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 65.4 p -114.28 12.65 17.7 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.8 p -127.73 -174.73 3.27 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.492 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.36 -7.82 47.75 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.311 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.661 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.5 t70 -50.47 -39.44 48.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.73 . . . . 0.0 110.002 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.543 ' CG2' ' HB ' ' A' ' 107' ' ' THR . 91.7 t -60.63 -49.03 86.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.131 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.89 -35.88 82.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.47 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.09 -46.0 72.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.724 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.2 p -66.93 -37.93 85.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.746 0.308 . . . . 0.0 110.811 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.487 ' CE1' ' HD2' ' A' ' 122' ' ' PRO . 7.0 m-30 -67.56 -24.14 65.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.083 0.468 . . . . 0.0 110.929 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.99 19.86 52.58 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.404 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.569 ' CG2' HG22 ' A' ' 120' ' ' THR . 4.4 t -142.85 -171.04 3.37 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -82.72 13.0 4.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.569 HG22 ' CG2' ' A' ' 118' ' ' THR . 9.8 t -117.49 20.46 13.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.527 0.679 . . . . 0.0 110.538 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 116' ' ' PHE . . . -68.38 115.1 26.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.969 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.487 ' HD2' ' CE1' ' A' ' 116' ' ' PHE . 11.4 Cg_exo -71.87 143.0 40.17 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.904 2.403 . . . . 0.0 112.156 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.79 -47.19 86.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.929 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -102.26 124.43 47.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.237 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 48.7 p90 -152.15 141.97 21.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.323 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.3 pt -127.26 135.51 63.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.45 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.29 125.97 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.141 0.496 . . . . 0.0 110.798 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.6 m -143.08 136.3 28.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.827 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.474 HD21 HG22 ' A' ' 72' ' ' VAL . 4.2 mm? -89.39 124.46 34.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.843 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.94 174.4 17.52 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.398 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.405 ' C ' ' HA3' ' A' ' 76' ' ' GLY . 61.5 m -144.9 169.01 18.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.9 m -105.89 122.51 46.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.669 0.271 . . . . 0.0 110.716 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.701 HG22 HG13 ' A' ' 37' ' ' ILE . 41.3 p -101.71 116.78 33.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.876 0.37 . . . . 0.0 111.172 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.531 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 3.0 t-105 -78.84 156.99 28.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.27 137.38 95.92 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.805 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.66 121.5 9.26 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.216 2.611 . . . . 0.0 112.616 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 75.39 -17.1 0.53 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.357 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 53.8 tp60 -73.91 -30.89 62.83 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.88 -0.512 . . . . 0.0 111.387 -174.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 143' ' ' ILE . 52.4 tp -54.75 -44.71 73.86 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.89 -33.36 75.82 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.994 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.513 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 34.3 tt0 -71.93 -38.37 69.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 11.2 mm-40 -61.21 -42.21 98.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.229 0.538 . . . . 0.0 109.67 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 139' ' ' LEU . 84.8 mt -60.55 -38.18 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.038 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.74 -17.7 64.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 111.662 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 50.1 mt-30 -85.94 -0.72 56.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.467 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 62.84 24.53 14.6 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 123.713 0.805 . . . . 0.0 112.58 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -88.63 -8.02 55.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.292 0.568 . . . . 0.0 109.542 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -135.22 115.09 12.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.13 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.704 HD12 HD22 ' A' ' 174' ' ' LEU . 4.7 tt -84.84 102.51 13.14 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.7 tp -82.92 134.75 35.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.401 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.7 p -150.23 163.92 37.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.8 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.26 154.24 19.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.282 0.563 . . . . 0.0 111.945 -175.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 154' ' ' ASN . . . -92.56 -160.11 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.653 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 153' ' ' ALA . 17.5 m120 70.91 15.23 6.8 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.61 -177.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -96.18 148.57 22.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.46 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.99 -63.0 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.445 ' HB ' ' SD ' ' A' ' 173' ' ' MET . 24.8 m -51.66 -29.16 16.93 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.0 tt -52.36 -49.13 64.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 111.285 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -123.61 -19.78 5.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.988 -173.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -88.17 -9.65 52.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.847 0.356 . . . . 0.0 111.051 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.1 -178.942 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 171' ' ' ASN . 16.1 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.542 0.211 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.625 ' OE2' ' HA ' ' A' ' 23' ' ' ARG . 1.1 pm0 -91.83 -50.18 5.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.017 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.454 ' N ' ' HG2' ' A' ' 169' ' ' GLU . . . -81.23 -48.74 11.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.795 0.331 . . . . 0.0 111.65 -173.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.558 ' HB2' HG21 ' A' ' 168' ' ' VAL . 1.9 m-20 -60.98 -25.43 66.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.123 0.487 . . . . 0.0 111.129 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -71.59 -21.04 61.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.175 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.494 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 68.7 mmm -65.93 -28.22 68.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.058 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.704 HD22 HD12 ' A' ' 149' ' ' LEU . 12.2 tp -95.79 -44.91 7.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.883 179.061 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.499 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 59.4 m-20 . . . . . 0 CA--C 1.517 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.7 mt -136.54 -123.54 0.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.291 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 66.77 119.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.178 0.989 . . . . 0.0 111.814 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.8 5.32 77.97 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.478 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 11.3 mptt -113.24 164.77 13.12 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.43 ' HE1' HD11 ' A' ' 11' ' ' ILE . 36.5 p90 -136.82 159.54 41.54 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.028 0.442 . . . . 0.0 111.062 -176.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.7 pt -128.87 127.89 66.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.248 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.813 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.5 mp -92.99 123.43 45.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.39 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -115.59 101.27 8.71 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.6 m . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 120.929 0.395 . . . . 0.0 111.488 -177.073 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.542 ' HE ' HD21 ' A' ' 73' ' ' LEU . 3.0 tmm_? . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.633 0.73 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.9 t -114.54 143.89 44.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.992 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.81 HG13 HG13 ' A' ' 11' ' ' ILE . 40.2 t 63.55 109.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.809 0.814 . . . . 0.0 112.054 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.842 HG21 HG21 ' A' ' 39' ' ' VAL . 5.6 tp -134.36 -161.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.538 ' HD1' HG13 ' A' ' 26' ' ' ILE . 5.0 p90 -117.56 169.67 9.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.975 0.807 . . . . 0.0 111.876 -164.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.18 112.14 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.187 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.3 m -73.89 -46.23 45.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.093 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.662 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 36.4 tt0 -135.77 144.45 45.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.424 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.499 ' CD2' ' HA ' ' A' ' 4' ' ' ASN . 74.8 t60 -146.35 104.67 3.81 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -122.87 174.86 6.89 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.22 -21.79 66.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.389 0.614 . . . . 0.0 109.826 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -70.27 -31.23 68.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.194 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 160.91 -179.93 36.06 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.308 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.1 m -115.64 127.68 55.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.654 0.264 . . . . 0.0 110.623 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.662 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.2 mp -112.84 115.92 51.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.415 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.32 163.71 26.0 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.842 HG21 HG21 ' A' ' 26' ' ' ILE . 18.3 m -123.84 36.88 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.501 0.667 . . . . 0.0 110.884 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.697 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -84.97 15.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -169.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 pt -64.62 -25.91 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.567 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.1 t-20 64.85 93.11 0.07 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.416 0.447 . . . . 0.0 111.996 176.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 12.4 t 169.48 137.77 0.06 OUTLIER Pre-proline 0 C--O 1.24 0.569 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.184 175.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.877 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 93.0 Cg_endo -85.18 176.88 5.56 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.728 2.285 . . . . 0.0 111.052 170.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 p -116.59 176.34 5.16 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.428 176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -91.12 5.62 48.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.943 0.877 . . . . 0.0 109.566 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 tp -106.66 156.4 18.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.487 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 10.5 m -100.27 151.49 21.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.539 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.7 p -65.54 -33.89 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.8 mt -68.33 -26.62 65.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.621 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 48' ' ' SER . 4.2 mm-40 -63.16 -47.28 83.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.562 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.6 -39.17 88.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.514 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 89.3 mt -64.8 -43.73 92.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.291 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -72.55 -29.09 63.25 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -56.63 -43.45 80.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.046 0.45 . . . . 0.0 110.169 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.8 mtm . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.615 176.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.16 0.505 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -125.55 123.12 38.4 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.609 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.543 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 1.9 mpt? -76.73 157.75 31.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.849 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.98 140.23 18.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.877 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 10.4 mp -104.39 152.26 22.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.876 0.37 . . . . 0.0 110.581 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -85.48 141.99 29.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.589 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.41 -25.39 7.02 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.703 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.83 170.94 30.46 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.974 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.64 -3.17 12.73 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.191 2.594 . . . . 0.0 112.96 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.4 t -102.23 146.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 61.45 42.84 10.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.933 0.397 . . . . 0.0 111.096 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.823 ' HA ' HE21 ' A' ' 80' ' ' GLN . 0.0 OUTLIER -65.06 -10.9 33.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -176.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.28 -12.55 56.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.73 0.3 . . . . 0.0 110.75 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -130.27 128.89 42.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.314 0.578 . . . . 0.0 112.068 -167.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.52 125.34 7.99 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.21 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.551 ' HB3' HD13 ' A' ' 106' ' ' LEU . 64.7 m-85 -99.99 126.15 46.13 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.444 HG12 HG12 ' A' ' 112' ' ' VAL . 3.8 mp -114.57 122.41 68.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.118 0.485 . . . . 0.0 110.989 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -101.59 125.23 55.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.533 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -131.18 160.7 34.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.609 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.1 p -71.55 132.78 45.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.08 0.467 . . . . 0.0 109.948 174.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.624 ' HB3' ' HA ' ' A' ' 103' ' ' ASP . 9.2 tmtt? -67.76 122.65 18.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.465 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.8 t -152.65 -12.93 0.17 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.307 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -83.57 159.69 21.58 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.69 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -148.52 104.89 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 65.95 -179.03 0.19 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.68 0.613 . . . . 0.0 110.634 -175.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 70.11 -61.7 0.45 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.224 0.609 . . . . 0.0 111.348 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.535 HG23 ' HB3' ' A' ' 111' ' ' ASP . 2.0 p -75.11 133.91 41.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.338 0.59 . . . . 0.0 110.77 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -82.36 61.79 5.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.905 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.5 m -85.46 138.39 32.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -100.69 123.32 44.73 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.598 ' HD2' ' HA ' ' A' ' 102' ' ' ASP . 28.8 ttpp -83.68 106.58 15.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.343 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.4 HG12 ' HE2' ' A' ' 27' ' ' TYR . 51.9 t -70.45 -54.01 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.226 0.536 . . . . 0.0 109.87 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -124.84 -54.6 1.63 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.562 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.598 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 14.9 t70 -177.1 -72.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.624 ' HA ' ' HB3' ' A' ' 89' ' ' LYS . 6.7 m-20 -77.27 -3.97 42.51 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.041 0.448 . . . . 0.0 111.396 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.663 HG13 HD13 ' A' ' 158' ' ' LEU . 51.6 mm -106.41 122.55 60.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.66 128.32 43.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.238 0.542 . . . . 0.0 111.624 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.551 HD13 ' HB3' ' A' ' 84' ' ' PHE . 63.3 tp -102.85 121.22 42.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.45 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 111' ' ' ASP . 4.2 m -126.82 134.46 50.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.623 0.249 . . . . 0.0 110.435 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -147.34 3.26 0.77 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.237 0.542 . . . . 0.0 111.392 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.495 ' HB2' ' OD1' ' A' ' 111' ' ' ASP . 14.2 m -85.9 15.05 5.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.332 . . . . 0.0 111.667 -174.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.19 -23.37 35.63 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.53 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 95' ' ' THR . 3.0 m-20 -51.34 -37.65 48.95 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.298 0.639 . . . . 0.0 111.545 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.444 HG12 HG12 ' A' ' 85' ' ' ILE . 60.1 t -47.98 -40.84 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.971 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.533 ' HA ' ' CE2' ' A' ' 116' ' ' PHE . 98.0 mt -62.88 -32.73 74.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.072 0.463 . . . . 0.0 110.933 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.18 -35.87 35.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.54 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.1 m -56.21 -50.34 71.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.811 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 113' ' ' LEU . 40.7 p90 -79.64 11.57 3.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.588 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.92 16.56 13.37 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.855 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 76.7 p -111.63 177.7 4.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.373 . . . . 0.0 110.781 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -83.21 -26.45 30.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.61 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 p -96.88 20.8 10.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.432 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -51.21 136.61 29.62 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.542 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 23.6 Cg_exo -62.16 150.78 85.44 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.028 2.485 . . . . 0.0 112.613 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -59.58 -49.6 77.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.911 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -143.59 146.21 33.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.559 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -152.1 137.52 17.64 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.473 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.13 148.11 16.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.447 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.76 129.45 74.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.191 0.52 . . . . 0.0 110.905 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.431 ' SG ' HG11 ' A' ' 39' ' ' VAL . 5.7 p -126.27 124.75 41.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.398 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 129' ' ' LEU . 1.2 tm? -84.22 119.0 24.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.343 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.81 178.78 27.32 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.539 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.5 m -147.81 171.96 14.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.86 0.362 . . . . 0.0 110.046 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 37.6 m -111.57 121.24 44.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.104 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.8 p -96.76 115.33 27.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.174 0.511 . . . . 0.0 111.364 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -101.35 149.9 23.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.473 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.481 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 1.5 mppt? -86.78 130.28 49.34 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.778 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 7.5 Cg_exo -73.32 44.5 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.538 2.825 . . . . 0.0 114.335 -168.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -154.11 -39.23 0.09 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.369 . . . . 0.0 110.545 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.523 ' HA ' ' OE1' ' A' ' 138' ' ' GLN . 5.5 tp60 -75.79 -30.72 59.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.693 -175.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 143' ' ' ILE . 60.1 tp -57.87 -38.83 76.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.013 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.9 -42.12 97.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.041 0.448 . . . . 0.0 110.526 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.57 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 31.0 mm-40 -68.17 -39.24 82.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.437 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.598 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 14.1 mm-40 -62.03 -43.34 99.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.167 0.508 . . . . 0.0 110.486 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 150' ' ' LEU . 77.1 mt -65.26 -39.4 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.096 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.42 73.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.536 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 67.1 mt-30 -78.76 2.95 18.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.372 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 19.1 m120 67.18 15.51 10.04 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.345 0.658 . . . . 0.0 112.265 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.427 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 57.0 m-85 -79.94 -21.79 43.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.35 0.595 . . . . 0.0 109.769 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.598 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 97.5 m95 -127.29 114.82 18.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.707 175.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.813 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 24.7 mt -86.36 103.09 14.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.529 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.485 ' HB2' HD12 ' A' ' 143' ' ' ILE . 60.3 tp -86.87 132.96 33.67 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.345 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.9 m -156.75 152.44 26.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.176 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.437 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -91.18 153.99 19.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.111 0.481 . . . . 0.0 110.651 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.52 114.25 28.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.62 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.99 68.09 3.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.226 0.536 . . . . 0.0 109.919 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 16.6 m120 65.5 -80.48 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.021 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -60.6 -42.92 97.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.857 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 11.8 m -54.24 -30.45 50.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.663 HD13 HG13 ' A' ' 104' ' ' ILE . 5.5 tt -62.68 -57.59 10.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.285 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -121.45 -23.13 5.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -170.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -100.2 -61.25 1.39 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.474 0.77 0 C-N-CA 124.184 0.994 . . . . 0.0 112.107 -174.012 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 120.844 0.354 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -59.91 -5.13 0.88 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.02 -29.27 70.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.896 0.379 . . . . 0.0 110.526 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -80.32 -24.09 40.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.474 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -59.43 -42.42 91.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.383 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -58.9 -31.68 68.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.158 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.5 tt -81.65 -46.43 14.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.549 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.158 -179.158 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 . . . . . 0 C--O 1.232 0.16 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.3 mt -129.4 -170.41 2.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.341 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 68.09 112.18 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.701 0.625 . . . . 0.0 110.892 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.29 3.58 65.04 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 12.6 mptt -106.22 171.24 7.45 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.412 ' CD1' ' HB1' ' A' ' 153' ' ' ALA . 54.9 p90 -140.43 150.73 44.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.803 0.335 . . . . 0.0 110.443 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 pt -109.14 130.75 61.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.226 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.649 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 2.8 mp -76.99 131.41 34.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.099 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HB1' ' HB ' ' A' ' 24' ' ' THR . . . -57.66 137.26 56.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.973 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.063 179.707 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.197 0.522 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.54 ' HA ' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -75.17 55.84 0.77 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.021 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 p -173.4 113.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.864 HG22 ' HD1' ' A' ' 27' ' ' TYR . 44.2 mm -120.71 -83.97 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.938 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.864 ' HD1' HG22 ' A' ' 26' ' ' ILE . 9.9 p90 -173.31 170.21 4.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.049 0.452 . . . . 0.0 111.15 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 mm -102.52 121.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.955 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.2 m -76.97 -46.37 24.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.439 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -151.07 159.27 44.61 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 79.2 t60 -148.12 138.2 22.63 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -174.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 t30 77.87 164.84 0.23 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.22 0.95 . . . . 0.0 111.547 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 68.52 -71.61 0.11 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.675 0.79 . . . . 0.0 112.145 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -88.41 -26.08 22.34 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.79 -177.19 20.38 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.109 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' A' ' 134' ' ' TRP . 23.8 m -100.0 101.85 13.05 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 37' ' ' ILE . 4.5 mp -95.22 112.0 26.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.41 157.36 27.23 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.005 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 4.3 m -123.53 93.74 2.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.266 0.555 . . . . 0.0 110.295 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.56 8.15 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.156 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 pt -80.92 -27.61 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 24' ' ' THR . 13.5 t30 38.96 85.98 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.237 0.961 . . . . 0.0 112.84 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 6.6 t -143.66 112.2 5.4 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-O 121.252 0.549 . . . . 0.0 109.95 176.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 4.8 Cg_exo -76.97 152.57 31.93 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.213 1.942 . . . . 0.0 111.318 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 p -124.88 163.15 22.85 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.716 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -82.82 1.06 41.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.191 0.52 . . . . 0.0 110.743 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.667 HD21 HD21 ' A' ' 52' ' ' LEU . 54.7 tp -83.36 144.48 29.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.235 173.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.66 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 14.5 m -104.19 145.66 29.89 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.7 p -63.57 -33.36 61.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.548 HD23 HD11 ' A' ' 53' ' ' LEU . 90.3 mt -66.99 -33.06 74.76 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.571 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.66 ' HG3' ' HB2' ' A' ' 48' ' ' SER . 32.8 mt-10 -61.26 -43.34 99.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.242 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.667 HD21 HD21 ' A' ' 47' ' ' LEU . 96.4 mt -67.91 -33.38 74.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.303 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.548 HD11 HD23 ' A' ' 50' ' ' LEU . 94.0 mt -69.67 -42.07 74.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.9 m -62.22 -39.75 93.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.351 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -58.48 -39.89 81.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.383 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.9 mtt . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.123 -178.321 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.536 ' HB3' HD11 ' A' ' 50' ' ' LEU . 1.1 m-20 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 121.405 0.621 . . . . 0.0 111.953 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -152.18 90.88 1.55 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.1 ptm -71.15 140.48 50.57 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.378 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.708 HG21 HD22 ' A' ' 129' ' ' LEU . 11.0 p -108.21 149.79 11.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.621 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.4 mp -94.29 152.88 18.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.404 . . . . 0.0 110.12 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.74 124.93 34.6 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.38 -26.26 21.35 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.851 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.86 164.47 15.09 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.871 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.68 -18.71 22.04 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.473 2.115 . . . . 0.0 112.627 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.407 HG22 ' OG1' ' A' ' 133' ' ' THR . 42.8 t -90.13 133.34 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.232 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 65.77 27.9 11.05 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 110.205 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.42 -17.7 64.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.044 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.59 -10.69 60.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.501 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -125.43 144.49 50.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.055 0.455 . . . . 0.0 110.436 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.31 120.91 7.03 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -98.74 126.55 44.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.749 0.309 . . . . 0.0 110.233 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.438 ' HB ' HG13 ' A' ' 112' ' ' VAL . 3.5 mp -113.07 112.7 41.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.194 0.521 . . . . 0.0 109.987 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.3 t -94.25 114.65 31.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.147 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -116.33 148.93 40.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.53 -174.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 m -82.39 150.25 27.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.974 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.574 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 43.8 tttm -70.16 114.0 7.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.836 0.827 . . . . 0.0 111.551 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.545 HG21 ' HG3' ' A' ' 123' ' ' GLU . 3.2 m -135.28 11.58 3.53 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.641 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -160.13 -173.08 3.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.167 -164.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -158.86 27.23 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.666 173.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -103.58 169.3 8.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.386 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.6 p90 176.74 157.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.038 0.446 . . . . 0.0 111.558 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 p -102.83 -37.72 7.73 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 164.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -168.15 91.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.152 169.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.2 m -100.63 167.42 10.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.51 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.497 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 12.6 t80 -124.57 98.18 5.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 105' ' ' THR . 86.3 tttt -73.27 108.37 6.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 -177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.3 -59.03 3.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.95 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.466 ' C ' ' H ' ' A' ' 103' ' ' ASP . 58.5 p -117.14 -176.33 2.97 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.407 ' HA ' ' CE ' ' A' ' 99' ' ' LYS . 31.0 t70 -82.22 34.2 0.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.821 0.819 . . . . 0.0 109.701 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.574 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 12.9 t0 -158.12 -67.25 0.09 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.437 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.86 121.93 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.673 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 99' ' ' LYS . 24.0 m -134.6 134.17 40.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.956 -173.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 63.6 tp -84.73 132.82 34.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.137 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.519 ' HB ' HG11 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -136.63 143.84 43.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -179.88 21.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.949 0.404 . . . . 0.0 111.32 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.0 t -101.22 8.52 42.53 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.613 -0.679 . . . . 0.0 111.207 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.76 -30.03 6.58 Favored Glycine 0 CA--C 1.509 -0.296 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -45.28 -50.39 11.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.411 -0.894 . . . . 0.0 111.407 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.519 HG11 ' HB ' ' A' ' 107' ' ' THR . 17.5 m -47.81 -45.06 11.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.904 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.19 -30.8 69.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.422 . . . . 0.0 110.789 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -77.99 -33.74 51.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.576 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.0 m -60.66 -62.86 1.55 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.403 -174.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -74.3 -2.77 26.53 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.797 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -96.26 3.67 64.19 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.222 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.4 t -138.89 171.82 13.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -82.26 4.92 21.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.661 0.267 . . . . 0.0 111.49 -175.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 69.2 p -102.97 15.73 28.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.906 0.384 . . . . 0.0 110.816 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -58.17 141.04 82.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.017 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 19.7 Cg_exo -65.16 146.01 85.74 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.763 2.308 . . . . 0.0 111.986 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.545 ' HG3' HG21 ' A' ' 90' ' ' THR . 38.1 mt-10 -65.4 -37.76 87.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.482 -176.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 123' ' ' GLU . 12.1 mtmt -128.41 132.15 48.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.353 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -163.55 147.53 10.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.447 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.1 pt -126.47 143.74 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.979 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.571 HG13 HG22 ' A' ' 72' ' ' VAL . 6.4 p -114.78 129.4 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.054 0.454 . . . . 0.0 110.588 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.8 p -134.73 136.08 42.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.382 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.708 HD22 HG21 ' A' ' 72' ' ' VAL . 4.0 mm? -86.52 120.99 28.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.356 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.76 -179.15 38.35 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.704 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 61.2 m -145.65 167.49 22.98 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.455 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 33.9 m -102.4 122.73 44.86 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 36' ' ' THR . 39.5 p -107.46 120.35 41.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.043 0.449 . . . . 0.0 112.162 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.601 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 1.5 m-90 -96.02 144.75 26.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.316 170.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -65.05 156.02 82.03 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.394 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.1 133.95 40.55 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.144 1.896 . . . . 0.0 110.642 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.449 ' HA ' ' CG ' ' A' ' 140' ' ' GLU . 49.4 m80 63.74 29.5 14.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.242 0.544 . . . . 0.0 111.325 -175.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -106.29 -68.89 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.225 173.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.506 ' O ' HG13 ' A' ' 143' ' ' ILE . 52.4 tp -63.14 -47.06 84.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.784 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.449 ' CG ' ' HA ' ' A' ' 137' ' ' HIS . 10.9 pt-20 -58.44 -34.21 70.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -65.77 -51.17 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.726 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -71.85 -29.85 64.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.36 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.571 HG12 ' HB2' ' A' ' 148' ' ' TRP . 71.5 mt -61.07 -43.59 96.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.44 -30.32 71.1 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 42.1 mt-30 -81.16 5.46 16.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.365 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 71.93 30.97 2.14 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.309 0.643 . . . . 0.0 112.369 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -93.84 -3.82 51.21 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.165 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.571 ' HB2' HG12 ' A' ' 143' ' ' ILE . 96.0 m95 -139.43 160.64 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.268 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.649 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 3.1 tt -113.08 118.62 35.27 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 8' ' ' LYS . 35.5 tp -105.08 148.58 26.66 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.994 0.425 . . . . 0.0 111.707 -175.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.5 t -159.69 166.84 29.74 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -106.24 154.1 21.21 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.983 -178.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.412 ' HB1' ' CD1' ' A' ' 9' ' ' PHE . . . -120.9 151.78 39.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.57 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.41 -61.15 1.78 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.522 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 103' ' ' ASP . 24.8 p-10 -170.8 -59.67 0.02 OUTLIER 'General case' 0 C--O 1.235 0.316 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 45.6 mt-30 -56.94 -41.94 79.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -173.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.44 ' HA ' ' OG1' ' A' ' 161' ' ' THR . 21.4 m -55.56 -32.87 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.37 -51.98 4.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -99.37 -23.34 15.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 39.5 mt-10 -111.83 -25.75 9.29 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -166.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.541 HG21 ' HG3' ' A' ' 169' ' ' GLU . 34.0 m . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -174.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t . . . . . 0 N--CA 1.468 0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.541 ' HG3' HG21 ' A' ' 161' ' ' THR . 0.0 OUTLIER -118.16 -41.19 2.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.842 178.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.77 -43.87 94.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.662 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -76.5 -26.32 55.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 0.0 110.344 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.34 -29.55 66.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.936 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.0 tpt -60.59 -32.65 71.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.116 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.555 HD12 HD23 ' A' ' 149' ' ' LEU . 13.0 tp -77.35 -42.68 35.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.908 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.698 178.878 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 p30 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.236 0.541 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.03 -93.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.205 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 65.15 117.07 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.191 0.52 . . . . 0.0 111.46 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.97 -4.27 74.7 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.391 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.481 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 2.3 mptp? -105.58 163.79 12.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.534 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 48.7 p90 -140.7 149.52 42.3 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.221 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.572 HD11 HG13 ' A' ' 40' ' ' ILE . 16.4 pt -98.17 145.01 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.43 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.706 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 45.1 mm -81.68 95.62 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.489 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -102.94 -44.93 5.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.757 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.47 0.57 0 C-N-CA 123.7 0.8 . . . . 0.0 111.224 -177.026 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.93 0.395 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.6 p -92.48 131.53 37.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.329 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.0 t 74.25 82.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 O-C-N 123.885 0.741 . . . . 0.0 111.28 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.509 ' CG2' ' H ' ' A' ' 27' ' ' TYR . 16.3 mm -107.76 -166.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.534 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 7.2 p90 -114.86 175.18 5.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.521 0.6 . . . . 0.0 111.683 -167.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.9 mm -86.13 112.55 22.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.358 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.9 -55.2 28.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.386 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -144.17 127.48 16.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.868 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -108.89 99.68 8.99 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 158.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -112.31 59.72 0.63 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.896 -166.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t70 63.2 -66.76 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.97 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.46 -39.45 11.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.75 147.57 17.07 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.886 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.631 ' O ' ' HA ' ' A' ' 133' ' ' THR . 26.2 m -133.79 102.73 5.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.468 HG13 HG22 ' A' ' 133' ' ' THR . 4.5 mp -111.02 121.77 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.32 -174.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.46 162.48 29.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.92 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 5.7 m -125.81 91.2 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.27 0.557 . . . . 0.0 110.215 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.572 HG13 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -135.85 16.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.401 HD12 ' HA2' ' A' ' 76' ' ' GLY . 26.9 pt -80.92 -20.89 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.247 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 61.15 47.93 6.75 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 167.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t -146.06 133.98 10.54 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.431 -177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.689 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 61.9 Cg_endo -73.89 165.44 32.14 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.973 2.449 . . . . 0.0 112.366 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 ' ND2' ' A' ' 74' ' ' ASN . 31.1 p -99.54 -166.2 1.32 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.966 0.413 . . . . 0.0 110.034 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.5 12.37 27.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.885 0.85 . . . . 0.0 108.848 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.9 tp -109.86 146.84 34.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.586 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 19.7 m -95.81 149.2 21.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.676 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.4 p -63.9 -30.47 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.297 0.57 . . . . 0.0 109.998 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.19 -26.65 59.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.367 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.0 OUTLIER -68.67 -40.67 80.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.377 -176.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.643 HD23 HD23 ' A' ' 129' ' ' LEU . 3.9 pp -71.78 -30.51 65.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.064 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 88.5 mt -66.3 -48.42 70.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.323 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.0 p -61.0 -30.24 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.195 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -72.62 -52.8 13.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.505 0.193 . . . . 0.0 110.685 -179.404 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -96.38 125.92 41.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.431 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.553 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 66.5 mtt -84.43 149.88 25.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.362 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.586 HG21 HD21 ' A' ' 129' ' ' LEU . 12.7 p -100.58 150.23 5.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.725 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.689 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.0 mp -99.74 164.41 12.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.255 0.55 . . . . 0.0 111.678 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.533 ' ND2' HG23 ' A' ' 45' ' ' THR . 47.9 m-80 -81.84 124.43 29.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.705 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -83.89 -27.6 37.4 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.601 173.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.41 ' HA3' ' C ' ' A' ' 131' ' ' CYS . . . 168.98 175.11 38.11 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -86.51 3.24 6.9 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.948 2.432 . . . . 0.0 112.511 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.403 HG12 HD21 ' A' ' 79' ' ' ASN . 21.9 t -109.06 121.25 61.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.238 -175.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.403 HD21 HG12 ' A' ' 78' ' ' VAL . 54.5 m-80 55.83 56.49 6.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.009 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.443 ' O ' HD13 ' A' ' 129' ' ' LEU . 84.3 mt-30 -70.93 -7.5 46.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.682 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.89 -10.02 58.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.262 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -112.26 131.36 55.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.939 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.41 117.75 5.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.807 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.511 ' HB3' HD11 ' A' ' 106' ' ' LEU . 71.9 m-85 -102.6 126.08 49.55 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.431 HG21 HG22 ' A' ' 112' ' ' VAL . 4.4 mp -119.88 107.77 21.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 0.0 110.544 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.717 HG21 HD12 ' A' ' 106' ' ' LEU . 12.5 t -91.8 120.66 41.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -134.9 158.83 43.25 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.441 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.5 t -76.21 167.86 21.1 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.146 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.606 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER -76.25 114.76 15.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.831 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 122' ' ' PRO . 1.5 p -116.3 -2.94 12.01 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.013 172.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 92' ' ' HIS . 17.1 t70 -175.68 -145.79 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.532 ' H ' ' CG ' ' A' ' 91' ' ' ASP . 37.4 m80 -88.48 -159.68 0.58 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.586 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 4.1 mp0 -76.19 169.93 17.26 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -117.48 -161.0 0.8 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.6 m -59.9 -37.45 79.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.623 0.249 . . . . 0.0 111.566 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -152.79 80.98 1.22 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.141 0.496 . . . . 0.0 110.342 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 75.0 m -133.77 143.89 48.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.479 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -102.21 128.41 48.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.293 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.586 ' HD3' ' HG3' ' A' ' 93' ' ' GLU . 5.1 tptm -90.65 110.36 21.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.9 t -81.3 -71.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.054 0.454 . . . . 0.0 110.461 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 t -130.48 67.07 1.49 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.481 0.658 . . . . 0.0 110.758 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.564 ' O ' ' HE2' ' A' ' 99' ' ' LYS . 28.1 t70 66.78 -69.83 0.12 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.412 176.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.606 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 11.0 t70 -77.74 -55.43 5.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.228 0.537 . . . . 0.0 110.019 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.423 HD11 ' CD1' ' A' ' 159' ' ' PHE . 33.0 mm -64.93 122.78 16.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.452 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.1 m -128.75 131.09 47.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.837 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.717 HD12 HG21 ' A' ' 86' ' ' VAL . 55.4 tp -107.75 112.61 25.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.083 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.5 m -96.6 124.77 40.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.408 HG22 ' CD2' ' A' ' 84' ' ' PHE . 60.2 p -107.36 17.1 23.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.1 m -147.7 -177.19 5.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.741 0.305 . . . . 0.0 111.184 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.44 -3.01 23.66 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.391 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -49.31 -32.8 11.77 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.961 0.905 . . . . 0.0 110.999 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.431 HG22 HG21 ' A' ' 85' ' ' ILE . 10.3 p -54.71 -34.68 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.972 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.73 -37.71 79.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.176 0.512 . . . . 0.0 110.492 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.28 -24.03 63.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.723 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -72.29 -18.29 61.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.213 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -97.01 144.93 26.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 0.0 110.767 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.26 -17.76 21.73 Favored Glycine 0 C--N 1.328 0.124 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.822 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 120' ' ' THR . 2.8 p -92.03 25.78 2.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 74.01 -39.82 0.44 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.607 0.763 . . . . 0.0 111.351 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 118' ' ' THR . 24.9 p -81.17 18.42 1.08 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.46 123.64 67.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.76 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.741 ' HA ' HG21 ' A' ' 90' ' ' THR . 29.7 Cg_endo -64.31 136.26 50.42 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.628 2.219 . . . . 0.0 112.862 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -66.71 -47.65 71.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.136 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -124.39 127.76 48.04 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.178 -174.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -155.9 152.36 28.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.51 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.8 pt -129.45 132.46 66.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.156 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.501 HG12 HG22 ' A' ' 72' ' ' VAL . 6.8 p -112.09 134.59 54.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.193 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 84.0 m -140.24 139.65 35.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.066 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.643 HD23 HD23 ' A' ' 52' ' ' LEU . 4.3 mm? -89.84 118.44 29.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.962 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.403 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 76.47 177.82 44.6 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.057 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.41 ' C ' ' HA3' ' A' ' 76' ' ' GLY . 73.5 m -145.6 171.58 14.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.904 0.383 . . . . 0.0 110.048 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.447 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 19.3 m -100.26 115.59 30.26 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 36' ' ' THR . 44.0 p -108.35 134.74 50.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.774 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.679 ' CD1' ' HB2' ' A' ' 139' ' ' LEU . 1.1 m-90 -119.9 165.02 15.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.302 0.572 . . . . 0.0 110.343 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -91.61 140.73 25.29 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.603 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.36 61.28 4.19 Favored 'Trans proline' 0 N--CA 1.473 0.313 0 C-N-CA 123.269 2.646 . . . . 0.0 113.298 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -167.73 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.59 ' HG3' ' OE2' ' A' ' 142' ' ' GLU . 52.2 tp60 -65.77 -68.36 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.377 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.679 ' HB2' ' CD1' ' A' ' 134' ' ' TRP . 55.8 tp -52.77 -42.02 64.6 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.887 0.375 . . . . 0.0 111.721 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.54 -32.85 71.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.078 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.586 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 25.3 mt-30 -72.31 -45.62 59.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.07 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.703 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 1.1 mp0 -54.42 -41.91 69.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.768 0.318 . . . . 0.0 111.199 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 139' ' ' LEU . 86.3 mt -56.91 -42.61 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.147 0.498 . . . . 0.0 110.538 175.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.46 -20.57 63.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.658 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 38.1 mt-30 -88.82 6.39 39.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.954 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 145' ' ' GLN . 14.0 m120 69.15 13.24 8.65 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.549 0.53 . . . . 0.0 111.233 -178.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -81.6 -21.86 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.714 0.768 . . . . 0.0 109.004 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.703 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 99.3 m95 -133.26 131.18 39.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.861 172.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.706 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 98.8 mt -95.64 155.3 16.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.5 tp -127.61 135.13 49.85 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.776 0.322 . . . . 0.0 111.039 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.1 t -141.04 176.84 8.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.481 ' HG2' ' HG3' ' A' ' 8' ' ' LYS . 33.0 mt-10 -125.69 153.85 43.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.584 0.23 . . . . 0.0 110.882 -175.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.33 124.19 18.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.962 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -89.52 -45.07 9.67 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.103 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -172.65 -60.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.625 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 44.6 mt-30 -53.89 -48.96 69.56 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.347 -172.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.9 m -59.33 -28.35 66.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.855 0.359 . . . . 0.0 111.913 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.22 -53.84 4.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 104' ' ' ILE . 34.5 m-85 -127.15 12.84 7.17 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -170.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 21.2 tt0 -109.83 -50.93 2.93 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.188 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 121.395 0.617 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -80.12 -2.28 43.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.491 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -51.78 -39.58 58.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -172.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -81.03 -37.16 29.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.084 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.16 -38.35 60.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.011 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 14.6 tpt -63.95 -27.8 69.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.277 0.561 . . . . 0.0 110.328 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.48 -35.31 40.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.132 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.405 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.086 -179.404 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 C--O 1.233 0.226 0 CA-C-O 121.162 0.506 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.45 HD11 HG13 ' A' ' 28' ' ' ILE . 97.3 mt -78.56 -92.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.516 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 39.63 84.52 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.563 0.745 . . . . 0.0 112.421 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.61 -9.57 12.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.461 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.417 ' HG3' ' HG3' ' A' ' 152' ' ' GLU . 10.4 mptt -107.19 172.46 6.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -129.29 143.1 50.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.008 0.432 . . . . 0.0 110.269 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 pt -107.03 127.33 62.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.224 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.902 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.3 mp -92.63 107.8 19.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.672 -174.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.609 ' HB3' ' CZ3' ' A' ' 148' ' ' TRP . . . -91.19 -45.36 8.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.705 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.597 -175.031 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.7 p -63.65 83.16 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.748 HG11 ' HB ' ' A' ' 40' ' ' ILE . 51.7 t 62.24 100.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 O-C-N 123.792 0.683 . . . . 0.0 112.136 173.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.63 ' CG2' HG22 ' A' ' 39' ' ' VAL . 11.3 tp -89.58 -141.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.919 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.538 ' HD1' HG13 ' A' ' 26' ' ' ILE . 2.8 p90 -115.75 175.0 5.73 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.718 1.144 . . . . 0.0 112.442 -163.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.45 HG13 HD11 ' A' ' 5' ' ' LEU . 49.8 mm -90.24 120.91 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.823 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.0 m -87.36 -38.21 16.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -171.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.925 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 9.3 tp10 -141.15 155.18 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.84 0.352 . . . . 0.0 110.998 -173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -146.18 104.36 3.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.85 170.09 8.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.317 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -62.76 -22.01 66.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.165 0.507 . . . . 0.0 111.031 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.23 5.61 25.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.108 -173.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.573 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 161.68 161.12 11.48 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.587 -1.292 . . . . 0.0 113.546 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.7 m -108.55 128.72 55.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.925 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.5 mp -106.47 117.69 52.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.746 -173.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.72 165.42 26.85 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.63 HG22 ' CG2' ' A' ' 26' ' ' ILE . 2.5 m -118.74 44.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.518 0.675 . . . . 0.0 110.616 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.748 ' HB ' HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -95.31 19.04 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.071 -175.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.6 tp -76.83 -31.73 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.658 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m120 58.07 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.163 0.585 . . . . 0.0 112.226 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -171.15 107.69 0.4 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 121.539 0.685 . . . . 0.0 110.313 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.582 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 6.5 Cg_exo -74.42 154.03 45.23 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.595 2.197 . . . . 0.0 111.209 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.3 p -127.73 158.43 37.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.884 0.373 . . . . 0.0 111.231 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.58 10.76 2.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.641 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.9 tp -86.09 146.08 26.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.8 t -99.0 149.57 22.85 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.704 0.288 . . . . 0.0 110.687 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.59 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 8.8 p -63.8 -26.02 39.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.25 0.548 . . . . 0.0 109.916 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.38 -27.54 59.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.312 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.25 -31.46 60.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.64 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.2 pp -72.67 -26.08 61.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.149 0.499 . . . . 0.0 109.745 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.547 HD13 HD13 ' A' ' 113' ' ' LEU . 87.8 mt -75.42 -42.56 53.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.886 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.4 p -68.24 -30.93 70.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -73.55 -11.41 60.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.3 mtt . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 172.107 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.994 0.426 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.472 ' HB2' HG11 ' A' ' 49' ' ' VAL . 25.6 mm-40 -94.16 104.07 16.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.914 -178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 87.8 mtp -78.86 142.75 36.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.633 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.59 HG22 HG13 ' A' ' 127' ' ' VAL . 12.6 p -98.96 149.66 5.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.183 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.582 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.8 mp -99.52 158.97 15.37 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.051 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.54 132.92 44.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 175.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.596 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -91.3 -12.52 59.8 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.353 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.23 174.89 30.59 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.098 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.06 -10.26 15.23 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.171 2.581 . . . . 0.0 112.944 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.07 122.55 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.05 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 64.92 46.52 2.86 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.461 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.42 ' O ' HD13 ' A' ' 129' ' ' LEU . 49.7 mt-30 -67.12 -10.3 48.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.98 -3.01 58.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.91 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -113.21 115.95 29.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.954 0.407 . . . . 0.0 110.69 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.84 115.49 4.99 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -96.5 126.17 41.5 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.4 HD11 ' N ' ' A' ' 85' ' ' ILE . 4.6 mp -108.21 103.91 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.002 0.429 . . . . 0.0 109.977 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 106' ' ' LEU . 31.1 t -93.13 124.74 45.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.557 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -135.09 164.61 27.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.864 0.364 . . . . 0.0 111.654 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 124' ' ' LYS . 14.6 m -70.36 160.67 31.86 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.196 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 23.4 tptm -76.72 121.31 23.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.374 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -107.5 -67.04 0.98 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -164.72 -172.1 2.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 171.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.56 93.61 4.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -104.36 -175.9 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.934 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -72.24 97.34 1.97 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.283 -172.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 111' ' ' ASP . 20.9 p -145.01 142.27 29.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.442 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -88.65 80.68 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 172.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.458 ' HB3' HG23 ' A' ' 105' ' ' THR . 15.7 m -116.46 150.93 37.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.233 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -104.83 139.53 39.46 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -101.57 116.0 31.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.76 -53.65 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 167.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.501 HG21 ' HB ' ' A' ' 104' ' ' ILE . 10.2 t -137.6 -166.18 1.9 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 169.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -83.32 -22.27 32.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 118.566 0.621 . . . . 0.0 111.023 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.53 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 28.7 m-20 -101.16 -11.66 19.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.623 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.501 ' HB ' HG21 ' A' ' 101' ' ' THR . 42.1 mm -120.72 122.67 68.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.458 HG23 ' HB3' ' A' ' 97' ' ' SER . 29.7 m -145.77 130.6 18.12 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.787 0.327 . . . . 0.0 111.167 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.681 ' HB3' HG22 ' A' ' 86' ' ' VAL . 1.1 pt? -108.21 132.69 53.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.477 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 50.3 m -96.06 129.36 43.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.105 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 p -107.0 21.13 18.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.031 0.443 . . . . 0.0 111.588 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -147.0 175.15 10.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.328 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.08 -0.0 49.41 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 113.004 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.453 ' HB3' HG21 ' A' ' 95' ' ' THR . 67.9 m-20 -56.22 -33.43 65.35 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.659 0.742 . . . . 0.0 110.514 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 p -52.25 -33.81 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.232 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.547 HD13 HD13 ' A' ' 53' ' ' LEU . 16.9 mt -73.02 -31.82 64.72 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.849 0.357 . . . . 0.0 111.171 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.21 -36.03 82.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.015 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -79.94 -2.93 45.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.213 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.35 146.54 23.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 111.046 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.42 -24.83 30.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.323 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 p -87.57 -175.5 5.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.787 0.327 . . . . 0.0 110.795 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -75.84 -16.46 60.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.284 0.564 . . . . 0.0 109.758 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.6 p -91.89 8.86 35.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.479 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.91 114.45 39.48 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.686 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.09 130.17 19.67 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.806 2.338 . . . . 0.0 111.926 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.45 -36.92 85.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.977 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.492 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 13.5 mmtp -103.65 100.54 10.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.465 -171.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 35.2 p90 -138.29 130.9 29.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.047 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.4 pt -116.84 132.86 65.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 72' ' ' VAL . 7.7 p -115.24 129.22 71.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.263 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 84.8 m -136.63 136.6 39.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.479 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 72' ' ' VAL . 4.2 mm? -90.51 114.36 26.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.653 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.27 173.64 42.18 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.533 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.3 m -147.14 169.97 18.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.795 0.331 . . . . 0.0 110.436 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.8 m -105.11 122.5 46.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.246 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.68 HG22 HG13 ' A' ' 37' ' ' ILE . 30.5 p -100.94 123.63 45.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.402 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -105.63 153.44 21.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.183 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -73.94 138.03 76.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.867 0.365 . . . . 0.0 111.262 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.573 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 36.3 Cg_endo -65.52 136.72 47.66 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.872 2.381 . . . . 0.0 111.69 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.706 ' HA ' ' CD ' ' A' ' 140' ' ' GLU . 81.3 m-70 64.98 13.76 8.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.876 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.6 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 26.7 tt0 -108.21 -54.68 2.47 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 171.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 143' ' ' ILE . 66.3 tp -57.79 -41.17 81.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.718 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.706 ' CD ' ' HA ' ' A' ' 137' ' ' HIS . 7.0 pt-20 -59.1 -38.15 78.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -76.39 -30.78 57.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.71 0.291 . . . . 0.0 110.806 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 9.5 mm-40 -61.51 -41.5 97.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.0 110.035 175.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.564 ' HA ' ' HB2' ' A' ' 148' ' ' TRP . 76.2 mt -58.61 -40.44 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.629 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.44 65.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.895 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -82.44 -1.08 49.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.946 -0.115 . . . . 0.0 111.041 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 71.3 11.58 6.74 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.713 0.633 . . . . 0.0 110.126 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -77.1 -24.65 51.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.927 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.609 ' CZ3' ' HB3' ' A' ' 12' ' ' ALA . 95.3 m95 -130.49 138.98 50.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.018 174.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.902 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 98.3 mt -100.91 157.7 16.53 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.8 tp -129.55 134.37 47.71 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.667 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.1 t -154.47 143.28 20.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.465 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.417 ' HG3' ' HG3' ' A' ' 8' ' ' LYS . 4.6 mp0 -73.13 154.63 40.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.44 -26.78 24.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.998 0.427 . . . . 0.0 110.509 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.4 m120 55.59 21.92 4.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.009 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 70.59 -51.47 0.67 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.435 0.694 . . . . 0.0 111.815 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.436 ' HA ' ' CB ' ' A' ' 160' ' ' GLU . 36.2 mt-30 -64.14 -50.02 69.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.098 -173.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.7 m -61.84 -29.45 70.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.109 0.48 . . . . 0.0 110.69 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.38 -57.76 3.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.907 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -120.99 -38.18 2.86 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 26.3 tt0 -56.87 -58.23 9.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.775 0.321 . . . . 0.0 111.238 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 CA--C 1.535 0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.924 -173.155 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.638 0.733 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.74 -37.34 7.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.071 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.73 -47.0 83.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.492 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -71.95 -30.9 65.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.791 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 175' ' ' GLY . 31.8 tt0 -68.07 -31.56 71.28 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.683 0.278 . . . . 0.0 110.714 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.826 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 20.1 mmt -58.73 -28.68 66.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.977 0.418 . . . . 0.0 110.858 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.4 tp -96.74 -57.73 2.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.696 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 172' ' ' GLU . . . . . . . . 0 N--CA 1.443 -0.85 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 31' ' ' HIS . 54.7 t30 . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.3 mt -123.89 -83.29 0.65 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.588 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 63.76 152.51 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.776 0.798 . . . . 0.0 111.713 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.37 23.71 70.29 Favored Glycine 0 C--N 1.316 -0.558 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.907 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.548 ' HZ2' ' HG3' ' A' ' 152' ' ' GLU . 71.0 mmtt -110.75 164.83 12.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -144.13 153.24 41.94 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.537 ' O ' HG21 ' A' ' 25' ' ' VAL . 4.5 pt -117.72 127.03 75.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.046 0.451 . . . . 0.0 111.098 -176.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.692 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 53.8 mt -94.41 112.95 28.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.287 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -158.7 124.1 4.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.318 172.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--N 1.32 -0.693 0 CA-C-O 121.108 0.48 . . . . 0.0 110.898 -177.65 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.455 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . 32.9 mmt180 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 121.503 0.668 . . . . 0.0 111.756 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . 32.0 p -96.61 89.96 5.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.498 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.727 HG12 HD22 ' A' ' 42' ' ' ASN . 1.9 m 62.51 174.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.427 1.091 . . . . 0.0 111.911 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.509 ' CG2' HG22 ' A' ' 39' ' ' VAL . 11.1 tp -156.22 -142.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.474 ' H ' HG13 ' A' ' 26' ' ' ILE . 1.1 p90 -109.49 170.08 8.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 119.552 1.069 . . . . 0.0 112.277 -163.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.83 126.87 49.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.617 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 55.6 m -78.49 -59.28 2.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.39 159.89 33.96 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.454 0.645 . . . . 0.0 111.742 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 49.0 t-80 -144.13 142.0 30.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.355 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 33' ' ' ASP . 3.6 t-20 83.88 177.98 0.05 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.553 1.158 . . . . 0.0 109.091 -177.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.459 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 33.3 t70 68.24 -76.2 0.06 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.22 0.608 . . . . 0.0 110.893 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' HD13 ' A' ' 37' ' ' ILE . 8.4 t30 -93.18 -34.44 13.61 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.49 -110.11 0.44 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.181 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 133' ' ' THR . 11.0 m -136.32 105.25 5.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.568 HG13 HG21 ' A' ' 133' ' ' THR . 4.1 mp -98.97 112.02 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.444 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.67 170.22 31.16 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.509 HG22 ' CG2' ' A' ' 26' ' ' ILE . 2.8 m -120.58 76.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.649 0.737 . . . . 0.0 111.004 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.436 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -121.9 20.91 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 -176.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.1 tp -73.05 -24.11 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.033 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.727 HD22 HG12 ' A' ' 25' ' ' VAL . 86.6 m-20 53.63 82.87 0.08 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.274 0.63 . . . . 0.0 112.299 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.414 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 6.5 t -172.81 113.45 0.36 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.433 0.635 . . . . 0.0 110.881 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 50.9 Cg_endo -71.94 153.92 58.17 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.078 1.852 . . . . 0.0 110.482 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 74' ' ' ASN . 11.2 p -96.65 169.93 9.55 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.773 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.33 5.88 11.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.91 161.31 17.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 57.6 p -116.4 160.89 19.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.337 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 12.5 p -67.72 -32.89 58.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.966 0.412 . . . . 0.0 110.361 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.538 HD21 HD12 ' A' ' 53' ' ' LEU . 59.6 mt -73.82 -32.02 63.52 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.993 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -57.46 -53.33 59.38 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.15 -43.83 70.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.237 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.538 HD12 HD21 ' A' ' 50' ' ' LEU . 80.9 mt -62.3 -45.56 92.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.267 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.8 p -73.47 -32.88 64.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.056 0.455 . . . . 0.0 111.314 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -67.74 -34.65 77.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.944 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 47.3 mtt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.203 178.769 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.404 ' HA ' HD13 ' A' ' 50' ' ' LEU . 6.4 p-10 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.266 0.555 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -99.85 129.66 45.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.665 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 91.5 mtp -75.85 136.12 40.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.236 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.456 HG21 HD22 ' A' ' 129' ' ' LEU . 14.0 p -88.98 141.48 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 7.4 mp -95.98 161.56 13.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.235 0.541 . . . . 0.0 111.099 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.4 ' HB2' HG22 ' A' ' 45' ' ' THR . 2.0 t-20 -92.37 132.71 36.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.941 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -88.22 -25.37 31.45 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.263 -0.97 . . . . 0.0 111.908 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.42 176.72 27.04 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.93 -17.84 22.12 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.971 2.447 . . . . 0.0 112.67 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.9 t -98.7 143.95 12.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.045 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 m120 62.95 31.76 15.99 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.975 0.51 . . . . 0.0 112.052 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -71.56 -10.12 59.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -80.7 -0.12 36.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.349 . . . . 0.0 110.262 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -122.49 133.77 54.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.607 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.23 110.42 3.63 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.504 ' HB3' HD13 ' A' ' 106' ' ' LEU . 93.7 m-85 -92.35 124.85 36.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.694 0.283 . . . . 0.0 110.322 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.513 HD11 HG23 ' A' ' 112' ' ' VAL . 2.7 mp -121.56 112.63 36.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.409 0.623 . . . . 0.0 110.224 177.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 66.0 t -90.74 110.96 22.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.198 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -137.28 165.01 27.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.704 0.287 . . . . 0.0 111.569 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.7 p -81.75 159.46 23.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.004 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -87.47 140.73 29.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.931 0.396 . . . . 0.0 110.144 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -95.06 -170.71 2.25 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.431 ' H ' HG23 ' A' ' 90' ' ' THR . 6.7 p-10 -64.2 -35.09 79.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.157 0.503 . . . . 0.0 110.118 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -83.4 163.54 20.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.684 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.44 -172.38 4.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.08 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -132.14 162.72 30.18 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.8 m -80.96 -47.0 14.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.876 0.37 . . . . 0.0 110.515 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.456 ' O ' HG23 ' A' ' 107' ' ' THR . 7.7 t60 -145.28 97.29 2.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.692 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.7 m -135.56 152.72 51.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.044 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -101.66 114.39 28.4 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 102' ' ' ASP . 88.3 tttt -78.14 102.33 7.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 0.0 110.727 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -86.11 -53.83 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.57 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.485 ' HG1' ' HB ' ' A' ' 104' ' ' ILE . 36.8 p -116.01 176.67 4.99 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.507 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 4.8 t70 -86.32 52.32 2.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.264 0.554 . . . . 0.0 110.289 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.489 ' HB3' HD22 ' A' ' 155' ' ' ASN . 28.6 t70 177.65 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.891 178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.485 ' HB ' ' HG1' ' A' ' 101' ' ' THR . 48.1 mm -90.3 124.38 42.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.123 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.36 139.14 53.82 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.443 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' A' ' 84' ' ' PHE . 65.5 tp -101.12 112.41 24.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.274 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.459 ' HB ' HG22 ' A' ' 112' ' ' VAL . 18.8 m -99.93 130.33 46.09 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.238 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -114.18 10.88 17.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.074 -174.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.0 m -132.19 -177.46 4.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.254 . . . . 0.0 110.926 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.438 ' HA2' HD22 ' A' ' 113' ' ' LEU . . . -70.7 4.85 8.48 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.688 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.43 ' HB3' HG22 ' A' ' 107' ' ' THR . 17.4 t0 -61.13 -29.54 69.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.331 0.586 . . . . 0.0 109.451 174.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.513 HG23 HD11 ' A' ' 85' ' ' ILE . 47.0 t -57.48 -39.42 68.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.732 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.5 HD12 ' CZ ' ' A' ' 116' ' ' PHE . 4.1 mm? -61.6 -32.51 72.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.594 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -81.87 -32.89 30.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.952 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 47.4 m -57.99 -51.93 67.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.415 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.5 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 10.7 p90 -92.73 8.89 37.35 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.746 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -104.81 37.02 4.01 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.62 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 t -151.47 165.46 34.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -67.81 -22.58 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.133 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 p -104.71 42.3 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.246 0.546 . . . . 0.0 110.832 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.484 ' CB ' ' HA ' ' A' ' 116' ' ' PHE . . . -64.19 140.58 97.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.093 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 12.2 Cg_exo -68.95 124.04 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.337 2.025 . . . . 0.0 111.025 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.66 -28.35 58.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.743 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -105.88 105.36 15.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.061 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 46.4 p90 -157.24 146.3 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.159 0.504 . . . . 0.0 111.587 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.7 142.83 39.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.566 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.18 131.7 66.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.903 0.382 . . . . 0.0 111.11 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 77.6 m -142.98 141.1 31.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.414 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 72' ' ' VAL . 4.1 mm? -94.02 119.25 32.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.255 177.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.497 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 78.35 -179.86 51.52 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.476 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.4 m -147.99 169.31 20.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.906 0.384 . . . . 0.0 110.005 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.817 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 30.2 m -106.85 126.96 52.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.779 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 36' ' ' THR . 39.4 p -114.49 119.69 37.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.425 0.631 . . . . 0.0 112.136 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.817 ' HZ3' ' HB3' ' A' ' 132' ' ' SER . 1.3 m-90 -99.94 136.27 40.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.025 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -83.23 147.54 53.84 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.315 -175.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.48 ' O ' ' HB3' ' A' ' 137' ' ' HIS . 21.6 Cg_exo -66.55 73.82 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.656 2.904 . . . . 0.0 112.736 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.48 ' HB3' ' O ' ' A' ' 136' ' ' PRO . 17.4 p-80 167.17 -23.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.652 1.181 . . . . 0.0 108.083 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.572 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 63.0 tt0 -84.68 -67.35 0.8 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.51 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 134' ' ' TRP . 51.2 tp -60.52 -44.88 95.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.114 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -61.18 -42.13 98.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.741 -0.208 . . . . 0.0 111.429 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.6 mp0 -68.44 -35.58 77.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.636 0.255 . . . . 0.0 110.676 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 8.6 mm-40 -64.01 -46.51 84.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.268 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 148' ' ' TRP . 68.6 mt -62.07 -41.17 90.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.581 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.52 81.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.459 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 40.6 mt-30 -82.46 7.11 15.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 67.03 37.14 3.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.834 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -83.98 -48.15 10.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.134 0.492 . . . . 0.0 109.893 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.605 ' HB2' HG12 ' A' ' 143' ' ' ILE . 96.7 m95 -107.37 130.18 54.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.486 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.692 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.9 tt -91.21 103.3 15.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 8' ' ' LYS . 55.2 tp -82.66 133.68 35.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.022 0.439 . . . . 0.0 111.198 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.8 m -145.32 172.89 12.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.126 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.548 ' HG3' ' HZ2' ' A' ' 8' ' ' LYS . 5.2 mp0 -96.65 153.44 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.234 0.54 . . . . 0.0 111.791 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -119.72 108.49 14.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.125 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -79.94 49.39 1.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -170.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.489 HD22 ' HB3' ' A' ' 103' ' ' ASP . 0.2 OUTLIER 64.7 -74.22 0.05 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.491 0.716 . . . . 0.0 111.361 175.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -61.47 -25.53 67.3 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.702 0.401 . . . . 0.0 111.132 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.897 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 13.6 m -52.73 -29.66 28.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.028 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.471 HD12 HG21 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -63.12 -44.03 96.76 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -175.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.67 -3.15 2.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -117.64 -37.25 3.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.897 ' HB ' ' HA ' ' A' ' 157' ' ' THR . 9.7 m . . . . . 0 C--N 1.324 -0.5 0 O-C-N 122.404 -0.185 . . . . 0.0 110.893 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.23 0.067 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -49.24 76.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.082 -170.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.49 83.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.045 0.45 . . . . 0.0 111.257 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -68.53 -37.54 80.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.305 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -64.02 -28.33 69.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.563 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -55.89 -34.57 65.64 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 110.271 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.0 tp -102.0 -55.09 2.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.157 0.503 . . . . 0.0 110.29 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.985 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.349 -175.896 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 121.591 0.71 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.452 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 96.8 mt -86.16 -10.99 53.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.128 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -65.98 127.27 31.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.959 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.24 0.84 79.72 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.615 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -115.22 -177.33 3.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.637 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 44.1 p90 -151.24 161.68 42.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 16.6 pt -121.32 129.19 75.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.519 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.731 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.6 mp -75.22 107.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.286 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.422 ' H ' HG23 ' A' ' 25' ' ' VAL . . . -79.43 101.05 7.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.8 m . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.31 179.691 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 . . . . . 0 C--O 1.234 0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.7 t -118.72 117.42 28.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.503 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.681 HG11 HG22 ' A' ' 40' ' ' ILE . 59.3 t 69.19 153.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.151 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.489 HG13 ' HD1' ' A' ' 27' ' ' TYR . 7.0 tp -136.68 -57.42 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.025 173.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.637 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 6.0 p90 -177.73 175.3 1.37 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 111.639 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 5' ' ' LEU . 50.3 mm -103.86 127.66 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.613 176.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.5 m -81.33 -53.31 6.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.723 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.51 160.82 36.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.512 0.672 . . . . 0.0 112.315 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' A' ' 32' ' ' ASN . 84.3 t60 -164.12 136.23 4.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.58 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 21.7 t-20 86.68 -38.96 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.229 0.956 . . . . 0.0 110.513 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 30.1 t70 -73.74 97.02 2.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 33' ' ' ASP . 28.9 t-20 76.33 -38.99 0.34 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.883 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.03 -141.76 5.73 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.552 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.2 m -125.03 112.75 16.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.066 0.433 . . . . 0.0 110.125 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 37' ' ' ILE . 4.0 mp -110.96 121.15 63.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.07 171.8 31.4 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.057 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.82 91.86 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.555 0.693 . . . . 0.0 110.423 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.681 HG22 HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -136.4 18.41 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.066 -175.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 tp -64.52 -29.7 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.183 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 58.98 82.47 0.14 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.114 0.483 . . . . 0.0 111.801 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 t -175.82 121.54 0.32 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.525 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 65.0 Cg_endo -78.59 153.66 26.82 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.313 2.009 . . . . 0.0 110.735 171.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.1 p -101.59 177.96 4.77 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.065 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -81.56 -17.36 48.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.19 0.519 . . . . 0.0 110.345 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.5 tp -80.28 150.66 29.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.443 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 34.9 t -103.51 151.35 22.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.073 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 14.1 p -65.8 -30.09 48.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.303 0.573 . . . . 0.0 109.692 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.0 mt -74.1 -26.76 60.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.023 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 48' ' ' SER . 5.8 mm-40 -69.83 -44.13 70.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.155 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.3 pp -68.9 -34.26 75.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.706 0.289 . . . . 0.0 110.724 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.81 -48.85 72.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.34 . . . . 0.0 110.75 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.0 p -69.2 -30.15 68.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.061 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.4 tpt85 -62.51 -30.74 71.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.556 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 81.0 mtp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.556 176.368 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 t0 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -103.25 115.42 30.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.183 0.516 . . . . 0.0 110.773 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 55.2 mtt -83.26 125.5 31.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.79 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.425 HG21 HD21 ' A' ' 129' ' ' LEU . 14.9 p -69.7 144.31 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.832 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.525 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.7 mp -96.71 157.68 15.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.997 0.427 . . . . 0.0 110.606 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.42 146.78 26.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.398 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -103.84 -27.07 6.47 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.758 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.87 167.66 17.66 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.696 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.25 -17.97 44.85 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 123.058 2.505 . . . . 0.0 113.143 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.442 HG23 ' OG1' ' A' ' 133' ' ' THR . 48.9 t -94.73 132.13 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.813 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 63.36 31.25 15.31 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.593 0.558 . . . . 0.0 110.852 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -12.18 61.44 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.105 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -79.02 -7.98 58.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -127.36 138.63 53.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.044 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.93 132.0 10.89 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.499 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.498 ' HB3' HD11 ' A' ' 106' ' ' LEU . 82.1 m-85 -106.79 126.11 51.87 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.532 ' HB ' HG22 ' A' ' 112' ' ' VAL . 2.6 mp -119.59 106.28 18.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.394 0.616 . . . . 0.0 110.925 -176.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.652 HG22 HD12 ' A' ' 106' ' ' LEU . 12.1 t -91.57 138.03 20.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.403 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.407 ' HE1' ' OG1' ' A' ' 107' ' ' THR . 52.6 p-80 -149.89 156.34 41.6 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.672 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.5 m -76.09 170.86 15.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.707 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -78.26 116.82 18.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.31 0.576 . . . . 0.0 110.977 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.6 m -140.27 -44.99 0.42 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -95.95 165.82 12.08 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -117.22 14.61 14.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.583 0.706 . . . . 0.0 109.997 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -100.64 163.33 12.39 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.789 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.2 p90 176.18 127.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.254 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 m -97.97 -49.96 4.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.187 0.518 . . . . 0.0 109.806 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.446 ' HB2' ' OG ' ' A' ' 109' ' ' SER . 12.7 m-70 -135.6 102.18 5.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.534 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.1 p -135.94 152.95 51.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.969 -177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -109.6 136.58 48.74 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 170.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -90.1 105.49 17.84 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.0 t -79.16 -55.49 9.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.7 p -132.59 -175.89 3.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.583 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -73.95 -13.81 60.94 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.898 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -105.56 -58.68 1.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.302 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.79 HD11 ' HD2' ' A' ' 159' ' ' PHE . 42.1 mm -67.96 122.79 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.117 0.484 . . . . 0.0 110.414 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 m -127.2 124.57 39.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.317 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.652 HD12 HG22 ' A' ' 86' ' ' VAL . 25.8 tp -96.0 115.55 27.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.547 174.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.831 HG22 ' HB2' ' A' ' 111' ' ' ASP . 42.1 m -117.64 126.91 53.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.481 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.6 p -96.8 -10.58 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.487 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.446 ' OG ' ' HB2' ' A' ' 96' ' ' HIS . 38.9 m -95.27 179.62 5.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.636 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.21 5.37 34.83 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.903 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.831 ' HB2' HG22 ' A' ' 107' ' ' THR . 25.7 m-20 -54.88 -40.45 69.75 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.574 ' CG2' ' HB ' ' A' ' 107' ' ' THR . 22.6 t -57.58 -48.98 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.805 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.28 -34.99 75.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.714 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -59.08 -46.66 87.71 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.749 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.4 m -66.2 -44.54 83.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.137 0.494 . . . . 0.0 110.873 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -68.42 -24.18 64.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.428 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -91.31 6.72 80.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.592 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 119' ' ' GLN . 22.1 p -128.85 -162.58 1.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.95 0.375 . . . . 0.0 111.331 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.423 ' H ' ' HB ' ' A' ' 118' ' ' THR . 20.5 mt-30 -80.89 0.51 34.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 111.603 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 p -113.83 25.68 10.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.085 0.469 . . . . 0.0 111.331 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.26 124.09 76.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.162 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -82.19 129.29 5.95 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.41 2.74 . . . . 0.0 111.958 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.54 -35.16 78.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.649 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -104.33 109.02 20.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.903 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 24.6 p90 -153.05 144.09 23.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.808 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.54 HG12 ' HZ ' ' A' ' 159' ' ' PHE . 30.4 pt -136.56 147.67 27.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.183 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.444 HG21 HG13 ' A' ' 85' ' ' ILE . 7.7 p -128.26 131.34 69.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.016 0.436 . . . . 0.0 110.789 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 26.6 p -133.31 144.03 49.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.399 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.425 HD21 HG21 ' A' ' 72' ' ' VAL . 3.8 mm? -92.05 110.56 21.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.465 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 83.91 -179.18 52.13 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.777 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.1 m -147.73 169.55 19.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.349 . . . . 0.0 110.101 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.573 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 38.9 m -108.02 125.4 51.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.055 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.442 ' OG1' HG23 ' A' ' 78' ' ' VAL . 18.1 p -107.66 127.37 53.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.217 0.532 . . . . 0.0 111.565 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.573 ' HZ3' ' HB3' ' A' ' 132' ' ' SER . 1.0 OUTLIER -115.43 150.6 36.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.246 175.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -74.17 151.49 88.07 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.054 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.19 129.55 34.83 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.652 2.235 . . . . 0.0 111.867 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 72.2 -6.09 1.61 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.521 0.729 . . . . 0.0 112.299 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -73.29 -57.53 3.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.936 0.398 . . . . 0.0 110.296 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.494 ' O ' HG13 ' A' ' 143' ' ' ILE . 44.3 tp -64.0 -34.52 78.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.198 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.48 -40.89 83.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.368 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.0 OUTLIER -65.11 -48.1 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.295 177.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -57.43 -40.14 77.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.312 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 139' ' ' LEU . 80.5 mt -62.28 -44.13 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 0.0 110.449 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.91 73.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.007 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 84.3 mt-30 -79.47 6.2 10.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.179 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 65.14 25.31 12.44 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.113 0.565 . . . . 0.0 112.239 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -84.17 -17.8 38.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.13 0.49 . . . . 0.0 109.963 173.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -135.52 137.5 42.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.22 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.731 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 87.2 mt -94.6 138.05 32.96 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.9 tp -111.51 136.72 50.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.418 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.9 t -156.2 160.68 40.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.274 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -87.37 154.01 21.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.903 0.383 . . . . 0.0 110.439 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.07 -36.5 3.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.836 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 58.3 t30 49.67 -97.9 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.528 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -140.18 -17.52 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.725 0.298 . . . . 0.0 110.539 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.643 ' HA ' ' HB3' ' A' ' 160' ' ' GLU . 2.1 mt-30 -73.62 -72.67 0.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.199 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.3 m -58.15 -29.26 65.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.027 0.441 . . . . 0.0 110.856 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -58.18 7.85 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.106 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.79 ' HD2' HD11 ' A' ' 104' ' ' ILE . 14.3 m-85 -135.05 -39.3 0.77 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.643 ' HB3' ' HA ' ' A' ' 156' ' ' GLN . 21.4 tt0 -62.7 -25.69 68.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.853 -170.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 120.648 0.261 . . . . 0.0 110.394 177.689 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.001 0.429 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.05 -11.64 60.63 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.101 0.477 . . . . 0.0 110.104 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.568 ' HB1' ' HE2' ' A' ' 9' ' ' PHE . . . -56.91 -45.94 82.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.554 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -81.34 -27.11 35.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.033 0.444 . . . . 0.0 110.175 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.38 -30.88 71.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.445 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 88.1 mmm -62.37 -28.65 69.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.934 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.61 -49.34 5.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.261 0.553 . . . . 0.0 110.369 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.026 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -176.085 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 94.0 m-20 . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 4' ' ' ASN . 81.8 mt 73.58 13.73 4.39 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 175.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -69.33 134.81 49.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 172.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.31 32.21 65.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.313 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -126.21 -177.89 4.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.645 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 4.3 p90 -149.55 148.92 29.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.023 0.44 . . . . 0.0 111.082 170.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.518 HG12 HD12 ' A' ' 28' ' ' ILE . 10.2 pt -118.96 128.86 75.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.344 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.656 HD13 HD21 ' A' ' 149' ' ' LEU . 4.3 mp -98.35 136.84 27.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.537 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.5 -174.5 4.25 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.0 m . . . . . 0 CA--C 1.536 0.423 0 CA-C-O 121.497 0.665 . . . . 0.0 111.685 177.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.429 ' CZ ' HD11 ' A' ' 73' ' ' LEU . 49.2 mtm180 . . . . . 0 C--O 1.233 0.217 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -82.1 108.5 15.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.017 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.0 t 74.3 133.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.22 0.608 . . . . 0.0 111.886 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.3 tp -135.0 -65.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.645 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -177.61 177.43 1.14 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.606 0.639 . . . . 0.0 111.781 -177.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.518 HD12 HG12 ' A' ' 10' ' ' ILE . 34.0 mm -103.22 133.64 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.288 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.9 m -81.23 -59.54 2.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.371 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -165.09 157.52 15.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.185 0.517 . . . . 0.0 111.26 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 4' ' ' ASN . 11.8 t-80 -103.3 132.01 49.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.245 174.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -129.12 172.0 11.85 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.6 -36.5 78.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.931 0.396 . . . . 0.0 111.035 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -72.42 -22.83 61.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.135 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.544 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 156.01 -177.77 32.9 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.131 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 m -97.76 121.6 39.86 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.688 HG13 HG23 ' A' ' 133' ' ' THR . 4.3 mp -88.54 117.45 32.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.253 -175.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.07 151.02 22.68 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.195 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 m -116.67 93.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.512 0.672 . . . . 0.0 110.764 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.95 13.3 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.294 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 pt -79.71 -26.91 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.569 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.4 t30 59.07 91.93 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.76 0.663 . . . . 0.0 112.13 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 43' ' ' THR . 9.2 t -156.72 93.63 2.36 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 122.06 0.933 . . . . 0.0 110.941 175.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.447 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 93.9 Cg_endo -81.96 157.49 18.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.665 2.243 . . . . 0.0 111.697 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.8 p -121.6 156.72 32.35 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -12.26 60.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.934 0.397 . . . . 0.0 110.692 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.7 tp -71.36 144.51 49.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.602 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.788 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 59.5 m -105.65 157.6 17.3 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.458 -174.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.89 -34.15 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.925 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.82 -36.78 85.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.936 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.788 ' HG2' ' HB2' ' A' ' 48' ' ' SER . 26.9 mm-40 -58.68 -45.87 88.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.775 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.76 -42.34 97.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.854 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.77 -41.66 91.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.323 -178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.4 p -71.9 -31.17 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.437 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -63.32 -36.5 83.9 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.813 0.34 . . . . 0.0 110.254 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 C--N 1.329 -0.318 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.057 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -126.86 113.24 16.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.937 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.597 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.8 mtt -82.0 148.64 28.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.235 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -96.7 147.76 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.134 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.6 mp -108.46 155.09 20.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.987 0.422 . . . . 0.0 110.554 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -94.32 121.13 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.72 -23.14 43.57 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.742 -173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.519 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 153.87 174.56 24.18 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.033 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.61 -21.56 14.63 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.767 2.312 . . . . 0.0 113.085 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.9 t -81.4 131.19 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 60.31 30.89 20.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.127 0.489 . . . . 0.0 110.155 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -59.15 -27.75 65.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.208 -173.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.67 -7.61 56.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.909 0.385 . . . . 0.0 111.224 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.6 mtm-85 -118.14 131.69 56.39 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.126 0.489 . . . . 0.0 111.142 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.56 118.3 5.08 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.358 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' A' ' 106' ' ' LEU . 85.9 m-85 -91.99 125.88 36.85 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.506 0.194 . . . . 0.0 110.494 -178.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.541 ' HB ' HG12 ' A' ' 112' ' ' VAL . 4.3 mp -112.94 110.62 32.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.182 0.515 . . . . 0.0 109.646 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 40.6 t -91.86 119.15 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.399 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -129.51 152.38 49.1 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.427 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -62.88 156.36 24.45 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.516 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -74.58 117.94 16.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.532 0.682 . . . . 0.0 110.218 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.6 m -140.41 157.64 45.22 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -64.85 124.71 22.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.688 0.756 . . . . 0.0 110.934 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -173.36 138.61 0.72 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.646 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.35 160.99 14.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -106.06 113.16 26.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.603 0.716 . . . . 0.0 111.67 -173.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.3 m -83.13 -45.09 14.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.477 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.98 37.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -77.66 125.02 28.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.926 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -105.46 136.08 45.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.446 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -86.59 128.85 35.02 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.781 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 72.0 t -70.39 -54.86 16.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -134.79 -48.53 0.75 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.96 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -176.38 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.951 169.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.42 -13.03 60.37 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.101 0.477 . . . . 0.0 111.245 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 100' ' ' VAL . 24.8 mm -105.06 124.24 59.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.0 m -117.36 130.41 56.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.1 0.476 . . . . 0.0 111.538 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 84' ' ' PHE . 67.1 tp -107.79 128.15 54.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.23 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 1.076 HG23 ' HB3' ' A' ' 111' ' ' ASP . 12.1 m -142.58 137.32 30.01 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.129 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 p -120.47 3.21 10.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.391 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 112' ' ' VAL . 15.2 m -109.61 -173.55 2.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.403 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.69 -15.61 13.21 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.907 -0.588 . . . . 0.0 114.541 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 1.076 ' HB3' HG23 ' A' ' 107' ' ' THR . 11.6 t70 -49.43 -46.66 47.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.247 0.523 . . . . 0.0 110.961 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 109' ' ' SER . 31.9 m -60.54 -39.61 81.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.634 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.518 HD11 ' HZ ' ' A' ' 116' ' ' PHE . 4.3 mm? -70.84 -42.73 69.78 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.356 0.598 . . . . 0.0 110.059 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.44 -28.47 66.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.019 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 65.5 m -54.34 -57.0 12.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.561 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.518 ' HZ ' HD11 ' A' ' 113' ' ' LEU . 37.8 p90 -84.24 13.38 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.274 0.559 . . . . 0.0 110.914 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -106.1 9.17 42.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.521 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.4 t -137.44 176.32 8.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -79.68 -9.72 59.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.864 0.364 . . . . 0.0 111.085 -173.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 p -104.03 25.96 9.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.332 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.419 ' HB1' ' HA ' ' A' ' 116' ' ' PHE . . . -54.34 121.59 32.53 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.199 174.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.06 145.58 73.93 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.977 2.451 . . . . 0.0 112.464 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.47 -42.97 82.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.489 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -107.89 125.06 51.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.155 -170.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 42.0 p90 -158.44 133.68 8.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.224 176.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 30.7 pt -124.83 147.95 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.245 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.7 p -122.64 129.16 75.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.193 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.423 ' HG ' ' HB2' ' A' ' 84' ' ' PHE . 23.6 p -138.99 132.23 29.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.296 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.82 114.09 19.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.391 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.59 178.26 39.84 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.402 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 75.4 m -147.71 172.08 14.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.7 m -111.78 132.37 54.71 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.688 HG23 HG13 ' A' ' 37' ' ' ILE . 34.9 p -112.4 117.02 31.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.003 0.43 . . . . 0.0 111.028 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -94.67 116.91 29.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.127 0.489 . . . . 0.0 110.15 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 4.4 mptp? -60.22 136.44 91.33 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.546 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.544 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 10.2 Cg_exo -72.14 54.92 2.31 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.706 2.937 . . . . 0.0 113.367 -175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -154.91 -55.21 0.1 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.0 tp60 -63.34 -35.93 82.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.287 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.34 -35.78 74.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.931 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.15 -41.54 94.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.038 0.447 . . . . 0.0 109.831 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.531 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 32.8 mm-40 -64.87 -47.56 77.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.703 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 16.2 mm-40 -54.61 -50.95 66.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.131 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.756 HG12 ' HB2' ' A' ' 148' ' ' TRP . 67.0 mt -68.57 -36.32 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.205 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.35 75.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 21.6 mt-30 -81.95 12.93 3.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.502 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 68.02 24.28 7.9 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.379 0.672 . . . . 0.0 112.318 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -92.59 -5.67 51.13 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.943 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.756 ' HB2' HG12 ' A' ' 143' ' ' ILE . 95.4 m95 -140.48 130.79 25.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.819 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.656 HD21 HD13 ' A' ' 11' ' ' ILE . 6.5 tt -92.96 117.26 29.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.407 HD11 HD21 ' A' ' 5' ' ' LEU . 9.3 tt -95.39 133.85 38.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.974 0.416 . . . . 0.0 110.889 -175.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.472 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 35.5 t -151.52 154.74 37.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.246 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -79.52 156.4 27.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.417 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . . . -126.59 -139.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.1 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.4 t30 61.69 53.63 3.19 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.913 0.863 . . . . 0.0 109.483 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -151.48 169.08 22.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.778 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -54.37 -25.74 26.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.951 0.501 . . . . 0.0 112.165 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -53.51 -28.19 29.68 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 122.581 0.352 . . . . 0.0 111.721 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.5 -57.12 7.98 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -127.66 0.06 6.13 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.06 12.33 17.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.329 0.585 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.703 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.042 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 121.135 0.493 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.22 -7.8 26.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.263 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.66 -34.09 69.0 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -74.22 -43.17 58.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.732 0.301 . . . . 0.0 111.046 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.71 -20.85 45.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.872 0.368 . . . . 0.0 110.402 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 14.9 tpt -64.39 -33.64 76.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.23 0.538 . . . . 0.0 110.069 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.631 HD21 HD22 ' A' ' 149' ' ' LEU . 11.2 tp -83.06 -39.0 21.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.454 0.645 . . . . 0.0 109.336 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.567 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.115 179.211 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.4 t30 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.855 0.36 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.44 -8.77 37.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.918 -173.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 30' ' ' GLU . 11.1 pt20 -82.61 149.52 27.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.69 4.19 79.8 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.344 -173.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HG3' ' HA ' ' A' ' 152' ' ' GLU . 11.3 mptt -121.87 179.0 4.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.639 ' HZ ' ' HG2' ' A' ' 173' ' ' MET . 2.2 p90 -149.31 139.36 22.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.239 0.542 . . . . 0.0 110.485 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 pt -108.85 127.72 65.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.294 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.769 HD12 HD23 ' A' ' 149' ' ' LEU . 4.5 mp -100.08 129.48 50.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.813 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.04 93.12 2.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.469 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.357 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 121.12 0.486 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' A' ' 42' ' ' ASN . 44.5 p -94.76 137.09 34.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.21 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.628 HG12 HG21 ' A' ' 40' ' ' ILE . 78.7 t 78.02 119.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 123.838 0.711 . . . . 0.0 111.656 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.5 tp -121.88 -55.64 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.366 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.582 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 2.8 p90 -178.69 172.63 1.37 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.027 0.442 . . . . 0.0 111.395 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.49 130.93 47.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.76 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.7 m -89.32 -42.65 11.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -170.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.514 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 42.0 tt0 -142.02 146.12 35.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 111.105 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -124.8 109.45 13.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.332 0.587 . . . . 0.0 110.529 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -95.06 176.6 6.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.67 -42.14 99.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 118.016 0.371 . . . . 0.0 111.325 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -119.87 4.82 10.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.29 0.567 . . . . 0.0 111.0 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.11 108.44 0.73 Allowed Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.943 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 m -100.34 105.98 17.56 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.653 HG13 HG21 ' A' ' 133' ' ' THR . 4.3 mp -88.75 114.27 26.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.722 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.95 173.9 32.53 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.866 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -121.01 83.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.608 0.718 . . . . 0.0 110.389 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.628 HG21 HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -134.92 28.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.791 -176.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.451 HG23 HG22 ' A' ' 43' ' ' THR . 11.0 tp -71.71 -16.71 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.383 -176.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.597 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 53.4 m-80 67.01 72.6 0.36 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.161 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 13.3 t 170.36 143.87 0.1 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HB3' HD23 ' A' ' 73' ' ' LEU . 49.5 Cg_endo -90.81 -170.59 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.957 2.438 . . . . 0.0 110.874 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.3 p -111.78 170.73 7.94 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -88.66 0.99 55.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.351 0.596 . . . . 0.0 110.021 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.17 162.28 13.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.253 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 2.0 m -105.13 158.19 16.75 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.35 -38.36 80.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.803 0.335 . . . . 0.0 110.757 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -65.31 -28.51 69.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -59.87 -44.31 94.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.47 -177.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 mp -73.07 -43.81 61.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 110.176 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.13 -45.84 86.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.552 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.9 p -73.34 -33.84 65.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.351 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -65.23 -41.95 93.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.796 0.331 . . . . 0.0 110.396 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 83.9 mtp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.233 178.102 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -128.0 119.81 26.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.741 0.305 . . . . 0.0 110.29 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.504 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 89.9 mtp -84.44 131.67 34.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 p -81.7 127.77 39.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.139 0.495 . . . . 0.0 110.701 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 44' ' ' PRO . 87.9 mt -70.33 160.13 32.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.64 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -98.49 117.81 33.75 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -79.76 -33.06 35.0 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.968 -175.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.51 -176.29 29.17 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.073 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -87.4 5.6 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.157 2.571 . . . . 0.0 113.278 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.47 132.6 57.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 59.1 37.56 24.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 110.494 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -70.01 -10.86 60.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.67 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.29 5.78 29.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.927 0.394 . . . . 0.0 110.819 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -130.95 132.28 44.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.289 0.566 . . . . 0.0 111.66 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.96 118.8 5.03 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.521 ' HB3' HD12 ' A' ' 106' ' ' LEU . 66.0 m-85 -97.79 125.4 42.61 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.538 ' HB ' HG12 ' A' ' 112' ' ' VAL . 3.8 mp -112.9 107.85 24.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.277 0.561 . . . . 0.0 109.949 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.616 HG22 HD13 ' A' ' 106' ' ' LEU . 33.6 t -86.71 115.73 28.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.85 159.49 38.43 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.522 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 22.2 m -70.19 160.8 31.46 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.585 172.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' A' ' 102' ' ' ASP . 13.9 ptpt -70.16 172.49 7.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -171.31 -43.8 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.839 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -154.91 -154.31 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -91.83 176.49 6.5 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 96' ' ' HIS . 5.6 pt-20 -93.7 168.59 10.91 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.507 0.67 . . . . 0.0 111.512 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -122.87 -36.62 2.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.706 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.416 ' HB ' ' OD1' ' A' ' 111' ' ' ASP . 10.0 m -112.94 -63.67 1.41 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.04 174.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.403 ' HA ' ' OE2' ' A' ' 93' ' ' GLU . 6.7 t60 179.45 126.82 0.07 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.095 0.474 . . . . 0.0 111.25 174.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 71.2 m -119.31 143.95 47.09 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.115 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -102.6 110.36 22.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.233 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.654 ' HD2' ' HA ' ' A' ' 102' ' ' ASP . 29.2 ttpt -84.42 102.64 12.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.398 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.8 t -69.34 -54.41 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.3 t -134.58 167.46 20.76 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.654 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 33.6 m-20 -58.91 -44.54 91.27 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -172.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 88' ' ' SER . 25.6 m-20 -76.99 -28.5 55.11 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -175.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.7 mm -118.29 123.07 71.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.08 0.467 . . . . 0.0 111.183 -175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.6 m -130.77 136.7 48.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.045 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.616 HD13 HG22 ' A' ' 86' ' ' VAL . 45.5 tp -99.07 125.68 44.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.488 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.951 HG23 ' HB2' ' A' ' 111' ' ' ASP . 17.8 m -135.9 128.96 31.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -136.36 1.48 2.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.216 0.531 . . . . 0.0 110.164 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.408 ' HB2' ' OD1' ' A' ' 111' ' ' ASP . 4.7 m -72.8 -7.67 51.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.782 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.31 -20.7 11.16 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.055 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.951 ' HB2' HG23 ' A' ' 107' ' ' THR . 2.2 m-20 -48.82 -42.97 37.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.12 0.568 . . . . 0.0 111.327 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.65 HG13 ' HB ' ' A' ' 107' ' ' THR . 5.1 m -53.01 -46.58 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.52 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.33 -36.04 74.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 110.499 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -70.66 -24.61 62.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.153 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -77.75 -14.64 59.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.942 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -85.25 132.09 34.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.965 0.412 . . . . 0.0 111.054 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 112.92 -4.21 25.74 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.765 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.8 t -123.26 157.5 33.0 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -66.85 -10.48 48.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.2 p -92.1 19.3 6.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.002 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.39 144.84 97.51 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.183 172.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.49 140.66 92.57 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.764 2.309 . . . . 0.0 112.729 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.467 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 48.5 mt-10 -57.99 -52.81 63.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.219 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HE2' ' HB2' ' A' ' 123' ' ' GLU . 5.4 mtmt -129.33 146.03 51.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.656 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -159.62 141.19 12.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.823 0.344 . . . . 0.0 110.692 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.02 144.41 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.827 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.24 129.22 68.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.037 0.446 . . . . 0.0 110.844 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.9 m -129.6 129.39 44.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.261 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.07 108.73 16.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.637 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.539 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 77.74 -176.44 53.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.189 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 83.4 m -147.85 173.48 12.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 0.0 110.191 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.3 m -120.02 116.76 26.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.157 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.653 HG21 HG13 ' A' ' 37' ' ' ILE . 38.3 p -96.32 113.95 25.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.085 0.469 . . . . 0.0 109.923 175.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.581 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -99.64 141.56 32.28 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.917 -178.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -90.28 117.51 68.09 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.396 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.26 55.77 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.523 2.815 . . . . 0.0 112.286 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -146.01 -37.36 0.25 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -87.56 -44.35 11.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.005 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.581 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 59.2 tp -56.92 -40.19 75.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.315 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.09 -33.44 73.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.828 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.557 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 71.1 mm-40 -67.25 -52.16 44.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.88 0.371 . . . . 0.0 110.234 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -41.57 95.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.717 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.555 HG12 ' HB2' ' A' ' 148' ' ' TRP . 60.3 mt -64.2 -40.71 90.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.721 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.72 71.01 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 111.027 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 37.0 mt-30 -87.26 9.09 21.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.942 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 10.4 m120 64.61 33.54 10.61 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.582 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -94.45 5.12 52.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.211 0.529 . . . . 0.0 110.085 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.555 ' HB2' HG12 ' A' ' 143' ' ' ILE . 92.1 m95 -142.49 123.69 14.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.725 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.769 HD23 HD12 ' A' ' 11' ' ' ILE . 6.0 tt -78.86 110.6 14.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.23 133.37 34.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.055 0.455 . . . . 0.0 111.501 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.8 t -162.25 157.06 22.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.083 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.504 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 8.6 pt-20 -85.12 154.1 22.25 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.76 119.78 39.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.747 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -168.58 -175.87 2.61 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 67.2 t30 75.29 163.67 0.26 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.398 0.679 . . . . 0.0 111.327 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 69.3 mt-30 -62.06 -25.43 67.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.036 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.7 m -51.82 -29.86 20.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.441 -175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.96 -54.53 43.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -125.34 -17.46 5.62 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -171.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 45.9 mt-10 -96.2 1.79 52.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.289 0.566 . . . . 0.0 110.914 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.857 176.337 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.572 HG21 ' H ' ' A' ' 171' ' ' ASN . 6.6 p . . . . . 0 N--CA 1.468 0.455 0 CA-C-O 122.191 0.996 . . . . 0.0 113.512 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.21 -28.05 63.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.883 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.56 -32.95 74.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.162 0.506 . . . . 0.0 110.597 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.572 ' H ' HG21 ' A' ' 168' ' ' VAL . 62.5 t30 -81.37 -32.72 32.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.105 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.78 -24.41 61.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.735 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.639 ' HG2' ' HZ ' ' A' ' 9' ' ' PHE . 13.3 tpt -55.64 -30.34 60.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.498 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.2 tp -97.68 -50.17 4.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.957 0.408 . . . . 0.0 109.915 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.524 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.979 179.102 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.7 t30 . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.941 0.401 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.452 ' O ' HD22 ' A' ' 5' ' ' LEU . 1.2 tt -90.77 -0.97 57.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.718 0.771 . . . . 0.0 109.066 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.82 136.81 37.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.768 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.07 2.46 80.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.753 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.91 159.53 15.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 151' ' ' SER . 37.6 p90 -125.41 154.0 42.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.9 pt -124.64 128.77 73.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.686 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.8 mp -75.46 119.63 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.501 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.608 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -102.12 155.37 18.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.975 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 121.682 0.753 . . . . 0.0 111.851 178.078 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.249 0.547 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 t -104.32 167.43 9.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.484 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t 50.02 79.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.422 0.629 . . . . 0.0 110.472 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.493 HD13 HD22 ' A' ' 158' ' ' LEU . 4.0 tp -93.31 -61.16 2.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -170.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.457 ' HD1' HG22 ' A' ' 26' ' ' ILE . 2.1 p90 -167.94 174.55 7.35 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.323 0.511 . . . . 0.0 111.688 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -92.09 123.5 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.611 175.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.2 m -78.45 -38.3 41.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.195 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.98 150.25 20.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 0.0 110.306 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -131.49 104.83 7.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -119.53 167.36 12.05 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.804 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -73.22 -12.95 61.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.771 0.319 . . . . 0.0 110.651 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -83.03 -21.74 33.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.458 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.77 176.31 28.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.835 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' A' ' 133' ' ' THR . 30.0 m -112.66 127.07 56.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.798 0.299 . . . . 0.0 110.779 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 37' ' ' ILE . 4.5 mp -104.42 110.21 29.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.35 165.39 27.47 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.44 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.45 80.11 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.802 0.811 . . . . 0.0 110.213 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.68 28.95 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.884 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.496 HG21 ' HB3' ' A' ' 74' ' ' ASN . 11.0 tp -62.01 -25.94 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.46 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.03 61.42 1.61 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.763 177.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.499 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 9.5 t 179.24 132.51 0.24 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.437 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 43' ' ' THR . 2.2 Cg_endo -82.44 178.64 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.65 2.233 . . . . 0.0 111.05 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.7 p -94.05 -169.22 2.03 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.86 20.03 13.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.812 0.815 . . . . 0.0 109.179 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -125.73 170.87 11.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.016 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.7 p -113.8 162.83 15.83 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.603 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.7 p -63.58 -33.6 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 mt -67.55 -44.92 77.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.221 0.534 . . . . 0.0 109.994 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -54.88 -42.8 72.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.004 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.502 HD13 HG12 ' A' ' 72' ' ' VAL . 66.2 mt -56.74 -55.09 38.66 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.957 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.6 mt -59.84 -43.13 94.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.089 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -80.33 -29.35 38.06 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -61.19 -59.65 4.99 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 C--N 1.332 -0.193 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -175.031 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.461 ' OD2' ' HG2' ' A' ' 70' ' ' GLN . 13.5 t70 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.461 ' HG2' ' OD2' ' A' ' 69' ' ' ASP . 27.1 mm-40 -99.65 125.15 45.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.985 0.421 . . . . 0.0 110.009 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.1 ttp -86.88 146.01 26.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.649 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.591 HG22 HG12 ' A' ' 127' ' ' VAL . 5.1 p -95.88 140.69 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.831 0.348 . . . . 0.0 110.608 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.5 mt -89.72 164.54 14.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.951 0.405 . . . . 0.0 110.875 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 41' ' ' ILE . 1.6 t-20 -95.0 145.57 24.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -99.99 -36.43 4.2 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.966 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.89 -171.88 35.58 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.16 -14.68 10.67 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.045 2.497 . . . . 0.0 112.936 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.87 139.08 25.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.75 -175.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 66.32 30.11 9.14 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.979 0.512 . . . . 0.0 111.639 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -65.83 -15.07 62.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.044 0.449 . . . . 0.0 111.548 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.06 -2.5 52.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.543 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -129.76 136.0 49.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.38 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.44 126.36 8.66 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.07 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -107.08 125.68 51.36 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.504 HD11 HG23 ' A' ' 112' ' ' VAL . 3.4 mp -118.03 113.66 42.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.931 0.396 . . . . 0.0 110.5 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.521 HG23 HD13 ' A' ' 106' ' ' LEU . 25.2 t -93.1 120.61 42.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.58 ' HE2' ' CD ' ' A' ' 93' ' ' GLU . 29.5 p-80 -139.29 161.17 38.08 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.768 -175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.418 ' OG ' ' HE3' ' A' ' 124' ' ' LYS . 47.4 p -83.51 151.16 25.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.961 0.41 . . . . 0.0 111.315 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 89' ' ' LYS . 13.6 ttpt -71.4 127.28 32.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.175 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -129.59 -43.41 1.26 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.649 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -124.83 -15.22 6.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.159 0.504 . . . . 0.0 110.741 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 71.08 80.48 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.856 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.58 ' CD ' ' HE2' ' A' ' 87' ' ' HIS . 1.3 pm0 -75.39 169.03 18.86 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.719 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -168.32 82.2 0.17 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.5 m -111.2 -37.74 5.23 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 161.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -171.12 77.51 0.07 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.903 165.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 p -97.71 134.62 40.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.958 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -103.06 121.2 42.1 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -87.59 115.8 25.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.046 0.451 . . . . 0.0 111.273 -174.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.69 -54.38 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.34 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.5 t -147.73 173.84 12.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.959 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -84.44 59.7 5.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.132 0.491 . . . . 0.0 110.624 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -175.9 -37.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.755 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.796 HG13 HD11 ' A' ' 158' ' ' LEU . 29.6 mm -117.95 129.7 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.687 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 m -127.88 139.37 52.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.052 0.453 . . . . 0.0 111.054 -174.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.521 HD13 HG23 ' A' ' 86' ' ' VAL . 57.3 tp -96.69 137.14 36.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.192 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.414 ' HB ' ' CG2' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -116.95 124.07 48.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.6 p -111.63 18.92 18.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.62 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.4 t -147.18 -178.41 6.2 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.1 4.11 8.95 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -49.75 -36.96 27.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.637 0.775 . . . . 0.0 109.756 172.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.504 HG23 HD11 ' A' ' 85' ' ' ILE . 29.3 t -53.5 -40.46 41.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.165 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.17 -33.19 73.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.393 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -71.28 -44.38 65.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.007 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m -64.22 -42.29 96.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.483 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -85.47 9.69 15.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.357 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.61 33.09 5.98 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.744 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 t -154.71 165.62 35.98 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -64.92 -24.33 67.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.773 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.0 p -88.91 32.02 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.114 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.89 146.0 82.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.854 173.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.469 ' HB3' ' CD2' ' A' ' 87' ' ' HIS . 9.2 Cg_endo -53.16 134.23 55.51 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.322 2.681 . . . . 0.0 113.398 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -62.7 -62.5 1.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.909 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.954 ' HD3' ' HG3' ' A' ' 160' ' ' GLU . 4.3 mtmt -103.69 145.31 30.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.8 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -167.71 140.89 3.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 0.0 111.475 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.03 145.02 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.248 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.591 HG12 HG22 ' A' ' 72' ' ' VAL . 4.6 p -117.06 124.9 73.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.008 0.432 . . . . 0.0 110.833 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 59.3 m -128.24 133.6 48.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.273 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.493 HD23 HG21 ' A' ' 72' ' ' VAL . 3.7 mm? -89.06 116.56 27.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.399 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.554 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 76.39 -174.69 53.47 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.758 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 68.2 m -149.18 168.15 24.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.8 m -107.73 119.07 38.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.191 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 36' ' ' THR . 11.1 p -101.69 114.83 29.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.301 0.572 . . . . 0.0 111.346 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -84.21 155.54 22.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.95 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -56.4 142.46 68.78 Favored Pre-proline 0 C--O 1.236 0.388 0 O-C-N 123.472 0.483 . . . . 0.0 111.077 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.45 119.18 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.164 2.576 . . . . 0.0 112.659 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 66.74 17.55 10.59 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.595 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.924 HE21 ' HA ' ' A' ' 138' ' ' GLN . 0.0 OUTLIER -98.66 -23.12 15.58 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.636 -178.089 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 36' ' ' THR . 57.6 tp -68.36 -50.33 53.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.529 0.204 . . . . 0.0 110.943 -175.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -60.35 -34.12 73.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.019 0.438 . . . . 0.0 110.789 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -40.08 77.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.4 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -69.69 -37.81 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 110.146 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.73 HG12 ' HB2' ' A' ' 148' ' ' TRP . 82.8 mt -60.34 -38.02 76.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.541 174.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.79 -28.61 69.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.302 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -88.13 4.41 45.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.928 175.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 16.5 m120 68.69 31.95 4.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.225 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -73.25 -30.54 63.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.466 0.65 . . . . 0.0 109.253 169.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.73 ' HB2' HG12 ' A' ' 143' ' ' ILE . 85.8 m95 -132.22 145.64 51.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.698 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 64.1 mt -104.43 118.33 36.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.99 135.6 40.16 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.46 -173.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 8.1 t -150.48 163.68 37.81 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 173.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -86.13 152.49 22.81 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.866 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -114.5 7.02 16.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.716 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -71.65 76.73 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.111 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -176.88 -178.67 0.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -65.11 -19.01 65.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.4 m -52.52 -27.17 15.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.527 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.796 HD11 HG13 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -57.1 -43.0 81.8 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.078 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -133.74 -46.89 0.8 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.954 ' HG3' ' HD3' ' A' ' 124' ' ' LYS . 34.1 mt-10 -85.63 16.97 3.52 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -166.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.317 -0.833 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 172.382 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.38 -28.97 68.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.875 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.13 95.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 110.716 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -81.21 -26.99 35.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.18 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.19 -37.78 72.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.566 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -62.43 -30.18 71.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.669 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.3 tp -79.48 -36.12 39.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.878 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.514 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.864 179.476 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.02 1.27 7.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.598 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.569 ' NE2' ' HA ' ' A' ' 100' ' ' VAL . 53.6 tt0 -66.08 131.68 46.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.831 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.23 -4.81 77.81 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.67 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -109.75 168.88 9.09 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -141.46 152.75 44.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.049 0.452 . . . . 0.0 110.938 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.1 pt -117.37 128.02 74.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.584 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 45.3 mt -101.3 133.25 45.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.794 -177.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.55 167.58 21.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.384 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 120.688 0.28 . . . . 0.0 110.78 178.952 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 . . . . . 0 N--CA 1.448 -0.572 0 CA-C-O 120.953 0.406 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.0 t -140.73 125.98 18.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.649 -177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.7 t 69.78 130.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.808 0.692 . . . . 0.0 112.106 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.48 HG13 ' HD1' ' A' ' 27' ' ' TYR . 7.0 tp -142.8 -64.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.678 176.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.48 ' HD1' HG13 ' A' ' 26' ' ' ILE . 1.8 p90 -177.01 177.14 1.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.142 0.428 . . . . 0.0 111.311 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.86 124.22 40.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.759 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.4 m -97.14 -40.45 8.8 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -128.89 147.88 50.86 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -175.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 6' ' ' GLN . 5.7 p80 -131.81 116.66 17.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 0.0 111.072 -177.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.448 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.9 OUTLIER -100.75 -7.85 23.32 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 169.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 72.43 -46.97 0.66 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.702 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -84.6 3.54 36.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 167.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.12 126.55 1.83 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.885 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 133' ' ' THR . 22.7 m -101.74 119.68 39.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.584 0.192 . . . . 0.0 110.94 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.776 HG13 HG23 ' A' ' 133' ' ' THR . 4.4 mp -109.08 111.47 36.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.933 0.397 . . . . 0.0 110.392 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.76 162.62 28.54 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.291 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.7 m -114.18 79.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.809 0.814 . . . . 0.0 110.754 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.69 18.6 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.907 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 tp -78.57 -21.41 13.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.122 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.4 t30 69.28 93.24 0.08 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.463 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -161.98 122.72 1.55 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.087 176.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.78 155.42 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.803 2.335 . . . . 0.0 110.817 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.487 HG22 ' HB2' ' A' ' 74' ' ' ASN . 9.2 p -101.1 170.48 8.24 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.679 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -92.49 16.13 12.6 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.55 159.05 31.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.964 -172.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 42.6 t -106.51 154.8 20.34 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.198 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 9.4 p -67.64 -35.13 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.73 -26.74 60.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.381 0.61 . . . . 0.0 109.577 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 12.8 mm-40 -68.46 -47.95 65.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.866 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.5 pp -69.84 -34.11 73.19 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.914 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.8 mt -61.6 -52.32 64.86 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.415 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 p -69.6 -28.47 65.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.087 0.47 . . . . 0.0 111.302 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -59.15 -34.76 72.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.601 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.683 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 121.056 0.455 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -98.46 122.57 41.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.255 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttt -79.09 140.91 37.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.474 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.92 140.17 22.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.137 0.494 . . . . 0.0 110.889 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.52 163.7 13.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.314 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.514 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 4.1 t-20 -105.3 113.16 26.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -77.31 -25.12 64.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.243 -171.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.21 176.63 26.76 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.5 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -83.52 4.81 6.77 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.118 2.545 . . . . 0.0 113.283 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.2 t -106.62 118.76 54.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 64.7 33.61 10.32 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.374 0.421 . . . . 0.0 110.233 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.58 ' HA ' ' HA3' ' A' ' 130' ' ' GLY . 26.0 tt0 -66.07 -15.96 63.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.374 -175.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -82.51 -7.29 59.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.511 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -109.41 140.7 42.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.055 0.455 . . . . 0.0 111.819 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 130.14 9.58 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.637 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -113.94 124.37 52.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.06 119.36 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.806 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.49 139.62 46.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -148.13 162.72 38.84 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.444 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -74.87 161.5 29.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -81.2 121.76 26.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.024 0.44 . . . . 0.0 110.195 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.525 ' CB ' ' HA ' ' A' ' 122' ' ' PRO . 21.7 m -144.33 -34.15 0.38 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.382 0.61 . . . . 0.0 109.402 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -102.09 179.22 4.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.567 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -120.56 79.85 1.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.399 0.618 . . . . 0.0 110.427 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -64.62 168.03 6.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.138 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -154.12 -29.54 0.12 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 p -46.74 -59.99 2.69 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -173.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -170.36 71.99 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.296 0.57 . . . . 0.0 109.49 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.45 ' HB3' HG21 ' A' ' 105' ' ' THR . 11.3 m -79.83 132.1 36.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.018 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.453 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 74.4 t80 -104.11 126.64 51.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.214 177.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 102' ' ' ASP . 13.8 mmmm -72.61 117.72 14.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.519 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.569 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 63.8 t -80.11 -54.68 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 t -131.53 -48.46 0.98 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.536 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 35.9 t70 -178.57 -66.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 172.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.41 -46.18 80.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.0 mm -72.94 123.52 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.45 HG21 ' HB3' ' A' ' 97' ' ' SER . 19.1 m -132.79 142.94 49.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.531 -174.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 31.3 tp -96.98 135.67 38.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.117 176.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.433 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 2.6 m -135.01 123.56 23.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.605 0.24 . . . . 0.0 110.681 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.9 p -134.97 -0.42 2.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.821 0.343 . . . . 0.0 111.728 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -92.99 17.33 10.9 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.31 -14.09 66.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.561 174.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.86 -27.61 60.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.884 0.373 . . . . 0.0 110.849 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 107' ' ' THR . 18.6 m -53.53 -32.81 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.926 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.35 -29.55 62.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 111.153 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -85.28 -35.56 21.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.609 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.5 m -58.76 -33.85 70.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.168 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -83.16 11.51 6.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.044 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.04 24.25 3.29 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.986 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 120' ' ' THR . 3.3 p -123.71 14.76 9.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.981 0.39 . . . . 0.0 111.636 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.41 ' C ' ' H ' ' A' ' 121' ' ' ALA . 0.8 OUTLIER 70.18 -37.16 0.37 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 111.442 -174.409 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 118' ' ' THR . 16.6 p -78.13 28.04 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.865 0.466 . . . . 0.0 111.781 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 119' ' ' GLN . . . -59.87 134.16 89.73 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.321 176.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.525 ' HA ' ' CB ' ' A' ' 90' ' ' THR . 9.8 Cg_endo -53.27 140.61 61.84 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.213 2.609 . . . . 0.0 112.771 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.404 ' CB ' ' HE2' ' A' ' 124' ' ' LYS . 66.0 mt-10 -57.28 -52.8 63.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.143 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.404 ' HE2' ' CB ' ' A' ' 123' ' ' GLU . 5.6 mtmt -128.84 142.98 50.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.029 -176.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -150.3 145.17 26.01 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.876 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.2 pt -114.75 133.4 61.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.36 128.84 74.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.158 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 78.4 m -142.89 150.04 39.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.256 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.09 112.98 24.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.899 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 80' ' ' GLN . . . 81.48 176.76 51.26 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.716 -178.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.6 m -147.71 173.36 12.84 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.5 m -113.97 121.62 44.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.071 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.776 HG23 HG13 ' A' ' 37' ' ' ILE . 73.7 p -110.25 119.75 40.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.129 0.49 . . . . 0.0 110.773 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -80.27 159.9 25.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.84 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -75.28 138.02 71.74 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.891 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.34 132.39 50.46 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.815 2.343 . . . . 0.0 111.291 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 2.0 t60 79.14 -33.81 0.15 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.926 0.766 . . . . 0.0 111.437 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -59.17 -48.33 82.0 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.504 0.193 . . . . 0.0 111.485 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.8 tp -57.99 -37.43 74.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.129 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -62.03 -43.62 98.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.0 110.22 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.623 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -62.16 -43.58 98.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.894 177.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -63.16 -42.82 99.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.882 0.373 . . . . 0.0 110.712 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.575 HG12 ' HB2' ' A' ' 148' ' ' TRP . 83.4 mt -62.35 -39.98 86.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.343 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.35 -28.59 69.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.496 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 60.8 mt-30 -88.75 8.9 26.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.967 177.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.9 m120 66.78 30.72 7.83 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -81.53 -29.24 33.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.275 0.56 . . . . 0.0 109.742 171.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.575 ' HB2' HG12 ' A' ' 143' ' ' ILE . 95.3 m95 -131.01 131.49 44.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.761 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.669 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 44.0 mt -89.99 112.57 24.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.957 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.5 tp -87.04 133.01 33.63 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.653 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 p -161.23 148.83 15.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.106 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -95.47 165.23 12.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.054 0.454 . . . . 0.0 110.893 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.71 -88.13 0.63 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.593 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 53.26 29.77 9.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.779 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -137.29 176.26 8.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -174.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -57.63 -35.93 71.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.602 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -52.83 -29.44 27.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.694 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.49 -56.99 12.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.04 7.41 6.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -169.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -106.24 -19.25 13.76 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.136 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -172.292 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 170' ' ' ALA . 1.5 pm0 -63.01 -52.87 61.25 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.619 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.442 ' H ' ' HG2' ' A' ' 169' ' ' GLU . . . -70.26 -31.65 69.12 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 110.613 -177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -66.98 -42.84 84.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.87 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -74.98 -21.21 59.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.098 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.887 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 14.1 mmt -62.93 -34.41 77.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.242 0.544 . . . . 0.0 109.699 172.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.6 tp -83.52 -40.24 19.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.996 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.926 177.974 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.1 mt 64.61 -90.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.384 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 31.45 86.54 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.308 1.005 . . . . 0.0 112.96 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 123.83 -0.59 9.22 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.385 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.773 ' HE3' ' HG3' ' A' ' 152' ' ' GLU . 13.6 mptt -105.52 169.16 8.62 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -142.45 167.89 21.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.413 HD11 ' CE3' ' A' ' 148' ' ' TRP . 4.8 pt -128.16 128.44 68.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.083 0.468 . . . . 0.0 111.477 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 4.6 mp -98.36 127.08 51.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.626 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.46 -72.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.083 0.239 . . . . 0.0 110.763 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.7 m . . . . . 0 CA--C 1.531 0.239 0 O-C-N 123.778 0.674 . . . . 0.0 110.958 -178.343 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 120.971 0.415 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.413 ' HA ' ' OD1' ' A' ' 42' ' ' ASN . 4.3 m -65.51 96.05 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.497 -177.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.882 HG11 ' H ' ' A' ' 26' ' ' ILE . 3.1 t 60.79 -170.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.253 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.893 HG21 HG23 ' A' ' 39' ' ' VAL . 10.1 tp -174.13 -147.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.71 ' HD1' HG13 ' A' ' 26' ' ' ILE . 2.6 p90 -120.87 176.33 5.6 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.217 0.917 . . . . 0.0 111.368 -168.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.9 127.95 43.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.416 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.44 -44.76 7.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.937 -176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.787 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.9 tp10 -136.03 156.38 48.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.411 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -140.87 110.18 6.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.184 0.516 . . . . 0.0 110.254 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -113.3 179.95 3.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -76.1 -35.0 59.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.055 0.455 . . . . 0.0 110.488 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.96 -24.27 60.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.975 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 171.63 178.28 41.89 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 119.966 -1.111 . . . . 0.0 112.959 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -103.62 130.38 51.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.787 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 mp -100.87 114.5 40.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.059 0.457 . . . . 0.0 110.89 -174.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.41 178.85 19.29 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.893 HG23 HG21 ' A' ' 26' ' ' ILE . 10.7 m -125.08 33.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.626 0.727 . . . . 0.0 110.316 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.513 ' HB ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -82.98 20.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.366 -173.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.447 HG22 HG21 ' A' ' 43' ' ' THR . 10.4 tp -67.24 -25.04 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.646 0.26 . . . . 0.0 111.249 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' A' ' 24' ' ' THR . 4.6 t30 67.16 80.64 0.21 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.409 173.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.447 HG21 HG22 ' A' ' 41' ' ' ILE . 5.1 t -178.2 126.39 0.27 Allowed Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 121.319 0.581 . . . . 0.0 111.877 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.677 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 83.7 Cg_endo -84.33 179.69 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.677 2.251 . . . . 0.0 110.689 169.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 p -119.6 -175.32 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -93.55 9.03 38.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.174 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 tp -125.43 163.95 21.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.84 0.353 . . . . 0.0 110.857 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 10.6 m -107.48 163.21 13.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.295 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.581 ' HB ' HG12 ' A' ' 127' ' ' VAL . 11.3 p -66.15 -35.72 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.744 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.21 -26.44 62.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 110.487 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -35.47 78.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.944 177.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.02 -44.74 91.75 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.064 0.459 . . . . 0.0 109.87 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.57 HD12 HD11 ' A' ' 113' ' ' LEU . 27.3 mt -66.54 -33.48 75.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.655 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.6 m -62.3 -35.35 78.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.086 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -76.05 -60.58 2.27 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.397 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 C--O 1.233 0.217 0 C-N-CA 123.114 0.566 . . . . 0.0 110.815 -178.32 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 N--CA 1.458 -0.052 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -104.43 112.29 25.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.549 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 88.2 mtp -82.26 144.46 30.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.465 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.529 ' HA ' HG13 ' A' ' 127' ' ' VAL . 7.3 p -93.97 137.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.886 0.374 . . . . 0.0 110.06 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.677 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.9 mp -102.02 -179.79 4.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.937 0.398 . . . . 0.0 110.341 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -115.41 137.14 52.36 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.04 -23.78 14.25 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.813 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.34 173.76 30.37 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.04 -12.15 16.16 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.023 2.482 . . . . 0.0 112.823 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.4 t -87.73 125.21 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.67 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 59.53 40.28 20.64 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.883 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -70.65 -10.95 60.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.298 0.57 . . . . 0.0 110.524 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.13 -22.69 67.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.155 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -104.15 147.17 27.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.432 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.86 124.34 7.13 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.618 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.494 ' HB3' HD13 ' A' ' 106' ' ' LEU . 60.5 m-85 -106.12 124.83 50.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.482 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.7 mp -120.23 110.06 27.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.652 HG21 HD11 ' A' ' 106' ' ' LEU . 21.4 t -95.55 124.46 48.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.651 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 125' ' ' PHE . 25.6 p80 -138.29 168.76 19.07 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.804 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.0 t -64.99 168.34 6.6 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' A' ' 103' ' ' ASP . 12.7 mmmt -51.25 112.9 0.81 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.235 0.541 . . . . 0.0 110.427 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 m -158.74 122.43 3.9 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.68 -150.03 0.45 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.319 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 77.97 13.85 1.64 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.409 1.083 . . . . 0.0 109.701 -169.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -98.35 155.48 17.2 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -147.65 -27.43 0.36 Allowed 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.656 -0.418 . . . . 0.0 112.083 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.2 m -67.1 -55.2 15.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.926 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -169.0 110.28 0.49 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 111.12 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 m -118.74 137.24 53.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.195 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -123.02 137.21 55.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.99 118.46 34.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.313 0.578 . . . . 0.0 110.781 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.82 -54.08 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.169 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 t -134.67 165.53 25.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.26 67.89 6.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.488 0.661 . . . . 0.0 111.177 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.51 ' HA ' ' HG2' ' A' ' 89' ' ' LYS . 24.6 t70 178.92 -31.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.089 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 49.2 mm -105.95 124.42 61.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.248 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.4 m -113.96 128.34 56.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.897 0.379 . . . . 0.0 110.955 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.652 HD11 HG21 ' A' ' 86' ' ' VAL . 54.5 tp -109.31 113.14 25.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.614 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 m -100.01 124.09 44.98 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -109.02 25.78 11.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.314 0.578 . . . . 0.0 111.122 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 111' ' ' ASP . 19.9 m -144.8 172.92 12.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.506 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.78 8.42 3.37 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.705 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -66.56 -17.19 64.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.482 HG11 ' HB ' ' A' ' 85' ' ' ILE . 25.6 m -58.01 -29.63 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.73 174.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.57 HD11 HD12 ' A' ' 53' ' ' LEU . 4.5 mm? -60.78 -31.87 71.21 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.132 0.491 . . . . 0.0 110.464 177.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -78.59 -37.25 42.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.864 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -53.65 -45.07 70.1 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.887 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -97.98 140.84 31.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.782 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.04 2.37 45.37 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.058 -177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -115.75 -175.83 2.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -58.87 -34.35 71.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.071 0.463 . . . . 0.0 110.504 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.6 p -112.01 64.03 0.62 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.136 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.03 125.51 85.18 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.192 172.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.07 133.1 24.2 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.538 2.158 . . . . 0.0 112.312 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -61.73 -57.81 10.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.355 0.598 . . . . 0.0 111.702 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.1 mtmm -118.54 127.48 53.66 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 -168.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 87' ' ' HIS . 37.5 p90 -150.62 138.52 19.98 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.819 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.2 pt -116.06 134.14 60.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.834 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.581 HG12 ' HB ' ' A' ' 49' ' ' VAL . 6.5 p -114.17 128.36 71.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.253 0.549 . . . . 0.0 110.702 -177.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 18.2 p -142.23 138.23 31.3 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.187 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.8 mt -89.3 140.14 29.79 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.768 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.89 -175.15 4.02 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.47 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 79.1 m -148.83 173.06 13.67 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.0 p -114.05 122.3 46.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.915 0.388 . . . . 0.0 110.445 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.663 HG22 HG13 ' A' ' 37' ' ' ILE . 25.3 p -98.65 117.01 32.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.042 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.499 ' HZ3' HD11 ' A' ' 40' ' ' ILE . 1.2 t-105 -68.48 148.4 50.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.279 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -69.16 144.91 95.77 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.142 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.91 125.27 18.58 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.274 2.649 . . . . 0.0 113.484 -173.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 2.8 t60 71.59 -8.28 1.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.056 172.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -67.07 -44.75 79.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.343 . . . . 0.0 111.491 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 47.7 tp -57.51 -31.43 66.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.548 -175.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.83 -41.11 86.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.301 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.52 -49.66 18.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.842 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 0.3 OUTLIER -54.88 -40.93 70.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.139 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.93 -48.16 76.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.856 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.63 -35.98 81.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.828 0.347 . . . . 0.0 111.407 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -87.33 16.08 5.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.891 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 68.14 24.38 7.68 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.492 ' HD2' ' HA ' ' A' ' 142' ' ' GLU . 75.6 m-85 -83.57 -25.48 30.89 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.842 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 94.5 m95 -133.96 132.96 40.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.885 176.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.8 tt -90.62 115.13 27.5 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.6 tp -93.98 135.55 35.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.764 0.316 . . . . 0.0 111.386 -175.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.5 t -156.21 156.17 33.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.773 ' HG3' ' HE3' ' A' ' 8' ' ' LYS . 7.6 mp0 -70.11 153.54 43.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.61 -3.56 9.82 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -71.97 81.64 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.795 0.807 . . . . 0.0 111.322 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -158.57 165.48 34.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.0 -30.05 32.94 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.1 m -55.76 -30.5 61.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.938 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.49 -53.19 52.06 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.945 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.402 ' CZ ' HG11 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -115.77 -46.07 2.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -65.01 -47.34 77.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.81 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.534 0.358 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.656 179.533 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -4.33 20.76 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.69 -57.32 12.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 111.627 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -75.25 -24.54 57.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -66.02 -22.44 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.19 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 13.7 tpt -55.12 -33.29 62.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.45 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.476 HD23 HD22 ' A' ' 149' ' ' LEU . 12.1 tp -107.79 -51.96 2.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.958 0.409 . . . . 0.0 110.878 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.016 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -175.414 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.634 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 61.2 t30 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.83 -98.49 0.45 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.466 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 29' ' ' CYS . 56.2 mt-30 61.84 122.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.429 1.109 . . . . 0.0 112.557 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.04 5.77 88.94 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.937 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -93.74 158.18 15.8 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' HE1' HD13 ' A' ' 11' ' ' ILE . 29.8 p90 -134.52 163.04 30.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.049 0.452 . . . . 0.0 110.924 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 pt -127.54 128.16 69.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.421 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.645 HG12 ' HA ' ' A' ' 171' ' ' ASN . 4.5 mp -87.92 132.51 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.364 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.32 168.59 26.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.418 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 m . . . . . 0 C--N 1.322 -0.629 0 CA-C-O 120.951 0.405 . . . . 0.0 110.66 178.768 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.9 p -84.78 -168.13 2.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.417 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.736 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 p -56.01 136.19 18.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.479 173.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.403 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.2 tp -114.14 -55.41 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.78 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.403 ' HD1' HG13 ' A' ' 26' ' ' ILE . 5.2 p90 -175.45 171.93 2.75 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.212 0.529 . . . . 0.0 111.852 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.0 mm -90.95 126.55 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.754 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 6' ' ' GLN . 43.2 t -81.98 -50.89 8.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.046 -174.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 45.8 mt-10 -136.21 146.59 46.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.963 0.411 . . . . 0.0 111.454 -177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.634 ' CD2' ' HA ' ' A' ' 4' ' ' ASN . 43.2 t60 -137.21 114.05 10.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.088 175.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -116.7 172.31 7.32 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -82.23 -20.03 38.5 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 172.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -16.03 24.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.665 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.43 174.46 44.41 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.303 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -149.23 133.58 17.47 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.437 -0.449 . . . . 0.0 110.401 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.723 HG13 HG23 ' A' ' 133' ' ' THR . 4.5 mp -122.87 123.64 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.246 -177.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.41 172.0 24.46 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.044 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.2 97.53 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.394 0.616 . . . . 0.0 110.51 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.736 HG21 HG21 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -130.98 24.48 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.195 -176.177 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.863 HG12 ' HB3' ' A' ' 74' ' ' ASN . 10.0 tp -55.81 -39.17 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.447 -173.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.48 25.19 14.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.613 0.365 . . . . 0.0 111.605 175.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.554 HG21 HG13 ' A' ' 41' ' ' ILE . 3.8 t -166.81 148.27 5.46 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 122.076 -0.39 . . . . 0.0 110.144 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 2.3 Cg_endo -81.99 -173.57 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.22 2.613 . . . . 0.0 112.471 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -101.58 -161.23 0.84 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.18 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.86 -7.69 22.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.284 0.564 . . . . 0.0 110.443 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 48' ' ' SER . 16.4 tp -107.21 171.22 7.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.252 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.823 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 14.7 m -119.65 161.77 20.12 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.106 -0.371 . . . . 0.0 110.342 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 12.8 p -69.39 -35.49 67.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.046 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.0 mt -59.69 -37.61 79.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.084 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.823 ' HG2' ' HB2' ' A' ' 48' ' ' SER . 23.2 mm-40 -60.01 -53.18 60.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.445 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.402 ' O ' ' HG2' ' A' ' 56' ' ' MET . 94.5 mt -61.05 -46.78 89.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.663 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 85.1 mt -57.53 -44.67 85.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.299 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.7 p -75.5 -36.35 60.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.259 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.431 ' HD2' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -58.51 -50.82 72.38 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.661 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 52' ' ' LEU . 25.4 ptt? . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.225 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.002 0.43 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.42 ' O ' HG13 ' A' ' 49' ' ' VAL . 25.9 mm-40 -120.07 120.27 35.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.247 0.546 . . . . 0.0 110.304 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 12.4 ttt -88.44 144.05 26.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.407 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.534 HG22 HD23 ' A' ' 129' ' ' LEU . 9.0 p -89.08 137.12 21.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.202 0.525 . . . . 0.0 110.73 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 67.3 mt -80.43 167.84 19.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.216 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.863 ' HB3' HG12 ' A' ' 41' ' ' ILE . 7.1 t-20 -97.64 155.85 16.8 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -109.69 -25.6 5.38 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.455 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.88 174.1 20.19 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.46 -9.18 18.69 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.858 2.372 . . . . 0.0 112.221 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.491 HG12 ' OD1' ' A' ' 79' ' ' ASN . 6.1 t -104.12 139.22 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.269 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.573 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 20.3 m120 56.05 34.5 23.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.442 0.297 . . . . 0.0 111.325 176.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.597 ' HA ' ' CA ' ' A' ' 130' ' ' GLY . 15.7 tt0 -66.54 -13.67 61.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.154 0.502 . . . . 0.0 111.524 -174.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.71 -8.48 57.36 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.735 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -102.25 133.7 46.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.032 0.444 . . . . 0.0 111.228 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.35 124.24 6.37 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.715 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -108.73 123.1 48.48 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 112' ' ' VAL . 5.2 mp -139.56 112.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 0.0 110.662 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.8 t -115.29 132.04 65.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.302 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -125.53 152.51 44.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.62 ' HB3' ' HB3' ' A' ' 159' ' ' PHE . 20.1 p -81.38 148.46 29.32 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.455 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 87.8 tttt -67.01 114.35 5.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.865 0.841 . . . . 0.0 111.57 -176.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.723 ' HB ' ' HA ' ' A' ' 122' ' ' PRO . 3.5 m -138.55 10.51 2.71 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -140.3 164.6 29.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.031 -168.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -136.44 15.69 3.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.331 0.586 . . . . 0.0 109.74 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -124.87 160.75 28.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.844 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.1 p90 170.44 154.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.188 0.93 . . . . 0.0 109.887 -175.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.4 m -104.08 -45.19 4.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.229 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -151.71 108.32 3.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.834 0.35 . . . . 0.0 110.494 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 p -139.89 150.18 44.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.067 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -102.18 112.12 24.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -90.56 123.68 34.41 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.184 0.516 . . . . 0.0 111.557 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.4 -54.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.2 p -116.43 -165.86 1.1 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -90.03 15.57 9.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.683 0.754 . . . . 0.0 109.349 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 13.2 t70 -131.03 -59.97 0.97 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.251 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.676 HG13 HD12 ' A' ' 158' ' ' LEU . 50.7 mm -72.49 122.15 24.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.126 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.96 133.17 45.57 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.328 0.585 . . . . 0.0 112.383 -176.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 85' ' ' ILE . 31.1 tp -99.77 122.11 42.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.216 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m -102.54 123.86 47.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.822 0.344 . . . . 0.0 110.113 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.6 p -116.53 20.62 14.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.887 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 m -139.67 177.58 7.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.445 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.77 -6.17 49.6 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.518 -0.372 . . . . 0.0 112.262 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.22 -29.38 63.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.207 0.527 . . . . 0.0 110.619 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 85' ' ' ILE . 14.8 p -54.63 -34.02 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.714 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.44 HD12 HD22 ' A' ' 53' ' ' LEU . 2.9 mm? -63.57 -35.99 82.32 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.026 0.441 . . . . 0.0 110.356 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.27 -34.54 65.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.88 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.2 m -58.31 -49.46 77.07 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.136 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -99.9 3.73 44.67 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.886 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.13 11.55 65.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.82 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -118.24 164.71 14.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -66.98 -23.01 65.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.898 0.38 . . . . 0.0 110.856 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.9 p -94.07 24.57 4.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.934 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -51.07 136.37 28.42 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.14 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.723 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 31.3 Cg_exo -58.74 145.96 94.16 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.095 2.53 . . . . 0.0 112.339 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.99 -47.93 70.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.242 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -141.8 143.53 33.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.663 -176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -152.03 148.59 27.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.83 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.4 pt -118.71 141.34 38.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.71 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.99 122.8 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.246 0.546 . . . . 0.0 110.495 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 81.3 m -132.81 158.14 43.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.153 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.534 HD23 HG22 ' A' ' 72' ' ' VAL . 3.4 mm? -112.76 113.21 25.21 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.852 0.358 . . . . 0.0 110.555 175.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.597 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . 101.98 -178.24 26.92 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.556 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 34.8 m -144.43 168.43 20.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.7 m -114.33 116.09 28.4 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.723 HG23 HG13 ' A' ' 37' ' ' ILE . 40.8 p -117.56 143.79 45.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.257 0.551 . . . . 0.0 111.731 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -110.89 177.47 4.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.233 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.525 ' HB3' ' HD2' ' A' ' 136' ' ' PRO . 65.6 mttp -85.17 167.13 27.52 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.221 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 135' ' ' LYS . 90.4 Cg_exo -44.15 105.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.969 2.446 . . . . 0.0 113.507 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 65.48 7.62 4.48 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.946 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.553 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.7 tp60 -57.5 -48.1 80.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.105 0.411 . . . . 0.0 111.396 -174.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.508 ' O ' HG13 ' A' ' 143' ' ' ILE . 65.3 tp -57.04 -34.86 68.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.981 0.42 . . . . 0.0 110.993 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.89 -46.05 91.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.59 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 13.4 mp0 -73.14 -30.15 63.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.09 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 66.9 mm-40 -60.92 -42.55 98.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.254 0.549 . . . . 0.0 110.013 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.521 HG12 ' HB2' ' A' ' 148' ' ' TRP . 86.0 mt -65.09 -29.73 48.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.586 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.07 -12.7 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.371 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 48.0 mt-30 -88.94 1.18 55.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.418 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 68.69 17.44 8.89 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.607 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -80.34 -18.95 47.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.325 0.583 . . . . 0.0 110.137 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.521 ' HB2' HG12 ' A' ' 143' ' ' ILE . 84.7 m95 -126.1 138.89 53.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.05 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 48.8 mt -106.43 107.59 18.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.073 0.463 . . . . 0.0 110.232 176.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tt -84.73 134.13 34.35 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.286 -174.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.49 ' HB2' HD12 ' A' ' 174' ' ' LEU . 16.1 t -150.07 178.09 9.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.045 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.25 154.14 39.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.254 0.55 . . . . 0.0 111.549 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.81 145.16 32.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.202 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.424 HD21 ' N ' ' A' ' 154' ' ' ASN . 0.9 OUTLIER -88.61 26.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.097 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.8 t30 70.48 -45.66 0.6 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.884 0.874 . . . . 0.0 110.672 -174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -57.93 -43.49 86.32 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 121.185 0.517 . . . . 0.0 109.851 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -28.84 69.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.444 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.676 HD12 HG13 ' A' ' 104' ' ' ILE . 2.8 tt -74.5 -56.57 4.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.112 -173.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.62 ' HB3' ' HB3' ' A' ' 88' ' ' SER . 0.4 OUTLIER -125.27 -23.55 4.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -174.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.29 -51.09 14.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.357 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.63 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.23 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.546 0.689 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.11 -6.0 47.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.73 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.71 67.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.074 0.464 . . . . 0.0 110.649 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.645 ' HA ' HG12 ' A' ' 11' ' ' ILE . 44.6 t30 -67.87 -39.43 83.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.111 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -79.29 -20.89 46.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.718 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.842 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 2.2 tpt -63.11 -33.6 75.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.462 0.648 . . . . 0.0 109.263 173.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' A' ' 151' ' ' SER . 13.0 tp -81.0 -45.06 17.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.251 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 CA-C-N 115.437 -0.802 . . . . 0.0 113.247 175.614 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 121.339 0.59 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.453 HD13 HD22 ' A' ' 139' ' ' LEU . 85.1 mt -74.82 -8.86 57.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.633 -171.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.3 132.82 49.24 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.73 11.7 84.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.774 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.615 ' HG3' ' HA ' ' A' ' 152' ' ' GLU . 13.8 mptt -117.06 172.05 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.481 -0.423 . . . . 0.0 110.145 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.543 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 54.9 p90 -144.21 152.94 41.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.583 HD12 ' CE3' ' A' ' 148' ' ' TRP . 17.4 pt -109.79 151.83 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.992 0.425 . . . . 0.0 110.877 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.764 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 40.8 mm -100.66 115.51 42.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.801 ' HB3' HG23 ' A' ' 25' ' ' VAL . . . -149.63 147.65 28.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.588 0.232 . . . . 0.0 111.485 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.035 178.376 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.513 ' HD2' HD23 ' A' ' 73' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -74.82 79.89 2.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.108 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.801 HG23 ' HB3' ' A' ' 12' ' ' ALA . 91.9 t 72.72 132.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.875 174.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.577 HG13 ' HD1' ' A' ' 27' ' ' TYR . 4.6 tp -122.72 -103.65 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.941 174.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.577 ' HD1' HG13 ' A' ' 26' ' ' ILE . 8.8 p90 -129.33 173.8 10.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 120.027 1.285 . . . . 0.0 112.348 -171.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.3 mm -100.49 128.29 52.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.673 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.1 m -79.8 -57.8 3.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.519 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.44 157.75 43.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.268 0.556 . . . . 0.0 111.297 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -133.03 112.06 11.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.666 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 32' ' ' ASN . 0.9 OUTLIER -94.98 163.33 13.36 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 166.138 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.33 -30.9 71.49 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.189 0.519 . . . . 0.0 110.608 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -96.65 -33.98 11.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.718 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.93 123.45 4.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.354 -172.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 133' ' ' THR . 28.4 m -108.78 116.34 31.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 176.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.594 HG13 HG22 ' A' ' 133' ' ' THR . 3.5 mp -104.32 120.13 54.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.834 0.349 . . . . 0.0 110.943 -174.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.46 163.5 29.26 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.913 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.514 HG21 HG21 ' A' ' 26' ' ' ILE . 1.6 m -115.42 88.1 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.668 0.747 . . . . 0.0 110.501 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.532 HG21 HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -132.27 26.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.061 -175.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 74' ' ' ASN . 10.7 tp -64.74 -36.56 77.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.415 -172.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.496 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.1 t-20 63.38 63.88 0.86 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.126 0.489 . . . . 0.0 110.923 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.51 HG22 HG13 ' A' ' 41' ' ' ILE . 14.3 t 173.37 130.0 0.1 Allowed Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.927 175.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 75.1 Cg_endo -92.97 155.95 2.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.175 2.583 . . . . 0.0 112.038 173.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 74' ' ' ASN . 9.8 p -87.6 -177.99 6.0 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.74 -2.86 46.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.735 0.779 . . . . 0.0 109.458 177.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.446 HD22 HD22 ' A' ' 52' ' ' LEU . 62.2 tp -90.35 158.3 17.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.164 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 11.8 m -114.42 152.88 30.85 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.207 -0.308 . . . . 0.0 110.467 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.604 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.2 p -64.15 -37.62 80.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.043 0.449 . . . . 0.0 110.007 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.38 -34.2 77.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.339 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -63.51 -44.0 95.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.518 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.454 HD13 HD23 ' A' ' 129' ' ' LEU . 56.4 mt -66.59 -45.93 77.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.75 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 89.3 mt -56.04 -48.97 75.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.072 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -73.1 -31.42 64.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.539 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -68.63 -52.36 32.24 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.81 0.338 . . . . 0.0 111.021 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.9 mtm . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.916 -177.092 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 121.304 0.573 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -103.21 112.94 26.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 87.7 mtp -82.3 145.29 30.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.033 0.444 . . . . 0.0 111.397 -171.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.437 HG21 HG21 ' A' ' 127' ' ' VAL . 8.1 p -99.03 143.29 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.369 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 8.0 mp -90.78 164.14 14.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 110.373 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.636 ' O ' HG22 ' A' ' 41' ' ' ILE . 3.6 t-20 -100.27 103.49 14.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.59 -27.8 61.72 Favored Glycine 0 C--N 1.328 0.098 0 O-C-N 123.5 0.5 . . . . 0.0 112.885 -171.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.03 172.19 30.22 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.14 -13.04 28.42 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.333 2.022 . . . . 0.0 111.825 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.74 145.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.468 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.537 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 83.9 m-20 63.96 24.75 13.72 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.222 0.326 . . . . 0.0 111.765 174.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -69.16 -10.89 59.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.702 0.763 . . . . 0.0 110.595 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.0 -13.68 60.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.711 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -113.71 134.54 54.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.981 0.42 . . . . 0.0 110.935 -172.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.57 119.22 5.06 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.755 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -105.84 121.52 44.23 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.412 HG13 HG23 ' A' ' 127' ' ' VAL . 5.1 mp -141.96 117.72 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 95.3 t -112.14 119.82 61.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.434 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -129.5 159.64 35.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -177.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.6 m -82.45 167.68 18.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.119 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.434 ' HE2' ' CE1' ' A' ' 87' ' ' HIS . 4.7 mptp? -119.22 122.02 41.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 t -94.13 -21.11 19.31 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.573 -173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.868 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 2.6 t70 -114.03 -4.78 13.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.56 0.695 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.7 m170 67.29 34.39 4.9 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.07 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.868 ' HG3' ' HB3' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -87.97 165.72 15.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.94 175.03 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -159.06 116.57 2.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.294 0.568 . . . . 0.0 110.966 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.7 m -88.73 -60.57 1.92 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.97 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.493 ' H ' ' HB2' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -145.24 35.22 1.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.439 179.131 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 148.48 24.47 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.97 -175.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -102.16 135.68 43.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.565 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -87.3 116.12 25.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.37 -54.04 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 169.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.793 HG22 ' HB ' ' A' ' 104' ' ' ILE . 11.9 t -138.69 -158.43 0.86 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -59.33 -65.18 0.71 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -93.66 -23.96 18.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.751 0.31 . . . . 0.0 111.38 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.793 ' HB ' HG22 ' A' ' 101' ' ' THR . 41.3 mm -86.96 122.46 38.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.987 0.423 . . . . 0.0 110.823 -171.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.1 p -134.16 137.9 44.8 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.981 -175.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.6 tp -91.82 137.66 32.18 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.33 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.852 HG22 ' HB3' ' A' ' 111' ' ' ASP . 25.4 m -138.8 140.04 38.44 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.733 -0.604 . . . . 0.0 111.456 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.4 p -111.6 -29.07 7.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.417 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.5 m -155.55 160.29 40.39 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.689 0.281 . . . . 0.0 111.171 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.82 -82.19 0.41 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.903 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.852 ' HB3' HG22 ' A' ' 107' ' ' THR . 11.2 t70 -51.91 -48.57 64.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.546 0.738 . . . . 0.0 111.629 -173.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 113' ' ' LEU . 7.6 p -63.58 -38.64 82.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.988 -176.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 HG11 ' A' ' 112' ' ' VAL . 2.6 mm? -69.46 -33.27 72.67 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.303 0.573 . . . . 0.0 110.0 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -76.35 -28.2 56.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.607 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.6 m -57.48 -62.43 1.79 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.35 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -86.36 27.68 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -172.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.2 20.36 23.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.155 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.6 t -162.93 172.72 14.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -71.54 -19.49 62.16 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.722 0.296 . . . . 0.0 111.471 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.0 p -84.53 18.27 2.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 0.0 110.994 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.41 129.82 93.85 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.341 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.98 139.23 72.42 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.623 2.215 . . . . 0.0 112.195 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -60.71 -48.58 81.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.515 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 159' ' ' PHE . 2.0 mmpp? -101.05 119.09 38.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.937 -168.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 36.9 p90 -154.87 127.93 8.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.289 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.2 pt -109.43 133.54 54.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.082 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.53 HG11 ' HB ' ' A' ' 49' ' ' VAL . 7.5 p -116.44 128.94 73.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.279 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 81.2 m -143.52 151.97 40.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.105 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.454 HD23 HD13 ' A' ' 52' ' ' LEU . 2.4 mm? -102.45 117.18 34.17 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 174.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . 83.67 -175.85 52.19 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.964 -175.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 19.3 m -148.45 163.69 36.41 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 m -98.37 114.84 27.32 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.594 HG22 HG13 ' A' ' 37' ' ' ILE . 22.6 p -112.5 120.02 40.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.473 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 0.4 OUTLIER -86.23 133.25 33.85 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.243 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 136' ' ' PRO . 96.6 mttt -65.0 153.31 89.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.082 -175.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 135' ' ' LYS . 33.5 Cg_exo -28.7 98.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 1 C-N-CA 125.507 4.138 . . . . 0.0 115.233 -171.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.422 ' HE2' ' CD ' ' A' ' 140' ' ' GLU . 10.2 t-80 71.58 -2.71 2.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.88 168.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -62.82 -30.07 71.21 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 5' ' ' LEU . 36.2 tp -60.14 -29.16 68.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.604 0.24 . . . . 0.0 111.296 -176.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.422 ' CD ' ' HE2' ' A' ' 137' ' ' HIS . 35.0 tt0 -64.99 -38.4 90.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.07 0.462 . . . . 0.0 109.912 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.506 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.9 mp0 -70.43 -37.16 74.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.412 177.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.473 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 74.7 mm-40 -63.41 -43.7 96.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.341 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 139' ' ' LEU . 73.3 mt -68.56 -31.24 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.483 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.26 -24.43 67.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.215 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 39.1 mt-30 -83.7 -0.59 51.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.562 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 62.23 17.24 9.1 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.665 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -87.97 0.78 55.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.415 0.626 . . . . 0.0 109.703 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.583 ' CE3' HD12 ' A' ' 10' ' ' ILE . 99.4 m95 -138.07 122.11 17.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.651 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.764 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 75.8 mt -98.92 145.64 26.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.1 tp -124.49 134.65 52.97 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.138 0.494 . . . . 0.0 111.368 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.0 t -138.38 148.95 45.07 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.432 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.615 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 26.0 mp0 -87.32 153.32 21.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.032 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -115.05 128.71 56.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.123 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -62.4 -63.56 1.2 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.986 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -177.64 -56.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.095 175.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 42.0 mt-30 -62.85 -27.3 69.24 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.808 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.9 m -52.45 -29.06 22.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.134 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.1 mt -65.21 -54.72 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.46 ' HD2' ' HB3' ' A' ' 124' ' ' LYS . 54.1 m-85 -129.83 -14.17 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 44.2 mt-10 -96.41 0.89 51.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.162 0.506 . . . . 0.0 110.877 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.183 175.378 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 173' ' ' MET . 50.2 mt-10 -53.89 -42.99 69.27 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.59 -46.26 66.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.037 0.446 . . . . 0.0 111.276 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -80.44 -36.84 33.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.909 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.18 -29.29 70.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.504 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.629 ' HE1' ' HA ' ' A' ' 173' ' ' MET . 29.2 mmt -60.64 -29.35 69.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.918 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.42 HD11 HG13 ' A' ' 11' ' ' ILE . 5.2 tt -101.1 -51.66 3.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.925 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.94 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.443 -178.773 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.099 0.476 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.09 8.87 16.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.184 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -70.95 119.77 15.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.391 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.17 7.84 45.73 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.1 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -116.85 175.36 5.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.499 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 26.9 p90 -146.92 140.58 25.75 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 171.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 pt -93.92 131.74 39.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.311 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.945 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 3.4 mp -90.07 114.99 28.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.833 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.565 ' HB3' ' HZ3' ' A' ' 148' ' ' TRP . . . -90.71 125.2 35.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.609 174.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 120.89 0.376 . . . . 0.0 110.706 -179.706 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.513 ' HG2' HG21 ' A' ' 126' ' ' ILE . 7.1 tpm_? . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.235 0.541 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 t -91.91 132.41 36.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.501 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t 71.43 117.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.259 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.903 HG21 ' HD1' ' A' ' 27' ' ' TYR . 9.0 mm -116.17 -95.55 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.326 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.903 ' HD1' HG21 ' A' ' 26' ' ' ILE . 2.1 p90 178.09 -177.4 0.22 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.251 0.22 . . . . 0.0 110.56 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.2 mm -95.25 124.6 47.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.3 m -91.22 -46.46 8.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.722 -173.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.718 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 32.1 mt-10 -131.89 150.57 52.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.372 0.606 . . . . 0.0 112.218 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -132.37 105.95 7.6 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 167.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -109.3 171.05 7.67 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.453 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.53 -26.23 68.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.665 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -111.41 13.01 21.53 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.11 170.59 22.22 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.238 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 133' ' ' THR . 55.1 m -115.21 130.41 56.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.839 HG13 HG22 ' A' ' 133' ' ' THR . 3.8 mp -109.59 119.11 58.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.425 -173.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.01 165.12 28.56 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.121 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' A' ' 26' ' ' ILE . 3.3 m -126.99 102.5 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.237 0.541 . . . . 0.0 110.957 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.477 HD13 ' N ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -141.79 12.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.166 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 tp -74.55 -33.8 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.204 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 58.96 86.5 0.09 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.798 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 9.0 t -163.04 123.02 1.41 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.257 0.551 . . . . 0.0 111.411 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 2.4 Cg_endo -83.01 173.95 9.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.184 2.589 . . . . 0.0 111.607 176.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.401 HG23 ' ND2' ' A' ' 74' ' ' ASN . 16.6 p -118.17 -171.51 2.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.756 0.312 . . . . 0.0 110.366 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.76 7.11 47.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.387 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -112.12 155.52 23.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.427 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 43.0 m -104.91 157.44 17.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.003 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 14.7 p -68.67 -34.08 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.18 0.515 . . . . 0.0 109.92 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.82 -25.9 60.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.291 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -53.16 56.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.751 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.1 pp -65.57 -33.62 76.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.605 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.82 -50.58 66.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.179 0.514 . . . . 0.0 110.96 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.9 p -72.43 -29.19 63.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -72.47 -39.62 67.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.388 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 19.7 ptp . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -174.77 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 120.659 0.266 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -128.3 112.79 14.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.881 0.372 . . . . 0.0 110.704 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.608 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 69.7 mtm -92.59 161.29 14.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.186 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.66 141.39 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.6 mp -109.2 170.51 8.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -176.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.401 ' ND2' HG23 ' A' ' 45' ' ' THR . 75.1 m-20 -110.21 132.15 54.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.013 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.75 -16.94 53.79 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.424 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.49 -179.35 36.95 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.934 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -86.79 5.04 6.01 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.164 2.576 . . . . 0.0 112.824 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 133' ' ' THR . 21.7 t -120.19 153.84 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.405 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 89.4 m-20 65.53 33.44 8.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.873 0.368 . . . . 0.0 110.333 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -65.31 -14.51 60.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.102 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -91.1 -4.67 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.422 0.63 . . . . 0.0 110.553 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -109.5 120.36 42.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.074 0.464 . . . . 0.0 110.897 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.75 108.52 3.62 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.534 ' HB3' HD13 ' A' ' 106' ' ' LEU . 98.0 m-85 -97.19 125.27 41.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.698 0.285 . . . . 0.0 110.735 -176.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.417 ' HB ' HG13 ' A' ' 112' ' ' VAL . 3.7 mp -117.12 109.92 29.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.207 0.527 . . . . 0.0 109.891 175.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -94.13 121.01 44.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.322 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -138.55 155.56 48.27 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.461 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.1 m -73.98 164.38 26.7 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 89' ' ' LYS . 14.3 ttmm -88.5 118.1 27.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.072 0.939 . . . . 0.0 112.291 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.4 m -139.48 18.43 2.55 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 169.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -132.6 161.31 34.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.019 -167.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.14 28.14 1.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.603 171.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.51 170.27 13.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.708 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -162.66 79.98 0.5 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.7 m -92.56 -41.42 10.25 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -169.6 78.38 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.337 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.6 m -115.2 133.86 55.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.102 -172.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.585 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 4.8 t80 -102.11 102.54 13.02 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -81.73 106.27 13.53 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.08 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.408 HG13 ' HE2' ' A' ' 27' ' ' TYR . 16.8 t -91.06 -62.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 46.5 p -119.05 175.71 5.64 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.97 -33.06 64.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 20.5 t70 -106.37 -49.12 3.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.392 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.6 mm -76.2 121.95 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.208 0.528 . . . . 0.0 110.001 -169.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.6 m -122.11 132.45 54.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.758 -175.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 58.6 tp -102.23 112.24 24.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.839 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.669 HG21 ' HB3' ' A' ' 111' ' ' ASP . 15.2 m -106.96 124.3 49.43 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.03 28.35 8.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.881 -175.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 t -146.8 -174.24 4.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.711 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.34 -0.87 25.12 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.091 -176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.669 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.4 t70 -55.26 -37.7 67.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.258 0.552 . . . . 0.0 110.123 174.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.498 HG21 HD22 ' A' ' 113' ' ' LEU . 36.0 m -55.82 -34.33 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.142 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.498 HD22 HG21 ' A' ' 112' ' ' VAL . 3.5 mm? -62.49 -34.55 77.08 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.446 0.641 . . . . 0.0 110.197 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.37 -25.8 31.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.919 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.0 m -62.3 -57.1 12.62 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.236 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.441 ' HA ' ' HB2' ' A' ' 121' ' ' ALA . 11.7 p90 -91.46 3.66 54.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 110.858 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.67 29.18 12.07 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.954 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.4 t -140.62 174.19 10.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -65.05 -39.16 92.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.813 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.7 p -89.76 32.32 0.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.48 -176.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -58.51 130.46 84.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.993 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.22 140.22 91.07 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.916 2.411 . . . . 0.0 112.308 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.09 -52.87 44.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.723 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -104.75 113.3 26.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.221 -172.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -147.27 133.61 19.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.806 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG21 ' HG2' ' A' ' 23' ' ' ARG . 32.7 pt -123.99 143.03 38.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.578 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.24 119.35 60.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.227 0.537 . . . . 0.0 110.489 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.438 ' HG ' ' HB2' ' A' ' 84' ' ' PHE . 9.6 p -131.07 130.88 43.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.532 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.69 125.63 34.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.014 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . 75.56 178.48 43.2 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.884 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 77.8 m -150.76 173.32 14.33 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.4 m -102.16 116.9 33.63 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 37' ' ' ILE . 78.3 p -111.12 120.83 43.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.994 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -81.01 137.71 36.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.472 . . . . 0.0 110.487 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.421 ' HG3' ' HD2' ' A' ' 136' ' ' PRO . 29.0 tptt -71.67 140.23 84.01 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.521 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.421 ' HD2' ' HG3' ' A' ' 135' ' ' LYS . 35.6 Cg_exo -36.58 130.25 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.248 3.299 . . . . 0.0 114.716 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.2 t60 77.37 -34.43 0.2 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.41 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.547 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.6 tp60 -60.2 -44.38 95.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -173.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.8 tp -55.82 -35.46 66.39 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.661 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -64.36 -38.92 92.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.148 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -71.26 -39.47 71.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 8.4 mm-40 -57.8 -51.12 70.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.302 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.8 mt -68.75 -33.15 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.564 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.4 91.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.311 . . . . 0.0 111.057 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -86.1 12.64 9.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.09 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 62.32 32.97 16.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.082 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.519 ' HD2' ' HA ' ' A' ' 142' ' ' GLU . 15.9 m-85 -72.14 -28.0 62.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.229 0.538 . . . . 0.0 109.738 172.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.565 ' HZ3' ' HB3' ' A' ' 12' ' ' ALA . 91.0 m95 -134.08 139.41 45.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.695 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.945 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.9 tt -88.2 141.3 28.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.528 ' N ' HD22 ' A' ' 149' ' ' LEU . 59.3 tp -123.09 134.57 54.24 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.696 -175.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.9 p -161.42 164.07 30.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.877 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -71.13 155.78 40.36 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.142 0.496 . . . . 0.0 111.274 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.04 -155.16 0.53 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.935 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.3 t30 65.85 22.9 11.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.76 0.791 . . . . 0.0 109.891 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -88.31 165.72 14.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.883 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 38.0 mt-30 -59.31 -29.09 67.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.052 0.453 . . . . 0.0 110.624 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.558 ' HA ' HG21 ' A' ' 161' ' ' THR . 6.7 m -52.63 -30.48 31.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.262 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.54 -57.18 6.94 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.356 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -127.42 -19.26 4.27 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 41.0 mt-10 -82.74 -9.07 59.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 111.524 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.558 HG21 ' HA ' ' A' ' 157' ' ' THR . 1.6 p . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 121.401 0.62 . . . . 0.0 110.246 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 168' ' ' VAL . 6.8 t . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 121.329 0.585 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.4 -7.21 41.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.037 0.446 . . . . 0.0 110.933 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.472 ' HB2' ' CG1' ' A' ' 11' ' ' ILE . . . -53.79 -39.37 65.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.181 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -81.08 -33.03 33.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.554 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.19 -27.91 61.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 0.0 110.658 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.934 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 1.0 OUTLIER -59.6 -33.05 70.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.196 0.522 . . . . 0.0 110.213 175.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.73 HD12 HD21 ' A' ' 149' ' ' LEU . 12.8 tp -82.05 -48.73 11.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.473 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.228 -179.535 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 CA--C 1.519 -0.213 0 CA-C-O 120.633 0.254 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.79 -82.8 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 173.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 57.13 107.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 172.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.33 -1.96 79.1 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.565 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.675 ' HD2' ' HB3' ' A' ' 152' ' ' GLU . 37.9 mmtm -95.4 159.85 14.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.477 ' HZ ' ' HG2' ' A' ' 173' ' ' MET . 45.0 p90 -123.79 154.41 39.59 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.511 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.55 HD13 HG22 ' A' ' 40' ' ' ILE . 8.4 pt -114.45 144.56 21.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.758 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.7 mp -110.73 161.41 9.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.405 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.426 ' N ' HG21 ' A' ' 11' ' ' ILE . . . 70.51 -176.59 0.2 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.547 0.529 . . . . 0.0 110.784 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 C--N 1.325 -0.486 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.385 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 121.401 0.62 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.3 t -97.51 112.01 24.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.228 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.441 HG21 ' HB ' ' A' ' 40' ' ' ILE . 38.6 t 54.76 92.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.076 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.476 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.4 tp -95.02 -57.35 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.476 ' HD1' HG13 ' A' ' 26' ' ' ILE . 6.1 p90 -174.3 175.47 2.63 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.158 0.436 . . . . 0.0 111.637 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.8 mm -94.93 126.61 47.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.816 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.35 -51.24 15.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.753 0.311 . . . . 0.0 111.157 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -159.92 153.83 23.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 0.0 110.846 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -120.6 104.64 10.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -106.59 171.04 7.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.194 -173.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.76 -22.59 65.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.92 0.391 . . . . 0.0 110.999 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -80.69 -39.7 26.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.057 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 170.58 -167.31 40.47 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.605 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.7 m -103.21 121.18 42.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.683 0.277 . . . . 0.0 110.335 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.637 HG13 HG23 ' A' ' 133' ' ' THR . 4.3 mp -98.0 118.74 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.09 153.93 25.37 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.494 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -114.6 88.69 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.728 0.775 . . . . 0.0 110.692 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.55 HG22 HD13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -125.1 18.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.113 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -61.07 -36.17 70.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.382 -176.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.6 t30 56.23 66.83 1.1 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 110.582 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 t -169.47 103.41 0.47 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-O 121.545 0.688 . . . . 0.0 111.156 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.599 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 5.9 Cg_exo -78.83 158.75 27.8 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.612 2.208 . . . . 0.0 110.286 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.529 HG22 ' ND2' ' A' ' 74' ' ' ASN . 73.6 p -110.38 166.3 11.09 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.549 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -73.87 -30.35 62.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.976 0.417 . . . . 0.0 110.78 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.62 149.99 49.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.261 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.0 m -97.59 150.83 20.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.965 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.664 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.1 p -61.85 -36.62 74.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.71 -35.46 81.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.481 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 8.3 mm-40 -62.04 -39.0 90.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.038 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.1 mt -74.98 -35.6 62.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.941 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 83.2 mt -62.96 -49.46 74.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.497 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.2 p -67.56 -30.34 69.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.857 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 1.7 tpp180 -60.77 -52.24 65.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.6 -177.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.1 ptt? . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -173.428 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.935 0.398 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -122.57 118.18 27.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.205 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.6 mtt -77.9 152.24 33.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.554 HG21 HD21 ' A' ' 129' ' ' LEU . 13.8 p -106.52 149.38 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.283 174.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.599 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.0 mp -102.42 159.75 15.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.763 0.315 . . . . 0.0 110.333 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.529 ' ND2' HG22 ' A' ' 45' ' ' THR . 35.9 m-20 -101.83 121.75 42.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.29 -23.34 58.99 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.542 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.97 -177.07 36.6 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.397 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.53 -25.94 7.64 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.259 2.639 . . . . 0.0 112.835 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.3 t -86.62 125.93 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.988 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 67.19 31.04 6.92 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.485 0.491 . . . . 0.0 110.855 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -65.97 -21.62 66.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.46 -175.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -82.87 -0.23 47.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.265 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -125.42 142.5 51.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 110.675 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.78 131.88 10.74 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.11 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -112.72 123.1 49.55 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.426 ' O ' HD11 ' A' ' 106' ' ' LEU . 5.2 mp -137.49 120.16 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.913 0.387 . . . . 0.0 111.268 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.1 t -110.51 130.41 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -132.01 149.36 52.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.448 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 p -69.91 150.44 46.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.984 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -65.79 112.86 3.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.532 0.682 . . . . 0.0 110.53 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 92.5 m -157.87 -48.2 0.06 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.68 -165.77 1.41 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.645 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -165.79 134.07 3.05 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.869 ' HB3' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -100.35 -171.03 1.96 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.91 -177.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -118.0 -46.12 2.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.879 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 36.5 p -75.33 -84.32 0.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -168.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -110.6 91.29 3.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 111.571 -172.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.9 m -96.04 104.03 15.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.565 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -102.73 102.62 12.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.015 0.436 . . . . 0.0 109.9 175.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 102' ' ' ASP . 4.8 mtmm -89.76 107.01 18.84 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.58 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -60.55 -53.96 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.8 t -134.53 -176.16 4.12 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.429 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 33.5 t70 -65.3 -33.35 75.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 118.27 0.486 . . . . 0.0 112.285 -170.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -98.15 2.38 48.46 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.81 123.65 71.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.7 m -124.41 124.99 43.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.993 0.425 . . . . 0.0 111.325 -176.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.426 HD11 ' O ' ' A' ' 85' ' ' ILE . 21.4 tp -101.59 130.45 47.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.021 174.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.7 m -129.16 124.89 35.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.1 p -109.03 28.87 8.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.64 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m -138.08 177.24 8.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.51 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.437 ' HA2' HD21 ' A' ' 113' ' ' LEU . . . -63.5 -11.82 43.2 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.304 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.869 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . 0.9 OUTLIER -47.84 -38.02 15.1 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.781 0.433 . . . . 0.0 111.051 175.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.5 t -52.58 -40.82 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.376 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 53' ' ' LEU . 3.8 mm? -62.3 -36.46 82.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.08 -27.24 54.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.05 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 m -56.99 -55.73 30.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.192 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 20.8 p90 -90.49 26.5 1.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -173.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.67 17.12 36.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.566 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 t -145.5 -179.31 6.58 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.677 -0.308 . . . . 0.0 110.326 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -74.88 -21.74 59.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.678 0.275 . . . . 0.0 111.253 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.9 p -91.96 23.39 3.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.943 0.401 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.481 ' CB ' ' HA ' ' A' ' 116' ' ' PHE . . . -65.69 146.03 99.0 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.232 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.55 133.83 38.7 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.415 2.077 . . . . 0.0 111.452 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.49 -36.48 83.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.997 0.427 . . . . 0.0 110.794 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -136.74 128.1 28.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.075 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.01 140.78 24.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.745 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.5 pt -110.5 132.93 57.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.976 0.417 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.95 126.91 73.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.385 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 80.8 m -140.62 150.0 43.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.005 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.554 HD21 HG21 ' A' ' 72' ' ' VAL . 4.3 mm? -100.32 117.52 34.68 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.51 177.75 50.53 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.904 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 66.4 m -145.83 168.58 20.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.89 0.376 . . . . 0.0 110.432 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.5 m -114.2 119.95 38.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.265 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.637 HG23 HG13 ' A' ' 37' ' ' ILE . 21.5 p -102.03 114.7 29.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.584 0.707 . . . . 0.0 111.69 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.535 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.5 OUTLIER -99.55 135.59 40.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.925 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 10.5 mptt -75.64 136.69 70.81 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.025 -175.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 6.5 Cg_exo -74.86 42.56 0.84 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.647 2.898 . . . . 0.0 114.175 -170.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 55.1 m-70 -156.58 -38.72 0.08 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 171.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.605 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 50.4 tt0 -52.8 -60.72 2.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.906 171.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.535 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 57.4 tp -63.03 -35.88 81.71 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.402 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.508 ' HB3' ' HA ' ' A' ' 137' ' ' HIS . 40.6 tt0 -55.66 -48.75 74.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.893 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.566 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 23.5 mt-30 -72.47 -31.5 65.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.114 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 53.7 mm-40 -59.19 -44.17 92.21 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.156 0.503 . . . . 0.0 109.912 175.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.562 HG12 ' HB2' ' A' ' 148' ' ' TRP . 66.7 mt -64.43 -36.78 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.341 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.29 -24.92 67.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.403 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 73.4 mt-30 -78.17 -0.64 29.16 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.903 0.382 . . . . 0.0 110.351 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.1 m120 70.28 31.28 3.15 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.895 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . 0.447 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 59.7 m-85 -100.5 -4.23 29.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.262 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.562 ' HB2' HG12 ' A' ' 143' ' ' ILE . 97.2 m95 -134.48 148.94 50.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.768 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 60.3 mt -126.03 153.35 44.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.852 175.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.1 tp -121.87 134.93 54.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.017 0.437 . . . . 0.0 111.576 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.2 t -149.96 173.13 14.15 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.675 ' HB3' ' HD2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -129.26 154.1 47.15 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.246 -179.026 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 157' ' ' THR . . . -127.21 104.72 8.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.702 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -81.42 88.51 6.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.344 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 70.0 -65.97 0.29 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.828 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 30.7 mt-30 -56.62 -70.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -170.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 153' ' ' ALA . 3.1 m -54.21 -29.57 46.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -175.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -57.21 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.87 -174.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -128.83 -13.6 4.63 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 31.4 mt-10 -81.71 -52.33 7.27 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.273 174.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.33 -0.281 0 O-C-N 124.397 1.061 . . . . 0.0 111.664 177.565 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.702 0.763 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -94.04 -3.23 51.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.767 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -56.72 -33.26 66.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.581 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -79.51 -27.88 41.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.759 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -73.29 -23.41 60.28 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.01 0.433 . . . . 0.0 110.669 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.557 ' HE3' ' HA ' ' A' ' 173' ' ' MET . 0.1 OUTLIER -66.29 -28.47 68.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.732 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.424 ' CD2' HD12 ' A' ' 149' ' ' LEU . 10.4 tp -112.89 -50.5 2.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.198 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -176.824 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.114 0.483 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -99.98 15.6 26.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.453 0.644 . . . . 0.0 109.752 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.679 HE21 HG13 ' A' ' 100' ' ' VAL . 49.2 tt0 -91.51 131.49 36.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.674 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.8 0.14 59.09 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.684 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.425 ' HB2' HD21 ' A' ' 5' ' ' LEU . 3.3 mptp? -107.8 176.62 5.08 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 43.3 p90 -142.72 152.94 42.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.054 0.454 . . . . 0.0 110.39 173.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 pt -118.19 128.12 75.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.307 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 60.0 mt -86.63 111.92 22.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.168 -175.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.516 ' HB1' ' CZ3' ' A' ' 148' ' ' TRP . . . -120.78 94.87 4.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.558 173.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.276 -178.605 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.5 p -121.2 154.6 36.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.818 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t 67.91 96.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 O-C-N 123.815 0.697 . . . . 0.0 111.117 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.616 HG21 HG22 ' A' ' 39' ' ' VAL . 10.6 tp -124.65 -146.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.345 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.544 ' HD1' HG13 ' A' ' 26' ' ' ILE . 3.5 p90 -116.63 171.71 7.7 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.427 1.012 . . . . 0.0 111.623 -164.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.53 116.09 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.553 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.8 m -75.51 -45.07 40.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.109 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -140.48 144.86 36.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.86 0.362 . . . . 0.0 110.719 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -128.61 111.96 13.76 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.293 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -114.75 173.36 6.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -71.84 -23.14 61.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.744 0.307 . . . . 0.0 111.112 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -107.45 -27.59 10.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.468 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.82 127.12 3.32 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 119.8 -1.19 . . . . 0.0 113.06 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 133' ' ' THR . 82.1 m -107.39 110.72 22.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.732 HG13 HG23 ' A' ' 133' ' ' THR . 4.0 mp -96.54 114.33 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.843 -172.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -145.71 160.88 28.19 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.616 HG22 HG21 ' A' ' 26' ' ' ILE . 3.0 m -114.75 63.97 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.599 0.714 . . . . 0.0 110.491 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -111.66 15.3 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.544 -175.167 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.489 HG22 HG23 ' A' ' 43' ' ' THR . 10.4 tp -68.91 -28.25 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.359 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 63.7 87.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.103 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.489 HG23 HG22 ' A' ' 41' ' ' ILE . 4.1 t -168.52 96.84 0.56 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.455 0.645 . . . . 0.0 111.086 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 57.9 Cg_endo -74.84 154.19 43.13 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.059 1.839 . . . . 0.0 111.3 174.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -115.63 152.24 33.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.681 0.277 . . . . 0.0 110.614 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.77 -17.15 62.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.07 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.08 160.01 30.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.692 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 14.7 m -119.81 160.11 23.26 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.903 -174.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.561 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.9 p -65.82 -37.92 81.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.046 -175.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 53' ' ' LEU . 91.6 mt -66.54 -33.98 76.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.204 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.692 ' OE1' ' HB2' ' A' ' 48' ' ' SER . 3.1 mp0 -61.76 -40.41 95.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.627 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.02 -39.82 63.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.327 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.632 HD13 HD12 ' A' ' 113' ' ' LEU . 95.1 mt -62.62 -49.14 76.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.978 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.1 p -68.11 -30.97 70.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.634 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -60.25 -37.27 79.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.585 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 73.0 mtm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 176.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.258 0.551 . . . . 0.0 112.195 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 48' ' ' SER . 29.6 mm-40 -111.52 127.88 55.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.679 178.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 66.2 mtt -79.87 157.79 26.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.013 0.435 . . . . 0.0 111.47 -176.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.452 HG22 HD23 ' A' ' 129' ' ' LEU . 9.7 p -107.74 149.87 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.237 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 8.0 mp -107.98 168.39 9.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.0 110.142 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.39 137.07 46.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.52 ' HA3' HG11 ' A' ' 39' ' ' VAL . . . -103.09 -9.38 39.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.44 -0.885 . . . . 0.0 113.009 -173.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.11 164.7 12.25 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.95 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.6 -20.91 26.29 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.961 2.441 . . . . 0.0 112.502 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.51 128.38 39.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.972 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 64.66 24.99 13.04 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.44 0.462 . . . . 0.0 110.612 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.621 ' HA ' ' CA ' ' A' ' 130' ' ' GLY . 53.3 tt0 -65.29 -23.5 67.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.534 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.02 -19.63 62.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.674 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 82' ' ' ARG . 39.1 mtm180 -109.67 143.73 39.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.004 0.431 . . . . 0.0 111.057 -171.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.41 130.76 10.04 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.336 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -111.84 124.22 51.91 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.412 ' O ' HD11 ' A' ' 106' ' ' LEU . 5.4 mp -131.14 115.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.0 111.032 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.01 126.43 67.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.76 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -133.17 161.09 35.37 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.119 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 m -67.52 159.04 30.52 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.444 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 46.1 tttp -72.55 120.13 17.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.188 0.518 . . . . 0.0 110.645 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.1 m -144.99 107.67 4.45 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 173.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -54.31 138.15 39.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.345 0.593 . . . . 0.0 112.199 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -176.71 24.54 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.757 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 67.51 -165.52 0.21 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -167.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -151.56 137.32 17.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.018 0.437 . . . . 0.0 111.262 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 111' ' ' ASP . 30.9 m -89.81 -50.04 6.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.076 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 109' ' ' SER . 50.3 t60 -168.32 88.56 0.24 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.72 176.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 57.8 m -130.9 136.02 48.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.716 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -103.43 116.69 32.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 101' ' ' THR . 0.3 OUTLIER -81.32 122.08 27.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.06 0.457 . . . . 0.0 111.84 -175.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.679 HG13 HE21 ' A' ' 6' ' ' GLN . 64.2 t -68.4 -53.01 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 165.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 9.9 t -138.54 -169.67 2.66 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.886 -1.506 . . . . 0.0 107.0 167.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.05 -40.88 60.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 118.9 0.773 . . . . 0.0 110.983 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 6.3 m-20 -76.31 -25.55 54.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.7 mm -118.01 123.1 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 m -131.25 133.62 45.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.036 0.446 . . . . 0.0 111.987 -173.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.412 HD11 ' O ' ' A' ' 85' ' ' ILE . 19.1 tp -96.12 137.27 35.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.991 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.892 HG23 ' HB3' ' A' ' 111' ' ' ASP . 50.9 m -133.51 128.34 35.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.888 0.375 . . . . 0.0 111.164 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.9 p -120.08 25.4 9.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.831 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.5 ' CB ' ' HB3' ' A' ' 96' ' ' HIS . 8.6 t -136.9 -170.56 2.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.619 -174.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.12 -5.29 52.94 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 116.509 -0.314 . . . . 0.0 112.926 -178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.892 ' HB3' HG23 ' A' ' 107' ' ' THR . 14.6 t70 -55.22 -37.13 66.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.337 0.589 . . . . 0.0 110.483 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.09 -50.1 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.701 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.632 HD12 HD13 ' A' ' 53' ' ' LEU . 3.9 mm? -61.98 -41.02 97.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.854 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.19 -41.89 98.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.386 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 68.2 m -54.15 -68.76 0.16 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.309 -176.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . 0.421 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 32.2 p90 -86.87 21.97 2.12 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 111.979 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.33 19.12 10.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.896 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 120' ' ' THR . 8.9 t -157.48 -170.48 3.24 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.922 0.361 . . . . 0.0 110.524 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -67.7 -20.9 65.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.0 111.248 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 118' ' ' THR . 16.6 p -98.05 36.07 1.63 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.278 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -75.73 121.95 86.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.438 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.38 131.56 20.6 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.633 2.222 . . . . 0.0 111.295 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.61 -47.26 73.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.326 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -123.11 123.24 40.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.374 0.607 . . . . 0.0 111.897 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -146.13 131.92 19.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.02 175.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.3 pt -105.39 132.77 51.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.902 0.382 . . . . 0.0 110.311 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.83 123.49 71.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.235 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 74.2 m -136.07 142.96 44.41 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.413 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.452 HD23 HG22 ' A' ' 72' ' ' VAL . 3.9 mm? -93.63 115.49 27.97 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.621 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . 80.89 173.32 47.19 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.841 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 62.8 m -147.06 169.22 19.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.7 m -105.95 116.65 32.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.004 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.732 HG23 HG13 ' A' ' 37' ' ' ILE . 47.7 p -103.66 115.84 31.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.465 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.872 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 1.5 t-105 -78.77 157.49 28.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.749 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 12.9 mmmm -65.37 147.16 98.79 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.378 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.23 113.89 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.443 2.762 . . . . 0.0 112.949 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.493 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 10.9 m-70 66.83 -3.36 0.93 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.521 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 53.3 tt0 -74.82 -25.48 59.04 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.733 -177.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.446 ' O ' HG13 ' A' ' 143' ' ' ILE . 49.1 tp -56.95 -39.24 74.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.885 -175.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.579 ' HG3' ' NE2' ' A' ' 141' ' ' GLN . 12.7 pt-20 -66.36 -34.27 77.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.784 0.326 . . . . 0.0 110.76 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.579 ' NE2' ' HG3' ' A' ' 140' ' ' GLU . 2.2 mp0 -71.33 -38.9 71.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 110.243 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.872 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 32.9 mm-40 -59.54 -43.54 93.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 139' ' ' LEU . 78.7 mt -64.48 -34.07 67.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.803 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.04 -19.01 65.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.335 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 142' ' ' GLU . 54.2 mt-30 -79.94 -2.47 43.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.723 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 71.05 18.8 5.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.712 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -100.27 3.91 43.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.516 ' CZ3' ' HB1' ' A' ' 12' ' ' ALA . 99.8 m95 -134.83 119.86 18.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.83 0.347 . . . . 0.0 110.79 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 3.9 tt -100.21 113.05 25.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.9 tt -90.19 134.52 34.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 110.632 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.7 m -142.0 152.19 43.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.539 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.29 158.84 24.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.483 0.659 . . . . 0.0 111.618 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.69 -152.57 0.44 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.891 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.0 t30 67.87 65.97 0.37 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.959 0.409 . . . . 0.0 111.233 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -178.6 -89.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.969 174.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -106.4 -55.96 2.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.001 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.8 m -52.12 -29.81 23.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.571 -170.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.34 -53.98 40.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -134.39 15.29 3.76 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.89 -53.36 5.16 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.456 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.6 p . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.426 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.512 HG13 ' H ' ' A' ' 170' ' ' ALA . 31.9 t . . . . . 0 C--O 1.233 0.187 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -97.23 -4.76 38.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.462 0.172 . . . . 0.0 111.315 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.512 ' H ' HG13 ' A' ' 168' ' ' VAL . . . -53.1 -42.44 65.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -77.12 -37.41 54.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.025 0.44 . . . . 0.0 110.787 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -75.78 -22.89 55.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.688 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -57.18 -37.26 71.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.84 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.8 tp -89.53 -44.31 10.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.946 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.118 -179.989 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.234 0.251 0 CA-C-O 121.059 0.457 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.95 -107.47 0.27 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.268 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 59.36 117.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.905 0.753 . . . . 0.0 112.476 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.414 ' C ' ' HD3' ' A' ' 8' ' ' LYS . . . 84.84 8.16 82.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.676 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.904 ' HD2' ' HB2' ' A' ' 152' ' ' GLU . 22.2 mmtp -112.05 150.81 30.14 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -130.49 163.03 27.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.393 0.616 . . . . 0.0 111.895 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.425 HD13 ' CE3' ' A' ' 148' ' ' TRP . 2.5 pt -127.69 128.36 69.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.396 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.462 HD13 HD21 ' A' ' 174' ' ' LEU . 55.0 mt -96.03 150.58 4.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.804 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 76.19 130.75 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.11 0.881 . . . . 0.0 110.91 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.465 HG22 ' CH2' ' A' ' 148' ' ' TRP . 32.7 m . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.016 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.695 HH22 ' HG2' ' A' ' 71' ' ' MET . 62.7 mtm180 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.346 0.593 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -121.23 117.59 27.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.496 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.407 HG12 HG21 ' A' ' 40' ' ' ILE . 58.1 t 69.04 134.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.684 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.464 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.8 tp -134.97 -58.89 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.887 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.464 ' HD1' HG13 ' A' ' 26' ' ' ILE . 1.8 p90 -179.23 177.8 0.75 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.011 0.434 . . . . 0.0 111.805 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.9 mm -94.02 125.31 46.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.217 174.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.5 m -89.93 -41.01 12.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -171.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.47 145.29 35.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.209 0.528 . . . . 0.0 110.804 -176.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -122.48 103.61 8.82 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -112.27 166.38 11.33 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.926 -171.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -79.14 -12.34 59.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.384 0.611 . . . . 0.0 109.766 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -86.68 -36.63 18.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.307 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.82 178.88 48.88 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.13 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 133' ' ' THR . 18.0 m -107.26 118.27 36.27 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.602 HG12 HG23 ' A' ' 133' ' ' THR . 56.8 mt -103.4 113.07 39.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.865 0.364 . . . . 0.0 111.424 -170.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.76 164.95 29.6 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.764 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.32 96.23 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.609 0.719 . . . . 0.0 111.685 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.407 HG21 HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -129.8 17.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.463 177.666 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 74' ' ' ASN . 9.3 tp -54.89 -30.61 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.602 -172.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.489 ' O ' ' HB ' ' A' ' 43' ' ' THR . 49.2 t30 60.71 71.18 0.58 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.47 0.308 . . . . 0.0 111.279 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 14.8 t 178.31 117.64 0.19 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 121.583 0.706 . . . . 0.0 111.425 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 1.2 Cg_endo -85.49 157.3 10.75 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.174 2.583 . . . . 0.0 111.09 171.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.472 HG21 ' HB2' ' A' ' 74' ' ' ASN . 10.6 p -96.74 175.72 6.26 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.82 -29.29 40.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 110.526 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.4 tp -68.58 148.49 50.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.604 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.717 ' HB3' ' HG2' ' A' ' 51' ' ' GLU . 17.1 t -104.82 152.86 22.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.618 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -64.44 -31.94 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.068 0.461 . . . . 0.0 109.951 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.8 mt -75.03 -26.26 59.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.089 0.471 . . . . 0.0 110.321 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.717 ' HG2' ' HB3' ' A' ' 48' ' ' SER . 45.8 mm-40 -64.22 -36.62 84.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.563 176.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.29 -35.18 76.63 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.536 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.16 -39.5 63.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 56' ' ' MET . 20.9 p -70.59 -29.69 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 0.0 110.575 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 tpt85 -61.19 -29.55 69.88 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.932 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' A' ' 54' ' ' THR . 62.6 mtm . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.765 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -133.52 124.54 27.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.323 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.695 ' HG2' HH22 ' A' ' 23' ' ' ARG . 0.0 OUTLIER -68.12 133.49 49.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.251 0.548 . . . . 0.0 110.8 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.579 HG23 HG13 ' A' ' 127' ' ' VAL . 11.7 p -82.94 149.91 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.197 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.8 mp -93.55 157.86 15.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.273 0.559 . . . . 0.0 111.935 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.578 ' O ' HG22 ' A' ' 41' ' ' ILE . 3.1 t-20 -101.06 87.24 3.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.968 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.34 -32.39 80.69 Favored Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.844 -169.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.93 173.98 33.22 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.991 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.34 -22.97 12.09 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.741 2.294 . . . . 0.0 113.074 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.475 HG23 ' OG1' ' A' ' 133' ' ' THR . 59.4 t -81.21 117.56 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.378 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 62.79 32.87 15.73 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 123.704 0.628 . . . . 0.0 110.467 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.525 ' HA ' ' HA3' ' A' ' 130' ' ' GLY . 52.6 tt0 -61.86 -22.15 65.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.719 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -82.21 -1.55 49.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -113.95 140.88 48.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.52 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.09 118.4 6.12 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -100.86 125.96 47.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.21 114.04 44.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 110.328 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.531 HG21 HD12 ' A' ' 106' ' ' LEU . 34.7 t -100.3 122.56 52.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.441 177.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -136.47 160.97 37.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.639 0.257 . . . . 0.0 110.971 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.9 m -73.75 177.7 5.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.608 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -51.62 113.83 1.09 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 110.827 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.0 m -121.54 117.57 27.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 -176.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.8 -152.57 0.39 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.743 0.652 . . . . 0.0 109.327 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -137.33 18.88 2.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.163 0.506 . . . . 0.0 110.645 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.87 168.6 11.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.012 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -175.2 146.07 0.82 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.151 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.419 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 90.6 m -89.87 -56.66 3.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.065 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -158.31 104.7 1.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.1 m -116.98 159.17 22.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.811 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -108.33 116.5 32.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.0 tttm -75.92 102.41 5.56 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.997 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.3 t -81.21 -54.11 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.453 ' HG1' HG12 ' A' ' 104' ' ' ILE . 70.8 p -130.04 -162.78 1.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -86.32 4.76 37.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.932 0.396 . . . . 0.0 110.424 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -134.66 -48.95 0.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.363 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.729 HD13 ' HD2' ' A' ' 159' ' ' PHE . 24.2 mm -68.99 122.01 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.714 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.9 m -123.64 116.8 23.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.073 -174.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.531 HD12 HG21 ' A' ' 86' ' ' VAL . 56.1 tp -96.88 128.84 44.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.073 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 111' ' ' ASP . 26.6 m -128.89 130.96 47.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.3 p -109.03 -12.21 14.87 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 p -101.5 -172.21 2.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.093 0.473 . . . . 0.0 111.798 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.486 ' HA2' HD22 ' A' ' 113' ' ' LEU . . . -74.83 7.48 20.5 Favored Glycine 0 C--O 1.227 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.675 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.555 ' HB3' HG22 ' A' ' 107' ' ' THR . 18.2 t0 -64.43 -28.66 69.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.552 0.692 . . . . 0.0 109.698 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.13 -37.18 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.66 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.486 HD22 ' HA2' ' A' ' 110' ' ' GLY . 4.0 mm? -63.66 -34.68 78.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.803 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -80.17 -27.53 38.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.062 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -60.64 -42.37 96.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -104.45 170.31 7.97 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.224 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.27 11.54 83.31 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.036 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.5 t -127.98 168.27 15.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -77.8 -5.05 49.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.048 0.451 . . . . 0.0 110.789 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 p -113.14 27.73 9.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.019 0.438 . . . . 0.0 110.628 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.47 160.37 25.51 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.721 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.8 146.14 29.57 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.4 2.067 . . . . 0.0 111.954 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.43 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 88.6 mt-10 -58.64 -53.12 61.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.161 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 123' ' ' GLU . 9.9 mtmt -139.32 153.69 47.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.985 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -155.01 134.96 12.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.836 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.433 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 24.8 pt -110.57 133.03 57.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.117 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.579 HG13 HG23 ' A' ' 72' ' ' VAL . 5.7 p -119.77 128.17 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.151 0.5 . . . . 0.0 110.725 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 22.6 p -133.19 135.66 45.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.49 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.9 108.85 19.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.841 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 80' ' ' GLN . . . 79.2 174.44 45.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.83 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 63.4 m -144.45 168.9 19.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.0 m -105.6 130.72 53.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.183 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.602 HG23 HG12 ' A' ' 37' ' ' ILE . 66.9 p -118.37 125.55 50.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.502 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 27.1 m-90 -82.88 178.88 7.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 167.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.557 ' HB2' ' HB2' ' A' ' 138' ' ' GLN . 1.5 mptm? -74.74 159.95 81.99 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 168.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.56 111.17 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.968 1.779 . . . . 0.0 111.744 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 74.97 8.69 4.08 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.726 174.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 31.1 tt0 -64.24 -36.27 83.54 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.589 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 143' ' ' ILE . 49.3 tp -53.7 -29.62 39.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.976 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.76 -38.99 92.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.82 0.343 . . . . 0.0 110.569 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -69.53 -31.67 70.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.258 0.551 . . . . 0.0 110.3 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -70.14 -43.76 70.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.177 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 139' ' ' LEU . 74.3 mt -67.98 -31.51 52.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.21 -22.34 60.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.57 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -71.87 -4.56 28.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.513 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 65.19 23.92 12.31 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.272 0.629 . . . . 0.0 111.97 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -96.84 -36.02 10.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.585 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.465 ' CH2' HG22 ' A' ' 13' ' ' THR . 92.9 m95 -92.26 127.84 37.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.679 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 tt -100.69 110.51 22.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.1 tp -82.6 134.53 35.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.539 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.5 p -152.14 144.12 23.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.097 175.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.904 ' HB2' ' HD2' ' A' ' 8' ' ' LYS . 15.9 pt-20 -113.5 153.82 28.08 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.618 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -115.17 152.79 31.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.177 -174.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -94.87 -59.53 1.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.514 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -168.52 -47.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.142 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -52.93 -45.87 67.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.874 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 173' ' ' MET . 0.2 OUTLIER -56.89 -29.18 62.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.172 -177.201 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.469 HD11 HG13 ' A' ' 104' ' ' ILE . 84.1 mt -89.51 -50.89 5.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -174.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.729 ' HD2' HD13 ' A' ' 104' ' ' ILE . 11.8 m-85 -124.78 -0.2 8.01 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -174.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -89.7 -57.65 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.201 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.405 ' HB ' ' OD1' ' A' ' 171' ' ' ASN . 11.3 m . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 121.318 0.58 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -77.48 -18.75 56.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.502 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.88 -57.42 9.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.086 0.469 . . . . 0.0 111.207 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.405 ' OD1' ' HB ' ' A' ' 168' ' ' VAL . 3.8 p-10 -68.89 -25.53 64.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.416 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.85 -25.15 65.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.256 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.689 ' HG3' HG23 ' A' ' 157' ' ' THR . 1.5 tmt? -58.69 -36.6 74.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.441 0.639 . . . . 0.0 109.418 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.462 HD21 HD13 ' A' ' 11' ' ' ILE . 11.8 tp -84.43 -38.44 20.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.775 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.487 179.886 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.7 t30 . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.0 mt 57.44 -149.9 0.45 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.506 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 64.38 104.88 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.563 0.697 . . . . 0.0 111.154 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.73 -4.0 68.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.667 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -113.49 168.24 9.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 41.6 p90 -134.8 155.91 49.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.025 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.8 pt -129.53 128.03 65.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.23 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 58.6 mt -88.16 132.31 33.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.396 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.471 ' HB3' ' CZ3' ' A' ' 148' ' ' TRP . . . -125.7 143.96 50.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.932 176.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 C--N 1.324 -0.507 0 O-C-N 123.291 0.369 . . . . 0.0 110.71 178.648 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 121.354 0.597 . . . . 0.0 110.02 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 29.6 p -90.2 124.49 34.9 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.795 -177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t 66.86 87.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.503 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.58 HG23 HG23 ' A' ' 39' ' ' VAL . 7.0 tp -119.02 -117.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.134 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.58 ' N ' HG13 ' A' ' 26' ' ' ILE . 4.5 p90 -118.62 170.33 9.05 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.835 1.198 . . . . 0.0 113.055 -165.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.1 mm -87.73 121.49 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.528 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.3 m -85.57 -41.12 15.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.956 0.407 . . . . 0.0 111.308 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.11 151.83 42.67 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -149.65 105.03 3.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.469 0.652 . . . . 0.0 111.487 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -129.78 162.78 27.67 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.46 170.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.58 -24.13 64.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.268 0.556 . . . . 0.0 109.853 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.07 -9.76 58.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.933 176.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 164.45 129.62 1.06 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.777 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 133' ' ' THR . 88.5 m -103.86 117.8 35.2 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.538 HG22 ' HB3' ' A' ' 131' ' ' CYS . 3.8 mp -101.39 118.25 47.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.583 -175.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.94 139.64 7.66 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.794 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.654 HG11 ' HA2' ' A' ' 75' ' ' GLY . 2.4 m -92.1 77.31 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.972 0.891 . . . . 0.0 110.201 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.485 HD13 ' CH2' ' A' ' 148' ' ' TRP . 25.1 pt -126.51 4.83 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.815 -172.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.2 pt -73.39 -18.84 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -175.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.444 ' O ' ' HB ' ' A' ' 43' ' ' THR . 47.1 t-20 64.51 89.13 0.1 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.613 0.571 . . . . 0.0 111.618 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.448 HG23 ' HB3' ' A' ' 74' ' ' ASN . 10.0 t 173.85 127.74 0.11 Allowed Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.712 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.57 154.35 9.03 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.653 2.236 . . . . 0.0 110.732 169.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.3 p -88.14 177.53 6.88 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.385 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -84.8 -17.54 37.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.114 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.66 152.76 22.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.791 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 55.7 p -102.05 157.26 17.0 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.644 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 12.1 p -64.66 -32.78 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.033 0.444 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -70.93 -31.95 68.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.865 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.26 -43.97 96.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.1 pp -76.49 -32.49 58.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.042 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 67.6 mt -65.67 -37.89 87.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.302 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.6 p -78.72 -30.76 46.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.863 0.364 . . . . 0.0 111.072 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -63.83 -48.07 78.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.814 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.6 mmt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.533 179.858 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.927 0.394 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.81 ' HA ' HE21 ' A' ' 70' ' ' GLN . 0.0 OUTLIER -116.58 132.43 56.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.186 -178.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 58.8 mtm -82.81 151.35 26.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.489 HG21 HG21 ' A' ' 127' ' ' VAL . 11.0 p -95.54 133.75 35.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.977 0.417 . . . . 0.0 110.195 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.29 157.75 37.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.004 0.43 . . . . 0.0 111.666 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB3' HG23 ' A' ' 43' ' ' THR . 7.8 t-20 -98.4 113.16 25.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.254 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.654 ' HA2' HG11 ' A' ' 39' ' ' VAL . . . -79.24 -36.24 27.87 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.06 -178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.81 174.62 28.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.894 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.35 -11.87 27.0 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.887 2.391 . . . . 0.0 113.484 -174.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.44 132.01 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.37 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 65.86 39.26 4.71 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.236 0.335 . . . . 0.0 111.582 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -65.76 -21.66 66.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.91 7.65 43.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.741 0.782 . . . . 0.0 109.834 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.37 140.64 49.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.01 129.66 9.86 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.619 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.518 ' HB3' HD13 ' A' ' 106' ' ' LEU . 21.3 m-85 -115.19 125.03 52.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.54 ' HB ' HG21 ' A' ' 112' ' ' VAL . 4.7 mp -131.26 122.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.554 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.595 HG22 HD11 ' A' ' 106' ' ' LEU . 7.3 t -95.18 131.4 42.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -137.96 160.27 39.78 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.465 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.7 m -63.22 145.5 55.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.237 0.542 . . . . 0.0 111.63 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.44 ' CB ' ' HA ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -63.55 124.28 20.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.331 174.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -117.88 -176.54 3.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -174.226 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.749 ' HB2' HG23 ' A' ' 120' ' ' THR . 6.8 m-20 -79.78 -35.53 38.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -172.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.539 ' HE1' ' HA ' ' A' ' 115' ' ' SER . 10.1 p-80 -87.07 175.54 8.05 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.979 -173.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.39 169.18 3.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.759 0.79 . . . . 0.0 112.269 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -153.91 113.98 3.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.718 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.5 m -72.87 -77.36 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.154 -169.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -109.03 83.72 1.8 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.323 0.583 . . . . 0.0 110.844 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.3 m -126.04 151.8 46.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.156 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.32 102.0 12.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -69.95 115.7 9.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.77 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.79 -54.47 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.612 177.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 102' ' ' ASP . 2.3 t -131.19 -54.46 1.04 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.959 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 101' ' ' THR . 11.8 t70 173.45 -64.01 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.44 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 5.7 m-20 -62.77 -26.83 68.9 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.77 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.9 mm -99.51 122.26 51.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -129.2 114.76 16.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.945 0.402 . . . . 0.0 111.466 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.595 HD11 HG22 ' A' ' 86' ' ' VAL . 21.8 tp -93.99 112.19 23.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.794 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.818 HG21 ' HB3' ' A' ' 111' ' ' ASP . 29.8 m -99.96 127.67 46.13 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.07 0.462 . . . . 0.0 110.907 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.8 p -102.16 23.88 10.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.038 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.424 ' H ' HG23 ' A' ' 107' ' ' THR . 34.2 m -151.38 -177.74 6.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.395 -176.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.81 11.75 5.61 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.341 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.818 ' HB3' HG21 ' A' ' 107' ' ' THR . 14.7 t70 -63.42 -30.23 71.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.853 0.835 . . . . 0.0 109.708 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.54 HG21 ' HB ' ' A' ' 85' ' ' ILE . 40.8 t -54.79 -45.44 74.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.609 174.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.38 -33.8 73.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.612 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.58 -41.39 94.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.967 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.541 ' HB3' ' HD3' ' A' ' 122' ' ' PRO . 49.1 m -59.08 -39.66 82.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.761 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.18 4.66 25.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.996 0.427 . . . . 0.0 111.219 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.29 17.4 28.98 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.975 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.3 t -142.58 179.26 7.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -62.55 -32.33 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.851 0.357 . . . . 0.0 110.959 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.749 HG23 ' HB2' ' A' ' 91' ' ' ASP . 23.4 p -92.49 43.1 1.12 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.848 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -56.89 123.65 60.1 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.765 168.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 115' ' ' SER . 27.0 Cg_endo -61.27 129.52 28.69 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.824 2.349 . . . . 0.0 112.558 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.44 -45.82 92.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.875 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -114.14 142.07 46.69 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.6 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -161.29 143.08 11.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.569 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.03 132.6 69.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.232 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.489 HG21 HG21 ' A' ' 72' ' ' VAL . 7.3 p -115.01 131.07 68.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.113 0.482 . . . . 0.0 110.993 -176.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 8.9 p -142.98 146.46 33.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.456 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mt -102.33 142.81 32.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.83 179.73 7.41 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.074 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.538 ' HB3' HG22 ' A' ' 37' ' ' ILE . 61.9 m -149.14 162.72 39.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.077 0.465 . . . . 0.0 109.977 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -114.03 117.07 30.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.464 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' THR . 17.9 p -107.66 116.38 31.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.234 0.54 . . . . 0.0 112.004 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.65 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.6 OUTLIER -101.23 151.38 21.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.971 177.086 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 11.4 mptt -105.49 137.33 19.26 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.325 -174.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 137' ' ' HIS . 7.8 Cg_exo -72.09 92.26 0.73 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.379 2.719 . . . . 0.0 112.818 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' A' ' 136' ' ' PRO . 13.6 p80 170.85 -18.66 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.125 176.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.584 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 56.9 tp60 -110.32 -58.88 2.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 171.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.65 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 53.5 tp -56.89 -53.11 61.71 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -172.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -35.94 77.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -173.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 11.5 mt-30 -74.94 -36.22 62.14 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.45 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 7.6 mm-40 -65.81 -41.96 91.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.756 0.312 . . . . 0.0 110.305 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 139' ' ' LEU . 71.2 mt -62.19 -42.44 95.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.44 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.68 99.25 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.233 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 41.8 mt-30 -78.8 3.56 16.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.02 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.35 37.52 3.53 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 175.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -72.84 -28.41 62.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 164.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' TRP . . . . . 0.485 ' CH2' HD13 ' A' ' 40' ' ' ILE . 74.6 m95 -116.4 149.81 38.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.0 -1.454 . . . . 0.0 108.991 175.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.597 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.0 tt -104.6 110.1 22.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 34.0 tp -82.03 135.46 35.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 111.228 -176.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.2 m -143.87 156.04 44.31 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.09 153.74 18.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.385 0.612 . . . . 0.0 111.401 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.18 155.4 40.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.33 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -119.01 -62.36 1.53 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.786 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -161.8 -38.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -54.85 -56.43 19.58 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.2 m -55.12 -28.17 50.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.424 0.63 . . . . 0.0 111.063 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.8 mt -81.31 -54.57 5.38 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.849 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.454 ' HZ ' ' HB ' ' A' ' 86' ' ' VAL . 71.1 m-85 -133.51 17.66 3.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -172.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -110.65 -48.36 3.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.268 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 121.055 0.455 . . . . 0.0 111.185 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.236 0.343 0 CA-C-O 121.334 0.588 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 173' ' ' MET . 13.2 pt-20 -71.21 -29.22 64.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.723 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.24 91.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.979 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -71.99 -31.99 66.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.399 0.619 . . . . 0.0 109.593 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.61 -21.91 61.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.16 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.801 ' HE3' ' HA ' ' A' ' 173' ' ' MET . 23.6 mmt -58.27 -33.74 69.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.465 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.5 tt -117.02 -52.83 2.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.183 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.089 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -175.194 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 mtm . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 61.06 116.26 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 124.093 0.871 . . . . 0.0 112.114 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.94 72.79 0.53 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.095 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 69.9 114.83 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.96 0.904 . . . . 0.0 111.425 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 91.8 mt -82.25 -3.03 54.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.153 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.588 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -65.1 135.65 55.79 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.88 12.82 83.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.961 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 43.2 mmtm -112.8 163.4 14.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -140.28 150.45 44.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.04 0.448 . . . . 0.0 110.382 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.51 HD13 HG13 ' A' ' 40' ' ' ILE . 8.4 pt -116.06 129.14 72.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.851 -177.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.711 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.0 mp -86.37 103.83 13.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.8 -54.37 3.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.426 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m 58.35 82.38 0.23 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.86 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.18 151.89 76.56 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.73 2.287 . . . . 0.0 111.985 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -59.19 -46.16 89.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.665 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 ttt -168.52 -74.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.571 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 51.49 73.02 0.33 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.401 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 t70 75.64 -49.7 0.62 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.527 0.731 . . . . 0.0 111.934 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.32 156.93 38.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -124.63 -38.37 2.4 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -176.94 -12.64 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -93.81 73.16 4.22 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.704 -0.622 . . . . 0.0 111.666 -167.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 71.5 123.74 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.942 -1.027 . . . . 0.0 112.593 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 t -140.45 110.89 6.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.391 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.56 HG11 HG22 ' A' ' 40' ' ' ILE . 90.2 t 73.55 140.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 122.844 0.458 . . . . 0.0 110.918 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.54 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.3 tp -135.19 -58.42 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.54 ' HD1' HG13 ' A' ' 26' ' ' ILE . 20.4 p90 -168.05 171.44 9.62 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.647 0.658 . . . . 0.0 112.134 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.4 mp -98.68 133.75 40.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.195 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.8 m -75.97 -52.6 9.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.03 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.588 ' HA ' ' HB2' ' A' ' 6' ' ' GLN . 13.7 pt-20 -161.1 169.91 21.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.131 0.491 . . . . 0.0 111.752 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 37.6 t-80 -134.16 111.03 9.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.636 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -128.25 170.16 13.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.495 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.33 -31.97 73.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.133 0.492 . . . . 0.0 110.85 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -74.57 -18.11 60.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.857 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.31 -177.52 30.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.659 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.0 m -113.27 117.62 32.35 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.639 HG13 HG23 ' A' ' 133' ' ' THR . 3.9 mp -96.28 124.85 49.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.44 164.73 34.65 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.037 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.38 81.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.443 0.64 . . . . 0.0 110.355 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.56 HG22 HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -133.97 6.65 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.431 -176.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.9 tp -70.59 -35.9 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 120.506 0.193 . . . . 0.0 111.247 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 63.97 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.182 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.459 HG22 ' HB2' ' A' ' 74' ' ' ASN . 4.1 t -161.34 91.52 1.49 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 121.714 0.768 . . . . 0.0 110.062 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.521 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 58.6 Cg_endo -72.85 154.56 53.63 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.719 2.279 . . . . 0.0 112.058 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.1 p -114.95 167.98 10.31 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.46 -0.63 47.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 0.0 111.595 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.634 HD22 ' HB3' ' A' ' 52' ' ' LEU . 35.1 tp -92.4 152.38 19.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.9 0.381 . . . . 0.0 110.143 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.712 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 12.8 m -109.08 154.48 22.2 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 7.4 p -61.28 -45.56 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.237 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.588 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 90.3 mt -75.67 -25.82 57.12 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.407 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.712 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.5 OUTLIER -57.36 -53.47 57.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.097 178.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.634 ' HB3' HD22 ' A' ' 47' ' ' LEU . 3.8 pp -66.66 -36.52 82.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.04 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.69 -51.63 64.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.779 0.323 . . . . 0.0 111.105 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.7 p -72.49 -29.46 63.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.057 0.456 . . . . 0.0 111.186 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -69.61 -37.2 76.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.584 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' A' ' 52' ' ' LEU . 65.2 mtt -82.35 -91.69 0.07 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.928 0.394 . . . . 0.0 111.918 -176.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -146.76 24.35 1.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.938 0.875 . . . . 0.0 110.435 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -122.34 50.25 1.5 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -67.1 -37.63 84.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.611 -171.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.7 ttt -90.77 84.22 5.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.261 0.553 . . . . 0.0 110.682 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.34 -165.59 1.0 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.209 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 62' ' ' LYS . 13.5 ptmt -125.38 67.05 55.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -88.77 -14.77 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.202 1.935 . . . . 0.0 111.5 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.419 ' HB3' ' H ' ' A' ' 65' ' ' ILE . 0.2 OUTLIER 56.86 -163.41 0.17 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.393 -178.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.419 ' H ' ' HB3' ' A' ' 64' ' ' ARG . 31.7 pt -82.35 9.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.692 -176.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.425 ' C ' ' H ' ' A' ' 68' ' ' GLN . 96.6 m-85 -67.75 -42.94 81.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.19 177.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 m 73.31 -20.22 0.3 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.013 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 66' ' ' TYR . 29.5 pt20 -66.02 153.45 42.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.588 ' OD2' ' HB2' ' A' ' 50' ' ' LEU . 6.0 t0 -139.21 178.69 7.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.174 -174.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -118.34 137.11 53.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 23.3 mmt -81.93 140.44 34.04 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.353 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.427 HG21 HG13 ' A' ' 127' ' ' VAL . 14.2 p -93.94 137.71 22.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.012 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.1 mp -106.48 155.11 19.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.513 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.459 ' HB2' HG22 ' A' ' 43' ' ' THR . 44.2 m-20 -89.42 127.72 35.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.52 -15.0 69.5 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.178 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.22 175.12 29.8 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.66 -12.19 20.27 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.651 2.234 . . . . 0.0 112.719 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.95 145.38 9.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.514 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 64.9 30.7 11.92 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.504 0.321 . . . . 0.0 111.618 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.629 ' HA ' HE21 ' A' ' 80' ' ' GLN . 0.0 OUTLIER -65.78 -9.19 26.18 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.045 0.45 . . . . 0.0 111.314 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.1 -19.99 60.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.303 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -134.77 143.16 46.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 111.413 -171.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.14 122.6 7.28 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.537 ' HB3' HD13 ' A' ' 106' ' ' LEU . 92.9 m-85 -96.97 126.12 41.88 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.631 0.253 . . . . 0.0 110.426 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.474 ' HB ' HG12 ' A' ' 112' ' ' VAL . 3.6 mp -111.35 115.16 49.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.189 0.518 . . . . 0.0 110.479 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.446 HG23 HD11 ' A' ' 106' ' ' LEU . 31.2 t -94.24 124.42 46.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.309 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -139.51 166.84 23.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.882 0.373 . . . . 0.0 111.195 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.3 p -93.16 174.12 7.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.064 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.529 ' HG3' ' OD1' ' A' ' 103' ' ' ASP . 21.7 mmtp -57.6 134.81 56.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 172.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.628 ' OG1' ' HA ' ' A' ' 122' ' ' PRO . 81.9 m -155.05 114.68 3.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.663 173.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.3 t70 59.68 -147.89 0.47 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.993 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -126.65 36.25 4.5 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.86 -0.525 . . . . 0.0 112.378 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 94' ' ' PHE . 40.2 mm-40 -90.52 161.0 15.69 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.348 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 27.0 t80 167.59 102.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.789 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.4 m -121.26 -55.05 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.974 0.416 . . . . 0.0 110.913 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.715 ' HB2' ' HB2' ' A' ' 111' ' ' ASP . 9.6 m-70 -127.08 70.98 1.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.418 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.4 m -128.51 139.51 52.28 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.111 0.482 . . . . 0.0 111.036 -178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -102.91 133.35 48.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.548 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -76.31 113.49 13.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.111 0.481 . . . . 0.0 111.943 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.54 -53.73 9.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 166.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.757 HG23 ' HB ' ' A' ' 104' ' ' ILE . 6.3 t -142.72 -164.05 1.75 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.442 ' O ' ' HE3' ' A' ' 89' ' ' LYS . 10.5 t70 -67.42 -53.29 30.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.572 0.623 . . . . 0.0 111.272 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.529 ' OD1' ' HG3' ' A' ' 89' ' ' LYS . 91.8 m-20 -84.18 -34.26 24.01 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.757 ' HB ' HG23 ' A' ' 101' ' ' THR . 46.8 mm -81.48 121.64 35.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.097 0.475 . . . . 0.0 110.226 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.14 128.96 50.03 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.749 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.537 HD13 ' HB3' ' A' ' 84' ' ' PHE . 54.8 tp -96.87 112.43 24.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.242 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.596 ' CG2' ' HB3' ' A' ' 111' ' ' ASP . 10.8 m -118.69 128.43 54.5 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -132.91 -29.67 1.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 t -112.37 104.71 12.87 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.459 -0.497 . . . . 0.0 112.024 -172.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.88 -53.4 2.93 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.715 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 15.4 t0 -56.3 -34.48 66.54 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.89 0.476 . . . . 0.0 112.201 -170.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.52 HG21 HD21 ' A' ' 113' ' ' LEU . 3.7 m -59.2 -34.9 55.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.52 HD21 HG21 ' A' ' 112' ' ' VAL . 2.7 mm? -70.64 -27.29 63.94 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.437 0.637 . . . . 0.0 110.24 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.2 -33.54 56.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.288 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.407 ' HB3' ' HD3' ' A' ' 122' ' ' PRO . 20.2 m -60.82 -67.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.967 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.466 ' HA ' ' HB1' ' A' ' 121' ' ' ALA . 8.4 p90 -79.45 140.18 37.43 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.006 0.431 . . . . 0.0 111.055 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.74 -17.71 9.35 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 t -131.89 178.87 6.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -77.66 1.68 19.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -174.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.6 p -99.8 14.55 29.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.451 0.643 . . . . 0.0 110.828 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' A' ' 116' ' ' PHE . . . -71.52 130.93 86.8 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.473 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.628 ' HA ' ' OG1' ' A' ' 90' ' ' THR . 17.4 Cg_exo -63.95 140.09 71.06 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.542 2.161 . . . . 0.0 111.985 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -55.12 -51.35 66.71 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.152 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.527 ' HB2' ' HE2' ' A' ' 159' ' ' PHE . 67.2 mmtt -128.06 138.22 52.47 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.607 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -154.04 144.33 22.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.492 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 28.8 pt -122.27 144.45 31.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.004 177.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.427 HG13 HG21 ' A' ' 72' ' ' VAL . 7.4 p -119.39 134.29 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.154 0.502 . . . . 0.0 111.197 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 70.2 m -139.11 131.91 29.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.376 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.6 116.77 23.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.188 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.98 -177.33 50.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.388 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 64.1 m -150.41 169.39 21.55 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.168 0.587 . . . . 0.0 109.434 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.6 m -106.88 139.67 40.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.65 0.262 . . . . 0.0 110.502 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.639 HG23 HG13 ' A' ' 37' ' ' ILE . 27.5 p -117.55 114.22 23.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.037 0.446 . . . . 0.0 110.668 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -83.67 156.2 22.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.263 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -58.57 141.47 84.04 Favored Pre-proline 0 C--O 1.237 0.441 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.355 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.97 119.89 7.44 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.746 2.297 . . . . 0.0 112.319 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.468 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 58.4 t60 74.83 -9.19 1.39 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.262 174.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -66.68 -51.01 60.99 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.158 -0.339 . . . . 0.0 111.29 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.45 ' O ' HG13 ' A' ' 143' ' ' ILE . 47.7 tp -54.41 -35.93 63.43 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.468 ' OE2' ' HA ' ' A' ' 137' ' ' HIS . 45.3 mt-10 -57.8 -43.26 85.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.061 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 8.5 mt-30 -72.39 -38.1 68.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.478 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.64 -40.56 97.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.583 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 139' ' ' LEU . 76.1 mt -65.77 -33.01 60.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.249 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.07 64.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.059 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 75.2 mt-30 -75.97 -8.17 56.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.389 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.429 ' HB3' HD13 ' A' ' 180' ' ' LEU . 44.9 m-80 65.65 30.67 10.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.078 -173.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -87.74 -18.29 29.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.592 0.711 . . . . 0.0 109.477 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -125.62 137.49 53.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.474 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.711 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 58.0 mt -92.37 108.31 19.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.071 0.462 . . . . 0.0 109.9 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.0 tp -91.45 134.05 34.96 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.927 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.0 t -149.7 148.0 28.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.544 ' HG3' ' HD2' ' A' ' 8' ' ' LYS . 1.7 mp0 -85.5 152.62 23.04 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.928 0.394 . . . . 0.0 110.178 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.35 104.15 13.21 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -80.29 77.01 7.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.8 t30 49.97 -83.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.275 0.985 . . . . 0.0 112.889 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.06 -35.58 80.73 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.545 0.212 . . . . 0.0 110.772 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.0 m -58.58 -30.3 67.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.858 0.361 . . . . 0.0 111.385 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 tt -67.0 -50.23 62.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.985 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.618 ' HB2' HD13 ' A' ' 104' ' ' ILE . 2.4 t80 -112.08 -27.67 8.3 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -169.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.484 ' HB3' ' HB2' ' A' ' 163' ' ' TYR . 60.7 mt-10 -105.44 -54.87 2.41 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.493 -176.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 t 38.39 88.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.46 1.1 . . . . 0.0 111.863 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.8 m 76.29 -37.24 0.29 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.337 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.484 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . 87.2 t80 68.23 93.61 0.08 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.208 0.603 . . . . 0.0 111.925 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.518 ' HG ' ' N ' ' A' ' 165' ' ' ASP . 2.5 pt? -173.6 -55.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.291 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.518 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 0.8 OUTLIER 175.47 143.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 175.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.652 ' HB3' ' HB3' ' A' ' 169' ' ' GLU . 2.9 mmt-85 -159.4 145.86 16.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.197 0.522 . . . . 0.0 111.759 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -138.17 137.47 37.65 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 171.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 168' ' ' VAL . 17.0 t 68.41 20.11 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 122.429 1.109 . . . . 0.0 109.054 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.652 ' HB3' ' HB3' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -60.63 -36.3 78.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.48 -178.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.92 -36.16 80.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.049 0.452 . . . . 0.0 111.096 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.404 ' HB3' HG11 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -79.84 -28.36 40.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.739 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.29 -26.38 38.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.361 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -53.94 -33.77 57.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.273 0.559 . . . . 0.0 111.077 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.99 -39.13 14.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.971 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 130.45 46.36 0.15 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.139 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 39.5 mt 55.62 73.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.655 0.74 . . . . 0.0 110.532 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 15.8 p -99.2 131.59 45.12 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.958 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -124.51 -172.18 13.53 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 174.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.469 HG23 ' N ' ' A' ' 180' ' ' LEU . 45.5 mm 68.77 166.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 122.461 0.305 . . . . 0.0 110.607 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.469 ' N ' HG23 ' A' ' 179' ' ' ILE . 93.8 mt 63.01 62.51 1.02 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.149 0.58 . . . . 0.0 111.3 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.913 ' HB1' ' HD3' ' A' ' 182' ' ' PRO . . . 177.55 -59.14 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.253 175.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.913 ' HD3' ' HB1' ' A' ' 181' ' ' ALA . 25.4 Cg_endo -96.63 97.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.84 2.36 . . . . 0.0 111.2 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -108.96 -36.9 5.97 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.905 0.383 . . . . 0.0 110.209 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 66.9 23.8 72.77 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.528 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.593 ' NH1' ' HB3' ' A' ' 188' ' ' GLU . 51.7 ttp85 -108.47 78.4 1.16 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -89.45 -60.14 2.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.092 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.23 97.04 9.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.207 0.527 . . . . 0.0 111.162 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.593 ' HB3' ' NH1' ' A' ' 185' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.855 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.599 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 27.2 ttt . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 121.149 0.499 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -114.12 -44.17 3.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.98 -67.74 2.35 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.84 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -88.76 130.2 35.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.452 0.644 . . . . 0.0 110.588 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.448 ' O ' ' HB3' ' A' ' 6' ' ' GLN . 95.8 mt -130.0 -152.12 0.5 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.965 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.448 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 50.8 tt0 67.98 119.25 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.215 0.531 . . . . 0.0 110.792 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.18 19.7 27.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.758 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -134.96 169.79 16.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.494 ' CZ ' ' HG3' ' A' ' 173' ' ' MET . 29.4 p90 -143.85 162.41 36.16 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 175.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.482 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 3.3 pt -133.02 128.46 56.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.507 -174.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 4.9 mp -96.24 140.05 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.575 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.32 168.68 19.51 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.827 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.6 p 53.53 96.77 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.477 0 O-C-N 124.136 0.898 . . . . 0.0 113.044 177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.538 ' HD2' ' HB1' ' A' ' 181' ' ' ALA . 19.1 Cg_endo -62.65 -28.45 76.87 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.491 2.127 . . . . 0.0 111.482 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.88 148.29 50.89 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.298 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.483 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -162.1 149.64 14.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -94.83 96.17 9.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.89 0.376 . . . . 0.0 110.882 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 20' ' ' TYR . 6.1 t70 65.76 173.75 0.22 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.857 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 70.99 -39.7 0.46 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.581 0.752 . . . . 0.0 111.946 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.483 ' HB2' ' HB3' ' A' ' 16' ' ' MET . 41.5 t80 -56.31 -27.64 56.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.675 0.79 . . . . 0.0 111.92 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -103.71 17.04 24.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.22 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -128.19 61.92 1.44 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.158 0.504 . . . . 0.0 110.296 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.689 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 1.4 mmp_? 64.16 86.62 0.12 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.023 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.1 p -146.34 158.71 43.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t 68.24 100.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 O-C-N 123.897 0.748 . . . . 0.0 111.13 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.666 HG13 ' HD1' ' A' ' 27' ' ' TYR . 10.6 tp -129.67 -142.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.32 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.666 ' HD1' HG13 ' A' ' 26' ' ' ILE . 37.1 p90 -117.64 174.55 6.1 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.476 1.034 . . . . 0.0 112.259 -165.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -92.98 125.73 45.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.326 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.3 m -73.0 -59.03 2.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.064 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -145.89 164.21 32.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.409 0.623 . . . . 0.0 111.223 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -118.27 118.87 32.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -114.64 -176.87 3.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.326 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -66.51 -28.84 68.88 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.261 0.553 . . . . 0.0 110.438 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.82 9.52 43.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.835 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.09 -143.63 15.34 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.567 -1.302 . . . . 0.0 113.185 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 133' ' ' THR . 12.4 m -123.97 129.11 50.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.499 0.19 . . . . 0.0 110.94 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.701 HG13 HG22 ' A' ' 133' ' ' THR . 3.5 mp -103.74 114.78 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.272 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -145.82 165.72 28.0 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.534 HG22 ' CG2' ' A' ' 26' ' ' ILE . 3.5 m -113.37 68.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.628 0.728 . . . . 0.0 110.787 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.43 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -115.37 15.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.956 -173.498 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.35 -29.38 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.739 0.304 . . . . 0.0 110.737 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 62.99 85.88 0.12 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.093 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.1 t -179.1 123.11 0.24 Allowed Pre-proline 0 C--O 1.235 0.315 0 CA-C-O 121.358 0.599 . . . . 0.0 111.514 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.625 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 71.9 Cg_endo -81.67 155.73 18.33 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.503 2.136 . . . . 0.0 110.733 170.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 p -112.2 161.75 16.22 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.022 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.05 -20.42 63.24 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.467 ' O ' HG13 ' A' ' 72' ' ' VAL . 57.5 tp -67.44 145.07 55.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.609 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 17.9 m -101.06 153.33 19.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.16 -176.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.1 p -69.65 -33.97 59.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.0 mt -73.68 -26.84 60.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.514 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.3 OUTLIER -71.45 -40.24 70.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.091 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.5 pp -74.03 -32.34 63.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.013 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 94.9 mt -65.4 -51.28 61.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.328 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.7 p -67.07 -28.47 68.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.339 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -55.72 -39.52 71.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.158 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 46.2 mtt -108.35 -45.34 3.92 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -150.14 -150.47 0.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -170.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.0 t80 77.48 24.52 0.78 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.148 0.975 . . . . 0.0 109.72 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -84.18 14.67 4.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.626 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.6 ttm -155.55 150.68 26.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.145 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 74.84 159.6 0.22 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.083 0.864 . . . . 0.0 112.793 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.6 mttm 68.35 150.29 0.12 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 114.929 -1.032 . . . . 0.0 113.08 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.36 -179.65 4.63 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.011 2.474 . . . . 0.0 112.611 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -86.03 92.89 8.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.056 0.455 . . . . 0.0 111.497 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.9 pt -92.22 87.3 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.561 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -58.9 -59.8 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.399 -171.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 t -133.43 80.29 1.87 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.106 0.955 . . . . 0.0 110.283 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -129.91 34.69 4.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.374 1.083 . . . . 0.0 108.236 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.531 ' CG ' ' HB3' ' A' ' 48' ' ' SER . 25.3 t70 -80.58 152.68 28.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.445 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -126.86 14.46 7.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.836 -175.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 44.2 mtt 63.06 165.89 0.12 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.626 -174.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.474 HG22 HD21 ' A' ' 129' ' ' LEU . 11.7 p -116.0 144.16 24.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.785 172.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.625 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.2 mp -103.8 158.12 16.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.972 0.415 . . . . 0.0 110.355 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.43 127.44 53.29 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.52 ' HA3' HG13 ' A' ' 39' ' ' VAL . . . -87.79 -10.06 70.4 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.316 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' A' ' 131' ' ' CYS . . . 160.2 176.74 32.62 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.483 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 1.7 Cg_endo -85.41 -2.3 9.25 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.131 2.554 . . . . 0.0 113.322 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.415 HG13 HD21 ' A' ' 79' ' ' ASN . 19.7 t -103.3 128.39 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.785 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.415 HD21 HG13 ' A' ' 78' ' ' VAL . 45.7 m-80 62.59 39.18 11.7 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.111 0.564 . . . . 0.0 111.809 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.483 ' NE2' ' HA ' ' A' ' 77' ' ' PRO . 96.2 mt-30 -68.58 -10.37 55.46 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.201 0.524 . . . . 0.0 110.582 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -71.92 -17.61 62.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.292 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 82' ' ' ARG . 41.2 mtt180 -110.07 129.28 55.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.409 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 108' ' ' THR . . . -90.6 112.97 4.17 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.472 ' HB3' HD11 ' A' ' 106' ' ' LEU . 85.9 m-85 -93.53 125.04 37.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.646 0.223 . . . . 0.0 110.553 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.459 HG22 HG13 ' A' ' 112' ' ' VAL . 4.7 mp -123.34 105.56 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.975 0.417 . . . . 0.0 110.091 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 66.0 t -88.14 122.03 39.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.37 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -133.01 163.44 29.23 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.834 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 122' ' ' PRO . 4.9 m -64.33 158.67 22.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.66 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.74 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 1.5 tmtp? -66.48 118.22 9.8 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.944 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.428 ' HB ' ' OG1' ' A' ' 120' ' ' THR . 1.5 p -126.3 -169.3 1.99 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.456 173.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -116.27 155.92 27.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.245 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 75.53 165.94 0.27 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.644 0.59 . . . . 0.0 110.253 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.523 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 0.3 OUTLIER 69.41 169.29 0.3 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.349 0.66 . . . . 0.0 111.875 -176.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 93' ' ' GLU . 21.3 p90 157.46 117.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 113.98 -1.463 . . . . 0.0 109.307 -173.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.2 m -146.71 -71.19 0.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.394 0.616 . . . . 0.0 109.822 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -120.45 37.39 4.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.0 m -74.26 104.78 5.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.684 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -101.97 118.44 36.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.215 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.495 ' HD3' ' HA ' ' A' ' 102' ' ' ASP . 95.6 mttt -100.0 112.0 24.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.877 0.37 . . . . 0.0 110.814 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.06 -53.67 44.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.1 t -133.26 169.67 16.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 166.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.495 ' HA ' ' HD3' ' A' ' 99' ' ' LYS . 38.7 t70 -61.16 -36.59 80.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 118.872 0.76 . . . . 0.0 111.358 -174.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.74 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 4.1 m-20 -77.26 -7.9 56.71 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.2 mm -121.06 122.37 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.959 0.409 . . . . 0.0 110.027 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 m -121.47 113.74 20.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.422 0.63 . . . . 0.0 111.498 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 84' ' ' PHE . 54.1 tp -94.07 137.7 32.98 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.971 174.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.661 HG21 ' HB3' ' A' ' 111' ' ' ASP . 16.2 m -145.98 137.78 25.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 65.4 p -114.28 12.65 17.7 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 62.8 p -127.73 -174.73 3.27 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.492 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.36 -7.82 47.75 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.311 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.661 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.5 t70 -50.47 -39.44 48.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.73 . . . . 0.0 110.002 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.543 ' CG2' ' HB ' ' A' ' 107' ' ' THR . 91.7 t -60.63 -49.03 86.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.131 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.89 -35.88 82.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.47 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.09 -46.0 72.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.724 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.2 p -66.93 -37.93 85.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.746 0.308 . . . . 0.0 110.811 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.487 ' CE1' ' HD2' ' A' ' 122' ' ' PRO . 7.0 m-30 -67.56 -24.14 65.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.083 0.468 . . . . 0.0 110.929 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.99 19.86 52.58 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.404 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.569 ' CG2' HG22 ' A' ' 120' ' ' THR . 4.4 t -142.85 -171.04 3.37 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -82.72 13.0 4.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.569 HG22 ' CG2' ' A' ' 118' ' ' THR . 9.8 t -117.49 20.46 13.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.527 0.679 . . . . 0.0 110.538 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 116' ' ' PHE . . . -68.38 115.1 26.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.969 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.487 ' HD2' ' CE1' ' A' ' 116' ' ' PHE . 11.4 Cg_exo -71.87 143.0 40.17 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.904 2.403 . . . . 0.0 112.156 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.79 -47.19 86.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.929 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.447 ' HD2' ' HB3' ' A' ' 162' ' ' SER . 55.0 mmtt -102.26 124.43 47.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.237 -171.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 48.7 p90 -152.15 141.97 21.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.323 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.3 pt -127.26 135.51 63.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.45 175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.29 125.97 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.141 0.496 . . . . 0.0 110.798 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.6 m -143.08 136.3 28.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.827 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.474 HD21 HG22 ' A' ' 72' ' ' VAL . 4.2 mm? -89.39 124.46 34.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.843 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.94 174.4 17.52 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.398 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . 0.405 ' C ' ' HA3' ' A' ' 76' ' ' GLY . 61.5 m -144.9 169.01 18.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.9 m -105.89 122.51 46.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.669 0.271 . . . . 0.0 110.716 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.701 HG22 HG13 ' A' ' 37' ' ' ILE . 41.3 p -101.71 116.78 33.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.876 0.37 . . . . 0.0 111.172 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.531 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 3.0 t-105 -78.84 156.99 28.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -62.27 137.38 95.92 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.805 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.66 121.5 9.26 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.216 2.611 . . . . 0.0 112.616 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 75.39 -17.1 0.53 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.357 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.541 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 53.8 tp60 -73.91 -30.89 62.83 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.88 -0.512 . . . . 0.0 111.387 -174.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 143' ' ' ILE . 52.4 tp -54.75 -44.71 73.86 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.599 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 8.9 pt-20 -64.89 -33.36 75.82 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.994 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.513 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 34.3 tt0 -71.93 -38.37 69.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 11.2 mm-40 -61.21 -42.21 98.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.229 0.538 . . . . 0.0 109.67 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 139' ' ' LEU . 84.8 mt -60.55 -38.18 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.038 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.74 -17.7 64.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 111.662 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 50.1 mt-30 -85.94 -0.72 56.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.467 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 62.84 24.53 14.6 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 123.713 0.805 . . . . 0.0 112.58 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -88.63 -8.02 55.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.292 0.568 . . . . 0.0 109.542 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -135.22 115.09 12.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.13 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.704 HD12 HD22 ' A' ' 174' ' ' LEU . 4.7 tt -84.84 102.51 13.14 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.7 tp -82.92 134.75 35.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.401 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.7 p -150.23 163.92 37.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.8 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.26 154.24 19.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.282 0.563 . . . . 0.0 111.945 -175.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 154' ' ' ASN . . . -92.56 -160.11 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.653 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 153' ' ' ALA . 17.5 m120 70.91 15.23 6.8 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.61 -177.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -96.18 148.57 22.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.46 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.99 -63.0 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.445 ' HB ' ' SD ' ' A' ' 173' ' ' MET . 24.8 m -51.66 -29.16 16.93 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.0 tt -52.36 -49.13 64.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 111.285 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -123.61 -19.78 5.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.988 -173.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -88.17 -9.65 52.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.847 0.356 . . . . 0.0 111.051 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.1 t -63.16 -12.78 30.34 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.1 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.447 ' HB3' ' HD2' ' A' ' 124' ' ' LYS . 22.6 t -74.97 74.7 2.19 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.654 0.74 . . . . 0.0 109.482 174.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -157.15 -69.75 0.1 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.503 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.4 mt -124.43 -43.16 2.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.353 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 t70 63.51 -168.48 0.2 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.767 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.478 ' HG3' ' N ' ' A' ' 167' ' ' TRP . 0.2 OUTLIER -154.94 -38.66 0.09 Allowed 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.184 177.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.478 ' N ' ' HG3' ' A' ' 166' ' ' ARG . 2.1 t90 -174.71 -63.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.756 0.313 . . . . 0.0 110.517 -172.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 171' ' ' ASN . 16.1 m -131.65 149.22 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.507 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.625 ' OE2' ' HA ' ' A' ' 23' ' ' ARG . 1.1 pm0 -91.83 -50.18 5.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.017 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.454 ' N ' ' HG2' ' A' ' 169' ' ' GLU . . . -81.23 -48.74 11.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.795 0.331 . . . . 0.0 111.65 -173.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.558 ' HB2' HG21 ' A' ' 168' ' ' VAL . 1.9 m-20 -60.98 -25.43 66.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.123 0.487 . . . . 0.0 111.129 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.427 ' OE1' ' HD3' ' A' ' 166' ' ' ARG . 19.1 tp10 -71.59 -21.04 61.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.175 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.494 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 68.7 mmm -65.93 -28.22 68.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.058 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.704 HD22 HD12 ' A' ' 149' ' ' LEU . 12.2 tp -95.79 -44.91 7.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 123.15 52.56 0.21 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.883 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mp 64.57 94.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.076 0.465 . . . . 0.0 110.832 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.586 ' HB3' HD21 ' A' ' 174' ' ' LEU . 11.0 t -177.99 130.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.714 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -128.58 132.42 7.26 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.41 HG21 ' HG ' ' A' ' 180' ' ' LEU . 24.9 mt -113.03 118.73 58.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.964 0.382 . . . . 0.0 111.518 -175.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.41 ' HG ' HG21 ' A' ' 179' ' ' ILE . 80.4 mt 59.73 103.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 168.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.538 ' HB1' ' HD2' ' A' ' 14' ' ' PRO . . . -93.17 129.44 39.3 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.966 173.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 4.3 Cg_exo -76.39 5.24 4.81 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.204 2.603 . . . . 0.0 112.272 177.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 64.97 9.36 5.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.043 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 109.59 -19.75 28.29 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.186 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -83.88 105.67 14.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.114 0.483 . . . . 0.0 110.552 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -137.73 -45.89 0.54 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.292 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' A' ' 187' ' ' LEU . 1.6 pt? -139.91 95.51 2.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.692 0.758 . . . . 0.0 110.755 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.055 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -70.21 116.41 10.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.17 -58.15 16.07 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.576 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.499 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 59.4 m-20 -131.91 155.57 47.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.803 0.335 . . . . 0.0 110.904 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.7 mt -136.54 -123.54 0.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.291 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 66.77 119.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.178 0.989 . . . . 0.0 111.814 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.8 5.32 77.97 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.478 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 11.3 mptt -113.24 164.77 13.12 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.43 ' HE1' HD11 ' A' ' 11' ' ' ILE . 36.5 p90 -136.82 159.54 41.54 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.028 0.442 . . . . 0.0 111.062 -176.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.7 pt -128.87 127.89 66.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.248 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.813 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.5 mp -92.99 123.43 45.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.39 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -115.59 101.27 8.71 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.6 m -122.68 98.86 42.66 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-O 120.929 0.395 . . . . 0.0 111.488 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.66 -5.27 13.19 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.998 2.466 . . . . 0.0 110.511 170.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.536 ' OE2' ' HD2' ' A' ' 185' ' ' ARG . 32.5 mt-10 70.22 159.12 0.19 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.336 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 46.8 ttp 70.57 144.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.683 -171.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.545 ' HA ' ' HB3' ' A' ' 20' ' ' TYR . 15.5 t70 -65.45 -99.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.4 t70 52.3 71.12 0.49 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.108 0.48 . . . . 0.0 110.492 -173.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 64.45 43.82 4.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.266 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.545 ' HB3' ' HA ' ' A' ' 17' ' ' ASP . 55.6 t80 -119.16 -38.56 3.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.252 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -59.21 -22.24 60.73 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -172.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -96.33 97.03 9.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.184 0.516 . . . . 0.0 110.162 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.542 ' HE ' HD21 ' A' ' 73' ' ' LEU . 3.0 tmm_? 57.17 86.21 0.07 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.994 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.9 t -114.54 143.89 44.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.992 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.81 HG13 HG13 ' A' ' 11' ' ' ILE . 40.2 t 63.55 109.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.809 0.814 . . . . 0.0 112.054 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.842 HG21 HG21 ' A' ' 39' ' ' VAL . 5.6 tp -134.36 -161.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.538 ' HD1' HG13 ' A' ' 26' ' ' ILE . 5.0 p90 -117.56 169.67 9.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.975 0.807 . . . . 0.0 111.876 -164.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.18 112.14 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.187 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.3 m -73.89 -46.23 45.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.093 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.662 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 36.4 tt0 -135.77 144.45 45.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.424 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.499 ' CD2' ' HA ' ' A' ' 4' ' ' ASN . 74.8 t60 -146.35 104.67 3.81 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -122.87 174.86 6.89 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.22 -21.79 66.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.389 0.614 . . . . 0.0 109.826 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -70.27 -31.23 68.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.194 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 160.91 -179.93 36.06 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.308 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.1 m -115.64 127.68 55.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.654 0.264 . . . . 0.0 110.623 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.662 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.2 mp -112.84 115.92 51.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.415 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.32 163.71 26.0 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.842 HG21 HG21 ' A' ' 26' ' ' ILE . 18.3 m -123.84 36.88 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.501 0.667 . . . . 0.0 110.884 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.697 ' HA ' HG23 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -84.97 15.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -169.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 pt -64.62 -25.91 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.567 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.1 t-20 64.85 93.11 0.07 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.416 0.447 . . . . 0.0 111.996 176.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.567 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 12.4 t 169.48 137.77 0.06 OUTLIER Pre-proline 0 C--O 1.24 0.569 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.184 175.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.877 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 93.0 Cg_endo -85.18 176.88 5.56 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.728 2.285 . . . . 0.0 111.052 170.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 p -116.59 176.34 5.16 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.428 176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -91.12 5.62 48.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.943 0.877 . . . . 0.0 109.566 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 tp -106.66 156.4 18.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.487 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.543 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 10.5 m -100.27 151.49 21.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.539 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.7 p -65.54 -33.89 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 64' ' ' ARG . 35.8 mt -68.33 -26.62 65.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.621 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 48' ' ' SER . 4.2 mm-40 -63.16 -47.28 83.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.562 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.6 -39.17 88.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.514 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 89.3 mt -64.8 -43.73 92.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.291 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.599 HG22 ' HD2' ' A' ' 64' ' ' ARG . 17.8 p -72.55 -29.09 63.25 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -56.63 -43.45 80.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.046 0.45 . . . . 0.0 110.169 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.8 mtm -87.8 -24.7 23.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.615 176.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 73.8 137.27 0.05 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.253 1.021 . . . . 0.0 110.48 -173.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -139.33 -52.08 0.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.488 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -145.22 161.12 40.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.723 0.296 . . . . 0.0 110.417 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.9 ttp -72.65 124.1 24.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.222 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 62' ' ' LYS . . . 63.13 -113.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.598 169.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 52.1 mttm 67.13 159.66 0.14 Allowed Pre-proline 0 C--O 1.234 0.274 0 O-C-N 123.637 0.586 . . . . 0.0 111.752 -173.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.53 111.29 1.61 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.462 2.108 . . . . 0.0 110.785 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.67 ' HA ' HD12 ' A' ' 50' ' ' LEU . 47.6 ptt85 -156.14 7.98 0.22 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.948 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.7 mt -142.29 -48.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.474 ' O ' ' HB ' ' A' ' 67' ' ' THR . 75.8 m-85 -110.42 158.61 18.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.063 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 66' ' ' TYR . 47.4 m 76.57 151.61 0.12 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -67.37 112.1 4.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.12 0.486 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -87.7 -162.16 0.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.505 -172.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -125.55 123.12 38.4 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.609 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.543 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 1.9 mpt? -76.73 157.75 31.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.849 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.98 140.23 18.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.877 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 10.4 mp -104.39 152.26 22.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.876 0.37 . . . . 0.0 110.581 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -85.48 141.99 29.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.589 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.41 -25.39 7.02 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.703 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.83 170.94 30.46 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.974 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.64 -3.17 12.73 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.191 2.594 . . . . 0.0 112.96 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.4 t -102.23 146.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 61.45 42.84 10.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.933 0.397 . . . . 0.0 111.096 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.823 ' HA ' HE21 ' A' ' 80' ' ' GLN . 0.0 OUTLIER -65.06 -10.9 33.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -176.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.28 -12.55 56.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.73 0.3 . . . . 0.0 110.75 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -130.27 128.89 42.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.314 0.578 . . . . 0.0 112.068 -167.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.52 125.34 7.99 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.21 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.551 ' HB3' HD13 ' A' ' 106' ' ' LEU . 64.7 m-85 -99.99 126.15 46.13 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.444 HG12 HG12 ' A' ' 112' ' ' VAL . 3.8 mp -114.57 122.41 68.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.118 0.485 . . . . 0.0 110.989 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -101.59 125.23 55.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.533 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -131.18 160.7 34.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.609 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.1 p -71.55 132.78 45.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.08 0.467 . . . . 0.0 109.948 174.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.624 ' HB3' ' HA ' ' A' ' 103' ' ' ASP . 9.2 tmtt? -67.76 122.65 18.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.465 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.8 t -152.65 -12.93 0.17 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.307 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -83.57 159.69 21.58 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.69 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -148.52 104.89 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 65.95 -179.03 0.19 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.68 0.613 . . . . 0.0 110.634 -175.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 70.11 -61.7 0.45 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.224 0.609 . . . . 0.0 111.348 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.535 HG23 ' HB3' ' A' ' 111' ' ' ASP . 2.0 p -75.11 133.91 41.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.338 0.59 . . . . 0.0 110.77 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.6 m80 -82.36 61.79 5.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.905 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.5 m -85.46 138.39 32.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -100.69 123.32 44.73 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.598 ' HD2' ' HA ' ' A' ' 102' ' ' ASP . 28.8 ttpp -83.68 106.58 15.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.343 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.4 HG12 ' HE2' ' A' ' 27' ' ' TYR . 51.9 t -70.45 -54.01 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.226 0.536 . . . . 0.0 109.87 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -124.84 -54.6 1.63 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.562 176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.598 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 14.9 t70 -177.1 -72.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.624 ' HA ' ' HB3' ' A' ' 89' ' ' LYS . 6.7 m-20 -77.27 -3.97 42.51 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.041 0.448 . . . . 0.0 111.396 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.663 HG13 HD13 ' A' ' 158' ' ' LEU . 51.6 mm -106.41 122.55 60.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.66 128.32 43.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.238 0.542 . . . . 0.0 111.624 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.551 HD13 ' HB3' ' A' ' 84' ' ' PHE . 63.3 tp -102.85 121.22 42.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.45 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 111' ' ' ASP . 4.2 m -126.82 134.46 50.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.623 0.249 . . . . 0.0 110.435 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -147.34 3.26 0.77 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.237 0.542 . . . . 0.0 111.392 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.495 ' HB2' ' OD1' ' A' ' 111' ' ' ASP . 14.2 m -85.9 15.05 5.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.332 . . . . 0.0 111.667 -174.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.19 -23.37 35.63 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.53 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.535 ' HB3' HG23 ' A' ' 95' ' ' THR . 3.0 m-20 -51.34 -37.65 48.95 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.298 0.639 . . . . 0.0 111.545 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.444 HG12 HG12 ' A' ' 85' ' ' ILE . 60.1 t -47.98 -40.84 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.971 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.533 ' HA ' ' CE2' ' A' ' 116' ' ' PHE . 98.0 mt -62.88 -32.73 74.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.072 0.463 . . . . 0.0 110.933 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.18 -35.87 35.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.54 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.1 m -56.21 -50.34 71.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.811 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.533 ' CE2' ' HA ' ' A' ' 113' ' ' LEU . 40.7 p90 -79.64 11.57 3.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.588 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.92 16.56 13.37 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.855 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 76.7 p -111.63 177.7 4.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.373 . . . . 0.0 110.781 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -83.21 -26.45 30.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.61 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 p -96.88 20.8 10.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.432 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -51.21 136.61 29.62 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.542 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 23.6 Cg_exo -62.16 150.78 85.44 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.028 2.485 . . . . 0.0 112.613 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -59.58 -49.6 77.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.911 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -143.59 146.21 33.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.559 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -152.1 137.52 17.64 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.473 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.13 148.11 16.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.447 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.76 129.45 74.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.191 0.52 . . . . 0.0 110.905 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.431 ' SG ' HG11 ' A' ' 39' ' ' VAL . 5.7 p -126.27 124.75 41.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.398 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' A' ' 129' ' ' LEU . 1.2 tm? -84.22 119.0 24.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.343 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.81 178.78 27.32 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.539 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.5 m -147.81 171.96 14.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.86 0.362 . . . . 0.0 110.046 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 37.6 m -111.57 121.24 44.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.104 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.8 p -96.76 115.33 27.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.174 0.511 . . . . 0.0 111.364 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -101.35 149.9 23.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.473 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.481 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 1.5 mppt? -86.78 130.28 49.34 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.778 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 7.5 Cg_exo -73.32 44.5 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.538 2.825 . . . . 0.0 114.335 -168.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -154.11 -39.23 0.09 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.369 . . . . 0.0 110.545 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.523 ' HA ' ' OE1' ' A' ' 138' ' ' GLN . 5.5 tp60 -75.79 -30.72 59.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.693 -175.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 143' ' ' ILE . 60.1 tp -57.87 -38.83 76.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.013 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.9 -42.12 97.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.041 0.448 . . . . 0.0 110.526 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.57 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 31.0 mm-40 -68.17 -39.24 82.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.437 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.598 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 14.1 mm-40 -62.03 -43.34 99.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.167 0.508 . . . . 0.0 110.486 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 150' ' ' LEU . 77.1 mt -65.26 -39.4 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.096 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.42 73.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.536 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 67.1 mt-30 -78.76 2.95 18.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.372 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 19.1 m120 67.18 15.51 10.04 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.345 0.658 . . . . 0.0 112.265 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.427 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 57.0 m-85 -79.94 -21.79 43.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.35 0.595 . . . . 0.0 109.769 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.598 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 97.5 m95 -127.29 114.82 18.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.707 175.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.813 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 24.7 mt -86.36 103.09 14.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.529 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.485 ' HB2' HD12 ' A' ' 143' ' ' ILE . 60.3 tp -86.87 132.96 33.67 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.345 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.9 m -156.75 152.44 26.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.176 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.437 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -91.18 153.99 19.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.111 0.481 . . . . 0.0 110.651 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.52 114.25 28.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.62 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.99 68.09 3.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.226 0.536 . . . . 0.0 109.919 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 16.6 m120 65.5 -80.48 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.021 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -60.6 -42.92 97.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.857 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 11.8 m -54.24 -30.45 50.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.663 HD13 HG13 ' A' ' 104' ' ' ILE . 5.5 tt -62.68 -57.59 10.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.285 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -121.45 -23.13 5.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -170.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -100.2 -61.25 1.39 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 162' ' ' SER . 6.5 t 36.2 83.49 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.184 0.994 . . . . 0.0 112.107 -174.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 161' ' ' THR . 41.5 m 77.48 2.23 3.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.314 -174.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 86.6 t80 72.21 -42.17 0.53 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.196 0.998 . . . . 0.0 113.031 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 32.5 mt -50.78 -67.73 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -171.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -161.62 166.55 26.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -157.99 136.53 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.09 0.472 . . . . 0.0 111.691 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.432 ' HE3' ' H ' ' A' ' 23' ' ' ARG . 95.3 m95 -133.02 -50.54 0.88 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.658 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.4 p -129.98 -2.71 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.232 -172.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -59.91 -5.13 0.88 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.02 -29.27 70.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.896 0.379 . . . . 0.0 110.526 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -80.32 -24.09 40.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.474 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -59.43 -42.42 91.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.383 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -58.9 -31.68 68.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.158 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.738 ' HG ' ' HB ' ' A' ' 179' ' ' ILE . 7.5 tt -81.65 -46.43 14.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.549 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -61.41 -41.7 99.6 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.158 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 78.0 mt -66.6 -48.67 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.653 0.263 . . . . 0.0 111.235 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.1 m -76.43 -24.54 53.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.44 56.75 3.55 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.989 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.738 ' HB ' ' HG ' ' A' ' 174' ' ' LEU . 50.9 mm -85.15 132.12 32.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.573 0.225 . . . . 0.0 111.133 -176.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.711 ' HG ' HG23 ' A' ' 179' ' ' ILE . 87.3 mt 67.0 -163.86 0.23 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.271 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.72 114.39 19.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 111.758 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.32 140.05 21.58 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.54 2.16 . . . . 0.0 112.197 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 62.88 23.41 13.98 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.239 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -94.17 28.69 10.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.547 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.536 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 21.3 ptt180 -92.76 -166.28 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.3 -75.69 0.5 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.415 -173.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 74.3 mt 57.14 19.26 4.66 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.343 0.402 . . . . 0.0 111.487 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.664 -177.888 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -109.78 44.63 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.303 0.573 . . . . 0.0 110.508 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.94 -1.06 77.85 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.789 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -159.61 156.71 28.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.3 mt -129.4 -170.41 2.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.341 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 68.09 112.18 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.701 0.625 . . . . 0.0 110.892 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.29 3.58 65.04 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 12.6 mptt -106.22 171.24 7.45 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.412 ' CD1' ' HB1' ' A' ' 153' ' ' ALA . 54.9 p90 -140.43 150.73 44.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.803 0.335 . . . . 0.0 110.443 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 pt -109.14 130.75 61.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.226 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.649 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 2.8 mp -76.99 131.41 34.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.099 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' HB1' ' HB ' ' A' ' 24' ' ' THR . . . -57.66 137.26 56.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.973 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -80.63 110.38 16.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.063 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.579 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 20.2 Cg_exo -65.41 118.84 5.81 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.897 2.398 . . . . 0.0 111.849 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HA ' ' H ' ' A' ' 185' ' ' ARG . 7.1 pt-20 -148.58 -16.97 0.32 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -126.86 -54.93 1.4 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -167.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -117.06 -64.57 1.29 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.056 0.455 . . . . 0.0 111.619 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 20' ' ' TYR . 19.0 t70 -171.74 -45.76 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -172.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.579 ' HG2' ' HA ' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 72.06 1.77 4.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.059 171.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.476 ' HB2' ' OD2' ' A' ' 18' ' ' ASP . 96.7 m-85 -100.19 -27.68 13.39 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 161.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -61.23 -54.2 47.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.713 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -92.54 129.04 38.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -82.52 59.87 4.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.197 0.522 . . . . 0.0 110.511 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.54 ' HA ' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -75.17 55.84 0.77 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.021 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 p -173.4 113.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.864 HG22 ' HD1' ' A' ' 27' ' ' TYR . 44.2 mm -120.71 -83.97 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.938 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.864 ' HD1' HG22 ' A' ' 26' ' ' ILE . 9.9 p90 -173.31 170.21 4.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.049 0.452 . . . . 0.0 111.15 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 mm -102.52 121.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.955 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.2 m -76.97 -46.37 24.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.439 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -151.07 159.27 44.61 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 79.2 t60 -148.12 138.2 22.63 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -174.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 t30 77.87 164.84 0.23 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.22 0.95 . . . . 0.0 111.547 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 68.52 -71.61 0.11 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.675 0.79 . . . . 0.0 112.145 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -88.41 -26.08 22.34 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.79 -177.19 20.38 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.109 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' A' ' 134' ' ' TRP . 23.8 m -100.0 101.85 13.05 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 37' ' ' ILE . 4.5 mp -95.22 112.0 26.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.41 157.36 27.23 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.005 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.43 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 4.3 m -123.53 93.74 2.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.266 0.555 . . . . 0.0 110.295 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.56 8.15 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.156 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 pt -80.92 -27.61 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 24' ' ' THR . 13.5 t30 38.96 85.98 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.237 0.961 . . . . 0.0 112.84 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 6.6 t -143.66 112.2 5.4 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-O 121.252 0.549 . . . . 0.0 109.95 176.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 4.8 Cg_exo -76.97 152.57 31.93 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.213 1.942 . . . . 0.0 111.318 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 p -124.88 163.15 22.85 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.716 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -82.82 1.06 41.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.191 0.52 . . . . 0.0 110.743 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.667 HD21 HD21 ' A' ' 52' ' ' LEU . 54.7 tp -83.36 144.48 29.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.235 173.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.66 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 14.5 m -104.19 145.66 29.89 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.7 p -63.57 -33.36 61.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.548 HD23 HD11 ' A' ' 53' ' ' LEU . 90.3 mt -66.99 -33.06 74.76 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.571 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.66 ' HG3' ' HB2' ' A' ' 48' ' ' SER . 32.8 mt-10 -61.26 -43.34 99.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.242 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.667 HD21 HD21 ' A' ' 47' ' ' LEU . 96.4 mt -67.91 -33.38 74.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.303 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.782 ' HB3' ' HB3' ' A' ' 58' ' ' PHE . 94.0 mt -69.67 -42.07 74.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.9 m -62.22 -39.75 93.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.351 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -58.48 -39.89 81.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.383 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.9 mtt -86.6 -91.89 0.1 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.123 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -165.92 77.04 0.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.082 0.467 . . . . 0.0 109.807 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.782 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 25.7 t80 -165.2 138.72 4.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.761 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -139.64 151.29 45.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.38 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 68.7 mtt 69.98 -149.45 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.685 0.616 . . . . 0.0 111.168 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 71.11 69.0 0.17 Allowed 'General case' 0 N--CA 1.462 0.133 0 O-C-N 123.925 0.765 . . . . 0.0 111.58 -177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.4 mttp 64.58 81.17 0.22 Allowed Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.152 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' A' ' 69' ' ' ASP . 38.3 Cg_endo -67.79 -42.68 6.26 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.651 2.234 . . . . 0.0 112.935 -175.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 55.48 85.71 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.491 0.494 . . . . 0.0 110.491 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.4 mp -81.0 -43.75 20.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -170.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -60.66 -60.32 3.99 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.818 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 t -83.12 114.15 21.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -41.67 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -164.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.536 ' HB3' HD11 ' A' ' 50' ' ' LEU . 1.1 m-20 48.07 -108.07 0.23 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.953 177.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -152.18 90.88 1.55 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.1 ptm -71.15 140.48 50.57 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.378 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.708 HG21 HD22 ' A' ' 129' ' ' LEU . 11.0 p -108.21 149.79 11.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.621 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.4 mp -94.29 152.88 18.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.404 . . . . 0.0 110.12 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.74 124.93 34.6 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.38 -26.26 21.35 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.851 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.86 164.47 15.09 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.871 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.68 -18.71 22.04 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.473 2.115 . . . . 0.0 112.627 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.407 HG22 ' OG1' ' A' ' 133' ' ' THR . 42.8 t -90.13 133.34 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.232 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 65.77 27.9 11.05 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 110.205 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.42 -17.7 64.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.044 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.59 -10.69 60.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.501 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -125.43 144.49 50.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.055 0.455 . . . . 0.0 110.436 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.31 120.91 7.03 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -98.74 126.55 44.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.749 0.309 . . . . 0.0 110.233 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.438 ' HB ' HG13 ' A' ' 112' ' ' VAL . 3.5 mp -113.07 112.7 41.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.194 0.521 . . . . 0.0 109.987 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.3 t -94.25 114.65 31.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.147 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -116.33 148.93 40.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.53 -174.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 m -82.39 150.25 27.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.974 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.574 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 43.8 tttm -70.16 114.0 7.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.836 0.827 . . . . 0.0 111.551 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.545 HG21 ' HG3' ' A' ' 123' ' ' GLU . 3.2 m -135.28 11.58 3.53 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.641 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -160.13 -173.08 3.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.167 -164.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -158.86 27.23 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.666 173.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -103.58 169.3 8.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.386 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.6 p90 176.74 157.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.038 0.446 . . . . 0.0 111.558 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 p -102.83 -37.72 7.73 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 164.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -168.15 91.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.152 169.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.2 m -100.63 167.42 10.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.51 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.497 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 12.6 t80 -124.57 98.18 5.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.417 ' HA ' HG22 ' A' ' 105' ' ' THR . 86.3 tttt -73.27 108.37 6.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 -177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.3 -59.03 3.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.95 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.466 ' C ' ' H ' ' A' ' 103' ' ' ASP . 58.5 p -117.14 -176.33 2.97 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.407 ' HA ' ' CE ' ' A' ' 99' ' ' LYS . 31.0 t70 -82.22 34.2 0.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.821 0.819 . . . . 0.0 109.701 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.574 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 12.9 t0 -158.12 -67.25 0.09 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.437 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.86 121.93 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.673 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 99' ' ' LYS . 24.0 m -134.6 134.17 40.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.956 -173.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 63.6 tp -84.73 132.82 34.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.137 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.519 ' HB ' HG11 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -136.63 143.84 43.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.6 t -179.88 21.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.949 0.404 . . . . 0.0 111.32 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.0 t -101.22 8.52 42.53 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.613 -0.679 . . . . 0.0 111.207 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.76 -30.03 6.58 Favored Glycine 0 CA--C 1.509 -0.296 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -45.28 -50.39 11.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.411 -0.894 . . . . 0.0 111.407 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.519 HG11 ' HB ' ' A' ' 107' ' ' THR . 17.5 m -47.81 -45.06 11.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.904 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.19 -30.8 69.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.422 . . . . 0.0 110.789 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -77.99 -33.74 51.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.576 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.0 m -60.66 -62.86 1.55 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.403 -174.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -74.3 -2.77 26.53 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.797 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -96.26 3.67 64.19 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.222 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.4 t -138.89 171.82 13.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -82.26 4.92 21.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.661 0.267 . . . . 0.0 111.49 -175.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 69.2 p -102.97 15.73 28.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.906 0.384 . . . . 0.0 110.816 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.44 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -58.17 141.04 82.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.017 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 19.7 Cg_exo -65.16 146.01 85.74 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.763 2.308 . . . . 0.0 111.986 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.545 ' HG3' HG21 ' A' ' 90' ' ' THR . 38.1 mt-10 -65.4 -37.76 87.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.482 -176.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 123' ' ' GLU . 12.1 mtmt -128.41 132.15 48.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.353 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -163.55 147.53 10.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.447 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.1 pt -126.47 143.74 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.979 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.571 HG13 HG22 ' A' ' 72' ' ' VAL . 6.4 p -114.78 129.4 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.054 0.454 . . . . 0.0 110.588 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.8 p -134.73 136.08 42.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.382 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.708 HD22 HG21 ' A' ' 72' ' ' VAL . 4.0 mm? -86.52 120.99 28.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.356 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.76 -179.15 38.35 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.704 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 61.2 m -145.65 167.49 22.98 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.455 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 33.9 m -102.4 122.73 44.86 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 36' ' ' THR . 39.5 p -107.46 120.35 41.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.043 0.449 . . . . 0.0 112.162 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.601 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 1.5 m-90 -96.02 144.75 26.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.316 170.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -65.05 156.02 82.03 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.394 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.1 133.95 40.55 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.144 1.896 . . . . 0.0 110.642 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.449 ' HA ' ' CG ' ' A' ' 140' ' ' GLU . 49.4 m80 63.74 29.5 14.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.242 0.544 . . . . 0.0 111.325 -175.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 55.5 tp60 -106.29 -68.89 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.225 173.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.506 ' O ' HG13 ' A' ' 143' ' ' ILE . 52.4 tp -63.14 -47.06 84.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.784 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.449 ' CG ' ' HA ' ' A' ' 137' ' ' HIS . 10.9 pt-20 -58.44 -34.21 70.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -65.77 -51.17 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.726 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -71.85 -29.85 64.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.36 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.571 HG12 ' HB2' ' A' ' 148' ' ' TRP . 71.5 mt -61.07 -43.59 96.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.44 -30.32 71.1 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 42.1 mt-30 -81.16 5.46 16.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.365 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 71.93 30.97 2.14 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.309 0.643 . . . . 0.0 112.369 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -93.84 -3.82 51.21 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.165 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.571 ' HB2' HG12 ' A' ' 143' ' ' ILE . 96.0 m95 -139.43 160.64 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.268 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.649 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 3.1 tt -113.08 118.62 35.27 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 8' ' ' LYS . 35.5 tp -105.08 148.58 26.66 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.994 0.425 . . . . 0.0 111.707 -175.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.5 t -159.69 166.84 29.74 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -106.24 154.1 21.21 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.983 -178.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.412 ' HB1' ' CD1' ' A' ' 9' ' ' PHE . . . -120.9 151.78 39.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.57 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.41 -61.15 1.78 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.522 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 103' ' ' ASP . 24.8 p-10 -170.8 -59.67 0.02 OUTLIER 'General case' 0 C--O 1.235 0.316 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 45.6 mt-30 -56.94 -41.94 79.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -173.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.44 ' HA ' ' OG1' ' A' ' 161' ' ' THR . 21.4 m -55.56 -32.87 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.37 -51.98 4.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -99.37 -23.34 15.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 39.5 mt-10 -111.83 -25.75 9.29 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -166.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.541 HG21 ' HG3' ' A' ' 169' ' ' GLU . 34.0 m -46.47 -42.46 15.51 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -174.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.3 m -58.83 -19.52 42.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -86.93 -52.68 5.32 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 164' ' ' LEU . 1.3 pt? -83.96 -35.87 23.67 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -173.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -99.45 -171.83 2.14 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -119.09 -57.11 2.04 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.781 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.444 ' CE3' HG23 ' A' ' 168' ' ' VAL . 2.2 t90 -166.74 140.76 3.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -175.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.444 HG23 ' CE3' ' A' ' 167' ' ' TRP . 95.6 t 69.82 90.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.786 0.679 . . . . 0.0 111.118 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.541 ' HG3' HG21 ' A' ' 161' ' ' THR . 0.0 OUTLIER -118.16 -41.19 2.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.842 178.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.77 -43.87 94.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.662 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -76.5 -26.32 55.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 0.0 110.344 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.34 -29.55 66.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.936 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.0 tpt -60.59 -32.65 71.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.116 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.555 HD12 HD23 ' A' ' 149' ' ' LEU . 13.0 tp -77.35 -42.68 35.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.908 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 112.93 -18.41 21.82 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.698 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.3 mt 63.87 81.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.046 0.538 . . . . 0.0 111.195 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.9 t -122.58 -46.76 2.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.515 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -157.99 121.52 1.07 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.552 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 12.8 tt -114.28 134.08 58.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.04 0.447 . . . . 0.0 110.338 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 92.7 mt -91.09 114.24 26.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.405 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -159.89 100.57 1.46 Allowed Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.421 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.86 108.75 2.59 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.903 2.402 . . . . 0.0 111.615 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 62.75 58.4 1.59 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.316 0.579 . . . . 0.0 110.305 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -96.15 143.64 16.81 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.613 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.452 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 18.5 mmt180 -128.4 98.28 5.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.144 0.497 . . . . 0.0 111.545 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.67 12.55 37.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.819 171.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -158.85 166.81 31.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.799 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.342 178.182 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.549 ' HB3' ' HB3' ' A' ' 140' ' ' GLU . 15.5 tpt . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.769 0.318 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -87.93 -21.87 24.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.862 0.363 . . . . 0.0 110.597 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.16 -150.59 17.52 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.865 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -90.47 105.55 17.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.236 0.541 . . . . 0.0 110.765 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.03 -93.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.205 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 65.15 117.07 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.191 0.52 . . . . 0.0 111.46 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.97 -4.27 74.7 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.391 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.481 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 2.3 mptp? -105.58 163.79 12.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.534 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 48.7 p90 -140.7 149.52 42.3 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.221 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.572 HD11 HG13 ' A' ' 40' ' ' ILE . 16.4 pt -98.17 145.01 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.43 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.706 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 45.1 mm -81.68 95.62 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.489 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -102.94 -44.93 5.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.757 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.601 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 52.0 p 56.3 -179.95 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 123.7 0.8 . . . . 0.0 111.224 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.601 ' HD2' ' HB ' ' A' ' 13' ' ' THR . 27.4 Cg_exo -64.0 -57.79 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.321 1.347 . . . . 0.0 110.499 169.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 176.0 72.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 54.2 ttp 74.05 -54.67 0.68 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.095 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 18' ' ' ASP . 8.5 t70 -145.62 -166.39 2.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.4 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 1.1 t70 69.42 -166.23 0.17 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.534 0.734 . . . . 0.0 111.59 176.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' HB3' ' H ' ' A' ' 20' ' ' TYR . 6.1 tp10 64.36 -92.43 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -173.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.458 ' H ' ' HB3' ' A' ' 19' ' ' GLU . 0.1 OUTLIER 173.14 -96.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.62 0.768 . . . . 0.0 111.038 167.332 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -173.82 15.07 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.717 0.294 . . . . 0.0 111.383 -174.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -105.43 110.37 22.7 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -168.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 66.98 16.89 10.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.933 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.6 p -92.48 131.53 37.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.329 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.0 t 74.25 82.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 O-C-N 123.885 0.741 . . . . 0.0 111.28 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.509 ' CG2' ' H ' ' A' ' 27' ' ' TYR . 16.3 mm -107.76 -166.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.534 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 7.2 p90 -114.86 175.18 5.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.521 0.6 . . . . 0.0 111.683 -167.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.9 mm -86.13 112.55 22.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.358 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.9 -55.2 28.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.386 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -144.17 127.48 16.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.868 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -108.89 99.68 8.99 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 158.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -112.31 59.72 0.63 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.896 -166.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t70 63.2 -66.76 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.97 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.46 -39.45 11.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.75 147.57 17.07 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.886 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.631 ' O ' ' HA ' ' A' ' 133' ' ' THR . 26.2 m -133.79 102.73 5.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.468 HG13 HG22 ' A' ' 133' ' ' THR . 4.5 mp -111.02 121.77 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.32 -174.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.46 162.48 29.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.92 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 5.7 m -125.81 91.2 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.27 0.557 . . . . 0.0 110.215 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.572 HG13 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -135.85 16.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.401 HD12 ' HA2' ' A' ' 76' ' ' GLY . 26.9 pt -80.92 -20.89 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.247 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 61.15 47.93 6.75 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 167.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t -146.06 133.98 10.54 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.431 -177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.689 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 61.9 Cg_endo -73.89 165.44 32.14 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.973 2.449 . . . . 0.0 112.366 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.533 HG23 ' ND2' ' A' ' 74' ' ' ASN . 31.1 p -99.54 -166.2 1.32 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.966 0.413 . . . . 0.0 110.034 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.5 12.37 27.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.885 0.85 . . . . 0.0 108.848 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.9 tp -109.86 146.84 34.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.586 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 19.7 m -95.81 149.2 21.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.676 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.514 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.4 p -63.9 -30.47 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.297 0.57 . . . . 0.0 109.998 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.7 ' HB3' ' HB3' ' A' ' 63' ' ' PRO . 86.7 mt -75.19 -26.65 59.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.367 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.0 OUTLIER -68.67 -40.67 80.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.377 -176.29 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.643 HD23 HD23 ' A' ' 129' ' ' LEU . 3.9 pp -71.78 -30.51 65.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.064 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 88.5 mt -66.3 -48.42 70.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.323 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.0 p -61.0 -30.24 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.195 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -72.62 -52.8 13.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.4 mtt -90.91 -92.46 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.505 0.193 . . . . 0.0 110.685 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -136.92 146.24 45.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.544 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 12.3 p90 -129.21 -30.86 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 69.56 128.02 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.135 0.493 . . . . 0.0 111.316 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.449 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 68.4 mtt 59.73 -156.81 0.34 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.687 -178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.449 ' H ' ' HB3' ' A' ' 60' ' ' MET . . . -115.68 38.39 3.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.239 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -53.94 36.06 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.823 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.7 ' HB3' ' HB3' ' A' ' 50' ' ' LEU . 12.3 Cg_exo -72.32 79.25 1.8 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.178 1.919 . . . . 0.0 111.251 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -135.39 -2.31 2.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.595 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.83 120.78 56.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.695 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.41 173.56 6.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.916 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.1 m 77.05 -47.51 0.52 Allowed 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.784 0.677 . . . . 0.0 110.376 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -102.61 34.12 2.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.243 1.021 . . . . 0.0 108.766 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -93.13 158.64 15.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.818 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -96.38 125.92 41.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.431 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.553 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 66.5 mtt -84.43 149.88 25.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.362 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.586 HG21 HD21 ' A' ' 129' ' ' LEU . 12.7 p -100.58 150.23 5.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.725 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.689 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.0 mp -99.74 164.41 12.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.255 0.55 . . . . 0.0 111.678 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.533 ' ND2' HG23 ' A' ' 45' ' ' THR . 47.9 m-80 -81.84 124.43 29.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.705 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -83.89 -27.6 37.4 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.601 173.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.41 ' HA3' ' C ' ' A' ' 131' ' ' CYS . . . 168.98 175.11 38.11 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -86.51 3.24 6.9 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.948 2.432 . . . . 0.0 112.511 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.403 HG12 HD21 ' A' ' 79' ' ' ASN . 21.9 t -109.06 121.25 61.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.238 -175.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.403 HD21 HG12 ' A' ' 78' ' ' VAL . 54.5 m-80 55.83 56.49 6.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.009 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.443 ' O ' HD13 ' A' ' 129' ' ' LEU . 84.3 mt-30 -70.93 -7.5 46.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.682 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.89 -10.02 58.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.262 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -112.26 131.36 55.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.939 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.41 117.75 5.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.807 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.511 ' HB3' HD11 ' A' ' 106' ' ' LEU . 71.9 m-85 -102.6 126.08 49.55 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.431 HG21 HG22 ' A' ' 112' ' ' VAL . 4.4 mp -119.88 107.77 21.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 0.0 110.544 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.717 HG21 HD12 ' A' ' 106' ' ' LEU . 12.5 t -91.8 120.66 41.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -134.9 158.83 43.25 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.441 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.5 t -76.21 167.86 21.1 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.146 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.606 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER -76.25 114.76 15.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.831 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 122' ' ' PRO . 1.5 p -116.3 -2.94 12.01 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.013 172.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.532 ' CG ' ' H ' ' A' ' 92' ' ' HIS . 17.1 t70 -175.68 -145.79 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.532 ' H ' ' CG ' ' A' ' 91' ' ' ASP . 37.4 m80 -88.48 -159.68 0.58 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.586 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 4.1 mp0 -76.19 169.93 17.26 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -117.48 -161.0 0.8 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.6 m -59.9 -37.45 79.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.623 0.249 . . . . 0.0 111.566 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -152.79 80.98 1.22 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.141 0.496 . . . . 0.0 110.342 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 75.0 m -133.77 143.89 48.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.479 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -102.21 128.41 48.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.293 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.586 ' HD3' ' HG3' ' A' ' 93' ' ' GLU . 5.1 tptm -90.65 110.36 21.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.9 t -81.3 -71.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.054 0.454 . . . . 0.0 110.461 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 t -130.48 67.07 1.49 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.481 0.658 . . . . 0.0 110.758 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.564 ' O ' ' HE2' ' A' ' 99' ' ' LYS . 28.1 t70 66.78 -69.83 0.12 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.412 176.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.606 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 11.0 t70 -77.74 -55.43 5.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.228 0.537 . . . . 0.0 110.019 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.423 HD11 ' CD1' ' A' ' 159' ' ' PHE . 33.0 mm -64.93 122.78 16.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.452 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.1 m -128.75 131.09 47.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.837 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.717 HD12 HG21 ' A' ' 86' ' ' VAL . 55.4 tp -107.75 112.61 25.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.083 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.5 m -96.6 124.77 40.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.408 HG22 ' CD2' ' A' ' 84' ' ' PHE . 60.2 p -107.36 17.1 23.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.1 m -147.7 -177.19 5.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.741 0.305 . . . . 0.0 111.184 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.44 -3.01 23.66 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.391 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -49.31 -32.8 11.77 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.961 0.905 . . . . 0.0 110.999 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.431 HG22 HG21 ' A' ' 85' ' ' ILE . 10.3 p -54.71 -34.68 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.972 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.73 -37.71 79.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.176 0.512 . . . . 0.0 110.492 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.28 -24.03 63.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.723 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -72.29 -18.29 61.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.213 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -97.01 144.93 26.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 0.0 110.767 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.26 -17.76 21.73 Favored Glycine 0 C--N 1.328 0.124 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.822 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 120' ' ' THR . 2.8 p -92.03 25.78 2.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -175.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 74.01 -39.82 0.44 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.607 0.763 . . . . 0.0 111.351 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 118' ' ' THR . 24.9 p -81.17 18.42 1.08 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.46 123.64 67.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.76 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.741 ' HA ' HG21 ' A' ' 90' ' ' THR . 29.7 Cg_endo -64.31 136.26 50.42 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.628 2.219 . . . . 0.0 112.862 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -66.71 -47.65 71.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.136 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -124.39 127.76 48.04 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.178 -174.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -155.9 152.36 28.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.51 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.8 pt -129.45 132.46 66.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.156 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.501 HG12 HG22 ' A' ' 72' ' ' VAL . 6.8 p -112.09 134.59 54.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.193 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 84.0 m -140.24 139.65 35.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.066 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.643 HD23 HD23 ' A' ' 52' ' ' LEU . 4.3 mm? -89.84 118.44 29.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.962 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.403 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 76.47 177.82 44.6 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.057 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . 0.41 ' C ' ' HA3' ' A' ' 76' ' ' GLY . 73.5 m -145.6 171.58 14.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.904 0.383 . . . . 0.0 110.048 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.447 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 19.3 m -100.26 115.59 30.26 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 36' ' ' THR . 44.0 p -108.35 134.74 50.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.774 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.679 ' CD1' ' HB2' ' A' ' 139' ' ' LEU . 1.1 m-90 -119.9 165.02 15.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.302 0.572 . . . . 0.0 110.343 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -91.61 140.73 25.29 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.603 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.36 61.28 4.19 Favored 'Trans proline' 0 N--CA 1.473 0.313 0 C-N-CA 123.269 2.646 . . . . 0.0 113.298 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -167.73 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.59 ' HG3' ' OE2' ' A' ' 142' ' ' GLU . 52.2 tp60 -65.77 -68.36 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.377 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.679 ' HB2' ' CD1' ' A' ' 134' ' ' TRP . 55.8 tp -52.77 -42.02 64.6 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.887 0.375 . . . . 0.0 111.721 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 50.7 mt-10 -60.54 -32.85 71.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.078 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.586 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 25.3 mt-30 -72.31 -45.62 59.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.07 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.703 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 1.1 mp0 -54.42 -41.91 69.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.768 0.318 . . . . 0.0 111.199 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 139' ' ' LEU . 86.3 mt -56.91 -42.61 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.147 0.498 . . . . 0.0 110.538 175.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.46 -20.57 63.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.658 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.586 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 38.1 mt-30 -88.82 6.39 39.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.954 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 145' ' ' GLN . 14.0 m120 69.15 13.24 8.65 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.549 0.53 . . . . 0.0 111.233 -178.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -81.6 -21.86 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.714 0.768 . . . . 0.0 109.004 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.703 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 99.3 m95 -133.26 131.18 39.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.861 172.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.706 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 98.8 mt -95.64 155.3 16.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.5 tp -127.61 135.13 49.85 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.776 0.322 . . . . 0.0 111.039 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.1 t -141.04 176.84 8.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.481 ' HG2' ' HG3' ' A' ' 8' ' ' LYS . 33.0 mt-10 -125.69 153.85 43.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.584 0.23 . . . . 0.0 110.882 -175.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.33 124.19 18.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.962 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -89.52 -45.07 9.67 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.103 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -172.65 -60.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.625 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.447 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 44.6 mt-30 -53.89 -48.96 69.56 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.347 -172.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.9 m -59.33 -28.35 66.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.855 0.359 . . . . 0.0 111.913 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.22 -53.84 4.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 104' ' ' ILE . 34.5 m-85 -127.15 12.84 7.17 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -170.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 21.2 tt0 -109.83 -50.93 2.93 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.7 p -99.61 143.23 30.08 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.3 t -171.7 -149.45 0.06 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -56.72 -18.45 12.51 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.859 0.463 . . . . 0.0 111.772 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.8 pp -88.39 -4.5 58.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.767 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 166' ' ' ARG . 10.5 t70 -138.74 -144.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.614 ' HD2' ' HG2' ' A' ' 169' ' ' GLU . 31.8 ttm180 -51.63 124.49 12.4 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.219 0.607 . . . . 0.0 111.762 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -73.29 102.48 3.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.105 -176.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.6 t 62.22 89.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 123.761 0.663 . . . . 0.0 111.481 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.614 ' HG2' ' HD2' ' A' ' 166' ' ' ARG . 49.5 mt-10 -80.12 -2.28 43.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.491 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -51.78 -39.58 58.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -172.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -81.03 -37.16 29.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.084 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.16 -38.35 60.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.011 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 14.6 tpt -63.95 -27.8 69.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.277 0.561 . . . . 0.0 110.328 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.48 -35.31 40.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.132 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 119.08 8.0 9.83 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.086 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 52.7 mt 59.77 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.556 0.693 . . . . 0.0 111.084 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 18.6 t -149.53 109.8 4.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.914 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.75 100.77 2.27 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.733 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.488 HG22 HD12 ' A' ' 180' ' ' LEU . 4.1 mp -102.79 114.84 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.488 HD12 HG22 ' A' ' 179' ' ' ILE . 6.3 mp 63.12 -170.6 0.18 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.726 0.641 . . . . 0.0 111.565 -174.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -125.49 128.37 24.69 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.149 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 32.1 Cg_exo -61.68 166.8 11.14 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.024 2.483 . . . . 0.0 112.455 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.98 108.59 0.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.301 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.6 137.79 27.84 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.482 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -75.27 93.73 2.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.827 0.346 . . . . 0.0 110.636 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -129.78 81.82 2.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.194 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 95.8 mt -135.62 166.06 24.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.342 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--O 1.25 1.107 0 O-C-N 123.482 0.489 . . . . 0.0 110.376 179.178 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 70.5 -74.44 0.08 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.219 0.608 . . . . 0.0 111.021 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.74 -105.57 1.76 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.776 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -80.61 105.09 11.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.162 0.506 . . . . 0.0 111.809 -174.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.45 HD11 HG13 ' A' ' 28' ' ' ILE . 97.3 mt -78.56 -92.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.516 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 39.63 84.52 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.563 0.745 . . . . 0.0 112.421 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.61 -9.57 12.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.461 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.417 ' HG3' ' HG3' ' A' ' 152' ' ' GLU . 10.4 mptt -107.19 172.46 6.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -129.29 143.1 50.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.008 0.432 . . . . 0.0 110.269 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 pt -107.03 127.33 62.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.224 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.902 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.3 mp -92.63 107.8 19.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.672 -174.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.609 ' HB3' ' CZ3' ' A' ' 148' ' ' TRP . . . -91.19 -45.36 8.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.705 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.752 HG23 HG12 ' A' ' 179' ' ' ILE . 18.2 m 63.1 80.47 0.24 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.597 -175.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.02 16.23 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.865 2.377 . . . . 0.0 112.117 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 65.64 16.87 10.7 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.703 -177.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.0 ttt -84.93 113.32 21.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.909 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 19.0 t70 -103.55 27.32 7.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.99 -169.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.891 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . 2.2 t70 68.66 129.2 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.494 0.664 . . . . 0.0 111.544 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -93.26 -41.82 9.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.74 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -160.19 -36.02 0.05 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.754 0.311 . . . . 0.0 110.985 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -153.16 37.45 0.48 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.716 0.769 . . . . 0.0 109.199 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.891 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 30.8 t70 -88.22 120.77 29.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.302 -176.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -89.22 112.14 23.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.7 p -63.65 83.16 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.748 HG11 ' HB ' ' A' ' 40' ' ' ILE . 51.7 t 62.24 100.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 O-C-N 123.792 0.683 . . . . 0.0 112.136 173.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.63 ' CG2' HG22 ' A' ' 39' ' ' VAL . 11.3 tp -89.58 -141.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.919 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.538 ' HD1' HG13 ' A' ' 26' ' ' ILE . 2.8 p90 -115.75 175.0 5.73 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.718 1.144 . . . . 0.0 112.442 -163.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.45 HG13 HD11 ' A' ' 5' ' ' LEU . 49.8 mm -90.24 120.91 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.823 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.0 m -87.36 -38.21 16.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -171.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.925 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 9.3 tp10 -141.15 155.18 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.84 0.352 . . . . 0.0 110.998 -173.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -146.18 104.36 3.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.85 170.09 8.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.317 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -62.76 -22.01 66.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.165 0.507 . . . . 0.0 111.031 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.23 5.61 25.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.108 -173.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.573 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 161.68 161.12 11.48 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.587 -1.292 . . . . 0.0 113.546 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.7 m -108.55 128.72 55.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.925 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.5 mp -106.47 117.69 52.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.746 -173.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.72 165.42 26.85 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.63 HG22 ' CG2' ' A' ' 26' ' ' ILE . 2.5 m -118.74 44.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.518 0.675 . . . . 0.0 110.616 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.748 ' HB ' HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -95.31 19.04 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.071 -175.309 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.6 tp -76.83 -31.73 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.658 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.1 m120 58.07 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.163 0.585 . . . . 0.0 112.226 -175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -171.15 107.69 0.4 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 121.539 0.685 . . . . 0.0 110.313 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.582 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 6.5 Cg_exo -74.42 154.03 45.23 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.595 2.197 . . . . 0.0 111.209 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.3 p -127.73 158.43 37.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.884 0.373 . . . . 0.0 111.231 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.58 10.76 2.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.641 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.9 tp -86.09 146.08 26.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.8 t -99.0 149.57 22.85 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.704 0.288 . . . . 0.0 110.687 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.59 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 8.8 p -63.8 -26.02 39.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.25 0.548 . . . . 0.0 109.916 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.509 ' HB3' HE22 ' A' ' 59' ' ' GLN . 91.8 mt -75.38 -27.54 59.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.312 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.25 -31.46 60.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.64 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.2 pp -72.67 -26.08 61.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.149 0.499 . . . . 0.0 109.745 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.547 HD13 HD13 ' A' ' 113' ' ' LEU . 87.8 mt -75.42 -42.56 53.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.886 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.4 p -68.24 -30.93 70.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -73.55 -11.41 60.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.3 mtt -91.89 -84.6 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 172.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.4 t70 179.7 25.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.542 0.687 . . . . 0.0 109.597 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.695 ' HB3' HD12 ' A' ' 113' ' ' LEU . 96.6 m-85 -132.81 166.88 21.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.03 -170.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.509 HE22 ' HB3' ' A' ' 50' ' ' LEU . 2.0 mm-40 -155.99 175.67 13.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.864 175.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.403 ' HE2' ' HB3' ' A' ' 60' ' ' MET . 42.5 ttp 67.94 101.47 0.05 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 111.486 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HB2' HD12 ' A' ' 53' ' ' LEU . . . -122.41 -50.46 2.0 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.373 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -131.89 154.4 81.73 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.204 178.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.89 43.75 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.851 2.367 . . . . 0.0 112.433 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -113.3 87.4 2.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 46.7 mt -86.55 85.98 2.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -171.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.7 t80 71.18 -42.57 0.54 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 168.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 t -56.87 -27.42 60.47 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.084 0.469 . . . . 0.0 111.426 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -144.42 86.52 1.83 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.582 0.706 . . . . 0.0 109.59 174.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -65.98 140.24 58.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.239 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.472 ' HB2' HG11 ' A' ' 49' ' ' VAL . 25.6 mm-40 -94.16 104.07 16.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.914 -178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 87.8 mtp -78.86 142.75 36.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.633 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.59 HG22 HG13 ' A' ' 127' ' ' VAL . 12.6 p -98.96 149.66 5.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.183 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.582 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.8 mp -99.52 158.97 15.37 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.051 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.54 132.92 44.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 175.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.596 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -91.3 -12.52 59.8 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.353 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.23 174.89 30.59 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.098 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.06 -10.26 15.23 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.171 2.581 . . . . 0.0 112.944 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.07 122.55 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.05 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 64.92 46.52 2.86 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.461 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.42 ' O ' HD13 ' A' ' 129' ' ' LEU . 49.7 mt-30 -67.12 -10.3 48.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.98 -3.01 58.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.91 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -113.21 115.95 29.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.954 0.407 . . . . 0.0 110.69 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.84 115.49 4.99 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -96.5 126.17 41.5 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.4 HD11 ' N ' ' A' ' 85' ' ' ILE . 4.6 mp -108.21 103.91 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.002 0.429 . . . . 0.0 109.977 177.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.681 HG22 ' HB3' ' A' ' 106' ' ' LEU . 31.1 t -93.13 124.74 45.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.557 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -135.09 164.61 27.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.864 0.364 . . . . 0.0 111.654 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.492 ' OG ' ' HB2' ' A' ' 124' ' ' LYS . 14.6 m -70.36 160.67 31.86 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.196 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 23.4 tptm -76.72 121.31 23.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.374 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -107.5 -67.04 0.98 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -164.72 -172.1 2.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 171.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.56 93.61 4.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -104.36 -175.9 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.934 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -72.24 97.34 1.97 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.283 -172.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.453 HG21 ' HB3' ' A' ' 111' ' ' ASP . 20.9 p -145.01 142.27 29.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.442 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -88.65 80.68 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 172.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.458 ' HB3' HG23 ' A' ' 105' ' ' THR . 15.7 m -116.46 150.93 37.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.233 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -104.83 139.53 39.46 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -101.57 116.0 31.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.76 -53.65 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 167.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.501 HG21 ' HB ' ' A' ' 104' ' ' ILE . 10.2 t -137.6 -166.18 1.9 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 169.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -83.32 -22.27 32.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 118.566 0.621 . . . . 0.0 111.023 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.53 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 28.7 m-20 -101.16 -11.66 19.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.623 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.501 ' HB ' HG21 ' A' ' 101' ' ' THR . 42.1 mm -120.72 122.67 68.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.458 HG23 ' HB3' ' A' ' 97' ' ' SER . 29.7 m -145.77 130.6 18.12 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.787 0.327 . . . . 0.0 111.167 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.681 ' HB3' HG22 ' A' ' 86' ' ' VAL . 1.1 pt? -108.21 132.69 53.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.477 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 50.3 m -96.06 129.36 43.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.105 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 p -107.0 21.13 18.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.031 0.443 . . . . 0.0 111.588 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.7 t -147.0 175.15 10.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.328 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.08 -0.0 49.41 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 113.004 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.453 ' HB3' HG21 ' A' ' 95' ' ' THR . 67.9 m-20 -56.22 -33.43 65.35 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.659 0.742 . . . . 0.0 110.514 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 p -52.25 -33.81 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.232 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 58' ' ' PHE . 16.9 mt -73.02 -31.82 64.72 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.849 0.357 . . . . 0.0 111.171 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.21 -36.03 82.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.015 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -79.94 -2.93 45.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.213 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.35 146.54 23.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 111.046 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.42 -24.83 30.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.323 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 p -87.57 -175.5 5.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.787 0.327 . . . . 0.0 110.795 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -75.84 -16.46 60.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.284 0.564 . . . . 0.0 109.758 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.6 p -91.89 8.86 35.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.479 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.91 114.45 39.48 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.686 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.09 130.17 19.67 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.806 2.338 . . . . 0.0 111.926 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.45 -36.92 85.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.977 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.492 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 13.5 mmtp -103.65 100.54 10.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.465 -171.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 35.2 p90 -138.29 130.9 29.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.047 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.4 pt -116.84 132.86 65.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.59 HG13 HG22 ' A' ' 72' ' ' VAL . 7.7 p -115.24 129.22 71.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.263 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 84.8 m -136.63 136.6 39.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.479 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.565 HD21 HG21 ' A' ' 72' ' ' VAL . 4.2 mm? -90.51 114.36 26.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.653 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.27 173.64 42.18 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.533 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.3 m -147.14 169.97 18.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.795 0.331 . . . . 0.0 110.436 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.8 m -105.11 122.5 46.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.246 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.68 HG22 HG13 ' A' ' 37' ' ' ILE . 30.5 p -100.94 123.63 45.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.402 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -105.63 153.44 21.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.183 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -73.94 138.03 76.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.867 0.365 . . . . 0.0 111.262 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.573 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 36.3 Cg_endo -65.52 136.72 47.66 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.872 2.381 . . . . 0.0 111.69 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.706 ' HA ' ' CD ' ' A' ' 140' ' ' GLU . 81.3 m-70 64.98 13.76 8.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.876 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.6 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 26.7 tt0 -108.21 -54.68 2.47 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 171.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 143' ' ' ILE . 66.3 tp -57.79 -41.17 81.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.718 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.706 ' CD ' ' HA ' ' A' ' 137' ' ' HIS . 7.0 pt-20 -59.1 -38.15 78.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -76.39 -30.78 57.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.71 0.291 . . . . 0.0 110.806 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 9.5 mm-40 -61.51 -41.5 97.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.0 110.035 175.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.564 ' HA ' ' HB2' ' A' ' 148' ' ' TRP . 76.2 mt -58.61 -40.44 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.629 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.44 65.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.895 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -82.44 -1.08 49.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.946 -0.115 . . . . 0.0 111.041 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 71.3 11.58 6.74 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.713 0.633 . . . . 0.0 110.126 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -77.1 -24.65 51.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.927 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.609 ' CZ3' ' HB3' ' A' ' 12' ' ' ALA . 95.3 m95 -130.49 138.98 50.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.018 174.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.902 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 98.3 mt -100.91 157.7 16.53 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.8 tp -129.55 134.37 47.71 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.667 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.1 t -154.47 143.28 20.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.465 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.417 ' HG3' ' HG3' ' A' ' 8' ' ' LYS . 4.6 mp0 -73.13 154.63 40.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.44 -26.78 24.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.998 0.427 . . . . 0.0 110.509 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.4 m120 55.59 21.92 4.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.009 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 70.59 -51.47 0.67 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.435 0.694 . . . . 0.0 111.815 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.436 ' HA ' ' CB ' ' A' ' 160' ' ' GLU . 36.2 mt-30 -64.14 -50.02 69.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.098 -173.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.7 m -61.84 -29.45 70.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.109 0.48 . . . . 0.0 110.69 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.38 -57.76 3.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.907 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -120.99 -38.18 2.86 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 26.3 tt0 -56.87 -58.23 9.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.775 0.321 . . . . 0.0 111.238 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.5 t -63.44 -13.95 45.56 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.924 -173.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 m -78.75 43.63 0.5 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.802 0.334 . . . . 0.0 111.154 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -79.77 -41.46 26.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.369 . . . . 0.0 111.239 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 53.1 mt -95.69 -81.89 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.328 -168.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.25 -27.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.664 -168.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.401 ' HD3' ' OE1' ' A' ' 172' ' ' GLU . 32.1 ttm180 -44.08 114.55 0.68 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -97.55 -178.98 4.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.19 168.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.8 t 60.98 68.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.638 0.733 . . . . 0.0 109.867 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.74 -37.34 7.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.071 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.73 -47.0 83.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.492 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -71.95 -30.9 65.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.791 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.502 ' HA ' ' O ' ' A' ' 175' ' ' GLY . 31.8 tt0 -68.07 -31.56 71.28 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.683 0.278 . . . . 0.0 110.714 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.826 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 20.1 mmt -58.73 -28.68 66.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.977 0.418 . . . . 0.0 110.858 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.4 tp -96.74 -57.73 2.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.696 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 172' ' ' GLU . . . -170.43 -110.81 0.24 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 175' ' ' GLY . 5.3 mm -160.49 -60.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.254 0.622 . . . . 0.0 109.904 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 19.8 m -99.68 123.01 43.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.806 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.421 ' O ' ' HB ' ' A' ' 179' ' ' ILE . . . 154.93 -100.74 0.2 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.4 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.752 HG12 HG23 ' A' ' 13' ' ' THR . 2.0 mp 70.6 132.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-O 121.394 0.616 . . . . 0.0 110.382 -176.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.517 HD13 HD23 ' A' ' 149' ' ' LEU . 5.9 mp -72.86 97.84 2.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.588 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -124.44 102.65 32.87 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.209 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.04 -37.13 94.05 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.037 2.491 . . . . 0.0 112.466 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 50.57 58.95 4.95 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.505 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -157.61 -138.9 2.6 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.53 77.13 3.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.57 0.7 . . . . 0.0 111.501 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -120.89 30.48 6.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.198 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.432 ' H ' HD23 ' A' ' 187' ' ' LEU . 2.4 pt? -118.86 173.43 6.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.606 -174.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.099 179.354 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.707 0.289 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -165.01 160.22 18.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.551 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.41 -127.78 4.35 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.99 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.432 ' OD1' ' HB3' ' A' ' 31' ' ' HIS . 54.7 t30 -82.35 146.76 29.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.3 mt -123.89 -83.29 0.65 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.588 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 63.76 152.51 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.776 0.798 . . . . 0.0 111.713 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.37 23.71 70.29 Favored Glycine 0 C--N 1.316 -0.558 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.907 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.548 ' HZ2' ' HG3' ' A' ' 152' ' ' GLU . 71.0 mmtt -110.75 164.83 12.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -144.13 153.24 41.94 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 172.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.537 ' O ' HG21 ' A' ' 25' ' ' VAL . 4.5 pt -117.72 127.03 75.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.046 0.451 . . . . 0.0 111.098 -176.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.692 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 53.8 mt -94.41 112.95 28.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.287 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.416 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -158.7 124.1 4.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.318 172.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 19.1 p -90.61 107.88 23.36 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-O 121.108 0.48 . . . . 0.0 110.898 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 13' ' ' THR . 6.3 Cg_exo -73.52 89.18 0.97 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.184 2.59 . . . . 0.0 112.861 -173.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 67.78 -0.98 1.8 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.835 171.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.7 mtm 50.23 49.45 20.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.19 0.519 . . . . 0.0 110.464 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.57 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 3.0 t70 -78.85 -169.69 1.87 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.698 -172.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.32 -55.07 15.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.84 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 8.6 pt-20 -82.73 38.95 0.59 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.535 0.683 . . . . 0.0 110.873 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.57 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -116.75 -33.09 4.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.425 -174.005 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -58.8 -26.65 64.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.442 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 6.4 t70 -105.44 100.43 10.01 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 32.9 mmt180 79.04 103.49 0.07 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.59 1.181 . . . . 0.0 111.756 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.648 ' O ' HG23 ' A' ' 25' ' ' VAL . 32.0 p -96.61 89.96 5.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.498 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.727 HG12 HD22 ' A' ' 42' ' ' ASN . 1.9 m 62.51 174.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.427 1.091 . . . . 0.0 111.911 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.509 ' CG2' HG22 ' A' ' 39' ' ' VAL . 11.1 tp -156.22 -142.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.474 ' H ' HG13 ' A' ' 26' ' ' ILE . 1.1 p90 -109.49 170.08 8.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 119.552 1.069 . . . . 0.0 112.277 -163.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.83 126.87 49.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.617 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 55.6 m -78.49 -59.28 2.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.39 159.89 33.96 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.454 0.645 . . . . 0.0 111.742 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.432 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 49.0 t-80 -144.13 142.0 30.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.355 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.459 ' ND2' ' H ' ' A' ' 33' ' ' ASP . 3.6 t-20 83.88 177.98 0.05 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.553 1.158 . . . . 0.0 109.091 -177.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.459 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 33.3 t70 68.24 -76.2 0.06 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.22 0.608 . . . . 0.0 110.893 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' HD13 ' A' ' 37' ' ' ILE . 8.4 t30 -93.18 -34.44 13.61 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.49 -110.11 0.44 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.181 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 133' ' ' THR . 11.0 m -136.32 105.25 5.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.568 HG13 HG21 ' A' ' 133' ' ' THR . 4.1 mp -98.97 112.02 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.444 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.67 170.22 31.16 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.509 HG22 ' CG2' ' A' ' 26' ' ' ILE . 2.8 m -120.58 76.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.649 0.737 . . . . 0.0 111.004 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.436 ' H ' HD11 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -121.9 20.91 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 -176.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.1 tp -73.05 -24.11 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.033 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.727 HD22 HG12 ' A' ' 25' ' ' VAL . 86.6 m-20 53.63 82.87 0.08 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.274 0.63 . . . . 0.0 112.299 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.414 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 6.5 t -172.81 113.45 0.36 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.433 0.635 . . . . 0.0 110.881 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 50.9 Cg_endo -71.94 153.92 58.17 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.078 1.852 . . . . 0.0 110.482 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 74' ' ' ASN . 11.2 p -96.65 169.93 9.55 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.773 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.33 5.88 11.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.91 161.31 17.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 57.6 p -116.4 160.89 19.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.337 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 12.5 p -67.72 -32.89 58.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.966 0.412 . . . . 0.0 110.361 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.538 HD21 HD12 ' A' ' 53' ' ' LEU . 59.6 mt -73.82 -32.02 63.52 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.993 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -57.46 -53.33 59.38 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.15 -43.83 70.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.237 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.538 HD12 HD21 ' A' ' 50' ' ' LEU . 80.9 mt -62.3 -45.56 92.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.267 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.8 p -73.47 -32.88 64.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.056 0.455 . . . . 0.0 111.314 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -67.74 -34.65 77.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.944 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 47.3 mtt -106.56 1.01 24.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.203 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.4 t70 62.08 100.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.911 0.757 . . . . 0.0 111.05 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -81.69 155.01 25.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.808 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -61.37 130.27 45.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.888 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.9 mtt -76.25 88.88 3.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.392 0.615 . . . . 0.0 111.578 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.47 10.13 2.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.651 174.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -153.34 133.06 7.32 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.005 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.51 163.16 11.06 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.983 2.456 . . . . 0.0 112.711 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.421 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 9.7 tpt180 -64.49 -61.37 2.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.488 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 64' ' ' ARG . 2.0 mp 68.76 108.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.412 0.625 . . . . 0.0 110.068 -172.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.35 126.13 48.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.524 -175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.4 m 64.59 36.47 8.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.845 0.831 . . . . 0.0 111.677 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.412 ' HB3' ' CG2' ' A' ' 65' ' ' ILE . 7.7 tt0 -140.46 34.39 1.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.233 1.015 . . . . 0.0 108.286 171.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.404 ' HA ' HD13 ' A' ' 50' ' ' LEU . 6.4 p-10 -74.01 146.62 43.64 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.971 -174.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -99.85 129.66 45.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.665 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.557 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 91.5 mtp -75.85 136.12 40.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.236 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.456 HG21 HD22 ' A' ' 129' ' ' LEU . 14.0 p -88.98 141.48 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 7.4 mp -95.98 161.56 13.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.235 0.541 . . . . 0.0 111.099 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.4 ' HB2' HG22 ' A' ' 45' ' ' THR . 2.0 t-20 -92.37 132.71 36.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.941 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -88.22 -25.37 31.45 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.263 -0.97 . . . . 0.0 111.908 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.42 176.72 27.04 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.93 -17.84 22.12 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.971 2.447 . . . . 0.0 112.67 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.9 t -98.7 143.95 12.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.045 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 m120 62.95 31.76 15.99 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.975 0.51 . . . . 0.0 112.052 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -71.56 -10.12 59.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -80.7 -0.12 36.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.349 . . . . 0.0 110.262 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -122.49 133.77 54.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.607 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.23 110.42 3.63 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.504 ' HB3' HD13 ' A' ' 106' ' ' LEU . 93.7 m-85 -92.35 124.85 36.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.694 0.283 . . . . 0.0 110.322 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.513 HD11 HG23 ' A' ' 112' ' ' VAL . 2.7 mp -121.56 112.63 36.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.409 0.623 . . . . 0.0 110.224 177.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 66.0 t -90.74 110.96 22.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.198 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -137.28 165.01 27.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.704 0.287 . . . . 0.0 111.569 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.7 p -81.75 159.46 23.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.004 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -87.47 140.73 29.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.931 0.396 . . . . 0.0 110.144 177.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -95.06 -170.71 2.25 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.431 ' H ' HG23 ' A' ' 90' ' ' THR . 6.7 p-10 -64.2 -35.09 79.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.157 0.503 . . . . 0.0 110.118 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -83.4 163.54 20.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.684 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.44 -172.38 4.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.08 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -132.14 162.72 30.18 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.8 m -80.96 -47.0 14.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.876 0.37 . . . . 0.0 110.515 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.456 ' O ' HG23 ' A' ' 107' ' ' THR . 7.7 t60 -145.28 97.29 2.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.692 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 66.7 m -135.56 152.72 51.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.044 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -101.66 114.39 28.4 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 102' ' ' ASP . 88.3 tttt -78.14 102.33 7.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 0.0 110.727 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.3 t -86.11 -53.83 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.57 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.485 ' HG1' ' HB ' ' A' ' 104' ' ' ILE . 36.8 p -116.01 176.67 4.99 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.507 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 4.8 t70 -86.32 52.32 2.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.264 0.554 . . . . 0.0 110.289 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.489 ' HB3' HD22 ' A' ' 155' ' ' ASN . 28.6 t70 177.65 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.891 178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.485 ' HB ' ' HG1' ' A' ' 101' ' ' THR . 48.1 mm -90.3 124.38 42.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.123 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.36 139.14 53.82 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.443 -176.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' A' ' 84' ' ' PHE . 65.5 tp -101.12 112.41 24.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.274 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.459 ' HB ' HG22 ' A' ' 112' ' ' VAL . 18.8 m -99.93 130.33 46.09 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.238 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -114.18 10.88 17.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.074 -174.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.0 m -132.19 -177.46 4.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.254 . . . . 0.0 110.926 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.438 ' HA2' HD22 ' A' ' 113' ' ' LEU . . . -70.7 4.85 8.48 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.688 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.43 ' HB3' HG22 ' A' ' 107' ' ' THR . 17.4 t0 -61.13 -29.54 69.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.331 0.586 . . . . 0.0 109.451 174.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.513 HG23 HD11 ' A' ' 85' ' ' ILE . 47.0 t -57.48 -39.42 68.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.732 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.5 HD12 ' CZ ' ' A' ' 116' ' ' PHE . 4.1 mm? -61.6 -32.51 72.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.594 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -81.87 -32.89 30.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.952 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 47.4 m -57.99 -51.93 67.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.415 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.5 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 10.7 p90 -92.73 8.89 37.35 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.746 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -104.81 37.02 4.01 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.62 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 t -151.47 165.46 34.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -67.81 -22.58 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.133 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 p -104.71 42.3 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.246 0.546 . . . . 0.0 110.832 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.484 ' CB ' ' HA ' ' A' ' 116' ' ' PHE . . . -64.19 140.58 97.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.093 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 12.2 Cg_exo -68.95 124.04 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.337 2.025 . . . . 0.0 111.025 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.66 -28.35 58.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.743 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -105.88 105.36 15.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.061 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 46.4 p90 -157.24 146.3 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.159 0.504 . . . . 0.0 111.587 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.7 142.83 39.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.566 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.18 131.7 66.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.903 0.382 . . . . 0.0 111.11 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 77.6 m -142.98 141.1 31.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.414 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 72' ' ' VAL . 4.1 mm? -94.02 119.25 32.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.255 177.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.497 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 78.35 -179.86 51.52 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.476 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.4 m -147.99 169.31 20.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.906 0.384 . . . . 0.0 110.005 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.817 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 30.2 m -106.85 126.96 52.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.779 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 36' ' ' THR . 39.4 p -114.49 119.69 37.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.425 0.631 . . . . 0.0 112.136 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.817 ' HZ3' ' HB3' ' A' ' 132' ' ' SER . 1.3 m-90 -99.94 136.27 40.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.025 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.421 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -83.23 147.54 53.84 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.315 -175.245 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.48 ' O ' ' HB3' ' A' ' 137' ' ' HIS . 21.6 Cg_exo -66.55 73.82 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.656 2.904 . . . . 0.0 112.736 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.48 ' HB3' ' O ' ' A' ' 136' ' ' PRO . 17.4 p-80 167.17 -23.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.652 1.181 . . . . 0.0 108.083 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.572 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 63.0 tt0 -84.68 -67.35 0.8 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.51 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.494 ' HB2' ' HB3' ' A' ' 134' ' ' TRP . 51.2 tp -60.52 -44.88 95.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.114 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -61.18 -42.13 98.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.741 -0.208 . . . . 0.0 111.429 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.6 mp0 -68.44 -35.58 77.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.636 0.255 . . . . 0.0 110.676 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 8.6 mm-40 -64.01 -46.51 84.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.268 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 148' ' ' TRP . 68.6 mt -62.07 -41.17 90.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.581 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.52 81.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.459 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.587 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 40.6 mt-30 -82.46 7.11 15.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 67.03 37.14 3.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.834 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -83.98 -48.15 10.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.134 0.492 . . . . 0.0 109.893 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.605 ' HB2' HG12 ' A' ' 143' ' ' ILE . 96.7 m95 -107.37 130.18 54.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.486 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.95 ' HG ' ' HG ' ' A' ' 180' ' ' LEU . 4.9 tt -91.21 103.3 15.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.488 HD13 ' HB3' ' A' ' 8' ' ' LYS . 55.2 tp -82.66 133.68 35.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.022 0.439 . . . . 0.0 111.198 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.8 m -145.32 172.89 12.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.126 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.548 ' HG3' ' HZ2' ' A' ' 8' ' ' LYS . 5.2 mp0 -96.65 153.44 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.234 0.54 . . . . 0.0 111.791 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -119.72 108.49 14.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.125 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -79.94 49.39 1.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -170.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.489 HD22 ' HB3' ' A' ' 103' ' ' ASP . 0.2 OUTLIER 64.7 -74.22 0.05 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.491 0.716 . . . . 0.0 111.361 175.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -61.47 -25.53 67.3 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.702 0.401 . . . . 0.0 111.132 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.897 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 13.6 m -52.73 -29.66 28.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.028 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.471 HD12 HG21 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -63.12 -44.03 96.76 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -175.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.67 -3.15 2.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -117.64 -37.25 3.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.897 ' HB ' ' HA ' ' A' ' 157' ' ' THR . 9.7 m -94.33 112.53 24.33 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 122.404 -0.185 . . . . 0.0 110.893 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.1 t 66.65 90.31 0.09 Allowed 'General case' 0 N--CA 1.461 0.105 0 O-C-N 123.748 0.655 . . . . 0.0 110.336 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -71.45 -57.49 4.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.626 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.497 ' HG ' ' N ' ' A' ' 165' ' ' ASP . 2.1 pt? -161.9 -66.31 0.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.996 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.497 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 13.9 m-20 61.1 -68.28 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.392 0.677 . . . . 0.0 112.108 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -121.48 179.97 4.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.676 0.274 . . . . 0.0 110.452 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -87.76 24.38 1.75 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.107 0.479 . . . . 0.0 111.224 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.5 m -137.57 36.36 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.365 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -49.24 76.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.082 -170.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.49 83.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.045 0.45 . . . . 0.0 111.257 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -68.53 -37.54 80.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.305 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -64.02 -28.33 69.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.563 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -55.89 -34.57 65.64 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 110.271 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.0 tp -102.0 -55.09 2.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.157 0.503 . . . . 0.0 110.29 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 151.14 117.15 0.77 Allowed Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.349 -175.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 56.8 mt -55.99 -50.88 66.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.052 0.453 . . . . 0.0 110.512 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -86.74 104.22 15.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.832 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.53 -90.79 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.903 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.6 mt 72.7 139.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.203 0.525 . . . . 0.0 111.513 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.95 ' HG ' ' HG ' ' A' ' 149' ' ' LEU . 80.4 mt -72.44 124.3 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.352 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 57.59 70.75 1.23 Allowed Pre-proline 0 C--N 1.33 -0.246 0 O-C-N 124.024 0.827 . . . . 0.0 111.921 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.8 15.61 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.532 2.155 . . . . 0.0 112.15 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -120.46 104.29 9.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.576 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 167.44 130.87 1.21 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 185' ' ' ARG . 50.0 mtt85 -84.77 -91.71 0.09 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.087 0.47 . . . . 0.0 110.409 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -173.1 66.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.543 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 187' ' ' LEU . 2.5 pp -76.83 118.51 19.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.757 0.789 . . . . 0.0 110.29 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.001 -175.61 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.62 0.724 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -97.02 152.09 19.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.054 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.77 66.59 2.41 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.642 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 68.8 119.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.591 0.71 . . . . 0.0 112.611 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 96.8 mt -86.16 -10.99 53.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.128 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -65.98 127.27 31.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.959 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.24 0.84 79.72 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.615 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -115.22 -177.33 3.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.637 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 44.1 p90 -151.24 161.68 42.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 16.6 pt -121.32 129.19 75.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.519 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.731 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.6 mp -75.22 107.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.286 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.422 ' H ' HG23 ' A' ' 25' ' ' VAL . . . -79.43 101.05 7.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.8 m -105.0 107.73 59.52 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.31 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -71.61 -76.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.56 2.173 . . . . 0.0 112.108 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 185' ' ' ARG . 33.2 tt0 -153.15 84.37 1.2 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 67.2 mtt 65.19 -75.97 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.297 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -158.83 159.19 34.8 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -166.15 -83.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.49 17.55 10.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.131 0.967 . . . . 0.0 108.841 167.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -55.91 -35.06 66.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.606 -1.633 . . . . 0.0 111.539 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' ' 167' ' ' TRP . 73.7 t80 -65.39 -20.52 66.42 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.093 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -97.81 80.35 2.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.013 0.435 . . . . 0.0 110.935 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 60.79 86.95 0.09 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.265 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.7 t -118.72 117.42 28.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.503 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.681 HG11 HG22 ' A' ' 40' ' ' ILE . 59.3 t 69.19 153.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.151 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.489 HG13 ' HD1' ' A' ' 27' ' ' TYR . 7.0 tp -136.68 -57.42 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.025 173.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.637 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 6.0 p90 -177.73 175.3 1.37 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 111.639 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.452 ' HB ' ' O ' ' A' ' 5' ' ' LEU . 50.3 mm -103.86 127.66 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.613 176.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.5 m -81.33 -53.31 6.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.723 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.51 160.82 36.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.512 0.672 . . . . 0.0 112.315 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' A' ' 32' ' ' ASN . 84.3 t60 -164.12 136.23 4.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.58 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 21.7 t-20 86.68 -38.96 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.229 0.956 . . . . 0.0 110.513 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 30.1 t70 -73.74 97.02 2.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 33' ' ' ASP . 28.9 t-20 76.33 -38.99 0.34 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.883 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.03 -141.76 5.73 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.552 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.2 m -125.03 112.75 16.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.066 0.433 . . . . 0.0 110.125 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.418 HD13 ' N ' ' A' ' 37' ' ' ILE . 4.0 mp -110.96 121.15 63.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.07 171.8 31.4 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.057 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.82 91.86 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.555 0.693 . . . . 0.0 110.423 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.681 HG22 HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -136.4 18.41 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.066 -175.426 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 tp -64.52 -29.7 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.183 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 58.98 82.47 0.14 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.114 0.483 . . . . 0.0 111.801 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 t -175.82 121.54 0.32 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.525 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 65.0 Cg_endo -78.59 153.66 26.82 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.313 2.009 . . . . 0.0 110.735 171.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.1 p -101.59 177.96 4.77 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.065 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -81.56 -17.36 48.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.19 0.519 . . . . 0.0 110.345 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.5 tp -80.28 150.66 29.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.443 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.54 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 34.9 t -103.51 151.35 22.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.073 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 14.1 p -65.8 -30.09 48.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.303 0.573 . . . . 0.0 109.692 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.0 mt -74.1 -26.76 60.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.023 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.47 ' HG2' ' HB3' ' A' ' 48' ' ' SER . 5.8 mm-40 -69.83 -44.13 70.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.155 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.3 pp -68.9 -34.26 75.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.706 0.289 . . . . 0.0 110.724 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.421 ' HB3' ' HB2' ' A' ' 58' ' ' PHE . 87.0 mt -64.81 -48.85 72.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.34 . . . . 0.0 110.75 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.0 p -69.2 -30.15 68.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.061 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.4 tpt85 -62.51 -30.74 71.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.556 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 81.0 mtp -83.72 -92.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.556 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -161.52 30.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.755 0.788 . . . . 0.0 110.659 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.421 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 88.8 m-85 -107.91 108.66 19.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.26 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -137.39 4.78 2.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.4 mtp -147.69 162.73 38.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.683 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 78.07 134.09 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.486 1.116 . . . . 0.0 112.804 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.563 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 11.4 mmpt? 60.72 72.92 0.66 Allowed Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.779 174.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -95.8 122.07 0.27 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.205 2.604 . . . . 0.0 113.118 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.11 57.97 3.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 173.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.551 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 40.9 mt 62.96 -88.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.502 -173.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.551 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 21.4 p90 164.3 -24.17 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.55 -30.29 61.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.866 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -76.29 91.19 3.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.344 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -96.41 115.93 28.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.658 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -103.25 115.42 30.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.183 0.516 . . . . 0.0 110.773 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 55.2 mtt -83.26 125.5 31.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.79 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.425 HG21 HD21 ' A' ' 129' ' ' LEU . 14.9 p -69.7 144.31 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.832 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.525 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.7 mp -96.71 157.68 15.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.997 0.427 . . . . 0.0 110.606 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.42 146.78 26.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.398 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -103.84 -27.07 6.47 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.758 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.87 167.66 17.66 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.696 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.25 -17.97 44.85 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 123.058 2.505 . . . . 0.0 113.143 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.442 HG23 ' OG1' ' A' ' 133' ' ' THR . 48.9 t -94.73 132.13 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.813 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 63.36 31.25 15.31 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.593 0.558 . . . . 0.0 110.852 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -12.18 61.44 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.105 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -79.02 -7.98 58.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -127.36 138.63 53.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.044 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.93 132.0 10.89 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.499 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.498 ' HB3' HD11 ' A' ' 106' ' ' LEU . 82.1 m-85 -106.79 126.11 51.87 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.532 ' HB ' HG22 ' A' ' 112' ' ' VAL . 2.6 mp -119.59 106.28 18.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.394 0.616 . . . . 0.0 110.925 -176.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.652 HG22 HD12 ' A' ' 106' ' ' LEU . 12.1 t -91.57 138.03 20.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.403 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.407 ' HE1' ' OG1' ' A' ' 107' ' ' THR . 52.6 p-80 -149.89 156.34 41.6 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.672 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.5 m -76.09 170.86 15.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.707 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -78.26 116.82 18.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.31 0.576 . . . . 0.0 110.977 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.6 m -140.27 -44.99 0.42 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -95.95 165.82 12.08 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -117.22 14.61 14.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.583 0.706 . . . . 0.0 109.997 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -100.64 163.33 12.39 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.789 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.2 p90 176.18 127.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.254 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 m -97.97 -49.96 4.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.187 0.518 . . . . 0.0 109.806 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.446 ' HB2' ' OG ' ' A' ' 109' ' ' SER . 12.7 m-70 -135.6 102.18 5.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.534 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.1 p -135.94 152.95 51.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.969 -177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -109.6 136.58 48.74 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 170.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -90.1 105.49 17.84 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.0 t -79.16 -55.49 9.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.7 p -132.59 -175.89 3.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.583 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -73.95 -13.81 60.94 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.898 178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -105.56 -58.68 1.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.302 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.79 HD11 ' HD2' ' A' ' 159' ' ' PHE . 42.1 mm -67.96 122.79 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.117 0.484 . . . . 0.0 110.414 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 m -127.2 124.57 39.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.317 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.652 HD12 HG22 ' A' ' 86' ' ' VAL . 25.8 tp -96.0 115.55 27.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.547 174.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.831 HG22 ' HB2' ' A' ' 111' ' ' ASP . 42.1 m -117.64 126.91 53.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.481 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.6 p -96.8 -10.58 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.487 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.446 ' OG ' ' HB2' ' A' ' 96' ' ' HIS . 38.9 m -95.27 179.62 5.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.636 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.21 5.37 34.83 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.903 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.831 ' HB2' HG22 ' A' ' 107' ' ' THR . 25.7 m-20 -54.88 -40.45 69.75 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.574 ' CG2' ' HB ' ' A' ' 107' ' ' THR . 22.6 t -57.58 -48.98 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.805 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.28 -34.99 75.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.714 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -59.08 -46.66 87.71 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.749 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.4 m -66.2 -44.54 83.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.137 0.494 . . . . 0.0 110.873 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -68.42 -24.18 64.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.428 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -91.31 6.72 80.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.592 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 119' ' ' GLN . 22.1 p -128.85 -162.58 1.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.95 0.375 . . . . 0.0 111.331 -178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.423 ' H ' ' HB ' ' A' ' 118' ' ' THR . 20.5 mt-30 -80.89 0.51 34.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 111.603 -176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 p -113.83 25.68 10.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.085 0.469 . . . . 0.0 111.331 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.26 124.09 76.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.162 178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -82.19 129.29 5.95 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.41 2.74 . . . . 0.0 111.958 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.54 -35.16 78.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.649 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -104.33 109.02 20.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.903 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 24.6 p90 -153.05 144.09 23.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.808 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.54 HG12 ' HZ ' ' A' ' 159' ' ' PHE . 30.4 pt -136.56 147.67 27.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.183 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.444 HG21 HG13 ' A' ' 85' ' ' ILE . 7.7 p -128.26 131.34 69.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.016 0.436 . . . . 0.0 110.789 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 26.6 p -133.31 144.03 49.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.399 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.425 HD21 HG21 ' A' ' 72' ' ' VAL . 3.8 mm? -92.05 110.56 21.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.465 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.414 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 83.91 -179.18 52.13 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.777 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.1 m -147.73 169.55 19.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.349 . . . . 0.0 110.101 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.573 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 38.9 m -108.02 125.4 51.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.055 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.442 ' OG1' HG23 ' A' ' 78' ' ' VAL . 18.1 p -107.66 127.37 53.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.217 0.532 . . . . 0.0 111.565 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.573 ' HZ3' ' HB3' ' A' ' 132' ' ' SER . 1.0 OUTLIER -115.43 150.6 36.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.246 175.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -74.17 151.49 88.07 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.054 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.19 129.55 34.83 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.652 2.235 . . . . 0.0 111.867 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 72.2 -6.09 1.61 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.521 0.729 . . . . 0.0 112.299 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -73.29 -57.53 3.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.936 0.398 . . . . 0.0 110.296 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.494 ' O ' HG13 ' A' ' 143' ' ' ILE . 44.3 tp -64.0 -34.52 78.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.198 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.48 -40.89 83.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.368 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.0 OUTLIER -65.11 -48.1 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.295 177.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -57.43 -40.14 77.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.312 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 139' ' ' LEU . 80.5 mt -62.28 -44.13 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 0.0 110.449 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.91 73.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.007 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 84.3 mt-30 -79.47 6.2 10.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.179 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 65.14 25.31 12.44 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.113 0.565 . . . . 0.0 112.239 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -84.17 -17.8 38.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.13 0.49 . . . . 0.0 109.963 173.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -135.52 137.5 42.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.22 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.731 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 87.2 mt -94.6 138.05 32.96 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.9 tp -111.51 136.72 50.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.418 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.9 t -156.2 160.68 40.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.274 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -87.37 154.01 21.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.903 0.383 . . . . 0.0 110.439 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.07 -36.5 3.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.836 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 58.3 t30 49.67 -97.9 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.528 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -140.18 -17.52 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.725 0.298 . . . . 0.0 110.539 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.643 ' HA ' ' HB3' ' A' ' 160' ' ' GLU . 2.1 mt-30 -73.62 -72.67 0.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.199 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.3 m -58.15 -29.26 65.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.027 0.441 . . . . 0.0 110.856 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -58.18 7.85 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.106 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.79 ' HD2' HD11 ' A' ' 104' ' ' ILE . 14.3 m-85 -135.05 -39.3 0.77 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.643 ' HB3' ' HA ' ' A' ' 156' ' ' GLN . 21.4 tt0 -62.7 -25.69 68.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.853 -170.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.5 t -59.04 -33.81 71.19 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.648 0.261 . . . . 0.0 110.394 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.9 m 55.87 91.32 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 70.2 105.55 0.06 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.87 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.852 ' H ' HD23 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -71.31 -71.85 0.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.4 t70 69.16 -6.89 0.86 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.8 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' A' ' 164' ' ' LEU . 25.8 ptt180 -101.2 -162.94 0.97 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.948 175.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.431 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 8.7 m-90 -62.14 -92.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.686 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.3 m -151.59 104.61 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.658 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 166' ' ' ARG . 8.5 pt-20 -73.05 -11.64 60.63 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.101 0.477 . . . . 0.0 110.104 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.568 ' HB1' ' HE2' ' A' ' 9' ' ' PHE . . . -56.91 -45.94 82.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.554 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -81.34 -27.11 35.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.033 0.444 . . . . 0.0 110.175 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.38 -30.88 71.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.445 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 88.1 mmm -62.37 -28.65 69.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.934 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.61 -49.34 5.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.261 0.553 . . . . 0.0 110.369 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 151.28 118.65 0.83 Allowed Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 64.1 mt -56.57 94.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.411 0.625 . . . . 0.0 111.212 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.7 t -177.53 -171.96 0.34 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.314 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -147.3 -109.01 0.55 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.93 HG23 HD11 ' A' ' 180' ' ' LEU . 42.0 mm 73.0 146.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.114 0.566 . . . . 0.0 111.555 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.93 HD11 HG23 ' A' ' 179' ' ' ILE . 5.5 mp 63.13 63.29 0.93 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.132 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -148.96 106.53 3.41 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.893 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.86 108.3 1.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.51 2.14 . . . . 0.0 112.258 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.6 105.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.193 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 141.57 67.84 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.541 ' NH2' ' HA ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -77.34 85.95 3.75 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.441 -176.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.35 -51.04 4.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.998 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.832 ' HG ' ' H ' ' A' ' 188' ' ' GLU . 0.6 OUTLIER -107.75 -80.92 0.57 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.33 -174.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.832 ' H ' ' HG ' ' A' ' 187' ' ' LEU . 5.2 tp10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.206 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -105.92 -60.82 1.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.052 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 4' ' ' ASN . . . 61.31 56.41 23.71 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.072 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 94.0 m-20 74.7 -33.36 0.24 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.49 0.716 . . . . 0.0 112.402 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 4' ' ' ASN . 81.8 mt 73.58 13.73 4.39 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 175.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -69.33 134.81 49.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 172.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.31 32.21 65.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.313 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -126.21 -177.89 4.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.645 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 4.3 p90 -149.55 148.92 29.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.023 0.44 . . . . 0.0 111.082 170.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.518 HG12 HD12 ' A' ' 28' ' ' ILE . 10.2 pt -118.96 128.86 75.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.344 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.656 HD13 HD21 ' A' ' 149' ' ' LEU . 4.3 mp -98.35 136.84 27.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.537 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.5 -174.5 4.25 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.504 HG23 ' HB2' ' A' ' 17' ' ' ASP . 41.0 m 64.45 82.38 0.21 Allowed Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 121.497 0.665 . . . . 0.0 111.685 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -97.25 9.11 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.846 2.364 . . . . 0.0 114.054 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HG3' ' HG3' ' A' ' 16' ' ' MET . 9.1 pt-20 -173.27 -41.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.409 ' O ' HG21 ' A' ' 13' ' ' THR . 88.0 mtp -112.59 100.62 8.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.039 -175.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.504 ' HB2' HG23 ' A' ' 13' ' ' THR . 34.0 t70 -111.95 158.79 19.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -80.25 -30.51 38.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.887 0.375 . . . . 0.0 110.38 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 20' ' ' TYR . 1.5 tm-20 -103.28 -91.14 0.36 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 49.0 t80 166.21 -55.32 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.098 0 O-C-N 123.982 0.801 . . . . 0.0 110.384 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.535 ' HE1' ' HB3' ' A' ' 167' ' ' TRP . 88.0 t80 -143.78 -12.6 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' HB3' ' HG3' ' A' ' 19' ' ' GLU . 36.9 t70 -84.25 79.66 9.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.379 0.609 . . . . 0.0 110.905 -170.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.429 ' CZ ' HD11 ' A' ' 73' ' ' LEU . 49.2 mtm180 74.48 45.85 0.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.675 172.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -82.1 108.5 15.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.017 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.0 t 74.3 133.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.22 0.608 . . . . 0.0 111.886 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.3 tp -135.0 -65.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.645 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -177.61 177.43 1.14 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.606 0.639 . . . . 0.0 111.781 -177.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.518 HD12 HG12 ' A' ' 10' ' ' ILE . 34.0 mm -103.22 133.64 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.288 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.9 m -81.23 -59.54 2.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.371 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -165.09 157.52 15.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.185 0.517 . . . . 0.0 111.26 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 4' ' ' ASN . 11.8 t-80 -103.3 132.01 49.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.245 174.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -129.12 172.0 11.85 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.6 -36.5 78.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.931 0.396 . . . . 0.0 111.035 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -72.42 -22.83 61.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.135 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.544 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 156.01 -177.77 32.9 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.131 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 m -97.76 121.6 39.86 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.688 HG13 HG23 ' A' ' 133' ' ' THR . 4.3 mp -88.54 117.45 32.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.253 -175.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.07 151.02 22.68 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.195 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 m -116.67 93.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.512 0.672 . . . . 0.0 110.764 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.95 13.3 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.294 -176.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 pt -79.71 -26.91 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.569 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.4 t30 59.07 91.93 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.76 0.663 . . . . 0.0 112.13 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 43' ' ' THR . 9.2 t -156.72 93.63 2.36 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 122.06 0.933 . . . . 0.0 110.941 175.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.447 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 93.9 Cg_endo -81.96 157.49 18.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.665 2.243 . . . . 0.0 111.697 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.8 p -121.6 156.72 32.35 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -12.26 60.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.934 0.397 . . . . 0.0 110.692 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.7 tp -71.36 144.51 49.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.602 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.788 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 59.5 m -105.65 157.6 17.3 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.458 -174.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.1 p -65.89 -34.15 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.925 176.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.82 -36.78 85.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.936 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.788 ' HG2' ' HB2' ' A' ' 48' ' ' SER . 26.9 mm-40 -58.68 -45.87 88.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.775 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.76 -42.34 97.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.854 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 97.8 mt -65.77 -41.66 91.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.323 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.836 HG23 ' HG2' ' A' ' 59' ' ' GLN . 21.4 p -71.9 -31.17 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.437 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -63.32 -36.5 83.9 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.813 0.34 . . . . 0.0 110.254 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.522 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 65.6 mtt -71.66 -85.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 56' ' ' MET . 3.3 t70 171.36 33.21 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.922 0.764 . . . . 0.0 109.666 171.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.46 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 96.9 m-85 -116.24 87.66 2.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.332 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.836 ' HG2' HG23 ' A' ' 54' ' ' THR . 78.3 mt-30 -96.98 82.2 3.19 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.006 0.431 . . . . 0.0 110.093 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 71.0 mtm -136.6 -170.74 2.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.523 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.25 -76.57 0.05 Allowed 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.849 0.718 . . . . 0.0 111.172 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 5.2 mptp? -116.26 115.79 40.06 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 23.2 Cg_exo -63.82 92.44 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.068 2.512 . . . . 0.0 112.754 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 51.88 72.07 0.41 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.411 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 60.9 mt 72.98 -68.35 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.958 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.0 t80 59.79 36.91 22.17 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.04 0.448 . . . . 0.0 110.45 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.9 m 70.04 3.86 4.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.234 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -119.93 67.58 0.82 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.85 131.91 37.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -126.86 113.24 16.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.937 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.597 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.8 mtt -82.0 148.64 28.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.235 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -96.7 147.76 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.134 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.447 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.6 mp -108.46 155.09 20.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.987 0.422 . . . . 0.0 110.554 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -94.32 121.13 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.72 -23.14 43.57 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.742 -173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.519 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 153.87 174.56 24.18 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.033 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.61 -21.56 14.63 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.767 2.312 . . . . 0.0 113.085 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.9 t -81.4 131.19 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 60.31 30.89 20.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.127 0.489 . . . . 0.0 110.155 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -59.15 -27.75 65.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.208 -173.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.67 -7.61 56.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.909 0.385 . . . . 0.0 111.224 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.6 mtm-85 -118.14 131.69 56.39 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.126 0.489 . . . . 0.0 111.142 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.56 118.3 5.08 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.358 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' A' ' 106' ' ' LEU . 85.9 m-85 -91.99 125.88 36.85 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.506 0.194 . . . . 0.0 110.494 -178.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.541 ' HB ' HG12 ' A' ' 112' ' ' VAL . 4.3 mp -112.94 110.62 32.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.182 0.515 . . . . 0.0 109.646 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 40.6 t -91.86 119.15 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.399 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -129.51 152.38 49.1 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.427 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -62.88 156.36 24.45 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.516 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -74.58 117.94 16.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.532 0.682 . . . . 0.0 110.218 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.6 m -140.41 157.64 45.22 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -64.85 124.71 22.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.688 0.756 . . . . 0.0 110.934 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -173.36 138.61 0.72 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.646 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.35 160.99 14.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -106.06 113.16 26.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.603 0.716 . . . . 0.0 111.67 -173.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.3 m -83.13 -45.09 14.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.477 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.98 37.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -77.66 125.02 28.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.926 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -105.46 136.08 45.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.446 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -86.59 128.85 35.02 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.781 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.439 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 72.0 t -70.39 -54.86 16.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -134.79 -48.53 0.75 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.96 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -176.38 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.951 169.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.42 -13.03 60.37 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.101 0.477 . . . . 0.0 111.245 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 100' ' ' VAL . 24.8 mm -105.06 124.24 59.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.0 m -117.36 130.41 56.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.1 0.476 . . . . 0.0 111.538 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 84' ' ' PHE . 67.1 tp -107.79 128.15 54.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.23 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 1.076 HG23 ' HB3' ' A' ' 111' ' ' ASP . 12.1 m -142.58 137.32 30.01 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.129 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 p -120.47 3.21 10.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.391 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 112' ' ' VAL . 15.2 m -109.61 -173.55 2.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.403 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.69 -15.61 13.21 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.907 -0.588 . . . . 0.0 114.541 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 1.076 ' HB3' HG23 ' A' ' 107' ' ' THR . 11.6 t70 -49.43 -46.66 47.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.247 0.523 . . . . 0.0 110.961 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 109' ' ' SER . 31.9 m -60.54 -39.61 81.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.634 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.518 HD11 ' HZ ' ' A' ' 116' ' ' PHE . 4.3 mm? -70.84 -42.73 69.78 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.356 0.598 . . . . 0.0 110.059 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.44 -28.47 66.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.019 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 65.5 m -54.34 -57.0 12.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.561 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.518 ' HZ ' HD11 ' A' ' 113' ' ' LEU . 37.8 p90 -84.24 13.38 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.274 0.559 . . . . 0.0 110.914 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -106.1 9.17 42.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.521 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.4 t -137.44 176.32 8.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -79.68 -9.72 59.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.864 0.364 . . . . 0.0 111.085 -173.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 p -104.03 25.96 9.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.332 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.419 ' HB1' ' HA ' ' A' ' 116' ' ' PHE . . . -54.34 121.59 32.53 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.199 174.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.06 145.58 73.93 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.977 2.451 . . . . 0.0 112.464 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.47 -42.97 82.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.489 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -107.89 125.06 51.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.155 -170.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 42.0 p90 -158.44 133.68 8.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.224 176.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 30.7 pt -124.83 147.95 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.245 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.7 p -122.64 129.16 75.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.193 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.423 ' HG ' ' HB2' ' A' ' 84' ' ' PHE . 23.6 p -138.99 132.23 29.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.296 177.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.82 114.09 19.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.391 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.59 178.26 39.84 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.402 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 75.4 m -147.71 172.08 14.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.7 m -111.78 132.37 54.71 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.688 HG23 HG13 ' A' ' 37' ' ' ILE . 34.9 p -112.4 117.02 31.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.003 0.43 . . . . 0.0 111.028 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -94.67 116.91 29.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.127 0.489 . . . . 0.0 110.15 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 4.4 mptp? -60.22 136.44 91.33 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.546 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.544 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 10.2 Cg_exo -72.14 54.92 2.31 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.706 2.937 . . . . 0.0 113.367 -175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -154.91 -55.21 0.1 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.0 tp60 -63.34 -35.93 82.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.287 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.34 -35.78 74.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.931 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.15 -41.54 94.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.038 0.447 . . . . 0.0 109.831 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.531 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 32.8 mm-40 -64.87 -47.56 77.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.703 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 16.2 mm-40 -54.61 -50.95 66.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.131 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.756 HG12 ' HB2' ' A' ' 148' ' ' TRP . 67.0 mt -68.57 -36.32 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.205 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.35 75.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 21.6 mt-30 -81.95 12.93 3.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.502 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 68.02 24.28 7.9 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.379 0.672 . . . . 0.0 112.318 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -92.59 -5.67 51.13 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.943 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.756 ' HB2' HG12 ' A' ' 143' ' ' ILE . 95.4 m95 -140.48 130.79 25.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.819 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.656 HD21 HD13 ' A' ' 11' ' ' ILE . 6.5 tt -92.96 117.26 29.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.407 HD11 HD21 ' A' ' 5' ' ' LEU . 9.3 tt -95.39 133.85 38.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.974 0.416 . . . . 0.0 110.889 -175.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.472 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 35.5 t -151.52 154.74 37.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.246 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -79.52 156.4 27.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.417 ' HB3' ' CD2' ' A' ' 9' ' ' PHE . . . -126.59 -139.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.1 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.4 t30 61.69 53.63 3.19 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.913 0.863 . . . . 0.0 109.483 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -151.48 169.08 22.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.778 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -54.37 -25.74 26.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.951 0.501 . . . . 0.0 112.165 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -53.51 -28.19 29.68 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 122.581 0.352 . . . . 0.0 111.721 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.5 -57.12 7.98 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -127.66 0.06 6.13 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.06 12.33 17.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.329 0.585 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.41 156.4 1.24 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.042 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.6 t -74.19 147.74 42.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.371 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -108.29 2.5 22.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.823 0.344 . . . . 0.0 110.823 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.7 pp -118.05 -12.48 10.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.837 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 19.5 t70 -157.2 158.37 36.1 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.451 ' HD3' ' HA ' ' A' ' 166' ' ' ARG . 66.4 mmt-85 73.5 101.66 0.07 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.966 0.791 . . . . 0.0 112.597 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.535 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 10.5 p90 -84.81 89.38 7.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.685 174.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.3 t 65.79 95.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.603 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.22 -7.8 26.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.263 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.66 -34.09 69.0 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -74.22 -43.17 58.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.732 0.301 . . . . 0.0 111.046 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.71 -20.85 45.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.872 0.368 . . . . 0.0 110.402 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 14.9 tpt -64.39 -33.64 76.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.23 0.538 . . . . 0.0 110.069 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.631 HD21 HD22 ' A' ' 149' ' ' LEU . 11.2 tp -83.06 -39.0 21.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.454 0.645 . . . . 0.0 109.336 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 120.65 -6.2 11.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.115 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 67.0 mt 67.74 -78.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 123.277 0.631 . . . . 0.0 111.161 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.1 m 69.48 -58.73 0.51 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.608 0.763 . . . . 0.0 111.821 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 161.15 121.13 0.57 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.67 134.28 28.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.238 0.542 . . . . 0.0 111.117 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.51 99.95 12.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.969 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -125.19 122.56 25.26 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.459 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.84 138.81 59.59 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.795 2.33 . . . . 0.0 111.728 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.62 84.83 7.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.104 0.478 . . . . 0.0 110.535 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.515 ' HA3' HD21 ' A' ' 187' ' ' LEU . . . -160.16 144.62 10.23 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -118.72 119.95 35.95 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.385 -174.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 67.87 22.57 8.66 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.195 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.515 HD21 ' HA3' ' A' ' 184' ' ' GLY . 2.0 pp -86.23 154.18 21.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.044 0.449 . . . . 0.0 111.652 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 C--O 1.247 0.972 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.682 175.817 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.88 0.371 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -103.67 -36.65 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.483 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.58 -71.34 2.71 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.602 -175.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -129.22 111.33 12.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.855 0.36 . . . . 0.0 110.034 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.44 -8.77 37.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.918 -173.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.514 ' NE2' ' HA ' ' A' ' 30' ' ' GLU . 11.1 pt20 -82.61 149.52 27.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.69 4.19 79.8 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.344 -173.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HG3' ' HA ' ' A' ' 152' ' ' GLU . 11.3 mptt -121.87 179.0 4.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.639 ' HZ ' ' HG2' ' A' ' 173' ' ' MET . 2.2 p90 -149.31 139.36 22.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.239 0.542 . . . . 0.0 110.485 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 pt -108.85 127.72 65.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.294 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.769 HD12 HD23 ' A' ' 149' ' ' LEU . 4.5 mp -100.08 129.48 50.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.813 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.04 93.12 2.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.469 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -73.49 124.24 90.21 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -52.09 -70.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.033 2.489 . . . . 0.0 112.847 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -132.15 -75.55 0.51 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.869 0.366 . . . . 0.0 111.272 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 53.6 ttp -148.19 164.11 34.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.444 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.7 t70 72.34 117.82 0.05 OUTLIER 'General case' 0 C--O 1.237 0.406 0 O-C-N 124.056 0.847 . . . . 0.0 110.299 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -97.93 -146.59 0.31 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.121 -170.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 25.6 mt-10 -56.38 -81.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.49 -171.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.549 ' HA ' ' HB3' ' A' ' 166' ' ' ARG . 32.0 t80 70.85 -64.48 0.37 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.625 0.77 . . . . 0.0 110.214 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -153.01 11.9 0.48 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.051 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.525 ' OD2' ' HG3' ' A' ' 44' ' ' PRO . 12.4 t0 -133.68 94.34 3.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.411 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.441 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 32.3 mtp180 -101.26 105.74 16.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.12 0.486 . . . . 0.0 110.636 -172.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.597 ' HB ' ' HA ' ' A' ' 42' ' ' ASN . 44.5 p -94.76 137.09 34.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.21 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.628 HG12 HG21 ' A' ' 40' ' ' ILE . 78.7 t 78.02 119.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 123.838 0.711 . . . . 0.0 111.656 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.5 tp -121.88 -55.64 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.366 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.582 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 2.8 p90 -178.69 172.63 1.37 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.027 0.442 . . . . 0.0 111.395 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.49 130.93 47.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.76 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.7 m -89.32 -42.65 11.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -170.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.514 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 42.0 tt0 -142.02 146.12 35.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 111.105 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -124.8 109.45 13.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.332 0.587 . . . . 0.0 110.529 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -95.06 176.6 6.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.67 -42.14 99.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 118.016 0.371 . . . . 0.0 111.325 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -119.87 4.82 10.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.29 0.567 . . . . 0.0 111.0 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.11 108.44 0.73 Allowed Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.943 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 m -100.34 105.98 17.56 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.653 HG13 HG21 ' A' ' 133' ' ' THR . 4.3 mp -88.75 114.27 26.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.722 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.95 173.9 32.53 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.866 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -121.01 83.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.608 0.718 . . . . 0.0 110.389 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.628 HG21 HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -134.92 28.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.791 -176.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.451 HG23 HG22 ' A' ' 43' ' ' THR . 11.0 tp -71.71 -16.71 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.383 -176.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.597 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 53.4 m-80 67.01 72.6 0.36 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.161 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.566 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 13.3 t 170.36 143.87 0.1 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.538 ' HB3' HD23 ' A' ' 73' ' ' LEU . 49.5 Cg_endo -90.81 -170.59 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.957 2.438 . . . . 0.0 110.874 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.3 p -111.78 170.73 7.94 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -88.66 0.99 55.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.351 0.596 . . . . 0.0 110.021 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.17 162.28 13.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.253 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 2.0 m -105.13 158.19 16.75 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.35 -38.36 80.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.803 0.335 . . . . 0.0 110.757 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -65.31 -28.51 69.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -59.87 -44.31 94.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.47 -177.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.9 mp -73.07 -43.81 61.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 110.176 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.71 ' HB3' ' HB3' ' A' ' 58' ' ' PHE . 97.5 mt -58.13 -45.84 86.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.552 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.9 p -73.34 -33.84 65.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.351 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -65.23 -41.95 93.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.796 0.331 . . . . 0.0 110.396 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 83.9 mtp -79.18 -87.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.233 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -175.31 98.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.208 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.71 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 29.9 t80 -155.75 81.51 1.02 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.377 0.608 . . . . 0.0 109.558 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -110.34 -7.32 14.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.623 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.4 ttm -105.02 92.53 4.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.69 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -161.14 -106.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.152 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -141.05 99.46 6.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -73.94 104.73 1.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.781 2.321 . . . . 0.0 111.722 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.576 ' HG3' ' HD2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -101.2 -28.47 12.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.578 -179.238 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.0 mp 53.53 96.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.506 0.722 . . . . 0.0 112.511 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.576 ' HD2' ' HG3' ' A' ' 64' ' ' ARG . 63.8 m-85 -135.72 154.31 51.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.257 175.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -67.86 -36.96 81.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.197 0.522 . . . . 0.0 110.312 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -125.22 94.7 4.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -85.32 -102.68 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.026 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -128.0 119.81 26.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.741 0.305 . . . . 0.0 110.29 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.504 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 89.9 mtp -84.44 131.67 34.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 p -81.7 127.77 39.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.139 0.495 . . . . 0.0 110.701 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.538 HD23 ' HB3' ' A' ' 44' ' ' PRO . 87.9 mt -70.33 160.13 32.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.64 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -98.49 117.81 33.75 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -79.76 -33.06 35.0 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.968 -175.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.51 -176.29 29.17 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.073 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -87.4 5.6 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.157 2.571 . . . . 0.0 113.278 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.47 132.6 57.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 59.1 37.56 24.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 110.494 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -70.01 -10.86 60.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.67 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.29 5.78 29.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.927 0.394 . . . . 0.0 110.819 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -130.95 132.28 44.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.289 0.566 . . . . 0.0 111.66 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.96 118.8 5.03 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.521 ' HB3' HD12 ' A' ' 106' ' ' LEU . 66.0 m-85 -97.79 125.4 42.61 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.538 ' HB ' HG12 ' A' ' 112' ' ' VAL . 3.8 mp -112.9 107.85 24.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.277 0.561 . . . . 0.0 109.949 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.616 HG22 HD13 ' A' ' 106' ' ' LEU . 33.6 t -86.71 115.73 28.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.85 159.49 38.43 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.522 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 22.2 m -70.19 160.8 31.46 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.585 172.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' A' ' 102' ' ' ASP . 13.9 ptpt -70.16 172.49 7.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -171.31 -43.8 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.839 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -154.91 -154.31 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -91.83 176.49 6.5 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' OE2' ' HA ' ' A' ' 96' ' ' HIS . 5.6 pt-20 -93.7 168.59 10.91 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.507 0.67 . . . . 0.0 111.512 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -122.87 -36.62 2.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.706 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.416 ' HB ' ' OD1' ' A' ' 111' ' ' ASP . 10.0 m -112.94 -63.67 1.41 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.04 174.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.403 ' HA ' ' OE2' ' A' ' 93' ' ' GLU . 6.7 t60 179.45 126.82 0.07 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.095 0.474 . . . . 0.0 111.25 174.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 71.2 m -119.31 143.95 47.09 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.115 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -102.6 110.36 22.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.233 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.654 ' HD2' ' HA ' ' A' ' 102' ' ' ASP . 29.2 ttpt -84.42 102.64 12.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.398 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.8 t -69.34 -54.41 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 11.3 t -134.58 167.46 20.76 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.654 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 33.6 m-20 -58.91 -44.54 91.27 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -172.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 88' ' ' SER . 25.6 m-20 -76.99 -28.5 55.11 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -175.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 43.7 mm -118.29 123.07 71.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.08 0.467 . . . . 0.0 111.183 -175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.6 m -130.77 136.7 48.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.045 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.616 HD13 HG22 ' A' ' 86' ' ' VAL . 45.5 tp -99.07 125.68 44.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.488 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.951 HG23 ' HB2' ' A' ' 111' ' ' ASP . 17.8 m -135.9 128.96 31.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -136.36 1.48 2.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.216 0.531 . . . . 0.0 110.164 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.408 ' HB2' ' OD1' ' A' ' 111' ' ' ASP . 4.7 m -72.8 -7.67 51.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.782 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.31 -20.7 11.16 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.055 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.951 ' HB2' HG23 ' A' ' 107' ' ' THR . 2.2 m-20 -48.82 -42.97 37.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.12 0.568 . . . . 0.0 111.327 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.65 HG13 ' HB ' ' A' ' 107' ' ' THR . 5.1 m -53.01 -46.58 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.52 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.33 -36.04 74.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 110.499 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -70.66 -24.61 62.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.153 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -77.75 -14.64 59.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.942 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -85.25 132.09 34.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.965 0.412 . . . . 0.0 111.054 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 112.92 -4.21 25.74 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.765 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.8 t -123.26 157.5 33.0 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -66.85 -10.48 48.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.2 p -92.1 19.3 6.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.002 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.39 144.84 97.51 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.183 172.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.49 140.66 92.57 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.764 2.309 . . . . 0.0 112.729 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.467 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 48.5 mt-10 -57.99 -52.81 63.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.219 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.467 ' HE2' ' HB2' ' A' ' 123' ' ' GLU . 5.4 mtmt -129.33 146.03 51.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.656 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -159.62 141.19 12.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.823 0.344 . . . . 0.0 110.692 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.02 144.41 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.827 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.24 129.22 68.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.037 0.446 . . . . 0.0 110.844 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.9 m -129.6 129.39 44.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.261 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.07 108.73 16.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.637 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.539 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 77.74 -176.44 53.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.189 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 83.4 m -147.85 173.48 12.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 0.0 110.191 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.3 m -120.02 116.76 26.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.157 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.653 HG21 HG13 ' A' ' 37' ' ' ILE . 38.3 p -96.32 113.95 25.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.085 0.469 . . . . 0.0 109.923 175.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.581 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -99.64 141.56 32.28 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.917 -178.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -90.28 117.51 68.09 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.396 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.26 55.77 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.523 2.815 . . . . 0.0 112.286 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -146.01 -37.36 0.25 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -87.56 -44.35 11.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.005 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.581 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 59.2 tp -56.92 -40.19 75.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.315 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.09 -33.44 73.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.828 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.557 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 71.1 mm-40 -67.25 -52.16 44.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.88 0.371 . . . . 0.0 110.234 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.72 -41.57 95.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.717 179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.555 HG12 ' HB2' ' A' ' 148' ' ' TRP . 60.3 mt -64.2 -40.71 90.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.721 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.72 71.01 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 111.027 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 37.0 mt-30 -87.26 9.09 21.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.942 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 10.4 m120 64.61 33.54 10.61 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.582 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -94.45 5.12 52.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.211 0.529 . . . . 0.0 110.085 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.555 ' HB2' HG12 ' A' ' 143' ' ' ILE . 92.1 m95 -142.49 123.69 14.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.725 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.769 HD23 HD12 ' A' ' 11' ' ' ILE . 6.0 tt -78.86 110.6 14.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.23 133.37 34.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.055 0.455 . . . . 0.0 111.501 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.8 t -162.25 157.06 22.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.083 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.504 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 8.6 pt-20 -85.12 154.1 22.25 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.76 119.78 39.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.747 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -168.58 -175.87 2.61 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 67.2 t30 75.29 163.67 0.26 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.398 0.679 . . . . 0.0 111.327 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 69.3 mt-30 -62.06 -25.43 67.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.036 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.7 m -51.82 -29.86 20.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.441 -175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.96 -54.53 43.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -125.34 -17.46 5.62 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -171.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 45.9 mt-10 -96.2 1.79 52.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.289 0.566 . . . . 0.0 110.914 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 t -59.4 136.75 58.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.857 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 42.0 m -97.8 150.06 21.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.638 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -109.1 107.68 18.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.848 0.356 . . . . 0.0 110.953 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.417 HD11 ' N ' ' A' ' 165' ' ' ASP . 3.3 pp -128.51 -36.52 1.87 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.285 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.455 ' OD2' ' HD3' ' A' ' 166' ' ' ARG . 33.9 t70 -167.79 -105.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.549 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -164.88 137.82 4.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.783 0.802 . . . . 0.0 112.558 173.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -152.35 83.52 1.25 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 166.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.572 HG21 ' H ' ' A' ' 171' ' ' ASN . 6.6 p -37.7 95.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 124.625 1.203 . . . . 0.0 113.512 -163.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.21 -28.05 63.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.883 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.56 -32.95 74.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.162 0.506 . . . . 0.0 110.597 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.572 ' H ' HG21 ' A' ' 168' ' ' VAL . 62.5 t30 -81.37 -32.72 32.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.105 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.78 -24.41 61.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.735 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.639 ' HG2' ' HZ ' ' A' ' 9' ' ' PHE . 13.3 tpt -55.64 -30.34 60.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.498 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.2 tp -97.68 -50.17 4.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.957 0.408 . . . . 0.0 109.915 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 147.39 38.06 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.979 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mp 62.29 94.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.086 0.469 . . . . 0.0 110.119 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.8 t 66.31 -176.83 0.19 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.889 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.61 -92.04 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.904 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.595 HG12 ' HG ' ' A' ' 180' ' ' LEU . 10.8 tt -141.78 130.86 23.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.595 ' HG ' HG12 ' A' ' 179' ' ' ILE . 52.6 mt 52.1 62.45 2.69 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.79 0.681 . . . . 0.0 111.553 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -165.6 88.06 0.95 Allowed Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -93.34 -3.71 3.15 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.003 2.469 . . . . 0.0 112.072 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 61.6 -86.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.5 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -171.61 32.86 0.14 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -120.84 120.98 37.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.723 0.297 . . . . 0.0 110.399 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -131.43 88.39 2.58 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 80.6 mt -106.83 -3.25 20.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.89 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.664 -0.684 . . . . 0.0 110.307 178.773 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtm . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 61.15 95.33 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.881 0.738 . . . . 0.0 111.042 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.78 -68.91 1.5 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.813 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -94.56 99.11 11.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.941 0.401 . . . . 0.0 109.957 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' O ' HD22 ' A' ' 5' ' ' LEU . 1.2 tt -90.77 -0.97 57.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.718 0.771 . . . . 0.0 109.066 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.82 136.81 37.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.768 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.07 2.46 80.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.753 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.91 159.53 15.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 151' ' ' SER . 37.6 p90 -125.41 154.0 42.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.9 pt -124.64 128.77 73.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.686 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.528 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.8 mp -75.46 119.63 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.501 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.608 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -102.12 155.37 18.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.975 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.429 ' N ' ' HD3' ' A' ' 14' ' ' PRO . 7.1 t -147.08 69.22 11.74 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 121.682 0.753 . . . . 0.0 111.851 178.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 13' ' ' THR . 13.5 Cg_endo -96.09 129.25 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.31 2.673 . . . . 0.0 111.169 170.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.21 101.62 1.92 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.093 0.473 . . . . 0.0 111.673 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.444 ' HG2' ' H ' ' A' ' 18' ' ' ASP . 46.9 ttp -131.33 140.99 49.84 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -90.88 0.39 57.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.316 0.579 . . . . 0.0 111.182 -174.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.444 ' H ' ' HG2' ' A' ' 16' ' ' MET . 36.1 t70 -123.61 151.92 42.46 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 70.26 106.21 0.06 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.947 0.779 . . . . 0.0 110.088 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -154.62 -57.34 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.586 -174.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -82.4 -5.99 59.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -171.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -99.98 172.7 7.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -93.94 85.41 4.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.249 0.547 . . . . 0.0 111.351 -174.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 t -104.32 167.43 9.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.484 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t 50.02 79.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.422 0.629 . . . . 0.0 110.472 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.493 HD13 HD22 ' A' ' 158' ' ' LEU . 4.0 tp -93.31 -61.16 2.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -170.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.457 ' HD1' HG22 ' A' ' 26' ' ' ILE . 2.1 p90 -167.94 174.55 7.35 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.323 0.511 . . . . 0.0 111.688 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -92.09 123.5 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.611 175.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.2 m -78.45 -38.3 41.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.195 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.98 150.25 20.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 0.0 110.306 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -131.49 104.83 7.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -119.53 167.36 12.05 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.804 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -73.22 -12.95 61.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.771 0.319 . . . . 0.0 110.651 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -83.03 -21.74 33.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.458 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.77 176.31 28.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.835 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.583 ' O ' ' HA ' ' A' ' 133' ' ' THR . 30.0 m -112.66 127.07 56.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.798 0.299 . . . . 0.0 110.779 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 37' ' ' ILE . 4.5 mp -104.42 110.21 29.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.35 165.39 27.47 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.44 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.45 80.11 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.802 0.811 . . . . 0.0 110.213 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.68 28.95 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.884 -176.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.496 HG21 ' HB3' ' A' ' 74' ' ' ASN . 11.0 tp -62.01 -25.94 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.46 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.03 61.42 1.61 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.763 177.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.499 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 9.5 t 179.24 132.51 0.24 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.437 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 43' ' ' THR . 2.2 Cg_endo -82.44 178.64 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.65 2.233 . . . . 0.0 111.05 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.7 p -94.05 -169.22 2.03 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.86 20.03 13.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.812 0.815 . . . . 0.0 109.179 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.1 tp -125.73 170.87 11.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.016 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.7 p -113.8 162.83 15.83 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.603 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.7 p -63.58 -33.6 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.579 HD23 ' HB3' ' A' ' 62' ' ' LYS . 53.7 mt -67.55 -44.92 77.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.221 0.534 . . . . 0.0 109.994 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -54.88 -42.8 72.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.004 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.502 HD13 HG12 ' A' ' 72' ' ' VAL . 66.2 mt -56.74 -55.09 38.66 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.957 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 67.6 mt -59.84 -43.13 94.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.089 -175.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.593 HG22 ' HB3' ' A' ' 64' ' ' ARG . 18.9 p -80.33 -29.35 38.06 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -61.19 -59.65 4.99 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -164.71 -23.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -92.19 27.05 2.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.596 0.712 . . . . 0.0 111.54 -171.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 42.7 t80 -162.93 -104.39 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.481 172.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 58' ' ' PHE . 74.2 mt-30 -162.87 -90.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.233 0.54 . . . . 0.0 109.777 -177.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 27.4 ttt -172.23 118.7 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.256 -0.883 . . . . 0.0 108.934 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.27 -54.55 0.23 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.168 0.509 . . . . 0.0 109.974 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.579 ' HB3' HD23 ' A' ' 50' ' ' LEU . 4.0 mptp? -87.81 151.17 49.52 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.976 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.82 109.12 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.887 2.392 . . . . 0.0 113.134 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.593 ' HB3' HG22 ' A' ' 54' ' ' THR . 36.8 ptt180 -79.38 4.75 14.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.133 0.492 . . . . 0.0 110.933 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.1 tt -76.12 -23.35 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.822 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -98.69 97.54 8.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.363 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.3 p -77.71 -36.02 51.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -94.09 105.56 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.642 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.461 ' OD2' ' HG2' ' A' ' 70' ' ' GLN . 13.5 t70 -156.54 -105.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.461 ' HG2' ' OD2' ' A' ' 69' ' ' ASP . 27.1 mm-40 -99.65 125.15 45.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.985 0.421 . . . . 0.0 110.009 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.1 ttp -86.88 146.01 26.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.649 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.591 HG22 HG12 ' A' ' 127' ' ' VAL . 5.1 p -95.88 140.69 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.831 0.348 . . . . 0.0 110.608 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.5 mt -89.72 164.54 14.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.951 0.405 . . . . 0.0 110.875 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 41' ' ' ILE . 1.6 t-20 -95.0 145.57 24.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.554 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -99.99 -36.43 4.2 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.966 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.89 -171.88 35.58 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.16 -14.68 10.67 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.045 2.497 . . . . 0.0 112.936 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.87 139.08 25.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.75 -175.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 66.32 30.11 9.14 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.979 0.512 . . . . 0.0 111.639 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -65.83 -15.07 62.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.044 0.449 . . . . 0.0 111.548 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.06 -2.5 52.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.543 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -129.76 136.0 49.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.38 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.44 126.36 8.66 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.07 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -107.08 125.68 51.36 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.504 HD11 HG23 ' A' ' 112' ' ' VAL . 3.4 mp -118.03 113.66 42.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.931 0.396 . . . . 0.0 110.5 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG23 HD13 ' A' ' 106' ' ' LEU . 25.2 t -93.1 120.61 42.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.58 ' HE2' ' CD ' ' A' ' 93' ' ' GLU . 29.5 p-80 -139.29 161.17 38.08 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.768 -175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.418 ' OG ' ' HE3' ' A' ' 124' ' ' LYS . 47.4 p -83.51 151.16 25.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.961 0.41 . . . . 0.0 111.315 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 89' ' ' LYS . 13.6 ttpt -71.4 127.28 32.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.175 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -129.59 -43.41 1.26 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.649 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -124.83 -15.22 6.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.159 0.504 . . . . 0.0 110.741 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 71.08 80.48 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.856 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.58 ' CD ' ' HE2' ' A' ' 87' ' ' HIS . 1.3 pm0 -75.39 169.03 18.86 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.719 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -168.32 82.2 0.17 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.5 m -111.2 -37.74 5.23 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 161.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -171.12 77.51 0.07 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.903 165.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 p -97.71 134.62 40.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.958 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -103.06 121.2 42.1 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -87.59 115.8 25.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.046 0.451 . . . . 0.0 111.273 -174.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.69 -54.38 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.34 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.5 t -147.73 173.84 12.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.959 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -84.44 59.7 5.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.132 0.491 . . . . 0.0 110.624 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -175.9 -37.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.755 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.796 HG13 HD11 ' A' ' 158' ' ' LEU . 29.6 mm -117.95 129.7 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.687 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 m -127.88 139.37 52.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.052 0.453 . . . . 0.0 111.054 -174.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.521 HD13 HG23 ' A' ' 86' ' ' VAL . 57.3 tp -96.69 137.14 36.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.192 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.414 ' HB ' ' CG2' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -116.95 124.07 48.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.376 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.6 p -111.63 18.92 18.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.62 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.4 t -147.18 -178.41 6.2 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.1 4.11 8.95 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -49.75 -36.96 27.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.637 0.775 . . . . 0.0 109.756 172.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.504 HG23 HD11 ' A' ' 85' ' ' ILE . 29.3 t -53.5 -40.46 41.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.165 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.17 -33.19 73.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.393 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -71.28 -44.38 65.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.007 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m -64.22 -42.29 96.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.483 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -85.47 9.69 15.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.357 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.61 33.09 5.98 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.744 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 t -154.71 165.62 35.98 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -64.92 -24.33 67.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.773 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.0 p -88.91 32.02 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.114 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.89 146.0 82.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.854 173.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.469 ' HB3' ' CD2' ' A' ' 87' ' ' HIS . 9.2 Cg_endo -53.16 134.23 55.51 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.322 2.681 . . . . 0.0 113.398 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -62.7 -62.5 1.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.909 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.954 ' HD3' ' HG3' ' A' ' 160' ' ' GLU . 4.3 mtmt -103.69 145.31 30.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.8 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -167.71 140.89 3.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 0.0 111.475 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.03 145.02 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.248 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.591 HG12 HG22 ' A' ' 72' ' ' VAL . 4.6 p -117.06 124.9 73.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.008 0.432 . . . . 0.0 110.833 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 59.3 m -128.24 133.6 48.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.273 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.493 HD23 HG21 ' A' ' 72' ' ' VAL . 3.7 mm? -89.06 116.56 27.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.399 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.554 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 76.39 -174.69 53.47 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.758 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 68.2 m -149.18 168.15 24.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.8 m -107.73 119.07 38.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.191 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 36' ' ' THR . 11.1 p -101.69 114.83 29.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.301 0.572 . . . . 0.0 111.346 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -84.21 155.54 22.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.95 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -56.4 142.46 68.78 Favored Pre-proline 0 C--O 1.236 0.388 0 O-C-N 123.472 0.483 . . . . 0.0 111.077 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.45 119.18 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.164 2.576 . . . . 0.0 112.659 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 66.74 17.55 10.59 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.595 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.924 HE21 ' HA ' ' A' ' 138' ' ' GLN . 0.0 OUTLIER -98.66 -23.12 15.58 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.636 -178.089 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 36' ' ' THR . 57.6 tp -68.36 -50.33 53.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.529 0.204 . . . . 0.0 110.943 -175.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -60.35 -34.12 73.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.019 0.438 . . . . 0.0 110.789 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -40.08 77.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.4 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -69.69 -37.81 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 110.146 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.73 HG12 ' HB2' ' A' ' 148' ' ' TRP . 82.8 mt -60.34 -38.02 76.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.541 174.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.79 -28.61 69.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.302 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -88.13 4.41 45.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.928 175.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 16.5 m120 68.69 31.95 4.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.225 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -73.25 -30.54 63.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.466 0.65 . . . . 0.0 109.253 169.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.73 ' HB2' HG12 ' A' ' 143' ' ' ILE . 85.8 m95 -132.22 145.64 51.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.698 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.544 ' O ' ' HA ' ' A' ' 10' ' ' ILE . 64.1 mt -104.43 118.33 36.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.99 135.6 40.16 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.46 -173.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 8.1 t -150.48 163.68 37.81 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 173.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -86.13 152.49 22.81 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.866 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -114.5 7.02 16.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.716 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -71.65 76.73 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.111 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -176.88 -178.67 0.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -65.11 -19.01 65.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.4 m -52.52 -27.17 15.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.527 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.796 HD11 HG13 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -57.1 -43.0 81.8 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.078 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -133.74 -46.89 0.8 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.954 ' HG3' ' HD3' ' A' ' 124' ' ' LYS . 34.1 mt-10 -85.63 16.97 3.52 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -166.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 162' ' ' SER . 2.6 m -55.96 162.48 1.85 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 172.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.405 ' H ' HG23 ' A' ' 161' ' ' THR . 2.9 p -47.18 110.06 0.26 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.443 0.639 . . . . 0.0 112.497 -173.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -77.17 -17.21 58.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.252 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.5 -20.12 57.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.776 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -177.31 122.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.926 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -98.71 -37.53 9.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.037 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 30.9 t90 55.96 -100.71 0.11 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.684 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.22 75.95 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.38 -28.97 68.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.875 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.13 95.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 110.716 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.502 HD22 HG22 ' A' ' 176' ' ' ILE . 62.3 t30 -81.21 -26.99 35.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.18 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.19 -37.78 72.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.566 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -62.43 -30.18 71.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.669 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.3 tp -79.48 -36.12 39.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.878 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.87 8.93 38.56 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.864 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.502 HG22 HD22 ' A' ' 171' ' ' ASN . 13.9 mt 54.12 64.21 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.431 0.634 . . . . 0.0 110.63 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.8 t -158.98 124.3 4.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.135 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.78 177.13 43.66 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.746 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.724 HG12 HD12 ' A' ' 180' ' ' LEU . 14.8 tt -95.76 158.59 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.724 HD12 HG12 ' A' ' 179' ' ' ILE . 6.6 mp 65.28 87.67 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.476 0.655 . . . . 0.0 110.983 -173.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.414 ' HB3' ' HD2' ' A' ' 182' ' ' PRO . . . -93.24 159.74 34.75 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.907 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 181' ' ' ALA . 26.3 Cg_endo -62.89 90.19 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.525 2.15 . . . . 0.0 112.504 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -131.39 -77.96 0.52 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.728 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.8 -79.07 1.72 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.871 -0.681 . . . . 0.0 113.345 173.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 185' ' ' ARG . 8.7 ptp85 -162.14 151.45 15.82 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 -172.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 45.37 73.83 0.15 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.295 0.997 . . . . 0.0 113.049 174.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.9 mt -102.54 108.54 19.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.608 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.539 176.218 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.705 ' HE2' ' HA ' ' A' ' 1' ' ' MET . 4.3 tpt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.519 ' HB3' HD23 ' A' ' 5' ' ' LEU . 19.8 m-30 -76.6 93.86 3.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.188 174.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.54 163.78 12.47 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.679 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.64 40.6 26.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 111.233 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.519 HD23 ' HB3' ' A' ' 2' ' ' PHE . 93.5 mt -72.02 1.27 7.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.598 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.569 ' NE2' ' HA ' ' A' ' 100' ' ' VAL . 53.6 tt0 -66.08 131.68 46.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.831 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.23 -4.81 77.81 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.67 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -109.75 168.88 9.09 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -141.46 152.75 44.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.049 0.452 . . . . 0.0 110.938 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.1 pt -117.37 128.02 74.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.584 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 45.3 mt -101.3 133.25 45.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.794 -177.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.414 ' O ' ' HD3' ' A' ' 14' ' ' PRO . . . -136.55 167.58 21.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.384 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.8 p -97.62 107.61 40.56 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.688 0.28 . . . . 0.0 110.78 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 12' ' ' ALA . 89.3 Cg_endo -90.56 169.81 3.82 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.022 2.481 . . . . 0.0 112.454 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -96.43 128.64 43.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.1 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.5 mmt 72.48 125.37 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.21 0.944 . . . . 0.0 111.656 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -94.17 150.75 20.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.166 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -157.24 156.93 33.36 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.601 ' CD ' ' H ' ' A' ' 20' ' ' TYR . 2.8 tm-20 61.17 -150.31 0.4 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.601 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 91.7 m-85 -110.85 -40.56 4.5 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 172.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -176.19 -34.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.29 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.41 85.27 1.99 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 178.67 -30.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.2 -176.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.0 t -140.73 125.98 18.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.649 -177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.7 t 69.78 130.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.808 0.692 . . . . 0.0 112.106 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.48 HG13 ' HD1' ' A' ' 27' ' ' TYR . 7.0 tp -142.8 -64.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.678 176.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.48 ' HD1' HG13 ' A' ' 26' ' ' ILE . 1.8 p90 -177.01 177.14 1.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.142 0.428 . . . . 0.0 111.311 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.86 124.22 40.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.759 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.4 m -97.14 -40.45 8.8 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -128.89 147.88 50.86 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -175.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.492 ' HB3' ' HB2' ' A' ' 6' ' ' GLN . 5.7 p80 -131.81 116.66 17.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 0.0 111.072 -177.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.448 ' N ' HD21 ' A' ' 32' ' ' ASN . 0.9 OUTLIER -100.75 -7.85 23.32 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 169.756 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 72.43 -46.97 0.66 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.702 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -84.6 3.54 36.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 167.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.12 126.55 1.83 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.885 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 133' ' ' THR . 22.7 m -101.74 119.68 39.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.584 0.192 . . . . 0.0 110.94 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.776 HG13 HG23 ' A' ' 133' ' ' THR . 4.4 mp -109.08 111.47 36.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.933 0.397 . . . . 0.0 110.392 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.76 162.62 28.54 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.291 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.7 m -114.18 79.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.809 0.814 . . . . 0.0 110.754 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.69 18.6 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.907 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 tp -78.57 -21.41 13.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.122 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.4 t30 69.28 93.24 0.08 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.463 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -161.98 122.72 1.55 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.087 176.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.78 155.42 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.803 2.335 . . . . 0.0 110.817 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.487 HG22 ' HB2' ' A' ' 74' ' ' ASN . 9.2 p -101.1 170.48 8.24 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.679 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -92.49 16.13 12.6 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.55 159.05 31.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.964 -172.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 42.6 t -106.51 154.8 20.34 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.198 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 9.4 p -67.64 -35.13 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.73 -26.74 60.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.381 0.61 . . . . 0.0 109.577 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 12.8 mm-40 -68.46 -47.95 65.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.866 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.5 pp -69.84 -34.11 73.19 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.914 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 58' ' ' PHE . 62.8 mt -61.6 -52.32 64.86 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.415 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 p -69.6 -28.47 65.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.087 0.47 . . . . 0.0 111.302 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -59.15 -34.76 72.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.601 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -146.88 -23.71 0.41 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 59' ' ' GLN . 2.7 t70 -134.53 -152.28 0.47 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -169.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 81.2 t80 76.9 -32.54 0.19 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.164 0.586 . . . . 0.0 111.887 172.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.41 ' H ' ' C ' ' A' ' 57' ' ' ASP . 33.6 tt0 67.37 -83.64 0.03 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.139 0.575 . . . . 0.0 110.44 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.8 ttp 179.08 84.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.044 175.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.4 -20.84 18.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.32 154.42 60.64 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.684 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.1 153.36 74.33 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.372 2.048 . . . . 0.0 111.501 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -77.8 73.26 4.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.24 0.543 . . . . 0.0 110.852 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tp -141.2 115.79 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.721 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -141.09 95.15 2.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.366 0.603 . . . . 0.0 111.325 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.9 p -81.88 -61.47 1.91 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.364 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -98.11 85.9 3.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 174.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.9 163.93 14.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.97 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -98.46 122.57 41.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.255 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttt -79.09 140.91 37.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.474 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.92 140.17 22.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.137 0.494 . . . . 0.0 110.889 -177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.52 163.7 13.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.314 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.514 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 4.1 t-20 -105.3 113.16 26.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -77.31 -25.12 64.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.243 -171.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.21 176.63 26.76 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.5 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -83.52 4.81 6.77 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.118 2.545 . . . . 0.0 113.283 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.2 t -106.62 118.76 54.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 51.2 m-80 64.7 33.61 10.32 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.374 0.421 . . . . 0.0 110.233 -176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.58 ' HA ' ' HA3' ' A' ' 130' ' ' GLY . 26.0 tt0 -66.07 -15.96 63.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.374 -175.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -82.51 -7.29 59.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.511 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -109.41 140.7 42.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.055 0.455 . . . . 0.0 111.819 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 130.14 9.58 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.637 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -113.94 124.37 52.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.06 119.36 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.806 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.49 139.62 46.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -148.13 162.72 38.84 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.444 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -74.87 161.5 29.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -81.2 121.76 26.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.024 0.44 . . . . 0.0 110.195 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.525 ' CB ' ' HA ' ' A' ' 122' ' ' PRO . 21.7 m -144.33 -34.15 0.38 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.382 0.61 . . . . 0.0 109.402 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -102.09 179.22 4.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.567 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -120.56 79.85 1.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.399 0.618 . . . . 0.0 110.427 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -64.62 168.03 6.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.138 173.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -154.12 -29.54 0.12 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 p -46.74 -59.99 2.69 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -173.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -170.36 71.99 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.296 0.57 . . . . 0.0 109.49 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.45 ' HB3' HG21 ' A' ' 105' ' ' THR . 11.3 m -79.83 132.1 36.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.018 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.453 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 74.4 t80 -104.11 126.64 51.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.214 177.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 102' ' ' ASP . 13.8 mmmm -72.61 117.72 14.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.519 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.569 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 63.8 t -80.11 -54.68 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 t -131.53 -48.46 0.98 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.536 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 35.9 t70 -178.57 -66.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 172.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.41 -46.18 80.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.0 mm -72.94 123.52 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.45 HG21 ' HB3' ' A' ' 97' ' ' SER . 19.1 m -132.79 142.94 49.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.531 -174.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 31.3 tp -96.98 135.67 38.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.117 176.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.433 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 2.6 m -135.01 123.56 23.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.605 0.24 . . . . 0.0 110.681 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.9 p -134.97 -0.42 2.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.821 0.343 . . . . 0.0 111.728 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -92.99 17.33 10.9 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.31 -14.09 66.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.561 174.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.86 -27.61 60.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.884 0.373 . . . . 0.0 110.849 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 107' ' ' THR . 18.6 m -53.53 -32.81 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.926 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.35 -29.55 62.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 111.153 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -85.28 -35.56 21.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.609 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.5 m -58.76 -33.85 70.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.168 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -83.16 11.51 6.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.044 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.04 24.25 3.29 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.986 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 120' ' ' THR . 3.3 p -123.71 14.76 9.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.981 0.39 . . . . 0.0 111.636 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.41 ' C ' ' H ' ' A' ' 121' ' ' ALA . 0.8 OUTLIER 70.18 -37.16 0.37 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 111.442 -174.409 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.474 ' H ' ' C ' ' A' ' 118' ' ' THR . 16.6 p -78.13 28.04 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.865 0.466 . . . . 0.0 111.781 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 119' ' ' GLN . . . -59.87 134.16 89.73 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.321 176.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.525 ' HA ' ' CB ' ' A' ' 90' ' ' THR . 9.8 Cg_endo -53.27 140.61 61.84 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.213 2.609 . . . . 0.0 112.771 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.404 ' CB ' ' HE2' ' A' ' 124' ' ' LYS . 66.0 mt-10 -57.28 -52.8 63.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.143 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.404 ' HE2' ' CB ' ' A' ' 123' ' ' GLU . 5.6 mtmt -128.84 142.98 50.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.029 -176.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -150.3 145.17 26.01 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.876 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.2 pt -114.75 133.4 61.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.36 128.84 74.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.158 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 78.4 m -142.89 150.04 39.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.256 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -97.09 112.98 24.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.899 176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 80' ' ' GLN . . . 81.48 176.76 51.26 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.716 -178.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.6 m -147.71 173.36 12.84 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.5 m -113.97 121.62 44.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.071 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.776 HG23 HG13 ' A' ' 37' ' ' ILE . 73.7 p -110.25 119.75 40.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.129 0.49 . . . . 0.0 110.773 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -80.27 159.9 25.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.84 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -75.28 138.02 71.74 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.891 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.34 132.39 50.46 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.815 2.343 . . . . 0.0 111.291 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 2.0 t60 79.14 -33.81 0.15 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.926 0.766 . . . . 0.0 111.437 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -59.17 -48.33 82.0 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.504 0.193 . . . . 0.0 111.485 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.8 tp -57.99 -37.43 74.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.129 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 48.5 tt0 -62.03 -43.62 98.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.0 110.22 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.623 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -62.16 -43.58 98.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.894 177.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -63.16 -42.82 99.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.882 0.373 . . . . 0.0 110.712 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.575 HG12 ' HB2' ' A' ' 148' ' ' TRP . 83.4 mt -62.35 -39.98 86.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.343 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.35 -28.59 69.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.496 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 60.8 mt-30 -88.75 8.9 26.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.967 177.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.9 m120 66.78 30.72 7.83 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -81.53 -29.24 33.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.275 0.56 . . . . 0.0 109.742 171.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.575 ' HB2' HG12 ' A' ' 143' ' ' ILE . 95.3 m95 -131.01 131.49 44.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.761 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.669 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 44.0 mt -89.99 112.57 24.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.957 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.5 tp -87.04 133.01 33.63 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.653 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 p -161.23 148.83 15.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.106 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -95.47 165.23 12.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.054 0.454 . . . . 0.0 110.893 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.71 -88.13 0.63 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.593 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 53.26 29.77 9.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.779 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -137.29 176.26 8.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -174.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -57.63 -35.93 71.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.602 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -52.83 -29.44 27.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.694 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.49 -56.99 12.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.04 7.41 6.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -169.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -106.24 -19.25 13.76 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.136 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.7 t -63.59 -24.15 67.68 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.1 m -72.52 85.23 1.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.837 0.351 . . . . 0.0 111.079 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.448 ' HB3' ' H ' ' A' ' 164' ' ' LEU . 7.1 m-85 -133.96 -157.05 0.78 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.517 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.448 ' H ' ' HB3' ' A' ' 163' ' ' TYR . 3.5 pp -63.24 -27.27 69.23 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.117 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.421 ' N ' HD13 ' A' ' 164' ' ' LEU . 38.8 t70 -140.52 148.86 41.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.554 ' HB2' ' OE2' ' A' ' 169' ' ' GLU . 5.0 ptt180 -153.93 -97.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.843 -174.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.481 ' H ' ' HG3' ' A' ' 166' ' ' ARG . 19.5 t90 79.32 -53.63 0.43 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 165.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 10.1 m -129.48 29.64 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -170.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.554 ' OE2' ' HB2' ' A' ' 166' ' ' ARG . 1.5 pm0 -63.01 -52.87 61.25 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.619 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.442 ' H ' ' HG2' ' A' ' 169' ' ' GLU . . . -70.26 -31.65 69.12 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 110.613 -177.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -66.98 -42.84 84.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.87 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -74.98 -21.21 59.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.098 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.887 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 14.1 mmt -62.93 -34.41 77.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.242 0.544 . . . . 0.0 109.699 172.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.6 tp -83.52 -40.24 19.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.996 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.57 22.6 50.06 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.926 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.1 mt 51.42 50.06 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.796 0.807 . . . . 0.0 109.871 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 13.3 t -88.18 -167.29 1.83 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.171 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -69.74 90.36 0.31 Allowed Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.595 -178.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.9 tt -96.04 125.61 48.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.023 0.44 . . . . 0.0 110.597 177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.48 77.41 9.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.252 0.549 . . . . 0.0 110.336 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -166.3 113.57 0.74 Allowed Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.485 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.84 83.18 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.915 2.41 . . . . 0.0 112.041 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.19 -66.3 0.91 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.331 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 166.1 168.31 28.08 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.963 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -136.03 33.07 2.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.954 0.407 . . . . 0.0 110.641 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -103.27 8.55 38.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.758 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 187' ' ' LEU . 1.8 pt? -152.34 120.79 6.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.5 . . . . 0.0 111.69 -176.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.965 -1.017 . . . . 0.0 108.834 172.63 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tmm? . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.492 ' HE2' ' HG2' ' A' ' 140' ' ' GLU . 27.1 p90 -114.67 119.12 35.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.263 0.554 . . . . 0.0 111.634 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -117.61 -82.29 0.87 Allowed Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -104.76 -14.57 15.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.1 mt 64.61 -90.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.384 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 31.45 86.54 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.308 1.005 . . . . 0.0 112.96 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 123.83 -0.59 9.22 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.385 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.773 ' HE3' ' HG3' ' A' ' 152' ' ' GLU . 13.6 mptt -105.52 169.16 8.62 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -142.45 167.89 21.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.413 HD11 ' CE3' ' A' ' 148' ' ' TRP . 4.8 pt -128.16 128.44 68.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.083 0.468 . . . . 0.0 111.477 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 4.6 mp -98.36 127.08 51.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.626 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.46 -72.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.083 0.239 . . . . 0.0 110.763 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.7 m 67.13 95.9 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 O-C-N 123.778 0.674 . . . . 0.0 110.958 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.26 -48.78 19.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.796 2.331 . . . . 0.0 112.407 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.643 ' HG2' ' HG2' ' A' ' 16' ' ' MET . 43.6 tt0 -170.77 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.064 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.643 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 25.7 ptt? -175.08 -168.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.552 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -125.83 -74.3 0.61 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 175.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -119.94 -56.93 1.99 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 16' ' ' MET . 33.4 mt-10 -84.65 179.09 7.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.141 170.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -95.68 -66.49 0.91 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.566 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -128.41 74.65 1.57 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.211 0.529 . . . . 0.0 110.855 -170.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -111.78 98.71 7.59 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.433 ' HD3' ' NE1' ' A' ' 167' ' ' TRP . 0.8 OUTLIER 62.5 69.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.724 0.64 . . . . 0.0 110.3 -172.789 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.413 ' HA ' ' OD1' ' A' ' 42' ' ' ASN . 4.3 m -65.51 96.05 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.497 -177.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.882 HG11 ' H ' ' A' ' 26' ' ' ILE . 3.1 t 60.79 -170.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.253 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.893 HG21 HG23 ' A' ' 39' ' ' VAL . 10.1 tp -174.13 -147.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.71 ' HD1' HG13 ' A' ' 26' ' ' ILE . 2.6 p90 -120.87 176.33 5.6 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.217 0.917 . . . . 0.0 111.368 -168.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.9 127.95 43.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.416 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.44 -44.76 7.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.937 -176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.787 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.9 tp10 -136.03 156.38 48.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.411 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -140.87 110.18 6.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.184 0.516 . . . . 0.0 110.254 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -113.3 179.95 3.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -76.1 -35.0 59.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.055 0.455 . . . . 0.0 110.488 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.96 -24.27 60.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.975 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 171.63 178.28 41.89 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 119.966 -1.111 . . . . 0.0 112.959 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -103.62 130.38 51.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.787 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 mp -100.87 114.5 40.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.059 0.457 . . . . 0.0 110.89 -174.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.41 178.85 19.29 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.893 HG23 HG21 ' A' ' 26' ' ' ILE . 10.7 m -125.08 33.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.626 0.727 . . . . 0.0 110.316 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.513 ' HB ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -82.98 20.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.366 -173.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.447 HG22 HG21 ' A' ' 43' ' ' THR . 10.4 tp -67.24 -25.04 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.646 0.26 . . . . 0.0 111.249 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.413 ' OD1' ' HA ' ' A' ' 24' ' ' THR . 4.6 t30 67.16 80.64 0.21 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.409 173.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.447 HG21 HG22 ' A' ' 41' ' ' ILE . 5.1 t -178.2 126.39 0.27 Allowed Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 121.319 0.581 . . . . 0.0 111.877 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.677 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 83.7 Cg_endo -84.33 179.69 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.677 2.251 . . . . 0.0 110.689 169.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 p -119.6 -175.32 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -93.55 9.03 38.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.174 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 tp -125.43 163.95 21.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.84 0.353 . . . . 0.0 110.857 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 10.6 m -107.48 163.21 13.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.295 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.581 ' HB ' HG12 ' A' ' 127' ' ' VAL . 11.3 p -66.15 -35.72 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.744 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.622 HD13 ' HD3' ' A' ' 64' ' ' ARG . 81.2 mt -72.21 -26.44 62.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 110.487 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -35.47 78.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.944 177.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.02 -44.74 91.75 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.064 0.459 . . . . 0.0 109.87 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.57 HD12 HD11 ' A' ' 113' ' ' LEU . 27.3 mt -66.54 -33.48 75.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.655 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.6 m -62.3 -35.35 78.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.086 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -76.05 -60.58 2.27 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.397 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.4 ptt? 168.86 -24.99 0.0 OUTLIER 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.114 0.566 . . . . 0.0 110.815 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -61.41 125.96 25.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.334 -174.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.584 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 43.1 m-85 64.41 44.36 4.21 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.586 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.584 ' HB2' ' O ' ' A' ' 58' ' ' PHE . 1.8 mp0 82.22 154.81 0.11 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.69 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 25.7 ttt -111.66 145.26 39.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -166.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 77.88 108.71 0.08 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.219 168.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.534 ' HG2' HD22 ' A' ' 50' ' ' LEU . 1.7 tpmt? -155.38 85.42 3.43 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -62.34 138.89 74.13 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.224 2.616 . . . . 0.0 113.213 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.622 ' HD3' HD13 ' A' ' 50' ' ' LEU . 50.7 ptt85 -139.41 173.23 11.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.533 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.2 pt -117.88 -175.5 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.357 176.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 69.55 168.18 0.29 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.938 0.773 . . . . 0.0 111.041 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.6 m -67.63 -45.64 74.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.267 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.06 162.23 34.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.106 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -132.09 -97.53 0.31 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -104.43 112.29 25.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.549 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 88.2 mtp -82.26 144.46 30.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.465 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.529 ' HA ' HG13 ' A' ' 127' ' ' VAL . 7.3 p -93.97 137.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.886 0.374 . . . . 0.0 110.06 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.677 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.9 mp -102.02 -179.79 4.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.937 0.398 . . . . 0.0 110.341 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -115.41 137.14 52.36 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.04 -23.78 14.25 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.813 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.34 173.76 30.37 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.04 -12.15 16.16 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.023 2.482 . . . . 0.0 112.823 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.4 t -87.73 125.21 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.67 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 59.53 40.28 20.64 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.883 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -70.65 -10.95 60.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.298 0.57 . . . . 0.0 110.524 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.13 -22.69 67.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.155 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -104.15 147.17 27.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.432 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.86 124.34 7.13 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.618 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.494 ' HB3' HD13 ' A' ' 106' ' ' LEU . 60.5 m-85 -106.12 124.83 50.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.482 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.7 mp -120.23 110.06 27.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.652 HG21 HD11 ' A' ' 106' ' ' LEU . 21.4 t -95.55 124.46 48.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.651 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 125' ' ' PHE . 25.6 p80 -138.29 168.76 19.07 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.804 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.0 t -64.99 168.34 6.6 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' HG2' ' HA ' ' A' ' 103' ' ' ASP . 12.7 mmmt -51.25 112.9 0.81 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.235 0.541 . . . . 0.0 110.427 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 m -158.74 122.43 3.9 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.68 -150.03 0.45 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.319 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 77.97 13.85 1.64 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.409 1.083 . . . . 0.0 109.701 -169.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -98.35 155.48 17.2 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -147.65 -27.43 0.36 Allowed 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.656 -0.418 . . . . 0.0 112.083 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.2 m -67.1 -55.2 15.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.926 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -169.0 110.28 0.49 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 111.12 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 m -118.74 137.24 53.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.195 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -123.02 137.21 55.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.99 118.46 34.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.313 0.578 . . . . 0.0 110.781 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.82 -54.08 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.169 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 t -134.67 165.53 25.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.26 67.89 6.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.488 0.661 . . . . 0.0 111.177 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.51 ' HA ' ' HG2' ' A' ' 89' ' ' LYS . 24.6 t70 178.92 -31.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.089 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 49.2 mm -105.95 124.42 61.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.248 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.4 m -113.96 128.34 56.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.897 0.379 . . . . 0.0 110.955 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.652 HD11 HG21 ' A' ' 86' ' ' VAL . 54.5 tp -109.31 113.14 25.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.614 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 m -100.01 124.09 44.98 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -109.02 25.78 11.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.314 0.578 . . . . 0.0 111.122 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 111' ' ' ASP . 19.9 m -144.8 172.92 12.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.506 -178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.78 8.42 3.37 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.705 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.421 ' H ' ' C ' ' A' ' 109' ' ' SER . 0.5 OUTLIER -66.56 -17.19 64.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.482 HG11 ' HB ' ' A' ' 85' ' ' ILE . 25.6 m -58.01 -29.63 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.73 174.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.57 HD11 HD12 ' A' ' 53' ' ' LEU . 4.5 mm? -60.78 -31.87 71.21 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.132 0.491 . . . . 0.0 110.464 177.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -78.59 -37.25 42.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.864 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -53.65 -45.07 70.1 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.887 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -97.98 140.84 31.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.782 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.04 2.37 45.37 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.058 -177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.0 t -115.75 -175.83 2.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -58.87 -34.35 71.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.071 0.463 . . . . 0.0 110.504 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.6 p -112.01 64.03 0.62 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.136 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.03 125.51 85.18 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.192 172.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.07 133.1 24.2 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.538 2.158 . . . . 0.0 112.312 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -61.73 -57.81 10.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.355 0.598 . . . . 0.0 111.702 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.1 mtmm -118.54 127.48 53.66 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 -168.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.442 ' HB3' ' HB3' ' A' ' 87' ' ' HIS . 37.5 p90 -150.62 138.52 19.98 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.819 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.2 pt -116.06 134.14 60.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.834 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.581 HG12 ' HB ' ' A' ' 49' ' ' VAL . 6.5 p -114.17 128.36 71.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.253 0.549 . . . . 0.0 110.702 -177.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 18.2 p -142.23 138.23 31.3 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.187 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.8 mt -89.3 140.14 29.79 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.768 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.89 -175.15 4.02 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.47 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 79.1 m -148.83 173.06 13.67 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.0 p -114.05 122.3 46.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.915 0.388 . . . . 0.0 110.445 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.663 HG22 HG13 ' A' ' 37' ' ' ILE . 25.3 p -98.65 117.01 32.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.042 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.499 ' HZ3' HD11 ' A' ' 40' ' ' ILE . 1.2 t-105 -68.48 148.4 50.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.279 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -69.16 144.91 95.77 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.142 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.91 125.27 18.58 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.274 2.649 . . . . 0.0 113.484 -173.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 2.8 t60 71.59 -8.28 1.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.056 172.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -67.07 -44.75 79.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.343 . . . . 0.0 111.491 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 47.7 tp -57.51 -31.43 66.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.548 -175.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.492 ' HG2' ' HE2' ' A' ' 2' ' ' PHE . 48.7 mt-10 -58.83 -41.11 86.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.301 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.52 -49.66 18.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.842 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 0.3 OUTLIER -54.88 -40.93 70.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.139 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.93 -48.16 76.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.856 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.63 -35.98 81.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.828 0.347 . . . . 0.0 111.407 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -87.33 16.08 5.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.891 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 68.14 24.38 7.68 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.492 ' HD2' ' HA ' ' A' ' 142' ' ' GLU . 75.6 m-85 -83.57 -25.48 30.89 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.842 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 94.5 m95 -133.96 132.96 40.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.885 176.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.8 tt -90.62 115.13 27.5 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 2' ' ' PHE . 55.6 tp -93.98 135.55 35.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.764 0.316 . . . . 0.0 111.386 -175.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.5 t -156.21 156.17 33.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.773 ' HG3' ' HE3' ' A' ' 8' ' ' LYS . 7.6 mp0 -70.11 153.54 43.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.61 -3.56 9.82 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -71.97 81.64 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.795 0.807 . . . . 0.0 111.322 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -158.57 165.48 34.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.0 -30.05 32.94 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.1 m -55.76 -30.5 61.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.938 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.49 -53.19 52.06 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.945 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.402 ' CZ ' HG11 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -115.77 -46.07 2.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 162' ' ' SER . 25.5 tt0 -65.01 -47.34 77.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.81 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.0 m 72.76 -27.03 0.18 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.656 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 160' ' ' GLU . 48.2 m 64.74 100.35 0.04 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.347 0.594 . . . . 0.0 109.624 -173.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -67.3 91.48 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.331 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.1 pp -160.07 -33.14 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.07 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 166' ' ' ARG . 17.0 t70 -109.39 -170.15 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.495 ' HB3' ' CE3' ' A' ' 167' ' ' TRP . 26.1 mmt180 -119.23 -78.66 0.59 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.808 0.337 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.495 ' CE3' ' HB3' ' A' ' 166' ' ' ARG . 16.2 m-90 -146.89 26.77 1.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.115 -177.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.99 -38.44 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -171.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -4.33 20.76 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.69 -57.32 12.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 111.627 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.488 ' ND2' HG13 ' A' ' 176' ' ' ILE . 4.4 p-10 -75.25 -24.54 57.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -177.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -66.02 -22.44 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.19 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 13.7 tpt -55.12 -33.29 62.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.45 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.476 HD23 HD22 ' A' ' 149' ' ' LEU . 12.1 tp -107.79 -51.96 2.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.958 0.409 . . . . 0.0 110.878 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 156.54 115.85 0.5 Allowed Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.488 HG13 ' ND2' ' A' ' 171' ' ' ASN . 4.4 mp -48.83 -56.95 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 123.889 0.405 . . . . 0.0 110.86 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 20.7 m 71.65 -45.68 0.62 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.317 0.647 . . . . 0.0 111.901 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.54 -69.8 0.47 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 10.5 tp -169.62 148.05 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 97.6 mt -80.72 83.75 6.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.042 0.449 . . . . 0.0 110.065 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -159.13 156.7 26.75 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.229 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.58 -8.79 23.32 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.863 2.375 . . . . 0.0 112.91 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 63.93 -164.58 0.25 Allowed 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.449 0.468 . . . . 0.0 111.266 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.45 51.61 7.22 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.715 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 63.12 67.04 0.69 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.364 0.602 . . . . 0.0 109.883 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -101.0 69.11 1.29 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.029 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.25 146.69 40.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.946 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.707 179.176 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.573 ' HA ' ' CD ' ' A' ' 140' ' ' GLU . 89.5 mtp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.786 0.327 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -119.38 131.99 55.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.305 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.01 -58.88 10.19 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.824 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.634 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 61.2 t30 -149.37 154.81 39.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.83 -98.49 0.45 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.466 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' A' ' 29' ' ' CYS . 56.2 mt-30 61.84 122.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.429 1.109 . . . . 0.0 112.557 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.04 5.77 88.94 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.937 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -93.74 158.18 15.8 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' HE1' HD13 ' A' ' 11' ' ' ILE . 29.8 p90 -134.52 163.04 30.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.049 0.452 . . . . 0.0 110.924 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 pt -127.54 128.16 69.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.421 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.645 HG12 ' HA ' ' A' ' 171' ' ' ASN . 4.5 mp -87.92 132.51 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.364 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.32 168.59 26.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.418 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 m -122.17 99.12 43.76 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.951 0.405 . . . . 0.0 110.66 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.35 174.58 10.49 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.054 2.503 . . . . 0.0 111.462 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -69.27 112.31 5.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.219 0.533 . . . . 0.0 109.997 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.1 ptp -79.11 159.97 27.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.296 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -160.52 -57.74 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.379 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 66.17 115.8 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.906 0.754 . . . . 0.0 112.03 172.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -124.21 -46.49 1.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -145.38 -89.08 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -116.85 39.12 3.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.389 0.614 . . . . 0.0 110.092 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -49.68 125.43 11.56 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.655 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -110.61 120.82 43.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.0 110.089 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.9 p -84.78 -168.13 2.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.417 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.736 HG21 HG21 ' A' ' 40' ' ' ILE . 2.7 p -56.01 136.19 18.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.479 173.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.403 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.2 tp -114.14 -55.41 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.78 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.403 ' HD1' HG13 ' A' ' 26' ' ' ILE . 5.2 p90 -175.45 171.93 2.75 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.212 0.529 . . . . 0.0 111.852 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.0 mm -90.95 126.55 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.754 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 6' ' ' GLN . 43.2 t -81.98 -50.89 8.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.046 -174.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 45.8 mt-10 -136.21 146.59 46.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.963 0.411 . . . . 0.0 111.454 -177.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.634 ' CD2' ' HA ' ' A' ' 4' ' ' ASN . 43.2 t60 -137.21 114.05 10.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.088 175.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -116.7 172.31 7.32 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -82.23 -20.03 38.5 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 172.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -16.03 24.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.665 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.43 174.46 44.41 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.303 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -149.23 133.58 17.47 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.437 -0.449 . . . . 0.0 110.401 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.723 HG13 HG23 ' A' ' 133' ' ' THR . 4.5 mp -122.87 123.64 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.246 -177.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.41 172.0 24.46 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.044 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.2 97.53 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.394 0.616 . . . . 0.0 110.51 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.736 HG21 HG21 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -130.98 24.48 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.195 -176.177 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.863 HG12 ' HB3' ' A' ' 74' ' ' ASN . 10.0 tp -55.81 -39.17 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.447 -173.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.48 25.19 14.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.613 0.365 . . . . 0.0 111.605 175.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.554 HG21 HG13 ' A' ' 41' ' ' ILE . 3.8 t -166.81 148.27 5.46 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 122.076 -0.39 . . . . 0.0 110.144 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.564 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 2.3 Cg_endo -81.99 -173.57 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.22 2.613 . . . . 0.0 112.471 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -101.58 -161.23 0.84 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.18 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.86 -7.69 22.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.284 0.564 . . . . 0.0 110.443 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 48' ' ' SER . 16.4 tp -107.21 171.22 7.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.252 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.823 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 14.7 m -119.65 161.77 20.12 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.106 -0.371 . . . . 0.0 110.342 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 12.8 p -69.39 -35.49 67.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.046 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.561 HD11 ' O ' ' A' ' 68' ' ' GLN . 65.0 mt -59.69 -37.61 79.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.084 176.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.823 ' HG2' ' HB2' ' A' ' 48' ' ' SER . 23.2 mm-40 -60.01 -53.18 60.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.445 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.402 ' O ' ' HG2' ' A' ' 56' ' ' MET . 94.5 mt -61.05 -46.78 89.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.663 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 85.1 mt -57.53 -44.67 85.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.299 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.7 p -75.5 -36.35 60.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.259 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.431 ' HD2' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -58.51 -50.82 72.38 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.661 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 52' ' ' LEU . 25.4 ptt? -86.54 -6.19 58.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.225 -177.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 t70 60.59 97.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.0 0.905 . . . . 0.0 111.092 -174.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.648 ' O ' ' HG2' ' A' ' 59' ' ' GLN . 3.7 p90 -93.55 22.4 5.43 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.359 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.648 ' HG2' ' O ' ' A' ' 58' ' ' PHE . 16.6 pt20 65.17 100.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.581 1.152 . . . . 0.0 109.005 -164.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mtp -73.21 98.58 2.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.403 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.79 159.74 41.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.653 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 64' ' ' ARG . 67.9 mttm 59.33 95.73 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.216 0 O-C-N 123.807 0.692 . . . . 0.0 111.809 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.74 -1.1 10.29 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.033 2.489 . . . . 0.0 112.548 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER 69.39 164.61 0.25 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.513 0.673 . . . . 0.0 111.278 -179.122 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 68.4 mt -105.16 117.59 51.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.266 173.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 80.2 t80 74.31 143.11 0.07 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 124.126 0.891 . . . . 0.0 109.796 -172.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 67' ' ' THR . 12.2 t -57.69 110.41 0.89 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.841 0.829 . . . . 0.0 111.217 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.561 ' O ' HD11 ' A' ' 50' ' ' LEU . 36.2 tt0 -97.89 75.13 2.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.981 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -79.51 108.33 12.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.05 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.42 ' O ' HG13 ' A' ' 49' ' ' VAL . 25.9 mm-40 -120.07 120.27 35.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.247 0.546 . . . . 0.0 110.304 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 12.4 ttt -88.44 144.05 26.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.407 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.534 HG22 HD23 ' A' ' 129' ' ' LEU . 9.0 p -89.08 137.12 21.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.202 0.525 . . . . 0.0 110.73 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 67.3 mt -80.43 167.84 19.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.216 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.863 ' HB3' HG12 ' A' ' 41' ' ' ILE . 7.1 t-20 -97.64 155.85 16.8 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -109.69 -25.6 5.38 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.455 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.88 174.1 20.19 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.46 -9.18 18.69 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.858 2.372 . . . . 0.0 112.221 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.491 HG12 ' OD1' ' A' ' 79' ' ' ASN . 6.1 t -104.12 139.22 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.269 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.573 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 20.3 m120 56.05 34.5 23.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.442 0.297 . . . . 0.0 111.325 176.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.597 ' HA ' ' CA ' ' A' ' 130' ' ' GLY . 15.7 tt0 -66.54 -13.67 61.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.154 0.502 . . . . 0.0 111.524 -174.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.71 -8.48 57.36 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.735 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -102.25 133.7 46.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.032 0.444 . . . . 0.0 111.228 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.35 124.24 6.37 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.715 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -108.73 123.1 48.48 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.45 HG21 HG21 ' A' ' 112' ' ' VAL . 5.2 mp -139.56 112.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 0.0 110.662 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.8 t -115.29 132.04 65.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.302 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -125.53 152.51 44.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.62 ' HB3' ' HB3' ' A' ' 159' ' ' PHE . 20.1 p -81.38 148.46 29.32 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.455 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 87.8 tttt -67.01 114.35 5.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.865 0.841 . . . . 0.0 111.57 -176.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.723 ' HB ' ' HA ' ' A' ' 122' ' ' PRO . 3.5 m -138.55 10.51 2.71 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -140.3 164.6 29.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.031 -168.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -136.44 15.69 3.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.331 0.586 . . . . 0.0 109.74 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -124.87 160.75 28.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.844 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.1 p90 170.44 154.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.188 0.93 . . . . 0.0 109.887 -175.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.4 m -104.08 -45.19 4.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.229 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -151.71 108.32 3.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.834 0.35 . . . . 0.0 110.494 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 p -139.89 150.18 44.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.067 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -102.18 112.12 24.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -90.56 123.68 34.41 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.184 0.516 . . . . 0.0 111.557 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.4 -54.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.2 p -116.43 -165.86 1.1 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -90.03 15.57 9.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.683 0.754 . . . . 0.0 109.349 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 13.2 t70 -131.03 -59.97 0.97 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.251 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.676 HG13 HD12 ' A' ' 158' ' ' LEU . 50.7 mm -72.49 122.15 24.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.126 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.96 133.17 45.57 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.328 0.585 . . . . 0.0 112.383 -176.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 85' ' ' ILE . 31.1 tp -99.77 122.11 42.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.216 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m -102.54 123.86 47.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.822 0.344 . . . . 0.0 110.113 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.6 p -116.53 20.62 14.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.887 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 m -139.67 177.58 7.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.445 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.77 -6.17 49.6 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.518 -0.372 . . . . 0.0 112.262 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.22 -29.38 63.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.207 0.527 . . . . 0.0 110.619 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.45 HG21 HG21 ' A' ' 85' ' ' ILE . 14.8 p -54.63 -34.02 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.714 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.547 ' HG ' ' HB2' ' A' ' 58' ' ' PHE . 2.9 mm? -63.57 -35.99 82.32 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.026 0.441 . . . . 0.0 110.356 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.27 -34.54 65.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.88 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.2 m -58.31 -49.46 77.07 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.136 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -99.9 3.73 44.67 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.886 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.13 11.55 65.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.82 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -118.24 164.71 14.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -66.98 -23.01 65.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.898 0.38 . . . . 0.0 110.856 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.9 p -94.07 24.57 4.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.934 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -51.07 136.37 28.42 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.14 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.723 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 31.3 Cg_exo -58.74 145.96 94.16 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.095 2.53 . . . . 0.0 112.339 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.99 -47.93 70.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.242 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -141.8 143.53 33.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.663 -176.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -152.03 148.59 27.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.83 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.4 pt -118.71 141.34 38.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.71 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.99 122.8 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.246 0.546 . . . . 0.0 110.495 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 81.3 m -132.81 158.14 43.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.153 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.534 HD23 HG22 ' A' ' 72' ' ' VAL . 3.4 mm? -112.76 113.21 25.21 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.852 0.358 . . . . 0.0 110.555 175.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.597 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . 101.98 -178.24 26.92 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.556 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 34.8 m -144.43 168.43 20.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.7 m -114.33 116.09 28.4 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.723 HG23 HG13 ' A' ' 37' ' ' ILE . 40.8 p -117.56 143.79 45.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.257 0.551 . . . . 0.0 111.731 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -110.89 177.47 4.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.233 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.525 ' HB3' ' HD2' ' A' ' 136' ' ' PRO . 65.6 mttp -85.17 167.13 27.52 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.221 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 135' ' ' LYS . 90.4 Cg_exo -44.15 105.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.969 2.446 . . . . 0.0 113.507 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 65.48 7.62 4.48 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.946 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.553 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.7 tp60 -57.5 -48.1 80.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.105 0.411 . . . . 0.0 111.396 -174.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.508 ' O ' HG13 ' A' ' 143' ' ' ILE . 65.3 tp -57.04 -34.86 68.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.981 0.42 . . . . 0.0 110.993 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.573 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 39.6 tt0 -61.89 -46.05 91.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.59 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 13.4 mp0 -73.14 -30.15 63.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.09 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 66.9 mm-40 -60.92 -42.55 98.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.254 0.549 . . . . 0.0 110.013 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.521 HG12 ' HB2' ' A' ' 148' ' ' TRP . 86.0 mt -65.09 -29.73 48.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.586 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.07 -12.7 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.371 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 48.0 mt-30 -88.94 1.18 55.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.418 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 68.69 17.44 8.89 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.607 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -80.34 -18.95 47.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.325 0.583 . . . . 0.0 110.137 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.521 ' HB2' HG12 ' A' ' 143' ' ' ILE . 84.7 m95 -126.1 138.89 53.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.05 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 48.8 mt -106.43 107.59 18.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.073 0.463 . . . . 0.0 110.232 176.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tt -84.73 134.13 34.35 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.286 -174.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.49 ' HB2' HD12 ' A' ' 174' ' ' LEU . 16.1 t -150.07 178.09 9.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.045 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.25 154.14 39.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.254 0.55 . . . . 0.0 111.549 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.81 145.16 32.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.202 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.424 HD21 ' N ' ' A' ' 154' ' ' ASN . 0.9 OUTLIER -88.61 26.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.097 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.8 t30 70.48 -45.66 0.6 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.884 0.874 . . . . 0.0 110.672 -174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -57.93 -43.49 86.32 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 121.185 0.517 . . . . 0.0 109.851 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -28.84 69.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.444 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.676 HD12 HG13 ' A' ' 104' ' ' ILE . 2.8 tt -74.5 -56.57 4.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.112 -173.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.62 ' HB3' ' HB3' ' A' ' 88' ' ' SER . 0.4 OUTLIER -125.27 -23.55 4.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -174.455 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.29 -51.09 14.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.357 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.606 HG22 ' H ' ' A' ' 162' ' ' SER . 0.2 OUTLIER 59.74 -158.81 0.31 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.23 172.351 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.606 ' H ' HG22 ' A' ' 161' ' ' THR . 21.4 t -101.52 -14.4 17.5 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.87 -175.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 162' ' ' SER . 18.6 m-85 73.45 147.53 0.09 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.089 -175.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.6 mt 75.21 -46.49 0.59 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.01 0.924 . . . . 0.0 108.798 -168.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 163' ' ' TYR . 32.5 m-20 58.95 96.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.723 170.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -87.61 -40.97 13.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.189 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -157.89 -171.19 3.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.673 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.6 m -89.9 98.89 8.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.546 0.689 . . . . 0.0 110.863 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.11 -6.0 47.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.73 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.71 67.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.074 0.464 . . . . 0.0 110.649 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.645 ' HA ' HG12 ' A' ' 11' ' ' ILE . 44.6 t30 -67.87 -39.43 83.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.111 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.439 ' HA ' HG13 ' A' ' 176' ' ' ILE . 36.0 tt0 -79.29 -20.89 46.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.718 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.842 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 2.2 tpt -63.11 -33.6 75.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.462 0.648 . . . . 0.0 109.263 173.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.49 HD12 ' HB2' ' A' ' 151' ' ' SER . 13.0 tp -81.0 -45.06 17.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.251 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 135.18 7.5 1.97 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.437 -0.802 . . . . 0.0 113.247 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.439 HG13 ' HA ' ' A' ' 172' ' ' GLU . 55.6 mt 63.17 94.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 121.323 0.582 . . . . 0.0 111.299 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 7.0 t -115.76 165.74 12.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.355 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -84.24 152.77 28.47 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.143 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 8.7 tt -73.13 128.91 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.033 0.444 . . . . 0.0 111.127 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.1 mp -93.69 134.4 36.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.199 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 53.22 68.02 3.29 Favored Pre-proline 0 N--CA 1.466 0.335 0 O-C-N 123.673 0.608 . . . . 0.0 111.259 -176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.52 -4.93 13.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.705 2.27 . . . . 0.0 113.459 -173.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -140.51 148.3 40.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.587 0.232 . . . . 0.0 110.812 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 156.04 -81.73 0.16 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.569 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -146.81 130.96 17.36 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -86.35 43.16 1.04 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.567 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.5 mp 54.29 36.6 25.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.411 0.624 . . . . 0.0 110.45 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.464 -177.627 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tmm? . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 64.58 21.34 12.41 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 169.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.0 35.02 90.09 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.074 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 69.52 122.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.185 0.594 . . . . 0.0 110.607 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.453 HD13 HD22 ' A' ' 139' ' ' LEU . 85.1 mt -74.82 -8.86 57.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.633 -171.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.3 132.82 49.24 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.73 11.7 84.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.774 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.615 ' HG3' ' HA ' ' A' ' 152' ' ' GLU . 13.8 mptt -117.06 172.05 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.481 -0.423 . . . . 0.0 110.145 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.543 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 54.9 p90 -144.21 152.94 41.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.583 HD12 ' CE3' ' A' ' 148' ' ' TRP . 17.4 pt -109.79 151.83 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.992 0.425 . . . . 0.0 110.877 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.764 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 40.8 mm -100.66 115.51 42.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.801 ' HB3' HG23 ' A' ' 25' ' ' VAL . . . -149.63 147.65 28.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.588 0.232 . . . . 0.0 111.485 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 m 58.31 81.29 0.26 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.035 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.31 -14.09 7.15 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.16 1.906 . . . . 0.0 111.843 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -129.68 121.34 26.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.404 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.7 tpt -139.1 112.79 8.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.89 -35.83 18.75 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -71.47 -73.11 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.52 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . 1.1 mp0 -85.45 94.63 9.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 169.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -65.59 -32.61 74.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.012 0.435 . . . . 0.0 111.652 -172.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -125.24 64.53 1.15 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.681 0.753 . . . . 0.0 110.175 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.52 ' HB2' ' HB3' ' A' ' 19' ' ' GLU . 29.3 t70 -90.72 168.04 12.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.761 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.513 ' HD2' HD23 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -79.97 78.51 6.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -74.82 79.89 2.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.108 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.801 HG23 ' HB3' ' A' ' 12' ' ' ALA . 91.9 t 72.72 132.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.875 174.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.577 HG13 ' HD1' ' A' ' 27' ' ' TYR . 4.6 tp -122.72 -103.65 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.941 174.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.577 ' HD1' HG13 ' A' ' 26' ' ' ILE . 8.8 p90 -129.33 173.8 10.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 120.027 1.285 . . . . 0.0 112.348 -171.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.3 mm -100.49 128.29 52.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.673 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.1 m -79.8 -57.8 3.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.519 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.44 157.75 43.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.268 0.556 . . . . 0.0 111.297 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -133.03 112.06 11.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.666 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.4 HD21 ' N ' ' A' ' 32' ' ' ASN . 0.9 OUTLIER -94.98 163.33 13.36 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 166.138 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.33 -30.9 71.49 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.189 0.519 . . . . 0.0 110.608 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -96.65 -33.98 11.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.718 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.93 123.45 4.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.354 -172.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 133' ' ' THR . 28.4 m -108.78 116.34 31.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 176.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.594 HG13 HG22 ' A' ' 133' ' ' THR . 3.5 mp -104.32 120.13 54.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.834 0.349 . . . . 0.0 110.943 -174.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.46 163.5 29.26 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.913 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.514 HG21 HG21 ' A' ' 26' ' ' ILE . 1.6 m -115.42 88.1 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.668 0.747 . . . . 0.0 110.501 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.532 HG21 HG11 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -132.27 26.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.061 -175.689 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 74' ' ' ASN . 10.7 tp -64.74 -36.56 77.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.415 -172.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.496 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.1 t-20 63.38 63.88 0.86 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.126 0.489 . . . . 0.0 110.923 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.51 HG22 HG13 ' A' ' 41' ' ' ILE . 14.3 t 173.37 130.0 0.1 Allowed Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.927 175.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 75.1 Cg_endo -92.97 155.95 2.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.175 2.583 . . . . 0.0 112.038 173.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.489 HG21 ' HB2' ' A' ' 74' ' ' ASN . 9.8 p -87.6 -177.99 6.0 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.74 -2.86 46.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.735 0.779 . . . . 0.0 109.458 177.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.446 HD22 HD22 ' A' ' 52' ' ' LEU . 62.2 tp -90.35 158.3 17.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.164 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 11.8 m -114.42 152.88 30.85 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.207 -0.308 . . . . 0.0 110.467 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.604 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.2 p -64.15 -37.62 80.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.043 0.449 . . . . 0.0 110.007 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.38 -34.2 77.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.339 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -63.51 -44.0 95.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.518 177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.454 HD13 HD23 ' A' ' 129' ' ' LEU . 56.4 mt -66.59 -45.93 77.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.75 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 89.3 mt -56.04 -48.97 75.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.072 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -73.1 -31.42 64.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.539 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -68.63 -52.36 32.24 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.81 0.338 . . . . 0.0 111.021 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.9 mtm -84.05 -90.85 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.916 -177.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -164.17 142.28 7.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.219 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 43.2 p90 -137.51 21.61 2.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.731 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 58' ' ' PHE . 1.6 mp0 67.5 112.84 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.297 -170.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 17.1 ttt -67.82 164.04 20.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.444 -176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 77.31 4.68 3.18 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.656 0.783 . . . . 0.0 111.261 -175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -96.0 127.5 40.68 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.08 130.61 26.16 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.639 2.226 . . . . 0.0 112.65 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.25 154.02 43.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.907 178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.68 178.75 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.0 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -132.66 81.88 1.97 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.761 177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.7 t 178.57 162.87 0.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.365 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 56.21 73.21 0.45 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.574 0.702 . . . . 0.0 110.226 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -70.71 128.77 37.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.716 -173.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -103.21 112.94 26.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.59 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 87.7 mtp -82.3 145.29 30.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.033 0.444 . . . . 0.0 111.397 -171.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.437 HG21 HG21 ' A' ' 127' ' ' VAL . 8.1 p -99.03 143.29 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.369 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 8.0 mp -90.78 164.14 14.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 110.373 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.636 ' O ' HG22 ' A' ' 41' ' ' ILE . 3.6 t-20 -100.27 103.49 14.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.59 -27.8 61.72 Favored Glycine 0 C--N 1.328 0.098 0 O-C-N 123.5 0.5 . . . . 0.0 112.885 -171.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.03 172.19 30.22 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.14 -13.04 28.42 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.333 2.022 . . . . 0.0 111.825 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.74 145.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.468 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.537 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 83.9 m-20 63.96 24.75 13.72 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.222 0.326 . . . . 0.0 111.765 174.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -69.16 -10.89 59.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.702 0.763 . . . . 0.0 110.595 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.0 -13.68 60.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.711 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -113.71 134.54 54.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.981 0.42 . . . . 0.0 110.935 -172.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.57 119.22 5.06 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.755 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -105.84 121.52 44.23 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.412 HG13 HG23 ' A' ' 127' ' ' VAL . 5.1 mp -141.96 117.72 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 95.3 t -112.14 119.82 61.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.434 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -129.5 159.64 35.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -177.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.6 m -82.45 167.68 18.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.119 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.434 ' HE2' ' CE1' ' A' ' 87' ' ' HIS . 4.7 mptp? -119.22 122.02 41.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 t -94.13 -21.11 19.31 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.573 -173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.868 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 2.6 t70 -114.03 -4.78 13.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.56 0.695 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.7 m170 67.29 34.39 4.9 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.07 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.868 ' HG3' ' HB3' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -87.97 165.72 15.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.94 175.03 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -159.06 116.57 2.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.294 0.568 . . . . 0.0 110.966 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.7 m -88.73 -60.57 1.92 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.97 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.493 ' H ' ' HB2' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -145.24 35.22 1.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.439 179.131 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 148.48 24.47 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.97 -175.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -102.16 135.68 43.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.565 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -87.3 116.12 25.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.37 -54.04 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 169.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.793 HG22 ' HB ' ' A' ' 104' ' ' ILE . 11.9 t -138.69 -158.43 0.86 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -59.33 -65.18 0.71 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -93.66 -23.96 18.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.751 0.31 . . . . 0.0 111.38 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.793 ' HB ' HG22 ' A' ' 101' ' ' THR . 41.3 mm -86.96 122.46 38.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.987 0.423 . . . . 0.0 110.823 -171.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.1 p -134.16 137.9 44.8 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.981 -175.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.6 tp -91.82 137.66 32.18 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.33 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.852 HG22 ' HB3' ' A' ' 111' ' ' ASP . 25.4 m -138.8 140.04 38.44 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.733 -0.604 . . . . 0.0 111.456 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.4 p -111.6 -29.07 7.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.417 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.5 m -155.55 160.29 40.39 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.689 0.281 . . . . 0.0 111.171 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.82 -82.19 0.41 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.903 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.852 ' HB3' HG22 ' A' ' 107' ' ' THR . 11.2 t70 -51.91 -48.57 64.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.546 0.738 . . . . 0.0 111.629 -173.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.449 HG11 HD22 ' A' ' 113' ' ' LEU . 7.6 p -63.58 -38.64 82.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.988 -176.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 HG11 ' A' ' 112' ' ' VAL . 2.6 mm? -69.46 -33.27 72.67 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.303 0.573 . . . . 0.0 110.0 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -76.35 -28.2 56.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.607 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.6 m -57.48 -62.43 1.79 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.35 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -86.36 27.68 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -172.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.2 20.36 23.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.155 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.6 t -162.93 172.72 14.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -71.54 -19.49 62.16 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.722 0.296 . . . . 0.0 111.471 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.0 p -84.53 18.27 2.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 0.0 110.994 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.41 129.82 93.85 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.341 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.98 139.23 72.42 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.623 2.215 . . . . 0.0 112.195 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -60.71 -48.58 81.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.515 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 159' ' ' PHE . 2.0 mmpp? -101.05 119.09 38.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.937 -168.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 36.9 p90 -154.87 127.93 8.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.289 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.2 pt -109.43 133.54 54.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.082 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.53 HG11 ' HB ' ' A' ' 49' ' ' VAL . 7.5 p -116.44 128.94 73.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.279 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 81.2 m -143.52 151.97 40.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.105 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.454 HD23 HD13 ' A' ' 52' ' ' LEU . 2.4 mm? -102.45 117.18 34.17 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 174.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . 83.67 -175.85 52.19 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.964 -175.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 19.3 m -148.45 163.69 36.41 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 m -98.37 114.84 27.32 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.594 HG22 HG13 ' A' ' 37' ' ' ILE . 22.6 p -112.5 120.02 40.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.473 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 0.4 OUTLIER -86.23 133.25 33.85 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.243 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 136' ' ' PRO . 96.6 mttt -65.0 153.31 89.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.082 -175.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 135' ' ' LYS . 33.5 Cg_exo -28.7 98.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 1 C-N-CA 125.507 4.138 . . . . 0.0 115.233 -171.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.422 ' HE2' ' CD ' ' A' ' 140' ' ' GLU . 10.2 t-80 71.58 -2.71 2.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.88 168.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -62.82 -30.07 71.21 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.453 HD22 HD13 ' A' ' 5' ' ' LEU . 36.2 tp -60.14 -29.16 68.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.604 0.24 . . . . 0.0 111.296 -176.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.422 ' CD ' ' HE2' ' A' ' 137' ' ' HIS . 35.0 tt0 -64.99 -38.4 90.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.07 0.462 . . . . 0.0 109.912 178.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.506 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.9 mp0 -70.43 -37.16 74.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.412 177.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.473 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 74.7 mm-40 -63.41 -43.7 96.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.341 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 139' ' ' LEU . 73.3 mt -68.56 -31.24 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.483 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.26 -24.43 67.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.215 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 39.1 mt-30 -83.7 -0.59 51.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.562 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 62.23 17.24 9.1 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.665 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -87.97 0.78 55.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.415 0.626 . . . . 0.0 109.703 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.583 ' CE3' HD12 ' A' ' 10' ' ' ILE . 99.4 m95 -138.07 122.11 17.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.651 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.764 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 75.8 mt -98.92 145.64 26.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.1 tp -124.49 134.65 52.97 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.138 0.494 . . . . 0.0 111.368 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.0 t -138.38 148.95 45.07 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.432 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.615 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 26.0 mp0 -87.32 153.32 21.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.032 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -115.05 128.71 56.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.123 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -62.4 -63.56 1.2 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.986 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -177.64 -56.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.095 175.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 42.0 mt-30 -62.85 -27.3 69.24 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.808 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.9 m -52.45 -29.06 22.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.134 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.1 mt -65.21 -54.72 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.46 ' HD2' ' HB3' ' A' ' 124' ' ' LYS . 54.1 m-85 -129.83 -14.17 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 44.2 mt-10 -96.41 0.89 51.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.162 0.506 . . . . 0.0 110.877 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.5 t -66.41 150.93 48.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.183 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.71 ' HB2' ' HA ' ' A' ' 167' ' ' TRP . 22.6 t 67.19 4.41 3.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.201 0.6 . . . . 0.0 112.12 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -79.73 -14.11 58.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.975 0.417 . . . . 0.0 110.121 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' A' ' 165' ' ' ASP . 2.2 pp -135.48 -4.95 2.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.852 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 166' ' ' ARG . 5.6 t70 -153.3 -156.37 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.38 -175.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.537 ' O ' ' HG3' ' A' ' 169' ' ' GLU . 26.6 mmm180 -66.84 155.49 38.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.825 0.345 . . . . 0.0 111.275 -176.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.71 ' HA ' ' HB2' ' A' ' 162' ' ' SER . 5.2 t-105 -76.42 -17.61 59.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.517 0.675 . . . . 0.0 110.69 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.5 m -91.96 20.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.512 -172.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 173' ' ' MET . 50.2 mt-10 -53.89 -42.99 69.27 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.59 -46.26 66.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.037 0.446 . . . . 0.0 111.276 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.439 ' OD1' HG13 ' A' ' 176' ' ' ILE . 20.5 t-20 -80.44 -36.84 33.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.909 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.403 ' HA ' HD11 ' A' ' 176' ' ' ILE . 34.3 tt0 -64.18 -29.29 70.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.504 -176.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.629 ' HE1' ' HA ' ' A' ' 173' ' ' MET . 29.2 mmt -60.64 -29.35 69.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.918 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.42 HD11 HG13 ' A' ' 11' ' ' ILE . 5.2 tt -101.1 -51.66 3.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.925 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 151.35 117.41 0.77 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.443 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.439 HG13 ' OD1' ' A' ' 171' ' ' ASN . 4.4 mp -63.93 -44.46 97.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.509 0.671 . . . . 0.0 109.319 174.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 43.1 t -92.87 103.55 15.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.718 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 157.19 -140.27 7.01 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 54.0 mt 69.85 119.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.462 0.648 . . . . 0.0 111.511 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.4 mp -82.88 64.88 7.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.334 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -134.01 113.59 12.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.679 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -61.38 153.36 66.34 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.857 2.371 . . . . 0.0 112.004 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -77.89 66.38 3.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.346 0.593 . . . . 0.0 110.843 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 146.88 52.76 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.471 HH22 ' HB2' ' A' ' 12' ' ' ALA . 27.3 ptt180 -74.6 95.48 2.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.282 0.563 . . . . 0.0 111.219 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -87.98 75.82 8.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.258 0.551 . . . . 0.0 109.729 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.23 84.91 3.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.862 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.245 0.838 0 CA-C-O 118.381 -0.818 . . . . 0.0 109.922 176.222 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.532 ' HA ' ' HB2' ' A' ' 140' ' ' GLU . 2.0 mpt? . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 66.92 -59.24 0.38 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.508 0.723 . . . . 0.0 111.093 -172.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.14 -152.46 21.62 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -76.16 107.84 8.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.099 0.476 . . . . 0.0 110.096 175.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.09 8.87 16.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.184 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -70.95 119.77 15.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.391 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.17 7.84 45.73 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.1 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -116.85 175.36 5.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.499 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 26.9 p90 -146.92 140.58 25.75 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 171.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 pt -93.92 131.74 39.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.311 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.945 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 3.4 mp -90.07 114.99 28.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.833 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.565 ' HB3' ' HZ3' ' A' ' 148' ' ' TRP . . . -90.71 125.2 35.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.609 174.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.3 m -119.29 90.57 42.36 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.89 0.376 . . . . 0.0 110.706 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -93.94 177.93 1.09 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.135 2.557 . . . . 0.0 112.658 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -120.91 10.52 10.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.347 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -85.55 -76.74 0.32 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.951 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -166.54 129.27 1.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.949 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -115.57 152.96 32.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.49 ' HG3' ' HB3' ' A' ' 22' ' ' ASP . 3.3 mm-40 -91.31 164.89 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.194 0.521 . . . . 0.0 112.024 -172.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -122.28 -38.56 2.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.802 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -102.25 -38.06 7.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.732 -176.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.49 ' HB3' ' HG3' ' A' ' 19' ' ' GLU . 3.2 t70 -73.39 169.48 17.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.832 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.513 ' HG2' HG21 ' A' ' 126' ' ' ILE . 7.1 tpm_? -87.6 83.36 7.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.235 0.541 . . . . 0.0 110.858 -172.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 t -91.91 132.41 36.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.501 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t 71.43 117.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.259 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.903 HG21 ' HD1' ' A' ' 27' ' ' TYR . 9.0 mm -116.17 -95.55 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.326 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.903 ' HD1' HG21 ' A' ' 26' ' ' ILE . 2.1 p90 178.09 -177.4 0.22 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.251 0.22 . . . . 0.0 110.56 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.2 mm -95.25 124.6 47.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.3 m -91.22 -46.46 8.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.722 -173.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.718 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 32.1 mt-10 -131.89 150.57 52.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.372 0.606 . . . . 0.0 112.218 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -132.37 105.95 7.6 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 167.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -109.3 171.05 7.67 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.453 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.53 -26.23 68.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.665 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -111.41 13.01 21.53 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.11 170.59 22.22 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.238 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 133' ' ' THR . 55.1 m -115.21 130.41 56.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.839 HG13 HG22 ' A' ' 133' ' ' THR . 3.8 mp -109.59 119.11 58.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.425 -173.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.01 165.12 28.56 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.121 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.499 HG22 ' HB ' ' A' ' 26' ' ' ILE . 3.3 m -126.99 102.5 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.237 0.541 . . . . 0.0 110.957 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.477 HD13 ' N ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -141.79 12.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.166 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 tp -74.55 -33.8 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.204 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 58.96 86.5 0.09 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.798 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 9.0 t -163.04 123.02 1.41 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.257 0.551 . . . . 0.0 111.411 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.55 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 2.4 Cg_endo -83.01 173.95 9.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.184 2.589 . . . . 0.0 111.607 176.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.401 HG23 ' ND2' ' A' ' 74' ' ' ASN . 16.6 p -118.17 -171.51 2.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.756 0.312 . . . . 0.0 110.366 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.76 7.11 47.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.387 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -112.12 155.52 23.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.427 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.608 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 43.0 m -104.91 157.44 17.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.003 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 14.7 p -68.67 -34.08 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.18 0.515 . . . . 0.0 109.92 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD13 HD12 ' A' ' 65' ' ' ILE . 86.2 mt -73.82 -25.9 60.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.291 178.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -53.16 56.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.751 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.1 pp -65.57 -33.62 76.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.605 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.82 -50.58 66.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.179 0.514 . . . . 0.0 110.96 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.9 p -72.43 -29.19 63.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -72.47 -39.62 67.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.388 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.466 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 19.7 ptp -150.09 -57.27 0.18 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -174.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.466 ' N ' ' HG3' ' A' ' 56' ' ' MET . 10.4 t70 -97.37 131.16 44.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.835 -166.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.4 t80 66.92 87.49 0.12 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.295 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.54 77.52 9.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.804 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.0 ttt -174.23 144.43 0.95 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.1 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.35 142.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.936 0.773 . . . . 0.0 112.305 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 62' ' ' LYS . 73.3 mmtt 67.98 139.06 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.475 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 91.3 Cg_endo -94.01 -168.46 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.318 2.679 . . . . 0.0 112.368 177.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -73.48 89.11 1.65 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.141 0.496 . . . . 0.0 110.948 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.467 HD12 HD13 ' A' ' 50' ' ' LEU . 69.0 mt -100.94 110.52 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.747 176.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -126.26 7.49 7.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.889 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 m -75.61 -78.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.635 -172.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -176.21 88.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -132.36 -82.32 0.49 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.536 -173.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -128.3 112.79 14.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.881 0.372 . . . . 0.0 110.704 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.608 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 69.7 mtm -92.59 161.29 14.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.186 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.66 141.39 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.6 mp -109.2 170.51 8.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -176.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.401 ' ND2' HG23 ' A' ' 45' ' ' THR . 75.1 m-20 -110.21 132.15 54.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.013 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.75 -16.94 53.79 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.424 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.49 -179.35 36.95 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.934 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -86.79 5.04 6.01 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.164 2.576 . . . . 0.0 112.824 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.401 HG22 ' OG1' ' A' ' 133' ' ' THR . 21.7 t -120.19 153.84 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.405 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 89.4 m-20 65.53 33.44 8.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.873 0.368 . . . . 0.0 110.333 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -65.31 -14.51 60.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.102 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -91.1 -4.67 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.422 0.63 . . . . 0.0 110.553 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -109.5 120.36 42.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.074 0.464 . . . . 0.0 110.897 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.75 108.52 3.62 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.534 ' HB3' HD13 ' A' ' 106' ' ' LEU . 98.0 m-85 -97.19 125.27 41.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.698 0.285 . . . . 0.0 110.735 -176.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.417 ' HB ' HG13 ' A' ' 112' ' ' VAL . 3.7 mp -117.12 109.92 29.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.207 0.527 . . . . 0.0 109.891 175.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -94.13 121.01 44.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.322 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -138.55 155.56 48.27 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.461 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.1 m -73.98 164.38 26.7 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 89' ' ' LYS . 14.3 ttmm -88.5 118.1 27.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.072 0.939 . . . . 0.0 112.291 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.4 m -139.48 18.43 2.55 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 169.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -132.6 161.31 34.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.019 -167.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.14 28.14 1.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.603 171.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.51 170.27 13.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.708 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -162.66 79.98 0.5 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.7 m -92.56 -41.42 10.25 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -169.6 78.38 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.337 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.6 m -115.2 133.86 55.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.102 -172.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.585 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 4.8 t80 -102.11 102.54 13.02 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -81.73 106.27 13.53 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.08 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.408 HG13 ' HE2' ' A' ' 27' ' ' TYR . 16.8 t -91.06 -62.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 46.5 p -119.05 175.71 5.64 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.97 -33.06 64.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 20.5 t70 -106.37 -49.12 3.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.392 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.6 mm -76.2 121.95 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.208 0.528 . . . . 0.0 110.001 -169.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.6 m -122.11 132.45 54.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.758 -175.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 58.6 tp -102.23 112.24 24.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.839 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.669 HG21 ' HB3' ' A' ' 111' ' ' ASP . 15.2 m -106.96 124.3 49.43 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.03 28.35 8.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.881 -175.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 t -146.8 -174.24 4.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.711 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.34 -0.87 25.12 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.091 -176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.669 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.4 t70 -55.26 -37.7 67.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.258 0.552 . . . . 0.0 110.123 174.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.498 HG21 HD22 ' A' ' 113' ' ' LEU . 36.0 m -55.82 -34.33 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.142 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.498 HD22 HG21 ' A' ' 112' ' ' VAL . 3.5 mm? -62.49 -34.55 77.08 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.446 0.641 . . . . 0.0 110.197 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.37 -25.8 31.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.919 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.0 m -62.3 -57.1 12.62 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.236 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.441 ' HA ' ' HB2' ' A' ' 121' ' ' ALA . 11.7 p90 -91.46 3.66 54.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 110.858 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.67 29.18 12.07 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.954 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.4 t -140.62 174.19 10.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -65.05 -39.16 92.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.813 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.7 p -89.76 32.32 0.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.48 -176.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -58.51 130.46 84.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.993 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.22 140.22 91.07 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.916 2.411 . . . . 0.0 112.308 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.09 -52.87 44.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.723 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -104.75 113.3 26.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.221 -172.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -147.27 133.61 19.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.806 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG21 ' HG2' ' A' ' 23' ' ' ARG . 32.7 pt -123.99 143.03 38.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.578 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.24 119.35 60.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.227 0.537 . . . . 0.0 110.489 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.438 ' HG ' ' HB2' ' A' ' 84' ' ' PHE . 9.6 p -131.07 130.88 43.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.532 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.69 125.63 34.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.014 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.405 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . 75.56 178.48 43.2 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.884 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 77.8 m -150.76 173.32 14.33 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.4 m -102.16 116.9 33.63 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 37' ' ' ILE . 78.3 p -111.12 120.83 43.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.994 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -81.01 137.71 36.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.472 . . . . 0.0 110.487 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.421 ' HG3' ' HD2' ' A' ' 136' ' ' PRO . 29.0 tptt -71.67 140.23 84.01 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.521 -177.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.421 ' HD2' ' HG3' ' A' ' 135' ' ' LYS . 35.6 Cg_exo -36.58 130.25 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.248 3.299 . . . . 0.0 114.716 -178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.2 t60 77.37 -34.43 0.2 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.41 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.547 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.6 tp60 -60.2 -44.38 95.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -173.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.8 tp -55.82 -35.46 66.39 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.661 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 42.9 tt0 -64.36 -38.92 92.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.148 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -71.26 -39.47 71.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 8.4 mm-40 -57.8 -51.12 70.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.302 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.8 mt -68.75 -33.15 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.564 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.4 91.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.311 . . . . 0.0 111.057 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -86.1 12.64 9.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.09 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 62.32 32.97 16.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.082 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.78 ' HA ' ' HG2' ' A' ' 182' ' ' PRO . 15.9 m-85 -72.14 -28.0 62.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.229 0.538 . . . . 0.0 109.738 172.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.565 ' HZ3' ' HB3' ' A' ' 12' ' ' ALA . 91.0 m95 -134.08 139.41 45.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.695 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.945 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.9 tt -88.2 141.3 28.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.528 ' N ' HD22 ' A' ' 149' ' ' LEU . 59.3 tp -123.09 134.57 54.24 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.696 -175.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.9 p -161.42 164.07 30.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.877 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -71.13 155.78 40.36 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.142 0.496 . . . . 0.0 111.274 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.04 -155.16 0.53 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.935 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.3 t30 65.85 22.9 11.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.76 0.791 . . . . 0.0 109.891 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -88.31 165.72 14.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.883 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 38.0 mt-30 -59.31 -29.09 67.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.052 0.453 . . . . 0.0 110.624 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.558 ' HA ' HG21 ' A' ' 161' ' ' THR . 6.7 m -52.63 -30.48 31.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.262 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.54 -57.18 6.94 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.356 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -127.42 -19.26 4.27 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.506 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 41.0 mt-10 -82.74 -9.07 59.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 111.524 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.558 HG21 ' HA ' ' A' ' 157' ' ' THR . 1.6 p -65.51 -27.06 68.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.401 0.62 . . . . 0.0 110.246 173.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.0 m -97.77 22.87 8.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.475 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -122.3 -58.59 1.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.073 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 165' ' ' ASP . 2.4 pt? -116.41 -63.12 1.49 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.3 -178.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.558 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 6.2 t70 -170.64 -175.8 1.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -170.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.527 ' HD3' ' OE2' ' A' ' 169' ' ' GLU . 17.3 mtt180 71.61 155.72 0.15 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 174.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.479 ' HD1' HG22 ' A' ' 168' ' ' VAL . 2.2 p90 -170.04 161.95 8.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.429 173.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.479 HG22 ' HD1' ' A' ' 167' ' ' TRP . 6.8 t 60.01 30.37 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.329 0.585 . . . . 0.0 110.817 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.527 ' OE2' ' HD3' ' A' ' 166' ' ' ARG . 42.0 mt-10 -70.4 -7.21 41.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.037 0.446 . . . . 0.0 110.933 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.472 ' HB2' ' CG1' ' A' ' 11' ' ' ILE . . . -53.79 -39.37 65.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.181 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -81.08 -33.03 33.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.554 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.19 -27.91 61.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 0.0 110.658 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.934 ' HE2' ' HA ' ' A' ' 173' ' ' MET . 1.0 OUTLIER -59.6 -33.05 70.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.196 0.522 . . . . 0.0 110.213 175.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.73 HD12 HD21 ' A' ' 149' ' ' LEU . 12.8 tp -82.05 -48.73 11.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.473 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 135.87 29.66 0.35 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.228 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 45.9 mm 71.74 -48.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.332 0.653 . . . . 0.0 112.033 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 13.7 m -74.07 89.32 1.95 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.037 0.446 . . . . 0.0 111.112 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.41 142.23 15.63 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.5 mp -81.47 110.83 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 79.4 mt 63.8 179.77 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.586 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -170.6 86.75 0.52 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.999 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.78 ' HG2' ' HA ' ' A' ' 147' ' ' TYR . 24.2 Cg_endo -94.99 153.6 1.74 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.234 2.623 . . . . 0.0 112.742 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -132.36 -80.97 0.5 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.774 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.91 -173.72 54.71 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.215 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -129.92 156.33 44.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.078 0.466 . . . . 0.0 111.352 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.03 88.45 2.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.134 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 3.0 pp -70.1 145.91 51.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.187 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.213 -179.334 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.424 0.154 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.573 ' HD2' ' HG3' ' A' ' 140' ' ' GLU . 97.1 m-85 -84.56 136.85 33.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 111.112 -177.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.23 -127.4 4.26 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.301 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.35 102.79 7.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.633 0.254 . . . . 0.0 110.974 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.79 -82.8 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 173.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 57.13 107.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 172.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.33 -1.96 79.1 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.565 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.675 ' HD2' ' HB3' ' A' ' 152' ' ' GLU . 37.9 mmtm -95.4 159.85 14.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.477 ' HZ ' ' HG2' ' A' ' 173' ' ' MET . 45.0 p90 -123.79 154.41 39.59 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.511 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.55 HD13 HG22 ' A' ' 40' ' ' ILE . 8.4 pt -114.45 144.56 21.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.758 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.7 mp -110.73 161.41 9.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.405 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.426 ' N ' HG21 ' A' ' 11' ' ' ILE . . . 70.51 -176.59 0.2 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.547 0.529 . . . . 0.0 110.784 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 t -174.98 146.0 0.93 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.468 ' HA ' ' CD1' ' A' ' 147' ' ' TYR . 65.6 Cg_endo -73.98 -154.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.022 2.481 . . . . 0.0 111.861 174.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -79.46 49.01 0.95 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.108 0.48 . . . . 0.0 110.646 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.6 tpt -73.64 160.89 30.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.735 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.53 88.17 2.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.04 0.448 . . . . 0.0 110.515 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -75.29 111.64 10.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.22 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.547 ' HG3' ' CD2' ' A' ' 20' ' ' TYR . 9.6 tp10 -76.2 -65.22 0.95 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.242 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.547 ' CD2' ' HG3' ' A' ' 19' ' ' GLU . 66.8 m-85 -140.62 -86.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.7 t80 173.65 -24.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.119 -170.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.83 104.81 3.56 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 70.45 60.07 0.23 Allowed 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.935 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.3 t -97.51 112.01 24.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.228 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.441 HG21 ' HB ' ' A' ' 40' ' ' ILE . 38.6 t 54.76 92.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.076 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.476 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.4 tp -95.02 -57.35 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.476 ' HD1' HG13 ' A' ' 26' ' ' ILE . 6.1 p90 -174.3 175.47 2.63 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.158 0.436 . . . . 0.0 111.637 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.8 mm -94.93 126.61 47.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.816 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.35 -51.24 15.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.753 0.311 . . . . 0.0 111.157 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -159.92 153.83 23.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 0.0 110.846 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -120.6 104.64 10.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -106.59 171.04 7.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.194 -173.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.76 -22.59 65.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.92 0.391 . . . . 0.0 110.999 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -80.69 -39.7 26.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.057 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 170.58 -167.31 40.47 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.605 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.7 m -103.21 121.18 42.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.683 0.277 . . . . 0.0 110.335 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.637 HG13 HG23 ' A' ' 133' ' ' THR . 4.3 mp -98.0 118.74 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.09 153.93 25.37 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.494 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -114.6 88.69 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.728 0.775 . . . . 0.0 110.692 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.55 HG22 HD13 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -125.1 18.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.113 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.452 HG13 ' O ' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -61.07 -36.17 70.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.382 -176.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.6 t30 56.23 66.83 1.1 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 110.582 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 t -169.47 103.41 0.47 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-O 121.545 0.688 . . . . 0.0 111.156 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.599 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 5.9 Cg_exo -78.83 158.75 27.8 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.612 2.208 . . . . 0.0 110.286 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.529 HG22 ' ND2' ' A' ' 74' ' ' ASN . 73.6 p -110.38 166.3 11.09 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.549 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -73.87 -30.35 62.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.976 0.417 . . . . 0.0 110.78 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.62 149.99 49.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.261 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.0 m -97.59 150.83 20.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.965 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.664 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.1 p -61.85 -36.62 74.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.71 -35.46 81.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.481 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 8.3 mm-40 -62.04 -39.0 90.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.038 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.1 mt -74.98 -35.6 62.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.941 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.664 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 83.2 mt -62.96 -49.46 74.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.497 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.2 p -67.56 -30.34 69.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.857 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 1.7 tpp180 -60.77 -52.24 65.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.6 -177.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.411 ' HG3' ' H ' ' A' ' 57' ' ' ASP . 13.1 ptt? -109.85 -64.85 1.21 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -173.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.411 ' H ' ' HG3' ' A' ' 56' ' ' MET . 35.7 t70 -155.4 136.14 13.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.809 0.338 . . . . 0.0 111.586 -174.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -152.49 139.3 18.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.692 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -91.02 151.42 21.05 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 60.7 mtt -76.41 84.76 3.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.37 0.605 . . . . 0.0 111.365 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.726 ' HB1' ' HA3' ' A' ' 117' ' ' GLY . . . -124.77 1.54 8.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.863 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 31.8 mmmt -129.23 143.84 50.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.856 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.477 ' HB2' HG12 ' A' ' 65' ' ' ILE . 38.5 Cg_exo -62.24 -20.76 71.11 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.174 2.583 . . . . 0.0 113.089 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 70.55 17.28 6.79 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.201 0.6 . . . . 0.0 112.118 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.477 HG12 ' HB2' ' A' ' 63' ' ' PRO . 16.3 pt -81.44 126.56 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -61.57 107.5 0.81 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.38 0.61 . . . . 0.0 111.729 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.5 t -166.39 141.13 4.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.142 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 60.28 91.84 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.656 0.598 . . . . 0.0 111.924 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.09 132.09 37.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.935 0.398 . . . . 0.0 110.388 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -122.57 118.18 27.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.205 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.6 mtt -77.9 152.24 33.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.554 HG21 HD21 ' A' ' 129' ' ' LEU . 13.8 p -106.52 149.38 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.283 174.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.599 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.0 mp -102.42 159.75 15.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.763 0.315 . . . . 0.0 110.333 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.529 ' ND2' HG22 ' A' ' 45' ' ' THR . 35.9 m-20 -101.83 121.75 42.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.29 -23.34 58.99 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.542 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.97 -177.07 36.6 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.397 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.53 -25.94 7.64 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.259 2.639 . . . . 0.0 112.835 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.3 t -86.62 125.93 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.988 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 67.19 31.04 6.92 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.485 0.491 . . . . 0.0 110.855 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -65.97 -21.62 66.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.46 -175.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -82.87 -0.23 47.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.265 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -125.42 142.5 51.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 110.675 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.78 131.88 10.74 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.11 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -112.72 123.1 49.55 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.426 ' O ' HD11 ' A' ' 106' ' ' LEU . 5.2 mp -137.49 120.16 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.913 0.387 . . . . 0.0 111.268 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.1 t -110.51 130.41 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -132.01 149.36 52.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.448 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 p -69.91 150.44 46.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.984 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -65.79 112.86 3.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.532 0.682 . . . . 0.0 110.53 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 92.5 m -157.87 -48.2 0.06 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.68 -165.77 1.41 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.645 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -165.79 134.07 3.05 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.869 ' HB3' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -100.35 -171.03 1.96 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.91 -177.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -118.0 -46.12 2.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.879 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 36.5 p -75.33 -84.32 0.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -168.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -110.6 91.29 3.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 111.571 -172.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.9 m -96.04 104.03 15.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.565 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -102.73 102.62 12.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.015 0.436 . . . . 0.0 109.9 175.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 102' ' ' ASP . 4.8 mtmm -89.76 107.01 18.84 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.58 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -60.55 -53.96 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.8 t -134.53 -176.16 4.12 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 33.5 t70 -65.3 -33.35 75.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 118.27 0.486 . . . . 0.0 112.285 -170.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -98.15 2.38 48.46 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 47.0 mm -117.81 123.65 71.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.7 m -124.41 124.99 43.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.993 0.425 . . . . 0.0 111.325 -176.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.426 HD11 ' O ' ' A' ' 85' ' ' ILE . 21.4 tp -101.59 130.45 47.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.021 174.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.7 m -129.16 124.89 35.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.1 p -109.03 28.87 8.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.64 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m -138.08 177.24 8.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.51 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.437 ' HA2' HD21 ' A' ' 113' ' ' LEU . . . -63.5 -11.82 43.2 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.304 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.869 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . 0.9 OUTLIER -47.84 -38.02 15.1 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.781 0.433 . . . . 0.0 111.051 175.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.5 t -52.58 -40.82 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.376 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.466 HD11 HD22 ' A' ' 53' ' ' LEU . 3.8 mm? -62.3 -36.46 82.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.08 -27.24 54.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.05 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 m -56.99 -55.73 30.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.192 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.481 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 20.8 p90 -90.49 26.5 1.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -173.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.726 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -107.67 17.12 36.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.566 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 t -145.5 -179.31 6.58 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.677 -0.308 . . . . 0.0 110.326 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -74.88 -21.74 59.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.678 0.275 . . . . 0.0 111.253 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.9 p -91.96 23.39 3.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.943 0.401 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.481 ' CB ' ' HA ' ' A' ' 116' ' ' PHE . . . -65.69 146.03 99.0 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.232 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.55 133.83 38.7 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.415 2.077 . . . . 0.0 111.452 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.49 -36.48 83.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.997 0.427 . . . . 0.0 110.794 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -136.74 128.1 28.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.075 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.01 140.78 24.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.745 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.5 pt -110.5 132.93 57.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.976 0.417 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.95 126.91 73.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.385 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 80.8 m -140.62 150.0 43.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.005 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.554 HD21 HG21 ' A' ' 72' ' ' VAL . 4.3 mm? -100.32 117.52 34.68 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.51 177.75 50.53 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.904 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 66.4 m -145.83 168.58 20.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.89 0.376 . . . . 0.0 110.432 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.5 m -114.2 119.95 38.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.265 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.637 HG23 HG13 ' A' ' 37' ' ' ILE . 21.5 p -102.03 114.7 29.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.584 0.707 . . . . 0.0 111.69 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.535 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.5 OUTLIER -99.55 135.59 40.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.925 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.603 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 10.5 mptt -75.64 136.69 70.81 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.025 -175.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 6.5 Cg_exo -74.86 42.56 0.84 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.647 2.898 . . . . 0.0 114.175 -170.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.508 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 55.1 m-70 -156.58 -38.72 0.08 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 171.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.605 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 50.4 tt0 -52.8 -60.72 2.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.906 171.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.535 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 57.4 tp -63.03 -35.88 81.71 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.402 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.573 ' HG3' ' HD2' ' A' ' 2' ' ' PHE . 40.6 tt0 -55.66 -48.75 74.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.893 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.566 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 23.5 mt-30 -72.47 -31.5 65.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.114 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 53.7 mm-40 -59.19 -44.17 92.21 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.156 0.503 . . . . 0.0 109.912 175.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.562 HG12 ' HB2' ' A' ' 148' ' ' TRP . 66.7 mt -64.43 -36.78 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.341 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.29 -24.92 67.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.403 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.566 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 73.4 mt-30 -78.17 -0.64 29.16 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.903 0.382 . . . . 0.0 110.351 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.1 m120 70.28 31.28 3.15 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.895 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . 0.468 ' CD1' ' HA ' ' A' ' 14' ' ' PRO . 59.7 m-85 -100.5 -4.23 29.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.262 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.562 ' HB2' HG12 ' A' ' 143' ' ' ILE . 97.2 m95 -134.48 148.94 50.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.768 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 60.3 mt -126.03 153.35 44.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.852 175.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.1 tp -121.87 134.93 54.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.017 0.437 . . . . 0.0 111.576 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.2 t -149.96 173.13 14.15 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.675 ' HB3' ' HD2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -129.26 154.1 47.15 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.246 -179.026 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 157' ' ' THR . . . -127.21 104.72 8.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.702 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -81.42 88.51 6.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.344 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 70.0 -65.97 0.29 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.828 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 30.7 mt-30 -56.62 -70.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -170.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' A' ' 153' ' ' ALA . 3.1 m -54.21 -29.57 46.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -175.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -57.21 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.87 -174.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -128.83 -13.6 4.63 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 31.4 mt-10 -81.71 -52.33 7.27 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.273 174.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.5 m 61.89 113.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 124.397 1.061 . . . . 0.0 111.664 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.495 ' HB3' HD21 ' A' ' 164' ' ' LEU . 18.1 m -70.83 82.44 0.64 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.289 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -81.74 69.61 8.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.638 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 162' ' ' SER . 2.5 pt? -129.35 -31.25 2.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.007 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -115.95 -53.18 2.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.073 0.463 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.68 HH22 ' HG2' ' A' ' 172' ' ' GLU . 36.7 ttp-105 -145.81 171.57 14.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -86.49 -50.67 6.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.119 0.485 . . . . 0.0 110.723 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.09 91.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.702 0.763 . . . . 0.0 110.685 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.533 ' OE2' ' HB3' ' A' ' 166' ' ' ARG . 20.0 mm-40 -94.04 -3.23 51.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.767 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -56.72 -33.26 66.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.581 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -79.51 -27.88 41.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.759 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.68 ' HG2' HH22 ' A' ' 166' ' ' ARG . 23.8 mm-40 -73.29 -23.41 60.28 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.01 0.433 . . . . 0.0 110.669 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.557 ' HE3' ' HA ' ' A' ' 173' ' ' MET . 0.1 OUTLIER -66.29 -28.47 68.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.732 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.424 ' CD2' HD12 ' A' ' 149' ' ' LEU . 10.4 tp -112.89 -50.5 2.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.198 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 142.4 114.99 1.08 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 77.1 mt -54.49 -44.16 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.816 0.341 . . . . 0.0 111.358 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.0 m -92.68 30.39 1.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.104 0.478 . . . . 0.0 111.126 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.58 97.03 2.24 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.05 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.7 tt -114.39 142.85 25.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.747 0.308 . . . . 0.0 110.382 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.436 HD11 HD22 ' A' ' 149' ' ' LEU . 5.0 mp -88.13 153.44 21.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.68 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 55.42 64.7 5.3 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.033 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -86.27 -9.35 7.2 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.454 2.103 . . . . 0.0 112.043 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -111.18 29.76 7.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.714 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.86 139.27 47.48 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.429 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.438 ' NE ' ' HA ' ' A' ' 185' ' ' ARG . 5.1 tpm_? -78.29 -26.86 47.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.87 0.367 . . . . 0.0 110.417 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -129.1 83.17 2.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.243 0.545 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 94.2 mt -120.36 -37.34 3.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.949 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.248 0.981 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.666 -177.527 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.521 ' HA ' ' CD ' ' A' ' 140' ' ' GLU . 64.5 mtt . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.239 0.066 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 64.73 92.22 0.07 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.66 0.6 . . . . 0.0 110.794 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.92 -72.38 0.6 Allowed Glycine 0 C--N 1.33 0.196 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.652 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -103.57 99.93 9.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.114 0.483 . . . . 0.0 110.399 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -99.98 15.6 26.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.453 0.644 . . . . 0.0 109.752 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.679 HE21 HG13 ' A' ' 100' ' ' VAL . 49.2 tt0 -91.51 131.49 36.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.674 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.8 0.14 59.09 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.684 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.425 ' HB2' HD21 ' A' ' 5' ' ' LEU . 3.3 mptp? -107.8 176.62 5.08 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 43.3 p90 -142.72 152.94 42.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.054 0.454 . . . . 0.0 110.39 173.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 pt -118.19 128.12 75.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.307 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 60.0 mt -86.63 111.92 22.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.168 -175.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.516 ' HB1' ' CZ3' ' A' ' 148' ' ' TRP . . . -120.78 94.87 4.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.558 173.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 15' ' ' GLU . 5.7 m -145.24 103.51 4.37 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.276 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.48 -28.58 8.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.643 2.229 . . . . 0.0 112.647 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' O ' HG21 ' A' ' 13' ' ' THR . 73.2 mm-40 -107.42 -178.82 3.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.975 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -80.1 103.47 10.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 18' ' ' ASP . 12.3 t70 66.71 -165.59 0.22 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -171.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.475 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 35.3 t70 -125.71 -22.49 4.21 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.983 -0.448 . . . . 0.0 110.802 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.87 -85.65 0.19 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.743 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.3 t80 177.86 -44.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.609 -173.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.458 ' CD1' ' HA ' ' A' ' 166' ' ' ARG . 0.2 OUTLIER -141.62 29.85 1.72 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -176.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.715 ' HA ' ' NH1' ' A' ' 23' ' ' ARG . 1.9 t70 -100.95 -177.54 3.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.072 -171.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.715 ' NH1' ' HA ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -123.92 85.75 2.46 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.445 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.5 p -121.2 154.6 36.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.818 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t 67.91 96.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 O-C-N 123.815 0.697 . . . . 0.0 111.117 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.616 HG21 HG22 ' A' ' 39' ' ' VAL . 10.6 tp -124.65 -146.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.345 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.544 ' HD1' HG13 ' A' ' 26' ' ' ILE . 3.5 p90 -116.63 171.71 7.7 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.427 1.012 . . . . 0.0 111.623 -164.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.53 116.09 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.553 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.8 m -75.51 -45.07 40.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.109 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -140.48 144.86 36.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.86 0.362 . . . . 0.0 110.719 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -128.61 111.96 13.76 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.293 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -114.75 173.36 6.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -71.84 -23.14 61.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.744 0.307 . . . . 0.0 111.112 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -107.45 -27.59 10.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.468 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.82 127.12 3.32 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 119.8 -1.19 . . . . 0.0 113.06 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 133' ' ' THR . 82.1 m -107.39 110.72 22.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.732 HG13 HG23 ' A' ' 133' ' ' THR . 4.0 mp -96.54 114.33 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.843 -172.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -145.71 160.88 28.19 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.616 HG22 HG21 ' A' ' 26' ' ' ILE . 3.0 m -114.75 63.97 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.599 0.714 . . . . 0.0 110.491 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.445 ' H ' HD12 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -111.66 15.3 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.544 -175.167 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.489 HG22 HG23 ' A' ' 43' ' ' THR . 10.4 tp -68.91 -28.25 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.359 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 63.7 87.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.103 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.489 HG23 HG22 ' A' ' 41' ' ' ILE . 4.1 t -168.52 96.84 0.56 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.455 0.645 . . . . 0.0 111.086 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.552 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 57.9 Cg_endo -74.84 154.19 43.13 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.059 1.839 . . . . 0.0 111.3 174.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -115.63 152.24 33.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.681 0.277 . . . . 0.0 110.614 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.77 -17.15 62.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.07 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.4 tp -76.08 160.01 30.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.692 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 14.7 m -119.81 160.11 23.26 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.903 -174.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.561 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.9 p -65.82 -37.92 81.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.046 -175.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.437 HD21 HD11 ' A' ' 53' ' ' LEU . 91.6 mt -66.54 -33.98 76.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.204 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.692 ' OE1' ' HB2' ' A' ' 48' ' ' SER . 3.1 mp0 -61.76 -40.41 95.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.627 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.02 -39.82 63.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.327 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.632 HD13 HD12 ' A' ' 113' ' ' LEU . 95.1 mt -62.62 -49.14 76.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.978 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.664 HG23 ' HB3' ' A' ' 59' ' ' GLN . 40.1 p -68.11 -30.97 70.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.634 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -60.25 -37.27 79.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.585 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 73.0 mtm -78.53 -83.77 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -169.8 24.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.642 0.734 . . . . 0.0 110.714 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.459 ' CD1' ' HG ' ' A' ' 113' ' ' LEU . 98.9 m-85 -116.33 96.17 5.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.161 -178.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.664 ' HB3' HG23 ' A' ' 54' ' ' THR . 23.5 pt20 -142.14 115.56 8.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.568 0.699 . . . . 0.0 111.221 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 51.9 ttp -138.17 111.74 8.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.747 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.01 93.5 5.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.157 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 15.8 ptpt -68.66 142.38 93.9 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.759 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 27.5 Cg_exo -63.29 -16.87 57.19 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.17 2.58 . . . . 0.0 113.126 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -83.61 99.37 10.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.788 HD12 ' H ' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -80.0 15.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.255 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.417 ' O ' ' HB ' ' A' ' 67' ' ' THR . 79.6 m-85 -100.36 148.64 24.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.7 178.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.417 ' HB ' ' O ' ' A' ' 66' ' ' TYR . 38.3 m 76.98 112.29 0.07 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.983 0.802 . . . . 0.0 110.128 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.46 -174.11 4.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.118 0.485 . . . . 0.0 111.221 -174.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -58.97 153.97 16.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.195 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 48' ' ' SER . 29.6 mm-40 -111.52 127.88 55.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.679 178.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.54 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 66.2 mtt -79.87 157.79 26.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.013 0.435 . . . . 0.0 111.47 -176.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.452 HG22 HD23 ' A' ' 129' ' ' LEU . 9.7 p -107.74 149.87 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.237 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 8.0 mp -107.98 168.39 9.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.0 110.142 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.39 137.07 46.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.52 ' HA3' HG11 ' A' ' 39' ' ' VAL . . . -103.09 -9.38 39.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.44 -0.885 . . . . 0.0 113.009 -173.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.11 164.7 12.25 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.95 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.6 -20.91 26.29 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.961 2.441 . . . . 0.0 112.502 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.51 128.38 39.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.972 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 64.66 24.99 13.04 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.44 0.462 . . . . 0.0 110.612 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.621 ' HA ' ' CA ' ' A' ' 130' ' ' GLY . 53.3 tt0 -65.29 -23.5 67.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.534 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.02 -19.63 62.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.674 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 82' ' ' ARG . 39.1 mtm180 -109.67 143.73 39.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.004 0.431 . . . . 0.0 111.057 -171.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.41 130.76 10.04 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.336 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -111.84 124.22 51.91 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.412 ' O ' HD11 ' A' ' 106' ' ' LEU . 5.4 mp -131.14 115.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.0 111.032 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.01 126.43 67.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.76 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -133.17 161.09 35.37 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.119 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 m -67.52 159.04 30.52 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.444 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 46.1 tttp -72.55 120.13 17.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.188 0.518 . . . . 0.0 110.645 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.1 m -144.99 107.67 4.45 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 173.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -54.31 138.15 39.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.345 0.593 . . . . 0.0 112.199 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -176.71 24.54 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.757 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 67.51 -165.52 0.21 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -167.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -151.56 137.32 17.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.018 0.437 . . . . 0.0 111.262 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 111' ' ' ASP . 30.9 m -89.81 -50.04 6.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.076 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 109' ' ' SER . 50.3 t60 -168.32 88.56 0.24 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.72 176.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 57.8 m -130.9 136.02 48.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.716 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -103.43 116.69 32.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 101' ' ' THR . 0.3 OUTLIER -81.32 122.08 27.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.06 0.457 . . . . 0.0 111.84 -175.037 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.679 HG13 HE21 ' A' ' 6' ' ' GLN . 64.2 t -68.4 -53.01 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 165.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 9.9 t -138.54 -169.67 2.66 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.886 -1.506 . . . . 0.0 107.0 167.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.05 -40.88 60.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 118.9 0.773 . . . . 0.0 110.983 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 6.3 m-20 -76.31 -25.55 54.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.7 mm -118.01 123.1 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 m -131.25 133.62 45.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.036 0.446 . . . . 0.0 111.987 -173.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.412 HD11 ' O ' ' A' ' 85' ' ' ILE . 19.1 tp -96.12 137.27 35.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.991 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.892 HG23 ' HB3' ' A' ' 111' ' ' ASP . 50.9 m -133.51 128.34 35.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.888 0.375 . . . . 0.0 111.164 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.9 p -120.08 25.4 9.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.831 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.5 ' CB ' ' HB3' ' A' ' 96' ' ' HIS . 8.6 t -136.9 -170.56 2.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.619 -174.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.12 -5.29 52.94 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 116.509 -0.314 . . . . 0.0 112.926 -178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.892 ' HB3' HG23 ' A' ' 107' ' ' THR . 14.6 t70 -55.22 -37.13 66.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.337 0.589 . . . . 0.0 110.483 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.09 -50.1 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.701 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.632 HD12 HD13 ' A' ' 53' ' ' LEU . 3.9 mm? -61.98 -41.02 97.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.854 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.19 -41.89 98.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.386 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 68.2 m -54.15 -68.76 0.16 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.309 -176.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . 0.421 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 32.2 p90 -86.87 21.97 2.12 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 111.979 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.33 19.12 10.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.896 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 120' ' ' THR . 8.9 t -157.48 -170.48 3.24 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.922 0.361 . . . . 0.0 110.524 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -67.7 -20.9 65.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.0 111.248 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 118' ' ' THR . 16.6 p -98.05 36.07 1.63 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.278 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -75.73 121.95 86.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.438 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.38 131.56 20.6 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.633 2.222 . . . . 0.0 111.295 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.61 -47.26 73.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.326 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -123.11 123.24 40.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.374 0.607 . . . . 0.0 111.897 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -146.13 131.92 19.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.02 175.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.3 pt -105.39 132.77 51.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.902 0.382 . . . . 0.0 110.311 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.83 123.49 71.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.235 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 74.2 m -136.07 142.96 44.41 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.413 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.452 HD23 HG22 ' A' ' 72' ' ' VAL . 3.9 mm? -93.63 115.49 27.97 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.621 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . 80.89 173.32 47.19 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.841 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 62.8 m -147.06 169.22 19.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.7 m -105.95 116.65 32.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.004 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.732 HG23 HG13 ' A' ' 37' ' ' ILE . 47.7 p -103.66 115.84 31.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.465 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.872 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 1.5 t-105 -78.77 157.49 28.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.749 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 12.9 mmmm -65.37 147.16 98.79 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.378 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.23 113.89 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.443 2.762 . . . . 0.0 112.949 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.493 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 10.9 m-70 66.83 -3.36 0.93 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.521 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 53.3 tt0 -74.82 -25.48 59.04 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.733 -177.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.446 ' O ' HG13 ' A' ' 143' ' ' ILE . 49.1 tp -56.95 -39.24 74.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.885 -175.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.579 ' HG3' ' NE2' ' A' ' 141' ' ' GLN . 12.7 pt-20 -66.36 -34.27 77.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.784 0.326 . . . . 0.0 110.76 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.579 ' NE2' ' HG3' ' A' ' 140' ' ' GLU . 2.2 mp0 -71.33 -38.9 71.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 110.243 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.872 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 32.9 mm-40 -59.54 -43.54 93.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 139' ' ' LEU . 78.7 mt -64.48 -34.07 67.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.803 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.04 -19.01 65.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.335 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.464 ' NE2' ' HA ' ' A' ' 142' ' ' GLU . 54.2 mt-30 -79.94 -2.47 43.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.723 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 71.05 18.8 5.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.712 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -100.27 3.91 43.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.516 ' CZ3' ' HB1' ' A' ' 12' ' ' ALA . 99.8 m95 -134.83 119.86 18.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.83 0.347 . . . . 0.0 110.79 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.494 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 3.9 tt -100.21 113.05 25.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.9 tt -90.19 134.52 34.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 110.632 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.7 m -142.0 152.19 43.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.539 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.29 158.84 24.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.483 0.659 . . . . 0.0 111.618 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.69 -152.57 0.44 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.891 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.0 t30 67.87 65.97 0.37 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.959 0.409 . . . . 0.0 111.233 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -178.6 -89.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.969 174.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -106.4 -55.96 2.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.001 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.8 m -52.12 -29.81 23.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.571 -170.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.34 -53.98 40.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -134.39 15.29 3.76 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.89 -53.36 5.16 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.456 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.6 p -81.31 -75.44 0.28 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.3 m 60.02 -138.42 0.67 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.624 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -77.99 70.84 4.41 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.131 0.491 . . . . 0.0 111.806 -172.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.76 -4.8 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.112 0.482 . . . . 0.0 110.576 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -129.75 -169.55 2.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.458 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 55.5 mtt180 -95.36 -48.53 5.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.675 0.274 . . . . 0.0 111.035 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 -100.99 154.41 18.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.227 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.512 HG13 ' H ' ' A' ' 170' ' ' ALA . 31.9 t -69.45 135.4 28.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.322 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -97.23 -4.76 38.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.462 0.172 . . . . 0.0 111.315 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.512 ' H ' HG13 ' A' ' 168' ' ' VAL . . . -53.1 -42.44 65.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -77.12 -37.41 54.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.025 0.44 . . . . 0.0 110.787 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -75.78 -22.89 55.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.688 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -57.18 -37.26 71.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.84 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.8 tp -89.53 -44.31 10.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.946 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 120.02 0.61 13.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.118 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.8 mp 68.97 -72.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.259 0.624 . . . . 0.0 111.625 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 11.2 t 70.88 160.95 0.22 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.41 0.684 . . . . 0.0 111.029 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -90.93 -6.43 67.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.488 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.572 HG22 HD13 ' A' ' 180' ' ' LEU . 3.2 mp -101.32 131.06 49.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.572 HD13 HG22 ' A' ' 179' ' ' ILE . 6.3 mp 58.73 68.59 0.81 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.189 0.518 . . . . 0.0 110.752 -168.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -121.72 120.46 28.64 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.227 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 17.3 Cg_exo -66.54 134.24 34.9 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.876 2.384 . . . . 0.0 112.475 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -122.47 142.11 50.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.971 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -95.45 23.52 33.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -97.83 18.83 14.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.043 0.449 . . . . 0.0 110.296 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.35 -57.11 3.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.637 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 98.2 mt -116.27 178.26 4.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.251 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.62 179.07 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.789 0.328 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -131.01 172.67 11.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.543 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.25 -73.55 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.085 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -77.96 145.07 36.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.059 0.457 . . . . 0.0 110.725 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.95 -107.47 0.27 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.268 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 59.36 117.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.905 0.753 . . . . 0.0 112.476 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.414 ' C ' ' HD3' ' A' ' 8' ' ' LYS . . . 84.84 8.16 82.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.676 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.904 ' HD2' ' HB2' ' A' ' 152' ' ' GLU . 22.2 mmtp -112.05 150.81 30.14 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -130.49 163.03 27.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.393 0.616 . . . . 0.0 111.895 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.425 HD13 ' CE3' ' A' ' 148' ' ' TRP . 2.5 pt -127.69 128.36 69.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.396 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.462 HD13 HD21 ' A' ' 174' ' ' LEU . 55.0 mt -96.03 150.58 4.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.804 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 76.19 130.75 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.11 0.881 . . . . 0.0 110.91 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.871 ' HB ' ' HD3' ' A' ' 14' ' ' PRO . 32.7 m -140.83 -60.72 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.016 -177.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.871 ' HD3' ' HB ' ' A' ' 13' ' ' THR . 79.0 Cg_endo -91.21 179.17 1.66 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.287 1.992 . . . . 0.0 112.528 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.498 ' HG3' ' HG3' ' A' ' 16' ' ' MET . 14.4 tp10 -103.62 -48.89 3.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.946 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.498 ' HG3' ' HG3' ' A' ' 15' ' ' GLU . 64.4 mtm -132.74 -5.47 3.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.145 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -90.93 80.33 5.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.021 0.439 . . . . 0.0 111.253 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -152.12 137.34 17.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.976 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 42.7 tt0 177.36 158.17 0.37 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 19' ' ' GLU . 18.6 t80 76.81 -47.34 0.52 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.108 0.563 . . . . 0.0 111.278 174.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.412 ' HB2' ' HB3' ' A' ' 167' ' ' TRP . 79.9 m-85 51.35 55.46 9.42 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 173.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 32.0 t0 -91.1 84.42 5.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.695 HH22 ' HG2' ' A' ' 71' ' ' MET . 62.7 mtm180 59.89 82.15 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.192 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -121.23 117.59 27.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.496 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.407 HG12 HG21 ' A' ' 40' ' ' ILE . 58.1 t 69.04 134.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.684 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.464 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.8 tp -134.97 -58.89 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.887 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.464 ' HD1' HG13 ' A' ' 26' ' ' ILE . 1.8 p90 -179.23 177.8 0.75 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.011 0.434 . . . . 0.0 111.805 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.9 mm -94.02 125.31 46.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.217 174.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.5 m -89.93 -41.01 12.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -171.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.47 145.29 35.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.209 0.528 . . . . 0.0 110.804 -176.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -122.48 103.61 8.82 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -112.27 166.38 11.33 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.926 -171.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -79.14 -12.34 59.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.384 0.611 . . . . 0.0 109.766 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -86.68 -36.63 18.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.307 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.82 178.88 48.88 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.13 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.594 ' O ' ' HA ' ' A' ' 133' ' ' THR . 18.0 m -107.26 118.27 36.27 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.602 HG12 HG23 ' A' ' 133' ' ' THR . 56.8 mt -103.4 113.07 39.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.865 0.364 . . . . 0.0 111.424 -170.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.76 164.95 29.6 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.764 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.32 96.23 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.609 0.719 . . . . 0.0 111.685 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.407 HG21 HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -129.8 17.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.463 177.666 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 74' ' ' ASN . 9.3 tp -54.89 -30.61 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.602 -172.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.489 ' O ' ' HB ' ' A' ' 43' ' ' THR . 49.2 t30 60.71 71.18 0.58 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.47 0.308 . . . . 0.0 111.279 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 14.8 t 178.31 117.64 0.19 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 121.583 0.706 . . . . 0.0 111.425 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 1.2 Cg_endo -85.49 157.3 10.75 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.174 2.583 . . . . 0.0 111.09 171.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.472 HG21 ' HB2' ' A' ' 74' ' ' ASN . 10.6 p -96.74 175.72 6.26 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.82 -29.29 40.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 110.526 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.4 tp -68.58 148.49 50.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.604 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.717 ' HB3' ' HG2' ' A' ' 51' ' ' GLU . 17.1 t -104.82 152.86 22.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.618 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -64.44 -31.94 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.068 0.461 . . . . 0.0 109.951 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.504 HD22 HG23 ' A' ' 65' ' ' ILE . 27.8 mt -75.03 -26.26 59.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.089 0.471 . . . . 0.0 110.321 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.717 ' HG2' ' HB3' ' A' ' 48' ' ' SER . 45.8 mm-40 -64.22 -36.62 84.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.563 176.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.29 -35.18 76.63 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.536 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.16 -39.5 63.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 56' ' ' MET . 20.9 p -70.59 -29.69 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 0.0 110.575 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 tpt85 -61.19 -29.55 69.88 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.932 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' A' ' 54' ' ' THR . 62.6 mtm 68.61 17.51 8.96 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.765 173.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -93.84 88.8 5.89 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.553 ' CZ ' ' HB2' ' A' ' 62' ' ' LYS . 6.5 p90 -146.14 176.79 9.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.362 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.757 ' HB3' ' HA3' ' A' ' 110' ' ' GLY . 65.1 tt0 -98.64 74.66 2.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.865 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.3 mtp 66.82 167.96 0.23 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.162 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 68.67 101.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.113 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 27.5 tptp -117.74 89.14 32.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.557 170.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.48 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . 83.9 Cg_endo -95.94 -175.92 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.058 2.506 . . . . 0.0 112.544 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.559 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -89.73 131.76 35.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.315 175.761 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.504 HG23 HD22 ' A' ' 50' ' ' LEU . 7.0 tp -97.67 -30.53 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.466 -177.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.2 t80 64.26 -169.96 0.19 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.732 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.766 HG22 ' H ' ' A' ' 68' ' ' GLN . 1.5 m 65.54 -165.28 0.23 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.766 ' H ' HG22 ' A' ' 67' ' ' THR . 40.5 mt-30 -105.93 -178.26 3.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.166 0.508 . . . . 0.0 111.737 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.95 141.88 31.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.554 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -133.52 124.54 27.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.323 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.695 ' HG2' HH22 ' A' ' 23' ' ' ARG . 0.0 OUTLIER -68.12 133.49 49.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.251 0.548 . . . . 0.0 110.8 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.579 HG23 HG13 ' A' ' 127' ' ' VAL . 11.7 p -82.94 149.91 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.197 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.8 mp -93.55 157.86 15.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.273 0.559 . . . . 0.0 111.935 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.578 ' O ' HG22 ' A' ' 41' ' ' ILE . 3.1 t-20 -101.06 87.24 3.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.968 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.34 -32.39 80.69 Favored Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.844 -169.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.93 173.98 33.22 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.991 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.34 -22.97 12.09 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.741 2.294 . . . . 0.0 113.074 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.475 HG23 ' OG1' ' A' ' 133' ' ' THR . 59.4 t -81.21 117.56 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.378 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 62.79 32.87 15.73 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 123.704 0.628 . . . . 0.0 110.467 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.525 ' HA ' ' HA3' ' A' ' 130' ' ' GLY . 52.6 tt0 -61.86 -22.15 65.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.719 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -82.21 -1.55 49.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -113.95 140.88 48.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.52 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.09 118.4 6.12 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -100.86 125.96 47.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.21 114.04 44.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 110.328 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.531 HG21 HD12 ' A' ' 106' ' ' LEU . 34.7 t -100.3 122.56 52.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.441 177.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -136.47 160.97 37.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.639 0.257 . . . . 0.0 110.971 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.9 m -73.75 177.7 5.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.608 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -51.62 113.83 1.09 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 110.827 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.0 m -121.54 117.57 27.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 -176.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.8 -152.57 0.39 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.743 0.652 . . . . 0.0 109.327 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -137.33 18.88 2.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.163 0.506 . . . . 0.0 110.645 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.87 168.6 11.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.012 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -175.2 146.07 0.82 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.151 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.419 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 90.6 m -89.87 -56.66 3.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.065 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -158.31 104.7 1.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.1 m -116.98 159.17 22.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.811 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -108.33 116.5 32.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.0 tttm -75.92 102.41 5.56 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.997 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.3 t -81.21 -54.11 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.453 ' HG1' HG12 ' A' ' 104' ' ' ILE . 70.8 p -130.04 -162.78 1.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -86.32 4.76 37.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.932 0.396 . . . . 0.0 110.424 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -134.66 -48.95 0.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.363 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.729 HD13 ' HD2' ' A' ' 159' ' ' PHE . 24.2 mm -68.99 122.01 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.714 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.9 m -123.64 116.8 23.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.073 -174.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.531 HD12 HG21 ' A' ' 86' ' ' VAL . 56.1 tp -96.88 128.84 44.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.073 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.555 HG22 ' HB3' ' A' ' 111' ' ' ASP . 26.6 m -128.89 130.96 47.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.3 p -109.03 -12.21 14.87 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 p -101.5 -172.21 2.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.093 0.473 . . . . 0.0 111.798 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.757 ' HA3' ' HB3' ' A' ' 59' ' ' GLN . . . -74.83 7.48 20.5 Favored Glycine 0 C--O 1.227 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.675 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.555 ' HB3' HG22 ' A' ' 107' ' ' THR . 18.2 t0 -64.43 -28.66 69.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.552 0.692 . . . . 0.0 109.698 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.13 -37.18 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.66 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.486 HD22 ' HA2' ' A' ' 110' ' ' GLY . 4.0 mm? -63.66 -34.68 78.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.803 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -80.17 -27.53 38.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.062 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -60.64 -42.37 96.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -104.45 170.31 7.97 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.224 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 63' ' ' PRO . . . 81.27 11.54 83.31 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.036 -177.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.5 t -127.98 168.27 15.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -77.8 -5.05 49.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.048 0.451 . . . . 0.0 110.789 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 p -113.14 27.73 9.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.019 0.438 . . . . 0.0 110.628 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.47 160.37 25.51 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.721 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.8 146.14 29.57 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.4 2.067 . . . . 0.0 111.954 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.43 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 88.6 mt-10 -58.64 -53.12 61.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.161 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 123' ' ' GLU . 9.9 mtmt -139.32 153.69 47.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.985 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -155.01 134.96 12.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.836 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.433 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 24.8 pt -110.57 133.03 57.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.117 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.579 HG13 HG23 ' A' ' 72' ' ' VAL . 5.7 p -119.77 128.17 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.151 0.5 . . . . 0.0 110.725 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 22.6 p -133.19 135.66 45.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.49 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.9 108.85 19.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.841 176.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 80' ' ' GLN . . . 79.2 174.44 45.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.83 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 63.4 m -144.45 168.9 19.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.0 m -105.6 130.72 53.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.183 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.602 HG23 HG12 ' A' ' 37' ' ' ILE . 66.9 p -118.37 125.55 50.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.502 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 27.1 m-90 -82.88 178.88 7.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 167.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.557 ' HB2' ' HB2' ' A' ' 138' ' ' GLN . 1.5 mptm? -74.74 159.95 81.99 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 168.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.56 111.17 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.968 1.779 . . . . 0.0 111.744 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 74.97 8.69 4.08 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.726 174.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 31.1 tt0 -64.24 -36.27 83.54 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.589 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 143' ' ' ILE . 49.3 tp -53.7 -29.62 39.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.976 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.76 -38.99 92.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.82 0.343 . . . . 0.0 110.569 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -69.53 -31.67 70.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.258 0.551 . . . . 0.0 110.3 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -70.14 -43.76 70.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.177 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 139' ' ' LEU . 74.3 mt -67.98 -31.51 52.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.21 -22.34 60.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.57 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -71.87 -4.56 28.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.513 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 65.19 23.92 12.31 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.272 0.629 . . . . 0.0 111.97 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -96.84 -36.02 10.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.585 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.465 ' CH2' HG22 ' A' ' 13' ' ' THR . 92.9 m95 -92.26 127.84 37.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.679 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 tt -100.69 110.51 22.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.1 tp -82.6 134.53 35.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.539 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.5 p -152.14 144.12 23.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.097 175.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.904 ' HB2' ' HD2' ' A' ' 8' ' ' LYS . 15.9 pt-20 -113.5 153.82 28.08 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.618 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -115.17 152.79 31.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.177 -174.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -94.87 -59.53 1.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.514 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -168.52 -47.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.142 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -52.93 -45.87 67.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.874 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 173' ' ' MET . 0.2 OUTLIER -56.89 -29.18 62.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.172 -177.201 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.469 HD11 HG13 ' A' ' 104' ' ' ILE . 84.1 mt -89.51 -50.89 5.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -174.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.729 ' HD2' HD13 ' A' ' 104' ' ' ILE . 11.8 m-85 -124.78 -0.2 8.01 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -174.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -89.7 -57.65 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.0 m -82.53 79.87 8.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.2 t -152.05 95.12 2.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.784 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 53.7 t80 64.94 71.89 0.45 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.012 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.417 ' HG ' ' H ' ' A' ' 165' ' ' ASP . 0.2 OUTLIER -102.69 -59.36 1.72 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 171.586 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.417 ' H ' ' HG ' ' A' ' 164' ' ' LEU . 20.9 t70 178.65 67.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' A' ' 169' ' ' GLU . 13.0 tpt180 -166.97 140.91 3.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.478 -177.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 50.7 m0 -86.24 -34.6 20.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.276 0.56 . . . . 0.0 110.228 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.405 ' HB ' ' OD1' ' A' ' 171' ' ' ASN . 11.3 m -116.75 46.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.271 -176.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 166' ' ' ARG . 5.4 pt-20 -77.48 -18.75 56.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.502 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.88 -57.42 9.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.086 0.469 . . . . 0.0 111.207 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.405 ' OD1' ' HB ' ' A' ' 168' ' ' VAL . 3.8 p-10 -68.89 -25.53 64.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.416 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.85 -25.15 65.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.256 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.689 ' HG3' HG23 ' A' ' 157' ' ' THR . 1.5 tmt? -58.69 -36.6 74.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.441 0.639 . . . . 0.0 109.418 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.462 HD21 HD13 ' A' ' 11' ' ' ILE . 11.8 tp -84.43 -38.44 20.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.775 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 93.95 -3.18 70.12 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.487 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 22.6 mt 58.43 71.38 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.362 0.601 . . . . 0.0 110.386 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.7 m -157.76 -178.52 7.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.97 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.25 -88.23 0.94 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.974 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.605 HG12 HD13 ' A' ' 180' ' ' LEU . 17.3 tt -163.95 158.9 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.605 HD13 HG12 ' A' ' 179' ' ' ILE . 6.5 mp 68.06 157.05 0.13 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.317 0.647 . . . . 0.0 111.152 -172.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 52.79 66.8 4.46 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.307 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.88 -20.54 19.6 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.747 2.298 . . . . 0.0 112.24 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -154.54 122.68 5.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.717 ' H ' HD12 ' A' ' 187' ' ' LEU . . . -93.7 -169.73 38.61 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 172.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 185' ' ' ARG . 0.1 OUTLIER -95.18 -50.34 5.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.441 0.621 . . . . 0.0 110.451 -179.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -88.84 73.6 8.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.146 0.498 . . . . 0.0 110.717 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.717 HD12 ' H ' ' A' ' 184' ' ' GLY . 85.4 mt -110.83 -35.02 6.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.94 177.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 . . . . . 0 C--O 1.249 1.037 0 O-C-N 123.666 0.604 . . . . 0.0 110.116 -176.518 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.792 0.329 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.469 ' HB3' ' CD2' ' A' ' 150' ' ' LEU . 37.4 p90 -140.21 27.31 2.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.79 57.39 3.05 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 116.011 -0.541 . . . . 0.0 113.003 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -166.6 -55.0 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.0 mt 57.44 -149.9 0.45 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.506 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 64.38 104.88 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.563 0.697 . . . . 0.0 111.154 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.73 -4.0 68.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.667 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -113.49 168.24 9.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.529 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 41.6 p90 -134.8 155.91 49.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.025 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.8 pt -129.53 128.03 65.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.23 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.597 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 58.6 mt -88.16 132.31 33.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.396 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.471 ' HB3' ' CZ3' ' A' ' 148' ' ' TRP . . . -125.7 143.96 50.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.932 176.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.476 HG21 ' HA ' ' A' ' 183' ' ' ALA . 7.9 m -63.54 114.68 13.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 123.291 0.369 . . . . 0.0 110.71 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.76 151.23 28.02 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.543 2.162 . . . . 0.0 112.058 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -77.3 -80.5 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 49.9 ttp -166.66 119.4 1.01 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.216 0.532 . . . . 0.0 111.714 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.657 ' HB3' ' HG3' ' A' ' 19' ' ' GLU . 6.3 t70 -148.34 -166.51 2.56 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.66 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 58.3 m-20 -94.14 -43.19 8.59 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.657 ' HG3' ' HB3' ' A' ' 17' ' ' ASP . 35.1 mt-10 44.97 73.39 0.16 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.208 0.943 . . . . 0.0 111.944 173.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.878 ' HA ' ' HD1' ' A' ' 167' ' ' TRP . 32.6 m-85 -109.45 -64.38 1.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 111.435 -176.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -117.0 43.94 2.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.3 0.572 . . . . 0.0 110.524 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.648 ' O ' ' HD2' ' A' ' 23' ' ' ARG . 4.9 t70 -127.71 -174.74 3.27 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.379 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.648 ' HD2' ' O ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -127.53 81.12 2.0 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.354 0.597 . . . . 0.0 110.02 175.748 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.542 HG23 ' HG2' ' A' ' 19' ' ' GLU . 29.6 p -90.2 124.49 34.9 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.795 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t 66.86 87.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.503 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.58 HG23 HG23 ' A' ' 39' ' ' VAL . 7.0 tp -119.02 -117.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.134 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.58 ' N ' HG13 ' A' ' 26' ' ' ILE . 4.5 p90 -118.62 170.33 9.05 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.835 1.198 . . . . 0.0 113.055 -165.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.1 mm -87.73 121.49 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.528 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.3 m -85.57 -41.12 15.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.956 0.407 . . . . 0.0 111.308 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.11 151.83 42.67 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -149.65 105.03 3.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.469 0.652 . . . . 0.0 111.487 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -129.78 162.78 27.67 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.46 170.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.58 -24.13 64.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.268 0.556 . . . . 0.0 109.853 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.07 -9.76 58.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.933 176.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 164.45 129.62 1.06 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.777 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 133' ' ' THR . 88.5 m -103.86 117.8 35.2 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.538 HG22 ' HB3' ' A' ' 131' ' ' CYS . 3.8 mp -101.39 118.25 47.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.583 -175.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.94 139.64 7.66 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.794 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.654 HG11 ' HA2' ' A' ' 75' ' ' GLY . 2.4 m -92.1 77.31 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.972 0.891 . . . . 0.0 110.201 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.485 HD13 ' CH2' ' A' ' 148' ' ' TRP . 25.1 pt -126.51 4.83 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.815 -172.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.2 pt -73.39 -18.84 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -175.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.444 ' O ' ' HB ' ' A' ' 43' ' ' THR . 47.1 t-20 64.51 89.13 0.1 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.613 0.571 . . . . 0.0 111.618 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.448 HG23 ' HB3' ' A' ' 74' ' ' ASN . 10.0 t 173.85 127.74 0.11 Allowed Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.712 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.57 154.35 9.03 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.653 2.236 . . . . 0.0 110.732 169.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.3 p -88.14 177.53 6.88 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.385 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -84.8 -17.54 37.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.114 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.66 152.76 22.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.791 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 55.7 p -102.05 157.26 17.0 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.644 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 12.1 p -64.66 -32.78 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.033 0.444 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -70.93 -31.95 68.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.865 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.26 -43.97 96.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.1 pp -76.49 -32.49 58.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.042 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 67.6 mt -65.67 -37.89 87.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.302 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.6 p -78.72 -30.76 46.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.863 0.364 . . . . 0.0 111.072 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -63.83 -48.07 78.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.814 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.6 mmt -82.12 -33.01 29.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.533 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.598 ' OD1' ' HG3' ' A' ' 60' ' ' MET . 11.3 t70 68.02 123.63 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.89 0.852 . . . . 0.0 111.689 -172.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.554 ' HE2' ' HD3' ' A' ' 62' ' ' LYS . 36.6 p90 -113.79 -19.86 11.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.918 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 174.07 -39.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.598 ' HG3' ' OD1' ' A' ' 57' ' ' ASP . 66.6 mtt 63.72 84.49 0.15 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.698 -175.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.53 -42.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.0 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.554 ' HD3' ' HE2' ' A' ' 58' ' ' PHE . 13.5 mptt -58.99 146.77 76.09 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.911 177.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 24.8 Cg_exo -64.18 142.3 79.62 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.182 2.588 . . . . 0.0 113.337 -175.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.8 mtm-85 -125.67 115.7 20.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.671 HD11 ' HB3' ' A' ' 68' ' ' GLN . 4.8 pt -127.52 123.42 61.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.128 0.489 . . . . 0.0 111.127 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -82.01 46.94 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.007 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.2 m -158.24 -57.85 0.07 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 0.0 110.479 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.671 ' HB3' HD11 ' A' ' 65' ' ' ILE . 27.8 tt0 -101.73 53.0 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.64 0.733 . . . . 0.0 109.635 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.81 171.43 8.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.276 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.81 ' HA ' HE21 ' A' ' 70' ' ' GLN . 0.0 OUTLIER -116.58 132.43 56.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.186 -178.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 58.8 mtm -82.81 151.35 26.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.489 HG21 HG21 ' A' ' 127' ' ' VAL . 11.0 p -95.54 133.75 35.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.977 0.417 . . . . 0.0 110.195 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.57 HD23 ' OD1' ' A' ' 22' ' ' ASP . 13.4 mt -72.29 157.75 37.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.004 0.43 . . . . 0.0 111.666 -176.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.448 ' HB3' HG23 ' A' ' 43' ' ' THR . 7.8 t-20 -98.4 113.16 25.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.254 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.654 ' HA2' HG11 ' A' ' 39' ' ' VAL . . . -79.24 -36.24 27.87 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.06 -178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.81 174.62 28.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.894 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.35 -11.87 27.0 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.887 2.391 . . . . 0.0 113.484 -174.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.44 132.01 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.37 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 65.86 39.26 4.71 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.236 0.335 . . . . 0.0 111.582 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -65.76 -21.66 66.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.91 7.65 43.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.741 0.782 . . . . 0.0 109.834 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.37 140.64 49.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.01 129.66 9.86 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.619 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.518 ' HB3' HD13 ' A' ' 106' ' ' LEU . 21.3 m-85 -115.19 125.03 52.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.54 ' HB ' HG21 ' A' ' 112' ' ' VAL . 4.7 mp -131.26 122.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.554 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.595 HG22 HD11 ' A' ' 106' ' ' LEU . 7.3 t -95.18 131.4 42.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -137.96 160.27 39.78 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.465 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.7 m -63.22 145.5 55.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.237 0.542 . . . . 0.0 111.63 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.44 ' CB ' ' HA ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -63.55 124.28 20.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.331 174.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.446 HG22 ' O ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -117.88 -176.54 3.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -174.226 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.749 ' HB2' HG23 ' A' ' 120' ' ' THR . 6.8 m-20 -79.78 -35.53 38.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -172.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.539 ' HE1' ' HA ' ' A' ' 115' ' ' SER . 10.1 p-80 -87.07 175.54 8.05 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.979 -173.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.39 169.18 3.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.759 0.79 . . . . 0.0 112.269 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -153.91 113.98 3.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.718 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.5 m -72.87 -77.36 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.154 -169.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -109.03 83.72 1.8 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.323 0.583 . . . . 0.0 110.844 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.3 m -126.04 151.8 46.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.156 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.32 102.0 12.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -69.95 115.7 9.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.77 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.79 -54.47 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.612 177.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 102' ' ' ASP . 2.3 t -131.19 -54.46 1.04 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.959 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 101' ' ' THR . 11.8 t70 173.45 -64.01 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.44 ' HA ' ' CB ' ' A' ' 89' ' ' LYS . 5.7 m-20 -62.77 -26.83 68.9 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.77 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.9 mm -99.51 122.26 51.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -129.2 114.76 16.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.945 0.402 . . . . 0.0 111.466 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.595 HD11 HG22 ' A' ' 86' ' ' VAL . 21.8 tp -93.99 112.19 23.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.794 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.818 HG21 ' HB3' ' A' ' 111' ' ' ASP . 29.8 m -99.96 127.67 46.13 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.07 0.462 . . . . 0.0 110.907 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.8 p -102.16 23.88 10.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.038 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.424 ' H ' HG23 ' A' ' 107' ' ' THR . 34.2 m -151.38 -177.74 6.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.395 -176.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.81 11.75 5.61 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.341 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.818 ' HB3' HG21 ' A' ' 107' ' ' THR . 14.7 t70 -63.42 -30.23 71.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.853 0.835 . . . . 0.0 109.708 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.54 HG21 ' HB ' ' A' ' 85' ' ' ILE . 40.8 t -54.79 -45.44 74.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.609 174.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.38 -33.8 73.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.612 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.58 -41.39 94.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.967 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.541 ' HB3' ' HD3' ' A' ' 122' ' ' PRO . 49.1 m -59.08 -39.66 82.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.761 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.18 4.66 25.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.996 0.427 . . . . 0.0 111.219 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.29 17.4 28.98 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.975 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.3 t -142.58 179.26 7.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -62.55 -32.33 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.851 0.357 . . . . 0.0 110.959 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.749 HG23 ' HB2' ' A' ' 91' ' ' ASP . 23.4 p -92.49 43.1 1.12 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.848 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -56.89 123.65 60.1 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.765 168.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 115' ' ' SER . 27.0 Cg_endo -61.27 129.52 28.69 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.824 2.349 . . . . 0.0 112.558 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.44 -45.82 92.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.875 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -114.14 142.07 46.69 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.6 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -161.29 143.08 11.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.569 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.03 132.6 69.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.232 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.489 HG21 HG21 ' A' ' 72' ' ' VAL . 7.3 p -115.01 131.07 68.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.113 0.482 . . . . 0.0 110.993 -176.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 8.9 p -142.98 146.46 33.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.456 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mt -102.33 142.81 32.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.83 179.73 7.41 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.074 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . 0.538 ' HB3' HG22 ' A' ' 37' ' ' ILE . 61.9 m -149.14 162.72 39.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.077 0.465 . . . . 0.0 109.977 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -114.03 117.07 30.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.464 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 36' ' ' THR . 17.9 p -107.66 116.38 31.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.234 0.54 . . . . 0.0 112.004 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.65 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.6 OUTLIER -101.23 151.38 21.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.971 177.086 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 11.4 mptt -105.49 137.33 19.26 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.325 -174.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 137' ' ' HIS . 7.8 Cg_exo -72.09 92.26 0.73 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.379 2.719 . . . . 0.0 112.818 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' A' ' 136' ' ' PRO . 13.6 p80 170.85 -18.66 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.125 176.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.584 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 56.9 tp60 -110.32 -58.88 2.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 171.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.65 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 53.5 tp -56.89 -53.11 61.71 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -172.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -35.94 77.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -173.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 11.5 mt-30 -74.94 -36.22 62.14 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.45 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 7.6 mm-40 -65.81 -41.96 91.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.756 0.312 . . . . 0.0 110.305 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 139' ' ' LEU . 71.2 mt -62.19 -42.44 95.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.44 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.68 99.25 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.233 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 41.8 mt-30 -78.8 3.56 16.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.02 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.35 37.52 3.53 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 175.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -72.84 -28.41 62.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 164.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' TRP . . . . . 0.485 ' CH2' HD13 ' A' ' 40' ' ' ILE . 74.6 m95 -116.4 149.81 38.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.0 -1.454 . . . . 0.0 108.991 175.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.597 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.0 tt -104.6 110.1 22.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.469 ' CD2' ' HB3' ' A' ' 2' ' ' PHE . 34.0 tp -82.03 135.46 35.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 111.228 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.2 m -143.87 156.04 44.31 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -98.09 153.74 18.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.385 0.612 . . . . 0.0 111.401 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.18 155.4 40.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.33 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -119.01 -62.36 1.53 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.786 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -161.8 -38.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -54.85 -56.43 19.58 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.2 m -55.12 -28.17 50.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.424 0.63 . . . . 0.0 111.063 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.8 mt -81.31 -54.57 5.38 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.849 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.454 ' HZ ' ' HB ' ' A' ' 86' ' ' VAL . 71.1 m-85 -133.51 17.66 3.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -172.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -110.65 -48.36 3.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.268 175.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.462 ' HA ' HD12 ' A' ' 164' ' ' LEU . 0.8 OUTLIER -90.56 -9.46 47.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.055 0.455 . . . . 0.0 111.185 179.225 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.2 t -60.12 136.65 58.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.112 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 72.1 t80 75.2 -44.29 0.53 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.807 0.843 . . . . 0.0 112.554 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 161' ' ' THR . 4.0 pp -81.54 -14.79 56.45 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.583 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 166' ' ' ARG . 10.0 t70 -87.44 -161.39 0.69 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.456 ' H ' ' CG ' ' A' ' 165' ' ' ASP . 52.5 mtt180 -115.52 -135.79 0.35 Allowed 'General case' 0 C--O 1.214 -0.774 0 O-C-N 122.111 -0.368 . . . . 0.0 111.164 -174.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.878 ' HD1' ' HA ' ' A' ' 20' ' ' TYR . 2.2 m-90 -57.92 -89.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -168.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.435 ' H ' ' HB2' ' A' ' 167' ' ' TRP . 3.6 m -111.76 91.98 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.334 0.588 . . . . 0.0 111.535 -175.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 173' ' ' MET . 13.2 pt-20 -71.21 -29.22 64.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.723 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.24 91.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.979 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.573 ' OD1' ' HA ' ' A' ' 176' ' ' ILE . 11.1 t-20 -71.99 -31.99 66.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.399 0.619 . . . . 0.0 109.593 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.61 -21.91 61.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.16 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.801 ' HE3' ' HA ' ' A' ' 173' ' ' MET . 23.6 mmt -58.27 -33.74 69.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.465 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.5 tt -117.02 -52.83 2.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.183 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 157.73 115.97 0.47 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.573 ' HA ' ' OD1' ' A' ' 171' ' ' ASN . 3.1 mp -48.16 108.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 O-C-N 124.105 0.532 . . . . 0.0 110.572 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 39.7 m 74.58 98.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.46 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.81 -139.5 10.65 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.863 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.522 HD12 ' HG ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -106.42 137.38 37.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.678 0.275 . . . . 0.0 110.619 -175.33 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.522 ' HG ' HD12 ' A' ' 179' ' ' ILE . 31.3 mt 61.96 64.34 1.01 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.245 -176.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -111.57 108.61 56.26 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.05 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -89.34 114.04 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.914 2.41 . . . . 0.0 112.704 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.476 ' HA ' HG21 ' A' ' 13' ' ' THR . . . -81.38 -13.35 58.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.483 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -84.73 61.85 4.63 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.788 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 50.6 ttt-85 -139.23 91.37 2.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.859 0.362 . . . . 0.0 110.411 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -96.93 -47.23 5.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 96.2 mt -136.33 155.9 49.41 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.374 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.838 -0.601 . . . . 0.0 109.832 179.332 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 121.593 0.711 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 91.8 mt -82.25 -3.03 54.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.153 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.605 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -65.1 135.65 55.79 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.163 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.88 12.82 83.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.961 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.552 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 43.2 mmtm -112.8 163.4 14.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -140.28 150.45 44.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.04 0.448 . . . . 0.0 110.382 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.523 HD11 HG13 ' A' ' 40' ' ' ILE . 8.4 pt -116.06 129.14 72.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.851 -177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.74 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.0 mp -86.37 103.83 13.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -94.8 -54.37 3.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.426 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.86 -178.163 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 121.708 0.766 . . . . 0.0 112.593 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.409 ' O ' ' HB ' ' A' ' 25' ' ' VAL . 1.1 t -140.45 110.89 6.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.391 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.563 HG13 HG22 ' A' ' 40' ' ' ILE . 90.2 t 73.55 140.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 122.844 0.458 . . . . 0.0 110.918 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.564 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.3 tp -135.19 -58.42 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.564 ' HD1' HG13 ' A' ' 26' ' ' ILE . 20.4 p90 -168.05 171.44 9.62 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.647 0.658 . . . . 0.0 112.134 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.68 133.75 40.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.195 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.8 m -75.97 -52.6 9.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.03 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 6' ' ' GLN . 13.7 pt-20 -161.1 169.91 21.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.131 0.491 . . . . 0.0 111.752 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 37.6 t-80 -134.16 111.03 9.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.636 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -128.25 170.16 13.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.495 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.33 -31.97 73.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.133 0.492 . . . . 0.0 110.85 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -74.57 -18.11 60.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.857 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.31 -177.52 30.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.659 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.0 m -113.27 117.62 32.35 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.665 HG13 HG22 ' A' ' 133' ' ' THR . 3.9 mp -96.28 124.85 49.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.44 164.73 34.65 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.037 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.38 81.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.443 0.64 . . . . 0.0 110.355 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.563 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -133.97 6.65 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.431 -176.073 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.9 tp -70.59 -35.9 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 120.506 0.193 . . . . 0.0 111.247 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 63.97 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.182 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.495 HG23 ' HB2' ' A' ' 74' ' ' ASN . 4.1 t -161.34 91.52 1.49 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 121.714 0.768 . . . . 0.0 110.062 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 58.6 Cg_endo -72.85 154.56 53.63 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.719 2.279 . . . . 0.0 112.058 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.1 p -114.95 167.98 10.31 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.46 -0.63 47.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 0.0 111.595 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.648 HD21 ' HB3' ' A' ' 52' ' ' LEU . 35.1 tp -92.4 152.38 19.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.9 0.381 . . . . 0.0 110.143 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.721 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 12.8 m -109.08 154.48 22.2 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 7.4 p -61.28 -45.56 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.237 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.594 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 90.3 mt -75.67 -25.82 57.12 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.407 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.721 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.5 OUTLIER -57.36 -53.47 57.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.097 178.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HB3' HD21 ' A' ' 47' ' ' LEU . 3.8 pp -66.66 -36.52 82.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.04 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.69 -51.63 64.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.779 0.323 . . . . 0.0 111.105 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.7 p -72.49 -29.46 63.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.057 0.456 . . . . 0.0 111.186 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -69.61 -37.2 76.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.584 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.471 ' HG3' ' O ' ' A' ' 52' ' ' LEU . 65.2 mtt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.928 0.394 . . . . 0.0 111.918 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.594 ' OD2' ' HB2' ' A' ' 50' ' ' LEU . 6.0 t0 . . . . . 0 C--O 1.233 0.233 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -118.34 137.11 53.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 23.3 mmt -81.93 140.44 34.04 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.353 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.46 HG23 HG13 ' A' ' 127' ' ' VAL . 14.2 p -93.94 137.71 22.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.012 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.1 mp -106.48 155.11 19.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.513 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.495 ' HB2' HG23 ' A' ' 43' ' ' THR . 44.2 m-20 -89.42 127.72 35.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.52 -15.0 69.5 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.178 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.22 175.12 29.8 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.66 -12.19 20.27 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.651 2.234 . . . . 0.0 112.719 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.95 145.38 9.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.514 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 64.9 30.7 11.92 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.504 0.321 . . . . 0.0 111.618 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -65.78 -9.19 26.18 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.045 0.45 . . . . 0.0 111.314 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.1 -19.99 60.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.303 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -134.77 143.16 46.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 111.413 -171.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.14 122.6 7.28 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.597 ' HB3' HD11 ' A' ' 106' ' ' LEU . 92.9 m-85 -96.97 126.12 41.88 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.631 0.253 . . . . 0.0 110.426 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.47 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.6 mp -111.35 115.16 49.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.189 0.518 . . . . 0.0 110.479 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.426 HG22 HD13 ' A' ' 106' ' ' LEU . 31.2 t -94.24 124.42 46.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.309 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -139.51 166.84 23.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.882 0.373 . . . . 0.0 111.195 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.3 p -93.16 174.12 7.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.064 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.55 ' HG3' ' OD1' ' A' ' 103' ' ' ASP . 21.7 mmtp -57.6 134.81 56.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 172.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.624 ' OG1' ' HA ' ' A' ' 122' ' ' PRO . 81.9 m -155.05 114.68 3.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.663 173.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.3 t70 59.68 -147.89 0.47 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.993 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -126.65 36.25 4.5 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.86 -0.525 . . . . 0.0 112.378 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 94' ' ' PHE . 40.2 mm-40 -90.52 161.0 15.69 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.348 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 27.0 t80 167.59 102.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.789 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.4 m -121.26 -55.05 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.974 0.416 . . . . 0.0 110.913 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.74 ' HB2' ' HB2' ' A' ' 111' ' ' ASP . 9.6 m-70 -127.08 70.98 1.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.418 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' A' ' 94' ' ' PHE . 66.4 m -128.51 139.51 52.28 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.111 0.482 . . . . 0.0 111.036 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -102.91 133.35 48.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.548 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -76.31 113.49 13.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.111 0.481 . . . . 0.0 111.943 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.54 -53.73 9.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 166.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.773 HG22 ' HB ' ' A' ' 104' ' ' ILE . 6.3 t -142.72 -164.05 1.75 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.448 ' O ' ' HE3' ' A' ' 89' ' ' LYS . 10.5 t70 -67.42 -53.29 30.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.572 0.623 . . . . 0.0 111.272 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.55 ' OD1' ' HG3' ' A' ' 89' ' ' LYS . 91.8 m-20 -84.18 -34.26 24.01 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.773 ' HB ' HG22 ' A' ' 101' ' ' THR . 46.8 mm -81.48 121.64 35.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.097 0.475 . . . . 0.0 110.226 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.14 128.96 50.03 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.749 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 84' ' ' PHE . 54.8 tp -96.87 112.43 24.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.242 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.615 ' CG2' ' HB3' ' A' ' 111' ' ' ASP . 10.8 m -118.69 128.43 54.5 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -132.91 -29.67 1.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 t -112.37 104.71 12.87 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.459 -0.497 . . . . 0.0 112.024 -172.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.88 -53.4 2.93 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.74 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 15.4 t0 -56.3 -34.48 66.54 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.89 0.476 . . . . 0.0 112.201 -170.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.652 HG23 HD22 ' A' ' 113' ' ' LEU . 3.7 m -59.2 -34.9 55.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.652 HD22 HG23 ' A' ' 112' ' ' VAL . 2.7 mm? -70.64 -27.29 63.94 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.437 0.637 . . . . 0.0 110.24 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.2 -33.54 56.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.288 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.44 ' HB3' ' HD3' ' A' ' 122' ' ' PRO . 20.2 m -60.82 -67.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.967 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.553 ' HA ' ' HB2' ' A' ' 121' ' ' ALA . 8.4 p90 -79.45 140.18 37.43 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.006 0.431 . . . . 0.0 111.055 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.74 -17.71 9.35 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 t -131.89 178.87 6.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -77.66 1.68 19.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -174.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.6 p -99.8 14.55 29.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.451 0.643 . . . . 0.0 110.828 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -71.52 130.93 86.8 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.473 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.624 ' HA ' ' OG1' ' A' ' 90' ' ' THR . 17.4 Cg_exo -63.95 140.09 71.06 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.542 2.161 . . . . 0.0 111.985 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -55.12 -51.35 66.71 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.152 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.548 ' HB2' ' HE2' ' A' ' 159' ' ' PHE . 67.2 mmtt -128.06 138.22 52.47 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.607 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -154.04 144.33 22.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.492 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 28.8 pt -122.27 144.45 31.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.004 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.46 HG13 HG23 ' A' ' 72' ' ' VAL . 7.4 p -119.39 134.29 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.154 0.502 . . . . 0.0 111.197 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 70.2 m -139.11 131.91 29.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.376 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.6 116.77 23.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.188 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.98 -177.33 50.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.388 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 64.1 m -150.41 169.39 21.55 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.168 0.587 . . . . 0.0 109.434 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.6 m -106.88 139.67 40.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.65 0.262 . . . . 0.0 110.502 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.665 HG22 HG13 ' A' ' 37' ' ' ILE . 27.5 p -117.55 114.22 23.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.037 0.446 . . . . 0.0 110.668 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -83.67 156.2 22.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.263 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.401 ' HB2' ' CB ' ' A' ' 138' ' ' GLN . 72.1 mmtt -58.57 141.47 84.04 Favored Pre-proline 0 C--O 1.237 0.441 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.355 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.97 119.89 7.44 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.746 2.297 . . . . 0.0 112.319 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.476 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 57.0 t-80 74.83 -9.19 1.39 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.262 174.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.401 ' CB ' ' HB2' ' A' ' 135' ' ' LYS . 47.3 tt0 -66.68 -51.01 60.99 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.158 -0.339 . . . . 0.0 111.29 -177.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 143' ' ' ILE . 47.7 tp -54.41 -35.93 63.43 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.476 ' OE2' ' HA ' ' A' ' 137' ' ' HIS . 45.3 mt-10 -57.8 -43.26 85.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.061 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 35.6 mt-30 -72.39 -38.1 68.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.478 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.64 -40.56 97.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.583 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 139' ' ' LEU . 76.1 mt -65.77 -33.01 60.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.249 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.07 64.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.059 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 75.2 mt-30 -75.97 -8.17 56.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.389 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 65.65 30.67 10.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.078 -173.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -87.74 -18.29 29.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.592 0.711 . . . . 0.0 109.477 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.413 ' HZ3' ' HB2' ' A' ' 12' ' ' ALA . 93.5 m95 -125.62 137.49 53.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.474 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.74 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 58.0 mt -92.37 108.31 19.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.071 0.462 . . . . 0.0 109.9 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.0 tp -91.45 134.05 34.96 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.927 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.0 t -149.7 148.0 28.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 8' ' ' LYS . 1.7 mp0 -85.5 152.62 23.04 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.928 0.394 . . . . 0.0 110.178 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.35 104.15 13.21 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -80.29 77.01 7.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.8 t30 49.97 -83.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.275 0.985 . . . . 0.0 112.889 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -63.06 -35.58 80.73 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.545 0.212 . . . . 0.0 110.772 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.0 m -58.58 -30.3 67.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.858 0.361 . . . . 0.0 111.385 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 tt -67.0 -50.23 62.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.985 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.642 ' HB2' HD11 ' A' ' 104' ' ' ILE . 2.4 t80 -112.08 -27.67 8.3 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -169.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -105.44 -54.87 2.41 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.493 -176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.468 0.465 0 O-C-N 124.46 1.1 . . . . 0.0 111.863 -172.236 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 168' ' ' VAL . 17.0 t . . . . . 0 CA--C 1.539 0.519 0 CA-C-O 122.429 1.109 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -60.63 -36.3 78.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.48 -178.423 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.92 -36.16 80.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.049 0.452 . . . . 0.0 111.096 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.423 ' HB3' HG12 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -79.84 -28.36 40.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.739 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.29 -26.38 38.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.361 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -53.94 -33.77 57.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.273 0.559 . . . . 0.0 111.077 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.99 -39.13 14.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.971 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.232 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.139 179.03 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.7 p30 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.452 0.644 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 6' ' ' GLN . 95.8 mt -130.0 -152.12 0.5 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.965 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 50.8 tt0 67.98 119.25 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.215 0.531 . . . . 0.0 110.792 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.18 19.7 27.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.758 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -134.96 169.79 16.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.499 ' CZ ' ' HG3' ' A' ' 173' ' ' MET . 29.4 p90 -143.85 162.41 36.16 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 175.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 3.3 pt -133.02 128.46 56.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.507 -174.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 4.9 mp -96.24 140.05 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.575 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.32 168.68 19.51 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.827 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 N--CA 1.469 0.477 0 O-C-N 124.136 0.898 . . . . 0.0 113.044 177.295 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.712 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 1.4 mmp_? . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 120.917 0.389 . . . . 0.0 112.023 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.1 p -146.34 158.71 43.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t 68.24 100.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 O-C-N 123.897 0.748 . . . . 0.0 111.13 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.665 HG13 ' HD1' ' A' ' 27' ' ' TYR . 10.6 tp -129.67 -142.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.32 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.665 ' HD1' HG13 ' A' ' 26' ' ' ILE . 37.1 p90 -117.64 174.55 6.1 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.476 1.034 . . . . 0.0 112.259 -165.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -92.98 125.73 45.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.326 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.3 m -73.0 -59.03 2.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.064 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -145.89 164.21 32.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.409 0.623 . . . . 0.0 111.223 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 74.8 t60 -118.27 118.87 32.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -114.64 -176.87 3.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.326 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -66.51 -28.84 68.88 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.261 0.553 . . . . 0.0 110.438 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.82 9.52 43.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.835 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.09 -143.63 15.34 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.567 -1.302 . . . . 0.0 113.185 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 133' ' ' THR . 12.4 m -123.97 129.11 50.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.499 0.19 . . . . 0.0 110.94 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.7 HG13 HG22 ' A' ' 133' ' ' THR . 3.5 mp -103.74 114.78 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.272 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -145.82 165.72 28.0 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.557 HG12 ' HA3' ' A' ' 75' ' ' GLY . 3.5 m -113.37 68.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.628 0.728 . . . . 0.0 110.787 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.597 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -115.37 15.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.956 -173.498 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.35 -29.38 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.739 0.304 . . . . 0.0 110.737 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 62.99 85.88 0.12 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.093 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.1 t -179.1 123.11 0.24 Allowed Pre-proline 0 C--O 1.235 0.315 0 CA-C-O 121.358 0.599 . . . . 0.0 111.514 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 71.9 Cg_endo -81.67 155.73 18.33 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.503 2.136 . . . . 0.0 110.733 170.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 p -112.2 161.75 16.22 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.022 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.05 -20.42 63.24 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.494 ' O ' HG12 ' A' ' 72' ' ' VAL . 57.5 tp -67.44 145.07 55.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.609 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.533 ' HB3' ' CG ' ' A' ' 69' ' ' ASP . 17.9 m -101.06 153.33 19.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.16 -176.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.1 p -69.65 -33.97 59.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 69' ' ' ASP . 59.0 mt -73.68 -26.84 60.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.514 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.3 OUTLIER -71.45 -40.24 70.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.091 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.5 pp -74.03 -32.34 63.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.013 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 94.9 mt -65.4 -51.28 61.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.328 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.7 p -67.07 -28.47 68.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.339 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -55.72 -39.52 71.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.158 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 46.2 mtt . . . . . 0 C--N 1.326 -0.413 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.043 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.533 ' CG ' ' HB3' ' A' ' 48' ' ' SER . 25.3 t70 . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -126.86 14.46 7.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.836 -175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 44.2 mtt 63.06 165.89 0.12 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.626 -174.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG21 HD23 ' A' ' 129' ' ' LEU . 11.7 p -116.0 144.16 24.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.785 172.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.575 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.2 mp -103.8 158.12 16.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.972 0.415 . . . . 0.0 110.355 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.43 127.44 53.29 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.557 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -87.79 -10.06 70.4 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.316 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 131' ' ' CYS . . . 160.2 176.74 32.62 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.502 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 1.7 Cg_endo -85.41 -2.3 9.25 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.131 2.554 . . . . 0.0 113.322 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.49 HG12 HD22 ' A' ' 79' ' ' ASN . 19.7 t -103.3 128.39 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.785 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.49 HD22 HG12 ' A' ' 78' ' ' VAL . 45.7 m-80 62.59 39.18 11.7 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.111 0.564 . . . . 0.0 111.809 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.502 ' NE2' ' HA ' ' A' ' 77' ' ' PRO . 96.2 mt-30 -68.58 -10.37 55.46 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.201 0.524 . . . . 0.0 110.582 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -71.92 -17.61 62.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.292 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 82' ' ' ARG . 41.2 mtt180 -110.07 129.28 55.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.409 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 108' ' ' THR . . . -90.6 112.97 4.17 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.509 ' HB3' HD11 ' A' ' 106' ' ' LEU . 85.9 m-85 -93.53 125.04 37.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.646 0.223 . . . . 0.0 110.553 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.473 HG21 HG11 ' A' ' 112' ' ' VAL . 4.7 mp -123.34 105.56 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.975 0.417 . . . . 0.0 110.091 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 66.0 t -88.14 122.03 39.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.37 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -133.01 163.44 29.23 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.834 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 122' ' ' PRO . 4.9 m -64.33 158.67 22.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.66 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.761 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 1.5 tmtp? -66.48 118.22 9.8 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.944 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.443 ' HB ' ' OG1' ' A' ' 120' ' ' THR . 1.5 p -126.3 -169.3 1.99 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.456 173.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -116.27 155.92 27.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.245 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 75.53 165.94 0.27 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.644 0.59 . . . . 0.0 110.253 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 0.3 OUTLIER 69.41 169.29 0.3 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.349 0.66 . . . . 0.0 111.875 -176.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.522 ' HB3' ' O ' ' A' ' 93' ' ' GLU . 21.3 p90 157.46 117.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 113.98 -1.463 . . . . 0.0 109.307 -173.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.2 m -146.71 -71.19 0.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.394 0.616 . . . . 0.0 109.822 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -120.45 37.39 4.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.0 m -74.26 104.78 5.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.684 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -101.97 118.44 36.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.215 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 102' ' ' ASP . 95.6 mttt -100.0 112.0 24.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.877 0.37 . . . . 0.0 110.814 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.06 -53.67 44.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.1 t -133.26 169.67 16.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 166.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.511 ' HA ' ' HD3' ' A' ' 99' ' ' LYS . 38.7 t70 -61.16 -36.59 80.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 118.872 0.76 . . . . 0.0 111.358 -174.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.761 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 4.1 m-20 -77.26 -7.9 56.71 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.2 mm -121.06 122.37 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.959 0.409 . . . . 0.0 110.027 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 m -121.47 113.74 20.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.422 0.63 . . . . 0.0 111.498 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 84' ' ' PHE . 54.1 tp -94.07 137.7 32.98 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.971 174.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.677 HG21 ' HB3' ' A' ' 111' ' ' ASP . 16.2 m -145.98 137.78 25.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 65.4 p -114.28 12.65 17.7 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.434 ' H ' HG22 ' A' ' 107' ' ' THR . 62.8 p -127.73 -174.73 3.27 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.492 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.36 -7.82 47.75 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.311 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.677 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.5 t70 -50.47 -39.44 48.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.73 . . . . 0.0 110.002 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 107' ' ' THR . 91.7 t -60.63 -49.03 86.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.131 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.89 -35.88 82.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.47 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.09 -46.0 72.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.724 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.416 ' HA ' HG22 ' A' ' 118' ' ' THR . 5.2 p -66.93 -37.93 85.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.746 0.308 . . . . 0.0 110.811 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.508 ' CE1' ' HD2' ' A' ' 122' ' ' PRO . 7.0 m-30 -67.56 -24.14 65.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.083 0.468 . . . . 0.0 110.929 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.99 19.86 52.58 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.404 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.58 ' CG2' HG22 ' A' ' 120' ' ' THR . 4.4 t -142.85 -171.04 3.37 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -82.72 13.0 4.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.58 HG22 ' CG2' ' A' ' 118' ' ' THR . 9.8 t -117.49 20.46 13.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.527 0.679 . . . . 0.0 110.538 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.448 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -68.38 115.1 26.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.969 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.508 ' HD2' ' CE1' ' A' ' 116' ' ' PHE . 11.4 Cg_exo -71.87 143.0 40.17 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.904 2.403 . . . . 0.0 112.156 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.79 -47.19 86.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.929 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -102.26 124.43 47.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.237 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 48.7 p90 -152.15 141.97 21.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.323 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.4 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 24.3 pt -127.26 135.51 63.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.45 175.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.29 125.97 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.141 0.496 . . . . 0.0 110.798 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.6 m -143.08 136.3 28.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.827 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.501 HD23 HG21 ' A' ' 72' ' ' VAL . 4.2 mm? -89.39 124.46 34.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.843 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.94 174.4 17.52 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.398 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.401 ' C ' ' HA3' ' A' ' 76' ' ' GLY . 61.5 m -144.9 169.01 18.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.9 m -105.89 122.51 46.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.669 0.271 . . . . 0.0 110.716 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.7 HG22 HG13 ' A' ' 37' ' ' ILE . 41.3 p -101.71 116.78 33.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.876 0.37 . . . . 0.0 111.172 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.582 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 3.0 t-105 -78.84 156.99 28.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 12.9 mptt -62.27 137.38 95.92 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.805 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 51.9 Cg_exo -52.66 121.5 9.26 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.216 2.611 . . . . 0.0 112.616 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 75.39 -17.1 0.53 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.357 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.55 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 53.8 tp60 -73.91 -30.89 62.83 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.88 -0.512 . . . . 0.0 111.387 -174.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.486 ' O ' HG13 ' A' ' 143' ' ' ILE . 52.4 tp -54.75 -44.71 73.86 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.89 -33.36 75.82 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.994 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 34.3 tt0 -71.93 -38.37 69.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.582 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 11.2 mm-40 -61.21 -42.21 98.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.229 0.538 . . . . 0.0 109.67 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 139' ' ' LEU . 84.8 mt -60.55 -38.18 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.038 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.74 -17.7 64.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 111.662 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 50.1 mt-30 -85.94 -0.72 56.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.467 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 62.84 24.53 14.6 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 123.713 0.805 . . . . 0.0 112.58 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -88.63 -8.02 55.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.292 0.568 . . . . 0.0 109.542 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -135.22 115.09 12.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.13 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.726 HD11 HD22 ' A' ' 174' ' ' LEU . 4.7 tt -84.84 102.51 13.14 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.7 tp -82.92 134.75 35.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.401 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.7 p -150.23 163.92 37.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.8 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.26 154.24 19.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.282 0.563 . . . . 0.0 111.945 -175.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 154' ' ' ASN . . . -92.56 -160.11 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.653 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 153' ' ' ALA . 86.8 m-20 70.91 15.23 6.8 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.61 -177.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -96.18 148.57 22.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.46 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.99 -63.0 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.447 ' HB ' ' SD ' ' A' ' 173' ' ' MET . 24.8 m -51.66 -29.16 16.93 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.0 tt -52.36 -49.13 64.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 111.285 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -123.61 -19.78 5.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.988 -173.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -88.17 -9.65 52.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.847 0.356 . . . . 0.0 111.051 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 157' ' ' THR . 11.1 t . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.1 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 171' ' ' ASN . 16.1 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.542 0.211 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.638 ' OE2' ' HA ' ' A' ' 23' ' ' ARG . 1.1 pm0 -91.83 -50.18 5.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.017 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.446 ' N ' ' HG2' ' A' ' 169' ' ' GLU . . . -81.23 -48.74 11.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.795 0.331 . . . . 0.0 111.65 -173.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.558 ' HB2' HG21 ' A' ' 168' ' ' VAL . 1.9 m-20 -60.98 -25.43 66.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.123 0.487 . . . . 0.0 111.129 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -71.59 -21.04 61.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.175 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.499 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 68.7 mmm -65.93 -28.22 68.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.058 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.726 HD22 HD11 ' A' ' 149' ' ' LEU . 12.2 tp -95.79 -44.91 7.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.883 179.061 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.507 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 59.4 m-20 . . . . . 0 CA--C 1.517 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.7 mt -136.54 -123.54 0.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.291 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 66.77 119.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.178 0.989 . . . . 0.0 111.814 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.8 5.32 77.97 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.478 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 11.3 mptt -113.24 164.77 13.12 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.44 ' HE1' HD11 ' A' ' 11' ' ' ILE . 36.5 p90 -136.82 159.54 41.54 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.028 0.442 . . . . 0.0 111.062 -176.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.7 pt -128.87 127.89 66.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.248 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.83 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.5 mp -92.99 123.43 45.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.39 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -115.59 101.27 8.71 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.6 m . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 120.929 0.395 . . . . 0.0 111.488 -177.073 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.586 ' HE ' HD23 ' A' ' 73' ' ' LEU . 3.0 tmm_? . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.633 0.73 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.9 t -114.54 143.89 44.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.992 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.816 HG11 HG13 ' A' ' 11' ' ' ILE . 40.2 t 63.55 109.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.809 0.814 . . . . 0.0 112.054 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.857 HG21 HG23 ' A' ' 39' ' ' VAL . 5.6 tp -134.36 -161.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.56 ' H ' HG13 ' A' ' 26' ' ' ILE . 5.0 p90 -117.56 169.67 9.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.975 0.807 . . . . 0.0 111.876 -164.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.18 112.14 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.187 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.3 m -73.89 -46.23 45.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.093 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.691 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 36.4 tt0 -135.77 144.45 45.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.424 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.507 ' CD2' ' HA ' ' A' ' 4' ' ' ASN . 74.8 t60 -146.35 104.67 3.81 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -122.87 174.86 6.89 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.22 -21.79 66.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.389 0.614 . . . . 0.0 109.826 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -70.27 -31.23 68.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.194 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 160.91 -179.93 36.06 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.308 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.1 m -115.64 127.68 55.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.654 0.264 . . . . 0.0 110.623 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.2 mp -112.84 115.92 51.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.415 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.32 163.71 26.0 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.857 HG23 HG21 ' A' ' 26' ' ' ILE . 18.3 m -123.84 36.88 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.501 0.667 . . . . 0.0 110.884 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.713 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -84.97 15.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -169.311 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 pt -64.62 -25.91 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.59 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.1 t-20 64.85 93.11 0.07 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.416 0.447 . . . . 0.0 111.996 176.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 12.4 t 169.48 137.77 0.06 OUTLIER Pre-proline 0 C--O 1.24 0.569 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.184 175.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.845 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 93.0 Cg_endo -85.18 176.88 5.56 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.728 2.285 . . . . 0.0 111.052 170.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.401 HG22 ' ND2' ' A' ' 74' ' ' ASN . 15.2 p -116.59 176.34 5.16 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.428 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -91.12 5.62 48.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.943 0.877 . . . . 0.0 109.566 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 tp -106.66 156.4 18.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.487 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 10.5 m -100.27 151.49 21.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.7 p -65.54 -33.89 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.8 mt -68.33 -26.62 65.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.621 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 48' ' ' SER . 4.2 mm-40 -63.16 -47.28 83.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.562 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.6 -39.17 88.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.514 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 89.3 mt -64.8 -43.73 92.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.291 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -72.55 -29.09 63.25 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -56.63 -43.45 80.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.046 0.45 . . . . 0.0 110.169 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.8 mtm . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.615 176.945 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.16 0.505 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -125.55 123.12 38.4 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.609 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.558 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 1.9 mpt? -76.73 157.75 31.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.849 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.98 140.23 18.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.845 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 10.4 mp -104.39 152.26 22.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.876 0.37 . . . . 0.0 110.581 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.401 ' ND2' HG22 ' A' ' 45' ' ' THR . 57.8 m-20 -85.48 141.99 29.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.589 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.41 -25.39 7.02 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.703 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.83 170.94 30.46 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.974 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.56 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 6.3 Cg_exo -79.64 -3.17 12.73 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.191 2.594 . . . . 0.0 112.96 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.4 t -102.23 146.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 61.45 42.84 10.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.933 0.397 . . . . 0.0 111.096 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 77' ' ' PRO . 19.4 mm-40 -65.06 -10.9 33.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -176.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.28 -12.55 56.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.73 0.3 . . . . 0.0 110.75 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -130.27 128.89 42.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.314 0.578 . . . . 0.0 112.068 -167.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.52 125.34 7.99 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.21 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.572 ' HB3' HD11 ' A' ' 106' ' ' LEU . 64.7 m-85 -99.99 126.15 46.13 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.44 HG12 HG11 ' A' ' 112' ' ' VAL . 3.8 mp -114.57 122.41 68.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.118 0.485 . . . . 0.0 110.989 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -101.59 125.23 55.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.533 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -131.18 160.7 34.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.609 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.1 p -71.55 132.78 45.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.08 0.467 . . . . 0.0 109.948 174.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 103' ' ' ASP . 9.2 tmtt? -67.76 122.65 18.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.465 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.8 t -152.65 -12.93 0.17 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.307 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -83.57 159.69 21.58 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.69 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -148.52 104.89 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 65.95 -179.03 0.19 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.68 0.613 . . . . 0.0 110.634 -175.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 70.11 -61.7 0.45 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.224 0.609 . . . . 0.0 111.348 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 111' ' ' ASP . 2.0 p -75.11 133.91 41.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.338 0.59 . . . . 0.0 110.77 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.426 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 29.6 m80 -82.36 61.79 5.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.905 177.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.5 m -85.46 138.39 32.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -100.69 123.32 44.73 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.619 ' HD2' ' HA ' ' A' ' 102' ' ' ASP . 28.8 ttpp -83.68 106.58 15.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.343 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.435 HG11 ' HE2' ' A' ' 27' ' ' TYR . 51.9 t -70.45 -54.01 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.226 0.536 . . . . 0.0 109.87 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 102' ' ' ASP . 2.8 t -124.84 -54.6 1.63 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.562 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.619 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 14.9 t70 -177.1 -72.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.638 ' HA ' ' HB3' ' A' ' 89' ' ' LYS . 6.7 m-20 -77.27 -3.97 42.51 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.041 0.448 . . . . 0.0 111.396 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.683 HG13 HD13 ' A' ' 158' ' ' LEU . 51.6 mm -106.41 122.55 60.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.66 128.32 43.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.238 0.542 . . . . 0.0 111.624 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 84' ' ' PHE . 63.3 tp -102.85 121.22 42.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.45 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.53 HG21 ' HB2' ' A' ' 111' ' ' ASP . 4.2 m -126.82 134.46 50.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.623 0.249 . . . . 0.0 110.435 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -147.34 3.26 0.77 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.237 0.542 . . . . 0.0 111.392 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.504 ' HB2' ' OD1' ' A' ' 111' ' ' ASP . 14.2 m -85.9 15.05 5.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.332 . . . . 0.0 111.667 -174.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.19 -23.37 35.63 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.53 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.563 ' HB3' HG22 ' A' ' 95' ' ' THR . 3.0 m-20 -51.34 -37.65 48.95 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.298 0.639 . . . . 0.0 111.545 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.44 HG11 HG12 ' A' ' 85' ' ' ILE . 60.1 t -47.98 -40.84 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.971 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.544 ' HA ' ' CE2' ' A' ' 116' ' ' PHE . 98.0 mt -62.88 -32.73 74.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.072 0.463 . . . . 0.0 110.933 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.18 -35.87 35.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.54 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.1 m -56.21 -50.34 71.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.811 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.544 ' CE2' ' HA ' ' A' ' 113' ' ' LEU . 40.7 p90 -79.64 11.57 3.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.588 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.92 16.56 13.37 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.855 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 76.7 p -111.63 177.7 4.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.373 . . . . 0.0 110.781 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -83.21 -26.45 30.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.61 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 p -96.88 20.8 10.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.432 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -51.21 136.61 29.62 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.542 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 23.6 Cg_exo -62.16 150.78 85.44 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.028 2.485 . . . . 0.0 112.613 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -59.58 -49.6 77.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.911 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -143.59 146.21 33.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.559 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -152.1 137.52 17.64 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.473 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.13 148.11 16.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.447 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.76 129.45 74.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.191 0.52 . . . . 0.0 110.905 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.436 ' SG ' HG11 ' A' ' 39' ' ' VAL . 5.7 p -126.27 124.75 41.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.398 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 129' ' ' LEU . 1.2 tm? -84.22 119.0 24.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.343 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.81 178.78 27.32 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.539 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.5 m -147.81 171.96 14.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.86 0.362 . . . . 0.0 110.046 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 37.6 m -111.57 121.24 44.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.104 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.8 p -96.76 115.33 27.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.174 0.511 . . . . 0.0 111.364 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -101.35 149.9 23.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.473 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 1.5 mppt? -86.78 130.28 49.34 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.778 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 7.5 Cg_exo -73.32 44.5 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.538 2.825 . . . . 0.0 114.335 -168.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -154.11 -39.23 0.09 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.369 . . . . 0.0 110.545 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.538 ' HA ' ' OE1' ' A' ' 138' ' ' GLN . 5.5 tp60 -75.79 -30.72 59.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.693 -175.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.432 ' O ' HG13 ' A' ' 143' ' ' ILE . 60.1 tp -57.87 -38.83 76.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.013 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.9 -42.12 97.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.041 0.448 . . . . 0.0 110.526 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.569 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 31.0 mm-40 -68.17 -39.24 82.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.437 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.627 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 14.1 mm-40 -62.03 -43.34 99.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.167 0.508 . . . . 0.0 110.486 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 150' ' ' LEU . 77.1 mt -65.26 -39.4 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.096 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.42 73.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.536 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 67.1 mt-30 -78.76 2.95 18.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.372 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 19.1 m120 67.18 15.51 10.04 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.345 0.658 . . . . 0.0 112.265 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.447 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 57.0 m-85 -79.94 -21.79 43.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.35 0.595 . . . . 0.0 109.769 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.627 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 97.5 m95 -127.29 114.82 18.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.707 175.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.83 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 24.7 mt -86.36 103.09 14.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.529 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.5 ' HB2' HD13 ' A' ' 143' ' ' ILE . 60.3 tp -86.87 132.96 33.67 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.345 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.9 m -156.75 152.44 26.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.176 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -91.18 153.99 19.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.111 0.481 . . . . 0.0 110.651 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.52 114.25 28.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.62 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.99 68.09 3.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.226 0.536 . . . . 0.0 109.919 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 65.5 -80.48 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.021 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -60.6 -42.92 97.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.857 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 11.8 m -54.24 -30.45 50.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.683 HD13 HG13 ' A' ' 104' ' ' ILE . 5.5 tt -62.68 -57.59 10.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.285 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -121.45 -23.13 5.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -170.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -100.2 -61.25 1.39 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.474 0.77 0 C-N-CA 124.184 0.994 . . . . 0.0 112.107 -174.012 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 120.844 0.354 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -59.91 -5.13 0.88 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.02 -29.27 70.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.896 0.379 . . . . 0.0 110.526 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -80.32 -24.09 40.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.474 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -59.43 -42.42 91.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.383 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -58.9 -31.68 68.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.158 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.5 tt -81.65 -46.43 14.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.549 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.158 -179.158 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 . . . . . 0 C--O 1.232 0.16 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.3 mt -129.4 -170.41 2.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.341 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 68.09 112.18 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.701 0.625 . . . . 0.0 110.892 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.29 3.58 65.04 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 12.6 mptt -106.22 171.24 7.45 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 153' ' ' ALA . 54.9 p90 -140.43 150.73 44.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.803 0.335 . . . . 0.0 110.443 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 pt -109.14 130.75 61.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.226 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.674 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 2.8 mp -76.99 131.41 34.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.099 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 24' ' ' THR . . . -57.66 137.26 56.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.973 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.063 179.707 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.197 0.522 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.565 ' HA ' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -75.17 55.84 0.77 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.021 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 p -173.4 113.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.865 HG22 ' HD1' ' A' ' 27' ' ' TYR . 44.2 mm -120.71 -83.97 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.938 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.865 ' HD1' HG22 ' A' ' 26' ' ' ILE . 9.9 p90 -173.31 170.21 4.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.049 0.452 . . . . 0.0 111.15 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 mm -102.52 121.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.955 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.2 m -76.97 -46.37 24.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.439 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -151.07 159.27 44.61 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 79.2 t60 -148.12 138.2 22.63 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -174.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 t30 77.87 164.84 0.23 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.22 0.95 . . . . 0.0 111.547 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 68.52 -71.61 0.11 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.675 0.79 . . . . 0.0 112.145 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -88.41 -26.08 22.34 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.79 -177.19 20.38 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.109 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' A' ' 134' ' ' TRP . 23.8 m -100.0 101.85 13.05 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 37' ' ' ILE . 4.5 mp -95.22 112.0 26.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.41 157.36 27.23 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.005 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 4.3 m -123.53 93.74 2.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.266 0.555 . . . . 0.0 110.295 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.452 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -128.56 8.15 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.156 -177.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 pt -80.92 -27.61 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.565 ' HB3' ' HA ' ' A' ' 24' ' ' THR . 13.5 t30 38.96 85.98 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.237 0.961 . . . . 0.0 112.84 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 6.6 t -143.66 112.2 5.4 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-O 121.252 0.549 . . . . 0.0 109.95 176.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 4.8 Cg_exo -76.97 152.57 31.93 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.213 1.942 . . . . 0.0 111.318 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 p -124.88 163.15 22.85 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.716 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -82.82 1.06 41.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.191 0.52 . . . . 0.0 110.743 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.68 HD21 HD21 ' A' ' 52' ' ' LEU . 54.7 tp -83.36 144.48 29.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.235 173.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.65 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 14.5 m -104.19 145.66 29.89 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.7 p -63.57 -33.36 61.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.573 HD23 HD12 ' A' ' 53' ' ' LEU . 90.3 mt -66.99 -33.06 74.76 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.571 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.65 ' HG3' ' HB2' ' A' ' 48' ' ' SER . 32.8 mt-10 -61.26 -43.34 99.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.242 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.68 HD21 HD21 ' A' ' 47' ' ' LEU . 96.4 mt -67.91 -33.38 74.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.303 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.573 HD12 HD23 ' A' ' 50' ' ' LEU . 94.0 mt -69.67 -42.07 74.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.9 m -62.22 -39.75 93.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.351 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -58.48 -39.89 81.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.383 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.9 mtt . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.123 -178.321 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.539 ' HB3' HD12 ' A' ' 50' ' ' LEU . 1.1 m-20 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 121.405 0.621 . . . . 0.0 111.953 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -152.18 90.88 1.55 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.1 ptm -71.15 140.48 50.57 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.378 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.731 HG21 HD23 ' A' ' 129' ' ' LEU . 11.0 p -108.21 149.79 11.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.621 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.4 mp -94.29 152.88 18.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.404 . . . . 0.0 110.12 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.74 124.93 34.6 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.38 -26.26 21.35 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.851 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.86 164.47 15.09 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.871 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.68 -18.71 22.04 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.473 2.115 . . . . 0.0 112.627 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.411 HG21 ' OG1' ' A' ' 133' ' ' THR . 42.8 t -90.13 133.34 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.232 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 65.77 27.9 11.05 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 110.205 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.42 -17.7 64.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.044 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.59 -10.69 60.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.501 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -125.43 144.49 50.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.055 0.455 . . . . 0.0 110.436 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.31 120.91 7.03 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -98.74 126.55 44.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.749 0.309 . . . . 0.0 110.233 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.5 mp -113.07 112.7 41.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.194 0.521 . . . . 0.0 109.987 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.3 t -94.25 114.65 31.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.147 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -116.33 148.93 40.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.53 -174.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 m -82.39 150.25 27.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.974 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 43.8 tttm -70.16 114.0 7.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.836 0.827 . . . . 0.0 111.551 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.523 HG21 ' HG3' ' A' ' 123' ' ' GLU . 3.2 m -135.28 11.58 3.53 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.641 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -160.13 -173.08 3.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.167 -164.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -158.86 27.23 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.666 173.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -103.58 169.3 8.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.386 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.6 p90 176.74 157.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.038 0.446 . . . . 0.0 111.558 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 p -102.83 -37.72 7.73 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 164.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -168.15 91.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.152 169.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.2 m -100.63 167.42 10.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.51 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 12.6 t80 -124.57 98.18 5.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.428 ' HA ' HG23 ' A' ' 105' ' ' THR . 86.3 tttt -73.27 108.37 6.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 -177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.3 -59.03 3.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.95 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 103' ' ' ASP . 58.5 p -117.14 -176.33 2.97 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.417 ' HA ' ' CE ' ' A' ' 99' ' ' LYS . 31.0 t70 -82.22 34.2 0.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.821 0.819 . . . . 0.0 109.701 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.597 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 12.9 t0 -158.12 -67.25 0.09 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.437 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.86 121.93 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.673 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 99' ' ' LYS . 24.0 m -134.6 134.17 40.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.956 -173.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 63.6 tp -84.73 132.82 34.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.137 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.546 ' HB ' HG13 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -136.63 143.84 43.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 107' ' ' THR . 14.6 t -179.88 21.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.949 0.404 . . . . 0.0 111.32 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.0 t -101.22 8.52 42.53 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.613 -0.679 . . . . 0.0 111.207 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.76 -30.03 6.58 Favored Glycine 0 CA--C 1.509 -0.296 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -45.28 -50.39 11.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.411 -0.894 . . . . 0.0 111.407 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.546 HG13 ' HB ' ' A' ' 107' ' ' THR . 17.5 m -47.81 -45.06 11.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.904 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.19 -30.8 69.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.422 . . . . 0.0 110.789 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -77.99 -33.74 51.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.576 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.0 m -60.66 -62.86 1.55 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.403 -174.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -74.3 -2.77 26.53 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.797 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -96.26 3.67 64.19 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.222 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 120' ' ' THR . 12.4 t -138.89 171.82 13.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -82.26 4.92 21.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.661 0.267 . . . . 0.0 111.49 -175.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.457 ' H ' HG23 ' A' ' 118' ' ' THR . 69.2 p -102.97 15.73 28.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.906 0.384 . . . . 0.0 110.816 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -58.17 141.04 82.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.017 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 19.7 Cg_exo -65.16 146.01 85.74 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.763 2.308 . . . . 0.0 111.986 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.523 ' HG3' HG21 ' A' ' 90' ' ' THR . 38.1 mt-10 -65.4 -37.76 87.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.482 -176.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 123' ' ' GLU . 12.1 mtmt -128.41 132.15 48.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.353 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -163.55 147.53 10.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.447 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.1 pt -126.47 143.74 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.979 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.573 HG13 HG23 ' A' ' 72' ' ' VAL . 6.4 p -114.78 129.4 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.054 0.454 . . . . 0.0 110.588 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.8 p -134.73 136.08 42.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.382 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.731 HD23 HG21 ' A' ' 72' ' ' VAL . 4.0 mm? -86.52 120.99 28.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.356 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.76 -179.15 38.35 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.704 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 61.2 m -145.65 167.49 22.98 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 33.9 m -102.4 122.73 44.86 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 36' ' ' THR . 39.5 p -107.46 120.35 41.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.043 0.449 . . . . 0.0 112.162 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.622 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 1.5 m-90 -96.02 144.75 26.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.316 170.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 138' ' ' GLN . 12.0 mptt -65.05 156.02 82.03 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.394 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.1 133.95 40.55 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.144 1.896 . . . . 0.0 110.642 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.454 ' HA ' ' CG ' ' A' ' 140' ' ' GLU . 49.4 m80 63.74 29.5 14.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.242 0.544 . . . . 0.0 111.325 -175.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 55.5 tp60 -106.29 -68.89 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.225 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.506 ' O ' HG13 ' A' ' 143' ' ' ILE . 52.4 tp -63.14 -47.06 84.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.784 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 137' ' ' HIS . 10.9 pt-20 -58.44 -34.21 70.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.63 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -65.77 -51.17 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.726 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -71.85 -29.85 64.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.36 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' A' ' 148' ' ' TRP . 71.5 mt -61.07 -43.59 96.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.44 -30.32 71.1 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.63 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 42.8 mt-30 -81.16 5.46 16.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.365 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 71.93 30.97 2.14 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.309 0.643 . . . . 0.0 112.369 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -93.84 -3.82 51.21 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.165 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.595 ' HB2' HG12 ' A' ' 143' ' ' ILE . 96.0 m95 -139.43 160.64 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.268 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.674 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 3.1 tt -113.08 118.62 35.27 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 8' ' ' LYS . 35.5 tp -105.08 148.58 26.66 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.994 0.425 . . . . 0.0 111.707 -175.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.5 t -159.69 166.84 29.74 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -106.24 154.1 21.21 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.983 -178.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . . . -120.9 151.78 39.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.57 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -115.41 -61.15 1.78 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.522 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 103' ' ' ASP . 24.8 p-10 -170.8 -59.67 0.02 OUTLIER 'General case' 0 C--O 1.235 0.316 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 45.6 mt-30 -56.94 -41.94 79.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -173.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.463 ' HA ' ' OG1' ' A' ' 161' ' ' THR . 21.4 m -55.56 -32.87 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.37 -51.98 4.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -99.37 -23.34 15.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 39.5 mt-10 -111.83 -25.75 9.29 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -166.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 169' ' ' GLU . 34.0 m . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -174.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t . . . . . 0 N--CA 1.468 0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.536 ' HG3' HG21 ' A' ' 161' ' ' THR . 0.0 OUTLIER -118.16 -41.19 2.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.842 178.505 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.77 -43.87 94.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.662 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -76.5 -26.32 55.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 0.0 110.344 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.34 -29.55 66.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.936 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.0 tpt -60.59 -32.65 71.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.116 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.542 HD13 HD21 ' A' ' 149' ' ' LEU . 13.0 tp -77.35 -42.68 35.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.908 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.698 178.878 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 p30 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.236 0.541 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.03 -93.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.205 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 65.15 117.07 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.191 0.52 . . . . 0.0 111.46 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.97 -4.27 74.7 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.391 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 2.3 mptp? -105.58 163.79 12.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.543 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 48.7 p90 -140.7 149.52 42.3 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.221 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.584 HD11 HG13 ' A' ' 40' ' ' ILE . 16.4 pt -98.17 145.01 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.43 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.727 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 45.1 mm -81.68 95.62 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.506 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -102.94 -44.93 5.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.757 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.47 0.57 0 C-N-CA 123.7 0.8 . . . . 0.0 111.224 -177.026 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.93 0.395 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 42' ' ' ASN . 33.6 p -92.48 131.53 37.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.329 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.0 t 74.25 82.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 O-C-N 123.885 0.741 . . . . 0.0 111.28 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.887 HG22 ' H ' ' A' ' 27' ' ' TYR . 16.3 mm -107.76 -166.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.887 ' H ' HG22 ' A' ' 26' ' ' ILE . 7.2 p90 -114.86 175.18 5.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.521 0.6 . . . . 0.0 111.683 -167.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.9 mm -86.13 112.55 22.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.358 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.9 -55.2 28.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.386 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -144.17 127.48 16.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.868 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -108.89 99.68 8.99 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 158.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -112.31 59.72 0.63 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.896 -166.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t70 63.2 -66.76 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.97 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.46 -39.45 11.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.75 147.57 17.07 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.886 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 133' ' ' THR . 26.2 m -133.79 102.73 5.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.494 HG13 HG22 ' A' ' 133' ' ' THR . 4.5 mp -111.02 121.77 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.32 -174.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.46 162.48 29.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.92 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 5.7 m -125.81 91.2 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.27 0.557 . . . . 0.0 110.215 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.584 HG13 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -135.85 16.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.9 pt -80.92 -20.89 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.247 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.408 ' HB3' HG22 ' A' ' 24' ' ' THR . 46.1 m-20 61.15 47.93 6.75 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 167.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t -146.06 133.98 10.54 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.431 -177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 61.9 Cg_endo -73.89 165.44 32.14 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.973 2.449 . . . . 0.0 112.366 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.542 HG22 ' ND2' ' A' ' 74' ' ' ASN . 31.1 p -99.54 -166.2 1.32 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.966 0.413 . . . . 0.0 110.034 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.5 12.37 27.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.885 0.85 . . . . 0.0 108.848 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.9 tp -109.86 146.84 34.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.586 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 19.7 m -95.81 149.2 21.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.676 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.4 p -63.9 -30.47 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.297 0.57 . . . . 0.0 109.998 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.19 -26.65 59.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.367 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.0 OUTLIER -68.67 -40.67 80.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.377 -176.29 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.668 HD22 HD21 ' A' ' 129' ' ' LEU . 3.9 pp -71.78 -30.51 65.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.064 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 88.5 mt -66.3 -48.42 70.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.323 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.0 p -61.0 -30.24 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.195 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -72.62 -52.8 13.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.505 0.193 . . . . 0.0 110.685 -179.404 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 49' ' ' VAL . 30.0 mm-40 -96.38 125.92 41.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.431 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 66.5 mtt -84.43 149.88 25.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.362 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.621 HG21 HD23 ' A' ' 129' ' ' LEU . 12.7 p -100.58 150.23 5.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.725 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 7.0 mp -99.74 164.41 12.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.255 0.55 . . . . 0.0 111.678 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.542 ' ND2' HG22 ' A' ' 45' ' ' THR . 47.9 m-80 -81.84 124.43 29.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.705 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.89 -27.6 37.4 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.601 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.412 ' HA3' ' C ' ' A' ' 131' ' ' CYS . . . 168.98 175.11 38.11 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -86.51 3.24 6.9 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.948 2.432 . . . . 0.0 112.511 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.06 121.25 61.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.238 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.3 m120 55.83 56.49 6.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.009 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.465 ' O ' HD12 ' A' ' 129' ' ' LEU . 84.3 mt-30 -70.93 -7.5 46.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.682 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.89 -10.02 58.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.262 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -112.26 131.36 55.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.939 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.41 117.75 5.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.807 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.524 ' HB3' HD11 ' A' ' 106' ' ' LEU . 71.9 m-85 -102.6 126.08 49.55 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.413 HG21 HG21 ' A' ' 112' ' ' VAL . 4.4 mp -119.88 107.77 21.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 0.0 110.544 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.717 HG22 HD13 ' A' ' 106' ' ' LEU . 12.5 t -91.8 120.66 41.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -134.9 158.83 43.25 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.441 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.5 t -76.21 167.86 21.1 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.146 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER -76.25 114.76 15.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.831 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.755 HG21 ' HA ' ' A' ' 122' ' ' PRO . 1.5 p -116.3 -2.94 12.01 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.013 172.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 92' ' ' HIS . 17.1 t70 -175.68 -145.79 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.515 ' H ' ' CG ' ' A' ' 91' ' ' ASP . 37.4 m80 -88.48 -159.68 0.58 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.609 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 4.1 mp0 -76.19 169.93 17.26 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -117.48 -161.0 0.8 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.6 m -59.9 -37.45 79.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.623 0.249 . . . . 0.0 111.566 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -152.79 80.98 1.22 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.141 0.496 . . . . 0.0 110.342 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 75.0 m -133.77 143.89 48.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.479 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -102.21 128.41 48.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.293 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.609 ' HD3' ' HG3' ' A' ' 93' ' ' GLU . 5.1 tptm -90.65 110.36 21.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.9 t -81.3 -71.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.054 0.454 . . . . 0.0 110.461 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 t -130.48 67.07 1.49 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.481 0.658 . . . . 0.0 110.758 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' HE2' ' A' ' 99' ' ' LYS . 28.1 t70 66.78 -69.83 0.12 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.412 176.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.624 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 11.0 t70 -77.74 -55.43 5.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.228 0.537 . . . . 0.0 110.019 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.415 HD12 ' CD1' ' A' ' 159' ' ' PHE . 33.0 mm -64.93 122.78 16.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.452 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.1 m -128.75 131.09 47.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.837 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.717 HD13 HG22 ' A' ' 86' ' ' VAL . 55.4 tp -107.75 112.61 25.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.083 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.5 m -96.6 124.77 40.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.414 HG22 ' CD2' ' A' ' 84' ' ' PHE . 60.2 p -107.36 17.1 23.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.1 m -147.7 -177.19 5.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.741 0.305 . . . . 0.0 111.184 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.44 -3.01 23.66 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.391 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -49.31 -32.8 11.77 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.961 0.905 . . . . 0.0 110.999 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.413 HG21 HG21 ' A' ' 85' ' ' ILE . 10.3 p -54.71 -34.68 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.972 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.73 -37.71 79.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.176 0.512 . . . . 0.0 110.492 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.28 -24.03 63.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.723 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -72.29 -18.29 61.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.213 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -97.01 144.93 26.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 0.0 110.767 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.26 -17.76 21.73 Favored Glycine 0 C--N 1.328 0.124 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.822 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 p -92.03 25.78 2.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 74.01 -39.82 0.44 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.607 0.763 . . . . 0.0 111.351 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.9 p -81.17 18.42 1.08 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.46 123.64 67.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.76 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.755 ' HA ' HG21 ' A' ' 90' ' ' THR . 29.7 Cg_endo -64.31 136.26 50.42 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.628 2.219 . . . . 0.0 112.862 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -66.71 -47.65 71.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.136 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -124.39 127.76 48.04 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.178 -174.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -155.9 152.36 28.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.51 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.8 pt -129.45 132.46 66.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.156 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.528 HG13 HG23 ' A' ' 72' ' ' VAL . 6.8 p -112.09 134.59 54.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.193 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 84.0 m -140.24 139.65 35.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.066 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.668 HD21 HD22 ' A' ' 52' ' ' LEU . 4.3 mm? -89.84 118.44 29.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.962 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.47 177.82 44.6 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.057 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.412 ' C ' ' HA3' ' A' ' 76' ' ' GLY . 73.5 m -145.6 171.58 14.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.904 0.383 . . . . 0.0 110.048 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.472 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 19.3 m -100.26 115.59 30.26 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 36' ' ' THR . 44.0 p -108.35 134.74 50.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.774 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.691 ' CD1' ' HB2' ' A' ' 139' ' ' LEU . 1.1 m-90 -119.9 165.02 15.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.302 0.572 . . . . 0.0 110.343 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -91.61 140.73 25.29 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.603 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.36 61.28 4.19 Favored 'Trans proline' 0 N--CA 1.473 0.313 0 C-N-CA 123.269 2.646 . . . . 0.0 113.298 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -167.73 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.592 ' HG3' ' OE2' ' A' ' 142' ' ' GLU . 52.2 tp60 -65.77 -68.36 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.377 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.691 ' HB2' ' CD1' ' A' ' 134' ' ' TRP . 55.8 tp -52.77 -42.02 64.6 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.887 0.375 . . . . 0.0 111.721 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.54 -32.85 71.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.078 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.597 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 25.3 mt-30 -72.31 -45.62 59.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.07 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.73 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 1.1 mp0 -54.42 -41.91 69.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.768 0.318 . . . . 0.0 111.199 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 139' ' ' LEU . 86.3 mt -56.91 -42.61 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.147 0.498 . . . . 0.0 110.538 175.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.46 -20.57 63.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.658 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.597 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 38.1 mt-30 -88.82 6.39 39.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.954 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 145' ' ' GLN . 14.0 m120 69.15 13.24 8.65 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.549 0.53 . . . . 0.0 111.233 -178.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -81.6 -21.86 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.714 0.768 . . . . 0.0 109.004 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.73 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 99.3 m95 -133.26 131.18 39.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.861 172.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.727 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 98.8 mt -95.64 155.3 16.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.5 tp -127.61 135.13 49.85 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.776 0.322 . . . . 0.0 111.039 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.1 t -141.04 176.84 8.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 8' ' ' LYS . 33.0 mt-10 -125.69 153.85 43.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.584 0.23 . . . . 0.0 110.882 -175.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.33 124.19 18.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.962 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -89.52 -45.07 9.67 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.103 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -172.65 -60.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.625 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 44.6 mt-30 -53.89 -48.96 69.56 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.347 -172.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.9 m -59.33 -28.35 66.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.855 0.359 . . . . 0.0 111.913 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.22 -53.84 4.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.415 ' CD1' HD12 ' A' ' 104' ' ' ILE . 34.5 m-85 -127.15 12.84 7.17 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -170.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 21.2 tt0 -109.83 -50.93 2.93 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.188 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 121.395 0.617 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -80.12 -2.28 43.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.491 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.415 ' HB1' HD12 ' A' ' 11' ' ' ILE . . . -51.78 -39.58 58.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -172.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -81.03 -37.16 29.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.084 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.16 -38.35 60.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.011 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 14.6 tpt -63.95 -27.8 69.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.277 0.561 . . . . 0.0 110.328 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.48 -35.31 40.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.132 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.405 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.086 -179.404 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 C--O 1.233 0.226 0 CA-C-O 121.162 0.506 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.455 HD13 HG13 ' A' ' 28' ' ' ILE . 97.3 mt -78.56 -92.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.516 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 39.63 84.52 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.563 0.745 . . . . 0.0 112.421 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.61 -9.57 12.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.461 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.437 ' HG3' ' HG3' ' A' ' 152' ' ' GLU . 10.4 mptt -107.19 172.46 6.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -129.29 143.1 50.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.008 0.432 . . . . 0.0 110.269 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 9.3 pt -107.03 127.33 62.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.224 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.923 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.3 mp -92.63 107.8 19.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.672 -174.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.618 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -91.19 -45.36 8.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.705 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.597 -175.031 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.444 ' HA ' HD21 ' A' ' 42' ' ' ASN . 3.7 p -63.65 83.16 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -173.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.743 HG13 ' HB ' ' A' ' 40' ' ' ILE . 51.7 t 62.24 100.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 O-C-N 123.792 0.683 . . . . 0.0 112.136 173.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.644 ' CG2' HG23 ' A' ' 39' ' ' VAL . 11.3 tp -89.58 -141.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.919 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.557 ' H ' HG13 ' A' ' 26' ' ' ILE . 2.8 p90 -115.75 175.0 5.73 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.718 1.144 . . . . 0.0 112.442 -163.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.455 HG13 HD13 ' A' ' 5' ' ' LEU . 49.8 mm -90.24 120.91 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.823 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.0 m -87.36 -38.21 16.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -171.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.929 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 9.3 tp10 -141.15 155.18 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.84 0.352 . . . . 0.0 110.998 -173.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -146.18 104.36 3.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.85 170.09 8.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.317 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -62.76 -22.01 66.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.165 0.507 . . . . 0.0 111.031 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.23 5.61 25.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.108 -173.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.581 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 161.68 161.12 11.48 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.587 -1.292 . . . . 0.0 113.546 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.7 m -108.55 128.72 55.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.929 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.5 mp -106.47 117.69 52.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.746 -173.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.72 165.42 26.85 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.644 HG23 ' CG2' ' A' ' 26' ' ' ILE . 2.5 m -118.74 44.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.518 0.675 . . . . 0.0 110.616 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.743 ' HB ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -95.31 19.04 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.071 -175.309 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.6 tp -76.83 -31.73 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.658 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.444 HD21 ' HA ' ' A' ' 24' ' ' THR . 3.1 m120 58.07 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.163 0.585 . . . . 0.0 112.226 -175.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -171.15 107.69 0.4 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 121.539 0.685 . . . . 0.0 110.313 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 6.5 Cg_exo -74.42 154.03 45.23 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.595 2.197 . . . . 0.0 111.209 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.3 p -127.73 158.43 37.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.884 0.373 . . . . 0.0 111.231 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.58 10.76 2.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.641 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.9 tp -86.09 146.08 26.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.8 t -99.0 149.57 22.85 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.704 0.288 . . . . 0.0 110.687 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 8.8 p -63.8 -26.02 39.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.25 0.548 . . . . 0.0 109.916 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.38 -27.54 59.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.312 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.25 -31.46 60.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.64 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.2 pp -72.67 -26.08 61.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.149 0.499 . . . . 0.0 109.745 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 113' ' ' LEU . 87.8 mt -75.42 -42.56 53.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.886 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.4 p -68.24 -30.93 70.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -73.55 -11.41 60.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.3 mtt . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 172.107 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.994 0.426 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.495 ' HB2' HG12 ' A' ' 49' ' ' VAL . 25.6 mm-40 -94.16 104.07 16.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.914 -178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 87.8 mtp -78.86 142.75 36.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.633 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 127' ' ' VAL . 12.6 p -98.96 149.66 5.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.183 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.8 mp -99.52 158.97 15.37 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.051 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.54 132.92 44.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 175.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.619 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -91.3 -12.52 59.8 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.353 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.23 174.89 30.59 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.098 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.06 -10.26 15.23 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.171 2.581 . . . . 0.0 112.944 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.07 122.55 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.05 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 64.92 46.52 2.86 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.461 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.428 ' O ' HD12 ' A' ' 129' ' ' LEU . 49.7 mt-30 -67.12 -10.3 48.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.98 -3.01 58.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.91 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -113.21 115.95 29.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.954 0.407 . . . . 0.0 110.69 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.84 115.49 4.99 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -96.5 126.17 41.5 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.21 103.91 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.002 0.429 . . . . 0.0 109.977 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.702 HG22 ' HB3' ' A' ' 106' ' ' LEU . 31.1 t -93.13 124.74 45.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.557 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -135.09 164.61 27.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.864 0.364 . . . . 0.0 111.654 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 124' ' ' LYS . 14.6 m -70.36 160.67 31.86 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.196 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 23.4 tptm -76.72 121.31 23.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.374 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -107.5 -67.04 0.98 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -164.72 -172.1 2.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 171.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.56 93.61 4.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -104.36 -175.9 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.934 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -72.24 97.34 1.97 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.283 -172.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.488 HG22 ' HB3' ' A' ' 111' ' ' ASP . 20.9 p -145.01 142.27 29.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.442 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -88.65 80.68 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 172.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.492 ' HB3' HG22 ' A' ' 105' ' ' THR . 15.7 m -116.46 150.93 37.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.233 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -104.83 139.53 39.46 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -101.57 116.0 31.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.76 -53.65 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 167.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.503 HG22 ' HB ' ' A' ' 104' ' ' ILE . 10.2 t -137.6 -166.18 1.9 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 169.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -83.32 -22.27 32.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 118.566 0.621 . . . . 0.0 111.023 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 28.7 m-20 -101.16 -11.66 19.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.623 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.503 ' HB ' HG22 ' A' ' 101' ' ' THR . 42.1 mm -120.72 122.67 68.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 97' ' ' SER . 29.7 m -145.77 130.6 18.12 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.787 0.327 . . . . 0.0 111.167 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.702 ' HB3' HG22 ' A' ' 86' ' ' VAL . 1.1 pt? -108.21 132.69 53.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.477 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 109' ' ' SER . 50.3 m -96.06 129.36 43.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.105 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 p -107.0 21.13 18.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.031 0.443 . . . . 0.0 111.588 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.473 ' H ' HG22 ' A' ' 107' ' ' THR . 22.7 t -147.0 175.15 10.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.328 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.08 -0.0 49.41 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 113.004 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.488 ' HB3' HG22 ' A' ' 95' ' ' THR . 67.9 m-20 -56.22 -33.43 65.35 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.659 0.742 . . . . 0.0 110.514 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 p -52.25 -33.81 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.232 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.555 HD11 HD22 ' A' ' 53' ' ' LEU . 16.9 mt -73.02 -31.82 64.72 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.849 0.357 . . . . 0.0 111.171 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.21 -36.03 82.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.015 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -79.94 -2.93 45.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.213 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.35 146.54 23.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 111.046 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.42 -24.83 30.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.323 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 p -87.57 -175.5 5.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.787 0.327 . . . . 0.0 110.795 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -75.84 -16.46 60.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.284 0.564 . . . . 0.0 109.758 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.6 p -91.89 8.86 35.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.479 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.457 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -76.91 114.45 39.48 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.686 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 14.0 Cg_exo -69.09 130.17 19.67 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.806 2.338 . . . . 0.0 111.926 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.45 -36.92 85.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.977 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.494 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 13.5 mmtp -103.65 100.54 10.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.465 -171.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 35.2 p90 -138.29 130.9 29.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.047 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.4 pt -116.84 132.86 65.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 72' ' ' VAL . 7.7 p -115.24 129.22 71.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.263 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 84.8 m -136.63 136.6 39.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.479 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 72' ' ' VAL . 4.2 mm? -90.51 114.36 26.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.653 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.27 173.64 42.18 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.533 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.3 m -147.14 169.97 18.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.795 0.331 . . . . 0.0 110.436 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.8 m -105.11 122.5 46.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.246 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.692 HG22 HG13 ' A' ' 37' ' ' ILE . 30.5 p -100.94 123.63 45.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.402 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -105.63 153.44 21.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.183 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -73.94 138.03 76.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.867 0.365 . . . . 0.0 111.262 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.581 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 36.3 Cg_endo -65.52 136.72 47.66 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.872 2.381 . . . . 0.0 111.69 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.714 ' HA ' ' CD ' ' A' ' 140' ' ' GLU . 81.3 m-70 64.98 13.76 8.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.876 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 26.7 tt0 -108.21 -54.68 2.47 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 171.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 143' ' ' ILE . 66.3 tp -57.79 -41.17 81.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.718 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.714 ' CD ' ' HA ' ' A' ' 137' ' ' HIS . 7.0 pt-20 -59.1 -38.15 78.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -76.39 -30.78 57.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.71 0.291 . . . . 0.0 110.806 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 9.5 mm-40 -61.51 -41.5 97.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.0 110.035 175.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.592 ' HA ' ' HB2' ' A' ' 148' ' ' TRP . 76.2 mt -58.61 -40.44 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.629 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.44 65.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.895 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -82.44 -1.08 49.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.946 -0.115 . . . . 0.0 111.041 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 71.3 11.58 6.74 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.713 0.633 . . . . 0.0 110.126 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -77.1 -24.65 51.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.927 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.618 ' CZ3' ' HB2' ' A' ' 12' ' ' ALA . 95.3 m95 -130.49 138.98 50.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.018 174.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.923 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 98.3 mt -100.91 157.7 16.53 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.8 tp -129.55 134.37 47.71 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.667 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.1 t -154.47 143.28 20.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.465 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.437 ' HG3' ' HG3' ' A' ' 8' ' ' LYS . 4.6 mp0 -73.13 154.63 40.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.44 -26.78 24.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.998 0.427 . . . . 0.0 110.509 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.4 m120 55.59 21.92 4.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.009 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 70.59 -51.47 0.67 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.435 0.694 . . . . 0.0 111.815 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.443 ' HA ' ' CB ' ' A' ' 160' ' ' GLU . 36.2 mt-30 -64.14 -50.02 69.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.098 -173.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.7 m -61.84 -29.45 70.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.109 0.48 . . . . 0.0 110.69 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.38 -57.76 3.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.907 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -120.99 -38.18 2.86 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.443 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 26.3 tt0 -56.87 -58.23 9.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.775 0.321 . . . . 0.0 111.238 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 CA--C 1.535 0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.924 -173.155 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.638 0.733 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -104.74 -37.34 7.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.071 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.73 -47.0 83.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.492 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -71.95 -30.9 65.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.791 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 175' ' ' GLY . 31.8 tt0 -68.07 -31.56 71.28 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.683 0.278 . . . . 0.0 110.714 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.502 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 20.1 mmt -58.73 -28.68 66.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.977 0.418 . . . . 0.0 110.858 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.4 tp -96.74 -57.73 2.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.696 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 172' ' ' GLU . . . . . . . . 0 N--CA 1.443 -0.85 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 31' ' ' HIS . 54.7 t30 . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.3 mt -123.89 -83.29 0.65 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.588 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 63.76 152.51 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.776 0.798 . . . . 0.0 111.713 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.37 23.71 70.29 Favored Glycine 0 C--N 1.316 -0.558 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.907 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.556 ' NZ ' ' HG3' ' A' ' 152' ' ' GLU . 71.0 mmtt -110.75 164.83 12.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 29.3 p90 -144.13 153.24 41.94 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 172.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.549 ' O ' HG21 ' A' ' 25' ' ' VAL . 4.5 pt -117.72 127.03 75.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.046 0.451 . . . . 0.0 111.098 -176.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.714 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 53.8 mt -94.41 112.95 28.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.287 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 148' ' ' TRP . . . -158.7 124.1 4.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.318 172.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--N 1.32 -0.693 0 CA-C-O 121.108 0.48 . . . . 0.0 110.898 -177.65 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HD3' ' HA ' ' A' ' 23' ' ' ARG . 32.9 mmt180 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 121.503 0.668 . . . . 0.0 111.756 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.649 ' O ' HG22 ' A' ' 25' ' ' VAL . 32.0 p -96.61 89.96 5.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.498 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.77 HG12 HD21 ' A' ' 42' ' ' ASN . 1.9 m 62.51 174.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.427 1.091 . . . . 0.0 111.911 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.541 HG13 ' H ' ' A' ' 27' ' ' TYR . 11.1 tp -156.22 -142.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.541 ' H ' HG13 ' A' ' 26' ' ' ILE . 1.1 p90 -109.49 170.08 8.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 119.552 1.069 . . . . 0.0 112.277 -163.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.83 126.87 49.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.617 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 55.6 m -78.49 -59.28 2.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.39 159.89 33.96 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.454 0.645 . . . . 0.0 111.742 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.448 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 39.0 t60 -144.13 142.0 30.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.355 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.4 t30 83.88 177.98 0.05 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.553 1.158 . . . . 0.0 109.091 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 t70 68.24 -76.2 0.06 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.22 0.608 . . . . 0.0 110.893 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.489 ' HB3' HD11 ' A' ' 37' ' ' ILE . 8.4 t30 -93.18 -34.44 13.61 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.49 -110.11 0.44 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.181 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 133' ' ' THR . 11.0 m -136.32 105.25 5.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 133' ' ' THR . 4.1 mp -98.97 112.02 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.444 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.67 170.22 31.16 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.517 HG23 ' CG2' ' A' ' 26' ' ' ILE . 2.8 m -120.58 76.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.649 0.737 . . . . 0.0 111.004 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.501 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -121.9 20.91 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 -176.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.419 HG23 HG22 ' A' ' 43' ' ' THR . 10.1 tp -73.05 -24.11 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.033 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.77 HD21 HG12 ' A' ' 25' ' ' VAL . 86.6 m-20 53.63 82.87 0.08 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.274 0.63 . . . . 0.0 112.299 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 6.5 t -172.81 113.45 0.36 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.433 0.635 . . . . 0.0 110.881 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 50.9 Cg_endo -71.94 153.92 58.17 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.078 1.852 . . . . 0.0 110.482 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.431 HG22 HD22 ' A' ' 74' ' ' ASN . 11.2 p -96.65 169.93 9.55 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.773 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.33 5.88 11.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.91 161.31 17.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 57.6 p -116.4 160.89 19.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.337 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 12.5 p -67.72 -32.89 58.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.966 0.412 . . . . 0.0 110.361 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.553 HD23 HD12 ' A' ' 53' ' ' LEU . 59.6 mt -73.82 -32.02 63.52 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.993 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -57.46 -53.33 59.38 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.15 -43.83 70.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.237 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.553 HD12 HD23 ' A' ' 50' ' ' LEU . 80.9 mt -62.3 -45.56 92.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.267 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.8 p -73.47 -32.88 64.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.056 0.455 . . . . 0.0 111.314 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -67.74 -34.65 77.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.944 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 47.3 mtt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.203 178.769 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.266 0.555 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -99.85 129.66 45.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.665 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 91.5 mtp -75.85 136.12 40.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.236 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 129' ' ' LEU . 14.0 p -88.98 141.48 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 7.4 mp -95.98 161.56 13.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.235 0.541 . . . . 0.0 111.099 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.431 HD22 HG22 ' A' ' 45' ' ' THR . 2.0 t-20 -92.37 132.71 36.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.941 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -88.22 -25.37 31.45 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.263 -0.97 . . . . 0.0 111.908 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.42 176.72 27.04 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.93 -17.84 22.12 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.971 2.447 . . . . 0.0 112.67 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.9 t -98.7 143.95 12.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.045 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.95 31.76 15.99 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.975 0.51 . . . . 0.0 112.052 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -71.56 -10.12 59.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -80.7 -0.12 36.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.349 . . . . 0.0 110.262 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -122.49 133.77 54.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.607 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.23 110.42 3.63 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.516 ' HB3' HD11 ' A' ' 106' ' ' LEU . 93.7 m-85 -92.35 124.85 36.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.694 0.283 . . . . 0.0 110.322 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 112' ' ' VAL . 2.7 mp -121.56 112.63 36.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.409 0.623 . . . . 0.0 110.224 177.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 66.0 t -90.74 110.96 22.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.198 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -137.28 165.01 27.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.704 0.287 . . . . 0.0 111.569 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.7 p -81.75 159.46 23.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.004 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 90' ' ' THR . 58.5 tttm -87.47 140.73 29.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.931 0.396 . . . . 0.0 110.144 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -95.06 -170.71 2.25 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.341 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.417 ' H ' HG22 ' A' ' 90' ' ' THR . 6.7 p-10 -64.2 -35.09 79.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.157 0.503 . . . . 0.0 110.118 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -83.4 163.54 20.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.684 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.44 -172.38 4.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.08 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -132.14 162.72 30.18 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.8 m -80.96 -47.0 14.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.876 0.37 . . . . 0.0 110.515 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.473 ' O ' HG23 ' A' ' 107' ' ' THR . 13.0 t-160 -145.28 97.29 2.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.692 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.432 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 66.7 m -135.56 152.72 51.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.044 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -101.66 114.39 28.4 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 102' ' ' ASP . 88.3 tttt -78.14 102.33 7.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 0.0 110.727 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.438 HG11 ' HE2' ' A' ' 27' ' ' TYR . 40.3 t -86.11 -53.83 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.57 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.42 ' HB ' ' ND2' ' A' ' 155' ' ' ASN . 36.8 p -116.01 176.67 4.99 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 4.8 t70 -86.32 52.32 2.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.264 0.554 . . . . 0.0 110.289 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.6 t70 177.65 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.891 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.503 HG21 HD13 ' A' ' 158' ' ' LEU . 48.1 mm -90.3 124.38 42.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.123 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 97' ' ' SER . 0.5 OUTLIER -121.36 139.14 53.82 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.443 -176.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 84' ' ' PHE . 65.5 tp -101.12 112.41 24.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.274 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 96' ' ' HIS . 18.8 m -99.93 130.33 46.09 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.238 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -114.18 10.88 17.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.074 -174.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.0 m -132.19 -177.46 4.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.254 . . . . 0.0 110.926 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.458 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -70.7 4.85 8.48 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.688 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.454 ' HB3' HG21 ' A' ' 107' ' ' THR . 17.4 t0 -61.13 -29.54 69.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.331 0.586 . . . . 0.0 109.451 174.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.539 HG21 HD13 ' A' ' 85' ' ' ILE . 47.0 t -57.48 -39.42 68.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.732 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.509 HD13 ' CZ ' ' A' ' 116' ' ' PHE . 4.1 mm? -61.6 -32.51 72.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.594 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -81.87 -32.89 30.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.952 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 47.4 m -57.99 -51.93 67.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.415 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.517 ' HA ' ' HB1' ' A' ' 121' ' ' ALA . 10.7 p90 -92.73 8.89 37.35 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.746 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -104.81 37.02 4.01 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.62 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 t -151.47 165.46 34.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -67.81 -22.58 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.133 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 p -104.71 42.3 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.246 0.546 . . . . 0.0 110.832 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.517 ' HB1' ' HA ' ' A' ' 116' ' ' PHE . . . -64.19 140.58 97.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.093 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 12.2 Cg_exo -68.95 124.04 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.337 2.025 . . . . 0.0 111.025 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.66 -28.35 58.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.743 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -105.88 105.36 15.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.061 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 46.4 p90 -157.24 146.3 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.159 0.504 . . . . 0.0 111.587 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.7 142.83 39.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.566 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.18 131.7 66.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.903 0.382 . . . . 0.0 111.11 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 77.6 m -142.98 141.1 31.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.414 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.542 HD23 HG21 ' A' ' 72' ' ' VAL . 4.1 mm? -94.02 119.25 32.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.255 177.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.502 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 78.35 -179.86 51.52 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.476 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.4 m -147.99 169.31 20.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.906 0.384 . . . . 0.0 110.005 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.839 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 30.2 m -106.85 126.96 52.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.779 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 36' ' ' THR . 39.4 p -114.49 119.69 37.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.425 0.631 . . . . 0.0 112.136 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.839 ' HZ3' ' HB3' ' A' ' 132' ' ' SER . 1.3 m-90 -99.94 136.27 40.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.025 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -83.23 147.54 53.84 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.315 -175.245 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 137' ' ' HIS . 21.6 Cg_exo -66.55 73.82 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.656 2.904 . . . . 0.0 112.736 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 136' ' ' PRO . 17.4 p-80 167.17 -23.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.652 1.181 . . . . 0.0 108.083 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.585 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 63.0 tt0 -84.68 -67.35 0.8 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.51 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 134' ' ' TRP . 51.2 tp -60.52 -44.88 95.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.114 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -61.18 -42.13 98.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.741 -0.208 . . . . 0.0 111.429 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.585 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.6 mp0 -68.44 -35.58 77.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.636 0.255 . . . . 0.0 110.676 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 8.6 mm-40 -64.01 -46.51 84.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.268 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.659 HG12 ' HB2' ' A' ' 148' ' ' TRP . 68.6 mt -62.07 -41.17 90.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.581 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.52 81.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.459 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.585 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 40.6 mt-30 -82.46 7.11 15.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 67.03 37.14 3.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.834 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -83.98 -48.15 10.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.134 0.492 . . . . 0.0 109.893 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.659 ' HB2' HG12 ' A' ' 143' ' ' ILE . 96.7 m95 -107.37 130.18 54.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.486 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.714 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.9 tt -91.21 103.3 15.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 8' ' ' LYS . 55.2 tp -82.66 133.68 35.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.022 0.439 . . . . 0.0 111.198 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.8 m -145.32 172.89 12.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.126 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.556 ' HG3' ' NZ ' ' A' ' 8' ' ' LYS . 5.2 mp0 -96.65 153.44 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.234 0.54 . . . . 0.0 111.791 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -119.72 108.49 14.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.125 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -79.94 49.39 1.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -170.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.42 ' ND2' ' HB ' ' A' ' 101' ' ' THR . 26.5 t-20 64.7 -74.22 0.05 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.491 0.716 . . . . 0.0 111.361 175.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -61.47 -25.53 67.3 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.702 0.401 . . . . 0.0 111.132 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.902 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 13.6 m -52.73 -29.66 28.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.028 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.503 HD13 HG21 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -63.12 -44.03 96.76 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -175.241 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.67 -3.15 2.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -117.64 -37.25 3.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.902 ' HB ' ' HA ' ' A' ' 157' ' ' THR . 9.7 m . . . . . 0 C--N 1.324 -0.5 0 O-C-N 122.404 -0.185 . . . . 0.0 110.893 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.23 0.067 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.402 ' H ' ' HG3' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -57.27 -49.24 76.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.082 -170.632 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.49 83.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.045 0.45 . . . . 0.0 111.257 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.53 -37.54 80.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.305 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -64.02 -28.33 69.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.563 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -55.89 -34.57 65.64 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 110.271 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.0 tp -102.0 -55.09 2.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.157 0.503 . . . . 0.0 110.29 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.985 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.349 -175.896 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 121.591 0.71 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 96.8 mt -86.16 -10.99 53.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.128 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -65.98 127.27 31.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.959 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.24 0.84 79.72 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.615 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -115.22 -177.33 3.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.665 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 44.1 p90 -151.24 161.68 42.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 139' ' ' LEU . 16.6 pt -121.32 129.19 75.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.519 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.757 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.6 mp -75.22 107.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.286 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.455 ' H ' HG21 ' A' ' 25' ' ' VAL . . . -79.43 101.05 7.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.8 m . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.31 179.691 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 . . . . . 0 C--O 1.234 0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.7 t -118.72 117.42 28.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.503 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.699 HG13 HG22 ' A' ' 40' ' ' ILE . 59.3 t 69.19 153.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.151 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.514 HG13 ' HD1' ' A' ' 27' ' ' TYR . 7.0 tp -136.68 -57.42 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.025 173.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.665 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 6.0 p90 -177.73 175.3 1.37 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 111.639 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 5' ' ' LEU . 50.3 mm -103.86 127.66 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.613 176.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.5 m -81.33 -53.31 6.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.723 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.51 160.82 36.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.512 0.672 . . . . 0.0 112.315 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.531 ' O ' ' HB3' ' A' ' 32' ' ' ASN . 84.3 t60 -164.12 136.23 4.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.58 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 21.7 t-20 86.68 -38.96 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.229 0.956 . . . . 0.0 110.513 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 30.1 t70 -73.74 97.02 2.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 33' ' ' ASP . 28.9 t-20 76.33 -38.99 0.34 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.883 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.03 -141.76 5.73 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.552 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.2 m -125.03 112.75 16.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.066 0.433 . . . . 0.0 110.125 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 37' ' ' ILE . 4.0 mp -110.96 121.15 63.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.07 171.8 31.4 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.057 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.82 91.86 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.555 0.693 . . . . 0.0 110.423 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.699 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -136.4 18.41 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.066 -175.426 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 tp -64.52 -29.7 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.183 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 58.98 82.47 0.14 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.114 0.483 . . . . 0.0 111.801 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 t -175.82 121.54 0.32 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 65.0 Cg_endo -78.59 153.66 26.82 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.313 2.009 . . . . 0.0 110.735 171.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.1 p -101.59 177.96 4.77 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.065 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -81.56 -17.36 48.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.19 0.519 . . . . 0.0 110.345 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.5 tp -80.28 150.66 29.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.443 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 34.9 t -103.51 151.35 22.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.073 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 14.1 p -65.8 -30.09 48.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.303 0.573 . . . . 0.0 109.692 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.0 mt -74.1 -26.76 60.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.023 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 48' ' ' SER . 5.8 mm-40 -69.83 -44.13 70.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.155 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.3 pp -68.9 -34.26 75.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.706 0.289 . . . . 0.0 110.724 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.81 -48.85 72.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.34 . . . . 0.0 110.75 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.0 p -69.2 -30.15 68.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.061 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.4 tpt85 -62.51 -30.74 71.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.556 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 81.0 mtp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.556 176.368 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 t0 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -103.25 115.42 30.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.183 0.516 . . . . 0.0 110.773 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.552 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 55.2 mtt -83.26 125.5 31.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.79 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 129' ' ' LEU . 14.9 p -69.7 144.31 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.832 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 6.7 mp -96.71 157.68 15.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.997 0.427 . . . . 0.0 110.606 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.42 146.78 26.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.398 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -103.84 -27.07 6.47 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.758 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.87 167.66 17.66 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.696 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.25 -17.97 44.85 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 123.058 2.505 . . . . 0.0 113.143 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.446 HG21 ' OG1' ' A' ' 133' ' ' THR . 48.9 t -94.73 132.13 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.813 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 63.36 31.25 15.31 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.593 0.558 . . . . 0.0 110.852 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -12.18 61.44 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.105 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -79.02 -7.98 58.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -127.36 138.63 53.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.044 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.93 132.0 10.89 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.499 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.548 ' HB3' HD11 ' A' ' 106' ' ' LEU . 82.1 m-85 -106.79 126.11 51.87 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.557 HG21 HG11 ' A' ' 112' ' ' VAL . 2.6 mp -119.59 106.28 18.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.394 0.616 . . . . 0.0 110.925 -176.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.68 HG22 HD13 ' A' ' 106' ' ' LEU . 12.1 t -91.57 138.03 20.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.403 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -149.89 156.34 41.6 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.672 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.5 m -76.09 170.86 15.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.707 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -78.26 116.82 18.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.31 0.576 . . . . 0.0 110.977 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.6 m -140.27 -44.99 0.42 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -95.95 165.82 12.08 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -117.22 14.61 14.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.583 0.706 . . . . 0.0 109.997 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -100.64 163.33 12.39 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.789 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.2 p90 176.18 127.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.254 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 m -97.97 -49.96 4.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.187 0.518 . . . . 0.0 109.806 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.442 ' HB2' ' OG ' ' A' ' 109' ' ' SER . 12.7 m-70 -135.6 102.18 5.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.534 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.1 p -135.94 152.95 51.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.969 -177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -109.6 136.58 48.74 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 170.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 102' ' ' ASP . 87.1 tttt -90.1 105.49 17.84 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.0 t -79.16 -55.49 9.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.7 p -132.59 -175.89 3.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.583 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.426 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 11.5 m-20 -73.95 -13.81 60.94 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.898 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -105.56 -58.68 1.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.302 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.799 HD12 ' HD2' ' A' ' 159' ' ' PHE . 42.1 mm -67.96 122.79 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.117 0.484 . . . . 0.0 110.414 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 m -127.2 124.57 39.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.317 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.68 HD13 HG22 ' A' ' 86' ' ' VAL . 25.8 tp -96.0 115.55 27.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.547 174.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.854 HG21 ' HB2' ' A' ' 111' ' ' ASP . 42.1 m -117.64 126.91 53.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.481 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.6 p -96.8 -10.58 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.487 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.442 ' OG ' ' HB2' ' A' ' 96' ' ' HIS . 38.9 m -95.27 179.62 5.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.636 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.21 5.37 34.83 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.903 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.854 ' HB2' HG21 ' A' ' 107' ' ' THR . 25.7 m-20 -54.88 -40.45 69.75 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.58 ' CG2' ' HB ' ' A' ' 107' ' ' THR . 22.6 t -57.58 -48.98 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.805 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.28 -34.99 75.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.714 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -59.08 -46.66 87.71 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.749 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.4 m -66.2 -44.54 83.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.137 0.494 . . . . 0.0 110.873 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -68.42 -24.18 64.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.428 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -91.31 6.72 80.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.592 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.1 p -128.85 -162.58 1.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.95 0.375 . . . . 0.0 111.331 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -80.89 0.51 34.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 111.603 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 p -113.83 25.68 10.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.085 0.469 . . . . 0.0 111.331 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -60.26 124.09 76.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.162 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 2.8 Cg_endo -82.19 129.29 5.95 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.41 2.74 . . . . 0.0 111.958 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.54 -35.16 78.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.649 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -104.33 109.02 20.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.903 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 24.6 p90 -153.05 144.09 23.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.808 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.548 HG12 ' HZ ' ' A' ' 159' ' ' PHE . 30.4 pt -136.56 147.67 27.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.183 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.483 HG23 HG13 ' A' ' 85' ' ' ILE . 7.7 p -128.26 131.34 69.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.016 0.436 . . . . 0.0 110.789 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 26.6 p -133.31 144.03 49.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.399 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 72' ' ' VAL . 3.8 mm? -92.05 110.56 21.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.465 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.413 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 83.91 -179.18 52.13 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.777 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.1 m -147.73 169.55 19.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.349 . . . . 0.0 110.101 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.597 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 38.9 m -108.02 125.4 51.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.055 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.446 ' OG1' HG21 ' A' ' 78' ' ' VAL . 18.1 p -107.66 127.37 53.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.217 0.532 . . . . 0.0 111.565 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.597 ' HZ3' ' HB3' ' A' ' 132' ' ' SER . 1.0 OUTLIER -115.43 150.6 36.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.246 175.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.428 ' H ' ' HD2' ' A' ' 135' ' ' LYS . 10.6 mptt -74.17 151.49 88.07 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.054 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.19 129.55 34.83 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.652 2.235 . . . . 0.0 111.867 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 72.2 -6.09 1.61 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.521 0.729 . . . . 0.0 112.299 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 7.4 tp60 -73.29 -57.53 3.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.936 0.398 . . . . 0.0 110.296 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 10' ' ' ILE . 44.3 tp -64.0 -34.52 78.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.198 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.48 -40.89 83.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.368 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.595 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.0 OUTLIER -65.11 -48.1 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.295 177.298 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 148' ' ' TRP . 50.5 mt-10 -57.43 -40.14 77.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.312 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 139' ' ' LEU . 80.5 mt -62.28 -44.13 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 0.0 110.449 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.91 73.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.007 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 84.3 mt-30 -79.47 6.2 10.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.179 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 65.14 25.31 12.44 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.113 0.565 . . . . 0.0 112.239 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -84.17 -17.8 38.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.13 0.49 . . . . 0.0 109.963 173.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.417 ' CD1' ' HB3' ' A' ' 142' ' ' GLU . 89.5 m95 -135.52 137.5 42.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.22 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.757 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 87.2 mt -94.6 138.05 32.96 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.9 tp -111.51 136.72 50.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.418 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.9 t -156.2 160.68 40.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.274 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -87.37 154.01 21.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.903 0.383 . . . . 0.0 110.439 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.07 -36.5 3.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.836 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 58.3 t30 49.67 -97.9 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.528 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -140.18 -17.52 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.725 0.298 . . . . 0.0 110.539 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.684 ' HA ' ' HB3' ' A' ' 160' ' ' GLU . 2.1 mt-30 -73.62 -72.67 0.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.199 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.3 m -58.15 -29.26 65.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.027 0.441 . . . . 0.0 110.856 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -58.18 7.85 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.106 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.799 ' HD2' HD12 ' A' ' 104' ' ' ILE . 14.3 m-85 -135.05 -39.3 0.77 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.684 ' HB3' ' HA ' ' A' ' 156' ' ' GLN . 21.4 tt0 -62.7 -25.69 68.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.853 -170.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 120.648 0.261 . . . . 0.0 110.394 177.689 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.001 0.429 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.05 -11.64 60.63 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.101 0.477 . . . . 0.0 110.104 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.567 ' HB1' ' HE2' ' A' ' 9' ' ' PHE . . . -56.91 -45.94 82.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.554 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -81.34 -27.11 35.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.033 0.444 . . . . 0.0 110.175 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.38 -30.88 71.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.445 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 88.1 mmm -62.37 -28.65 69.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.934 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.61 -49.34 5.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.261 0.553 . . . . 0.0 110.369 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.026 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -176.085 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 94.0 m-20 . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.422 HD21 HD11 ' A' ' 150' ' ' LEU . 81.8 mt 73.58 13.73 4.39 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 175.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -69.33 134.81 49.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 172.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.31 32.21 65.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.313 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -126.21 -177.89 4.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 4.3 p90 -149.55 148.92 29.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.023 0.44 . . . . 0.0 111.082 170.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.504 HG12 HD11 ' A' ' 28' ' ' ILE . 10.2 pt -118.96 128.86 75.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.344 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.678 HD13 HD22 ' A' ' 149' ' ' LEU . 4.3 mp -98.35 136.84 27.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.537 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.5 -174.5 4.25 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.0 m . . . . . 0 CA--C 1.536 0.423 0 CA-C-O 121.497 0.665 . . . . 0.0 111.685 177.96 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.44 ' CZ ' HD11 ' A' ' 73' ' ' LEU . 49.2 mtm180 . . . . . 0 C--O 1.233 0.217 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -82.1 108.5 15.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.017 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.0 t 74.3 133.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.22 0.608 . . . . 0.0 111.886 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.54 HG23 ' H ' ' A' ' 27' ' ' TYR . 6.3 tp -135.0 -65.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.66 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -177.61 177.43 1.14 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.606 0.639 . . . . 0.0 111.781 -177.592 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.504 HD11 HG12 ' A' ' 10' ' ' ILE . 34.0 mm -103.22 133.64 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.288 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.9 m -81.23 -59.54 2.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.371 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -165.09 157.52 15.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.185 0.517 . . . . 0.0 111.26 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 4' ' ' ASN . 11.8 t-80 -103.3 132.01 49.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.245 174.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -129.12 172.0 11.85 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.6 -36.5 78.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.931 0.396 . . . . 0.0 111.035 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -72.42 -22.83 61.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.135 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.554 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 156.01 -177.77 32.9 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.131 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 m -97.76 121.6 39.86 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.698 HG13 HG22 ' A' ' 133' ' ' THR . 4.3 mp -88.54 117.45 32.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.253 -175.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.07 151.02 22.68 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.195 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 m -116.67 93.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.512 0.672 . . . . 0.0 110.764 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.434 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -132.95 13.3 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.294 -176.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 pt -79.71 -26.91 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.569 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.4 t30 59.07 91.93 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.76 0.663 . . . . 0.0 112.13 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 43' ' ' THR . 9.2 t -156.72 93.63 2.36 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 122.06 0.933 . . . . 0.0 110.941 175.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 93.9 Cg_endo -81.96 157.49 18.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.665 2.243 . . . . 0.0 111.697 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.8 p -121.6 156.72 32.35 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -12.26 60.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.934 0.397 . . . . 0.0 110.692 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.7 tp -71.36 144.51 49.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.602 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.821 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 59.5 m -105.65 157.6 17.3 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.458 -174.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.1 p -65.89 -34.15 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.925 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.82 -36.78 85.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.936 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.821 ' HG2' ' HB2' ' A' ' 48' ' ' SER . 26.9 mm-40 -58.68 -45.87 88.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.775 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.76 -42.34 97.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.854 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 97.8 mt -65.77 -41.66 91.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.323 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.4 p -71.9 -31.17 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.437 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -63.32 -36.5 83.9 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.813 0.34 . . . . 0.0 110.254 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 C--N 1.329 -0.318 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.057 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -126.86 113.24 16.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.937 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.624 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.8 mtt -82.0 148.64 28.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.235 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.431 HG21 HD23 ' A' ' 129' ' ' LEU . 13.7 p -96.7 147.76 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.134 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 6.6 mp -108.46 155.09 20.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.987 0.422 . . . . 0.0 110.554 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -94.32 121.13 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.72 -23.14 43.57 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.742 -173.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 153.87 174.56 24.18 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.033 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.61 -21.56 14.63 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.767 2.312 . . . . 0.0 113.085 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.408 HG21 ' OG1' ' A' ' 133' ' ' THR . 51.9 t -81.4 131.19 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 60.31 30.89 20.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.127 0.489 . . . . 0.0 110.155 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -59.15 -27.75 65.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.208 -173.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.67 -7.61 56.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.909 0.385 . . . . 0.0 111.224 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.6 mtm-85 -118.14 131.69 56.39 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.126 0.489 . . . . 0.0 111.142 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.56 118.3 5.08 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.358 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.505 ' HB3' HD11 ' A' ' 106' ' ' LEU . 85.9 m-85 -91.99 125.88 36.85 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.506 0.194 . . . . 0.0 110.494 -178.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.673 ' HB ' HG11 ' A' ' 112' ' ' VAL . 4.3 mp -112.94 110.62 32.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.182 0.515 . . . . 0.0 109.646 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 40.6 t -91.86 119.15 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.399 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -129.51 152.38 49.1 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.427 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -62.88 156.36 24.45 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.516 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -74.58 117.94 16.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.532 0.682 . . . . 0.0 110.218 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.6 m -140.41 157.64 45.22 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -64.85 124.71 22.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.688 0.756 . . . . 0.0 110.934 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -173.36 138.61 0.72 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.646 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.35 160.99 14.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -106.06 113.16 26.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.603 0.716 . . . . 0.0 111.67 -173.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.3 m -83.13 -45.09 14.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.477 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.98 37.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -77.66 125.02 28.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.926 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -105.46 136.08 45.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.446 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -86.59 128.85 35.02 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.781 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 72.0 t -70.39 -54.86 16.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -134.79 -48.53 0.75 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.96 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -176.38 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.951 169.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.42 -13.03 60.37 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.101 0.477 . . . . 0.0 111.245 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' ' 100' ' ' VAL . 24.8 mm -105.06 124.24 59.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.0 m -117.36 130.41 56.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.1 0.476 . . . . 0.0 111.538 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 84' ' ' PHE . 67.1 tp -107.79 128.15 54.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.23 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 1.024 HG21 ' HB3' ' A' ' 111' ' ' ASP . 12.1 m -142.58 137.32 30.01 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.129 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 p -120.47 3.21 10.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.391 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.591 ' O ' HG22 ' A' ' 112' ' ' VAL . 15.2 m -109.61 -173.55 2.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.403 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.69 -15.61 13.21 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.907 -0.588 . . . . 0.0 114.541 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 1.024 ' HB3' HG21 ' A' ' 107' ' ' THR . 11.6 t70 -49.43 -46.66 47.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.247 0.523 . . . . 0.0 110.961 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.673 HG11 ' HB ' ' A' ' 85' ' ' ILE . 31.9 m -60.54 -39.61 81.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.634 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.526 HD13 ' CZ ' ' A' ' 116' ' ' PHE . 4.3 mm? -70.84 -42.73 69.78 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.356 0.598 . . . . 0.0 110.059 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.44 -28.47 66.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.019 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 65.5 m -54.34 -57.0 12.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.561 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.526 ' CZ ' HD13 ' A' ' 113' ' ' LEU . 37.8 p90 -84.24 13.38 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.274 0.559 . . . . 0.0 110.914 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -106.1 9.17 42.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.521 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.4 t -137.44 176.32 8.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -79.68 -9.72 59.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.864 0.364 . . . . 0.0 111.085 -173.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 p -104.03 25.96 9.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.332 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -54.34 121.59 32.53 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.199 174.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 17.2 Cg_exo -67.06 145.58 73.93 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.977 2.451 . . . . 0.0 112.464 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.47 -42.97 82.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.489 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -107.89 125.06 51.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.155 -170.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 42.0 p90 -158.44 133.68 8.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.224 176.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 30.7 pt -124.83 147.95 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.245 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.7 p -122.64 129.16 75.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.193 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.6 p -138.99 132.23 29.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.296 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 72' ' ' VAL . 3.5 mm? -80.82 114.09 19.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.391 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.59 178.26 39.84 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.402 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 75.4 m -147.71 172.08 14.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.7 m -111.78 132.37 54.71 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.698 HG22 HG13 ' A' ' 37' ' ' ILE . 34.9 p -112.4 117.02 31.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.003 0.43 . . . . 0.0 111.028 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -94.67 116.91 29.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.127 0.489 . . . . 0.0 110.15 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 4.4 mptp? -60.22 136.44 91.33 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.546 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.554 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 10.2 Cg_exo -72.14 54.92 2.31 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.706 2.937 . . . . 0.0 113.367 -175.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -154.91 -55.21 0.1 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.562 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.0 tp60 -63.34 -35.93 82.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.287 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.34 -35.78 74.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.931 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.15 -41.54 94.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.038 0.447 . . . . 0.0 109.831 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.523 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 32.8 mm-40 -64.87 -47.56 77.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.703 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 16.2 mm-40 -54.61 -50.95 66.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.131 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.794 HG12 ' HB2' ' A' ' 148' ' ' TRP . 67.0 mt -68.57 -36.32 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.205 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.35 75.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 87.4 mt-30 -81.95 12.93 3.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.502 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 68.02 24.28 7.9 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.379 0.672 . . . . 0.0 112.318 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -92.59 -5.67 51.13 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.943 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.794 ' HB2' HG12 ' A' ' 143' ' ' ILE . 95.4 m95 -140.48 130.79 25.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.819 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.678 HD22 HD13 ' A' ' 11' ' ' ILE . 6.5 tt -92.96 117.26 29.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.422 HD11 HD21 ' A' ' 5' ' ' LEU . 9.3 tt -95.39 133.85 38.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.974 0.416 . . . . 0.0 110.889 -175.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.472 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 35.5 t -151.52 154.74 37.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.246 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -79.52 156.4 27.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . . . -126.59 -139.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.1 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.4 t30 61.69 53.63 3.19 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.913 0.863 . . . . 0.0 109.483 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -151.48 169.08 22.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.778 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -54.37 -25.74 26.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.951 0.501 . . . . 0.0 112.165 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -53.51 -28.19 29.68 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 122.581 0.352 . . . . 0.0 111.721 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.5 -57.12 7.98 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -127.66 0.06 6.13 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.06 12.33 17.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.329 0.585 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.703 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.042 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 121.135 0.493 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.22 -7.8 26.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.263 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.406 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -57.66 -34.09 69.0 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -74.22 -43.17 58.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.732 0.301 . . . . 0.0 111.046 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.71 -20.85 45.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.872 0.368 . . . . 0.0 110.402 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 14.9 tpt -64.39 -33.64 76.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.23 0.538 . . . . 0.0 110.069 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.644 HD22 HD21 ' A' ' 149' ' ' LEU . 11.2 tp -83.06 -39.0 21.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.454 0.645 . . . . 0.0 109.336 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.567 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.115 179.211 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.4 t30 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.855 0.36 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.44 -8.77 37.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.918 -173.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 30' ' ' GLU . 11.1 pt20 -82.61 149.52 27.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.69 4.19 79.8 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.344 -173.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HG3' ' HA ' ' A' ' 152' ' ' GLU . 11.3 mptt -121.87 179.0 4.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.648 ' HZ ' ' HG2' ' A' ' 173' ' ' MET . 2.2 p90 -149.31 139.36 22.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.239 0.542 . . . . 0.0 110.485 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 pt -108.85 127.72 65.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.294 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.79 HD13 HD22 ' A' ' 149' ' ' LEU . 4.5 mp -100.08 129.48 50.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.813 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.04 93.12 2.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.469 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.357 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 121.12 0.486 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.611 ' HB ' ' HA ' ' A' ' 42' ' ' ASN . 44.5 p -94.76 137.09 34.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.21 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.648 HG13 HG22 ' A' ' 40' ' ' ILE . 78.7 t 78.02 119.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 123.838 0.711 . . . . 0.0 111.656 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.5 tp -121.88 -55.64 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.366 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.606 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 2.8 p90 -178.69 172.63 1.37 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.027 0.442 . . . . 0.0 111.395 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.49 130.93 47.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.76 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.7 m -89.32 -42.65 11.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -170.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.524 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 42.0 tt0 -142.02 146.12 35.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 111.105 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -124.8 109.45 13.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.332 0.587 . . . . 0.0 110.529 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -95.06 176.6 6.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.67 -42.14 99.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 118.016 0.371 . . . . 0.0 111.325 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -119.87 4.82 10.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.29 0.567 . . . . 0.0 111.0 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.11 108.44 0.73 Allowed Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.943 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 m -100.34 105.98 17.56 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.676 HG13 HG22 ' A' ' 133' ' ' THR . 4.3 mp -88.75 114.27 26.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.722 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.95 173.9 32.53 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.866 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -121.01 83.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.608 0.718 . . . . 0.0 110.389 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.648 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -134.92 28.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.791 -176.098 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 43' ' ' THR . 11.0 tp -71.71 -16.71 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.383 -176.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.611 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 53.4 m-80 67.01 72.6 0.36 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.161 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 13.3 t 170.36 143.87 0.1 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HB3' HD23 ' A' ' 73' ' ' LEU . 49.5 Cg_endo -90.81 -170.59 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.957 2.438 . . . . 0.0 110.874 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.3 p -111.78 170.73 7.94 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -88.66 0.99 55.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.351 0.596 . . . . 0.0 110.021 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.17 162.28 13.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.253 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 2.0 m -105.13 158.19 16.75 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.35 -38.36 80.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.803 0.335 . . . . 0.0 110.757 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -65.31 -28.51 69.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -59.87 -44.31 94.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.47 -177.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 52' ' ' LEU . 4.9 mp -73.07 -43.81 61.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 110.176 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.13 -45.84 86.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.552 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.9 p -73.34 -33.84 65.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.351 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -65.23 -41.95 93.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.796 0.331 . . . . 0.0 110.396 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 83.9 mtp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.233 178.102 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -128.0 119.81 26.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.741 0.305 . . . . 0.0 110.29 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 89.9 mtp -84.44 131.67 34.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 p -81.7 127.77 39.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.139 0.495 . . . . 0.0 110.701 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 44' ' ' PRO . 87.9 mt -70.33 160.13 32.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.64 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.451 ' H ' ' HA ' ' A' ' 44' ' ' PRO . 7.1 t-20 -98.49 117.81 33.75 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -79.76 -33.06 35.0 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.968 -175.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.51 -176.29 29.17 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.073 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -87.4 5.6 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.157 2.571 . . . . 0.0 113.278 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.47 132.6 57.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 59.1 37.56 24.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 110.494 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -70.01 -10.86 60.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.67 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.29 5.78 29.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.927 0.394 . . . . 0.0 110.819 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -130.95 132.28 44.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.289 0.566 . . . . 0.0 111.66 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.96 118.8 5.03 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.531 ' HB3' HD11 ' A' ' 106' ' ' LEU . 66.0 m-85 -97.79 125.4 42.61 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.669 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.8 mp -112.9 107.85 24.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.277 0.561 . . . . 0.0 109.949 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 106' ' ' LEU . 33.6 t -86.71 115.73 28.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.85 159.49 38.43 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.522 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 22.2 m -70.19 160.8 31.46 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.585 172.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.453 ' HE3' ' O ' ' A' ' 102' ' ' ASP . 13.9 ptpt -70.16 172.49 7.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -171.31 -43.8 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.839 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -154.91 -154.31 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -91.83 176.49 6.5 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.415 ' OE2' ' HA ' ' A' ' 96' ' ' HIS . 5.6 pt-20 -93.7 168.59 10.91 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.507 0.67 . . . . 0.0 111.512 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -122.87 -36.62 2.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.706 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.42 ' HB ' ' OD1' ' A' ' 111' ' ' ASP . 10.0 m -112.94 -63.67 1.41 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.04 174.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.415 ' HA ' ' OE2' ' A' ' 93' ' ' GLU . 6.7 t60 179.45 126.82 0.07 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.095 0.474 . . . . 0.0 111.25 174.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 71.2 m -119.31 143.95 47.09 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.115 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -102.6 110.36 22.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.233 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' A' ' 102' ' ' ASP . 29.2 ttpt -84.42 102.64 12.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.398 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.8 t -69.34 -54.41 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 104' ' ' ILE . 11.3 t -134.58 167.46 20.76 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 170.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.648 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 33.6 m-20 -58.91 -44.54 91.27 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -172.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 88' ' ' SER . 25.6 m-20 -76.99 -28.5 55.11 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -175.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.427 ' H ' HG23 ' A' ' 101' ' ' THR . 43.7 mm -118.29 123.07 71.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.08 0.467 . . . . 0.0 111.183 -175.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.6 m -130.77 136.7 48.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.045 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.639 HD13 HG22 ' A' ' 86' ' ' VAL . 45.5 tp -99.07 125.68 44.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.488 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.956 HG21 ' HB2' ' A' ' 111' ' ' ASP . 17.8 m -135.9 128.96 31.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -136.36 1.48 2.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.216 0.531 . . . . 0.0 110.164 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.419 ' HB2' ' OD1' ' A' ' 111' ' ' ASP . 4.7 m -72.8 -7.67 51.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.782 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.31 -20.7 11.16 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.055 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.956 ' HB2' HG21 ' A' ' 107' ' ' THR . 2.2 m-20 -48.82 -42.97 37.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.12 0.568 . . . . 0.0 111.327 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.695 HG13 ' HB ' ' A' ' 107' ' ' THR . 5.1 m -53.01 -46.58 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.52 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.33 -36.04 74.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 110.499 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -70.66 -24.61 62.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.153 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -77.75 -14.64 59.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.942 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -85.25 132.09 34.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.965 0.412 . . . . 0.0 111.054 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 112.92 -4.21 25.74 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.765 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.8 t -123.26 157.5 33.0 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -66.85 -10.48 48.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.2 p -92.1 19.3 6.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.002 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.39 144.84 97.51 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.183 172.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.49 140.66 92.57 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.764 2.309 . . . . 0.0 112.729 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.524 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 48.5 mt-10 -57.99 -52.81 63.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.219 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HE2' ' HB2' ' A' ' 123' ' ' GLU . 5.4 mtmt -129.33 146.03 51.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.656 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 44.5 p90 -159.62 141.19 12.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.823 0.344 . . . . 0.0 110.692 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.02 144.41 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.827 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.24 129.22 68.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.037 0.446 . . . . 0.0 110.844 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.9 m -129.6 129.39 44.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.261 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.07 108.73 16.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.637 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.543 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 77.74 -176.44 53.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.189 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 83.4 m -147.85 173.48 12.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 0.0 110.191 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.3 m -120.02 116.76 26.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.157 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.676 HG22 HG13 ' A' ' 37' ' ' ILE . 38.3 p -96.32 113.95 25.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.085 0.469 . . . . 0.0 109.923 175.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.582 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -99.64 141.56 32.28 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.917 -178.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -90.28 117.51 68.09 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.396 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.26 55.77 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.523 2.815 . . . . 0.0 112.286 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -146.01 -37.36 0.25 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -87.56 -44.35 11.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.005 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.582 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 59.2 tp -56.92 -40.19 75.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.315 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.09 -33.44 73.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.828 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 71.1 mm-40 -67.25 -52.16 44.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.88 0.371 . . . . 0.0 110.234 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.428 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 0.4 OUTLIER -60.72 -41.57 95.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.717 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.593 HG12 ' HB2' ' A' ' 148' ' ' TRP . 60.3 mt -64.2 -40.71 90.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.721 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.72 71.01 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 111.027 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 37.0 mt-30 -87.26 9.09 21.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.942 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 64.61 33.54 10.61 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.582 174.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -94.45 5.12 52.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.211 0.529 . . . . 0.0 110.085 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.593 ' HB2' HG12 ' A' ' 143' ' ' ILE . 92.1 m95 -142.49 123.69 14.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.725 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.79 HD22 HD13 ' A' ' 11' ' ' ILE . 6.0 tt -78.86 110.6 14.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.23 133.37 34.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.055 0.455 . . . . 0.0 111.501 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.8 t -162.25 157.06 22.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.083 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.526 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 8.6 pt-20 -85.12 154.1 22.25 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.76 119.78 39.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.747 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -168.58 -175.87 2.61 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 67.2 t30 75.29 163.67 0.26 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.398 0.679 . . . . 0.0 111.327 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 69.3 mt-30 -62.06 -25.43 67.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.036 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.7 m -51.82 -29.86 20.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.441 -175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.96 -54.53 43.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -125.34 -17.46 5.62 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -171.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 45.9 mt-10 -96.2 1.79 52.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.289 0.566 . . . . 0.0 110.914 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.857 176.337 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.628 HG22 ' H ' ' A' ' 171' ' ' ASN . 6.6 p . . . . . 0 N--CA 1.468 0.455 0 CA-C-O 122.191 0.996 . . . . 0.0 113.512 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.21 -28.05 63.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.883 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.56 -32.95 74.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.162 0.506 . . . . 0.0 110.597 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.628 ' H ' HG22 ' A' ' 168' ' ' VAL . 62.5 t30 -81.37 -32.72 32.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.105 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.78 -24.41 61.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.735 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.648 ' HG2' ' HZ ' ' A' ' 9' ' ' PHE . 13.3 tpt -55.64 -30.34 60.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.498 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.2 tp -97.68 -50.17 4.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.957 0.408 . . . . 0.0 109.915 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.524 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.979 179.102 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.7 t30 . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.941 0.401 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.2 tt -90.77 -0.97 57.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.718 0.771 . . . . 0.0 109.066 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.82 136.81 37.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.768 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.07 2.46 80.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.753 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.91 159.53 15.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 151' ' ' SER . 37.6 p90 -125.41 154.0 42.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.9 pt -124.64 128.77 73.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.686 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.8 mp -75.46 119.63 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.501 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.638 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -102.12 155.37 18.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.975 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 121.682 0.753 . . . . 0.0 111.851 178.078 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.249 0.547 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 t -104.32 167.43 9.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.484 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t 50.02 79.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.422 0.629 . . . . 0.0 110.472 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.499 HD11 HD23 ' A' ' 158' ' ' LEU . 4.0 tp -93.31 -61.16 2.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -170.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.42 ' HD1' HG23 ' A' ' 26' ' ' ILE . 2.1 p90 -167.94 174.55 7.35 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.323 0.511 . . . . 0.0 111.688 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -92.09 123.5 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.611 175.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.2 m -78.45 -38.3 41.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.195 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.98 150.25 20.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 0.0 110.306 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -131.49 104.83 7.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -119.53 167.36 12.05 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.804 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -73.22 -12.95 61.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.771 0.319 . . . . 0.0 110.651 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -83.03 -21.74 33.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.458 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.77 176.31 28.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.835 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 133' ' ' THR . 30.0 m -112.66 127.07 56.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.798 0.299 . . . . 0.0 110.779 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 37' ' ' ILE . 4.5 mp -104.42 110.21 29.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.35 165.39 27.47 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.44 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.45 80.11 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.802 0.811 . . . . 0.0 110.213 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -131.68 28.95 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.884 -176.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.516 HG21 ' HB3' ' A' ' 74' ' ' ASN . 11.0 tp -62.01 -25.94 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.46 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 61.03 61.42 1.61 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.763 177.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.493 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 9.5 t 179.24 132.51 0.24 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.437 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 43' ' ' THR . 2.2 Cg_endo -82.44 178.64 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.65 2.233 . . . . 0.0 111.05 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.411 ' OG1' HG13 ' A' ' 72' ' ' VAL . 22.7 p -94.05 -169.22 2.03 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.86 20.03 13.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.812 0.815 . . . . 0.0 109.179 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 47' ' ' LEU . 14.1 tp -125.73 170.87 11.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.016 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.7 p -113.8 162.83 15.83 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.603 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.7 p -63.58 -33.6 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 mt -67.55 -44.92 77.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.221 0.534 . . . . 0.0 109.994 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -54.88 -42.8 72.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.004 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.508 HD11 HG11 ' A' ' 72' ' ' VAL . 66.2 mt -56.74 -55.09 38.66 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.957 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.6 mt -59.84 -43.13 94.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.089 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -80.33 -29.35 38.06 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -61.19 -59.65 4.99 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 C--N 1.332 -0.193 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -175.031 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.467 ' OD2' ' HG2' ' A' ' 70' ' ' GLN . 13.5 t70 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.467 ' HG2' ' OD2' ' A' ' 69' ' ' ASP . 27.1 mm-40 -99.65 125.15 45.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.985 0.421 . . . . 0.0 110.009 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.1 ttp -86.88 146.01 26.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.649 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.586 HG23 HG13 ' A' ' 127' ' ' VAL . 5.1 p -95.88 140.69 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.831 0.348 . . . . 0.0 110.608 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.5 mt -89.72 164.54 14.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.951 0.405 . . . . 0.0 110.875 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.516 ' HB3' HG21 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -95.0 145.57 24.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.079 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -99.99 -36.43 4.2 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.966 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.89 -171.88 35.58 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.16 -14.68 10.67 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.045 2.497 . . . . 0.0 112.936 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.87 139.08 25.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.75 -175.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 66.32 30.11 9.14 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.979 0.512 . . . . 0.0 111.639 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -65.83 -15.07 62.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.044 0.449 . . . . 0.0 111.548 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.06 -2.5 52.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.543 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -129.76 136.0 49.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.38 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.44 126.36 8.66 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.07 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -107.08 125.68 51.36 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.541 HD13 HG21 ' A' ' 112' ' ' VAL . 3.4 mp -118.03 113.66 42.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.931 0.396 . . . . 0.0 110.5 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.519 HG22 HD13 ' A' ' 106' ' ' LEU . 25.2 t -93.1 120.61 42.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.494 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 29.5 p-80 -139.29 161.17 38.08 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.768 -175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.427 ' OG ' ' HE3' ' A' ' 124' ' ' LYS . 47.4 p -83.51 151.16 25.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.961 0.41 . . . . 0.0 111.315 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 89' ' ' LYS . 13.6 ttpt -71.4 127.28 32.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.175 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -129.59 -43.41 1.26 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.649 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -124.83 -15.22 6.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.159 0.504 . . . . 0.0 110.741 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 71.08 80.48 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.856 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 93' ' ' GLU . 1.3 pm0 -75.39 169.03 18.86 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.719 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -168.32 82.2 0.17 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.5 m -111.2 -37.74 5.23 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 161.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -171.12 77.51 0.07 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.903 165.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 p -97.71 134.62 40.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.958 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -103.06 121.2 42.1 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -87.59 115.8 25.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.046 0.451 . . . . 0.0 111.273 -174.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.69 -54.38 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.34 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.5 t -147.73 173.84 12.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.959 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -84.44 59.7 5.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.132 0.491 . . . . 0.0 110.624 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -175.9 -37.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.755 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.808 HG13 HD13 ' A' ' 158' ' ' LEU . 29.6 mm -117.95 129.7 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.687 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 m -127.88 139.37 52.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.052 0.453 . . . . 0.0 111.054 -174.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.519 HD13 HG22 ' A' ' 86' ' ' VAL . 57.3 tp -96.69 137.14 36.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.192 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.416 ' HB ' ' CG2' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -116.95 124.07 48.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.376 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.6 p -111.63 18.92 18.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.62 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.4 t -147.18 -178.41 6.2 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.1 4.11 8.95 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -49.75 -36.96 27.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.637 0.775 . . . . 0.0 109.756 172.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.541 HG21 HD13 ' A' ' 85' ' ' ILE . 29.3 t -53.5 -40.46 41.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.165 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.17 -33.19 73.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.393 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -71.28 -44.38 65.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.007 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m -64.22 -42.29 96.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.483 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -85.47 9.69 15.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.357 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.61 33.09 5.98 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.744 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 t -154.71 165.62 35.98 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -64.92 -24.33 67.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.773 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.0 p -88.91 32.02 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.114 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.89 146.0 82.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.854 173.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.494 ' HB3' ' CD2' ' A' ' 87' ' ' HIS . 9.2 Cg_endo -53.16 134.23 55.51 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.322 2.681 . . . . 0.0 113.398 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -62.7 -62.5 1.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.909 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.992 ' HD3' ' HG3' ' A' ' 160' ' ' GLU . 4.3 mtmt -103.69 145.31 30.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.8 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -167.71 140.89 3.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 0.0 111.475 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.03 145.02 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.248 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.586 HG13 HG23 ' A' ' 72' ' ' VAL . 4.6 p -117.06 124.9 73.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.008 0.432 . . . . 0.0 110.833 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 59.3 m -128.24 133.6 48.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.273 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 72' ' ' VAL . 3.7 mm? -89.06 116.56 27.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.399 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.563 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 76.39 -174.69 53.47 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.758 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 68.2 m -149.18 168.15 24.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.8 m -107.73 119.07 38.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.191 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 36' ' ' THR . 11.1 p -101.69 114.83 29.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.301 0.572 . . . . 0.0 111.346 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -84.21 155.54 22.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.95 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -56.4 142.46 68.78 Favored Pre-proline 0 C--O 1.236 0.388 0 O-C-N 123.472 0.483 . . . . 0.0 111.077 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.45 119.18 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.164 2.576 . . . . 0.0 112.659 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 66.74 17.55 10.59 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.595 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -98.66 -23.12 15.58 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.636 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 36' ' ' THR . 57.6 tp -68.36 -50.33 53.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.529 0.204 . . . . 0.0 110.943 -175.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -60.35 -34.12 73.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.019 0.438 . . . . 0.0 110.789 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -40.08 77.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.4 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -69.69 -37.81 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 110.146 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.76 HG12 ' HB2' ' A' ' 148' ' ' TRP . 82.8 mt -60.34 -38.02 76.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.541 174.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.79 -28.61 69.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.302 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -88.13 4.41 45.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.928 175.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 16.5 m120 68.69 31.95 4.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.225 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -73.25 -30.54 63.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.466 0.65 . . . . 0.0 109.253 169.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.76 ' HB2' HG12 ' A' ' 143' ' ' ILE . 85.8 m95 -132.22 145.64 51.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.698 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 64.1 mt -104.43 118.33 36.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.99 135.6 40.16 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.46 -173.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 8.1 t -150.48 163.68 37.81 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 173.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -86.13 152.49 22.81 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.866 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -114.5 7.02 16.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.716 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -71.65 76.73 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.111 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -176.88 -178.67 0.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -65.11 -19.01 65.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.4 m -52.52 -27.17 15.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.527 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.808 HD13 HG13 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -57.1 -43.0 81.8 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.078 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -133.74 -46.89 0.8 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.992 ' HG3' ' HD3' ' A' ' 124' ' ' LYS . 34.1 mt-10 -85.63 16.97 3.52 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -166.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.317 -0.833 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 172.382 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.38 -28.97 68.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.875 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.13 95.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 110.716 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -81.21 -26.99 35.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.18 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.19 -37.78 72.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.566 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -62.43 -30.18 71.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.669 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.3 tp -79.48 -36.12 39.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.878 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.514 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.864 179.476 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.02 1.27 7.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.598 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.574 ' NE2' ' HA ' ' A' ' 100' ' ' VAL . 53.6 tt0 -66.08 131.68 46.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.831 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.23 -4.81 77.81 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.67 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 12.1 mptt -109.75 168.88 9.09 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -141.46 152.75 44.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.049 0.452 . . . . 0.0 110.938 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.1 pt -117.37 128.02 74.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.584 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.691 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 45.3 mt -101.3 133.25 45.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.794 -177.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.55 167.58 21.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.384 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 120.688 0.28 . . . . 0.0 110.78 178.952 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 . . . . . 0 N--CA 1.448 -0.572 0 CA-C-O 120.953 0.406 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.0 t -140.73 125.98 18.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.649 -177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.7 t 69.78 130.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.808 0.692 . . . . 0.0 112.106 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.54 HG23 ' H ' ' A' ' 27' ' ' TYR . 7.0 tp -142.8 -64.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.678 176.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.54 ' H ' HG23 ' A' ' 26' ' ' ILE . 1.8 p90 -177.01 177.14 1.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.142 0.428 . . . . 0.0 111.311 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.86 124.22 40.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.759 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.4 m -97.14 -40.45 8.8 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -128.89 147.88 50.86 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -175.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 6' ' ' GLN . 5.7 p80 -131.81 116.66 17.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 0.0 111.072 -177.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -100.75 -7.85 23.32 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 72.43 -46.97 0.66 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.702 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -84.6 3.54 36.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 167.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.12 126.55 1.83 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.885 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' A' ' 133' ' ' THR . 22.7 m -101.74 119.68 39.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.584 0.192 . . . . 0.0 110.94 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.803 HG13 HG22 ' A' ' 133' ' ' THR . 4.4 mp -109.08 111.47 36.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.933 0.397 . . . . 0.0 110.392 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.76 162.62 28.54 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.291 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.7 m -114.18 79.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.809 0.814 . . . . 0.0 110.754 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -134.69 18.6 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.907 -178.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 tp -78.57 -21.41 13.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.122 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.4 t30 69.28 93.24 0.08 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.463 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -161.98 122.72 1.55 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.087 176.796 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.78 155.42 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.803 2.335 . . . . 0.0 110.817 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 p -101.1 170.48 8.24 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.679 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -92.49 16.13 12.6 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.55 159.05 31.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.964 -172.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 42.6 t -106.51 154.8 20.34 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.198 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 9.4 p -67.64 -35.13 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.73 -26.74 60.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.381 0.61 . . . . 0.0 109.577 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 12.8 mm-40 -68.46 -47.95 65.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.866 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.5 pp -69.84 -34.11 73.19 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.914 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.8 mt -61.6 -52.32 64.86 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.415 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 p -69.6 -28.47 65.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.087 0.47 . . . . 0.0 111.302 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -59.15 -34.76 72.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.601 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.683 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 121.056 0.455 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -98.46 122.57 41.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.255 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttt -79.09 140.91 37.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.474 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.403 HG21 HD23 ' A' ' 129' ' ' LEU . 8.0 p -103.92 140.17 22.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.137 0.494 . . . . 0.0 110.889 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.52 163.7 13.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.314 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.536 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 1.4 t30 -105.3 113.16 26.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -77.31 -25.12 64.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.243 -171.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.21 176.63 26.76 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.5 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -83.52 4.81 6.77 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.118 2.545 . . . . 0.0 113.283 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.451 HG12 HD22 ' A' ' 79' ' ' ASN . 19.2 t -106.62 118.76 54.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.451 HD22 HG12 ' A' ' 78' ' ' VAL . 51.2 m-80 64.7 33.61 10.32 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.374 0.421 . . . . 0.0 110.233 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.591 ' HA ' ' HA3' ' A' ' 130' ' ' GLY . 5.1 tt0 -66.07 -15.96 63.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.374 -175.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -82.51 -7.29 59.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.511 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -109.41 140.7 42.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.055 0.455 . . . . 0.0 111.819 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 130.14 9.58 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.637 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -113.94 124.37 52.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.06 119.36 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.806 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.49 139.62 46.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -148.13 162.72 38.84 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.444 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -74.87 161.5 29.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -81.2 121.76 26.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.024 0.44 . . . . 0.0 110.195 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.517 ' CB ' ' HA ' ' A' ' 122' ' ' PRO . 21.7 m -144.33 -34.15 0.38 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.382 0.61 . . . . 0.0 109.402 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -102.09 179.22 4.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.567 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -120.56 79.85 1.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.399 0.618 . . . . 0.0 110.427 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 93' ' ' GLU . 4.8 pt-20 -64.62 168.03 6.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.138 173.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -154.12 -29.54 0.12 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 p -46.74 -59.99 2.69 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -173.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -170.36 71.99 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.296 0.57 . . . . 0.0 109.49 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.465 ' HB3' HG21 ' A' ' 105' ' ' THR . 11.3 m -79.83 132.1 36.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.018 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 74.4 t80 -104.11 126.64 51.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.214 177.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.528 ' HE2' ' HA ' ' A' ' 102' ' ' ASP . 13.8 mmmm -72.61 117.72 14.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.519 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.574 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 63.8 t -80.11 -54.68 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 t -131.53 -48.46 0.98 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.528 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 35.9 t70 -178.57 -66.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 172.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.41 -46.18 80.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.0 mm -72.94 123.52 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 97' ' ' SER . 19.1 m -132.79 142.94 49.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.531 -174.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 31.3 tp -96.98 135.67 38.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.117 176.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.436 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 2.6 m -135.01 123.56 23.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.605 0.24 . . . . 0.0 110.681 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.9 p -134.97 -0.42 2.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.821 0.343 . . . . 0.0 111.728 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -92.99 17.33 10.9 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.31 -14.09 66.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.561 174.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.86 -27.61 60.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.884 0.373 . . . . 0.0 110.849 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.436 ' CG1' ' HB ' ' A' ' 107' ' ' THR . 18.6 m -53.53 -32.81 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.926 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.35 -29.55 62.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 111.153 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -85.28 -35.56 21.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.609 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.5 m -58.76 -33.85 70.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.168 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -83.16 11.51 6.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.044 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.04 24.25 3.29 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.986 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 120' ' ' THR . 3.3 p -123.71 14.76 9.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.981 0.39 . . . . 0.0 111.636 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' THR . 0.8 OUTLIER 70.18 -37.16 0.37 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 111.442 -174.409 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.446 ' H ' ' C ' ' A' ' 118' ' ' THR . 16.6 p -78.13 28.04 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.865 0.466 . . . . 0.0 111.781 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.87 134.16 89.73 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.321 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.517 ' HA ' ' CB ' ' A' ' 90' ' ' THR . 9.8 Cg_endo -53.27 140.61 61.84 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.213 2.609 . . . . 0.0 112.771 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' CB ' ' HE2' ' A' ' 124' ' ' LYS . 66.0 mt-10 -57.28 -52.8 63.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.143 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HE2' ' CB ' ' A' ' 123' ' ' GLU . 5.6 mtmt -128.84 142.98 50.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.029 -176.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -150.3 145.17 26.01 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.876 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.2 pt -114.75 133.4 61.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.36 128.84 74.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.158 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 78.4 m -142.89 150.04 39.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.256 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.403 HD23 HG21 ' A' ' 72' ' ' VAL . 3.8 mm? -97.09 112.98 24.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.899 176.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 80' ' ' GLN . . . 81.48 176.76 51.26 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.716 -178.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.6 m -147.71 173.36 12.84 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.5 m -113.97 121.62 44.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.071 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.803 HG22 HG13 ' A' ' 37' ' ' ILE . 73.7 p -110.25 119.75 40.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.129 0.49 . . . . 0.0 110.773 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -80.27 159.9 25.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.84 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -75.28 138.02 71.74 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.891 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.34 132.39 50.46 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.815 2.343 . . . . 0.0 111.291 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 79.14 -33.81 0.15 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.926 0.766 . . . . 0.0 111.437 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -59.17 -48.33 82.0 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.504 0.193 . . . . 0.0 111.485 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.8 tp -57.99 -37.43 74.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.129 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -62.03 -43.62 98.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.0 110.22 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.627 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -62.16 -43.58 98.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.894 177.42 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -63.16 -42.82 99.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.882 0.373 . . . . 0.0 110.712 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 148' ' ' TRP . 83.4 mt -62.35 -39.98 86.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.343 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.35 -28.59 69.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.496 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 60.8 mt-30 -88.75 8.9 26.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.967 177.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.9 m120 66.78 30.72 7.83 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -81.53 -29.24 33.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.275 0.56 . . . . 0.0 109.742 171.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.615 ' HB2' HG12 ' A' ' 143' ' ' ILE . 95.3 m95 -131.01 131.49 44.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.761 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.691 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 44.0 mt -89.99 112.57 24.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.957 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.5 tp -87.04 133.01 33.63 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.653 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 p -161.23 148.83 15.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.106 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 3.3 pm0 -95.47 165.23 12.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.054 0.454 . . . . 0.0 110.893 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.71 -88.13 0.63 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.593 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 53.26 29.77 9.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.779 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -137.29 176.26 8.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -174.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -57.63 -35.93 71.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.602 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -52.83 -29.44 27.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.694 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.49 -56.99 12.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.04 7.41 6.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -169.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -106.24 -19.25 13.76 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.136 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -172.292 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 170' ' ' ALA . 1.5 pm0 -63.01 -52.87 61.25 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.619 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 169' ' ' GLU . . . -70.26 -31.65 69.12 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 110.613 -177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -66.98 -42.84 84.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.87 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -74.98 -21.21 59.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.098 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.555 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 14.1 mmt -62.93 -34.41 77.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.242 0.544 . . . . 0.0 109.699 172.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.6 tp -83.52 -40.24 19.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.996 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.926 177.974 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.473 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.1 mt 64.61 -90.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.384 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 31.45 86.54 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.308 1.005 . . . . 0.0 112.96 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 123.83 -0.59 9.22 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.385 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.782 ' HE3' ' HG3' ' A' ' 152' ' ' GLU . 13.6 mptt -105.52 169.16 8.62 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 2.5 p90 -142.45 167.89 21.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.418 HD12 ' CE3' ' A' ' 148' ' ' TRP . 4.8 pt -128.16 128.44 68.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.083 0.468 . . . . 0.0 111.477 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.619 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 4.6 mp -98.36 127.08 51.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.626 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.46 -72.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.083 0.239 . . . . 0.0 110.763 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.7 m . . . . . 0 CA--C 1.531 0.239 0 O-C-N 123.778 0.674 . . . . 0.0 110.958 -178.343 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 120.971 0.415 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.434 ' HA ' ' OD1' ' A' ' 42' ' ' ASN . 4.3 m -65.51 96.05 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.497 -177.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.897 HG12 ' H ' ' A' ' 26' ' ' ILE . 3.1 t 60.79 -170.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.253 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.902 HG21 HG23 ' A' ' 39' ' ' VAL . 10.1 tp -174.13 -147.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.723 ' HD1' HG13 ' A' ' 26' ' ' ILE . 2.6 p90 -120.87 176.33 5.6 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.217 0.917 . . . . 0.0 111.368 -168.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.9 127.95 43.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.416 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.44 -44.76 7.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.937 -176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.796 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.9 tp10 -136.03 156.38 48.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.411 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -140.87 110.18 6.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.184 0.516 . . . . 0.0 110.254 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -113.3 179.95 3.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -76.1 -35.0 59.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.055 0.455 . . . . 0.0 110.488 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.96 -24.27 60.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.975 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 171.63 178.28 41.89 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 119.966 -1.111 . . . . 0.0 112.959 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -103.62 130.38 51.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.796 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 mp -100.87 114.5 40.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.059 0.457 . . . . 0.0 110.89 -174.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.41 178.85 19.29 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.902 HG23 HG21 ' A' ' 26' ' ' ILE . 10.7 m -125.08 33.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.626 0.727 . . . . 0.0 110.316 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.569 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -82.98 20.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.366 -173.748 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.466 HG23 HG22 ' A' ' 43' ' ' THR . 10.4 tp -67.24 -25.04 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.646 0.26 . . . . 0.0 111.249 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 24' ' ' THR . 4.6 t30 67.16 80.64 0.21 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.409 173.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.466 HG22 HG23 ' A' ' 41' ' ' ILE . 5.1 t -178.2 126.39 0.27 Allowed Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 121.319 0.581 . . . . 0.0 111.877 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.64 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 83.7 Cg_endo -84.33 179.69 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.677 2.251 . . . . 0.0 110.689 169.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 p -119.6 -175.32 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -93.55 9.03 38.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.174 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 tp -125.43 163.95 21.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.84 0.353 . . . . 0.0 110.857 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 10.6 m -107.48 163.21 13.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.295 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.602 ' HB ' HG11 ' A' ' 127' ' ' VAL . 11.3 p -66.15 -35.72 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.744 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.21 -26.44 62.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 110.487 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -35.47 78.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.944 177.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.02 -44.74 91.75 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.064 0.459 . . . . 0.0 109.87 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.582 HD13 HD11 ' A' ' 113' ' ' LEU . 27.3 mt -66.54 -33.48 75.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.655 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.6 m -62.3 -35.35 78.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.086 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -76.05 -60.58 2.27 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.397 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 C--O 1.233 0.217 0 C-N-CA 123.114 0.566 . . . . 0.0 110.815 -178.32 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 N--CA 1.458 -0.052 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -104.43 112.29 25.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 88.2 mtp -82.26 144.46 30.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.465 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 127' ' ' VAL . 7.3 p -93.97 137.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.886 0.374 . . . . 0.0 110.06 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.64 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.9 mp -102.02 -179.79 4.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.937 0.398 . . . . 0.0 110.341 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -115.41 137.14 52.36 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -97.04 -23.78 14.25 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.813 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.34 173.76 30.37 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.04 -12.15 16.16 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.023 2.482 . . . . 0.0 112.823 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.4 t -87.73 125.21 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.67 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 59.53 40.28 20.64 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.883 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -70.65 -10.95 60.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.298 0.57 . . . . 0.0 110.524 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.13 -22.69 67.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.155 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -104.15 147.17 27.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.432 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.86 124.34 7.13 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.618 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HB3' HD11 ' A' ' 106' ' ' LEU . 60.5 m-85 -106.12 124.83 50.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.487 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.7 mp -120.23 110.06 27.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.683 HG22 HD13 ' A' ' 106' ' ' LEU . 21.4 t -95.55 124.46 48.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.651 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 125' ' ' PHE . 25.6 p80 -138.29 168.76 19.07 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.804 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.0 t -64.99 168.34 6.6 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.505 ' HG2' ' HA ' ' A' ' 103' ' ' ASP . 12.7 mmmt -51.25 112.9 0.81 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.235 0.541 . . . . 0.0 110.427 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 m -158.74 122.43 3.9 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.68 -150.03 0.45 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.319 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 77.97 13.85 1.64 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.409 1.083 . . . . 0.0 109.701 -169.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -98.35 155.48 17.2 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -147.65 -27.43 0.36 Allowed 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.656 -0.418 . . . . 0.0 112.083 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.2 m -67.1 -55.2 15.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.926 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -169.0 110.28 0.49 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 111.12 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 m -118.74 137.24 53.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.195 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -123.02 137.21 55.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.99 118.46 34.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.313 0.578 . . . . 0.0 110.781 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.82 -54.08 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.169 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 t -134.67 165.53 25.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.26 67.89 6.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.488 0.661 . . . . 0.0 111.177 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 89' ' ' LYS . 24.6 t70 178.92 -31.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.089 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 49.2 mm -105.95 124.42 61.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.248 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.4 m -113.96 128.34 56.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.897 0.379 . . . . 0.0 110.955 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.683 HD13 HG22 ' A' ' 86' ' ' VAL . 54.5 tp -109.31 113.14 25.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.614 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 m -100.01 124.09 44.98 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -109.02 25.78 11.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.314 0.578 . . . . 0.0 111.122 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.9 m -144.8 172.92 12.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.506 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.78 8.42 3.37 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.705 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.56 -17.19 64.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.487 HG11 ' HB ' ' A' ' 85' ' ' ILE . 25.6 m -58.01 -29.63 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.73 174.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.582 HD11 HD13 ' A' ' 53' ' ' LEU . 4.5 mm? -60.78 -31.87 71.21 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.132 0.491 . . . . 0.0 110.464 177.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -78.59 -37.25 42.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.864 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -53.65 -45.07 70.1 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.887 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -97.98 140.84 31.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.782 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.04 2.37 45.37 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.058 -177.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 120' ' ' THR . 9.0 t -115.75 -175.83 2.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -58.87 -34.35 71.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.071 0.463 . . . . 0.0 110.504 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 118' ' ' THR . 21.6 p -112.01 64.03 0.62 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.136 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.03 125.51 85.18 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.192 172.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.07 133.1 24.2 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.538 2.158 . . . . 0.0 112.312 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -61.73 -57.81 10.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.355 0.598 . . . . 0.0 111.702 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.1 mtmm -118.54 127.48 53.66 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 -168.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 87' ' ' HIS . 37.5 p90 -150.62 138.52 19.98 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.819 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.2 pt -116.06 134.14 60.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.834 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.602 HG11 ' HB ' ' A' ' 49' ' ' VAL . 6.5 p -114.17 128.36 71.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.253 0.549 . . . . 0.0 110.702 -177.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 18.2 p -142.23 138.23 31.3 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.187 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.8 mt -89.3 140.14 29.79 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.768 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.89 -175.15 4.02 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.47 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 79.1 m -148.83 173.06 13.67 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.0 p -114.05 122.3 46.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.915 0.388 . . . . 0.0 110.445 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.702 HG22 HG13 ' A' ' 37' ' ' ILE . 25.3 p -98.65 117.01 32.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.042 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.437 ' HZ3' HD11 ' A' ' 40' ' ' ILE . 1.2 t-105 -68.48 148.4 50.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.279 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -69.16 144.91 95.77 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.142 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.91 125.27 18.58 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.274 2.649 . . . . 0.0 113.484 -173.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 71.59 -8.28 1.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.056 172.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -67.07 -44.75 79.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.343 . . . . 0.0 111.491 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 47.7 tp -57.51 -31.43 66.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.548 -175.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.83 -41.11 86.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.301 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.52 -49.66 18.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.849 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 0.3 OUTLIER -54.88 -40.93 70.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.139 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.93 -48.16 76.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.856 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.63 -35.98 81.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.828 0.347 . . . . 0.0 111.407 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -87.33 16.08 5.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.891 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 68.14 24.38 7.68 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.511 ' HD2' ' HA ' ' A' ' 142' ' ' GLU . 75.6 m-85 -83.57 -25.48 30.89 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.849 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 94.5 m95 -133.96 132.96 40.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.885 176.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.619 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.8 tt -90.62 115.13 27.5 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.6 tp -93.98 135.55 35.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.764 0.316 . . . . 0.0 111.386 -175.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.5 t -156.21 156.17 33.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.782 ' HG3' ' HE3' ' A' ' 8' ' ' LYS . 7.6 mp0 -70.11 153.54 43.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.61 -3.56 9.82 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -71.97 81.64 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.795 0.807 . . . . 0.0 111.322 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -158.57 165.48 34.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.0 -30.05 32.94 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.1 m -55.76 -30.5 61.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.938 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.49 -53.19 52.06 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.945 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.403 ' CZ ' HG12 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -115.77 -46.07 2.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.844 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -65.01 -47.34 77.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.81 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.534 0.358 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.656 179.533 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -4.33 20.76 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.69 -57.32 12.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 111.627 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -75.25 -24.54 57.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -66.02 -22.44 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.19 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 13.7 tpt -55.12 -33.29 62.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.45 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.472 HD22 HD21 ' A' ' 149' ' ' LEU . 12.1 tp -107.79 -51.96 2.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.958 0.409 . . . . 0.0 110.878 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.016 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -175.414 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.43 ' HA ' ' ND1' ' A' ' 31' ' ' HIS . 61.2 t30 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.83 -98.49 0.45 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.466 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 29' ' ' CYS . 56.2 mt-30 61.84 122.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.429 1.109 . . . . 0.0 112.557 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.04 5.77 88.94 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.937 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -93.74 158.18 15.8 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.455 ' HE1' HD11 ' A' ' 11' ' ' ILE . 29.8 p90 -134.52 163.04 30.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.049 0.452 . . . . 0.0 110.924 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 4.2 pt -127.54 128.16 69.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.421 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.668 HG12 ' HA ' ' A' ' 171' ' ' ASN . 4.5 mp -87.92 132.51 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.364 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.32 168.59 26.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.418 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 m . . . . . 0 C--N 1.322 -0.629 0 CA-C-O 120.951 0.405 . . . . 0.0 110.66 178.768 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.9 p -84.78 -168.13 2.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.417 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.743 HG23 HG22 ' A' ' 40' ' ' ILE . 2.7 p -56.01 136.19 18.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.479 173.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.425 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.2 tp -114.14 -55.41 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.78 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.425 ' HD1' HG13 ' A' ' 26' ' ' ILE . 5.2 p90 -175.45 171.93 2.75 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.212 0.529 . . . . 0.0 111.852 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.0 mm -90.95 126.55 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.754 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 6' ' ' GLN . 43.2 t -81.98 -50.89 8.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.046 -174.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 45.8 mt-10 -136.21 146.59 46.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.963 0.411 . . . . 0.0 111.454 -177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.43 ' ND1' ' HA ' ' A' ' 4' ' ' ASN . 30.1 t-80 -137.21 114.05 10.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.088 175.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -116.7 172.31 7.32 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.406 ' HA ' ' CD2' ' A' ' 137' ' ' HIS . 41.0 m-20 -82.23 -20.03 38.5 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 172.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -16.03 24.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.665 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.43 174.46 44.41 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.303 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -149.23 133.58 17.47 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.437 -0.449 . . . . 0.0 110.401 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.75 HG13 HG22 ' A' ' 133' ' ' THR . 4.5 mp -122.87 123.64 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.246 -177.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.41 172.0 24.46 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.044 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.2 97.53 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.394 0.616 . . . . 0.0 110.51 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.743 HG22 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -130.98 24.48 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.195 -176.177 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.885 HG12 ' HB3' ' A' ' 74' ' ' ASN . 10.0 tp -55.81 -39.17 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.447 -173.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.48 25.19 14.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.613 0.365 . . . . 0.0 111.605 175.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.625 HG22 HG13 ' A' ' 41' ' ' ILE . 3.8 t -166.81 148.27 5.46 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 122.076 -0.39 . . . . 0.0 110.144 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 2.3 Cg_endo -81.99 -173.57 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.22 2.613 . . . . 0.0 112.471 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -101.58 -161.23 0.84 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.18 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.86 -7.69 22.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.284 0.564 . . . . 0.0 110.443 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.416 ' O ' HG12 ' A' ' 72' ' ' VAL . 16.4 tp -107.21 171.22 7.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.252 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.822 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 14.7 m -119.65 161.77 20.12 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.106 -0.371 . . . . 0.0 110.342 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 12.8 p -69.39 -35.49 67.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.046 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.0 mt -59.69 -37.61 79.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.084 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.822 ' HG2' ' HB2' ' A' ' 48' ' ' SER . 23.2 mm-40 -60.01 -53.18 60.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.445 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' A' ' 56' ' ' MET . 94.5 mt -61.05 -46.78 89.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.663 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 85.1 mt -57.53 -44.67 85.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.299 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.7 p -75.5 -36.35 60.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.259 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.438 ' HD2' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -58.51 -50.82 72.38 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.661 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 52' ' ' LEU . 25.4 ptt? . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.225 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.002 0.43 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.427 ' O ' HG12 ' A' ' 49' ' ' VAL . 25.9 mm-40 -120.07 120.27 35.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.247 0.546 . . . . 0.0 110.304 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 12.4 ttt -88.44 144.05 26.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.407 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.528 HG21 HD23 ' A' ' 129' ' ' LEU . 9.0 p -89.08 137.12 21.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.202 0.525 . . . . 0.0 110.73 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 67.3 mt -80.43 167.84 19.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.216 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.885 ' HB3' HG12 ' A' ' 41' ' ' ILE . 7.1 t-20 -97.64 155.85 16.8 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -109.69 -25.6 5.38 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.455 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.88 174.1 20.19 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.46 -9.18 18.69 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.858 2.372 . . . . 0.0 112.221 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.499 HG12 ' OD1' ' A' ' 79' ' ' ASN . 6.1 t -104.12 139.22 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.269 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.582 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 20.3 m120 56.05 34.5 23.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.442 0.297 . . . . 0.0 111.325 176.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.613 ' HA ' ' CA ' ' A' ' 130' ' ' GLY . 15.7 tt0 -66.54 -13.67 61.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.154 0.502 . . . . 0.0 111.524 -174.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.71 -8.48 57.36 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.735 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -102.25 133.7 46.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.032 0.444 . . . . 0.0 111.228 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.35 124.24 6.37 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.715 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -108.73 123.1 48.48 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.44 HG21 HG21 ' A' ' 112' ' ' VAL . 5.2 mp -139.56 112.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 0.0 110.662 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.8 t -115.29 132.04 65.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.302 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -125.53 152.51 44.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.64 ' HB3' ' HB3' ' A' ' 159' ' ' PHE . 20.1 p -81.38 148.46 29.32 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 87.8 tttt -67.01 114.35 5.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.865 0.841 . . . . 0.0 111.57 -176.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.706 ' HB ' ' HA ' ' A' ' 122' ' ' PRO . 3.5 m -138.55 10.51 2.71 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -140.3 164.6 29.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.031 -168.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -136.44 15.69 3.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.331 0.586 . . . . 0.0 109.74 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -124.87 160.75 28.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.844 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.1 p90 170.44 154.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.188 0.93 . . . . 0.0 109.887 -175.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.4 m -104.08 -45.19 4.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.229 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -151.71 108.32 3.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.834 0.35 . . . . 0.0 110.494 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 p -139.89 150.18 44.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.067 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -102.18 112.12 24.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -90.56 123.68 34.41 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.184 0.516 . . . . 0.0 111.557 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.4 -54.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.2 p -116.43 -165.86 1.1 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -90.03 15.57 9.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.683 0.754 . . . . 0.0 109.349 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 13.2 t70 -131.03 -59.97 0.97 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.251 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.699 HG13 HD13 ' A' ' 158' ' ' LEU . 50.7 mm -72.49 122.15 24.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.126 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.96 133.17 45.57 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.328 0.585 . . . . 0.0 112.383 -176.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 85' ' ' ILE . 31.1 tp -99.77 122.11 42.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.216 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m -102.54 123.86 47.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.822 0.344 . . . . 0.0 110.113 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.6 p -116.53 20.62 14.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.887 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 m -139.67 177.58 7.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.445 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.77 -6.17 49.6 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.518 -0.372 . . . . 0.0 112.262 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.22 -29.38 63.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.207 0.527 . . . . 0.0 110.619 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.454 HG13 HD22 ' A' ' 113' ' ' LEU . 14.8 p -54.63 -34.02 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.714 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.473 HD11 HD22 ' A' ' 53' ' ' LEU . 2.9 mm? -63.57 -35.99 82.32 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.026 0.441 . . . . 0.0 110.356 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.27 -34.54 65.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.88 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.2 m -58.31 -49.46 77.07 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.136 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -99.9 3.73 44.67 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.886 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.13 11.55 65.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.82 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -118.24 164.71 14.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -66.98 -23.01 65.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.898 0.38 . . . . 0.0 110.856 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.9 p -94.07 24.57 4.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.934 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -51.07 136.37 28.42 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.14 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.706 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 31.3 Cg_exo -58.74 145.96 94.16 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.095 2.53 . . . . 0.0 112.339 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.99 -47.93 70.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.242 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -141.8 143.53 33.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.663 -176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -152.03 148.59 27.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.83 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.4 pt -118.71 141.34 38.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.71 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.99 122.8 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.246 0.546 . . . . 0.0 110.495 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 81.3 m -132.81 158.14 43.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.153 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 72' ' ' VAL . 3.4 mm? -112.76 113.21 25.21 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.852 0.358 . . . . 0.0 110.555 175.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.613 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . 101.98 -178.24 26.92 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.556 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 34.8 m -144.43 168.43 20.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.7 m -114.33 116.09 28.4 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.75 HG22 HG13 ' A' ' 37' ' ' ILE . 40.8 p -117.56 143.79 45.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.257 0.551 . . . . 0.0 111.731 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -110.89 177.47 4.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.233 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.542 ' HB3' ' HD2' ' A' ' 136' ' ' PRO . 65.6 mttp -85.17 167.13 27.52 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.221 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 135' ' ' LYS . 90.4 Cg_exo -44.15 105.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.969 2.446 . . . . 0.0 113.507 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 4.4 m-70 65.48 7.62 4.48 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.946 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.561 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.7 tp60 -57.5 -48.1 80.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.105 0.411 . . . . 0.0 111.396 -174.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.504 ' O ' HG13 ' A' ' 143' ' ' ILE . 65.3 tp -57.04 -34.86 68.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.981 0.42 . . . . 0.0 110.993 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.89 -46.05 91.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.59 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 13.4 mp0 -73.14 -30.15 63.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.09 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 66.9 mm-40 -60.92 -42.55 98.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.254 0.549 . . . . 0.0 110.013 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.547 HG12 ' HB2' ' A' ' 148' ' ' TRP . 86.0 mt -65.09 -29.73 48.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.586 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.07 -12.7 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.371 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 48.0 mt-30 -88.94 1.18 55.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.418 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 68.69 17.44 8.89 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.607 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -80.34 -18.95 47.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.325 0.583 . . . . 0.0 110.137 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.547 ' HB2' HG12 ' A' ' 143' ' ' ILE . 84.7 m95 -126.1 138.89 53.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.05 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 48.8 mt -106.43 107.59 18.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.073 0.463 . . . . 0.0 110.232 176.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tt -84.73 134.13 34.35 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.286 -174.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.505 ' HB2' HD13 ' A' ' 174' ' ' LEU . 16.1 t -150.07 178.09 9.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.045 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.25 154.14 39.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.254 0.55 . . . . 0.0 111.549 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.81 145.16 32.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.202 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -88.61 26.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.097 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.8 t30 70.48 -45.66 0.6 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.884 0.874 . . . . 0.0 110.672 -174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -57.93 -43.49 86.32 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 121.185 0.517 . . . . 0.0 109.851 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -28.84 69.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.444 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.699 HD13 HG13 ' A' ' 104' ' ' ILE . 2.8 tt -74.5 -56.57 4.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.112 -173.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.64 ' HB3' ' HB3' ' A' ' 88' ' ' SER . 0.4 OUTLIER -125.27 -23.55 4.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -174.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.29 -51.09 14.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.357 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.63 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.23 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.546 0.689 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.11 -6.0 47.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.73 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.71 67.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.074 0.464 . . . . 0.0 110.649 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.668 ' HA ' HG12 ' A' ' 11' ' ' ILE . 44.6 t30 -67.87 -39.43 83.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.111 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -79.29 -20.89 46.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.718 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.514 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 2.2 tpt -63.11 -33.6 75.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.462 0.648 . . . . 0.0 109.263 173.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 151' ' ' SER . 13.0 tp -81.0 -45.06 17.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.251 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 CA-C-N 115.437 -0.802 . . . . 0.0 113.247 175.614 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 121.339 0.59 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.47 HD13 HD23 ' A' ' 139' ' ' LEU . 85.1 mt -74.82 -8.86 57.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.633 -171.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.3 132.82 49.24 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.73 11.7 84.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.774 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.634 ' HG3' ' HA ' ' A' ' 152' ' ' GLU . 13.8 mptt -117.06 172.05 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.481 -0.423 . . . . 0.0 110.145 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 54.9 p90 -144.21 152.94 41.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.587 HD12 ' CE3' ' A' ' 148' ' ' TRP . 17.4 pt -109.79 151.83 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.992 0.425 . . . . 0.0 110.877 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.793 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 40.8 mm -100.66 115.51 42.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.826 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -149.63 147.65 28.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.588 0.232 . . . . 0.0 111.485 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.035 178.376 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HD2' HD21 ' A' ' 73' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -74.82 79.89 2.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.108 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.826 HG21 ' HB3' ' A' ' 12' ' ' ALA . 91.9 t 72.72 132.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.875 174.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.598 HG13 ' HD1' ' A' ' 27' ' ' TYR . 4.6 tp -122.72 -103.65 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.941 174.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.598 ' HD1' HG13 ' A' ' 26' ' ' ILE . 8.8 p90 -129.33 173.8 10.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 120.027 1.285 . . . . 0.0 112.348 -171.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.3 mm -100.49 128.29 52.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.673 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.1 m -79.8 -57.8 3.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.519 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.44 157.75 43.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.268 0.556 . . . . 0.0 111.297 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -133.03 112.06 11.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.666 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -94.98 163.33 13.36 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 166.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.33 -30.9 71.49 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.189 0.519 . . . . 0.0 110.608 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -96.65 -33.98 11.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.718 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.93 123.45 4.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.354 -172.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 133' ' ' THR . 28.4 m -108.78 116.34 31.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 176.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.602 HG13 HG22 ' A' ' 133' ' ' THR . 3.5 mp -104.32 120.13 54.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.834 0.349 . . . . 0.0 110.943 -174.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.46 163.5 29.26 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.913 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.534 HG23 HG23 ' A' ' 26' ' ' ILE . 1.6 m -115.42 88.1 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.668 0.747 . . . . 0.0 110.501 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.548 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -132.27 26.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.061 -175.689 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.648 HG21 ' O ' ' A' ' 74' ' ' ASN . 10.7 tp -64.74 -36.56 77.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.415 -172.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.522 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.1 t-20 63.38 63.88 0.86 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.126 0.489 . . . . 0.0 110.923 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.551 HG22 HG13 ' A' ' 41' ' ' ILE . 14.3 t 173.37 130.0 0.1 Allowed Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.927 175.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 75.1 Cg_endo -92.97 155.95 2.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.175 2.583 . . . . 0.0 112.038 173.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 74' ' ' ASN . 9.8 p -87.6 -177.99 6.0 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.74 -2.86 46.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.735 0.779 . . . . 0.0 109.458 177.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.437 HD21 HD21 ' A' ' 52' ' ' LEU . 62.2 tp -90.35 158.3 17.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.164 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 11.8 m -114.42 152.88 30.85 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.207 -0.308 . . . . 0.0 110.467 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.615 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.2 p -64.15 -37.62 80.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.043 0.449 . . . . 0.0 110.007 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.38 -34.2 77.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.339 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 48' ' ' SER . 34.1 mt-10 -63.51 -44.0 95.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.518 177.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.497 HD13 HD21 ' A' ' 129' ' ' LEU . 56.4 mt -66.59 -45.93 77.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.75 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 89.3 mt -56.04 -48.97 75.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.072 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -73.1 -31.42 64.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.539 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -68.63 -52.36 32.24 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.81 0.338 . . . . 0.0 111.021 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.9 mtm . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.916 -177.092 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 121.304 0.573 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -103.21 112.94 26.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.618 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 87.7 mtp -82.3 145.29 30.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.033 0.444 . . . . 0.0 111.397 -171.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.458 HG23 HG22 ' A' ' 127' ' ' VAL . 8.1 p -99.03 143.29 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.369 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 8.0 mp -90.78 164.14 14.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 110.373 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 41' ' ' ILE . 3.6 t-20 -100.27 103.49 14.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.59 -27.8 61.72 Favored Glycine 0 C--N 1.328 0.098 0 O-C-N 123.5 0.5 . . . . 0.0 112.885 -171.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.03 172.19 30.22 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.14 -13.04 28.42 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.333 2.022 . . . . 0.0 111.825 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.74 145.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.468 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.545 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 83.9 m-20 63.96 24.75 13.72 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.222 0.326 . . . . 0.0 111.765 174.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -69.16 -10.89 59.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.702 0.763 . . . . 0.0 110.595 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.0 -13.68 60.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.711 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -113.71 134.54 54.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.981 0.42 . . . . 0.0 110.935 -172.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.57 119.22 5.06 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.755 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -105.84 121.52 44.23 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.436 HG13 HG23 ' A' ' 127' ' ' VAL . 5.1 mp -141.96 117.72 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 95.3 t -112.14 119.82 61.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.431 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -129.5 159.64 35.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -177.383 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.6 m -82.45 167.68 18.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.119 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.431 ' HE2' ' CE1' ' A' ' 87' ' ' HIS . 4.7 mptp? -119.22 122.02 41.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 t -94.13 -21.11 19.31 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.573 -173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.885 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 2.6 t70 -114.03 -4.78 13.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.56 0.695 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.7 m170 67.29 34.39 4.9 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.07 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.885 ' HG3' ' HB3' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -87.97 165.72 15.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.94 175.03 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -159.06 116.57 2.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.294 0.568 . . . . 0.0 110.966 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.7 m -88.73 -60.57 1.92 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.97 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.557 ' H ' ' HB2' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -145.24 35.22 1.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.439 179.131 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 148.48 24.47 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.97 -175.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -102.16 135.68 43.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.565 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -87.3 116.12 25.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.37 -54.04 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 169.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.807 HG22 ' HB ' ' A' ' 104' ' ' ILE . 11.9 t -138.69 -158.43 0.86 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -59.33 -65.18 0.71 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -93.66 -23.96 18.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.751 0.31 . . . . 0.0 111.38 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.807 ' HB ' HG22 ' A' ' 101' ' ' THR . 41.3 mm -86.96 122.46 38.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.987 0.423 . . . . 0.0 110.823 -171.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.1 p -134.16 137.9 44.8 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.981 -175.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.6 tp -91.82 137.66 32.18 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.33 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.818 HG21 ' HB3' ' A' ' 111' ' ' ASP . 25.4 m -138.8 140.04 38.44 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.733 -0.604 . . . . 0.0 111.456 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.4 p -111.6 -29.07 7.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.417 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.5 m -155.55 160.29 40.39 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.689 0.281 . . . . 0.0 111.171 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.82 -82.19 0.41 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.903 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.818 ' HB3' HG21 ' A' ' 107' ' ' THR . 11.2 t70 -51.91 -48.57 64.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.546 0.738 . . . . 0.0 111.629 -173.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.561 HG13 HD22 ' A' ' 113' ' ' LEU . 7.6 p -63.58 -38.64 82.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.988 -176.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.561 HD22 HG13 ' A' ' 112' ' ' VAL . 2.6 mm? -69.46 -33.27 72.67 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.303 0.573 . . . . 0.0 110.0 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -76.35 -28.2 56.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.607 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.6 m -57.48 -62.43 1.79 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.35 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -86.36 27.68 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -172.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.2 20.36 23.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.155 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.6 t -162.93 172.72 14.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -71.54 -19.49 62.16 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.722 0.296 . . . . 0.0 111.471 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.0 p -84.53 18.27 2.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 0.0 110.994 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.41 129.82 93.85 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.341 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.98 139.23 72.42 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.623 2.215 . . . . 0.0 112.195 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -60.71 -48.58 81.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.515 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 159' ' ' PHE . 2.0 mmpp? -101.05 119.09 38.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.937 -168.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 36.9 p90 -154.87 127.93 8.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.289 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.2 pt -109.43 133.54 54.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.082 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.557 HG11 ' HB ' ' A' ' 49' ' ' VAL . 7.5 p -116.44 128.94 73.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.279 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 81.2 m -143.52 151.97 40.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.105 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 52' ' ' LEU . 2.4 mm? -102.45 117.18 34.17 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 174.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . 83.67 -175.85 52.19 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.964 -175.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 19.3 m -148.45 163.69 36.41 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 m -98.37 114.84 27.32 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.602 HG22 HG13 ' A' ' 37' ' ' ILE . 22.6 p -112.5 120.02 40.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.522 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 0.4 OUTLIER -86.23 133.25 33.85 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.243 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 136' ' ' PRO . 96.6 mttt -65.0 153.31 89.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.082 -175.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 135' ' ' LYS . 33.5 Cg_exo -28.7 98.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 1 C-N-CA 125.507 4.138 . . . . 0.0 115.233 -171.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 71.58 -2.71 2.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.88 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -62.82 -30.07 71.21 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.47 HD23 HD13 ' A' ' 5' ' ' LEU . 36.2 tp -60.14 -29.16 68.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.604 0.24 . . . . 0.0 111.296 -176.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.99 -38.4 90.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.07 0.462 . . . . 0.0 109.912 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.518 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.9 mp0 -70.43 -37.16 74.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.412 177.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.522 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 74.7 mm-40 -63.41 -43.7 96.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.341 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 139' ' ' LEU . 73.3 mt -68.56 -31.24 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.483 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.26 -24.43 67.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.215 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 39.9 mt-30 -83.7 -0.59 51.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.562 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 62.23 17.24 9.1 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.665 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -87.97 0.78 55.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.415 0.626 . . . . 0.0 109.703 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.587 ' CE3' HD12 ' A' ' 10' ' ' ILE . 99.4 m95 -138.07 122.11 17.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.651 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.793 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 75.8 mt -98.92 145.64 26.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.1 tp -124.49 134.65 52.97 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.138 0.494 . . . . 0.0 111.368 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.0 t -138.38 148.95 45.07 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.432 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.634 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 26.0 mp0 -87.32 153.32 21.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.032 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -115.05 128.71 56.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.123 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -62.4 -63.56 1.2 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.986 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -177.64 -56.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.095 175.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 42.0 mt-30 -62.85 -27.3 69.24 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.808 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.9 m -52.45 -29.06 22.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.134 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.1 mt -65.21 -54.72 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.463 ' HD2' ' HB3' ' A' ' 124' ' ' LYS . 54.1 m-85 -129.83 -14.17 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 44.2 mt-10 -96.41 0.89 51.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.162 0.506 . . . . 0.0 110.877 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.183 175.378 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 173' ' ' MET . 50.2 mt-10 -53.89 -42.99 69.27 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.59 -46.26 66.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.037 0.446 . . . . 0.0 111.276 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -80.44 -36.84 33.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.909 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.18 -29.29 70.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.504 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 169' ' ' GLU . 29.2 mmt -60.64 -29.35 69.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.918 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.425 HD13 HG13 ' A' ' 11' ' ' ILE . 5.2 tt -101.1 -51.66 3.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.925 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.94 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.443 -178.773 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.099 0.476 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.09 8.87 16.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.184 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -70.95 119.77 15.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.391 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.17 7.84 45.73 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.1 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -116.85 175.36 5.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.512 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 26.9 p90 -146.92 140.58 25.75 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 171.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 pt -93.92 131.74 39.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.311 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.978 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 3.4 mp -90.07 114.99 28.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.833 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.573 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -90.71 125.2 35.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.609 174.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 120.89 0.376 . . . . 0.0 110.706 -179.706 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.525 ' HG2' HG21 ' A' ' 126' ' ' ILE . 7.1 tpm_? . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.235 0.541 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 t -91.91 132.41 36.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.501 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t 71.43 117.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.259 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.916 HG22 ' HD1' ' A' ' 27' ' ' TYR . 9.0 mm -116.17 -95.55 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.326 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.916 ' HD1' HG22 ' A' ' 26' ' ' ILE . 2.1 p90 178.09 -177.4 0.22 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.251 0.22 . . . . 0.0 110.56 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.2 mm -95.25 124.6 47.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.3 m -91.22 -46.46 8.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.722 -173.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.739 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 32.1 mt-10 -131.89 150.57 52.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.372 0.606 . . . . 0.0 112.218 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -132.37 105.95 7.6 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 167.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -109.3 171.05 7.67 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.453 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.53 -26.23 68.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.665 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -111.41 13.01 21.53 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.11 170.59 22.22 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.238 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 133' ' ' THR . 55.1 m -115.21 130.41 56.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.839 HG13 HG22 ' A' ' 133' ' ' THR . 3.8 mp -109.59 119.11 58.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.425 -173.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.01 165.12 28.56 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.121 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.515 HG23 ' HB ' ' A' ' 26' ' ' ILE . 3.3 m -126.99 102.5 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.237 0.541 . . . . 0.0 110.957 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.489 HD13 ' N ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -141.79 12.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.166 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 tp -74.55 -33.8 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.204 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 58.96 86.5 0.09 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.798 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 9.0 t -163.04 123.02 1.41 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.257 0.551 . . . . 0.0 111.411 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 2.4 Cg_endo -83.01 173.95 9.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.184 2.589 . . . . 0.0 111.607 176.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.405 HG22 ' ND2' ' A' ' 74' ' ' ASN . 16.6 p -118.17 -171.51 2.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.756 0.312 . . . . 0.0 110.366 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.76 7.11 47.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.387 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -112.12 155.52 23.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.427 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 43.0 m -104.91 157.44 17.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.003 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 14.7 p -68.67 -34.08 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.18 0.515 . . . . 0.0 109.92 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.82 -25.9 60.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.291 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -53.16 56.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.751 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.1 pp -65.57 -33.62 76.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.605 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.82 -50.58 66.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.179 0.514 . . . . 0.0 110.96 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.9 p -72.43 -29.19 63.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -72.47 -39.62 67.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.388 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 19.7 ptp . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -174.77 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 120.659 0.266 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -128.3 112.79 14.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.881 0.372 . . . . 0.0 110.704 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.634 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 69.7 mtm -92.59 161.29 14.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.186 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.66 141.39 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.516 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.6 mp -109.2 170.51 8.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -176.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.405 ' ND2' HG22 ' A' ' 45' ' ' THR . 75.1 m-20 -110.21 132.15 54.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.013 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.75 -16.94 53.79 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.424 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.49 -179.35 36.95 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.934 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -86.79 5.04 6.01 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.164 2.576 . . . . 0.0 112.824 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.407 HG21 ' OG1' ' A' ' 133' ' ' THR . 21.7 t -120.19 153.84 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.415 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 89.4 m-20 65.53 33.44 8.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.873 0.368 . . . . 0.0 110.333 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -65.31 -14.51 60.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.102 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -91.1 -4.67 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.422 0.63 . . . . 0.0 110.553 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -109.5 120.36 42.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.074 0.464 . . . . 0.0 110.897 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.75 108.52 3.62 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.55 ' HB3' HD11 ' A' ' 106' ' ' LEU . 98.0 m-85 -97.19 125.27 41.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.698 0.285 . . . . 0.0 110.735 -176.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.444 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.7 mp -117.12 109.92 29.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.207 0.527 . . . . 0.0 109.891 175.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -94.13 121.01 44.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.322 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -138.55 155.56 48.27 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.461 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.1 m -73.98 164.38 26.7 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 103' ' ' ASP . 14.3 ttmm -88.5 118.1 27.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.072 0.939 . . . . 0.0 112.291 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.4 m -139.48 18.43 2.55 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 169.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -132.6 161.31 34.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.019 -167.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.14 28.14 1.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.603 171.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.51 170.27 13.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.708 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -162.66 79.98 0.5 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.7 m -92.56 -41.42 10.25 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -169.6 78.38 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.337 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.6 m -115.2 133.86 55.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.102 -172.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.601 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 4.8 t80 -102.11 102.54 13.02 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -81.73 106.27 13.53 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.08 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.55 HG11 ' HE2' ' A' ' 27' ' ' TYR . 16.8 t -91.06 -62.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 46.5 p -119.05 175.71 5.64 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.97 -33.06 64.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 20.5 t70 -106.37 -49.12 3.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.392 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.6 mm -76.2 121.95 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.208 0.528 . . . . 0.0 110.001 -169.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.6 m -122.11 132.45 54.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.758 -175.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 58.6 tp -102.23 112.24 24.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.839 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.664 HG21 ' HB3' ' A' ' 111' ' ' ASP . 15.2 m -106.96 124.3 49.43 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.03 28.35 8.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.881 -175.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 t -146.8 -174.24 4.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.711 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.34 -0.87 25.12 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.091 -176.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.664 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.4 t70 -55.26 -37.7 67.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.258 0.552 . . . . 0.0 110.123 174.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.559 HG23 HD22 ' A' ' 113' ' ' LEU . 36.0 m -55.82 -34.33 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.142 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.559 HD22 HG23 ' A' ' 112' ' ' VAL . 3.5 mm? -62.49 -34.55 77.08 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.446 0.641 . . . . 0.0 110.197 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.37 -25.8 31.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.919 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.0 m -62.3 -57.1 12.62 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.236 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.433 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 11.7 p90 -91.46 3.66 54.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 110.858 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.67 29.18 12.07 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.954 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.4 t -140.62 174.19 10.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -65.05 -39.16 92.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.813 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.7 p -89.76 32.32 0.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.48 -176.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 116' ' ' PHE . . . -58.51 130.46 84.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.993 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.22 140.22 91.07 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.916 2.411 . . . . 0.0 112.308 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.09 -52.87 44.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.723 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -104.75 113.3 26.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.221 -172.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -147.27 133.61 19.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.806 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.525 HG21 ' HG2' ' A' ' 23' ' ' ARG . 32.7 pt -123.99 143.03 38.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.578 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.24 119.35 60.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.227 0.537 . . . . 0.0 110.489 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.6 p -131.07 130.88 43.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.532 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.69 125.63 34.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.014 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . 75.56 178.48 43.2 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.884 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 77.8 m -150.76 173.32 14.33 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.4 m -102.16 116.9 33.63 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 37' ' ' ILE . 78.3 p -111.12 120.83 43.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.994 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -81.01 137.71 36.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.472 . . . . 0.0 110.487 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -71.67 140.23 84.01 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.521 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -36.58 130.25 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.248 3.299 . . . . 0.0 114.716 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 77.37 -34.43 0.2 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.41 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.6 tp60 -60.2 -44.38 95.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -173.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.8 tp -55.82 -35.46 66.39 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.661 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -64.36 -38.92 92.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.148 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -71.26 -39.47 71.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 8.4 mm-40 -57.8 -51.12 70.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.302 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.8 mt -68.75 -33.15 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.564 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.4 91.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.311 . . . . 0.0 111.057 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -86.1 12.64 9.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.09 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 62.32 32.97 16.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.082 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.531 ' HD2' ' HA ' ' A' ' 142' ' ' GLU . 15.9 m-85 -72.14 -28.0 62.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.229 0.538 . . . . 0.0 109.738 172.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.573 ' HZ3' ' HB2' ' A' ' 12' ' ' ALA . 91.0 m95 -134.08 139.41 45.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.695 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.978 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.9 tt -88.2 141.3 28.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.535 ' N ' HD23 ' A' ' 149' ' ' LEU . 59.3 tp -123.09 134.57 54.24 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.696 -175.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.9 p -161.42 164.07 30.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.877 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -71.13 155.78 40.36 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.142 0.496 . . . . 0.0 111.274 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.04 -155.16 0.53 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.935 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.3 t30 65.85 22.9 11.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.76 0.791 . . . . 0.0 109.891 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -88.31 165.72 14.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.883 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 38.0 mt-30 -59.31 -29.09 67.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.052 0.453 . . . . 0.0 110.624 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.664 ' HA ' HG23 ' A' ' 161' ' ' THR . 6.7 m -52.63 -30.48 31.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.262 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.54 -57.18 6.94 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.356 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -127.42 -19.26 4.27 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 41.0 mt-10 -82.74 -9.07 59.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 111.524 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 157' ' ' THR . 1.6 p . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 121.401 0.62 . . . . 0.0 110.246 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 168' ' ' VAL . 6.8 t . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 121.329 0.585 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.4 -7.21 41.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.037 0.446 . . . . 0.0 110.933 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.477 ' HB1' ' CG1' ' A' ' 11' ' ' ILE . . . -53.79 -39.37 65.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.181 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -81.08 -33.03 33.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.554 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.19 -27.91 61.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 0.0 110.658 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.615 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 1.0 OUTLIER -59.6 -33.05 70.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.196 0.522 . . . . 0.0 110.213 175.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 149' ' ' LEU . 12.8 tp -82.05 -48.73 11.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.473 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.228 -179.535 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 CA--C 1.519 -0.213 0 CA-C-O 120.633 0.254 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.79 -82.8 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 173.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 57.13 107.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 172.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.33 -1.96 79.1 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.565 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.69 ' HD2' ' HB3' ' A' ' 152' ' ' GLU . 37.9 mmtm -95.4 159.85 14.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.478 ' HZ ' ' HG2' ' A' ' 173' ' ' MET . 45.0 p90 -123.79 154.41 39.59 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.511 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.567 HD11 HG21 ' A' ' 40' ' ' ILE . 8.4 pt -114.45 144.56 21.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.758 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.7 mp -110.73 161.41 9.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.405 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 70.51 -176.59 0.2 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.547 0.529 . . . . 0.0 110.784 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 C--N 1.325 -0.486 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.385 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 121.401 0.62 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.3 t -97.51 112.01 24.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.228 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.464 HG22 ' HB ' ' A' ' 40' ' ' ILE . 38.6 t 54.76 92.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.076 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.496 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.4 tp -95.02 -57.35 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.496 ' HD1' HG13 ' A' ' 26' ' ' ILE . 6.1 p90 -174.3 175.47 2.63 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.158 0.436 . . . . 0.0 111.637 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.8 mm -94.93 126.61 47.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.816 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.35 -51.24 15.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.753 0.311 . . . . 0.0 111.157 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -159.92 153.83 23.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 0.0 110.846 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -120.6 104.64 10.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -106.59 171.04 7.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.194 -173.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.76 -22.59 65.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.92 0.391 . . . . 0.0 110.999 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -80.69 -39.7 26.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.057 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 170.58 -167.31 40.47 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.605 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.7 m -103.21 121.18 42.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.683 0.277 . . . . 0.0 110.335 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.647 HG13 HG22 ' A' ' 133' ' ' THR . 4.3 mp -98.0 118.74 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.09 153.93 25.37 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.494 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -114.6 88.69 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.728 0.775 . . . . 0.0 110.692 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.581 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -125.1 18.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.113 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.537 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -61.07 -36.17 70.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.382 -176.063 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.6 t30 56.23 66.83 1.1 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 110.582 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 t -169.47 103.41 0.47 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-O 121.545 0.688 . . . . 0.0 111.156 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 5.9 Cg_exo -78.83 158.75 27.8 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.612 2.208 . . . . 0.0 110.286 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.54 HG21 ' ND2' ' A' ' 74' ' ' ASN . 73.6 p -110.38 166.3 11.09 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.549 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -73.87 -30.35 62.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.976 0.417 . . . . 0.0 110.78 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.62 149.99 49.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.261 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.0 m -97.59 150.83 20.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.965 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.676 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.1 p -61.85 -36.62 74.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.71 -35.46 81.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.481 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 8.3 mm-40 -62.04 -39.0 90.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.038 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.1 mt -74.98 -35.6 62.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.941 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 83.2 mt -62.96 -49.46 74.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.497 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.2 p -67.56 -30.34 69.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.857 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 1.7 tpp180 -60.77 -52.24 65.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.6 -177.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.1 ptt? . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -173.428 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.935 0.398 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -122.57 118.18 27.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.205 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.6 mtt -77.9 152.24 33.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.568 HG21 HD23 ' A' ' 129' ' ' LEU . 13.8 p -106.52 149.38 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.283 174.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.565 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.0 mp -102.42 159.75 15.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.763 0.315 . . . . 0.0 110.333 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.54 ' ND2' HG21 ' A' ' 45' ' ' THR . 35.9 m-20 -101.83 121.75 42.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.29 -23.34 58.99 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.542 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.97 -177.07 36.6 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.397 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.53 -25.94 7.64 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.259 2.639 . . . . 0.0 112.835 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.3 t -86.62 125.93 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.988 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 67.19 31.04 6.92 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.485 0.491 . . . . 0.0 110.855 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -65.97 -21.62 66.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.46 -175.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -82.87 -0.23 47.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.265 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -125.42 142.5 51.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 110.675 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.78 131.88 10.74 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.11 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -112.72 123.1 49.55 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 106' ' ' LEU . 5.2 mp -137.49 120.16 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.913 0.387 . . . . 0.0 111.268 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.1 t -110.51 130.41 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -132.01 149.36 52.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.448 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 p -69.91 150.44 46.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.984 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -65.79 112.86 3.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.532 0.682 . . . . 0.0 110.53 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 92.5 m -157.87 -48.2 0.06 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.68 -165.77 1.41 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.645 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -165.79 134.07 3.05 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.894 ' HB3' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -100.35 -171.03 1.96 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.91 -177.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -118.0 -46.12 2.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.879 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 36.5 p -75.33 -84.32 0.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -168.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -110.6 91.29 3.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 111.571 -172.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.9 m -96.04 104.03 15.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.565 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -102.73 102.62 12.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.015 0.436 . . . . 0.0 109.9 175.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 102' ' ' ASP . 4.8 mtmm -89.76 107.01 18.84 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.58 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -60.55 -53.96 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.424 HG22 HG12 ' A' ' 104' ' ' ILE . 5.8 t -134.53 -176.16 4.12 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.469 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 33.5 t70 -65.3 -33.35 75.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 118.27 0.486 . . . . 0.0 112.285 -170.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -98.15 2.38 48.46 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 101' ' ' THR . 47.0 mm -117.81 123.65 71.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.7 m -124.41 124.99 43.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.993 0.425 . . . . 0.0 111.325 -176.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 85' ' ' ILE . 21.4 tp -101.59 130.45 47.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.021 174.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.7 m -129.16 124.89 35.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.1 p -109.03 28.87 8.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.64 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m -138.08 177.24 8.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.51 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.453 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -63.5 -11.82 43.2 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.304 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.894 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . 0.9 OUTLIER -47.84 -38.02 15.1 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.781 0.433 . . . . 0.0 111.051 175.552 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.424 HG11 HG21 ' A' ' 85' ' ' ILE . 86.5 t -52.58 -40.82 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.376 178.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.554 HD11 HD22 ' A' ' 53' ' ' LEU . 3.8 mm? -62.3 -36.46 82.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.08 -27.24 54.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.05 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 m -56.99 -55.73 30.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.192 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.492 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 20.8 p90 -90.49 26.5 1.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -173.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.67 17.12 36.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.566 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 t -145.5 -179.31 6.58 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.677 -0.308 . . . . 0.0 110.326 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -74.88 -21.74 59.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.678 0.275 . . . . 0.0 111.253 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.9 p -91.96 23.39 3.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.943 0.401 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.492 ' CB ' ' HA ' ' A' ' 116' ' ' PHE . . . -65.69 146.03 99.0 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.232 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.55 133.83 38.7 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.415 2.077 . . . . 0.0 111.452 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.49 -36.48 83.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.997 0.427 . . . . 0.0 110.794 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -136.74 128.1 28.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.075 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.01 140.78 24.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.745 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.5 pt -110.5 132.93 57.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.976 0.417 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.95 126.91 73.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.385 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 80.8 m -140.62 150.0 43.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.005 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.568 HD23 HG21 ' A' ' 72' ' ' VAL . 4.3 mm? -100.32 117.52 34.68 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.51 177.75 50.53 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.904 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 66.4 m -145.83 168.58 20.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.89 0.376 . . . . 0.0 110.432 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.5 m -114.2 119.95 38.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.265 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.647 HG22 HG13 ' A' ' 37' ' ' ILE . 21.5 p -102.03 114.7 29.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.584 0.707 . . . . 0.0 111.69 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.53 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.5 OUTLIER -99.55 135.59 40.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.925 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 10.5 mptt -75.64 136.69 70.81 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.025 -175.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 6.5 Cg_exo -74.86 42.56 0.84 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.647 2.898 . . . . 0.0 114.175 -170.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 55.1 m-70 -156.58 -38.72 0.08 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 171.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.617 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 50.4 tt0 -52.8 -60.72 2.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.906 171.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.53 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 57.4 tp -63.03 -35.88 81.71 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.402 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.476 ' HB3' ' HA ' ' A' ' 137' ' ' HIS . 40.6 tt0 -55.66 -48.75 74.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.893 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 75.5 mt-30 -72.47 -31.5 65.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.114 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 53.7 mm-40 -59.19 -44.17 92.21 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.156 0.503 . . . . 0.0 109.912 175.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.588 HG12 ' HB2' ' A' ' 148' ' ' TRP . 66.7 mt -64.43 -36.78 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.341 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.29 -24.92 67.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.403 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 73.4 mt-30 -78.17 -0.64 29.16 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.903 0.382 . . . . 0.0 110.351 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 70.28 31.28 3.15 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.895 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' TYR . . . . . 0.47 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 59.7 m-85 -100.5 -4.23 29.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.262 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.588 ' HB2' HG12 ' A' ' 143' ' ' ILE . 97.2 m95 -134.48 148.94 50.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.768 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 60.3 mt -126.03 153.35 44.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.852 175.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.1 tp -121.87 134.93 54.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.017 0.437 . . . . 0.0 111.576 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.2 t -149.96 173.13 14.15 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.69 ' HB3' ' HD2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -129.26 154.1 47.15 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.246 -179.026 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' ' 157' ' ' THR . . . -127.21 104.72 8.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.702 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -81.42 88.51 6.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.344 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 70.0 -65.97 0.29 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.828 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.581 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 30.7 mt-30 -56.62 -70.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -170.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.536 ' HB ' ' HB1' ' A' ' 153' ' ' ALA . 3.1 m -54.21 -29.57 46.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -175.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -57.21 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.87 -174.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -128.83 -13.6 4.63 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 31.4 mt-10 -81.71 -52.33 7.27 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.273 174.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.33 -0.281 0 O-C-N 124.397 1.061 . . . . 0.0 111.664 177.565 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.702 0.763 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -94.04 -3.23 51.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.767 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -56.72 -33.26 66.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.581 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -79.51 -27.88 41.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.759 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -73.29 -23.41 60.28 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.01 0.433 . . . . 0.0 110.669 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.478 ' HG2' ' HZ ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -66.29 -28.47 68.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.732 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.425 ' CD2' HD13 ' A' ' 149' ' ' LEU . 10.4 tp -112.89 -50.5 2.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.198 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -176.824 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.114 0.483 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -99.98 15.6 26.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.453 0.644 . . . . 0.0 109.752 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.732 HE21 HG13 ' A' ' 100' ' ' VAL . 49.2 tt0 -91.51 131.49 36.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.674 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.8 0.14 59.09 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.684 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.439 ' HB2' HD23 ' A' ' 5' ' ' LEU . 3.3 mptp? -107.8 176.62 5.08 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 43.3 p90 -142.72 152.94 42.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.054 0.454 . . . . 0.0 110.39 173.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 pt -118.19 128.12 75.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.307 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 60.0 mt -86.63 111.92 22.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.168 -175.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -120.78 94.87 4.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.558 173.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.276 -178.605 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.5 p -121.2 154.6 36.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.818 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t 67.91 96.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 O-C-N 123.815 0.697 . . . . 0.0 111.117 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.642 HG21 HG23 ' A' ' 39' ' ' VAL . 10.6 tp -124.65 -146.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.345 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.561 ' H ' HG13 ' A' ' 26' ' ' ILE . 3.5 p90 -116.63 171.71 7.7 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.427 1.012 . . . . 0.0 111.623 -164.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.53 116.09 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.553 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.8 m -75.51 -45.07 40.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.109 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -140.48 144.86 36.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.86 0.362 . . . . 0.0 110.719 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -128.61 111.96 13.76 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.293 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -114.75 173.36 6.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -71.84 -23.14 61.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.744 0.307 . . . . 0.0 111.112 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -107.45 -27.59 10.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.468 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.82 127.12 3.32 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 119.8 -1.19 . . . . 0.0 113.06 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 133' ' ' THR . 82.1 m -107.39 110.72 22.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.745 HG13 HG22 ' A' ' 133' ' ' THR . 4.0 mp -96.54 114.33 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.843 -172.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -145.71 160.88 28.19 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.642 HG23 HG21 ' A' ' 26' ' ' ILE . 3.0 m -114.75 63.97 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.599 0.714 . . . . 0.0 110.491 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -111.66 15.3 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.544 -175.167 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 43' ' ' THR . 10.4 tp -68.91 -28.25 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.359 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 63.7 87.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.103 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.487 HG22 HG23 ' A' ' 41' ' ' ILE . 4.1 t -168.52 96.84 0.56 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.455 0.645 . . . . 0.0 111.086 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 57.9 Cg_endo -74.84 154.19 43.13 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.059 1.839 . . . . 0.0 111.3 174.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -115.63 152.24 33.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.681 0.277 . . . . 0.0 110.614 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.77 -17.15 62.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.07 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.401 ' O ' HG12 ' A' ' 72' ' ' VAL . 21.4 tp -76.08 160.01 30.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.709 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 14.7 m -119.81 160.11 23.26 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.903 -174.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.571 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.9 p -65.82 -37.92 81.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.046 -175.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.468 HD23 HD12 ' A' ' 53' ' ' LEU . 91.6 mt -66.54 -33.98 76.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.204 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.709 ' OE1' ' HB2' ' A' ' 48' ' ' SER . 3.1 mp0 -61.76 -40.41 95.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.627 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.02 -39.82 63.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.327 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 113' ' ' LEU . 95.1 mt -62.62 -49.14 76.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.978 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.1 p -68.11 -30.97 70.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.634 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -60.25 -37.27 79.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.585 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 73.0 mtm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 176.993 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.258 0.551 . . . . 0.0 112.195 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 48' ' ' SER . 29.6 mm-40 -111.52 127.88 55.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.679 178.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 66.2 mtt -79.87 157.79 26.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.013 0.435 . . . . 0.0 111.47 -176.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 129' ' ' LEU . 9.7 p -107.74 149.87 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.237 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 8.0 mp -107.98 168.39 9.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.0 110.142 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.39 137.07 46.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.537 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -103.09 -9.38 39.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.44 -0.885 . . . . 0.0 113.009 -173.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.11 164.7 12.25 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.95 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.6 -20.91 26.29 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.961 2.441 . . . . 0.0 112.502 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.51 128.38 39.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.972 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 64.66 24.99 13.04 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.44 0.462 . . . . 0.0 110.612 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HA ' ' CA ' ' A' ' 130' ' ' GLY . 53.3 tt0 -65.29 -23.5 67.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.534 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.02 -19.63 62.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.674 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 82' ' ' ARG . 39.1 mtm180 -109.67 143.73 39.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.004 0.431 . . . . 0.0 111.057 -171.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.41 130.76 10.04 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.336 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -111.84 124.22 51.91 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.408 ' O ' HD12 ' A' ' 106' ' ' LEU . 5.4 mp -131.14 115.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.0 111.032 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.01 126.43 67.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.76 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -133.17 161.09 35.37 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.119 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 m -67.52 159.04 30.52 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.444 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 46.1 tttp -72.55 120.13 17.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.188 0.518 . . . . 0.0 110.645 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.1 m -144.99 107.67 4.45 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 173.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -54.31 138.15 39.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.345 0.593 . . . . 0.0 112.199 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -176.71 24.54 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.757 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 67.51 -165.52 0.21 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -167.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -151.56 137.32 17.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.018 0.437 . . . . 0.0 111.262 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 111' ' ' ASP . 30.9 m -89.81 -50.04 6.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.076 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 109' ' ' SER . 50.3 t60 -168.32 88.56 0.24 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.72 176.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 57.8 m -130.9 136.02 48.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.716 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -103.43 116.69 32.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 101' ' ' THR . 0.3 OUTLIER -81.32 122.08 27.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.06 0.457 . . . . 0.0 111.84 -175.037 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.732 HG13 HE21 ' A' ' 6' ' ' GLN . 64.2 t -68.4 -53.01 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 165.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 9.9 t -138.54 -169.67 2.66 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.886 -1.506 . . . . 0.0 107.0 167.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.05 -40.88 60.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 118.9 0.773 . . . . 0.0 110.983 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 6.3 m-20 -76.31 -25.55 54.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.7 mm -118.01 123.1 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 m -131.25 133.62 45.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.036 0.446 . . . . 0.0 111.987 -173.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 85' ' ' ILE . 19.1 tp -96.12 137.27 35.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.991 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.866 HG21 ' HB3' ' A' ' 111' ' ' ASP . 50.9 m -133.51 128.34 35.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.888 0.375 . . . . 0.0 111.164 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.9 p -120.08 25.4 9.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.831 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.515 ' CB ' ' HB3' ' A' ' 96' ' ' HIS . 8.6 t -136.9 -170.56 2.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.619 -174.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.12 -5.29 52.94 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 116.509 -0.314 . . . . 0.0 112.926 -178.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.866 ' HB3' HG21 ' A' ' 107' ' ' THR . 14.6 t70 -55.22 -37.13 66.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.337 0.589 . . . . 0.0 110.483 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.09 -50.1 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.701 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.623 HD11 HD13 ' A' ' 53' ' ' LEU . 3.9 mm? -61.98 -41.02 97.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.854 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.19 -41.89 98.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.386 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 68.2 m -54.15 -68.76 0.16 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.309 -176.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PHE . . . . . 0.434 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 32.2 p90 -86.87 21.97 2.12 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 111.979 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.33 19.12 10.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.896 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 120' ' ' THR . 8.9 t -157.48 -170.48 3.24 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.922 0.361 . . . . 0.0 110.524 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -67.7 -20.9 65.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.0 111.248 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.509 ' H ' HG23 ' A' ' 118' ' ' THR . 16.6 p -98.05 36.07 1.63 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.278 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -75.73 121.95 86.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.438 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.38 131.56 20.6 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.633 2.222 . . . . 0.0 111.295 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.61 -47.26 73.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.326 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -123.11 123.24 40.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.374 0.607 . . . . 0.0 111.897 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -146.13 131.92 19.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.02 175.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.3 pt -105.39 132.77 51.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.902 0.382 . . . . 0.0 110.311 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.83 123.49 71.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.235 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 74.2 m -136.07 142.96 44.41 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.413 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 72' ' ' VAL . 3.9 mm? -93.63 115.49 27.97 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.631 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . 80.89 173.32 47.19 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.841 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 62.8 m -147.06 169.22 19.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.7 m -105.95 116.65 32.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.004 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.745 HG22 HG13 ' A' ' 37' ' ' ILE . 47.7 p -103.66 115.84 31.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.465 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.908 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 1.5 t-105 -78.77 157.49 28.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.749 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 12.9 mmmm -65.37 147.16 98.79 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.378 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.23 113.89 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.443 2.762 . . . . 0.0 112.949 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.509 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 10.9 m-70 66.83 -3.36 0.93 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.534 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 53.3 tt0 -74.82 -25.48 59.04 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.733 -177.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.446 ' O ' HG13 ' A' ' 143' ' ' ILE . 49.1 tp -56.95 -39.24 74.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.885 -175.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 137' ' ' HIS . 12.7 pt-20 -66.36 -34.27 77.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.784 0.326 . . . . 0.0 110.76 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 2.6 mp0 -71.33 -38.9 71.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 110.243 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.908 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 32.9 mm-40 -59.54 -43.54 93.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 139' ' ' LEU . 78.7 mt -64.48 -34.07 67.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.803 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.04 -19.01 65.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.335 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 15.5 mt-30 -79.94 -2.47 43.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.723 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 71.05 18.8 5.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.712 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -100.27 3.91 43.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 12' ' ' ALA . 99.8 m95 -134.83 119.86 18.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.83 0.347 . . . . 0.0 110.79 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.521 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 3.9 tt -100.21 113.05 25.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.9 tt -90.19 134.52 34.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 110.632 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.7 m -142.0 152.19 43.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.539 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.29 158.84 24.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.483 0.659 . . . . 0.0 111.618 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.69 -152.57 0.44 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.891 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.0 t30 67.87 65.97 0.37 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.959 0.409 . . . . 0.0 111.233 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -178.6 -89.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.969 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -106.4 -55.96 2.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.001 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.8 m -52.12 -29.81 23.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.571 -170.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.34 -53.98 40.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -134.39 15.29 3.76 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.89 -53.36 5.16 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.456 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.6 p . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.426 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 170' ' ' ALA . 31.9 t . . . . . 0 C--O 1.233 0.187 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -97.23 -4.76 38.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.462 0.172 . . . . 0.0 111.315 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.588 ' H ' HG12 ' A' ' 168' ' ' VAL . . . -53.1 -42.44 65.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -77.12 -37.41 54.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.025 0.44 . . . . 0.0 110.787 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -75.78 -22.89 55.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.688 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -57.18 -37.26 71.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.84 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.8 tp -89.53 -44.31 10.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.946 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.118 -179.989 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.234 0.251 0 CA-C-O 121.059 0.457 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.95 -107.47 0.27 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.268 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 59.36 117.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.905 0.753 . . . . 0.0 112.476 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.413 ' C ' ' HD3' ' A' ' 8' ' ' LYS . . . 84.84 8.16 82.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.676 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.94 ' HD2' ' HB2' ' A' ' 152' ' ' GLU . 22.2 mmtp -112.05 150.81 30.14 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -130.49 163.03 27.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.393 0.616 . . . . 0.0 111.895 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.434 HD12 ' CE3' ' A' ' 148' ' ' TRP . 2.5 pt -127.69 128.36 69.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.396 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.495 HD12 HD22 ' A' ' 174' ' ' LEU . 55.0 mt -96.03 150.58 4.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.804 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 76.19 130.75 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.11 0.881 . . . . 0.0 110.91 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.477 HG23 ' CH2' ' A' ' 148' ' ' TRP . 32.7 m . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.016 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.708 HH22 ' HG2' ' A' ' 71' ' ' MET . 62.7 mtm180 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.346 0.593 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -121.23 117.59 27.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.496 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.424 HG13 HG22 ' A' ' 40' ' ' ILE . 58.1 t 69.04 134.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.684 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.49 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.8 tp -134.97 -58.89 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.887 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.49 ' HD1' HG13 ' A' ' 26' ' ' ILE . 1.8 p90 -179.23 177.8 0.75 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.011 0.434 . . . . 0.0 111.805 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.9 mm -94.02 125.31 46.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.217 174.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.5 m -89.93 -41.01 12.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -171.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.47 145.29 35.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.209 0.528 . . . . 0.0 110.804 -176.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -122.48 103.61 8.82 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -112.27 166.38 11.33 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.926 -171.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -79.14 -12.34 59.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.384 0.611 . . . . 0.0 109.766 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -86.68 -36.63 18.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.307 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.82 178.88 48.88 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.13 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 133' ' ' THR . 18.0 m -107.26 118.27 36.27 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.615 HG12 HG22 ' A' ' 133' ' ' THR . 56.8 mt -103.4 113.07 39.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.865 0.364 . . . . 0.0 111.424 -170.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.76 164.95 29.6 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.764 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.32 96.23 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.609 0.719 . . . . 0.0 111.685 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.602 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -129.8 17.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.463 177.666 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 74' ' ' ASN . 9.3 tp -54.89 -30.61 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.602 -172.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' O ' ' HB ' ' A' ' 43' ' ' THR . 49.2 t30 60.71 71.18 0.58 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.47 0.308 . . . . 0.0 111.279 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 14.8 t 178.31 117.64 0.19 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 121.583 0.706 . . . . 0.0 111.425 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 1.2 Cg_endo -85.49 157.3 10.75 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.174 2.583 . . . . 0.0 111.09 171.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 74' ' ' ASN . 10.6 p -96.74 175.72 6.26 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.82 -29.29 40.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 110.526 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.4 tp -68.58 148.49 50.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.604 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.748 ' HB3' ' HG2' ' A' ' 51' ' ' GLU . 17.1 t -104.82 152.86 22.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.618 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -64.44 -31.94 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.068 0.461 . . . . 0.0 109.951 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.8 mt -75.03 -26.26 59.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.089 0.471 . . . . 0.0 110.321 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.748 ' HG2' ' HB3' ' A' ' 48' ' ' SER . 45.8 mm-40 -64.22 -36.62 84.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.563 176.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.29 -35.18 76.63 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.536 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.16 -39.5 63.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 56' ' ' MET . 20.9 p -70.59 -29.69 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 0.0 110.575 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 tpt85 -61.19 -29.55 69.88 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.932 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 54' ' ' THR . 62.6 mtm . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.765 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -133.52 124.54 27.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.323 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.708 ' HG2' HH22 ' A' ' 23' ' ' ARG . 0.0 OUTLIER -68.12 133.49 49.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.251 0.548 . . . . 0.0 110.8 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.619 HG23 HG13 ' A' ' 127' ' ' VAL . 11.7 p -82.94 149.91 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.197 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.8 mp -93.55 157.86 15.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.273 0.559 . . . . 0.0 111.935 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.588 ' O ' HG21 ' A' ' 41' ' ' ILE . 3.1 t-20 -101.06 87.24 3.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.968 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.34 -32.39 80.69 Favored Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.844 -169.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.93 173.98 33.22 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.991 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.34 -22.97 12.09 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.741 2.294 . . . . 0.0 113.074 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.484 HG21 ' OG1' ' A' ' 133' ' ' THR . 59.4 t -81.21 117.56 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.378 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 62.79 32.87 15.73 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 123.704 0.628 . . . . 0.0 110.467 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HA ' ' HA3' ' A' ' 130' ' ' GLY . 52.6 tt0 -61.86 -22.15 65.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.719 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -82.21 -1.55 49.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -113.95 140.88 48.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.52 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.09 118.4 6.12 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -100.86 125.96 47.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.21 114.04 44.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 110.328 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.533 HG22 HD13 ' A' ' 106' ' ' LEU . 34.7 t -100.3 122.56 52.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.441 177.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -136.47 160.97 37.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.639 0.257 . . . . 0.0 110.971 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.9 m -73.75 177.7 5.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.608 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -51.62 113.83 1.09 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 110.827 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.0 m -121.54 117.57 27.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 -176.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.8 -152.57 0.39 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.743 0.652 . . . . 0.0 109.327 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -137.33 18.88 2.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.163 0.506 . . . . 0.0 110.645 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.87 168.6 11.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.012 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -175.2 146.07 0.82 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.151 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.443 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 90.6 m -89.87 -56.66 3.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.065 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -158.31 104.7 1.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.1 m -116.98 159.17 22.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.811 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -108.33 116.5 32.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.0 tttm -75.92 102.41 5.56 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.997 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.3 t -81.21 -54.11 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.465 ' OG1' HG12 ' A' ' 104' ' ' ILE . 70.8 p -130.04 -162.78 1.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -86.32 4.76 37.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.932 0.396 . . . . 0.0 110.424 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -134.66 -48.95 0.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.363 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.74 HD12 ' HD2' ' A' ' 159' ' ' PHE . 24.2 mm -68.99 122.01 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.714 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.9 m -123.64 116.8 23.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.073 -174.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.533 HD13 HG22 ' A' ' 86' ' ' VAL . 56.1 tp -96.88 128.84 44.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.073 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.573 HG21 ' HB3' ' A' ' 111' ' ' ASP . 26.6 m -128.89 130.96 47.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.3 p -109.03 -12.21 14.87 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 p -101.5 -172.21 2.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.093 0.473 . . . . 0.0 111.798 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.507 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -74.83 7.48 20.5 Favored Glycine 0 C--O 1.227 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.675 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.573 ' HB3' HG21 ' A' ' 107' ' ' THR . 18.2 t0 -64.43 -28.66 69.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.552 0.692 . . . . 0.0 109.698 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.13 -37.18 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.66 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.507 HD23 ' HA2' ' A' ' 110' ' ' GLY . 4.0 mm? -63.66 -34.68 78.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.803 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -80.17 -27.53 38.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.062 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -60.64 -42.37 96.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -104.45 170.31 7.97 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.224 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.27 11.54 83.31 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.036 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.5 t -127.98 168.27 15.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -77.8 -5.05 49.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.048 0.451 . . . . 0.0 110.789 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 p -113.14 27.73 9.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.019 0.438 . . . . 0.0 110.628 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.47 160.37 25.51 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.721 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.8 146.14 29.57 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.4 2.067 . . . . 0.0 111.954 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.465 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 88.6 mt-10 -58.64 -53.12 61.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.161 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 123' ' ' GLU . 9.9 mtmt -139.32 153.69 47.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.985 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -155.01 134.96 12.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.836 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.443 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 24.8 pt -110.57 133.03 57.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.117 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.619 HG13 HG23 ' A' ' 72' ' ' VAL . 5.7 p -119.77 128.17 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.151 0.5 . . . . 0.0 110.725 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 22.6 p -133.19 135.66 45.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.49 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.409 HD23 HG21 ' A' ' 72' ' ' VAL . 4.0 mm? -87.9 108.85 19.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.841 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 80' ' ' GLN . . . 79.2 174.44 45.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.83 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 63.4 m -144.45 168.9 19.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.0 m -105.6 130.72 53.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.183 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.615 HG22 HG12 ' A' ' 37' ' ' ILE . 66.9 p -118.37 125.55 50.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.514 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 27.1 m-90 -82.88 178.88 7.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 167.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 138' ' ' GLN . 1.5 mptm? -74.74 159.95 81.99 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 168.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.56 111.17 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.968 1.779 . . . . 0.0 111.744 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 74.97 8.69 4.08 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.726 174.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 31.1 tt0 -64.24 -36.27 83.54 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.589 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 143' ' ' ILE . 49.3 tp -53.7 -29.62 39.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.976 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.76 -38.99 92.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.82 0.343 . . . . 0.0 110.569 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -69.53 -31.67 70.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.258 0.551 . . . . 0.0 110.3 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -70.14 -43.76 70.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.177 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.445 HG12 ' HB2' ' A' ' 148' ' ' TRP . 74.3 mt -67.98 -31.51 52.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.21 -22.34 60.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.57 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -71.87 -4.56 28.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.513 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 65.19 23.92 12.31 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.272 0.629 . . . . 0.0 111.97 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -96.84 -36.02 10.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.585 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.477 ' CH2' HG23 ' A' ' 13' ' ' THR . 92.9 m95 -92.26 127.84 37.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.679 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 tt -100.69 110.51 22.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.1 tp -82.6 134.53 35.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.539 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.5 p -152.14 144.12 23.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.097 175.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.94 ' HB2' ' HD2' ' A' ' 8' ' ' LYS . 15.9 pt-20 -113.5 153.82 28.08 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.618 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -115.17 152.79 31.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.177 -174.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -94.87 -59.53 1.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.514 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -168.52 -47.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.142 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -52.93 -45.87 67.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.874 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 173' ' ' MET . 0.2 OUTLIER -56.89 -29.18 62.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.172 -177.201 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.461 HD12 HG13 ' A' ' 104' ' ' ILE . 84.1 mt -89.51 -50.89 5.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -174.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.74 ' HD2' HD12 ' A' ' 104' ' ' ILE . 11.8 m-85 -124.78 -0.2 8.01 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -174.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -89.7 -57.65 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.201 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.412 ' HB ' ' OD1' ' A' ' 171' ' ' ASN . 11.3 m . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 121.318 0.58 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 169' ' ' GLU . 5.4 pt-20 -77.48 -18.75 56.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.502 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.88 -57.42 9.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.086 0.469 . . . . 0.0 111.207 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.412 ' OD1' ' HB ' ' A' ' 168' ' ' VAL . 3.8 p-10 -68.89 -25.53 64.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.416 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.85 -25.15 65.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.256 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.702 ' HG3' HG23 ' A' ' 157' ' ' THR . 1.5 tmt? -58.69 -36.6 74.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.441 0.639 . . . . 0.0 109.418 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 11' ' ' ILE . 11.8 tp -84.43 -38.44 20.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.775 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.487 179.886 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.7 t30 . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.0 mt 57.44 -149.9 0.45 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.506 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 64.38 104.88 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.563 0.697 . . . . 0.0 111.154 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.73 -4.0 68.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.667 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -113.49 168.24 9.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 41.6 p90 -134.8 155.91 49.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.025 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.8 pt -129.53 128.03 65.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.23 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 58.6 mt -88.16 132.31 33.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.396 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.467 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -125.7 143.96 50.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.932 176.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 C--N 1.324 -0.507 0 O-C-N 123.291 0.369 . . . . 0.0 110.71 178.648 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 121.354 0.597 . . . . 0.0 110.02 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.4 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 29.6 p -90.2 124.49 34.9 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.795 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t 66.86 87.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.503 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.584 HG13 ' N ' ' A' ' 27' ' ' TYR . 7.0 tp -119.02 -117.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.134 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.584 ' N ' HG13 ' A' ' 26' ' ' ILE . 4.5 p90 -118.62 170.33 9.05 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.835 1.198 . . . . 0.0 113.055 -165.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.1 mm -87.73 121.49 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.528 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.3 m -85.57 -41.12 15.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.956 0.407 . . . . 0.0 111.308 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HB3' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -142.11 151.83 42.67 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -149.65 105.03 3.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.469 0.652 . . . . 0.0 111.487 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -129.78 162.78 27.67 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.46 170.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.58 -24.13 64.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.268 0.556 . . . . 0.0 109.853 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -77.07 -9.76 58.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.933 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 164.45 129.62 1.06 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.777 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 133' ' ' THR . 88.5 m -103.86 117.8 35.2 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.574 HG23 ' HB3' ' A' ' 131' ' ' CYS . 3.8 mp -101.39 118.25 47.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.583 -175.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.94 139.64 7.66 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.794 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.665 HG12 ' HA2' ' A' ' 75' ' ' GLY . 2.4 m -92.1 77.31 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.972 0.891 . . . . 0.0 110.201 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.47 HD12 ' CH2' ' A' ' 148' ' ' TRP . 25.1 pt -126.51 4.83 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.815 -172.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.2 pt -73.39 -18.84 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -175.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.469 ' O ' ' HB ' ' A' ' 43' ' ' THR . 47.1 t-20 64.51 89.13 0.1 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.613 0.571 . . . . 0.0 111.618 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 74' ' ' ASN . 10.0 t 173.85 127.74 0.11 Allowed Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.712 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.57 154.35 9.03 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.653 2.236 . . . . 0.0 110.732 169.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.3 p -88.14 177.53 6.88 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.385 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -84.8 -17.54 37.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.114 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.66 152.76 22.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.791 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 55.7 p -102.05 157.26 17.0 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.644 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.499 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 12.1 p -64.66 -32.78 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.033 0.444 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -70.93 -31.95 68.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.865 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.26 -43.97 96.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.1 pp -76.49 -32.49 58.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.042 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 67.6 mt -65.67 -37.89 87.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.302 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.6 p -78.72 -30.76 46.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.863 0.364 . . . . 0.0 111.072 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -63.83 -48.07 78.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.814 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.6 mmt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.533 179.858 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.927 0.394 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -116.58 132.43 56.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.186 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 58.8 mtm -82.81 151.35 26.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.526 HG23 HG22 ' A' ' 127' ' ' VAL . 11.0 p -95.54 133.75 35.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.977 0.417 . . . . 0.0 110.195 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.29 157.75 37.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.004 0.43 . . . . 0.0 111.666 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.481 ' HB3' HG23 ' A' ' 43' ' ' THR . 7.8 t-20 -98.4 113.16 25.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.254 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.665 ' HA2' HG12 ' A' ' 39' ' ' VAL . . . -79.24 -36.24 27.87 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.06 -178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.81 174.62 28.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.894 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.35 -11.87 27.0 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.887 2.391 . . . . 0.0 113.484 -174.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.44 132.01 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.37 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 65.86 39.26 4.71 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.236 0.335 . . . . 0.0 111.582 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -65.76 -21.66 66.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.91 7.65 43.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.741 0.782 . . . . 0.0 109.834 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.37 140.64 49.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.01 129.66 9.86 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.619 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB3' HD11 ' A' ' 106' ' ' LEU . 21.3 m-85 -115.19 125.03 52.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.71 ' HB ' HG21 ' A' ' 112' ' ' VAL . 4.7 mp -131.26 122.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.554 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.623 HG22 HD13 ' A' ' 106' ' ' LEU . 7.3 t -95.18 131.4 42.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -137.96 160.27 39.78 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.465 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.7 m -63.22 145.5 55.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.237 0.542 . . . . 0.0 111.63 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -63.55 124.28 20.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.331 174.449 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -117.88 -176.54 3.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -174.226 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.752 ' HB2' HG21 ' A' ' 120' ' ' THR . 6.8 m-20 -79.78 -35.53 38.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -172.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.546 ' HE1' ' HA ' ' A' ' 115' ' ' SER . 10.1 p-80 -87.07 175.54 8.05 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.979 -173.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.39 169.18 3.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.759 0.79 . . . . 0.0 112.269 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -153.91 113.98 3.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.718 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.5 m -72.87 -77.36 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.154 -169.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -109.03 83.72 1.8 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.323 0.583 . . . . 0.0 110.844 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.3 m -126.04 151.8 46.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.156 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.32 102.0 12.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -69.95 115.7 9.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.77 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.79 -54.47 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.612 177.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.459 HG23 ' H ' ' A' ' 102' ' ' ASP . 2.3 t -131.19 -54.46 1.04 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.959 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.459 ' H ' HG23 ' A' ' 101' ' ' THR . 11.8 t70 173.45 -64.01 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 5.7 m-20 -62.77 -26.83 68.9 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.77 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.9 mm -99.51 122.26 51.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -129.2 114.76 16.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.945 0.402 . . . . 0.0 111.466 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.623 HD13 HG22 ' A' ' 86' ' ' VAL . 21.8 tp -93.99 112.19 23.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.794 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.829 HG21 ' HB3' ' A' ' 111' ' ' ASP . 29.8 m -99.96 127.67 46.13 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.07 0.462 . . . . 0.0 110.907 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.8 p -102.16 23.88 10.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.038 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.496 ' H ' HG22 ' A' ' 107' ' ' THR . 34.2 m -151.38 -177.74 6.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.395 -176.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.81 11.75 5.61 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.341 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.829 ' HB3' HG21 ' A' ' 107' ' ' THR . 14.7 t70 -63.42 -30.23 71.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.853 0.835 . . . . 0.0 109.708 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.71 HG21 ' HB ' ' A' ' 85' ' ' ILE . 40.8 t -54.79 -45.44 74.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.609 174.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.38 -33.8 73.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.612 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.58 -41.39 94.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.967 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.584 ' HB3' ' HD3' ' A' ' 122' ' ' PRO . 49.1 m -59.08 -39.66 82.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.761 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.18 4.66 25.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.996 0.427 . . . . 0.0 111.219 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.29 17.4 28.98 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.975 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.3 t -142.58 179.26 7.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -62.55 -32.33 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.851 0.357 . . . . 0.0 110.959 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.752 HG21 ' HB2' ' A' ' 91' ' ' ASP . 23.4 p -92.49 43.1 1.12 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.848 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -56.89 123.65 60.1 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.765 168.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 115' ' ' SER . 27.0 Cg_endo -61.27 129.52 28.69 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.824 2.349 . . . . 0.0 112.558 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.44 -45.82 92.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.875 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -114.14 142.07 46.69 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.6 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -161.29 143.08 11.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.569 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.03 132.6 69.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.232 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 72' ' ' VAL . 7.3 p -115.01 131.07 68.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.113 0.482 . . . . 0.0 110.993 -176.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 8.9 p -142.98 146.46 33.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.456 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mt -102.33 142.81 32.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.83 179.73 7.41 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.074 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.574 ' HB3' HG23 ' A' ' 37' ' ' ILE . 61.9 m -149.14 162.72 39.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.077 0.465 . . . . 0.0 109.977 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -114.03 117.07 30.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.464 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' THR . 17.9 p -107.66 116.38 31.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.234 0.54 . . . . 0.0 112.004 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.653 ' CD1' ' HB2' ' A' ' 139' ' ' LEU . 0.6 OUTLIER -101.23 151.38 21.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.971 177.086 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 11.4 mptt -105.49 137.33 19.26 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.325 -174.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 7.8 Cg_exo -72.09 92.26 0.73 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.379 2.719 . . . . 0.0 112.818 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' HIS . . . . . 0.462 ' HB3' ' O ' ' A' ' 136' ' ' PRO . 13.6 p80 170.85 -18.66 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.125 176.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.593 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 56.9 tp60 -110.32 -58.88 2.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 171.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.653 ' HB2' ' CD1' ' A' ' 134' ' ' TRP . 53.5 tp -56.89 -53.11 61.71 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -172.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -35.94 77.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -173.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.441 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 11.5 mt-30 -74.94 -36.22 62.14 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.45 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 7.6 mm-40 -65.81 -41.96 91.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.756 0.312 . . . . 0.0 110.305 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 139' ' ' LEU . 71.2 mt -62.19 -42.44 95.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.44 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.68 99.25 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.233 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 41.8 mt-30 -78.8 3.56 16.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.02 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 67.35 37.52 3.53 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -72.84 -28.41 62.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 164.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' TRP . . . . . 0.47 ' CH2' HD12 ' A' ' 40' ' ' ILE . 74.6 m95 -116.4 149.81 38.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.0 -1.454 . . . . 0.0 108.991 175.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.623 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.0 tt -104.6 110.1 22.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 34.0 tp -82.03 135.46 35.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 111.228 -176.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.2 m -143.87 156.04 44.31 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 152' ' ' GLU . 0.7 OUTLIER -98.09 153.74 18.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.385 0.612 . . . . 0.0 111.401 -175.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.18 155.4 40.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.33 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -119.01 -62.36 1.53 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.786 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -161.8 -38.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 44.4 mt-30 -54.85 -56.43 19.58 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.2 m -55.12 -28.17 50.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.424 0.63 . . . . 0.0 111.063 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.8 mt -81.31 -54.57 5.38 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.849 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PHE . . . . . 0.455 ' HZ ' ' HB ' ' A' ' 86' ' ' VAL . 71.1 m-85 -133.51 17.66 3.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -172.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 28.6 tt0 -110.65 -48.36 3.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.268 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 121.055 0.455 . . . . 0.0 111.185 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.236 0.343 0 CA-C-O 121.334 0.588 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 173' ' ' MET . 13.2 pt-20 -71.21 -29.22 64.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.723 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.24 91.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.979 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -71.99 -31.99 66.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.399 0.619 . . . . 0.0 109.593 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.61 -21.91 61.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.16 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.484 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 23.6 mmt -58.27 -33.74 69.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.465 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.5 tt -117.02 -52.83 2.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.183 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.089 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -175.194 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 mtm . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 61.06 116.26 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 124.093 0.871 . . . . 0.0 112.114 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.94 72.79 0.53 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.095 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 69.9 114.83 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.96 0.904 . . . . 0.0 111.425 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 91.8 mt -82.25 -3.03 54.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.153 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.605 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . 0.3 OUTLIER -65.1 135.65 55.79 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.88 12.82 83.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.961 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.552 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 43.2 mmtm -112.8 163.4 14.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -140.28 150.45 44.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.04 0.448 . . . . 0.0 110.382 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.523 HD11 HG13 ' A' ' 40' ' ' ILE . 8.4 pt -116.06 129.14 72.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.851 -177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.74 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.0 mp -86.37 103.83 13.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -94.8 -54.37 3.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.426 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m 58.35 82.38 0.23 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.86 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.18 151.89 76.56 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.73 2.287 . . . . 0.0 111.985 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -59.19 -46.16 89.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.665 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 ttt -168.52 -74.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.571 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 51.49 73.02 0.33 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.401 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 t70 75.64 -49.7 0.62 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.527 0.731 . . . . 0.0 111.934 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.32 156.93 38.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -124.63 -38.37 2.4 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -176.94 -12.64 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -93.81 73.16 4.22 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.704 -0.622 . . . . 0.0 111.666 -167.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 71.5 123.74 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.942 -1.027 . . . . 0.0 112.593 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.409 ' O ' ' HB ' ' A' ' 25' ' ' VAL . 1.1 t -140.45 110.89 6.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.391 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.563 HG13 HG22 ' A' ' 40' ' ' ILE . 90.2 t 73.55 140.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 122.844 0.458 . . . . 0.0 110.918 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.564 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.3 tp -135.19 -58.42 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.564 ' HD1' HG13 ' A' ' 26' ' ' ILE . 20.4 p90 -168.05 171.44 9.62 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.647 0.658 . . . . 0.0 112.134 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.68 133.75 40.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.195 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.8 m -75.97 -52.6 9.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.03 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 6' ' ' GLN . 13.7 pt-20 -161.1 169.91 21.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.131 0.491 . . . . 0.0 111.752 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 37.6 t-80 -134.16 111.03 9.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.636 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -128.25 170.16 13.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.495 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.33 -31.97 73.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.133 0.492 . . . . 0.0 110.85 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -74.57 -18.11 60.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.857 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.31 -177.52 30.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.659 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.0 m -113.27 117.62 32.35 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.665 HG13 HG22 ' A' ' 133' ' ' THR . 3.9 mp -96.28 124.85 49.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.44 164.73 34.65 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.037 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.38 81.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.443 0.64 . . . . 0.0 110.355 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.563 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -133.97 6.65 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.431 -176.073 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.9 tp -70.59 -35.9 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 120.506 0.193 . . . . 0.0 111.247 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 63.97 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.182 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.495 HG23 ' HB2' ' A' ' 74' ' ' ASN . 4.1 t -161.34 91.52 1.49 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 121.714 0.768 . . . . 0.0 110.062 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 58.6 Cg_endo -72.85 154.56 53.63 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.719 2.279 . . . . 0.0 112.058 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.1 p -114.95 167.98 10.31 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.46 -0.63 47.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 0.0 111.595 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.648 HD21 ' HB3' ' A' ' 52' ' ' LEU . 35.1 tp -92.4 152.38 19.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.9 0.381 . . . . 0.0 110.143 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.721 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 12.8 m -109.08 154.48 22.2 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 7.4 p -61.28 -45.56 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.237 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.594 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 90.3 mt -75.67 -25.82 57.12 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.407 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.721 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.5 OUTLIER -57.36 -53.47 57.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.097 178.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HB3' HD21 ' A' ' 47' ' ' LEU . 3.8 pp -66.66 -36.52 82.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.04 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.69 -51.63 64.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.779 0.323 . . . . 0.0 111.105 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.7 p -72.49 -29.46 63.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.057 0.456 . . . . 0.0 111.186 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -69.61 -37.2 76.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.584 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.471 ' HG3' ' O ' ' A' ' 52' ' ' LEU . 65.2 mtt -82.35 -91.69 0.07 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.928 0.394 . . . . 0.0 111.918 -176.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -146.76 24.35 1.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.938 0.875 . . . . 0.0 110.435 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -122.34 50.25 1.5 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -67.1 -37.63 84.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.611 -171.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.7 ttt -90.77 84.22 5.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.261 0.553 . . . . 0.0 110.682 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.34 -165.59 1.0 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.209 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 62' ' ' LYS . 13.5 ptmt -125.38 67.05 55.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -88.77 -14.77 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.202 1.935 . . . . 0.0 111.5 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 56.86 -163.41 0.17 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.393 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.7 pt -82.35 9.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.692 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -67.75 -42.94 81.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.19 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 m 73.31 -20.22 0.3 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.013 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -66.02 153.45 42.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.594 ' OD2' ' HB2' ' A' ' 50' ' ' LEU . 6.0 t0 -139.21 178.69 7.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.174 -174.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -118.34 137.11 53.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 23.3 mmt -81.93 140.44 34.04 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.353 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.46 HG23 HG13 ' A' ' 127' ' ' VAL . 14.2 p -93.94 137.71 22.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.012 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.1 mp -106.48 155.11 19.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.513 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.495 ' HB2' HG23 ' A' ' 43' ' ' THR . 44.2 m-20 -89.42 127.72 35.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.52 -15.0 69.5 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.178 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.22 175.12 29.8 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.66 -12.19 20.27 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.651 2.234 . . . . 0.0 112.719 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.95 145.38 9.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.514 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 64.9 30.7 11.92 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.504 0.321 . . . . 0.0 111.618 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -65.78 -9.19 26.18 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.045 0.45 . . . . 0.0 111.314 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.1 -19.99 60.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.303 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -134.77 143.16 46.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 111.413 -171.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.14 122.6 7.28 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.597 ' HB3' HD11 ' A' ' 106' ' ' LEU . 92.9 m-85 -96.97 126.12 41.88 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.631 0.253 . . . . 0.0 110.426 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.47 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.6 mp -111.35 115.16 49.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.189 0.518 . . . . 0.0 110.479 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.426 HG22 HD13 ' A' ' 106' ' ' LEU . 31.2 t -94.24 124.42 46.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.309 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -139.51 166.84 23.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.882 0.373 . . . . 0.0 111.195 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.3 p -93.16 174.12 7.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.064 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.55 ' HG3' ' OD1' ' A' ' 103' ' ' ASP . 21.7 mmtp -57.6 134.81 56.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 172.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.624 ' OG1' ' HA ' ' A' ' 122' ' ' PRO . 81.9 m -155.05 114.68 3.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.663 173.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.3 t70 59.68 -147.89 0.47 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.993 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -126.65 36.25 4.5 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.86 -0.525 . . . . 0.0 112.378 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 94' ' ' PHE . 40.2 mm-40 -90.52 161.0 15.69 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.348 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 27.0 t80 167.59 102.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.789 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.4 m -121.26 -55.05 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.974 0.416 . . . . 0.0 110.913 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.74 ' HB2' ' HB2' ' A' ' 111' ' ' ASP . 9.6 m-70 -127.08 70.98 1.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.418 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' A' ' 94' ' ' PHE . 66.4 m -128.51 139.51 52.28 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.111 0.482 . . . . 0.0 111.036 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -102.91 133.35 48.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.548 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -76.31 113.49 13.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.111 0.481 . . . . 0.0 111.943 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.54 -53.73 9.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 166.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.773 HG22 ' HB ' ' A' ' 104' ' ' ILE . 6.3 t -142.72 -164.05 1.75 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.448 ' O ' ' HE3' ' A' ' 89' ' ' LYS . 10.5 t70 -67.42 -53.29 30.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.572 0.623 . . . . 0.0 111.272 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.55 ' OD1' ' HG3' ' A' ' 89' ' ' LYS . 91.8 m-20 -84.18 -34.26 24.01 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.773 ' HB ' HG22 ' A' ' 101' ' ' THR . 46.8 mm -81.48 121.64 35.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.097 0.475 . . . . 0.0 110.226 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.14 128.96 50.03 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.749 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 84' ' ' PHE . 54.8 tp -96.87 112.43 24.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.242 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.615 ' CG2' ' HB3' ' A' ' 111' ' ' ASP . 10.8 m -118.69 128.43 54.5 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -132.91 -29.67 1.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 t -112.37 104.71 12.87 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.459 -0.497 . . . . 0.0 112.024 -172.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.88 -53.4 2.93 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.74 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 15.4 t0 -56.3 -34.48 66.54 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.89 0.476 . . . . 0.0 112.201 -170.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.652 HG23 HD22 ' A' ' 113' ' ' LEU . 3.7 m -59.2 -34.9 55.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.652 HD22 HG23 ' A' ' 112' ' ' VAL . 2.7 mm? -70.64 -27.29 63.94 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.437 0.637 . . . . 0.0 110.24 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.2 -33.54 56.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.288 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.44 ' HB3' ' HD3' ' A' ' 122' ' ' PRO . 20.2 m -60.82 -67.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.967 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.553 ' HA ' ' HB2' ' A' ' 121' ' ' ALA . 8.4 p90 -79.45 140.18 37.43 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.006 0.431 . . . . 0.0 111.055 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.74 -17.71 9.35 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 t -131.89 178.87 6.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -77.66 1.68 19.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -174.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.6 p -99.8 14.55 29.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.451 0.643 . . . . 0.0 110.828 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -71.52 130.93 86.8 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.473 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.624 ' HA ' ' OG1' ' A' ' 90' ' ' THR . 17.4 Cg_exo -63.95 140.09 71.06 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.542 2.161 . . . . 0.0 111.985 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -55.12 -51.35 66.71 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.152 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.548 ' HB2' ' HE2' ' A' ' 159' ' ' PHE . 67.2 mmtt -128.06 138.22 52.47 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.607 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -154.04 144.33 22.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.492 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 28.8 pt -122.27 144.45 31.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.004 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.46 HG13 HG23 ' A' ' 72' ' ' VAL . 7.4 p -119.39 134.29 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.154 0.502 . . . . 0.0 111.197 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 70.2 m -139.11 131.91 29.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.376 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.6 116.77 23.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.188 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.98 -177.33 50.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.388 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 64.1 m -150.41 169.39 21.55 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.168 0.587 . . . . 0.0 109.434 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.6 m -106.88 139.67 40.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.65 0.262 . . . . 0.0 110.502 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.665 HG22 HG13 ' A' ' 37' ' ' ILE . 27.5 p -117.55 114.22 23.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.037 0.446 . . . . 0.0 110.668 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -83.67 156.2 22.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.263 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.401 ' HB2' ' CB ' ' A' ' 138' ' ' GLN . 72.1 mmtt -58.57 141.47 84.04 Favored Pre-proline 0 C--O 1.237 0.441 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.355 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.97 119.89 7.44 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.746 2.297 . . . . 0.0 112.319 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.476 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 57.0 t-80 74.83 -9.19 1.39 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.262 174.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.401 ' CB ' ' HB2' ' A' ' 135' ' ' LYS . 47.3 tt0 -66.68 -51.01 60.99 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.158 -0.339 . . . . 0.0 111.29 -177.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 143' ' ' ILE . 47.7 tp -54.41 -35.93 63.43 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.476 ' OE2' ' HA ' ' A' ' 137' ' ' HIS . 45.3 mt-10 -57.8 -43.26 85.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.061 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 35.6 mt-30 -72.39 -38.1 68.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.478 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.64 -40.56 97.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.583 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 139' ' ' LEU . 76.1 mt -65.77 -33.01 60.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.249 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.07 64.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.059 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 75.2 mt-30 -75.97 -8.17 56.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.389 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.456 ' HB3' HD13 ' A' ' 180' ' ' LEU . 44.9 m-80 65.65 30.67 10.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.078 -173.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -87.74 -18.29 29.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.592 0.711 . . . . 0.0 109.477 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.413 ' HZ3' ' HB2' ' A' ' 12' ' ' ALA . 93.5 m95 -125.62 137.49 53.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.474 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.74 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 58.0 mt -92.37 108.31 19.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.071 0.462 . . . . 0.0 109.9 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.0 tp -91.45 134.05 34.96 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.927 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.0 t -149.7 148.0 28.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 8' ' ' LYS . 1.7 mp0 -85.5 152.62 23.04 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.928 0.394 . . . . 0.0 110.178 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.35 104.15 13.21 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -80.29 77.01 7.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.8 t30 49.97 -83.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.275 0.985 . . . . 0.0 112.889 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -63.06 -35.58 80.73 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.545 0.212 . . . . 0.0 110.772 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.0 m -58.58 -30.3 67.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.858 0.361 . . . . 0.0 111.385 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 tt -67.0 -50.23 62.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.985 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.642 ' HB2' HD11 ' A' ' 104' ' ' ILE . 2.4 t80 -112.08 -27.67 8.3 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -169.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 163' ' ' TYR . 60.7 mt-10 -105.44 -54.87 2.41 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.493 -176.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 t 38.39 88.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.46 1.1 . . . . 0.0 111.863 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.8 m 76.29 -37.24 0.29 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.337 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . 87.2 t80 68.23 93.61 0.08 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.208 0.603 . . . . 0.0 111.925 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.549 ' HG ' ' N ' ' A' ' 165' ' ' ASP . 2.5 pt? -173.6 -55.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.291 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.549 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 0.8 OUTLIER 175.47 143.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 175.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.657 ' HB3' ' HB3' ' A' ' 169' ' ' GLU . 2.9 mmt-85 -159.4 145.86 16.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.197 0.522 . . . . 0.0 111.759 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -138.17 137.47 37.65 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 171.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 168' ' ' VAL . 17.0 t 68.41 20.11 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 122.429 1.109 . . . . 0.0 109.054 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.657 ' HB3' ' HB3' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -60.63 -36.3 78.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.48 -178.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.92 -36.16 80.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.049 0.452 . . . . 0.0 111.096 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.423 ' HB3' HG12 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -79.84 -28.36 40.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.739 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.29 -26.38 38.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.361 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -53.94 -33.77 57.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.273 0.559 . . . . 0.0 111.077 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.99 -39.13 14.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.971 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 130.45 46.36 0.15 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.139 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 39.5 mt 55.62 73.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.655 0.74 . . . . 0.0 110.532 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 15.8 p -99.2 131.59 45.12 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.958 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -124.51 -172.18 13.53 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 174.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 180' ' ' LEU . 45.5 mm 68.77 166.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 122.461 0.305 . . . . 0.0 110.607 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.484 ' N ' HG22 ' A' ' 179' ' ' ILE . 93.8 mt 63.01 62.51 1.02 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.149 0.58 . . . . 0.0 111.3 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.908 ' HB3' ' HD3' ' A' ' 182' ' ' PRO . . . 177.55 -59.14 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.253 175.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.908 ' HD3' ' HB3' ' A' ' 181' ' ' ALA . 25.4 Cg_endo -96.63 97.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.84 2.36 . . . . 0.0 111.2 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -108.96 -36.9 5.97 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.905 0.383 . . . . 0.0 110.209 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 66.9 23.8 72.77 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.528 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.597 ' NH1' ' HB3' ' A' ' 188' ' ' GLU . 51.7 ttp85 -108.47 78.4 1.16 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -89.45 -60.14 2.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.092 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.23 97.04 9.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.207 0.527 . . . . 0.0 111.162 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.597 ' HB3' ' NH1' ' A' ' 185' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.855 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.604 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 27.2 ttt . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 121.149 0.499 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -114.12 -44.17 3.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.98 -67.74 2.35 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.84 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -88.76 130.2 35.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.452 0.644 . . . . 0.0 110.588 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 6' ' ' GLN . 95.8 mt -130.0 -152.12 0.5 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.965 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 50.8 tt0 67.98 119.25 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.215 0.531 . . . . 0.0 110.792 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.18 19.7 27.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.758 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -134.96 169.79 16.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.499 ' CZ ' ' HG3' ' A' ' 173' ' ' MET . 29.4 p90 -143.85 162.41 36.16 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 175.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 3.3 pt -133.02 128.46 56.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.507 -174.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 4.9 mp -96.24 140.05 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.575 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.32 168.68 19.51 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.827 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.414 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 30.6 p 53.53 96.77 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.477 0 O-C-N 124.136 0.898 . . . . 0.0 113.044 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 181' ' ' ALA . 19.1 Cg_endo -62.65 -28.45 76.87 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.491 2.127 . . . . 0.0 111.482 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.88 148.29 50.89 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.298 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.517 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -162.1 149.64 14.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.322 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -94.83 96.17 9.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.89 0.376 . . . . 0.0 110.882 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 20' ' ' TYR . 6.1 t70 65.76 173.75 0.22 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.857 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 70.99 -39.7 0.46 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.581 0.752 . . . . 0.0 111.946 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 16' ' ' MET . 41.5 t80 -56.31 -27.64 56.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.675 0.79 . . . . 0.0 111.92 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -103.71 17.04 24.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.22 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -128.19 61.92 1.44 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.158 0.504 . . . . 0.0 110.296 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.712 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 1.4 mmp_? 64.16 86.62 0.12 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.023 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.1 p -146.34 158.71 43.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t 68.24 100.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 O-C-N 123.897 0.748 . . . . 0.0 111.13 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.665 HG13 ' HD1' ' A' ' 27' ' ' TYR . 10.6 tp -129.67 -142.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.32 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.665 ' HD1' HG13 ' A' ' 26' ' ' ILE . 37.1 p90 -117.64 174.55 6.1 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.476 1.034 . . . . 0.0 112.259 -165.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -92.98 125.73 45.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.326 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.3 m -73.0 -59.03 2.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.064 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -145.89 164.21 32.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.409 0.623 . . . . 0.0 111.223 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 74.8 t60 -118.27 118.87 32.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -114.64 -176.87 3.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.326 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -66.51 -28.84 68.88 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.261 0.553 . . . . 0.0 110.438 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.82 9.52 43.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.835 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.09 -143.63 15.34 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.567 -1.302 . . . . 0.0 113.185 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 133' ' ' THR . 12.4 m -123.97 129.11 50.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.499 0.19 . . . . 0.0 110.94 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.7 HG13 HG22 ' A' ' 133' ' ' THR . 3.5 mp -103.74 114.78 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.272 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -145.82 165.72 28.0 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.557 HG12 ' HA3' ' A' ' 75' ' ' GLY . 3.5 m -113.37 68.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.628 0.728 . . . . 0.0 110.787 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.597 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -115.37 15.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.956 -173.498 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.35 -29.38 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.739 0.304 . . . . 0.0 110.737 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 62.99 85.88 0.12 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.093 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.1 t -179.1 123.11 0.24 Allowed Pre-proline 0 C--O 1.235 0.315 0 CA-C-O 121.358 0.599 . . . . 0.0 111.514 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 71.9 Cg_endo -81.67 155.73 18.33 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.503 2.136 . . . . 0.0 110.733 170.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 p -112.2 161.75 16.22 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.022 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.05 -20.42 63.24 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.494 ' O ' HG12 ' A' ' 72' ' ' VAL . 57.5 tp -67.44 145.07 55.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.609 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.533 ' HB3' ' CG ' ' A' ' 69' ' ' ASP . 17.9 m -101.06 153.33 19.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.16 -176.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.1 p -69.65 -33.97 59.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 69' ' ' ASP . 59.0 mt -73.68 -26.84 60.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.514 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.3 OUTLIER -71.45 -40.24 70.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.091 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.5 pp -74.03 -32.34 63.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.013 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 94.9 mt -65.4 -51.28 61.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.328 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.7 p -67.07 -28.47 68.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.339 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -55.72 -39.52 71.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.158 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 46.2 mtt -108.35 -45.34 3.92 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -150.14 -150.47 0.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -170.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.0 t80 77.48 24.52 0.78 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.148 0.975 . . . . 0.0 109.72 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -84.18 14.67 4.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.626 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.6 ttm -155.55 150.68 26.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.145 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 74.84 159.6 0.22 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.083 0.864 . . . . 0.0 112.793 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.6 mttm 68.35 150.29 0.12 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 114.929 -1.032 . . . . 0.0 113.08 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.36 -179.65 4.63 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.011 2.474 . . . . 0.0 112.611 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -86.03 92.89 8.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.056 0.455 . . . . 0.0 111.497 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.9 pt -92.22 87.3 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.561 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -58.9 -59.8 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.399 -171.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 t -133.43 80.29 1.87 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.106 0.955 . . . . 0.0 110.283 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -129.91 34.69 4.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.374 1.083 . . . . 0.0 108.236 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.533 ' CG ' ' HB3' ' A' ' 48' ' ' SER . 25.3 t70 -80.58 152.68 28.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.445 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -126.86 14.46 7.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.836 -175.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 44.2 mtt 63.06 165.89 0.12 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.626 -174.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG21 HD23 ' A' ' 129' ' ' LEU . 11.7 p -116.0 144.16 24.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.785 172.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.575 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.2 mp -103.8 158.12 16.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.972 0.415 . . . . 0.0 110.355 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.43 127.44 53.29 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.557 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -87.79 -10.06 70.4 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.316 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 131' ' ' CYS . . . 160.2 176.74 32.62 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.502 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 1.7 Cg_endo -85.41 -2.3 9.25 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.131 2.554 . . . . 0.0 113.322 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.49 HG12 HD22 ' A' ' 79' ' ' ASN . 19.7 t -103.3 128.39 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.785 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.49 HD22 HG12 ' A' ' 78' ' ' VAL . 45.7 m-80 62.59 39.18 11.7 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.111 0.564 . . . . 0.0 111.809 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.502 ' NE2' ' HA ' ' A' ' 77' ' ' PRO . 96.2 mt-30 -68.58 -10.37 55.46 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.201 0.524 . . . . 0.0 110.582 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -71.92 -17.61 62.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.292 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 82' ' ' ARG . 41.2 mtt180 -110.07 129.28 55.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.409 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 108' ' ' THR . . . -90.6 112.97 4.17 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.509 ' HB3' HD11 ' A' ' 106' ' ' LEU . 85.9 m-85 -93.53 125.04 37.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.646 0.223 . . . . 0.0 110.553 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.473 HG21 HG11 ' A' ' 112' ' ' VAL . 4.7 mp -123.34 105.56 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.975 0.417 . . . . 0.0 110.091 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 66.0 t -88.14 122.03 39.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.37 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.3 p80 -133.01 163.44 29.23 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.834 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 122' ' ' PRO . 4.9 m -64.33 158.67 22.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.66 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.761 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 1.5 tmtp? -66.48 118.22 9.8 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.944 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.443 ' HB ' ' OG1' ' A' ' 120' ' ' THR . 1.5 p -126.3 -169.3 1.99 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.456 173.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -116.27 155.92 27.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.245 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 75.53 165.94 0.27 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.644 0.59 . . . . 0.0 110.253 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 0.3 OUTLIER 69.41 169.29 0.3 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.349 0.66 . . . . 0.0 111.875 -176.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.522 ' HB3' ' O ' ' A' ' 93' ' ' GLU . 21.3 p90 157.46 117.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 113.98 -1.463 . . . . 0.0 109.307 -173.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.2 m -146.71 -71.19 0.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.394 0.616 . . . . 0.0 109.822 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -120.45 37.39 4.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.0 m -74.26 104.78 5.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.684 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -101.97 118.44 36.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.215 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 102' ' ' ASP . 95.6 mttt -100.0 112.0 24.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.877 0.37 . . . . 0.0 110.814 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.06 -53.67 44.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.1 t -133.26 169.67 16.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 166.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.511 ' HA ' ' HD3' ' A' ' 99' ' ' LYS . 38.7 t70 -61.16 -36.59 80.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 118.872 0.76 . . . . 0.0 111.358 -174.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.761 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 4.1 m-20 -77.26 -7.9 56.71 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.2 mm -121.06 122.37 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.959 0.409 . . . . 0.0 110.027 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 m -121.47 113.74 20.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.422 0.63 . . . . 0.0 111.498 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 84' ' ' PHE . 54.1 tp -94.07 137.7 32.98 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.971 174.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.677 HG21 ' HB3' ' A' ' 111' ' ' ASP . 16.2 m -145.98 137.78 25.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 65.4 p -114.28 12.65 17.7 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.434 ' H ' HG22 ' A' ' 107' ' ' THR . 62.8 p -127.73 -174.73 3.27 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.492 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.36 -7.82 47.75 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.311 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.677 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.5 t70 -50.47 -39.44 48.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.73 . . . . 0.0 110.002 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 107' ' ' THR . 91.7 t -60.63 -49.03 86.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.131 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.89 -35.88 82.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.47 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.09 -46.0 72.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.724 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.416 ' HA ' HG22 ' A' ' 118' ' ' THR . 5.2 p -66.93 -37.93 85.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.746 0.308 . . . . 0.0 110.811 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.508 ' CE1' ' HD2' ' A' ' 122' ' ' PRO . 7.0 m-30 -67.56 -24.14 65.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.083 0.468 . . . . 0.0 110.929 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.99 19.86 52.58 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.404 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.58 ' CG2' HG22 ' A' ' 120' ' ' THR . 4.4 t -142.85 -171.04 3.37 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -82.72 13.0 4.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.58 HG22 ' CG2' ' A' ' 118' ' ' THR . 9.8 t -117.49 20.46 13.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.527 0.679 . . . . 0.0 110.538 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.448 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -68.38 115.1 26.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.969 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.508 ' HD2' ' CE1' ' A' ' 116' ' ' PHE . 11.4 Cg_exo -71.87 143.0 40.17 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.904 2.403 . . . . 0.0 112.156 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.79 -47.19 86.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.929 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 162' ' ' SER . 55.0 mmtt -102.26 124.43 47.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.237 -171.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 48.7 p90 -152.15 141.97 21.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.323 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.4 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 24.3 pt -127.26 135.51 63.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.45 175.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.29 125.97 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.141 0.496 . . . . 0.0 110.798 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.6 m -143.08 136.3 28.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.827 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.501 HD23 HG21 ' A' ' 72' ' ' VAL . 4.2 mm? -89.39 124.46 34.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.843 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.94 174.4 17.52 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.398 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.401 ' C ' ' HA3' ' A' ' 76' ' ' GLY . 61.5 m -144.9 169.01 18.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.9 m -105.89 122.51 46.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.669 0.271 . . . . 0.0 110.716 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.7 HG22 HG13 ' A' ' 37' ' ' ILE . 41.3 p -101.71 116.78 33.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.876 0.37 . . . . 0.0 111.172 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.582 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 3.0 t-105 -78.84 156.99 28.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 12.9 mptt -62.27 137.38 95.92 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.805 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 51.9 Cg_exo -52.66 121.5 9.26 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.216 2.611 . . . . 0.0 112.616 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 75.39 -17.1 0.53 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.357 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.55 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 53.8 tp60 -73.91 -30.89 62.83 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.88 -0.512 . . . . 0.0 111.387 -174.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.486 ' O ' HG13 ' A' ' 143' ' ' ILE . 52.4 tp -54.75 -44.71 73.86 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.604 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 8.9 pt-20 -64.89 -33.36 75.82 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.994 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 34.3 tt0 -71.93 -38.37 69.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.582 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 11.2 mm-40 -61.21 -42.21 98.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.229 0.538 . . . . 0.0 109.67 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 139' ' ' LEU . 84.8 mt -60.55 -38.18 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.038 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.74 -17.7 64.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 111.662 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 50.1 mt-30 -85.94 -0.72 56.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.467 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 62.84 24.53 14.6 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 123.713 0.805 . . . . 0.0 112.58 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -88.63 -8.02 55.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.292 0.568 . . . . 0.0 109.542 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -135.22 115.09 12.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.13 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.726 HD11 HD22 ' A' ' 174' ' ' LEU . 4.7 tt -84.84 102.51 13.14 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.7 tp -82.92 134.75 35.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.401 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.7 p -150.23 163.92 37.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.8 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.26 154.24 19.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.282 0.563 . . . . 0.0 111.945 -175.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 154' ' ' ASN . . . -92.56 -160.11 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.653 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 153' ' ' ALA . 86.8 m-20 70.91 15.23 6.8 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.61 -177.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -96.18 148.57 22.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.46 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.99 -63.0 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.447 ' HB ' ' SD ' ' A' ' 173' ' ' MET . 24.8 m -51.66 -29.16 16.93 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.0 tt -52.36 -49.13 64.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 111.285 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -123.61 -19.78 5.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.988 -173.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -88.17 -9.65 52.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.847 0.356 . . . . 0.0 111.051 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 157' ' ' THR . 11.1 t -63.16 -12.78 30.34 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.1 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.454 ' HB3' ' HD2' ' A' ' 124' ' ' LYS . 22.6 t -74.97 74.7 2.19 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.654 0.74 . . . . 0.0 109.482 174.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -157.15 -69.75 0.1 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.503 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.4 mt -124.43 -43.16 2.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.353 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 t70 63.51 -168.48 0.2 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.767 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.478 ' HG3' ' N ' ' A' ' 167' ' ' TRP . 0.2 OUTLIER -154.94 -38.66 0.09 Allowed 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.184 177.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.478 ' N ' ' HG3' ' A' ' 166' ' ' ARG . 2.1 t90 -174.71 -63.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.756 0.313 . . . . 0.0 110.517 -172.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 171' ' ' ASN . 16.1 m -131.65 149.22 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.507 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.638 ' OE2' ' HA ' ' A' ' 23' ' ' ARG . 1.1 pm0 -91.83 -50.18 5.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.017 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.446 ' N ' ' HG2' ' A' ' 169' ' ' GLU . . . -81.23 -48.74 11.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.795 0.331 . . . . 0.0 111.65 -173.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.558 ' HB2' HG21 ' A' ' 168' ' ' VAL . 1.9 m-20 -60.98 -25.43 66.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.123 0.487 . . . . 0.0 111.129 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.446 ' OE1' ' HD3' ' A' ' 166' ' ' ARG . 19.1 tp10 -71.59 -21.04 61.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.175 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.499 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 68.7 mmm -65.93 -28.22 68.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.058 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.726 HD22 HD11 ' A' ' 149' ' ' LEU . 12.2 tp -95.79 -44.91 7.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 123.15 52.56 0.21 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.883 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mp 64.57 94.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.076 0.465 . . . . 0.0 110.832 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.612 ' HB3' HD23 ' A' ' 174' ' ' LEU . 11.0 t -177.99 130.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.714 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -128.58 132.42 7.26 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.421 HG22 ' HG ' ' A' ' 180' ' ' LEU . 24.9 mt -113.03 118.73 58.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.964 0.382 . . . . 0.0 111.518 -175.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 179' ' ' ILE . 80.4 mt 59.73 103.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 168.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.535 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . . . -93.17 129.44 39.3 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.966 173.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 4.3 Cg_exo -76.39 5.24 4.81 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.204 2.603 . . . . 0.0 112.272 177.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 64.97 9.36 5.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.043 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 109.59 -19.75 28.29 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.186 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -83.88 105.67 14.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.114 0.483 . . . . 0.0 110.552 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -137.73 -45.89 0.54 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.292 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.46 ' O ' ' HG ' ' A' ' 187' ' ' LEU . 1.6 pt? -139.91 95.51 2.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.692 0.758 . . . . 0.0 110.755 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.055 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -70.21 116.41 10.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.17 -58.15 16.07 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.576 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.507 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 59.4 m-20 -131.91 155.57 47.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.803 0.335 . . . . 0.0 110.904 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.7 mt -136.54 -123.54 0.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.291 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 66.77 119.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.178 0.989 . . . . 0.0 111.814 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.8 5.32 77.97 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.478 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 11.3 mptt -113.24 164.77 13.12 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.44 ' HE1' HD11 ' A' ' 11' ' ' ILE . 36.5 p90 -136.82 159.54 41.54 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.028 0.442 . . . . 0.0 111.062 -176.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.7 pt -128.87 127.89 66.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.248 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.83 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.5 mp -92.99 123.43 45.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.39 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -115.59 101.27 8.71 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.6 m -122.68 98.86 42.66 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-O 120.929 0.395 . . . . 0.0 111.488 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.66 -5.27 13.19 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.998 2.466 . . . . 0.0 110.511 170.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.552 ' OE2' ' HD2' ' A' ' 185' ' ' ARG . 32.5 mt-10 70.22 159.12 0.19 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.336 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.454 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 46.8 ttp 70.57 144.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.683 -171.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.569 ' HA ' ' HB3' ' A' ' 20' ' ' TYR . 15.5 t70 -65.45 -99.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.4 t70 52.3 71.12 0.49 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.108 0.48 . . . . 0.0 110.492 -173.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 64.45 43.82 4.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.266 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 17' ' ' ASP . 55.6 t80 -119.16 -38.56 3.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.252 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -59.21 -22.24 60.73 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -172.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -96.33 97.03 9.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.184 0.516 . . . . 0.0 110.162 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.586 ' HE ' HD23 ' A' ' 73' ' ' LEU . 3.0 tmm_? 57.17 86.21 0.07 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.994 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.9 t -114.54 143.89 44.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.992 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.816 HG11 HG13 ' A' ' 11' ' ' ILE . 40.2 t 63.55 109.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.809 0.814 . . . . 0.0 112.054 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.857 HG21 HG23 ' A' ' 39' ' ' VAL . 5.6 tp -134.36 -161.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.56 ' H ' HG13 ' A' ' 26' ' ' ILE . 5.0 p90 -117.56 169.67 9.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.975 0.807 . . . . 0.0 111.876 -164.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.18 112.14 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.187 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.3 m -73.89 -46.23 45.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.093 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.691 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 36.4 tt0 -135.77 144.45 45.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.424 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.507 ' CD2' ' HA ' ' A' ' 4' ' ' ASN . 74.8 t60 -146.35 104.67 3.81 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -122.87 174.86 6.89 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.22 -21.79 66.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.389 0.614 . . . . 0.0 109.826 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -70.27 -31.23 68.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.194 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 160.91 -179.93 36.06 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.308 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.1 m -115.64 127.68 55.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.654 0.264 . . . . 0.0 110.623 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.2 mp -112.84 115.92 51.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.415 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.32 163.71 26.0 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.857 HG23 HG21 ' A' ' 26' ' ' ILE . 18.3 m -123.84 36.88 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.501 0.667 . . . . 0.0 110.884 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.713 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -84.97 15.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -169.311 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 pt -64.62 -25.91 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.59 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.1 t-20 64.85 93.11 0.07 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.416 0.447 . . . . 0.0 111.996 176.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 12.4 t 169.48 137.77 0.06 OUTLIER Pre-proline 0 C--O 1.24 0.569 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.184 175.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.845 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 93.0 Cg_endo -85.18 176.88 5.56 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.728 2.285 . . . . 0.0 111.052 170.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.401 HG22 ' ND2' ' A' ' 74' ' ' ASN . 15.2 p -116.59 176.34 5.16 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.428 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -91.12 5.62 48.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.943 0.877 . . . . 0.0 109.566 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 tp -106.66 156.4 18.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.487 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 10.5 m -100.27 151.49 21.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.7 p -65.54 -33.89 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.659 HD13 ' HA ' ' A' ' 64' ' ' ARG . 35.8 mt -68.33 -26.62 65.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.621 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 48' ' ' SER . 4.2 mm-40 -63.16 -47.28 83.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.562 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.6 -39.17 88.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.514 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 89.3 mt -64.8 -43.73 92.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.291 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.612 HG21 ' HD2' ' A' ' 64' ' ' ARG . 17.8 p -72.55 -29.09 63.25 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -56.63 -43.45 80.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.046 0.45 . . . . 0.0 110.169 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.8 mtm -87.8 -24.7 23.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.615 176.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 73.8 137.27 0.05 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.253 1.021 . . . . 0.0 110.48 -173.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -139.33 -52.08 0.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.488 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -145.22 161.12 40.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.723 0.296 . . . . 0.0 110.417 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.9 ttp -72.65 124.1 24.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.222 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 62' ' ' LYS . . . 63.13 -113.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.598 169.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 52.1 mttm 67.13 159.66 0.14 Allowed Pre-proline 0 C--O 1.234 0.274 0 O-C-N 123.637 0.586 . . . . 0.0 111.752 -173.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.53 111.29 1.61 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.462 2.108 . . . . 0.0 110.785 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.659 ' HA ' HD13 ' A' ' 50' ' ' LEU . 47.6 ptt85 -156.14 7.98 0.22 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.948 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.7 mt -142.29 -48.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.482 ' O ' ' HB ' ' A' ' 67' ' ' THR . 75.8 m-85 -110.42 158.61 18.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.063 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 66' ' ' TYR . 47.4 m 76.57 151.61 0.12 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -67.37 112.1 4.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.12 0.486 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -87.7 -162.16 0.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.505 -172.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -125.55 123.12 38.4 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.609 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.558 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 1.9 mpt? -76.73 157.75 31.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.849 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.98 140.23 18.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.845 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 10.4 mp -104.39 152.26 22.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.876 0.37 . . . . 0.0 110.581 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.401 ' ND2' HG22 ' A' ' 45' ' ' THR . 57.8 m-20 -85.48 141.99 29.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.589 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.41 -25.39 7.02 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.703 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.83 170.94 30.46 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.974 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.56 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 6.3 Cg_exo -79.64 -3.17 12.73 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.191 2.594 . . . . 0.0 112.96 -178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.4 t -102.23 146.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 61.45 42.84 10.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.933 0.397 . . . . 0.0 111.096 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.56 ' NE2' ' HA ' ' A' ' 77' ' ' PRO . 19.4 mm-40 -65.06 -10.9 33.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -176.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.28 -12.55 56.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.73 0.3 . . . . 0.0 110.75 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -130.27 128.89 42.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.314 0.578 . . . . 0.0 112.068 -167.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.52 125.34 7.99 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.21 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.572 ' HB3' HD11 ' A' ' 106' ' ' LEU . 64.7 m-85 -99.99 126.15 46.13 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.44 HG12 HG11 ' A' ' 112' ' ' VAL . 3.8 mp -114.57 122.41 68.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.118 0.485 . . . . 0.0 110.989 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -101.59 125.23 55.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.533 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -131.18 160.7 34.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.609 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.1 p -71.55 132.78 45.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.08 0.467 . . . . 0.0 109.948 174.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 103' ' ' ASP . 9.2 tmtt? -67.76 122.65 18.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.465 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.8 t -152.65 -12.93 0.17 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.307 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -83.57 159.69 21.58 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.69 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -148.52 104.89 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 65.95 -179.03 0.19 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.68 0.613 . . . . 0.0 110.634 -175.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 70.11 -61.7 0.45 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.224 0.609 . . . . 0.0 111.348 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 111' ' ' ASP . 2.0 p -75.11 133.91 41.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.338 0.59 . . . . 0.0 110.77 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.426 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 29.6 m80 -82.36 61.79 5.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.905 177.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.5 m -85.46 138.39 32.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -100.69 123.32 44.73 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.619 ' HD2' ' HA ' ' A' ' 102' ' ' ASP . 28.8 ttpp -83.68 106.58 15.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.343 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.435 HG11 ' HE2' ' A' ' 27' ' ' TYR . 51.9 t -70.45 -54.01 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.226 0.536 . . . . 0.0 109.87 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 102' ' ' ASP . 2.8 t -124.84 -54.6 1.63 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.562 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.619 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 14.9 t70 -177.1 -72.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.638 ' HA ' ' HB3' ' A' ' 89' ' ' LYS . 6.7 m-20 -77.27 -3.97 42.51 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.041 0.448 . . . . 0.0 111.396 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.683 HG13 HD13 ' A' ' 158' ' ' LEU . 51.6 mm -106.41 122.55 60.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.66 128.32 43.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.238 0.542 . . . . 0.0 111.624 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 84' ' ' PHE . 63.3 tp -102.85 121.22 42.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.45 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.53 HG21 ' HB2' ' A' ' 111' ' ' ASP . 4.2 m -126.82 134.46 50.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.623 0.249 . . . . 0.0 110.435 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -147.34 3.26 0.77 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.237 0.542 . . . . 0.0 111.392 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.504 ' HB2' ' OD1' ' A' ' 111' ' ' ASP . 14.2 m -85.9 15.05 5.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.332 . . . . 0.0 111.667 -174.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.19 -23.37 35.63 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.53 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.563 ' HB3' HG22 ' A' ' 95' ' ' THR . 3.0 m-20 -51.34 -37.65 48.95 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.298 0.639 . . . . 0.0 111.545 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.44 HG11 HG12 ' A' ' 85' ' ' ILE . 60.1 t -47.98 -40.84 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.971 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.544 ' HA ' ' CE2' ' A' ' 116' ' ' PHE . 98.0 mt -62.88 -32.73 74.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.072 0.463 . . . . 0.0 110.933 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.18 -35.87 35.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.54 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.1 m -56.21 -50.34 71.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.811 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.544 ' CE2' ' HA ' ' A' ' 113' ' ' LEU . 40.7 p90 -79.64 11.57 3.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.588 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.92 16.56 13.37 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.855 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 76.7 p -111.63 177.7 4.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.373 . . . . 0.0 110.781 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -83.21 -26.45 30.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.61 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 p -96.88 20.8 10.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.432 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -51.21 136.61 29.62 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.542 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 23.6 Cg_exo -62.16 150.78 85.44 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.028 2.485 . . . . 0.0 112.613 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -59.58 -49.6 77.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.911 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -143.59 146.21 33.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.559 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -152.1 137.52 17.64 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.473 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.13 148.11 16.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.447 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.76 129.45 74.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.191 0.52 . . . . 0.0 110.905 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.436 ' SG ' HG11 ' A' ' 39' ' ' VAL . 5.7 p -126.27 124.75 41.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.398 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 129' ' ' LEU . 1.2 tm? -84.22 119.0 24.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.343 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.81 178.78 27.32 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.539 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.5 m -147.81 171.96 14.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.86 0.362 . . . . 0.0 110.046 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 37.6 m -111.57 121.24 44.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.104 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.8 p -96.76 115.33 27.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.174 0.511 . . . . 0.0 111.364 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -101.35 149.9 23.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.473 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 1.5 mppt? -86.78 130.28 49.34 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.778 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 7.5 Cg_exo -73.32 44.5 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.538 2.825 . . . . 0.0 114.335 -168.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -154.11 -39.23 0.09 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.369 . . . . 0.0 110.545 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.538 ' HA ' ' OE1' ' A' ' 138' ' ' GLN . 5.5 tp60 -75.79 -30.72 59.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.693 -175.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.432 ' O ' HG13 ' A' ' 143' ' ' ILE . 60.1 tp -57.87 -38.83 76.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.013 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.9 -42.12 97.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.041 0.448 . . . . 0.0 110.526 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.569 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 31.0 mm-40 -68.17 -39.24 82.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.437 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.627 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 14.1 mm-40 -62.03 -43.34 99.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.167 0.508 . . . . 0.0 110.486 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 150' ' ' LEU . 77.1 mt -65.26 -39.4 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.096 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.42 73.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.536 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 67.1 mt-30 -78.76 2.95 18.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.372 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 19.1 m120 67.18 15.51 10.04 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.345 0.658 . . . . 0.0 112.265 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.447 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 57.0 m-85 -79.94 -21.79 43.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.35 0.595 . . . . 0.0 109.769 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.627 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 97.5 m95 -127.29 114.82 18.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.707 175.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.83 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 24.7 mt -86.36 103.09 14.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.529 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.5 ' HB2' HD13 ' A' ' 143' ' ' ILE . 60.3 tp -86.87 132.96 33.67 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.345 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.9 m -156.75 152.44 26.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.176 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -91.18 153.99 19.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.111 0.481 . . . . 0.0 110.651 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.52 114.25 28.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.62 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.99 68.09 3.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.226 0.536 . . . . 0.0 109.919 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 65.5 -80.48 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.021 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -60.6 -42.92 97.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.857 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 11.8 m -54.24 -30.45 50.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.683 HD13 HG13 ' A' ' 104' ' ' ILE . 5.5 tt -62.68 -57.59 10.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.285 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -121.45 -23.13 5.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -170.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -100.2 -61.25 1.39 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 162' ' ' SER . 6.5 t 36.2 83.49 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.184 0.994 . . . . 0.0 112.107 -174.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 161' ' ' THR . 41.5 m 77.48 2.23 3.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.314 -174.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 86.6 t80 72.21 -42.17 0.53 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.196 0.998 . . . . 0.0 113.031 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 32.5 mt -50.78 -67.73 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -171.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -161.62 166.55 26.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -157.99 136.53 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.09 0.472 . . . . 0.0 111.691 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.502 ' HE3' ' H ' ' A' ' 23' ' ' ARG . 95.3 m95 -133.02 -50.54 0.88 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.658 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.4 p -129.98 -2.71 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.232 -172.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -59.91 -5.13 0.88 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.02 -29.27 70.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.896 0.379 . . . . 0.0 110.526 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -80.32 -24.09 40.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.474 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -59.43 -42.42 91.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.383 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -58.9 -31.68 68.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.158 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.744 ' HG ' ' HB ' ' A' ' 179' ' ' ILE . 7.5 tt -81.65 -46.43 14.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.549 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -61.41 -41.7 99.6 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.158 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 78.0 mt -66.6 -48.67 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.653 0.263 . . . . 0.0 111.235 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.1 m -76.43 -24.54 53.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.44 56.75 3.55 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.989 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.744 ' HB ' ' HG ' ' A' ' 174' ' ' LEU . 50.9 mm -85.15 132.12 32.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.573 0.225 . . . . 0.0 111.133 -176.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.737 ' HG ' HG22 ' A' ' 179' ' ' ILE . 87.3 mt 67.0 -163.86 0.23 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.271 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.72 114.39 19.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 111.758 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.32 140.05 21.58 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.54 2.16 . . . . 0.0 112.197 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 62.88 23.41 13.98 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.239 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -94.17 28.69 10.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.547 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.552 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 21.3 ptt180 -92.76 -166.28 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.3 -75.69 0.5 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.415 -173.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 74.3 mt 57.14 19.26 4.66 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.343 0.402 . . . . 0.0 111.487 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.664 -177.888 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -109.78 44.63 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.303 0.573 . . . . 0.0 110.508 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.94 -1.06 77.85 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.789 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -159.61 156.71 28.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.3 mt -129.4 -170.41 2.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.341 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 68.09 112.18 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.701 0.625 . . . . 0.0 110.892 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.29 3.58 65.04 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 12.6 mptt -106.22 171.24 7.45 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 153' ' ' ALA . 54.9 p90 -140.43 150.73 44.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.803 0.335 . . . . 0.0 110.443 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 pt -109.14 130.75 61.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.226 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.674 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 2.8 mp -76.99 131.41 34.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.099 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 24' ' ' THR . . . -57.66 137.26 56.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.973 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -80.63 110.38 16.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.063 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 20.2 Cg_exo -65.41 118.84 5.81 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.897 2.398 . . . . 0.0 111.849 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.502 ' HA ' ' H ' ' A' ' 185' ' ' ARG . 7.1 pt-20 -148.58 -16.97 0.32 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -126.86 -54.93 1.4 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -167.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -117.06 -64.57 1.29 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.056 0.455 . . . . 0.0 111.619 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.479 ' OD2' ' HB2' ' A' ' 20' ' ' TYR . 19.0 t70 -171.74 -45.76 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -172.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 72.06 1.77 4.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.059 171.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.479 ' HB2' ' OD2' ' A' ' 18' ' ' ASP . 96.7 m-85 -100.19 -27.68 13.39 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 161.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -61.23 -54.2 47.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.713 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -92.54 129.04 38.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -82.52 59.87 4.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.197 0.522 . . . . 0.0 110.511 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.565 ' HA ' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -75.17 55.84 0.77 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.021 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 p -173.4 113.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.865 HG22 ' HD1' ' A' ' 27' ' ' TYR . 44.2 mm -120.71 -83.97 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.938 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.865 ' HD1' HG22 ' A' ' 26' ' ' ILE . 9.9 p90 -173.31 170.21 4.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.049 0.452 . . . . 0.0 111.15 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 mm -102.52 121.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.955 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.2 m -76.97 -46.37 24.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.439 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -151.07 159.27 44.61 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 79.2 t60 -148.12 138.2 22.63 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -174.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 t30 77.87 164.84 0.23 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.22 0.95 . . . . 0.0 111.547 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 68.52 -71.61 0.11 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.675 0.79 . . . . 0.0 112.145 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -88.41 -26.08 22.34 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.79 -177.19 20.38 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.109 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' A' ' 134' ' ' TRP . 23.8 m -100.0 101.85 13.05 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 37' ' ' ILE . 4.5 mp -95.22 112.0 26.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.41 157.36 27.23 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.005 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 4.3 m -123.53 93.74 2.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.266 0.555 . . . . 0.0 110.295 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.452 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -128.56 8.15 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.156 -177.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 pt -80.92 -27.61 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.565 ' HB3' ' HA ' ' A' ' 24' ' ' THR . 13.5 t30 38.96 85.98 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.237 0.961 . . . . 0.0 112.84 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 6.6 t -143.66 112.2 5.4 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-O 121.252 0.549 . . . . 0.0 109.95 176.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 4.8 Cg_exo -76.97 152.57 31.93 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.213 1.942 . . . . 0.0 111.318 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 p -124.88 163.15 22.85 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.716 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -82.82 1.06 41.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.191 0.52 . . . . 0.0 110.743 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.68 HD21 HD21 ' A' ' 52' ' ' LEU . 54.7 tp -83.36 144.48 29.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.235 173.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.65 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 14.5 m -104.19 145.66 29.89 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.7 p -63.57 -33.36 61.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.573 HD23 HD12 ' A' ' 53' ' ' LEU . 90.3 mt -66.99 -33.06 74.76 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.571 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.65 ' HG3' ' HB2' ' A' ' 48' ' ' SER . 32.8 mt-10 -61.26 -43.34 99.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.242 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.68 HD21 HD21 ' A' ' 47' ' ' LEU . 96.4 mt -67.91 -33.38 74.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.303 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 58' ' ' PHE . 94.0 mt -69.67 -42.07 74.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.9 m -62.22 -39.75 93.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.351 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -58.48 -39.89 81.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.383 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.9 mtt -86.6 -91.89 0.1 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.123 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -165.92 77.04 0.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.082 0.467 . . . . 0.0 109.807 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.788 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 25.7 t80 -165.2 138.72 4.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.761 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.409 ' HG2' ' HG3' ' A' ' 60' ' ' MET . 48.2 tt0 -139.64 151.29 45.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.38 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.418 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 68.7 mtt 69.98 -149.45 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.685 0.616 . . . . 0.0 111.168 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' H ' ' HB3' ' A' ' 60' ' ' MET . . . 71.11 69.0 0.17 Allowed 'General case' 0 N--CA 1.462 0.133 0 O-C-N 123.925 0.765 . . . . 0.0 111.58 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.4 mttp 64.58 81.17 0.22 Allowed Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.152 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 69' ' ' ASP . 38.3 Cg_endo -67.79 -42.68 6.26 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.651 2.234 . . . . 0.0 112.935 -175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 55.48 85.71 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.491 0.494 . . . . 0.0 110.491 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 65' ' ' ILE . 4.4 mp -81.0 -43.75 20.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -170.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -60.66 -60.32 3.99 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.818 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 t -83.12 114.15 21.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -41.67 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -164.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.539 ' HB3' HD12 ' A' ' 50' ' ' LEU . 1.1 m-20 48.07 -108.07 0.23 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.953 177.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -152.18 90.88 1.55 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.1 ptm -71.15 140.48 50.57 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.378 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.731 HG21 HD23 ' A' ' 129' ' ' LEU . 11.0 p -108.21 149.79 11.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.621 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.4 mp -94.29 152.88 18.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.404 . . . . 0.0 110.12 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.74 124.93 34.6 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.38 -26.26 21.35 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.851 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.86 164.47 15.09 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.871 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.68 -18.71 22.04 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.473 2.115 . . . . 0.0 112.627 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.411 HG21 ' OG1' ' A' ' 133' ' ' THR . 42.8 t -90.13 133.34 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.232 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 65.77 27.9 11.05 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 110.205 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.42 -17.7 64.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.044 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.59 -10.69 60.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.501 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -125.43 144.49 50.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.055 0.455 . . . . 0.0 110.436 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.31 120.91 7.03 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -98.74 126.55 44.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.749 0.309 . . . . 0.0 110.233 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.5 mp -113.07 112.7 41.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.194 0.521 . . . . 0.0 109.987 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.3 t -94.25 114.65 31.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.147 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -116.33 148.93 40.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.53 -174.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 m -82.39 150.25 27.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.974 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 43.8 tttm -70.16 114.0 7.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.836 0.827 . . . . 0.0 111.551 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.523 HG21 ' HG3' ' A' ' 123' ' ' GLU . 3.2 m -135.28 11.58 3.53 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.641 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -160.13 -173.08 3.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.167 -164.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -158.86 27.23 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.666 173.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -103.58 169.3 8.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.386 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.6 p90 176.74 157.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.038 0.446 . . . . 0.0 111.558 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 p -102.83 -37.72 7.73 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 164.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -168.15 91.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.152 169.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.2 m -100.63 167.42 10.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.51 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 12.6 t80 -124.57 98.18 5.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.428 ' HA ' HG23 ' A' ' 105' ' ' THR . 86.3 tttt -73.27 108.37 6.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 -177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.3 -59.03 3.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.95 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 103' ' ' ASP . 58.5 p -117.14 -176.33 2.97 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.417 ' HA ' ' CE ' ' A' ' 99' ' ' LYS . 31.0 t70 -82.22 34.2 0.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.821 0.819 . . . . 0.0 109.701 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.597 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 12.9 t0 -158.12 -67.25 0.09 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.437 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.86 121.93 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.673 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 99' ' ' LYS . 24.0 m -134.6 134.17 40.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.956 -173.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 63.6 tp -84.73 132.82 34.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.137 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.546 ' HB ' HG13 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -136.63 143.84 43.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 107' ' ' THR . 14.6 t -179.88 21.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.949 0.404 . . . . 0.0 111.32 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.0 t -101.22 8.52 42.53 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.613 -0.679 . . . . 0.0 111.207 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.76 -30.03 6.58 Favored Glycine 0 CA--C 1.509 -0.296 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -45.28 -50.39 11.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.411 -0.894 . . . . 0.0 111.407 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.546 HG13 ' HB ' ' A' ' 107' ' ' THR . 17.5 m -47.81 -45.06 11.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.904 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.19 -30.8 69.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.422 . . . . 0.0 110.789 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -77.99 -33.74 51.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.576 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.0 m -60.66 -62.86 1.55 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.403 -174.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -74.3 -2.77 26.53 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.797 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -96.26 3.67 64.19 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.222 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 120' ' ' THR . 12.4 t -138.89 171.82 13.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -82.26 4.92 21.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.661 0.267 . . . . 0.0 111.49 -175.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.457 ' H ' HG23 ' A' ' 118' ' ' THR . 69.2 p -102.97 15.73 28.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.906 0.384 . . . . 0.0 110.816 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -58.17 141.04 82.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.017 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 19.7 Cg_exo -65.16 146.01 85.74 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.763 2.308 . . . . 0.0 111.986 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.523 ' HG3' HG21 ' A' ' 90' ' ' THR . 38.1 mt-10 -65.4 -37.76 87.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.482 -176.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 123' ' ' GLU . 12.1 mtmt -128.41 132.15 48.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.353 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -163.55 147.53 10.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.447 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.1 pt -126.47 143.74 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.979 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.573 HG13 HG23 ' A' ' 72' ' ' VAL . 6.4 p -114.78 129.4 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.054 0.454 . . . . 0.0 110.588 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.8 p -134.73 136.08 42.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.382 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.731 HD23 HG21 ' A' ' 72' ' ' VAL . 4.0 mm? -86.52 120.99 28.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.356 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.76 -179.15 38.35 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.704 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 61.2 m -145.65 167.49 22.98 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 33.9 m -102.4 122.73 44.86 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 36' ' ' THR . 39.5 p -107.46 120.35 41.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.043 0.449 . . . . 0.0 112.162 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.622 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 1.5 m-90 -96.02 144.75 26.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.316 170.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 138' ' ' GLN . 12.0 mptt -65.05 156.02 82.03 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.394 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.1 133.95 40.55 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.144 1.896 . . . . 0.0 110.642 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.454 ' HA ' ' CG ' ' A' ' 140' ' ' GLU . 49.4 m80 63.74 29.5 14.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.242 0.544 . . . . 0.0 111.325 -175.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 55.5 tp60 -106.29 -68.89 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.225 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.506 ' O ' HG13 ' A' ' 143' ' ' ILE . 52.4 tp -63.14 -47.06 84.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.784 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 137' ' ' HIS . 10.9 pt-20 -58.44 -34.21 70.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.63 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -65.77 -51.17 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.726 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -71.85 -29.85 64.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.36 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' A' ' 148' ' ' TRP . 71.5 mt -61.07 -43.59 96.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.44 -30.32 71.1 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.63 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 42.8 mt-30 -81.16 5.46 16.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.365 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 71.93 30.97 2.14 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.309 0.643 . . . . 0.0 112.369 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -93.84 -3.82 51.21 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.165 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.595 ' HB2' HG12 ' A' ' 143' ' ' ILE . 96.0 m95 -139.43 160.64 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.268 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.674 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 3.1 tt -113.08 118.62 35.27 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 8' ' ' LYS . 35.5 tp -105.08 148.58 26.66 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.994 0.425 . . . . 0.0 111.707 -175.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.5 t -159.69 166.84 29.74 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -106.24 154.1 21.21 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.983 -178.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . . . -120.9 151.78 39.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.57 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -115.41 -61.15 1.78 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.522 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 103' ' ' ASP . 24.8 p-10 -170.8 -59.67 0.02 OUTLIER 'General case' 0 C--O 1.235 0.316 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 45.6 mt-30 -56.94 -41.94 79.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -173.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.463 ' HA ' ' OG1' ' A' ' 161' ' ' THR . 21.4 m -55.56 -32.87 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.37 -51.98 4.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -99.37 -23.34 15.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 39.5 mt-10 -111.83 -25.75 9.29 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -166.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 169' ' ' GLU . 34.0 m -46.47 -42.46 15.51 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -174.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.3 m -58.83 -19.52 42.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -86.93 -52.68 5.32 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.624 ' H ' HD23 ' A' ' 164' ' ' LEU . 1.3 pt? -83.96 -35.87 23.67 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -173.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -99.45 -171.83 2.14 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -119.09 -57.11 2.04 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.781 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.454 ' CE3' HG23 ' A' ' 168' ' ' VAL . 2.2 t90 -166.74 140.76 3.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -175.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.454 HG23 ' CE3' ' A' ' 167' ' ' TRP . 95.6 t 69.82 90.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.786 0.679 . . . . 0.0 111.118 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.536 ' HG3' HG21 ' A' ' 161' ' ' THR . 0.0 OUTLIER -118.16 -41.19 2.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.842 178.505 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.77 -43.87 94.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.662 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -76.5 -26.32 55.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 0.0 110.344 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.34 -29.55 66.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.936 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.0 tpt -60.59 -32.65 71.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.116 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.542 HD13 HD21 ' A' ' 149' ' ' LEU . 13.0 tp -77.35 -42.68 35.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.908 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 112.93 -18.41 21.82 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.698 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.3 mt 63.87 81.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.046 0.538 . . . . 0.0 111.195 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.9 t -122.58 -46.76 2.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.515 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -157.99 121.52 1.07 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.552 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 12.8 tt -114.28 134.08 58.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.04 0.447 . . . . 0.0 110.338 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 92.7 mt -91.09 114.24 26.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.405 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -159.89 100.57 1.46 Allowed Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.421 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.86 108.75 2.59 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.903 2.402 . . . . 0.0 111.615 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 62.75 58.4 1.59 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.316 0.579 . . . . 0.0 110.305 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -96.15 143.64 16.81 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.613 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.502 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 18.5 mmt180 -128.4 98.28 5.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.144 0.497 . . . . 0.0 111.545 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.67 12.55 37.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.819 171.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -158.85 166.81 31.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.799 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.342 178.182 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.581 ' HB3' ' HB3' ' A' ' 140' ' ' GLU . 15.5 tpt . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.769 0.318 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -87.93 -21.87 24.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.862 0.363 . . . . 0.0 110.597 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.16 -150.59 17.52 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.865 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -90.47 105.55 17.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.236 0.541 . . . . 0.0 110.765 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.03 -93.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.205 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 65.15 117.07 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.191 0.52 . . . . 0.0 111.46 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.97 -4.27 74.7 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.391 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 2.3 mptp? -105.58 163.79 12.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.543 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 48.7 p90 -140.7 149.52 42.3 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.221 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.584 HD11 HG13 ' A' ' 40' ' ' ILE . 16.4 pt -98.17 145.01 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.43 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.727 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 45.1 mm -81.68 95.62 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.506 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -102.94 -44.93 5.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.757 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.638 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 52.0 p 56.3 -179.95 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 123.7 0.8 . . . . 0.0 111.224 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 13' ' ' THR . 27.4 Cg_exo -64.0 -57.79 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.321 1.347 . . . . 0.0 110.499 169.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 176.0 72.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 54.2 ttp 74.05 -54.67 0.68 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.095 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -145.62 -166.39 2.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 69.42 -166.23 0.17 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.534 0.734 . . . . 0.0 111.59 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 14' ' ' PRO . 6.1 tp10 64.36 -92.43 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -173.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 173.14 -96.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.62 0.768 . . . . 0.0 111.038 167.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -173.82 15.07 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.717 0.294 . . . . 0.0 111.383 -174.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -105.43 110.37 22.7 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -168.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 66.98 16.89 10.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.933 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 42' ' ' ASN . 33.6 p -92.48 131.53 37.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.329 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.0 t 74.25 82.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 O-C-N 123.885 0.741 . . . . 0.0 111.28 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.887 HG22 ' H ' ' A' ' 27' ' ' TYR . 16.3 mm -107.76 -166.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.887 ' H ' HG22 ' A' ' 26' ' ' ILE . 7.2 p90 -114.86 175.18 5.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.521 0.6 . . . . 0.0 111.683 -167.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.9 mm -86.13 112.55 22.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.358 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.9 -55.2 28.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.386 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -144.17 127.48 16.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.868 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -108.89 99.68 8.99 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 158.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -112.31 59.72 0.63 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.896 -166.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t70 63.2 -66.76 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.97 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.46 -39.45 11.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.75 147.57 17.07 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.886 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 133' ' ' THR . 26.2 m -133.79 102.73 5.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.494 HG13 HG22 ' A' ' 133' ' ' THR . 4.5 mp -111.02 121.77 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.32 -174.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.46 162.48 29.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.92 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 5.7 m -125.81 91.2 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.27 0.557 . . . . 0.0 110.215 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.584 HG13 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -135.85 16.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.9 pt -80.92 -20.89 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.247 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.408 ' HB3' HG22 ' A' ' 24' ' ' THR . 46.1 m-20 61.15 47.93 6.75 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 167.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t -146.06 133.98 10.54 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.431 -177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 61.9 Cg_endo -73.89 165.44 32.14 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.973 2.449 . . . . 0.0 112.366 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.542 HG22 ' ND2' ' A' ' 74' ' ' ASN . 31.1 p -99.54 -166.2 1.32 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.966 0.413 . . . . 0.0 110.034 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.5 12.37 27.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.885 0.85 . . . . 0.0 108.848 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.9 tp -109.86 146.84 34.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.586 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 19.7 m -95.81 149.2 21.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.676 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.4 p -63.9 -30.47 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.297 0.57 . . . . 0.0 109.998 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 63' ' ' PRO . 86.7 mt -75.19 -26.65 59.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.367 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.0 OUTLIER -68.67 -40.67 80.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.377 -176.29 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.668 HD22 HD21 ' A' ' 129' ' ' LEU . 3.9 pp -71.78 -30.51 65.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.064 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 88.5 mt -66.3 -48.42 70.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.323 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.0 p -61.0 -30.24 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.195 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -72.62 -52.8 13.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.4 mtt -90.91 -92.46 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.505 0.193 . . . . 0.0 110.685 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -136.92 146.24 45.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.574 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 12.3 p90 -129.21 -30.86 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 69.56 128.02 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.135 0.493 . . . . 0.0 111.316 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.417 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 68.4 mtt 59.73 -156.81 0.34 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.687 -178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' H ' ' HB3' ' A' ' 60' ' ' MET . . . -115.68 38.39 3.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.239 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -53.94 36.06 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.823 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.699 ' HB3' ' HB3' ' A' ' 50' ' ' LEU . 12.3 Cg_exo -72.32 79.25 1.8 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.178 1.919 . . . . 0.0 111.251 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -135.39 -2.31 2.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.595 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.83 120.78 56.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.695 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.41 173.56 6.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.916 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.1 m 77.05 -47.51 0.52 Allowed 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.784 0.677 . . . . 0.0 110.376 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -102.61 34.12 2.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.243 1.021 . . . . 0.0 108.766 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -93.13 158.64 15.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.818 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 49' ' ' VAL . 30.0 mm-40 -96.38 125.92 41.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.431 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 66.5 mtt -84.43 149.88 25.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.362 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.621 HG21 HD23 ' A' ' 129' ' ' LEU . 12.7 p -100.58 150.23 5.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.725 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 7.0 mp -99.74 164.41 12.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.255 0.55 . . . . 0.0 111.678 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.542 ' ND2' HG22 ' A' ' 45' ' ' THR . 47.9 m-80 -81.84 124.43 29.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.705 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.89 -27.6 37.4 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.601 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.412 ' HA3' ' C ' ' A' ' 131' ' ' CYS . . . 168.98 175.11 38.11 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -86.51 3.24 6.9 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.948 2.432 . . . . 0.0 112.511 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.06 121.25 61.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.238 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.3 m120 55.83 56.49 6.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.009 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.465 ' O ' HD12 ' A' ' 129' ' ' LEU . 84.3 mt-30 -70.93 -7.5 46.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.682 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.89 -10.02 58.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.262 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -112.26 131.36 55.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.939 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.41 117.75 5.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.807 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.524 ' HB3' HD11 ' A' ' 106' ' ' LEU . 71.9 m-85 -102.6 126.08 49.55 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.413 HG21 HG21 ' A' ' 112' ' ' VAL . 4.4 mp -119.88 107.77 21.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 0.0 110.544 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.717 HG22 HD13 ' A' ' 106' ' ' LEU . 12.5 t -91.8 120.66 41.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -134.9 158.83 43.25 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.441 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.5 t -76.21 167.86 21.1 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.146 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER -76.25 114.76 15.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.831 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.755 HG21 ' HA ' ' A' ' 122' ' ' PRO . 1.5 p -116.3 -2.94 12.01 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.013 172.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 92' ' ' HIS . 17.1 t70 -175.68 -145.79 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.515 ' H ' ' CG ' ' A' ' 91' ' ' ASP . 37.4 m80 -88.48 -159.68 0.58 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.609 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 4.1 mp0 -76.19 169.93 17.26 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -117.48 -161.0 0.8 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.6 m -59.9 -37.45 79.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.623 0.249 . . . . 0.0 111.566 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -152.79 80.98 1.22 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.141 0.496 . . . . 0.0 110.342 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 75.0 m -133.77 143.89 48.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.479 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -102.21 128.41 48.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.293 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.609 ' HD3' ' HG3' ' A' ' 93' ' ' GLU . 5.1 tptm -90.65 110.36 21.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.9 t -81.3 -71.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.054 0.454 . . . . 0.0 110.461 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 t -130.48 67.07 1.49 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.481 0.658 . . . . 0.0 110.758 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' HE2' ' A' ' 99' ' ' LYS . 28.1 t70 66.78 -69.83 0.12 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.412 176.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.624 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 11.0 t70 -77.74 -55.43 5.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.228 0.537 . . . . 0.0 110.019 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.415 HD12 ' CD1' ' A' ' 159' ' ' PHE . 33.0 mm -64.93 122.78 16.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.452 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.1 m -128.75 131.09 47.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.837 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.717 HD13 HG22 ' A' ' 86' ' ' VAL . 55.4 tp -107.75 112.61 25.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.083 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.5 m -96.6 124.77 40.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.414 HG22 ' CD2' ' A' ' 84' ' ' PHE . 60.2 p -107.36 17.1 23.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.1 m -147.7 -177.19 5.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.741 0.305 . . . . 0.0 111.184 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.44 -3.01 23.66 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.391 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -49.31 -32.8 11.77 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.961 0.905 . . . . 0.0 110.999 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.413 HG21 HG21 ' A' ' 85' ' ' ILE . 10.3 p -54.71 -34.68 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.972 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.73 -37.71 79.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.176 0.512 . . . . 0.0 110.492 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.28 -24.03 63.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.723 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -72.29 -18.29 61.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.213 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -97.01 144.93 26.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 0.0 110.767 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.26 -17.76 21.73 Favored Glycine 0 C--N 1.328 0.124 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.822 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 p -92.03 25.78 2.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 74.01 -39.82 0.44 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.607 0.763 . . . . 0.0 111.351 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.9 p -81.17 18.42 1.08 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.46 123.64 67.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.76 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.755 ' HA ' HG21 ' A' ' 90' ' ' THR . 29.7 Cg_endo -64.31 136.26 50.42 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.628 2.219 . . . . 0.0 112.862 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -66.71 -47.65 71.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.136 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -124.39 127.76 48.04 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.178 -174.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -155.9 152.36 28.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.51 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.8 pt -129.45 132.46 66.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.156 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.528 HG13 HG23 ' A' ' 72' ' ' VAL . 6.8 p -112.09 134.59 54.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.193 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 84.0 m -140.24 139.65 35.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.066 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.668 HD21 HD22 ' A' ' 52' ' ' LEU . 4.3 mm? -89.84 118.44 29.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.962 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.47 177.82 44.6 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.057 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.412 ' C ' ' HA3' ' A' ' 76' ' ' GLY . 73.5 m -145.6 171.58 14.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.904 0.383 . . . . 0.0 110.048 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.472 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 19.3 m -100.26 115.59 30.26 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 36' ' ' THR . 44.0 p -108.35 134.74 50.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.774 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.691 ' CD1' ' HB2' ' A' ' 139' ' ' LEU . 1.1 m-90 -119.9 165.02 15.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.302 0.572 . . . . 0.0 110.343 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -91.61 140.73 25.29 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.603 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.36 61.28 4.19 Favored 'Trans proline' 0 N--CA 1.473 0.313 0 C-N-CA 123.269 2.646 . . . . 0.0 113.298 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -167.73 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.592 ' HG3' ' OE2' ' A' ' 142' ' ' GLU . 52.2 tp60 -65.77 -68.36 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.377 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.691 ' HB2' ' CD1' ' A' ' 134' ' ' TRP . 55.8 tp -52.77 -42.02 64.6 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.887 0.375 . . . . 0.0 111.721 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 50.7 mt-10 -60.54 -32.85 71.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.078 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.597 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 25.3 mt-30 -72.31 -45.62 59.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.07 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.73 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 1.1 mp0 -54.42 -41.91 69.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.768 0.318 . . . . 0.0 111.199 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 139' ' ' LEU . 86.3 mt -56.91 -42.61 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.147 0.498 . . . . 0.0 110.538 175.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.46 -20.57 63.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.658 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.597 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 38.1 mt-30 -88.82 6.39 39.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.954 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 145' ' ' GLN . 14.0 m120 69.15 13.24 8.65 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.549 0.53 . . . . 0.0 111.233 -178.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -81.6 -21.86 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.714 0.768 . . . . 0.0 109.004 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.73 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 99.3 m95 -133.26 131.18 39.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.861 172.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.727 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 98.8 mt -95.64 155.3 16.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.5 tp -127.61 135.13 49.85 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.776 0.322 . . . . 0.0 111.039 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.1 t -141.04 176.84 8.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 8' ' ' LYS . 33.0 mt-10 -125.69 153.85 43.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.584 0.23 . . . . 0.0 110.882 -175.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.33 124.19 18.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.962 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -89.52 -45.07 9.67 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.103 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -172.65 -60.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.625 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 44.6 mt-30 -53.89 -48.96 69.56 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.347 -172.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.9 m -59.33 -28.35 66.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.855 0.359 . . . . 0.0 111.913 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.22 -53.84 4.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.415 ' CD1' HD12 ' A' ' 104' ' ' ILE . 34.5 m-85 -127.15 12.84 7.17 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -170.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 21.2 tt0 -109.83 -50.93 2.93 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.7 p -99.61 143.23 30.08 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.3 t -171.7 -149.45 0.06 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -56.72 -18.45 12.51 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.859 0.463 . . . . 0.0 111.772 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 164' ' ' LEU . 2.8 pp -88.39 -4.5 58.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.767 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 166' ' ' ARG . 10.5 t70 -138.74 -144.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.63 ' HD2' ' HG2' ' A' ' 169' ' ' GLU . 31.8 ttm180 -51.63 124.49 12.4 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.219 0.607 . . . . 0.0 111.762 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -73.29 102.48 3.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.105 -176.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.6 t 62.22 89.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 123.761 0.663 . . . . 0.0 111.481 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.63 ' HG2' ' HD2' ' A' ' 166' ' ' ARG . 49.5 mt-10 -80.12 -2.28 43.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.491 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.415 ' HB1' HD12 ' A' ' 11' ' ' ILE . . . -51.78 -39.58 58.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -172.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -81.03 -37.16 29.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.084 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.16 -38.35 60.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.011 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 14.6 tpt -63.95 -27.8 69.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.277 0.561 . . . . 0.0 110.328 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.48 -35.31 40.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.132 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 119.08 8.0 9.83 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.086 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 52.7 mt 59.77 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.556 0.693 . . . . 0.0 111.084 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 18.6 t -149.53 109.8 4.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.914 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.75 100.77 2.27 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.733 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.475 HG22 HD12 ' A' ' 180' ' ' LEU . 4.1 mp -102.79 114.84 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.475 HD12 HG22 ' A' ' 179' ' ' ILE . 6.3 mp 63.12 -170.6 0.18 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.726 0.641 . . . . 0.0 111.565 -174.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -125.49 128.37 24.69 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.149 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 32.1 Cg_exo -61.68 166.8 11.14 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.024 2.483 . . . . 0.0 112.455 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.98 108.59 0.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.301 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.6 137.79 27.84 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.482 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -75.27 93.73 2.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.827 0.346 . . . . 0.0 110.636 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -129.78 81.82 2.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.194 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 95.8 mt -135.62 166.06 24.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.342 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--O 1.25 1.107 0 O-C-N 123.482 0.489 . . . . 0.0 110.376 179.178 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 70.5 -74.44 0.08 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.219 0.608 . . . . 0.0 111.021 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.74 -105.57 1.76 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.776 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -80.61 105.09 11.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.162 0.506 . . . . 0.0 111.809 -174.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.455 HD13 HG13 ' A' ' 28' ' ' ILE . 97.3 mt -78.56 -92.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.516 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 39.63 84.52 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.563 0.745 . . . . 0.0 112.421 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.61 -9.57 12.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.461 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' HG3' ' HG3' ' A' ' 152' ' ' GLU . 10.4 mptt -107.19 172.46 6.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -129.29 143.1 50.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.008 0.432 . . . . 0.0 110.269 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 9.3 pt -107.03 127.33 62.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.224 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.923 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.3 mp -92.63 107.8 19.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.672 -174.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.618 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -91.19 -45.36 8.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.705 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.764 HG21 HG12 ' A' ' 179' ' ' ILE . 18.2 m 63.1 80.47 0.24 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.597 -175.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.02 16.23 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.865 2.377 . . . . 0.0 112.117 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 65.64 16.87 10.7 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.703 -177.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.0 ttt -84.93 113.32 21.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.909 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 19.0 t70 -103.55 27.32 7.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.99 -169.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.923 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . 2.2 t70 68.66 129.2 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.494 0.664 . . . . 0.0 111.544 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -93.26 -41.82 9.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.74 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -160.19 -36.02 0.05 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.754 0.311 . . . . 0.0 110.985 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -153.16 37.45 0.48 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.716 0.769 . . . . 0.0 109.199 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.923 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 30.8 t70 -88.22 120.77 29.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.302 -176.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -89.22 112.14 23.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.444 ' HA ' HD21 ' A' ' 42' ' ' ASN . 3.7 p -63.65 83.16 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -173.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.743 HG13 ' HB ' ' A' ' 40' ' ' ILE . 51.7 t 62.24 100.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 O-C-N 123.792 0.683 . . . . 0.0 112.136 173.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.644 ' CG2' HG23 ' A' ' 39' ' ' VAL . 11.3 tp -89.58 -141.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.919 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.557 ' H ' HG13 ' A' ' 26' ' ' ILE . 2.8 p90 -115.75 175.0 5.73 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.718 1.144 . . . . 0.0 112.442 -163.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.455 HG13 HD13 ' A' ' 5' ' ' LEU . 49.8 mm -90.24 120.91 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.823 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.0 m -87.36 -38.21 16.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -171.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.929 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 9.3 tp10 -141.15 155.18 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.84 0.352 . . . . 0.0 110.998 -173.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -146.18 104.36 3.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.85 170.09 8.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.317 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -62.76 -22.01 66.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.165 0.507 . . . . 0.0 111.031 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.23 5.61 25.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.108 -173.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.581 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 161.68 161.12 11.48 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.587 -1.292 . . . . 0.0 113.546 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.7 m -108.55 128.72 55.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.929 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.5 mp -106.47 117.69 52.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.746 -173.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.72 165.42 26.85 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.644 HG23 ' CG2' ' A' ' 26' ' ' ILE . 2.5 m -118.74 44.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.518 0.675 . . . . 0.0 110.616 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.743 ' HB ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -95.31 19.04 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.071 -175.309 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.6 tp -76.83 -31.73 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.658 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.444 HD21 ' HA ' ' A' ' 24' ' ' THR . 3.1 m120 58.07 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.163 0.585 . . . . 0.0 112.226 -175.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -171.15 107.69 0.4 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 121.539 0.685 . . . . 0.0 110.313 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 6.5 Cg_exo -74.42 154.03 45.23 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.595 2.197 . . . . 0.0 111.209 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.3 p -127.73 158.43 37.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.884 0.373 . . . . 0.0 111.231 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.58 10.76 2.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.641 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.9 tp -86.09 146.08 26.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.8 t -99.0 149.57 22.85 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.704 0.288 . . . . 0.0 110.687 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 8.8 p -63.8 -26.02 39.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.25 0.548 . . . . 0.0 109.916 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.554 ' HB3' HE22 ' A' ' 59' ' ' GLN . 91.8 mt -75.38 -27.54 59.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.312 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.25 -31.46 60.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.64 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.2 pp -72.67 -26.08 61.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.149 0.499 . . . . 0.0 109.745 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 113' ' ' LEU . 87.8 mt -75.42 -42.56 53.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.886 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.4 p -68.24 -30.93 70.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -73.55 -11.41 60.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.3 mtt -91.89 -84.6 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 172.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.4 t70 179.7 25.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.542 0.687 . . . . 0.0 109.597 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.709 ' HB3' HD12 ' A' ' 113' ' ' LEU . 96.6 m-85 -132.81 166.88 21.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.03 -170.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.554 HE22 ' HB3' ' A' ' 50' ' ' LEU . 2.0 mm-40 -155.99 175.67 13.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.864 175.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 42.5 ttp 67.94 101.47 0.05 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 111.486 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' A' ' 53' ' ' LEU . . . -122.41 -50.46 2.0 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.373 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 57.2 mtpt -131.89 154.4 81.73 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.204 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 12.1 Cg_exo -71.89 43.75 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.851 2.367 . . . . 0.0 112.433 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.41 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 0.4 OUTLIER -113.3 87.4 2.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.19 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 46.7 mt -86.55 85.98 2.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -171.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.7 t80 71.18 -42.57 0.54 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 168.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 t -56.87 -27.42 60.47 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.084 0.469 . . . . 0.0 111.426 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.41 ' HG3' ' HB3' ' A' ' 64' ' ' ARG . 11.1 pt20 -144.42 86.52 1.83 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.582 0.706 . . . . 0.0 109.59 174.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -65.98 140.24 58.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.239 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.495 ' HB2' HG12 ' A' ' 49' ' ' VAL . 25.6 mm-40 -94.16 104.07 16.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.914 -178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 87.8 mtp -78.86 142.75 36.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.633 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 127' ' ' VAL . 12.6 p -98.96 149.66 5.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.183 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.8 mp -99.52 158.97 15.37 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.051 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.54 132.92 44.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 175.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.619 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -91.3 -12.52 59.8 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.353 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.23 174.89 30.59 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.098 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.06 -10.26 15.23 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.171 2.581 . . . . 0.0 112.944 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.07 122.55 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.05 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 64.92 46.52 2.86 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.461 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.428 ' O ' HD12 ' A' ' 129' ' ' LEU . 49.7 mt-30 -67.12 -10.3 48.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.98 -3.01 58.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.91 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -113.21 115.95 29.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.954 0.407 . . . . 0.0 110.69 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.84 115.49 4.99 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -96.5 126.17 41.5 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.21 103.91 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.002 0.429 . . . . 0.0 109.977 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.702 HG22 ' HB3' ' A' ' 106' ' ' LEU . 31.1 t -93.13 124.74 45.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.557 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -135.09 164.61 27.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.864 0.364 . . . . 0.0 111.654 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 124' ' ' LYS . 14.6 m -70.36 160.67 31.86 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.196 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 23.4 tptm -76.72 121.31 23.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.374 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -107.5 -67.04 0.98 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -164.72 -172.1 2.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 171.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.56 93.61 4.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -104.36 -175.9 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.934 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -72.24 97.34 1.97 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.283 -172.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.488 HG22 ' HB3' ' A' ' 111' ' ' ASP . 20.9 p -145.01 142.27 29.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.442 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -88.65 80.68 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 172.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.492 ' HB3' HG22 ' A' ' 105' ' ' THR . 15.7 m -116.46 150.93 37.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.233 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -104.83 139.53 39.46 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -101.57 116.0 31.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.76 -53.65 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 167.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.503 HG22 ' HB ' ' A' ' 104' ' ' ILE . 10.2 t -137.6 -166.18 1.9 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 169.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -83.32 -22.27 32.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 118.566 0.621 . . . . 0.0 111.023 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 28.7 m-20 -101.16 -11.66 19.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.623 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.503 ' HB ' HG22 ' A' ' 101' ' ' THR . 42.1 mm -120.72 122.67 68.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 97' ' ' SER . 29.7 m -145.77 130.6 18.12 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.787 0.327 . . . . 0.0 111.167 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.702 ' HB3' HG22 ' A' ' 86' ' ' VAL . 1.1 pt? -108.21 132.69 53.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.477 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 109' ' ' SER . 50.3 m -96.06 129.36 43.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.105 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 p -107.0 21.13 18.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.031 0.443 . . . . 0.0 111.588 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.473 ' H ' HG22 ' A' ' 107' ' ' THR . 22.7 t -147.0 175.15 10.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.328 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.08 -0.0 49.41 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 113.004 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.488 ' HB3' HG22 ' A' ' 95' ' ' THR . 67.9 m-20 -56.22 -33.43 65.35 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.659 0.742 . . . . 0.0 110.514 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 p -52.25 -33.81 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.232 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.709 HD12 ' HB3' ' A' ' 58' ' ' PHE . 16.9 mt -73.02 -31.82 64.72 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.849 0.357 . . . . 0.0 111.171 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.21 -36.03 82.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.015 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -79.94 -2.93 45.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.213 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.35 146.54 23.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 111.046 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.42 -24.83 30.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.323 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 p -87.57 -175.5 5.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.787 0.327 . . . . 0.0 110.795 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -75.84 -16.46 60.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.284 0.564 . . . . 0.0 109.758 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.6 p -91.89 8.86 35.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.479 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.457 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -76.91 114.45 39.48 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.686 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 14.0 Cg_exo -69.09 130.17 19.67 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.806 2.338 . . . . 0.0 111.926 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.45 -36.92 85.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.977 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.494 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 13.5 mmtp -103.65 100.54 10.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.465 -171.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 35.2 p90 -138.29 130.9 29.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.047 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.4 pt -116.84 132.86 65.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 72' ' ' VAL . 7.7 p -115.24 129.22 71.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.263 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 84.8 m -136.63 136.6 39.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.479 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 72' ' ' VAL . 4.2 mm? -90.51 114.36 26.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.653 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.27 173.64 42.18 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.533 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.3 m -147.14 169.97 18.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.795 0.331 . . . . 0.0 110.436 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.8 m -105.11 122.5 46.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.246 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.692 HG22 HG13 ' A' ' 37' ' ' ILE . 30.5 p -100.94 123.63 45.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.402 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -105.63 153.44 21.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.183 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -73.94 138.03 76.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.867 0.365 . . . . 0.0 111.262 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.581 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 36.3 Cg_endo -65.52 136.72 47.66 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.872 2.381 . . . . 0.0 111.69 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.714 ' HA ' ' CD ' ' A' ' 140' ' ' GLU . 81.3 m-70 64.98 13.76 8.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.876 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 26.7 tt0 -108.21 -54.68 2.47 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 171.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 143' ' ' ILE . 66.3 tp -57.79 -41.17 81.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.718 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.714 ' CD ' ' HA ' ' A' ' 137' ' ' HIS . 7.0 pt-20 -59.1 -38.15 78.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -76.39 -30.78 57.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.71 0.291 . . . . 0.0 110.806 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 9.5 mm-40 -61.51 -41.5 97.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.0 110.035 175.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.592 ' HA ' ' HB2' ' A' ' 148' ' ' TRP . 76.2 mt -58.61 -40.44 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.629 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.44 65.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.895 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -82.44 -1.08 49.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.946 -0.115 . . . . 0.0 111.041 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 71.3 11.58 6.74 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.713 0.633 . . . . 0.0 110.126 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -77.1 -24.65 51.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.927 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.618 ' CZ3' ' HB2' ' A' ' 12' ' ' ALA . 95.3 m95 -130.49 138.98 50.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.018 174.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.923 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 98.3 mt -100.91 157.7 16.53 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.8 tp -129.55 134.37 47.71 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.667 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.1 t -154.47 143.28 20.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.465 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.437 ' HG3' ' HG3' ' A' ' 8' ' ' LYS . 4.6 mp0 -73.13 154.63 40.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.44 -26.78 24.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.998 0.427 . . . . 0.0 110.509 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.4 m120 55.59 21.92 4.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.009 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 70.59 -51.47 0.67 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.435 0.694 . . . . 0.0 111.815 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.443 ' HA ' ' CB ' ' A' ' 160' ' ' GLU . 36.2 mt-30 -64.14 -50.02 69.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.098 -173.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.7 m -61.84 -29.45 70.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.109 0.48 . . . . 0.0 110.69 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.38 -57.76 3.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.907 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -120.99 -38.18 2.86 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.443 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 26.3 tt0 -56.87 -58.23 9.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.775 0.321 . . . . 0.0 111.238 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.5 t -63.44 -13.95 45.56 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.924 -173.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 m -78.75 43.63 0.5 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.802 0.334 . . . . 0.0 111.154 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -79.77 -41.46 26.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.369 . . . . 0.0 111.239 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 53.1 mt -95.69 -81.89 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.328 -168.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.25 -27.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.664 -168.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.412 ' HD3' ' OE1' ' A' ' 172' ' ' GLU . 32.1 ttm180 -44.08 114.55 0.68 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -97.55 -178.98 4.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.19 168.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.8 t 60.98 68.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.638 0.733 . . . . 0.0 109.867 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -104.74 -37.34 7.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.071 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.73 -47.0 83.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.492 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -71.95 -30.9 65.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.791 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 175' ' ' GLY . 31.8 tt0 -68.07 -31.56 71.28 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.683 0.278 . . . . 0.0 110.714 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.502 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 20.1 mmt -58.73 -28.68 66.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.977 0.418 . . . . 0.0 110.858 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.4 tp -96.74 -57.73 2.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.696 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 172' ' ' GLU . . . -170.43 -110.81 0.24 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 175' ' ' GLY . 5.3 mm -160.49 -60.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.254 0.622 . . . . 0.0 109.904 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 19.8 m -99.68 123.01 43.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.806 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 179' ' ' ILE . . . 154.93 -100.74 0.2 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.4 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.764 HG12 HG21 ' A' ' 13' ' ' THR . 2.0 mp 70.6 132.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-O 121.394 0.616 . . . . 0.0 110.382 -176.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.544 HD13 HD21 ' A' ' 149' ' ' LEU . 5.9 mp -72.86 97.84 2.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.588 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -124.44 102.65 32.87 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.209 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.04 -37.13 94.05 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.037 2.491 . . . . 0.0 112.466 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 50.57 58.95 4.95 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.505 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -157.61 -138.9 2.6 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -76.53 77.13 3.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.57 0.7 . . . . 0.0 111.501 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -120.89 30.48 6.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.198 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 187' ' ' LEU . 2.4 pt? -118.86 173.43 6.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.606 -174.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.099 179.354 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.707 0.289 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -165.01 160.22 18.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.551 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.41 -127.78 4.35 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.99 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 31' ' ' HIS . 54.7 t30 -82.35 146.76 29.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.3 mt -123.89 -83.29 0.65 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.588 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 63.76 152.51 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.776 0.798 . . . . 0.0 111.713 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.37 23.71 70.29 Favored Glycine 0 C--N 1.316 -0.558 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.907 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.556 ' NZ ' ' HG3' ' A' ' 152' ' ' GLU . 71.0 mmtt -110.75 164.83 12.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 29.3 p90 -144.13 153.24 41.94 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 172.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.549 ' O ' HG21 ' A' ' 25' ' ' VAL . 4.5 pt -117.72 127.03 75.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.046 0.451 . . . . 0.0 111.098 -176.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.714 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 53.8 mt -94.41 112.95 28.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.287 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 148' ' ' TRP . . . -158.7 124.1 4.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.318 172.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.478 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 19.1 p -90.61 107.88 23.36 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-O 121.108 0.48 . . . . 0.0 110.898 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.502 ' HG2' HD22 ' A' ' 42' ' ' ASN . 6.3 Cg_exo -73.52 89.18 0.97 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.184 2.59 . . . . 0.0 112.861 -173.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 67.78 -0.98 1.8 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.835 171.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.7 mtm 50.23 49.45 20.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.19 0.519 . . . . 0.0 110.464 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 3.0 t70 -78.85 -169.69 1.87 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.698 -172.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.32 -55.07 15.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.84 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.513 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 8.6 pt-20 -82.73 38.95 0.59 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.535 0.683 . . . . 0.0 110.873 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.578 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -116.75 -33.09 4.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.425 -174.005 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -58.8 -26.65 64.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.442 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 6.4 t70 -105.44 100.43 10.01 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HD3' ' HA ' ' A' ' 23' ' ' ARG . 32.9 mmt180 79.04 103.49 0.07 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.59 1.181 . . . . 0.0 111.756 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.649 ' O ' HG22 ' A' ' 25' ' ' VAL . 32.0 p -96.61 89.96 5.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.498 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.77 HG12 HD21 ' A' ' 42' ' ' ASN . 1.9 m 62.51 174.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.427 1.091 . . . . 0.0 111.911 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.541 HG13 ' H ' ' A' ' 27' ' ' TYR . 11.1 tp -156.22 -142.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.541 ' H ' HG13 ' A' ' 26' ' ' ILE . 1.1 p90 -109.49 170.08 8.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 119.552 1.069 . . . . 0.0 112.277 -163.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.83 126.87 49.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.617 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 55.6 m -78.49 -59.28 2.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.39 159.89 33.96 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.454 0.645 . . . . 0.0 111.742 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.448 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 49.0 t-80 -144.13 142.0 30.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.355 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.4 t30 83.88 177.98 0.05 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.553 1.158 . . . . 0.0 109.091 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 t70 68.24 -76.2 0.06 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.22 0.608 . . . . 0.0 110.893 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.489 ' HB3' HD11 ' A' ' 37' ' ' ILE . 8.4 t30 -93.18 -34.44 13.61 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.49 -110.11 0.44 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.181 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 133' ' ' THR . 11.0 m -136.32 105.25 5.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 133' ' ' THR . 4.1 mp -98.97 112.02 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.444 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.67 170.22 31.16 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.517 HG23 ' CG2' ' A' ' 26' ' ' ILE . 2.8 m -120.58 76.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.649 0.737 . . . . 0.0 111.004 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.501 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -121.9 20.91 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 -176.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.419 HG23 HG22 ' A' ' 43' ' ' THR . 10.1 tp -73.05 -24.11 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.033 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.77 HD21 HG12 ' A' ' 25' ' ' VAL . 86.6 m-20 53.63 82.87 0.08 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.274 0.63 . . . . 0.0 112.299 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 6.5 t -172.81 113.45 0.36 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.433 0.635 . . . . 0.0 110.881 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 50.9 Cg_endo -71.94 153.92 58.17 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.078 1.852 . . . . 0.0 110.482 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.431 HG22 HD22 ' A' ' 74' ' ' ASN . 11.2 p -96.65 169.93 9.55 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.773 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.33 5.88 11.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.91 161.31 17.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 57.6 p -116.4 160.89 19.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.337 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 12.5 p -67.72 -32.89 58.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.966 0.412 . . . . 0.0 110.361 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.553 HD23 HD12 ' A' ' 53' ' ' LEU . 59.6 mt -73.82 -32.02 63.52 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.993 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -57.46 -53.33 59.38 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.15 -43.83 70.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.237 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.553 HD12 HD23 ' A' ' 50' ' ' LEU . 80.9 mt -62.3 -45.56 92.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.267 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.8 p -73.47 -32.88 64.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.056 0.455 . . . . 0.0 111.314 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -67.74 -34.65 77.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.944 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 47.3 mtt -106.56 1.01 24.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.203 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.4 t70 62.08 100.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.911 0.757 . . . . 0.0 111.05 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -81.69 155.01 25.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.808 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -61.37 130.27 45.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.888 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.9 mtt -76.25 88.88 3.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.392 0.615 . . . . 0.0 111.578 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.47 10.13 2.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.651 174.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -153.34 133.06 7.32 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.005 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.51 163.16 11.06 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.983 2.456 . . . . 0.0 112.711 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.44 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 9.7 tpt180 -64.49 -61.37 2.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.488 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 64' ' ' ARG . 2.0 mp 68.76 108.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.412 0.625 . . . . 0.0 110.068 -172.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.35 126.13 48.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.524 -175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.4 m 64.59 36.47 8.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.845 0.831 . . . . 0.0 111.677 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.428 ' HB3' ' CG2' ' A' ' 65' ' ' ILE . 7.7 tt0 -140.46 34.39 1.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.233 1.015 . . . . 0.0 108.286 171.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.01 146.62 43.64 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.971 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -99.85 129.66 45.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.665 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 91.5 mtp -75.85 136.12 40.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.236 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 129' ' ' LEU . 14.0 p -88.98 141.48 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 7.4 mp -95.98 161.56 13.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.235 0.541 . . . . 0.0 111.099 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.431 HD22 HG22 ' A' ' 45' ' ' THR . 2.0 t-20 -92.37 132.71 36.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.941 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -88.22 -25.37 31.45 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.263 -0.97 . . . . 0.0 111.908 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.42 176.72 27.04 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.93 -17.84 22.12 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.971 2.447 . . . . 0.0 112.67 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.9 t -98.7 143.95 12.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.045 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 62.95 31.76 15.99 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.975 0.51 . . . . 0.0 112.052 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -71.56 -10.12 59.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -80.7 -0.12 36.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.349 . . . . 0.0 110.262 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -122.49 133.77 54.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.607 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.23 110.42 3.63 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.516 ' HB3' HD11 ' A' ' 106' ' ' LEU . 93.7 m-85 -92.35 124.85 36.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.694 0.283 . . . . 0.0 110.322 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 112' ' ' VAL . 2.7 mp -121.56 112.63 36.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.409 0.623 . . . . 0.0 110.224 177.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 66.0 t -90.74 110.96 22.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.198 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -137.28 165.01 27.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.704 0.287 . . . . 0.0 111.569 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.7 p -81.75 159.46 23.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.004 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 90' ' ' THR . 58.5 tttm -87.47 140.73 29.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.931 0.396 . . . . 0.0 110.144 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -95.06 -170.71 2.25 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.341 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.417 ' H ' HG22 ' A' ' 90' ' ' THR . 6.7 p-10 -64.2 -35.09 79.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.157 0.503 . . . . 0.0 110.118 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -83.4 163.54 20.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.684 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.44 -172.38 4.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.08 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -132.14 162.72 30.18 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.8 m -80.96 -47.0 14.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.876 0.37 . . . . 0.0 110.515 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.473 ' O ' HG23 ' A' ' 107' ' ' THR . 13.0 t-160 -145.28 97.29 2.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.692 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.432 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 66.7 m -135.56 152.72 51.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.044 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -101.66 114.39 28.4 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 102' ' ' ASP . 88.3 tttt -78.14 102.33 7.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 0.0 110.727 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.438 HG11 ' HE2' ' A' ' 27' ' ' TYR . 40.3 t -86.11 -53.83 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.57 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.42 ' HB ' ' ND2' ' A' ' 155' ' ' ASN . 36.8 p -116.01 176.67 4.99 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 4.8 t70 -86.32 52.32 2.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.264 0.554 . . . . 0.0 110.289 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 28.6 t70 177.65 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.891 178.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.503 HG21 HD13 ' A' ' 158' ' ' LEU . 48.1 mm -90.3 124.38 42.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.123 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 97' ' ' SER . 0.5 OUTLIER -121.36 139.14 53.82 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.443 -176.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 84' ' ' PHE . 65.5 tp -101.12 112.41 24.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.274 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 96' ' ' HIS . 18.8 m -99.93 130.33 46.09 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.238 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -114.18 10.88 17.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.074 -174.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.0 m -132.19 -177.46 4.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.254 . . . . 0.0 110.926 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.458 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -70.7 4.85 8.48 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.688 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.454 ' HB3' HG21 ' A' ' 107' ' ' THR . 17.4 t0 -61.13 -29.54 69.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.331 0.586 . . . . 0.0 109.451 174.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.539 HG21 HD13 ' A' ' 85' ' ' ILE . 47.0 t -57.48 -39.42 68.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.732 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.509 HD13 ' CZ ' ' A' ' 116' ' ' PHE . 4.1 mm? -61.6 -32.51 72.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.594 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -81.87 -32.89 30.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.952 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 47.4 m -57.99 -51.93 67.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.415 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.517 ' HA ' ' HB1' ' A' ' 121' ' ' ALA . 10.7 p90 -92.73 8.89 37.35 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.746 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -104.81 37.02 4.01 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.62 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 t -151.47 165.46 34.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -67.81 -22.58 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.133 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 p -104.71 42.3 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.246 0.546 . . . . 0.0 110.832 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.517 ' HB1' ' HA ' ' A' ' 116' ' ' PHE . . . -64.19 140.58 97.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.093 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 12.2 Cg_exo -68.95 124.04 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.337 2.025 . . . . 0.0 111.025 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.66 -28.35 58.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.743 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -105.88 105.36 15.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.061 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 46.4 p90 -157.24 146.3 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.159 0.504 . . . . 0.0 111.587 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.7 142.83 39.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.566 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.18 131.7 66.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.903 0.382 . . . . 0.0 111.11 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 77.6 m -142.98 141.1 31.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.414 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.542 HD23 HG21 ' A' ' 72' ' ' VAL . 4.1 mm? -94.02 119.25 32.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.255 177.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.502 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 78.35 -179.86 51.52 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.476 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.4 m -147.99 169.31 20.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.906 0.384 . . . . 0.0 110.005 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.839 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 30.2 m -106.85 126.96 52.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.779 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 36' ' ' THR . 39.4 p -114.49 119.69 37.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.425 0.631 . . . . 0.0 112.136 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.839 ' HZ3' ' HB3' ' A' ' 132' ' ' SER . 1.3 m-90 -99.94 136.27 40.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.025 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -83.23 147.54 53.84 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.315 -175.245 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 137' ' ' HIS . 21.6 Cg_exo -66.55 73.82 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.656 2.904 . . . . 0.0 112.736 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 136' ' ' PRO . 17.4 p-80 167.17 -23.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.652 1.181 . . . . 0.0 108.083 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.585 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 63.0 tt0 -84.68 -67.35 0.8 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.51 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 134' ' ' TRP . 51.2 tp -60.52 -44.88 95.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.114 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -61.18 -42.13 98.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.741 -0.208 . . . . 0.0 111.429 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.585 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.6 mp0 -68.44 -35.58 77.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.636 0.255 . . . . 0.0 110.676 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 8.6 mm-40 -64.01 -46.51 84.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.268 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.659 HG12 ' HB2' ' A' ' 148' ' ' TRP . 68.6 mt -62.07 -41.17 90.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.581 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.52 81.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.459 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.585 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 40.6 mt-30 -82.46 7.11 15.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 67.03 37.14 3.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.834 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -83.98 -48.15 10.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.134 0.492 . . . . 0.0 109.893 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.659 ' HB2' HG12 ' A' ' 143' ' ' ILE . 96.7 m95 -107.37 130.18 54.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.486 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.927 ' HG ' ' HG ' ' A' ' 180' ' ' LEU . 4.9 tt -91.21 103.3 15.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 8' ' ' LYS . 55.2 tp -82.66 133.68 35.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.022 0.439 . . . . 0.0 111.198 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.8 m -145.32 172.89 12.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.126 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.556 ' HG3' ' NZ ' ' A' ' 8' ' ' LYS . 5.2 mp0 -96.65 153.44 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.234 0.54 . . . . 0.0 111.791 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -119.72 108.49 14.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.125 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -79.94 49.39 1.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -170.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.42 ' ND2' ' HB ' ' A' ' 101' ' ' THR . 26.5 t-20 64.7 -74.22 0.05 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.491 0.716 . . . . 0.0 111.361 175.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -61.47 -25.53 67.3 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.702 0.401 . . . . 0.0 111.132 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.902 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 13.6 m -52.73 -29.66 28.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.028 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.503 HD13 HG21 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -63.12 -44.03 96.76 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -175.241 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.67 -3.15 2.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -117.64 -37.25 3.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.902 ' HB ' ' HA ' ' A' ' 157' ' ' THR . 9.7 m -94.33 112.53 24.33 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 122.404 -0.185 . . . . 0.0 110.893 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.1 t 66.65 90.31 0.09 Allowed 'General case' 0 N--CA 1.461 0.105 0 O-C-N 123.748 0.655 . . . . 0.0 110.336 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -71.45 -57.49 4.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.626 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.54 ' HG ' ' N ' ' A' ' 165' ' ' ASP . 2.1 pt? -161.9 -66.31 0.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.996 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.54 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 13.9 m-20 61.1 -68.28 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.392 0.677 . . . . 0.0 112.108 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -121.48 179.97 4.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.676 0.274 . . . . 0.0 110.452 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -87.76 24.38 1.75 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.107 0.479 . . . . 0.0 111.224 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.5 m -137.57 36.36 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.365 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.402 ' H ' ' HG3' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -57.27 -49.24 76.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.082 -170.632 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.49 83.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.045 0.45 . . . . 0.0 111.257 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' ' 176' ' ' ILE . 2.7 t-20 -68.53 -37.54 80.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.305 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -64.02 -28.33 69.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.563 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -55.89 -34.57 65.64 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 110.271 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.0 tp -102.0 -55.09 2.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.157 0.503 . . . . 0.0 110.29 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 151.14 117.15 0.77 Allowed Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.349 -175.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.4 ' HA ' ' OD1' ' A' ' 171' ' ' ASN . 56.8 mt -55.99 -50.88 66.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.052 0.453 . . . . 0.0 110.512 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -86.74 104.22 15.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.832 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.53 -90.79 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.903 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.6 mt 72.7 139.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.203 0.525 . . . . 0.0 111.513 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.927 ' HG ' ' HG ' ' A' ' 149' ' ' LEU . 80.4 mt -72.44 124.3 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.352 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 57.59 70.75 1.23 Allowed Pre-proline 0 C--N 1.33 -0.246 0 O-C-N 124.024 0.827 . . . . 0.0 111.921 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.8 15.61 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.532 2.155 . . . . 0.0 112.15 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -120.46 104.29 9.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.576 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 167.44 130.87 1.21 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 185' ' ' ARG . 50.0 mtt85 -84.77 -91.71 0.09 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.087 0.47 . . . . 0.0 110.409 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -173.1 66.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.543 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 187' ' ' LEU . 2.5 pp -76.83 118.51 19.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.757 0.789 . . . . 0.0 110.29 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.001 -175.61 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.62 0.724 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -97.02 152.09 19.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.054 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.77 66.59 2.41 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.642 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 68.8 119.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.591 0.71 . . . . 0.0 112.611 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 96.8 mt -86.16 -10.99 53.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.128 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -65.98 127.27 31.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.959 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.24 0.84 79.72 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.615 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -115.22 -177.33 3.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.665 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 44.1 p90 -151.24 161.68 42.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 139' ' ' LEU . 16.6 pt -121.32 129.19 75.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.519 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.757 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.6 mp -75.22 107.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.286 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.455 ' H ' HG21 ' A' ' 25' ' ' VAL . . . -79.43 101.05 7.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.8 m -105.0 107.73 59.52 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.31 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -71.61 -76.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.56 2.173 . . . . 0.0 112.108 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 185' ' ' ARG . 33.2 tt0 -153.15 84.37 1.2 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 67.2 mtt 65.19 -75.97 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.297 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -158.83 159.19 34.8 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -166.15 -83.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.49 17.55 10.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.131 0.967 . . . . 0.0 108.841 167.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -55.91 -35.06 66.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.606 -1.633 . . . . 0.0 111.539 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 167' ' ' TRP . 73.7 t80 -65.39 -20.52 66.42 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.093 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -97.81 80.35 2.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.013 0.435 . . . . 0.0 110.935 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 60.79 86.95 0.09 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.265 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.7 t -118.72 117.42 28.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.503 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.699 HG13 HG22 ' A' ' 40' ' ' ILE . 59.3 t 69.19 153.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.151 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.514 HG13 ' HD1' ' A' ' 27' ' ' TYR . 7.0 tp -136.68 -57.42 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.025 173.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.665 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 6.0 p90 -177.73 175.3 1.37 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 111.639 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 5' ' ' LEU . 50.3 mm -103.86 127.66 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.613 176.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.5 m -81.33 -53.31 6.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.723 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.51 160.82 36.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.512 0.672 . . . . 0.0 112.315 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.531 ' O ' ' HB3' ' A' ' 32' ' ' ASN . 84.3 t60 -164.12 136.23 4.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.58 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 21.7 t-20 86.68 -38.96 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.229 0.956 . . . . 0.0 110.513 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 30.1 t70 -73.74 97.02 2.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 33' ' ' ASP . 28.9 t-20 76.33 -38.99 0.34 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.883 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.03 -141.76 5.73 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.552 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.2 m -125.03 112.75 16.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.066 0.433 . . . . 0.0 110.125 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 37' ' ' ILE . 4.0 mp -110.96 121.15 63.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.07 171.8 31.4 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.057 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.82 91.86 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.555 0.693 . . . . 0.0 110.423 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.699 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -136.4 18.41 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.066 -175.426 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 tp -64.52 -29.7 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.183 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 38.4 t30 58.98 82.47 0.14 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.114 0.483 . . . . 0.0 111.801 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 t -175.82 121.54 0.32 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 65.0 Cg_endo -78.59 153.66 26.82 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.313 2.009 . . . . 0.0 110.735 171.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.1 p -101.59 177.96 4.77 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.065 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -81.56 -17.36 48.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.19 0.519 . . . . 0.0 110.345 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.5 tp -80.28 150.66 29.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.443 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 34.9 t -103.51 151.35 22.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.073 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 14.1 p -65.8 -30.09 48.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.303 0.573 . . . . 0.0 109.692 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.0 mt -74.1 -26.76 60.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.023 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 48' ' ' SER . 5.8 mm-40 -69.83 -44.13 70.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.155 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.3 pp -68.9 -34.26 75.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.706 0.289 . . . . 0.0 110.724 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 58' ' ' PHE . 87.0 mt -64.81 -48.85 72.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.34 . . . . 0.0 110.75 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.0 p -69.2 -30.15 68.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.061 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.4 tpt85 -62.51 -30.74 71.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.556 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 81.0 mtp -83.72 -92.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.556 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -161.52 30.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.755 0.788 . . . . 0.0 110.659 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 88.8 m-85 -107.91 108.66 19.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.26 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -137.39 4.78 2.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.4 mtp -147.69 162.73 38.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.683 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 78.07 134.09 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.486 1.116 . . . . 0.0 112.804 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 11.4 mmpt? 60.72 72.92 0.66 Allowed Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.779 174.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -95.8 122.07 0.27 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.205 2.604 . . . . 0.0 113.118 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.11 57.97 3.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 173.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.555 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 40.9 mt 62.96 -88.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.502 -173.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.555 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 21.4 p90 164.3 -24.17 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.55 -30.29 61.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.866 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -76.29 91.19 3.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.344 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -96.41 115.93 28.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.658 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -103.25 115.42 30.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.183 0.516 . . . . 0.0 110.773 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.552 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 55.2 mtt -83.26 125.5 31.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.79 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 129' ' ' LEU . 14.9 p -69.7 144.31 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.832 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 6.7 mp -96.71 157.68 15.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.997 0.427 . . . . 0.0 110.606 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.42 146.78 26.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.398 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -103.84 -27.07 6.47 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.758 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.87 167.66 17.66 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.696 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.25 -17.97 44.85 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 123.058 2.505 . . . . 0.0 113.143 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.446 HG21 ' OG1' ' A' ' 133' ' ' THR . 48.9 t -94.73 132.13 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.813 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 63.36 31.25 15.31 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.593 0.558 . . . . 0.0 110.852 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -12.18 61.44 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.105 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -79.02 -7.98 58.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -127.36 138.63 53.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.044 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.93 132.0 10.89 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.499 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.548 ' HB3' HD11 ' A' ' 106' ' ' LEU . 82.1 m-85 -106.79 126.11 51.87 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.557 HG21 HG11 ' A' ' 112' ' ' VAL . 2.6 mp -119.59 106.28 18.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.394 0.616 . . . . 0.0 110.925 -176.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.68 HG22 HD13 ' A' ' 106' ' ' LEU . 12.1 t -91.57 138.03 20.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.403 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -149.89 156.34 41.6 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.672 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.5 m -76.09 170.86 15.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.707 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -78.26 116.82 18.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.31 0.576 . . . . 0.0 110.977 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.6 m -140.27 -44.99 0.42 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -95.95 165.82 12.08 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -117.22 14.61 14.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.583 0.706 . . . . 0.0 109.997 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -100.64 163.33 12.39 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.789 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.2 p90 176.18 127.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.254 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 m -97.97 -49.96 4.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.187 0.518 . . . . 0.0 109.806 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.442 ' HB2' ' OG ' ' A' ' 109' ' ' SER . 12.7 m-70 -135.6 102.18 5.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.534 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.1 p -135.94 152.95 51.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.969 -177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -109.6 136.58 48.74 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 170.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 102' ' ' ASP . 87.1 tttt -90.1 105.49 17.84 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.0 t -79.16 -55.49 9.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.7 p -132.59 -175.89 3.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.583 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.426 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 11.5 m-20 -73.95 -13.81 60.94 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.898 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -105.56 -58.68 1.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.302 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.799 HD12 ' HD2' ' A' ' 159' ' ' PHE . 42.1 mm -67.96 122.79 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.117 0.484 . . . . 0.0 110.414 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 m -127.2 124.57 39.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.317 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.68 HD13 HG22 ' A' ' 86' ' ' VAL . 25.8 tp -96.0 115.55 27.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.547 174.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.854 HG21 ' HB2' ' A' ' 111' ' ' ASP . 42.1 m -117.64 126.91 53.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.481 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.6 p -96.8 -10.58 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.487 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.442 ' OG ' ' HB2' ' A' ' 96' ' ' HIS . 38.9 m -95.27 179.62 5.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.636 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.21 5.37 34.83 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.903 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.854 ' HB2' HG21 ' A' ' 107' ' ' THR . 25.7 m-20 -54.88 -40.45 69.75 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.58 ' CG2' ' HB ' ' A' ' 107' ' ' THR . 22.6 t -57.58 -48.98 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.805 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.28 -34.99 75.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.714 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -59.08 -46.66 87.71 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.749 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.4 m -66.2 -44.54 83.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.137 0.494 . . . . 0.0 110.873 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -68.42 -24.18 64.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.428 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -91.31 6.72 80.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.592 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.1 p -128.85 -162.58 1.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.95 0.375 . . . . 0.0 111.331 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -80.89 0.51 34.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 111.603 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 p -113.83 25.68 10.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.085 0.469 . . . . 0.0 111.331 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -60.26 124.09 76.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.162 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 2.8 Cg_endo -82.19 129.29 5.95 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.41 2.74 . . . . 0.0 111.958 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.54 -35.16 78.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.649 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -104.33 109.02 20.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.903 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 24.6 p90 -153.05 144.09 23.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.808 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.548 HG12 ' HZ ' ' A' ' 159' ' ' PHE . 30.4 pt -136.56 147.67 27.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.183 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.483 HG23 HG13 ' A' ' 85' ' ' ILE . 7.7 p -128.26 131.34 69.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.016 0.436 . . . . 0.0 110.789 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 26.6 p -133.31 144.03 49.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.399 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 72' ' ' VAL . 3.8 mm? -92.05 110.56 21.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.465 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.413 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 83.91 -179.18 52.13 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.777 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.1 m -147.73 169.55 19.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.349 . . . . 0.0 110.101 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.597 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 38.9 m -108.02 125.4 51.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.055 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.446 ' OG1' HG21 ' A' ' 78' ' ' VAL . 18.1 p -107.66 127.37 53.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.217 0.532 . . . . 0.0 111.565 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.597 ' HZ3' ' HB3' ' A' ' 132' ' ' SER . 1.0 OUTLIER -115.43 150.6 36.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.246 175.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.428 ' H ' ' HD2' ' A' ' 135' ' ' LYS . 10.6 mptt -74.17 151.49 88.07 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.054 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.19 129.55 34.83 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.652 2.235 . . . . 0.0 111.867 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 72.2 -6.09 1.61 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.521 0.729 . . . . 0.0 112.299 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 7.4 tp60 -73.29 -57.53 3.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.936 0.398 . . . . 0.0 110.296 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 10' ' ' ILE . 44.3 tp -64.0 -34.52 78.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.198 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.48 -40.89 83.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.368 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.595 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.0 OUTLIER -65.11 -48.1 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.295 177.298 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 148' ' ' TRP . 50.5 mt-10 -57.43 -40.14 77.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.312 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 139' ' ' LEU . 80.5 mt -62.28 -44.13 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 0.0 110.449 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.91 73.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.007 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 84.3 mt-30 -79.47 6.2 10.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.179 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 65.14 25.31 12.44 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.113 0.565 . . . . 0.0 112.239 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -84.17 -17.8 38.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.13 0.49 . . . . 0.0 109.963 173.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.417 ' CD1' ' HB3' ' A' ' 142' ' ' GLU . 89.5 m95 -135.52 137.5 42.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.22 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.757 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 87.2 mt -94.6 138.05 32.96 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.9 tp -111.51 136.72 50.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.418 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.9 t -156.2 160.68 40.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.274 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -87.37 154.01 21.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.903 0.383 . . . . 0.0 110.439 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.07 -36.5 3.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.836 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 58.3 t30 49.67 -97.9 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.528 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -140.18 -17.52 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.725 0.298 . . . . 0.0 110.539 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.684 ' HA ' ' HB3' ' A' ' 160' ' ' GLU . 2.1 mt-30 -73.62 -72.67 0.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.199 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.3 m -58.15 -29.26 65.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.027 0.441 . . . . 0.0 110.856 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -58.18 7.85 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.106 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.799 ' HD2' HD12 ' A' ' 104' ' ' ILE . 14.3 m-85 -135.05 -39.3 0.77 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.684 ' HB3' ' HA ' ' A' ' 156' ' ' GLN . 21.4 tt0 -62.7 -25.69 68.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.853 -170.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.5 t -59.04 -33.81 71.19 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.648 0.261 . . . . 0.0 110.394 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.9 m 55.87 91.32 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 70.2 105.55 0.06 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.87 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.901 ' H ' HD22 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -71.31 -71.85 0.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.4 t70 69.16 -6.89 0.86 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.8 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 169' ' ' GLU . 25.8 ptt180 -101.2 -162.94 0.97 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.948 175.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.439 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 8.7 m-90 -62.14 -92.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.686 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.41 ' H ' ' HB2' ' A' ' 167' ' ' TRP . 1.3 m -151.59 104.61 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.658 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 166' ' ' ARG . 8.5 pt-20 -73.05 -11.64 60.63 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.101 0.477 . . . . 0.0 110.104 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.567 ' HB1' ' HE2' ' A' ' 9' ' ' PHE . . . -56.91 -45.94 82.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.554 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -81.34 -27.11 35.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.033 0.444 . . . . 0.0 110.175 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.38 -30.88 71.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.445 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 88.1 mmm -62.37 -28.65 69.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.934 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.61 -49.34 5.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.261 0.553 . . . . 0.0 110.369 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 151.28 118.65 0.83 Allowed Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 64.1 mt -56.57 94.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.411 0.625 . . . . 0.0 111.212 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.7 t -177.53 -171.96 0.34 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.314 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -147.3 -109.01 0.55 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.992 HG22 HD12 ' A' ' 180' ' ' LEU . 42.0 mm 73.0 146.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.114 0.566 . . . . 0.0 111.555 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.992 HD12 HG22 ' A' ' 179' ' ' ILE . 5.5 mp 63.13 63.29 0.93 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.132 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -148.96 106.53 3.41 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.893 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.86 108.3 1.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.51 2.14 . . . . 0.0 112.258 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.6 105.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.193 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 141.57 67.84 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.553 ' NH2' ' HA ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -77.34 85.95 3.75 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.441 -176.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.35 -51.04 4.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.998 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.857 ' HG ' ' H ' ' A' ' 188' ' ' GLU . 0.6 OUTLIER -107.75 -80.92 0.57 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.33 -174.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.857 ' H ' ' HG ' ' A' ' 187' ' ' LEU . 5.2 tp10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.206 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -105.92 -60.82 1.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.052 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 61.31 56.41 23.71 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.072 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 94.0 m-20 74.7 -33.36 0.24 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.49 0.716 . . . . 0.0 112.402 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.422 HD21 HD11 ' A' ' 150' ' ' LEU . 81.8 mt 73.58 13.73 4.39 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 175.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -69.33 134.81 49.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 172.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.31 32.21 65.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.313 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -126.21 -177.89 4.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 4.3 p90 -149.55 148.92 29.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.023 0.44 . . . . 0.0 111.082 170.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.504 HG12 HD11 ' A' ' 28' ' ' ILE . 10.2 pt -118.96 128.86 75.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.344 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.678 HD13 HD22 ' A' ' 149' ' ' LEU . 4.3 mp -98.35 136.84 27.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.537 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.5 -174.5 4.25 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.484 HG21 ' HB2' ' A' ' 17' ' ' ASP . 41.0 m 64.45 82.38 0.21 Allowed Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 121.497 0.665 . . . . 0.0 111.685 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -97.25 9.11 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.846 2.364 . . . . 0.0 114.054 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HG3' ' HG3' ' A' ' 16' ' ' MET . 9.1 pt-20 -173.27 -41.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.414 ' O ' HG23 ' A' ' 13' ' ' THR . 88.0 mtp -112.59 100.62 8.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.039 -175.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.484 ' HB2' HG21 ' A' ' 13' ' ' THR . 34.0 t70 -111.95 158.79 19.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -80.25 -30.51 38.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.887 0.375 . . . . 0.0 110.38 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 20' ' ' TYR . 1.5 tm-20 -103.28 -91.14 0.36 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 49.0 t80 166.21 -55.32 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.098 0 O-C-N 123.982 0.801 . . . . 0.0 110.384 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.556 ' HE1' ' HB3' ' A' ' 167' ' ' TRP . 88.0 t80 -143.78 -12.6 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' A' ' 19' ' ' GLU . 36.9 t70 -84.25 79.66 9.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.379 0.609 . . . . 0.0 110.905 -170.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.44 ' CZ ' HD11 ' A' ' 73' ' ' LEU . 49.2 mtm180 74.48 45.85 0.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.675 172.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -82.1 108.5 15.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.017 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.0 t 74.3 133.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.22 0.608 . . . . 0.0 111.886 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.54 HG23 ' H ' ' A' ' 27' ' ' TYR . 6.3 tp -135.0 -65.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.66 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -177.61 177.43 1.14 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.606 0.639 . . . . 0.0 111.781 -177.592 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.504 HD11 HG12 ' A' ' 10' ' ' ILE . 34.0 mm -103.22 133.64 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.288 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.9 m -81.23 -59.54 2.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.371 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -165.09 157.52 15.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.185 0.517 . . . . 0.0 111.26 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 4' ' ' ASN . 11.8 t-80 -103.3 132.01 49.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.245 174.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -129.12 172.0 11.85 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.6 -36.5 78.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.931 0.396 . . . . 0.0 111.035 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -72.42 -22.83 61.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.135 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.554 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 156.01 -177.77 32.9 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.131 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 m -97.76 121.6 39.86 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.698 HG13 HG22 ' A' ' 133' ' ' THR . 4.3 mp -88.54 117.45 32.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.253 -175.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.07 151.02 22.68 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.195 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 m -116.67 93.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.512 0.672 . . . . 0.0 110.764 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.434 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -132.95 13.3 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.294 -176.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 pt -79.71 -26.91 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.569 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.4 t30 59.07 91.93 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.76 0.663 . . . . 0.0 112.13 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 43' ' ' THR . 9.2 t -156.72 93.63 2.36 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 122.06 0.933 . . . . 0.0 110.941 175.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 93.9 Cg_endo -81.96 157.49 18.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.665 2.243 . . . . 0.0 111.697 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.8 p -121.6 156.72 32.35 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -12.26 60.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.934 0.397 . . . . 0.0 110.692 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.7 tp -71.36 144.51 49.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.602 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.821 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 59.5 m -105.65 157.6 17.3 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.458 -174.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.1 p -65.89 -34.15 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.925 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.82 -36.78 85.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.936 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.821 ' HG2' ' HB2' ' A' ' 48' ' ' SER . 26.9 mm-40 -58.68 -45.87 88.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.775 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.76 -42.34 97.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.854 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 97.8 mt -65.77 -41.66 91.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.323 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.856 HG22 ' HG2' ' A' ' 59' ' ' GLN . 21.4 p -71.9 -31.17 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.437 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -63.32 -36.5 83.9 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.813 0.34 . . . . 0.0 110.254 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.518 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 65.6 mtt -71.66 -85.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 56' ' ' MET . 3.3 t70 171.36 33.21 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.922 0.764 . . . . 0.0 109.666 171.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 96.9 m-85 -116.24 87.66 2.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.332 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.856 ' HG2' HG22 ' A' ' 54' ' ' THR . 78.3 mt-30 -96.98 82.2 3.19 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.006 0.431 . . . . 0.0 110.093 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 71.0 mtm -136.6 -170.74 2.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.523 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.25 -76.57 0.05 Allowed 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.849 0.718 . . . . 0.0 111.172 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 5.2 mptp? -116.26 115.79 40.06 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 23.2 Cg_exo -63.82 92.44 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.068 2.512 . . . . 0.0 112.754 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 51.88 72.07 0.41 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.411 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 60.9 mt 72.98 -68.35 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.958 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.0 t80 59.79 36.91 22.17 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.04 0.448 . . . . 0.0 110.45 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.9 m 70.04 3.86 4.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.234 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -119.93 67.58 0.82 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.85 131.91 37.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -126.86 113.24 16.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.937 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.624 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.8 mtt -82.0 148.64 28.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.235 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.431 HG21 HD23 ' A' ' 129' ' ' LEU . 13.7 p -96.7 147.76 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.134 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 6.6 mp -108.46 155.09 20.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.987 0.422 . . . . 0.0 110.554 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -94.32 121.13 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.72 -23.14 43.57 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.742 -173.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 153.87 174.56 24.18 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.033 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.61 -21.56 14.63 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.767 2.312 . . . . 0.0 113.085 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.408 HG21 ' OG1' ' A' ' 133' ' ' THR . 51.9 t -81.4 131.19 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 60.31 30.89 20.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.127 0.489 . . . . 0.0 110.155 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -59.15 -27.75 65.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.208 -173.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.67 -7.61 56.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.909 0.385 . . . . 0.0 111.224 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.6 mtm-85 -118.14 131.69 56.39 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.126 0.489 . . . . 0.0 111.142 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.56 118.3 5.08 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.358 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.505 ' HB3' HD11 ' A' ' 106' ' ' LEU . 85.9 m-85 -91.99 125.88 36.85 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.506 0.194 . . . . 0.0 110.494 -178.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.673 ' HB ' HG11 ' A' ' 112' ' ' VAL . 4.3 mp -112.94 110.62 32.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.182 0.515 . . . . 0.0 109.646 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 40.6 t -91.86 119.15 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.399 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -129.51 152.38 49.1 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.427 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -62.88 156.36 24.45 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.516 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -74.58 117.94 16.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.532 0.682 . . . . 0.0 110.218 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.6 m -140.41 157.64 45.22 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -64.85 124.71 22.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.688 0.756 . . . . 0.0 110.934 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -173.36 138.61 0.72 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.646 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.35 160.99 14.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -106.06 113.16 26.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.603 0.716 . . . . 0.0 111.67 -173.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.3 m -83.13 -45.09 14.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.477 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.98 37.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -77.66 125.02 28.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.926 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -105.46 136.08 45.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.446 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -86.59 128.85 35.02 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.781 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 72.0 t -70.39 -54.86 16.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -134.79 -48.53 0.75 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.96 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -176.38 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.951 169.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.42 -13.03 60.37 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.101 0.477 . . . . 0.0 111.245 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' ' 100' ' ' VAL . 24.8 mm -105.06 124.24 59.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.0 m -117.36 130.41 56.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.1 0.476 . . . . 0.0 111.538 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 84' ' ' PHE . 67.1 tp -107.79 128.15 54.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.23 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 1.024 HG21 ' HB3' ' A' ' 111' ' ' ASP . 12.1 m -142.58 137.32 30.01 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.129 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 p -120.47 3.21 10.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.391 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.591 ' O ' HG22 ' A' ' 112' ' ' VAL . 15.2 m -109.61 -173.55 2.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.403 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.69 -15.61 13.21 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.907 -0.588 . . . . 0.0 114.541 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 1.024 ' HB3' HG21 ' A' ' 107' ' ' THR . 11.6 t70 -49.43 -46.66 47.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.247 0.523 . . . . 0.0 110.961 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.673 HG11 ' HB ' ' A' ' 85' ' ' ILE . 31.9 m -60.54 -39.61 81.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.634 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.526 HD13 ' CZ ' ' A' ' 116' ' ' PHE . 4.3 mm? -70.84 -42.73 69.78 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.356 0.598 . . . . 0.0 110.059 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.44 -28.47 66.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.019 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 65.5 m -54.34 -57.0 12.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.561 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.526 ' CZ ' HD13 ' A' ' 113' ' ' LEU . 37.8 p90 -84.24 13.38 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.274 0.559 . . . . 0.0 110.914 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -106.1 9.17 42.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.521 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.4 t -137.44 176.32 8.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -79.68 -9.72 59.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.864 0.364 . . . . 0.0 111.085 -173.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 p -104.03 25.96 9.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.332 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -54.34 121.59 32.53 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.199 174.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 17.2 Cg_exo -67.06 145.58 73.93 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.977 2.451 . . . . 0.0 112.464 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.47 -42.97 82.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.489 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -107.89 125.06 51.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.155 -170.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 42.0 p90 -158.44 133.68 8.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.224 176.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 30.7 pt -124.83 147.95 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.245 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.7 p -122.64 129.16 75.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.193 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.6 p -138.99 132.23 29.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.296 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 72' ' ' VAL . 3.5 mm? -80.82 114.09 19.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.391 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.59 178.26 39.84 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.402 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 75.4 m -147.71 172.08 14.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.7 m -111.78 132.37 54.71 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.698 HG22 HG13 ' A' ' 37' ' ' ILE . 34.9 p -112.4 117.02 31.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.003 0.43 . . . . 0.0 111.028 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -94.67 116.91 29.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.127 0.489 . . . . 0.0 110.15 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 4.4 mptp? -60.22 136.44 91.33 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.546 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.554 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 10.2 Cg_exo -72.14 54.92 2.31 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.706 2.937 . . . . 0.0 113.367 -175.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -154.91 -55.21 0.1 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.562 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.0 tp60 -63.34 -35.93 82.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.287 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.34 -35.78 74.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.931 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.15 -41.54 94.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.038 0.447 . . . . 0.0 109.831 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.523 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 32.8 mm-40 -64.87 -47.56 77.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.703 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 16.2 mm-40 -54.61 -50.95 66.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.131 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.794 HG12 ' HB2' ' A' ' 148' ' ' TRP . 67.0 mt -68.57 -36.32 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.205 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.35 75.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 87.4 mt-30 -81.95 12.93 3.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.502 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 68.02 24.28 7.9 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.379 0.672 . . . . 0.0 112.318 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -92.59 -5.67 51.13 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.943 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.794 ' HB2' HG12 ' A' ' 143' ' ' ILE . 95.4 m95 -140.48 130.79 25.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.819 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.678 HD22 HD13 ' A' ' 11' ' ' ILE . 6.5 tt -92.96 117.26 29.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.422 HD11 HD21 ' A' ' 5' ' ' LEU . 9.3 tt -95.39 133.85 38.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.974 0.416 . . . . 0.0 110.889 -175.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.472 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 35.5 t -151.52 154.74 37.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.246 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -79.52 156.4 27.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . . . -126.59 -139.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.1 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.4 t30 61.69 53.63 3.19 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.913 0.863 . . . . 0.0 109.483 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -151.48 169.08 22.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.778 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -54.37 -25.74 26.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.951 0.501 . . . . 0.0 112.165 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -53.51 -28.19 29.68 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 122.581 0.352 . . . . 0.0 111.721 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.5 -57.12 7.98 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -127.66 0.06 6.13 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.06 12.33 17.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.329 0.585 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.41 156.4 1.24 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.042 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.6 t -74.19 147.74 42.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.371 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -108.29 2.5 22.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.823 0.344 . . . . 0.0 110.823 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.7 pp -118.05 -12.48 10.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.837 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 19.5 t70 -157.2 158.37 36.1 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.464 ' HD3' ' HA ' ' A' ' 166' ' ' ARG . 66.4 mmt-85 73.5 101.66 0.07 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.966 0.791 . . . . 0.0 112.597 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.556 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 10.5 p90 -84.81 89.38 7.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.685 174.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.3 t 65.79 95.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.603 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.22 -7.8 26.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.263 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.406 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -57.66 -34.09 69.0 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -74.22 -43.17 58.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.732 0.301 . . . . 0.0 111.046 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.71 -20.85 45.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.872 0.368 . . . . 0.0 110.402 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 14.9 tpt -64.39 -33.64 76.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.23 0.538 . . . . 0.0 110.069 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.644 HD22 HD21 ' A' ' 149' ' ' LEU . 11.2 tp -83.06 -39.0 21.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.454 0.645 . . . . 0.0 109.336 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 120.65 -6.2 11.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.115 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 67.0 mt 67.74 -78.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 123.277 0.631 . . . . 0.0 111.161 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.1 m 69.48 -58.73 0.51 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.608 0.763 . . . . 0.0 111.821 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 161.15 121.13 0.57 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.67 134.28 28.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.238 0.542 . . . . 0.0 111.117 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.51 99.95 12.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.969 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -125.19 122.56 25.26 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.459 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 23.2 Cg_exo -64.84 138.81 59.59 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.795 2.33 . . . . 0.0 111.728 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.62 84.83 7.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.104 0.478 . . . . 0.0 110.535 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.482 ' HA3' ' CD2' ' A' ' 187' ' ' LEU . . . -160.16 144.62 10.23 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -118.72 119.95 35.95 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.385 -174.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 67.87 22.57 8.66 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.195 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.482 ' CD2' ' HA3' ' A' ' 184' ' ' GLY . 2.0 pp -86.23 154.18 21.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.044 0.449 . . . . 0.0 111.652 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 C--O 1.247 0.972 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.682 175.817 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.88 0.371 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -103.67 -36.65 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.483 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.58 -71.34 2.71 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.602 -175.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -129.22 111.33 12.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.855 0.36 . . . . 0.0 110.034 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.44 -8.77 37.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.918 -173.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 30' ' ' GLU . 11.1 pt20 -82.61 149.52 27.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.69 4.19 79.8 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.344 -173.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HG3' ' HA ' ' A' ' 152' ' ' GLU . 11.3 mptt -121.87 179.0 4.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.648 ' HZ ' ' HG2' ' A' ' 173' ' ' MET . 2.2 p90 -149.31 139.36 22.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.239 0.542 . . . . 0.0 110.485 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 pt -108.85 127.72 65.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.294 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.79 HD13 HD22 ' A' ' 149' ' ' LEU . 4.5 mp -100.08 129.48 50.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.813 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.04 93.12 2.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.469 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -73.49 124.24 90.21 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -52.09 -70.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.033 2.489 . . . . 0.0 112.847 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -132.15 -75.55 0.51 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.869 0.366 . . . . 0.0 111.272 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 53.6 ttp -148.19 164.11 34.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.444 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.7 t70 72.34 117.82 0.05 OUTLIER 'General case' 0 C--O 1.237 0.406 0 O-C-N 124.056 0.847 . . . . 0.0 110.299 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 19' ' ' GLU . 33.3 m-20 -97.93 -146.59 0.31 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.121 -170.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 25.6 mt-10 -56.38 -81.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.49 -171.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 166' ' ' ARG . 32.0 t80 70.85 -64.48 0.37 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.625 0.77 . . . . 0.0 110.214 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -153.01 11.9 0.48 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.051 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.54 ' OD2' ' HG3' ' A' ' 44' ' ' PRO . 12.4 t0 -133.68 94.34 3.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.411 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.454 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 32.3 mtp180 -101.26 105.74 16.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.12 0.486 . . . . 0.0 110.636 -172.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.611 ' HB ' ' HA ' ' A' ' 42' ' ' ASN . 44.5 p -94.76 137.09 34.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.21 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.648 HG13 HG22 ' A' ' 40' ' ' ILE . 78.7 t 78.02 119.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 123.838 0.711 . . . . 0.0 111.656 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.5 tp -121.88 -55.64 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.366 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.606 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 2.8 p90 -178.69 172.63 1.37 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.027 0.442 . . . . 0.0 111.395 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.49 130.93 47.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.76 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.7 m -89.32 -42.65 11.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -170.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.524 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 42.0 tt0 -142.02 146.12 35.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 111.105 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -124.8 109.45 13.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.332 0.587 . . . . 0.0 110.529 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -95.06 176.6 6.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.67 -42.14 99.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 118.016 0.371 . . . . 0.0 111.325 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -119.87 4.82 10.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.29 0.567 . . . . 0.0 111.0 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.11 108.44 0.73 Allowed Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.943 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 m -100.34 105.98 17.56 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.676 HG13 HG22 ' A' ' 133' ' ' THR . 4.3 mp -88.75 114.27 26.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.722 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.95 173.9 32.53 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.866 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -121.01 83.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.608 0.718 . . . . 0.0 110.389 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.648 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -134.92 28.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.791 -176.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 43' ' ' THR . 11.0 tp -71.71 -16.71 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.383 -176.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.611 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 53.4 m-80 67.01 72.6 0.36 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.161 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 13.3 t 170.36 143.87 0.1 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HB3' HD23 ' A' ' 73' ' ' LEU . 49.5 Cg_endo -90.81 -170.59 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.957 2.438 . . . . 0.0 110.874 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.3 p -111.78 170.73 7.94 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -88.66 0.99 55.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.351 0.596 . . . . 0.0 110.021 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.17 162.28 13.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.253 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 2.0 m -105.13 158.19 16.75 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.35 -38.36 80.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.803 0.335 . . . . 0.0 110.757 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -65.31 -28.51 69.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -59.87 -44.31 94.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.47 -177.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 52' ' ' LEU . 4.9 mp -73.07 -43.81 61.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 110.176 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.73 ' HB3' ' HB3' ' A' ' 58' ' ' PHE . 97.5 mt -58.13 -45.84 86.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.552 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.9 p -73.34 -33.84 65.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.351 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -65.23 -41.95 93.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.796 0.331 . . . . 0.0 110.396 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 83.9 mtp -79.18 -87.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.233 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -175.31 98.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.208 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.73 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 29.9 t80 -155.75 81.51 1.02 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.377 0.608 . . . . 0.0 109.558 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -110.34 -7.32 14.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.623 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.4 ttm -105.02 92.53 4.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.69 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -161.14 -106.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.152 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -141.05 99.46 6.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -73.94 104.73 1.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.781 2.321 . . . . 0.0 111.722 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.573 ' HG3' ' HD2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -101.2 -28.47 12.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.578 -179.238 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.0 mp 53.53 96.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.506 0.722 . . . . 0.0 112.511 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.573 ' HD2' ' HG3' ' A' ' 64' ' ' ARG . 63.8 m-85 -135.72 154.31 51.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.257 175.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -67.86 -36.96 81.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.197 0.522 . . . . 0.0 110.312 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -125.22 94.7 4.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -85.32 -102.68 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.026 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -128.0 119.81 26.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.741 0.305 . . . . 0.0 110.29 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 89.9 mtp -84.44 131.67 34.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 p -81.7 127.77 39.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.139 0.495 . . . . 0.0 110.701 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 44' ' ' PRO . 87.9 mt -70.33 160.13 32.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.64 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.451 ' H ' ' HA ' ' A' ' 44' ' ' PRO . 7.1 t-20 -98.49 117.81 33.75 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -79.76 -33.06 35.0 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.968 -175.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.51 -176.29 29.17 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.073 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -87.4 5.6 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.157 2.571 . . . . 0.0 113.278 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.47 132.6 57.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 59.1 37.56 24.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 110.494 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -70.01 -10.86 60.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.67 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.29 5.78 29.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.927 0.394 . . . . 0.0 110.819 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -130.95 132.28 44.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.289 0.566 . . . . 0.0 111.66 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.96 118.8 5.03 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.531 ' HB3' HD11 ' A' ' 106' ' ' LEU . 66.0 m-85 -97.79 125.4 42.61 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.669 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.8 mp -112.9 107.85 24.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.277 0.561 . . . . 0.0 109.949 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 106' ' ' LEU . 33.6 t -86.71 115.73 28.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.85 159.49 38.43 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.522 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 22.2 m -70.19 160.8 31.46 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.585 172.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.453 ' HE3' ' O ' ' A' ' 102' ' ' ASP . 13.9 ptpt -70.16 172.49 7.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -171.31 -43.8 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.839 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -154.91 -154.31 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -91.83 176.49 6.5 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.415 ' OE2' ' HA ' ' A' ' 96' ' ' HIS . 5.6 pt-20 -93.7 168.59 10.91 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.507 0.67 . . . . 0.0 111.512 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -122.87 -36.62 2.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.706 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.42 ' HB ' ' OD1' ' A' ' 111' ' ' ASP . 10.0 m -112.94 -63.67 1.41 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.04 174.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.415 ' HA ' ' OE2' ' A' ' 93' ' ' GLU . 6.7 t60 179.45 126.82 0.07 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.095 0.474 . . . . 0.0 111.25 174.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 71.2 m -119.31 143.95 47.09 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.115 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -102.6 110.36 22.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.233 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' A' ' 102' ' ' ASP . 29.2 ttpt -84.42 102.64 12.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.398 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.8 t -69.34 -54.41 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 104' ' ' ILE . 11.3 t -134.58 167.46 20.76 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 170.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.648 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 33.6 m-20 -58.91 -44.54 91.27 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -172.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 88' ' ' SER . 25.6 m-20 -76.99 -28.5 55.11 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -175.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.427 ' H ' HG23 ' A' ' 101' ' ' THR . 43.7 mm -118.29 123.07 71.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.08 0.467 . . . . 0.0 111.183 -175.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.6 m -130.77 136.7 48.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.045 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.639 HD13 HG22 ' A' ' 86' ' ' VAL . 45.5 tp -99.07 125.68 44.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.488 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.956 HG21 ' HB2' ' A' ' 111' ' ' ASP . 17.8 m -135.9 128.96 31.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -136.36 1.48 2.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.216 0.531 . . . . 0.0 110.164 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.419 ' HB2' ' OD1' ' A' ' 111' ' ' ASP . 4.7 m -72.8 -7.67 51.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.782 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.31 -20.7 11.16 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.055 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.956 ' HB2' HG21 ' A' ' 107' ' ' THR . 2.2 m-20 -48.82 -42.97 37.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.12 0.568 . . . . 0.0 111.327 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.695 HG13 ' HB ' ' A' ' 107' ' ' THR . 5.1 m -53.01 -46.58 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.52 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.33 -36.04 74.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 110.499 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -70.66 -24.61 62.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.153 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -77.75 -14.64 59.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.942 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -85.25 132.09 34.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.965 0.412 . . . . 0.0 111.054 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 112.92 -4.21 25.74 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.765 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.8 t -123.26 157.5 33.0 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -66.85 -10.48 48.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.2 p -92.1 19.3 6.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.002 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.39 144.84 97.51 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.183 172.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.49 140.66 92.57 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.764 2.309 . . . . 0.0 112.729 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.524 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 48.5 mt-10 -57.99 -52.81 63.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.219 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HE2' ' HB2' ' A' ' 123' ' ' GLU . 5.4 mtmt -129.33 146.03 51.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.656 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 44.5 p90 -159.62 141.19 12.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.823 0.344 . . . . 0.0 110.692 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.02 144.41 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.827 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.24 129.22 68.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.037 0.446 . . . . 0.0 110.844 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.9 m -129.6 129.39 44.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.261 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.07 108.73 16.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.637 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.543 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 77.74 -176.44 53.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.189 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 83.4 m -147.85 173.48 12.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 0.0 110.191 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.3 m -120.02 116.76 26.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.157 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.676 HG22 HG13 ' A' ' 37' ' ' ILE . 38.3 p -96.32 113.95 25.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.085 0.469 . . . . 0.0 109.923 175.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.582 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -99.64 141.56 32.28 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.917 -178.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -90.28 117.51 68.09 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.396 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.26 55.77 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.523 2.815 . . . . 0.0 112.286 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -146.01 -37.36 0.25 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -87.56 -44.35 11.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.005 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.582 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 59.2 tp -56.92 -40.19 75.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.315 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.09 -33.44 73.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.828 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 71.1 mm-40 -67.25 -52.16 44.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.88 0.371 . . . . 0.0 110.234 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.428 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 0.4 OUTLIER -60.72 -41.57 95.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.717 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.593 HG12 ' HB2' ' A' ' 148' ' ' TRP . 60.3 mt -64.2 -40.71 90.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.721 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.72 71.01 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 111.027 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 37.0 mt-30 -87.26 9.09 21.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.942 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.412 HD22 ' HA ' ' A' ' 146' ' ' ASN . 10.4 m120 64.61 33.54 10.61 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.582 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -94.45 5.12 52.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.211 0.529 . . . . 0.0 110.085 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.593 ' HB2' HG12 ' A' ' 143' ' ' ILE . 92.1 m95 -142.49 123.69 14.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.725 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.79 HD22 HD13 ' A' ' 11' ' ' ILE . 6.0 tt -78.86 110.6 14.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.23 133.37 34.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.055 0.455 . . . . 0.0 111.501 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.8 t -162.25 157.06 22.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.083 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.526 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 8.6 pt-20 -85.12 154.1 22.25 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.76 119.78 39.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.747 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -168.58 -175.87 2.61 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 67.2 t30 75.29 163.67 0.26 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.398 0.679 . . . . 0.0 111.327 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 69.3 mt-30 -62.06 -25.43 67.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.036 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.7 m -51.82 -29.86 20.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.441 -175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.96 -54.53 43.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -125.34 -17.46 5.62 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -171.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 45.9 mt-10 -96.2 1.79 52.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.289 0.566 . . . . 0.0 110.914 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 t -59.4 136.75 58.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.857 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 42.0 m -97.8 150.06 21.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.638 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -109.1 107.68 18.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.848 0.356 . . . . 0.0 110.953 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 165' ' ' ASP . 3.3 pp -128.51 -36.52 1.87 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.285 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.469 ' OD2' ' HD3' ' A' ' 166' ' ' ARG . 33.9 t70 -167.79 -105.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -164.88 137.82 4.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.783 0.802 . . . . 0.0 112.558 173.497 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -152.35 83.52 1.25 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 166.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.628 HG22 ' H ' ' A' ' 171' ' ' ASN . 6.6 p -37.7 95.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 124.625 1.203 . . . . 0.0 113.512 -163.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.21 -28.05 63.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.883 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.56 -32.95 74.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.162 0.506 . . . . 0.0 110.597 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.628 ' H ' HG22 ' A' ' 168' ' ' VAL . 62.5 t30 -81.37 -32.72 32.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.105 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.78 -24.41 61.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.735 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.648 ' HG2' ' HZ ' ' A' ' 9' ' ' PHE . 13.3 tpt -55.64 -30.34 60.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.498 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.2 tp -97.68 -50.17 4.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.957 0.408 . . . . 0.0 109.915 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 147.39 38.06 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.979 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mp 62.29 94.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.086 0.469 . . . . 0.0 110.119 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.8 t 66.31 -176.83 0.19 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.889 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.61 -92.04 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.904 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.621 HG12 ' HG ' ' A' ' 180' ' ' LEU . 10.8 tt -141.78 130.86 23.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.621 ' HG ' HG12 ' A' ' 179' ' ' ILE . 52.6 mt 52.1 62.45 2.69 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.79 0.681 . . . . 0.0 111.553 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -165.6 88.06 0.95 Allowed Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -93.34 -3.71 3.15 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.003 2.469 . . . . 0.0 112.072 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 61.6 -86.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.5 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -171.61 32.86 0.14 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -120.84 120.98 37.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.723 0.297 . . . . 0.0 110.399 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -131.43 88.39 2.58 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 80.6 mt -106.83 -3.25 20.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.89 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.664 -0.684 . . . . 0.0 110.307 178.773 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtm . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 61.15 95.33 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.881 0.738 . . . . 0.0 111.042 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.78 -68.91 1.5 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.813 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -94.56 99.11 11.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.941 0.401 . . . . 0.0 109.957 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.456 ' O ' HD23 ' A' ' 5' ' ' LEU . 1.2 tt -90.77 -0.97 57.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.718 0.771 . . . . 0.0 109.066 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.82 136.81 37.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.768 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.07 2.46 80.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.753 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.91 159.53 15.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 151' ' ' SER . 37.6 p90 -125.41 154.0 42.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.9 pt -124.64 128.77 73.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.686 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.8 mp -75.46 119.63 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.501 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.638 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -102.12 155.37 18.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.975 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.429 ' N ' ' HD3' ' A' ' 14' ' ' PRO . 7.1 t -147.08 69.22 11.74 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 121.682 0.753 . . . . 0.0 111.851 178.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 13' ' ' THR . 13.5 Cg_endo -96.09 129.25 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.31 2.673 . . . . 0.0 111.169 170.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.21 101.62 1.92 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.093 0.473 . . . . 0.0 111.673 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.523 ' HG2' ' H ' ' A' ' 18' ' ' ASP . 46.9 ttp -131.33 140.99 49.84 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -90.88 0.39 57.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.316 0.579 . . . . 0.0 111.182 -174.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.523 ' H ' ' HG2' ' A' ' 16' ' ' MET . 36.1 t70 -123.61 151.92 42.46 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 70.26 106.21 0.06 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.947 0.779 . . . . 0.0 110.088 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -154.62 -57.34 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.586 -174.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -82.4 -5.99 59.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -171.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -99.98 172.7 7.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -93.94 85.41 4.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.249 0.547 . . . . 0.0 111.351 -174.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 t -104.32 167.43 9.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.484 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t 50.02 79.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.422 0.629 . . . . 0.0 110.472 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.499 HD11 HD23 ' A' ' 158' ' ' LEU . 4.0 tp -93.31 -61.16 2.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -170.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.42 ' HD1' HG23 ' A' ' 26' ' ' ILE . 2.1 p90 -167.94 174.55 7.35 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.323 0.511 . . . . 0.0 111.688 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -92.09 123.5 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.611 175.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.2 m -78.45 -38.3 41.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.195 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.98 150.25 20.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 0.0 110.306 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -131.49 104.83 7.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -119.53 167.36 12.05 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.804 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -73.22 -12.95 61.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.771 0.319 . . . . 0.0 110.651 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -83.03 -21.74 33.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.458 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.77 176.31 28.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.835 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 133' ' ' THR . 30.0 m -112.66 127.07 56.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.798 0.299 . . . . 0.0 110.779 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 37' ' ' ILE . 4.5 mp -104.42 110.21 29.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.35 165.39 27.47 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.44 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.45 80.11 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.802 0.811 . . . . 0.0 110.213 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -131.68 28.95 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.884 -176.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.516 HG21 ' HB3' ' A' ' 74' ' ' ASN . 11.0 tp -62.01 -25.94 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.46 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.03 61.42 1.61 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.763 177.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.493 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 9.5 t 179.24 132.51 0.24 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.437 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 43' ' ' THR . 2.2 Cg_endo -82.44 178.64 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.65 2.233 . . . . 0.0 111.05 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.411 ' OG1' HG13 ' A' ' 72' ' ' VAL . 22.7 p -94.05 -169.22 2.03 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.86 20.03 13.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.812 0.815 . . . . 0.0 109.179 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 47' ' ' LEU . 14.1 tp -125.73 170.87 11.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.016 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.7 p -113.8 162.83 15.83 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.603 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.7 p -63.58 -33.6 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 62' ' ' LYS . 53.7 mt -67.55 -44.92 77.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.221 0.534 . . . . 0.0 109.994 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -54.88 -42.8 72.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.004 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.508 HD11 HG11 ' A' ' 72' ' ' VAL . 66.2 mt -56.74 -55.09 38.66 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.957 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 67.6 mt -59.84 -43.13 94.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.089 -175.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.59 HG21 ' HB3' ' A' ' 64' ' ' ARG . 18.9 p -80.33 -29.35 38.06 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -61.19 -59.65 4.99 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -164.71 -23.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -92.19 27.05 2.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.596 0.712 . . . . 0.0 111.54 -171.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 42.7 t80 -162.93 -104.39 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.481 172.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 58' ' ' PHE . 74.2 mt-30 -162.87 -90.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.233 0.54 . . . . 0.0 109.777 -177.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 27.4 ttt -172.23 118.7 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.256 -0.883 . . . . 0.0 108.934 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.27 -54.55 0.23 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.168 0.509 . . . . 0.0 109.974 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.601 ' HB3' HD22 ' A' ' 50' ' ' LEU . 4.0 mptp? -87.81 151.17 49.52 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.976 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.82 109.12 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.887 2.392 . . . . 0.0 113.134 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.59 ' HB3' HG21 ' A' ' 54' ' ' THR . 36.8 ptt180 -79.38 4.75 14.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.133 0.492 . . . . 0.0 110.933 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.1 tt -76.12 -23.35 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.822 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -98.69 97.54 8.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.363 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.3 p -77.71 -36.02 51.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -94.09 105.56 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.642 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.467 ' OD2' ' HG2' ' A' ' 70' ' ' GLN . 13.5 t70 -156.54 -105.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.467 ' HG2' ' OD2' ' A' ' 69' ' ' ASP . 27.1 mm-40 -99.65 125.15 45.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.985 0.421 . . . . 0.0 110.009 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.1 ttp -86.88 146.01 26.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.649 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.586 HG23 HG13 ' A' ' 127' ' ' VAL . 5.1 p -95.88 140.69 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.831 0.348 . . . . 0.0 110.608 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.5 mt -89.72 164.54 14.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.951 0.405 . . . . 0.0 110.875 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.516 ' HB3' HG21 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -95.0 145.57 24.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.079 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -99.99 -36.43 4.2 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.966 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.89 -171.88 35.58 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.16 -14.68 10.67 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.045 2.497 . . . . 0.0 112.936 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.87 139.08 25.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.75 -175.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 66.32 30.11 9.14 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.979 0.512 . . . . 0.0 111.639 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -65.83 -15.07 62.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.044 0.449 . . . . 0.0 111.548 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.06 -2.5 52.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.543 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -129.76 136.0 49.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.38 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.44 126.36 8.66 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.07 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -107.08 125.68 51.36 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.541 HD13 HG21 ' A' ' 112' ' ' VAL . 3.4 mp -118.03 113.66 42.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.931 0.396 . . . . 0.0 110.5 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.519 HG22 HD13 ' A' ' 106' ' ' LEU . 25.2 t -93.1 120.61 42.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.494 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 29.5 p-80 -139.29 161.17 38.08 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.768 -175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.427 ' OG ' ' HE3' ' A' ' 124' ' ' LYS . 47.4 p -83.51 151.16 25.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.961 0.41 . . . . 0.0 111.315 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 89' ' ' LYS . 13.6 ttpt -71.4 127.28 32.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.175 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -129.59 -43.41 1.26 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.649 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -124.83 -15.22 6.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.159 0.504 . . . . 0.0 110.741 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 71.08 80.48 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.856 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 93' ' ' GLU . 1.3 pm0 -75.39 169.03 18.86 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.719 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -168.32 82.2 0.17 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.5 m -111.2 -37.74 5.23 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 161.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -171.12 77.51 0.07 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.903 165.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 p -97.71 134.62 40.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.958 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -103.06 121.2 42.1 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -87.59 115.8 25.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.046 0.451 . . . . 0.0 111.273 -174.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.69 -54.38 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.34 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.5 t -147.73 173.84 12.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.959 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -84.44 59.7 5.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.132 0.491 . . . . 0.0 110.624 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -175.9 -37.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.755 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.808 HG13 HD13 ' A' ' 158' ' ' LEU . 29.6 mm -117.95 129.7 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.687 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 m -127.88 139.37 52.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.052 0.453 . . . . 0.0 111.054 -174.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.519 HD13 HG22 ' A' ' 86' ' ' VAL . 57.3 tp -96.69 137.14 36.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.192 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.416 ' HB ' ' CG2' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -116.95 124.07 48.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.376 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.6 p -111.63 18.92 18.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.62 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.4 t -147.18 -178.41 6.2 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.1 4.11 8.95 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -49.75 -36.96 27.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.637 0.775 . . . . 0.0 109.756 172.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.541 HG21 HD13 ' A' ' 85' ' ' ILE . 29.3 t -53.5 -40.46 41.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.165 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.17 -33.19 73.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.393 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -71.28 -44.38 65.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.007 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m -64.22 -42.29 96.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.483 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -85.47 9.69 15.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.357 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.61 33.09 5.98 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.744 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 t -154.71 165.62 35.98 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -64.92 -24.33 67.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.773 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.0 p -88.91 32.02 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.114 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.89 146.0 82.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.854 173.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.494 ' HB3' ' CD2' ' A' ' 87' ' ' HIS . 9.2 Cg_endo -53.16 134.23 55.51 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.322 2.681 . . . . 0.0 113.398 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -62.7 -62.5 1.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.909 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.992 ' HD3' ' HG3' ' A' ' 160' ' ' GLU . 4.3 mtmt -103.69 145.31 30.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.8 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -167.71 140.89 3.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 0.0 111.475 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.03 145.02 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.248 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.586 HG13 HG23 ' A' ' 72' ' ' VAL . 4.6 p -117.06 124.9 73.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.008 0.432 . . . . 0.0 110.833 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 59.3 m -128.24 133.6 48.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.273 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 72' ' ' VAL . 3.7 mm? -89.06 116.56 27.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.399 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.563 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 76.39 -174.69 53.47 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.758 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 68.2 m -149.18 168.15 24.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.8 m -107.73 119.07 38.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.191 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 36' ' ' THR . 11.1 p -101.69 114.83 29.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.301 0.572 . . . . 0.0 111.346 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -84.21 155.54 22.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.95 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -56.4 142.46 68.78 Favored Pre-proline 0 C--O 1.236 0.388 0 O-C-N 123.472 0.483 . . . . 0.0 111.077 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.45 119.18 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.164 2.576 . . . . 0.0 112.659 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 66.74 17.55 10.59 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.595 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -98.66 -23.12 15.58 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.636 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 36' ' ' THR . 57.6 tp -68.36 -50.33 53.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.529 0.204 . . . . 0.0 110.943 -175.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -60.35 -34.12 73.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.019 0.438 . . . . 0.0 110.789 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -40.08 77.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.4 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -69.69 -37.81 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 110.146 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.76 HG12 ' HB2' ' A' ' 148' ' ' TRP . 82.8 mt -60.34 -38.02 76.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.541 174.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.79 -28.61 69.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.302 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -88.13 4.41 45.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.928 175.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 16.5 m120 68.69 31.95 4.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.225 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -73.25 -30.54 63.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.466 0.65 . . . . 0.0 109.253 169.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.76 ' HB2' HG12 ' A' ' 143' ' ' ILE . 85.8 m95 -132.22 145.64 51.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.698 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 64.1 mt -104.43 118.33 36.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.99 135.6 40.16 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.46 -173.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 8.1 t -150.48 163.68 37.81 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 173.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -86.13 152.49 22.81 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.866 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -114.5 7.02 16.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.716 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -71.65 76.73 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.111 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -176.88 -178.67 0.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -65.11 -19.01 65.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.4 m -52.52 -27.17 15.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.527 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.808 HD13 HG13 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -57.1 -43.0 81.8 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.078 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -133.74 -46.89 0.8 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.992 ' HG3' ' HD3' ' A' ' 124' ' ' LYS . 34.1 mt-10 -85.63 16.97 3.52 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -166.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -55.96 162.48 1.85 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 172.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.9 p -47.18 110.06 0.26 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.443 0.639 . . . . 0.0 112.497 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -77.17 -17.21 58.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.252 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.5 -20.12 57.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.776 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -177.31 122.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.926 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -98.71 -37.53 9.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.037 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 30.9 t90 55.96 -100.71 0.11 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.684 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.22 75.95 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.38 -28.97 68.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.875 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.13 95.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 110.716 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.543 HD21 HG23 ' A' ' 176' ' ' ILE . 62.3 t30 -81.21 -26.99 35.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.18 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.19 -37.78 72.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.566 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -62.43 -30.18 71.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.669 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.3 tp -79.48 -36.12 39.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.878 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.87 8.93 38.56 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.864 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.543 HG23 HD21 ' A' ' 171' ' ' ASN . 13.9 mt 54.12 64.21 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.431 0.634 . . . . 0.0 110.63 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.8 t -158.98 124.3 4.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.135 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.78 177.13 43.66 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.746 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.735 HG12 HD12 ' A' ' 180' ' ' LEU . 14.8 tt -95.76 158.59 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.735 HD12 HG12 ' A' ' 179' ' ' ILE . 6.6 mp 65.28 87.67 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.476 0.655 . . . . 0.0 110.983 -173.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.416 ' HB1' ' HD2' ' A' ' 182' ' ' PRO . . . -93.24 159.74 34.75 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.907 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.416 ' HD2' ' HB1' ' A' ' 181' ' ' ALA . 26.3 Cg_endo -62.89 90.19 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.525 2.15 . . . . 0.0 112.504 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -131.39 -77.96 0.52 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.728 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.8 -79.07 1.72 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.871 -0.681 . . . . 0.0 113.345 173.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 185' ' ' ARG . 8.7 ptp85 -162.14 151.45 15.82 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 -172.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 45.37 73.83 0.15 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.295 0.997 . . . . 0.0 113.049 174.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.9 mt -102.54 108.54 19.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.608 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.539 176.218 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 4.3 tpt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.533 ' HB3' HD21 ' A' ' 5' ' ' LEU . 19.8 m-30 -76.6 93.86 3.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.188 174.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.54 163.78 12.47 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.679 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.64 40.6 26.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 111.233 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 2' ' ' PHE . 93.5 mt -72.02 1.27 7.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.598 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.574 ' NE2' ' HA ' ' A' ' 100' ' ' VAL . 53.6 tt0 -66.08 131.68 46.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.831 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.23 -4.81 77.81 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.67 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 12.1 mptt -109.75 168.88 9.09 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -141.46 152.75 44.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.049 0.452 . . . . 0.0 110.938 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.1 pt -117.37 128.02 74.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.584 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.691 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 45.3 mt -101.3 133.25 45.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.794 -177.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.424 ' O ' ' HD3' ' A' ' 14' ' ' PRO . . . -136.55 167.58 21.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.384 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.8 p -97.62 107.61 40.56 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.688 0.28 . . . . 0.0 110.78 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 12' ' ' ALA . 89.3 Cg_endo -90.56 169.81 3.82 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.022 2.481 . . . . 0.0 112.454 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -96.43 128.64 43.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.1 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.5 mmt 72.48 125.37 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.21 0.944 . . . . 0.0 111.656 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -94.17 150.75 20.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.166 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -157.24 156.93 33.36 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 20' ' ' TYR . 2.8 tm-20 61.17 -150.31 0.4 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.606 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 91.7 m-85 -110.85 -40.56 4.5 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 172.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -176.19 -34.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.29 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.41 85.27 1.99 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 178.67 -30.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.2 -176.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.0 t -140.73 125.98 18.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.649 -177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.7 t 69.78 130.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.808 0.692 . . . . 0.0 112.106 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.54 HG23 ' H ' ' A' ' 27' ' ' TYR . 7.0 tp -142.8 -64.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.678 176.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.54 ' H ' HG23 ' A' ' 26' ' ' ILE . 1.8 p90 -177.01 177.14 1.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.142 0.428 . . . . 0.0 111.311 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.86 124.22 40.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.759 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.4 m -97.14 -40.45 8.8 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -128.89 147.88 50.86 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -175.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 6' ' ' GLN . 5.7 p80 -131.81 116.66 17.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 0.0 111.072 -177.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -100.75 -7.85 23.32 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 169.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 72.43 -46.97 0.66 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.702 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -84.6 3.54 36.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 167.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.12 126.55 1.83 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.885 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' A' ' 133' ' ' THR . 22.7 m -101.74 119.68 39.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.584 0.192 . . . . 0.0 110.94 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.803 HG13 HG22 ' A' ' 133' ' ' THR . 4.4 mp -109.08 111.47 36.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.933 0.397 . . . . 0.0 110.392 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.76 162.62 28.54 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.291 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.7 m -114.18 79.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.809 0.814 . . . . 0.0 110.754 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -134.69 18.6 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.907 -178.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 tp -78.57 -21.41 13.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.122 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.4 t30 69.28 93.24 0.08 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.463 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -161.98 122.72 1.55 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.087 176.796 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.78 155.42 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.803 2.335 . . . . 0.0 110.817 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.2 p -101.1 170.48 8.24 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.679 178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -92.49 16.13 12.6 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.55 159.05 31.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.964 -172.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 42.6 t -106.51 154.8 20.34 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.198 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 9.4 p -67.64 -35.13 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.73 -26.74 60.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.381 0.61 . . . . 0.0 109.577 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 12.8 mm-40 -68.46 -47.95 65.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.866 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.5 pp -69.84 -34.11 73.19 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.914 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 58' ' ' PHE . 62.8 mt -61.6 -52.32 64.86 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.415 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 p -69.6 -28.47 65.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.087 0.47 . . . . 0.0 111.302 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -59.15 -34.76 72.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.601 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -146.88 -23.71 0.41 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -134.53 -152.28 0.47 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -169.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.531 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 81.2 t80 76.9 -32.54 0.19 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.164 0.586 . . . . 0.0 111.887 172.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 67.37 -83.64 0.03 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.139 0.575 . . . . 0.0 110.44 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.8 ttp 179.08 84.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.044 175.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.4 -20.84 18.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.32 154.42 60.64 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.684 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.1 153.36 74.33 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.372 2.048 . . . . 0.0 111.501 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -77.8 73.26 4.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.24 0.543 . . . . 0.0 110.852 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tp -141.2 115.79 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.721 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -141.09 95.15 2.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.366 0.603 . . . . 0.0 111.325 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.9 p -81.88 -61.47 1.91 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.364 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -98.11 85.9 3.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 174.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.9 163.93 14.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.97 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -98.46 122.57 41.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.255 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttt -79.09 140.91 37.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.474 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.403 HG21 HD23 ' A' ' 129' ' ' LEU . 8.0 p -103.92 140.17 22.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.137 0.494 . . . . 0.0 110.889 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.52 163.7 13.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.314 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.536 ' HB3' ' HB ' ' A' ' 43' ' ' THR . 1.4 t30 -105.3 113.16 26.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -77.31 -25.12 64.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.243 -171.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.21 176.63 26.76 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.5 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -83.52 4.81 6.77 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.118 2.545 . . . . 0.0 113.283 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.451 HG12 HD22 ' A' ' 79' ' ' ASN . 19.2 t -106.62 118.76 54.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.451 HD22 HG12 ' A' ' 78' ' ' VAL . 51.2 m-80 64.7 33.61 10.32 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.374 0.421 . . . . 0.0 110.233 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.591 ' HA ' ' HA3' ' A' ' 130' ' ' GLY . 5.1 tt0 -66.07 -15.96 63.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.374 -175.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -82.51 -7.29 59.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.511 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -109.41 140.7 42.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.055 0.455 . . . . 0.0 111.819 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 130.14 9.58 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.637 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -113.94 124.37 52.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.06 119.36 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.806 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.49 139.62 46.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -148.13 162.72 38.84 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.444 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -74.87 161.5 29.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -81.2 121.76 26.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.024 0.44 . . . . 0.0 110.195 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.517 ' CB ' ' HA ' ' A' ' 122' ' ' PRO . 21.7 m -144.33 -34.15 0.38 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.382 0.61 . . . . 0.0 109.402 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -102.09 179.22 4.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.567 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -120.56 79.85 1.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.399 0.618 . . . . 0.0 110.427 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.414 ' H ' ' HG2' ' A' ' 93' ' ' GLU . 4.8 pt-20 -64.62 168.03 6.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.138 173.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -154.12 -29.54 0.12 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 p -46.74 -59.99 2.69 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -173.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -170.36 71.99 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.296 0.57 . . . . 0.0 109.49 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.465 ' HB3' HG21 ' A' ' 105' ' ' THR . 11.3 m -79.83 132.1 36.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.018 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 74.4 t80 -104.11 126.64 51.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.214 177.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.528 ' HE2' ' HA ' ' A' ' 102' ' ' ASP . 13.8 mmmm -72.61 117.72 14.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.519 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.574 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 63.8 t -80.11 -54.68 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 t -131.53 -48.46 0.98 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.528 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 35.9 t70 -178.57 -66.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 172.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.41 -46.18 80.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.0 mm -72.94 123.52 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 97' ' ' SER . 19.1 m -132.79 142.94 49.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.531 -174.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 31.3 tp -96.98 135.67 38.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.117 176.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.436 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 2.6 m -135.01 123.56 23.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.605 0.24 . . . . 0.0 110.681 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.9 p -134.97 -0.42 2.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.821 0.343 . . . . 0.0 111.728 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -92.99 17.33 10.9 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.31 -14.09 66.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.561 174.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.86 -27.61 60.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.884 0.373 . . . . 0.0 110.849 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.436 ' CG1' ' HB ' ' A' ' 107' ' ' THR . 18.6 m -53.53 -32.81 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.926 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.35 -29.55 62.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 111.153 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -85.28 -35.56 21.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.609 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.5 m -58.76 -33.85 70.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.168 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -83.16 11.51 6.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.044 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.04 24.25 3.29 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.986 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 120' ' ' THR . 3.3 p -123.71 14.76 9.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.981 0.39 . . . . 0.0 111.636 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' THR . 0.8 OUTLIER 70.18 -37.16 0.37 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 111.442 -174.409 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.446 ' H ' ' C ' ' A' ' 118' ' ' THR . 16.6 p -78.13 28.04 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.865 0.466 . . . . 0.0 111.781 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.87 134.16 89.73 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.321 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.517 ' HA ' ' CB ' ' A' ' 90' ' ' THR . 9.8 Cg_endo -53.27 140.61 61.84 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.213 2.609 . . . . 0.0 112.771 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' CB ' ' HE2' ' A' ' 124' ' ' LYS . 66.0 mt-10 -57.28 -52.8 63.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.143 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HE2' ' CB ' ' A' ' 123' ' ' GLU . 5.6 mtmt -128.84 142.98 50.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.029 -176.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -150.3 145.17 26.01 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.876 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.2 pt -114.75 133.4 61.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.36 128.84 74.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.158 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 78.4 m -142.89 150.04 39.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.256 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.403 HD23 HG21 ' A' ' 72' ' ' VAL . 3.8 mm? -97.09 112.98 24.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.899 176.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 80' ' ' GLN . . . 81.48 176.76 51.26 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.716 -178.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.6 m -147.71 173.36 12.84 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.5 m -113.97 121.62 44.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.071 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.803 HG22 HG13 ' A' ' 37' ' ' ILE . 73.7 p -110.25 119.75 40.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.129 0.49 . . . . 0.0 110.773 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -80.27 159.9 25.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.84 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -75.28 138.02 71.74 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.891 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.34 132.39 50.46 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.815 2.343 . . . . 0.0 111.291 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 79.14 -33.81 0.15 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.926 0.766 . . . . 0.0 111.437 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -59.17 -48.33 82.0 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.504 0.193 . . . . 0.0 111.485 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.8 tp -57.99 -37.43 74.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.129 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 48.5 tt0 -62.03 -43.62 98.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.0 110.22 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.627 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -62.16 -43.58 98.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.894 177.42 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -63.16 -42.82 99.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.882 0.373 . . . . 0.0 110.712 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 148' ' ' TRP . 83.4 mt -62.35 -39.98 86.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.343 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.35 -28.59 69.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.496 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 60.8 mt-30 -88.75 8.9 26.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.967 177.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 66.78 30.72 7.83 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -81.53 -29.24 33.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.275 0.56 . . . . 0.0 109.742 171.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.615 ' HB2' HG12 ' A' ' 143' ' ' ILE . 95.3 m95 -131.01 131.49 44.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.761 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.691 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 44.0 mt -89.99 112.57 24.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.957 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.5 tp -87.04 133.01 33.63 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.653 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 p -161.23 148.83 15.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.106 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 3.3 pm0 -95.47 165.23 12.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.054 0.454 . . . . 0.0 110.893 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.71 -88.13 0.63 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.593 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 53.26 29.77 9.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.779 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -137.29 176.26 8.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -174.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -57.63 -35.93 71.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.602 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -52.83 -29.44 27.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.694 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.49 -56.99 12.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.04 7.41 6.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -169.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -106.24 -19.25 13.76 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.136 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.7 t -63.59 -24.15 67.68 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.1 m -72.52 85.23 1.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.837 0.351 . . . . 0.0 111.079 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.502 ' HB3' ' H ' ' A' ' 164' ' ' LEU . 7.1 m-85 -133.96 -157.05 0.78 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.517 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.502 ' H ' ' HB3' ' A' ' 163' ' ' TYR . 3.5 pp -63.24 -27.27 69.23 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.117 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.431 ' N ' HD12 ' A' ' 164' ' ' LEU . 38.8 t70 -140.52 148.86 41.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.574 ' HB2' ' OE2' ' A' ' 169' ' ' GLU . 5.0 ptt180 -153.93 -97.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.843 -174.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.488 ' H ' ' HG3' ' A' ' 166' ' ' ARG . 19.5 t90 79.32 -53.63 0.43 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 165.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 10.1 m -129.48 29.64 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -170.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.574 ' OE2' ' HB2' ' A' ' 166' ' ' ARG . 1.5 pm0 -63.01 -52.87 61.25 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.619 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 169' ' ' GLU . . . -70.26 -31.65 69.12 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 110.613 -177.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -66.98 -42.84 84.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.87 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -74.98 -21.21 59.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.098 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.555 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 14.1 mmt -62.93 -34.41 77.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.242 0.544 . . . . 0.0 109.699 172.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.6 tp -83.52 -40.24 19.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.996 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.57 22.6 50.06 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.926 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.1 mt 51.42 50.06 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.796 0.807 . . . . 0.0 109.871 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 13.3 t -88.18 -167.29 1.83 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.171 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -69.74 90.36 0.31 Allowed Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.595 -178.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.406 HD12 HD11 ' A' ' 149' ' ' LEU . 4.9 tt -96.04 125.61 48.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.023 0.44 . . . . 0.0 110.597 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.48 77.41 9.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.252 0.549 . . . . 0.0 110.336 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -166.3 113.57 0.74 Allowed Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.485 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.84 83.18 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.915 2.41 . . . . 0.0 112.041 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.19 -66.3 0.91 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.331 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 166.1 168.31 28.08 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.963 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -136.03 33.07 2.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.954 0.407 . . . . 0.0 110.641 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -103.27 8.55 38.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.758 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 187' ' ' LEU . 1.8 pt? -152.34 120.79 6.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.5 . . . . 0.0 111.69 -176.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.965 -1.017 . . . . 0.0 108.834 172.63 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tmm? . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.489 ' HE2' ' HG2' ' A' ' 140' ' ' GLU . 27.1 p90 -114.67 119.12 35.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.263 0.554 . . . . 0.0 111.634 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -117.61 -82.29 0.87 Allowed Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -104.76 -14.57 15.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.1 mt 64.61 -90.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.384 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 31.45 86.54 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.308 1.005 . . . . 0.0 112.96 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 123.83 -0.59 9.22 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.385 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.782 ' HE3' ' HG3' ' A' ' 152' ' ' GLU . 13.6 mptt -105.52 169.16 8.62 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 2.5 p90 -142.45 167.89 21.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.418 HD12 ' CE3' ' A' ' 148' ' ' TRP . 4.8 pt -128.16 128.44 68.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.083 0.468 . . . . 0.0 111.477 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.619 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 4.6 mp -98.36 127.08 51.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.626 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.46 -72.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.083 0.239 . . . . 0.0 110.763 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.7 m 67.13 95.9 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 O-C-N 123.778 0.674 . . . . 0.0 110.958 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.26 -48.78 19.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.796 2.331 . . . . 0.0 112.407 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.654 ' HG2' ' HG2' ' A' ' 16' ' ' MET . 43.6 tt0 -170.77 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.064 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.654 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 25.7 ptt? -175.08 -168.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.552 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -125.83 -74.3 0.61 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 175.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -119.94 -56.93 1.99 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 16' ' ' MET . 33.4 mt-10 -84.65 179.09 7.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.141 170.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -95.68 -66.49 0.91 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.566 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -128.41 74.65 1.57 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.211 0.529 . . . . 0.0 110.855 -170.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -111.78 98.71 7.59 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.445 ' HD3' ' NE1' ' A' ' 167' ' ' TRP . 0.8 OUTLIER 62.5 69.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.724 0.64 . . . . 0.0 110.3 -172.789 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.434 ' HA ' ' OD1' ' A' ' 42' ' ' ASN . 4.3 m -65.51 96.05 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.497 -177.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.897 HG12 ' H ' ' A' ' 26' ' ' ILE . 3.1 t 60.79 -170.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.253 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.902 HG21 HG23 ' A' ' 39' ' ' VAL . 10.1 tp -174.13 -147.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.723 ' HD1' HG13 ' A' ' 26' ' ' ILE . 2.6 p90 -120.87 176.33 5.6 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.217 0.917 . . . . 0.0 111.368 -168.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.9 127.95 43.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.416 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.44 -44.76 7.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.937 -176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.796 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.9 tp10 -136.03 156.38 48.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.411 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -140.87 110.18 6.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.184 0.516 . . . . 0.0 110.254 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -113.3 179.95 3.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -76.1 -35.0 59.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.055 0.455 . . . . 0.0 110.488 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.96 -24.27 60.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.975 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 171.63 178.28 41.89 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 119.966 -1.111 . . . . 0.0 112.959 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -103.62 130.38 51.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.796 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 mp -100.87 114.5 40.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.059 0.457 . . . . 0.0 110.89 -174.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.41 178.85 19.29 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.902 HG23 HG21 ' A' ' 26' ' ' ILE . 10.7 m -125.08 33.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.626 0.727 . . . . 0.0 110.316 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.569 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -82.98 20.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.366 -173.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.466 HG23 HG22 ' A' ' 43' ' ' THR . 10.4 tp -67.24 -25.04 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.646 0.26 . . . . 0.0 111.249 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 24' ' ' THR . 4.6 t30 67.16 80.64 0.21 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.409 173.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.466 HG22 HG23 ' A' ' 41' ' ' ILE . 5.1 t -178.2 126.39 0.27 Allowed Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 121.319 0.581 . . . . 0.0 111.877 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.64 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 83.7 Cg_endo -84.33 179.69 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.677 2.251 . . . . 0.0 110.689 169.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 p -119.6 -175.32 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -93.55 9.03 38.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.174 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 tp -125.43 163.95 21.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.84 0.353 . . . . 0.0 110.857 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 10.6 m -107.48 163.21 13.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.295 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.602 ' HB ' HG11 ' A' ' 127' ' ' VAL . 11.3 p -66.15 -35.72 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.744 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.648 HD12 ' HD3' ' A' ' 64' ' ' ARG . 81.2 mt -72.21 -26.44 62.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 110.487 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -35.47 78.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.944 177.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.02 -44.74 91.75 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.064 0.459 . . . . 0.0 109.87 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.582 HD13 HD11 ' A' ' 113' ' ' LEU . 27.3 mt -66.54 -33.48 75.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.655 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.6 m -62.3 -35.35 78.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.086 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -76.05 -60.58 2.27 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.397 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.4 ptt? 168.86 -24.99 0.0 OUTLIER 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.114 0.566 . . . . 0.0 110.815 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -61.41 125.96 25.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.334 -174.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 43.1 m-85 64.41 44.36 4.21 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.586 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.587 ' HB2' ' O ' ' A' ' 58' ' ' PHE . 1.8 mp0 82.22 154.81 0.11 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.69 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 25.7 ttt -111.66 145.26 39.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -166.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 77.88 108.71 0.08 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.219 168.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.573 ' HA ' ' HE3' ' A' ' 62' ' ' LYS . 1.7 tpmt? -155.38 85.42 3.43 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -62.34 138.89 74.13 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.224 2.616 . . . . 0.0 113.213 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.648 ' HD3' HD12 ' A' ' 50' ' ' LEU . 50.7 ptt85 -139.41 173.23 11.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.533 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.2 pt -117.88 -175.5 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.357 176.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 69.55 168.18 0.29 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.938 0.773 . . . . 0.0 111.041 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.6 m -67.63 -45.64 74.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.267 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.06 162.23 34.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.106 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -132.09 -97.53 0.31 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -104.43 112.29 25.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 88.2 mtp -82.26 144.46 30.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.465 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 127' ' ' VAL . 7.3 p -93.97 137.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.886 0.374 . . . . 0.0 110.06 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.64 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.9 mp -102.02 -179.79 4.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.937 0.398 . . . . 0.0 110.341 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -115.41 137.14 52.36 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -97.04 -23.78 14.25 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.813 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.34 173.76 30.37 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.04 -12.15 16.16 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.023 2.482 . . . . 0.0 112.823 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.4 t -87.73 125.21 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.67 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 59.53 40.28 20.64 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.883 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -70.65 -10.95 60.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.298 0.57 . . . . 0.0 110.524 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.13 -22.69 67.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.155 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -104.15 147.17 27.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.432 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.86 124.34 7.13 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.618 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HB3' HD11 ' A' ' 106' ' ' LEU . 60.5 m-85 -106.12 124.83 50.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.487 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.7 mp -120.23 110.06 27.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.683 HG22 HD13 ' A' ' 106' ' ' LEU . 21.4 t -95.55 124.46 48.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.651 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 125' ' ' PHE . 25.6 p80 -138.29 168.76 19.07 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.804 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.0 t -64.99 168.34 6.6 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.505 ' HG2' ' HA ' ' A' ' 103' ' ' ASP . 12.7 mmmt -51.25 112.9 0.81 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.235 0.541 . . . . 0.0 110.427 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 m -158.74 122.43 3.9 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.68 -150.03 0.45 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.319 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 77.97 13.85 1.64 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.409 1.083 . . . . 0.0 109.701 -169.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -98.35 155.48 17.2 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -147.65 -27.43 0.36 Allowed 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.656 -0.418 . . . . 0.0 112.083 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.2 m -67.1 -55.2 15.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.926 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -169.0 110.28 0.49 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 111.12 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 m -118.74 137.24 53.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.195 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -123.02 137.21 55.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.99 118.46 34.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.313 0.578 . . . . 0.0 110.781 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.82 -54.08 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.169 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 t -134.67 165.53 25.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.26 67.89 6.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.488 0.661 . . . . 0.0 111.177 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 89' ' ' LYS . 24.6 t70 178.92 -31.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.089 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 49.2 mm -105.95 124.42 61.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.248 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.4 m -113.96 128.34 56.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.897 0.379 . . . . 0.0 110.955 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.683 HD13 HG22 ' A' ' 86' ' ' VAL . 54.5 tp -109.31 113.14 25.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.614 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 m -100.01 124.09 44.98 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -109.02 25.78 11.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.314 0.578 . . . . 0.0 111.122 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.9 m -144.8 172.92 12.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.506 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.78 8.42 3.37 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.705 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.56 -17.19 64.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.487 HG11 ' HB ' ' A' ' 85' ' ' ILE . 25.6 m -58.01 -29.63 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.73 174.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.582 HD11 HD13 ' A' ' 53' ' ' LEU . 4.5 mm? -60.78 -31.87 71.21 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.132 0.491 . . . . 0.0 110.464 177.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -78.59 -37.25 42.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.864 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -53.65 -45.07 70.1 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.887 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -97.98 140.84 31.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.782 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.04 2.37 45.37 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.058 -177.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 120' ' ' THR . 9.0 t -115.75 -175.83 2.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -58.87 -34.35 71.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.071 0.463 . . . . 0.0 110.504 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 118' ' ' THR . 21.6 p -112.01 64.03 0.62 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.136 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.03 125.51 85.18 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.192 172.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.07 133.1 24.2 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.538 2.158 . . . . 0.0 112.312 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -61.73 -57.81 10.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.355 0.598 . . . . 0.0 111.702 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.1 mtmm -118.54 127.48 53.66 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 -168.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 87' ' ' HIS . 37.5 p90 -150.62 138.52 19.98 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.819 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.2 pt -116.06 134.14 60.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.834 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.602 HG11 ' HB ' ' A' ' 49' ' ' VAL . 6.5 p -114.17 128.36 71.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.253 0.549 . . . . 0.0 110.702 -177.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 18.2 p -142.23 138.23 31.3 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.187 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.8 mt -89.3 140.14 29.79 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.768 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.89 -175.15 4.02 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.47 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 79.1 m -148.83 173.06 13.67 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.0 p -114.05 122.3 46.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.915 0.388 . . . . 0.0 110.445 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.702 HG22 HG13 ' A' ' 37' ' ' ILE . 25.3 p -98.65 117.01 32.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.042 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.437 ' HZ3' HD11 ' A' ' 40' ' ' ILE . 1.2 t-105 -68.48 148.4 50.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.279 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -69.16 144.91 95.77 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.142 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.91 125.27 18.58 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.274 2.649 . . . . 0.0 113.484 -173.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 71.59 -8.28 1.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.056 172.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -67.07 -44.75 79.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.343 . . . . 0.0 111.491 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 47.7 tp -57.51 -31.43 66.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.548 -175.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.489 ' HG2' ' HE2' ' A' ' 2' ' ' PHE . 48.7 mt-10 -58.83 -41.11 86.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.301 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -75.52 -49.66 18.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.849 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 0.3 OUTLIER -54.88 -40.93 70.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.139 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.93 -48.16 76.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.856 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.63 -35.98 81.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.828 0.347 . . . . 0.0 111.407 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -87.33 16.08 5.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.891 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 68.14 24.38 7.68 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.511 ' HD2' ' HA ' ' A' ' 142' ' ' GLU . 75.6 m-85 -83.57 -25.48 30.89 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.849 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 94.5 m95 -133.96 132.96 40.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.885 176.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.619 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.8 tt -90.62 115.13 27.5 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' ' 2' ' ' PHE . 55.6 tp -93.98 135.55 35.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.764 0.316 . . . . 0.0 111.386 -175.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.5 t -156.21 156.17 33.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.782 ' HG3' ' HE3' ' A' ' 8' ' ' LYS . 7.6 mp0 -70.11 153.54 43.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.61 -3.56 9.82 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -71.97 81.64 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.795 0.807 . . . . 0.0 111.322 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -158.57 165.48 34.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.0 -30.05 32.94 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.1 m -55.76 -30.5 61.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.938 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.49 -53.19 52.06 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.945 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.403 ' CZ ' HG12 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -115.77 -46.07 2.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 162' ' ' SER . 25.5 tt0 -65.01 -47.34 77.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.81 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.0 m 72.76 -27.03 0.18 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.656 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 160' ' ' GLU . 48.2 m 64.74 100.35 0.04 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.347 0.594 . . . . 0.0 109.624 -173.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -67.3 91.48 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.331 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.1 pp -160.07 -33.14 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.07 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 166' ' ' ARG . 17.0 t70 -109.39 -170.15 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.511 ' HB3' ' CE3' ' A' ' 167' ' ' TRP . 26.1 mmt180 -119.23 -78.66 0.59 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.808 0.337 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.511 ' CE3' ' HB3' ' A' ' 166' ' ' ARG . 16.2 m-90 -146.89 26.77 1.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.115 -177.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.99 -38.44 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -171.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -4.33 20.76 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.69 -57.32 12.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 111.627 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -75.25 -24.54 57.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -66.02 -22.44 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.19 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 13.7 tpt -55.12 -33.29 62.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.45 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.472 HD22 HD21 ' A' ' 149' ' ' LEU . 12.1 tp -107.79 -51.96 2.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.958 0.409 . . . . 0.0 110.878 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 156.54 115.85 0.5 Allowed Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.666 HD12 ' H ' ' A' ' 176' ' ' ILE . 4.4 mp -48.83 -56.95 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 123.889 0.405 . . . . 0.0 110.86 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 20.7 m 71.65 -45.68 0.62 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.317 0.647 . . . . 0.0 111.901 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.54 -69.8 0.47 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 10.5 tp -169.62 148.05 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 97.6 mt -80.72 83.75 6.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.042 0.449 . . . . 0.0 110.065 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -159.13 156.7 26.75 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.229 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.58 -8.79 23.32 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.863 2.375 . . . . 0.0 112.91 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 63.93 -164.58 0.25 Allowed 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.449 0.468 . . . . 0.0 111.266 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.45 51.61 7.22 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.715 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 63.12 67.04 0.69 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.364 0.602 . . . . 0.0 109.883 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -101.0 69.11 1.29 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.029 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.25 146.69 40.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.946 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.707 179.176 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.582 ' HA ' ' CD ' ' A' ' 140' ' ' GLU . 89.5 mtp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.786 0.327 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -119.38 131.99 55.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.305 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.01 -58.88 10.19 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.824 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.43 ' HA ' ' ND1' ' A' ' 31' ' ' HIS . 61.2 t30 -149.37 154.81 39.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.83 -98.49 0.45 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.466 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 29' ' ' CYS . 56.2 mt-30 61.84 122.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.429 1.109 . . . . 0.0 112.557 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.04 5.77 88.94 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.937 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -93.74 158.18 15.8 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.455 ' HE1' HD11 ' A' ' 11' ' ' ILE . 29.8 p90 -134.52 163.04 30.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.049 0.452 . . . . 0.0 110.924 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 4.2 pt -127.54 128.16 69.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.421 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.668 HG12 ' HA ' ' A' ' 171' ' ' ASN . 4.5 mp -87.92 132.51 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.364 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.32 168.59 26.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.418 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 m -122.17 99.12 43.76 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.951 0.405 . . . . 0.0 110.66 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.35 174.58 10.49 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.054 2.503 . . . . 0.0 111.462 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -69.27 112.31 5.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.219 0.533 . . . . 0.0 109.997 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.1 ptp -79.11 159.97 27.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.296 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -160.52 -57.74 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.379 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 66.17 115.8 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.906 0.754 . . . . 0.0 112.03 172.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -124.21 -46.49 1.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -145.38 -89.08 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -116.85 39.12 3.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.389 0.614 . . . . 0.0 110.092 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -49.68 125.43 11.56 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.655 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -110.61 120.82 43.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.0 110.089 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.9 p -84.78 -168.13 2.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.417 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.743 HG23 HG22 ' A' ' 40' ' ' ILE . 2.7 p -56.01 136.19 18.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.479 173.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.425 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.2 tp -114.14 -55.41 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.78 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.425 ' HD1' HG13 ' A' ' 26' ' ' ILE . 5.2 p90 -175.45 171.93 2.75 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.212 0.529 . . . . 0.0 111.852 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.0 mm -90.95 126.55 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.754 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 6' ' ' GLN . 43.2 t -81.98 -50.89 8.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.046 -174.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 45.8 mt-10 -136.21 146.59 46.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.963 0.411 . . . . 0.0 111.454 -177.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.43 ' ND1' ' HA ' ' A' ' 4' ' ' ASN . 30.1 t-80 -137.21 114.05 10.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.088 175.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -116.7 172.31 7.32 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.406 ' HA ' ' CD2' ' A' ' 137' ' ' HIS . 41.0 m-20 -82.23 -20.03 38.5 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 172.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -16.03 24.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.665 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.43 174.46 44.41 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.303 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -149.23 133.58 17.47 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.437 -0.449 . . . . 0.0 110.401 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.75 HG13 HG22 ' A' ' 133' ' ' THR . 4.5 mp -122.87 123.64 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.246 -177.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.41 172.0 24.46 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.044 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.2 97.53 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.394 0.616 . . . . 0.0 110.51 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.743 HG22 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -130.98 24.48 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.195 -176.177 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.885 HG12 ' HB3' ' A' ' 74' ' ' ASN . 10.0 tp -55.81 -39.17 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.447 -173.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.48 25.19 14.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.613 0.365 . . . . 0.0 111.605 175.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.625 HG22 HG13 ' A' ' 41' ' ' ILE . 3.8 t -166.81 148.27 5.46 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 122.076 -0.39 . . . . 0.0 110.144 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 2.3 Cg_endo -81.99 -173.57 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.22 2.613 . . . . 0.0 112.471 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -101.58 -161.23 0.84 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.18 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.86 -7.69 22.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.284 0.564 . . . . 0.0 110.443 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.416 ' O ' HG12 ' A' ' 72' ' ' VAL . 16.4 tp -107.21 171.22 7.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.252 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.822 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 14.7 m -119.65 161.77 20.12 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.106 -0.371 . . . . 0.0 110.342 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 12.8 p -69.39 -35.49 67.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.046 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.567 HD11 ' O ' ' A' ' 68' ' ' GLN . 65.0 mt -59.69 -37.61 79.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.084 176.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.822 ' HG2' ' HB2' ' A' ' 48' ' ' SER . 23.2 mm-40 -60.01 -53.18 60.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.445 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' A' ' 56' ' ' MET . 94.5 mt -61.05 -46.78 89.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.663 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 85.1 mt -57.53 -44.67 85.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.299 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.7 p -75.5 -36.35 60.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.259 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.438 ' HD2' ' C ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -58.51 -50.82 72.38 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.661 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 52' ' ' LEU . 25.4 ptt? -86.54 -6.19 58.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.225 -177.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 t70 60.59 97.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.0 0.905 . . . . 0.0 111.092 -174.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.662 ' O ' ' HG2' ' A' ' 59' ' ' GLN . 3.7 p90 -93.55 22.4 5.43 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.359 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' A' ' 58' ' ' PHE . 16.6 pt20 65.17 100.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.581 1.152 . . . . 0.0 109.005 -164.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mtp -73.21 98.58 2.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.403 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.79 159.74 41.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.653 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 64' ' ' ARG . 67.9 mttm 59.33 95.73 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.216 0 O-C-N 123.807 0.692 . . . . 0.0 111.809 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.74 -1.1 10.29 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.033 2.489 . . . . 0.0 112.548 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER 69.39 164.61 0.25 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.513 0.673 . . . . 0.0 111.278 -179.122 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 68.4 mt -105.16 117.59 51.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.266 173.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 80.2 t80 74.31 143.11 0.07 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 124.126 0.891 . . . . 0.0 109.796 -172.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 67' ' ' THR . 12.2 t -57.69 110.41 0.89 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.841 0.829 . . . . 0.0 111.217 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.567 ' O ' HD11 ' A' ' 50' ' ' LEU . 36.2 tt0 -97.89 75.13 2.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.981 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -79.51 108.33 12.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.05 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.427 ' O ' HG12 ' A' ' 49' ' ' VAL . 25.9 mm-40 -120.07 120.27 35.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.247 0.546 . . . . 0.0 110.304 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 12.4 ttt -88.44 144.05 26.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.407 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.528 HG21 HD23 ' A' ' 129' ' ' LEU . 9.0 p -89.08 137.12 21.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.202 0.525 . . . . 0.0 110.73 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 67.3 mt -80.43 167.84 19.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.216 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.885 ' HB3' HG12 ' A' ' 41' ' ' ILE . 7.1 t-20 -97.64 155.85 16.8 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -109.69 -25.6 5.38 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.455 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.88 174.1 20.19 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.46 -9.18 18.69 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.858 2.372 . . . . 0.0 112.221 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.499 HG12 ' OD1' ' A' ' 79' ' ' ASN . 6.1 t -104.12 139.22 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.269 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.582 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 20.3 m120 56.05 34.5 23.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.442 0.297 . . . . 0.0 111.325 176.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.613 ' HA ' ' CA ' ' A' ' 130' ' ' GLY . 15.7 tt0 -66.54 -13.67 61.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.154 0.502 . . . . 0.0 111.524 -174.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.71 -8.48 57.36 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.735 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -102.25 133.7 46.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.032 0.444 . . . . 0.0 111.228 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.35 124.24 6.37 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.715 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -108.73 123.1 48.48 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.44 HG21 HG21 ' A' ' 112' ' ' VAL . 5.2 mp -139.56 112.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 0.0 110.662 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.8 t -115.29 132.04 65.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.302 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -125.53 152.51 44.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.64 ' HB3' ' HB3' ' A' ' 159' ' ' PHE . 20.1 p -81.38 148.46 29.32 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 87.8 tttt -67.01 114.35 5.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.865 0.841 . . . . 0.0 111.57 -176.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.706 ' HB ' ' HA ' ' A' ' 122' ' ' PRO . 3.5 m -138.55 10.51 2.71 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -140.3 164.6 29.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.031 -168.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -136.44 15.69 3.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.331 0.586 . . . . 0.0 109.74 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -124.87 160.75 28.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.844 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.1 p90 170.44 154.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.188 0.93 . . . . 0.0 109.887 -175.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.4 m -104.08 -45.19 4.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.229 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -151.71 108.32 3.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.834 0.35 . . . . 0.0 110.494 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 p -139.89 150.18 44.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.067 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -102.18 112.12 24.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -90.56 123.68 34.41 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.184 0.516 . . . . 0.0 111.557 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.4 -54.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.2 p -116.43 -165.86 1.1 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -90.03 15.57 9.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.683 0.754 . . . . 0.0 109.349 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 13.2 t70 -131.03 -59.97 0.97 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.251 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.699 HG13 HD13 ' A' ' 158' ' ' LEU . 50.7 mm -72.49 122.15 24.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.126 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.96 133.17 45.57 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.328 0.585 . . . . 0.0 112.383 -176.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 85' ' ' ILE . 31.1 tp -99.77 122.11 42.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.216 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m -102.54 123.86 47.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.822 0.344 . . . . 0.0 110.113 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.6 p -116.53 20.62 14.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.887 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 m -139.67 177.58 7.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.445 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.77 -6.17 49.6 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.518 -0.372 . . . . 0.0 112.262 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.22 -29.38 63.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.207 0.527 . . . . 0.0 110.619 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.454 HG13 HD22 ' A' ' 113' ' ' LEU . 14.8 p -54.63 -34.02 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.714 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.552 ' HG ' ' HB2' ' A' ' 58' ' ' PHE . 2.9 mm? -63.57 -35.99 82.32 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.026 0.441 . . . . 0.0 110.356 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.27 -34.54 65.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.88 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.2 m -58.31 -49.46 77.07 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.136 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -99.9 3.73 44.67 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.886 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.13 11.55 65.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.82 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -118.24 164.71 14.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -66.98 -23.01 65.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.898 0.38 . . . . 0.0 110.856 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.9 p -94.07 24.57 4.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.934 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -51.07 136.37 28.42 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.14 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.706 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 31.3 Cg_exo -58.74 145.96 94.16 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.095 2.53 . . . . 0.0 112.339 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.99 -47.93 70.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.242 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -141.8 143.53 33.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.663 -176.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -152.03 148.59 27.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.83 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.4 pt -118.71 141.34 38.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.71 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.99 122.8 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.246 0.546 . . . . 0.0 110.495 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 81.3 m -132.81 158.14 43.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.153 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 72' ' ' VAL . 3.4 mm? -112.76 113.21 25.21 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.852 0.358 . . . . 0.0 110.555 175.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.613 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . 101.98 -178.24 26.92 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.556 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 34.8 m -144.43 168.43 20.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.7 m -114.33 116.09 28.4 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.75 HG22 HG13 ' A' ' 37' ' ' ILE . 40.8 p -117.56 143.79 45.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.257 0.551 . . . . 0.0 111.731 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -110.89 177.47 4.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.233 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.542 ' HB3' ' HD2' ' A' ' 136' ' ' PRO . 65.6 mttp -85.17 167.13 27.52 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.221 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 135' ' ' LYS . 90.4 Cg_exo -44.15 105.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.969 2.446 . . . . 0.0 113.507 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 4.4 m-70 65.48 7.62 4.48 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.946 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.561 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.7 tp60 -57.5 -48.1 80.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.105 0.411 . . . . 0.0 111.396 -174.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.504 ' O ' HG13 ' A' ' 143' ' ' ILE . 65.3 tp -57.04 -34.86 68.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.981 0.42 . . . . 0.0 110.993 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.582 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 39.6 tt0 -61.89 -46.05 91.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.59 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 13.4 mp0 -73.14 -30.15 63.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.09 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 66.9 mm-40 -60.92 -42.55 98.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.254 0.549 . . . . 0.0 110.013 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.547 HG12 ' HB2' ' A' ' 148' ' ' TRP . 86.0 mt -65.09 -29.73 48.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.586 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.07 -12.7 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.371 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 48.0 mt-30 -88.94 1.18 55.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.418 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 68.69 17.44 8.89 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.607 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -80.34 -18.95 47.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.325 0.583 . . . . 0.0 110.137 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.547 ' HB2' HG12 ' A' ' 143' ' ' ILE . 84.7 m95 -126.1 138.89 53.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.05 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 48.8 mt -106.43 107.59 18.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.073 0.463 . . . . 0.0 110.232 176.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tt -84.73 134.13 34.35 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.286 -174.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.505 ' HB2' HD13 ' A' ' 174' ' ' LEU . 16.1 t -150.07 178.09 9.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.045 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.25 154.14 39.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.254 0.55 . . . . 0.0 111.549 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.81 145.16 32.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.202 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -88.61 26.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.097 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.8 t30 70.48 -45.66 0.6 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.884 0.874 . . . . 0.0 110.672 -174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -57.93 -43.49 86.32 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 121.185 0.517 . . . . 0.0 109.851 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -28.84 69.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.444 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.699 HD13 HG13 ' A' ' 104' ' ' ILE . 2.8 tt -74.5 -56.57 4.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.112 -173.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.64 ' HB3' ' HB3' ' A' ' 88' ' ' SER . 0.4 OUTLIER -125.27 -23.55 4.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -174.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.29 -51.09 14.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.357 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 162' ' ' SER . 0.2 OUTLIER 59.74 -158.81 0.31 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.23 172.351 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.595 ' H ' HG22 ' A' ' 161' ' ' THR . 21.4 t -101.52 -14.4 17.5 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.87 -175.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 162' ' ' SER . 18.6 m-85 73.45 147.53 0.09 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.089 -175.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.6 mt 75.21 -46.49 0.59 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.01 0.924 . . . . 0.0 108.798 -168.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 58.95 96.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.723 170.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -87.61 -40.97 13.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.189 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -157.89 -171.19 3.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.673 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.6 m -89.9 98.89 8.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.546 0.689 . . . . 0.0 110.863 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.11 -6.0 47.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.73 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.71 67.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.074 0.464 . . . . 0.0 110.649 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.668 ' HA ' HG12 ' A' ' 11' ' ' ILE . 44.6 t30 -67.87 -39.43 83.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.111 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.455 ' HA ' HG13 ' A' ' 176' ' ' ILE . 36.0 tt0 -79.29 -20.89 46.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.718 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.514 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 2.2 tpt -63.11 -33.6 75.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.462 0.648 . . . . 0.0 109.263 173.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 151' ' ' SER . 13.0 tp -81.0 -45.06 17.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.251 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 135.18 7.5 1.97 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.437 -0.802 . . . . 0.0 113.247 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.455 HG13 ' HA ' ' A' ' 172' ' ' GLU . 55.6 mt 63.17 94.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 121.323 0.582 . . . . 0.0 111.299 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 7.0 t -115.76 165.74 12.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.355 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -84.24 152.77 28.47 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.143 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 8.7 tt -73.13 128.91 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.033 0.444 . . . . 0.0 111.127 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.1 mp -93.69 134.4 36.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.199 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 53.22 68.02 3.29 Favored Pre-proline 0 N--CA 1.466 0.335 0 O-C-N 123.673 0.608 . . . . 0.0 111.259 -176.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.52 -4.93 13.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.705 2.27 . . . . 0.0 113.459 -173.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -140.51 148.3 40.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.587 0.232 . . . . 0.0 110.812 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 156.04 -81.73 0.16 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.569 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -146.81 130.96 17.36 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -86.35 43.16 1.04 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.567 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.5 mp 54.29 36.6 25.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.411 0.624 . . . . 0.0 110.45 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.464 -177.627 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tmm? . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 64.58 21.34 12.41 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 169.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.0 35.02 90.09 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.074 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 69.52 122.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.185 0.594 . . . . 0.0 110.607 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.47 HD13 HD23 ' A' ' 139' ' ' LEU . 85.1 mt -74.82 -8.86 57.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.633 -171.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.3 132.82 49.24 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.73 11.7 84.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.774 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.634 ' HG3' ' HA ' ' A' ' 152' ' ' GLU . 13.8 mptt -117.06 172.05 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.481 -0.423 . . . . 0.0 110.145 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 54.9 p90 -144.21 152.94 41.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.587 HD12 ' CE3' ' A' ' 148' ' ' TRP . 17.4 pt -109.79 151.83 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.992 0.425 . . . . 0.0 110.877 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.793 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 40.8 mm -100.66 115.51 42.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.826 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -149.63 147.65 28.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.588 0.232 . . . . 0.0 111.485 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 m 58.31 81.29 0.26 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.035 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.31 -14.09 7.15 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.16 1.906 . . . . 0.0 111.843 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -129.68 121.34 26.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.404 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.7 tpt -139.1 112.79 8.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.89 -35.83 18.75 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -71.47 -73.11 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . 1.1 mp0 -85.45 94.63 9.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 169.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -65.59 -32.61 74.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.012 0.435 . . . . 0.0 111.652 -172.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -125.24 64.53 1.15 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.681 0.753 . . . . 0.0 110.175 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.544 ' HB2' ' HB3' ' A' ' 19' ' ' GLU . 29.3 t70 -90.72 168.04 12.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.761 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HD2' HD21 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -79.97 78.51 6.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.187 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -74.82 79.89 2.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.108 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.826 HG21 ' HB3' ' A' ' 12' ' ' ALA . 91.9 t 72.72 132.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.875 174.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.598 HG13 ' HD1' ' A' ' 27' ' ' TYR . 4.6 tp -122.72 -103.65 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.941 174.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.598 ' HD1' HG13 ' A' ' 26' ' ' ILE . 8.8 p90 -129.33 173.8 10.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 120.027 1.285 . . . . 0.0 112.348 -171.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.3 mm -100.49 128.29 52.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.673 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.1 m -79.8 -57.8 3.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.519 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.44 157.75 43.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.268 0.556 . . . . 0.0 111.297 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -133.03 112.06 11.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.666 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -94.98 163.33 13.36 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 166.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.33 -30.9 71.49 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.189 0.519 . . . . 0.0 110.608 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -96.65 -33.98 11.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.718 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.93 123.45 4.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.354 -172.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 133' ' ' THR . 28.4 m -108.78 116.34 31.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 176.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.602 HG13 HG22 ' A' ' 133' ' ' THR . 3.5 mp -104.32 120.13 54.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.834 0.349 . . . . 0.0 110.943 -174.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.46 163.5 29.26 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.913 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.534 HG23 HG23 ' A' ' 26' ' ' ILE . 1.6 m -115.42 88.1 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.668 0.747 . . . . 0.0 110.501 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.548 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -132.27 26.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.061 -175.689 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.648 HG21 ' O ' ' A' ' 74' ' ' ASN . 10.7 tp -64.74 -36.56 77.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.415 -172.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.522 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.1 t-20 63.38 63.88 0.86 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.126 0.489 . . . . 0.0 110.923 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.551 HG22 HG13 ' A' ' 41' ' ' ILE . 14.3 t 173.37 130.0 0.1 Allowed Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.927 175.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 75.1 Cg_endo -92.97 155.95 2.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.175 2.583 . . . . 0.0 112.038 173.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 74' ' ' ASN . 9.8 p -87.6 -177.99 6.0 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.74 -2.86 46.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.735 0.779 . . . . 0.0 109.458 177.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.437 HD21 HD21 ' A' ' 52' ' ' LEU . 62.2 tp -90.35 158.3 17.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.164 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 11.8 m -114.42 152.88 30.85 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.207 -0.308 . . . . 0.0 110.467 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.615 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.2 p -64.15 -37.62 80.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.043 0.449 . . . . 0.0 110.007 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.38 -34.2 77.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.339 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 48' ' ' SER . 34.1 mt-10 -63.51 -44.0 95.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.518 177.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.497 HD13 HD21 ' A' ' 129' ' ' LEU . 56.4 mt -66.59 -45.93 77.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.75 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 89.3 mt -56.04 -48.97 75.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.072 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -73.1 -31.42 64.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.539 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -68.63 -52.36 32.24 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.81 0.338 . . . . 0.0 111.021 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.9 mtm -84.05 -90.85 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.916 -177.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -164.17 142.28 7.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.219 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.426 ' HA ' ' HG ' ' A' ' 113' ' ' LEU . 43.2 p90 -137.51 21.61 2.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.731 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 58' ' ' PHE . 1.6 mp0 67.5 112.84 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.297 -170.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 17.1 ttt -67.82 164.04 20.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.444 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 60' ' ' MET . . . 77.31 4.68 3.18 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.656 0.783 . . . . 0.0 111.261 -175.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -96.0 127.5 40.68 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.08 130.61 26.16 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.639 2.226 . . . . 0.0 112.65 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -143.25 154.02 43.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.907 178.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.68 178.75 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.0 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.414 ' O ' ' HB ' ' A' ' 67' ' ' THR . 75.9 t80 -132.66 81.88 1.97 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.761 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 66' ' ' TYR . 14.7 t 178.57 162.87 0.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.365 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 56.21 73.21 0.45 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.574 0.702 . . . . 0.0 110.226 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -70.71 128.77 37.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.716 -173.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -103.21 112.94 26.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.618 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 87.7 mtp -82.3 145.29 30.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.033 0.444 . . . . 0.0 111.397 -171.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.458 HG23 HG22 ' A' ' 127' ' ' VAL . 8.1 p -99.03 143.29 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.369 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 8.0 mp -90.78 164.14 14.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 110.373 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 41' ' ' ILE . 3.6 t-20 -100.27 103.49 14.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.59 -27.8 61.72 Favored Glycine 0 C--N 1.328 0.098 0 O-C-N 123.5 0.5 . . . . 0.0 112.885 -171.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.03 172.19 30.22 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.14 -13.04 28.42 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.333 2.022 . . . . 0.0 111.825 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.74 145.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.468 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.545 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 83.9 m-20 63.96 24.75 13.72 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.222 0.326 . . . . 0.0 111.765 174.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -69.16 -10.89 59.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.702 0.763 . . . . 0.0 110.595 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.0 -13.68 60.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.711 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -113.71 134.54 54.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.981 0.42 . . . . 0.0 110.935 -172.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.57 119.22 5.06 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.755 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -105.84 121.52 44.23 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.436 HG13 HG23 ' A' ' 127' ' ' VAL . 5.1 mp -141.96 117.72 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 95.3 t -112.14 119.82 61.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.431 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -129.5 159.64 35.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -177.383 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.6 m -82.45 167.68 18.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.119 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.431 ' HE2' ' CE1' ' A' ' 87' ' ' HIS . 4.7 mptp? -119.22 122.02 41.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 t -94.13 -21.11 19.31 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.573 -173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.885 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 2.6 t70 -114.03 -4.78 13.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.56 0.695 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.7 m170 67.29 34.39 4.9 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.07 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.885 ' HG3' ' HB3' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -87.97 165.72 15.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.94 175.03 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -159.06 116.57 2.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.294 0.568 . . . . 0.0 110.966 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.7 m -88.73 -60.57 1.92 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.97 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.557 ' H ' ' HB2' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -145.24 35.22 1.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.439 179.131 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 148.48 24.47 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.97 -175.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -102.16 135.68 43.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.565 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -87.3 116.12 25.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.37 -54.04 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 169.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.807 HG22 ' HB ' ' A' ' 104' ' ' ILE . 11.9 t -138.69 -158.43 0.86 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -59.33 -65.18 0.71 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -93.66 -23.96 18.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.751 0.31 . . . . 0.0 111.38 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.807 ' HB ' HG22 ' A' ' 101' ' ' THR . 41.3 mm -86.96 122.46 38.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.987 0.423 . . . . 0.0 110.823 -171.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.1 p -134.16 137.9 44.8 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.981 -175.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.6 tp -91.82 137.66 32.18 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.33 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.818 HG21 ' HB3' ' A' ' 111' ' ' ASP . 25.4 m -138.8 140.04 38.44 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.733 -0.604 . . . . 0.0 111.456 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.4 p -111.6 -29.07 7.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.417 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.5 m -155.55 160.29 40.39 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.689 0.281 . . . . 0.0 111.171 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.82 -82.19 0.41 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.903 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.818 ' HB3' HG21 ' A' ' 107' ' ' THR . 11.2 t70 -51.91 -48.57 64.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.546 0.738 . . . . 0.0 111.629 -173.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.561 HG13 HD22 ' A' ' 113' ' ' LEU . 7.6 p -63.58 -38.64 82.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.988 -176.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.561 HD22 HG13 ' A' ' 112' ' ' VAL . 2.6 mm? -69.46 -33.27 72.67 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.303 0.573 . . . . 0.0 110.0 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -76.35 -28.2 56.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.607 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.6 m -57.48 -62.43 1.79 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.35 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -86.36 27.68 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -172.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.2 20.36 23.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.155 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.6 t -162.93 172.72 14.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -71.54 -19.49 62.16 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.722 0.296 . . . . 0.0 111.471 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.0 p -84.53 18.27 2.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 0.0 110.994 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.41 129.82 93.85 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.341 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.98 139.23 72.42 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.623 2.215 . . . . 0.0 112.195 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -60.71 -48.58 81.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.515 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 159' ' ' PHE . 2.0 mmpp? -101.05 119.09 38.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.937 -168.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 36.9 p90 -154.87 127.93 8.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.289 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.2 pt -109.43 133.54 54.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.082 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.557 HG11 ' HB ' ' A' ' 49' ' ' VAL . 7.5 p -116.44 128.94 73.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.279 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 81.2 m -143.52 151.97 40.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.105 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 52' ' ' LEU . 2.4 mm? -102.45 117.18 34.17 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 174.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . 83.67 -175.85 52.19 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.964 -175.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 19.3 m -148.45 163.69 36.41 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 m -98.37 114.84 27.32 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.602 HG22 HG13 ' A' ' 37' ' ' ILE . 22.6 p -112.5 120.02 40.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.522 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 0.4 OUTLIER -86.23 133.25 33.85 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.243 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 136' ' ' PRO . 96.6 mttt -65.0 153.31 89.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.082 -175.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 135' ' ' LYS . 33.5 Cg_exo -28.7 98.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 1 C-N-CA 125.507 4.138 . . . . 0.0 115.233 -171.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 71.58 -2.71 2.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.88 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -62.82 -30.07 71.21 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.47 HD23 HD13 ' A' ' 5' ' ' LEU . 36.2 tp -60.14 -29.16 68.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.604 0.24 . . . . 0.0 111.296 -176.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.99 -38.4 90.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.07 0.462 . . . . 0.0 109.912 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.518 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.9 mp0 -70.43 -37.16 74.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.412 177.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.522 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 74.7 mm-40 -63.41 -43.7 96.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.341 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 139' ' ' LEU . 73.3 mt -68.56 -31.24 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.483 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.26 -24.43 67.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.215 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 39.9 mt-30 -83.7 -0.59 51.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.562 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 62.23 17.24 9.1 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.665 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -87.97 0.78 55.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.415 0.626 . . . . 0.0 109.703 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.587 ' CE3' HD12 ' A' ' 10' ' ' ILE . 99.4 m95 -138.07 122.11 17.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.651 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.793 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 75.8 mt -98.92 145.64 26.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.1 tp -124.49 134.65 52.97 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.138 0.494 . . . . 0.0 111.368 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.0 t -138.38 148.95 45.07 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.432 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.634 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 26.0 mp0 -87.32 153.32 21.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.032 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -115.05 128.71 56.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.123 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -62.4 -63.56 1.2 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.986 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -177.64 -56.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.095 175.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 42.0 mt-30 -62.85 -27.3 69.24 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.808 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.9 m -52.45 -29.06 22.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.134 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.1 mt -65.21 -54.72 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.463 ' HD2' ' HB3' ' A' ' 124' ' ' LYS . 54.1 m-85 -129.83 -14.17 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 44.2 mt-10 -96.41 0.89 51.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.162 0.506 . . . . 0.0 110.877 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.5 t -66.41 150.93 48.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.183 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.711 ' HB2' ' HA ' ' A' ' 167' ' ' TRP . 22.6 t 67.19 4.41 3.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.201 0.6 . . . . 0.0 112.12 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -79.73 -14.11 58.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.975 0.417 . . . . 0.0 110.121 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' A' ' 165' ' ' ASP . 2.2 pp -135.48 -4.95 2.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.852 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.44 ' HB2' HD12 ' A' ' 164' ' ' LEU . 5.6 t70 -153.3 -156.37 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.38 -175.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' A' ' 169' ' ' GLU . 26.6 mmm180 -66.84 155.49 38.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.825 0.345 . . . . 0.0 111.275 -176.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.711 ' HA ' ' HB2' ' A' ' 162' ' ' SER . 5.2 t-105 -76.42 -17.61 59.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.517 0.675 . . . . 0.0 110.69 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.5 m -91.96 20.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.512 -172.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 173' ' ' MET . 50.2 mt-10 -53.89 -42.99 69.27 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.59 -46.26 66.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.037 0.446 . . . . 0.0 111.276 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.444 ' OD1' HG13 ' A' ' 176' ' ' ILE . 20.5 t-20 -80.44 -36.84 33.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.909 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.18 -29.29 70.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.504 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 169' ' ' GLU . 29.2 mmt -60.64 -29.35 69.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.918 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.425 HD13 HG13 ' A' ' 11' ' ' ILE . 5.2 tt -101.1 -51.66 3.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.925 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 151.35 117.41 0.77 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.443 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 176' ' ' ILE . 4.4 mp -63.93 -44.46 97.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.509 0.671 . . . . 0.0 109.319 174.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 43.1 t -92.87 103.55 15.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.718 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 157.19 -140.27 7.01 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 54.0 mt 69.85 119.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.462 0.648 . . . . 0.0 111.511 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.4 mp -82.88 64.88 7.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.334 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -134.01 113.59 12.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.679 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -61.38 153.36 66.34 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.857 2.371 . . . . 0.0 112.004 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -77.89 66.38 3.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.346 0.593 . . . . 0.0 110.843 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 146.88 52.76 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.474 HH22 ' HB1' ' A' ' 12' ' ' ALA . 27.3 ptt180 -74.6 95.48 2.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.282 0.563 . . . . 0.0 111.219 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -87.98 75.82 8.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.258 0.551 . . . . 0.0 109.729 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.23 84.91 3.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.862 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.245 0.838 0 CA-C-O 118.381 -0.818 . . . . 0.0 109.922 176.222 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.547 ' HA ' ' HB2' ' A' ' 140' ' ' GLU . 2.0 mpt? . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 66.92 -59.24 0.38 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.508 0.723 . . . . 0.0 111.093 -172.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.14 -152.46 21.62 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -76.16 107.84 8.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.099 0.476 . . . . 0.0 110.096 175.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.09 8.87 16.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.184 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -70.95 119.77 15.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.391 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.17 7.84 45.73 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.1 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -116.85 175.36 5.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.512 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 26.9 p90 -146.92 140.58 25.75 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 171.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 pt -93.92 131.74 39.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.311 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.978 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 3.4 mp -90.07 114.99 28.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.833 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.573 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -90.71 125.2 35.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.609 174.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.3 m -119.29 90.57 42.36 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.89 0.376 . . . . 0.0 110.706 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 87.5 Cg_endo -93.94 177.93 1.09 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.135 2.557 . . . . 0.0 112.658 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -120.91 10.52 10.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.347 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -85.55 -76.74 0.32 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.951 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -166.54 129.27 1.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.949 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -115.57 152.96 32.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.51 ' HG3' ' HB3' ' A' ' 22' ' ' ASP . 3.3 mm-40 -91.31 164.89 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.194 0.521 . . . . 0.0 112.024 -172.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -122.28 -38.56 2.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.802 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -102.25 -38.06 7.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.732 -176.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' HB3' ' HG3' ' A' ' 19' ' ' GLU . 3.2 t70 -73.39 169.48 17.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.832 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.525 ' HG2' HG21 ' A' ' 126' ' ' ILE . 7.1 tpm_? -87.6 83.36 7.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.235 0.541 . . . . 0.0 110.858 -172.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 t -91.91 132.41 36.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.501 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t 71.43 117.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.259 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.916 HG22 ' HD1' ' A' ' 27' ' ' TYR . 9.0 mm -116.17 -95.55 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.326 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.916 ' HD1' HG22 ' A' ' 26' ' ' ILE . 2.1 p90 178.09 -177.4 0.22 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.251 0.22 . . . . 0.0 110.56 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.2 mm -95.25 124.6 47.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.3 m -91.22 -46.46 8.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.722 -173.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.739 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 32.1 mt-10 -131.89 150.57 52.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.372 0.606 . . . . 0.0 112.218 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -132.37 105.95 7.6 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 167.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -109.3 171.05 7.67 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.453 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.53 -26.23 68.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.665 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -111.41 13.01 21.53 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.11 170.59 22.22 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.238 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 133' ' ' THR . 55.1 m -115.21 130.41 56.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.839 HG13 HG22 ' A' ' 133' ' ' THR . 3.8 mp -109.59 119.11 58.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.425 -173.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.01 165.12 28.56 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.121 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG23 ' HB ' ' A' ' 26' ' ' ILE . 3.3 m -126.99 102.5 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.237 0.541 . . . . 0.0 110.957 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.489 HD13 ' N ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -141.79 12.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.166 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 tp -74.55 -33.8 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.204 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 58.96 86.5 0.09 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.798 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 9.0 t -163.04 123.02 1.41 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.257 0.551 . . . . 0.0 111.411 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 2.4 Cg_endo -83.01 173.95 9.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.184 2.589 . . . . 0.0 111.607 176.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.405 HG22 ' ND2' ' A' ' 74' ' ' ASN . 16.6 p -118.17 -171.51 2.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.756 0.312 . . . . 0.0 110.366 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.76 7.11 47.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.387 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -112.12 155.52 23.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.427 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 43.0 m -104.91 157.44 17.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.003 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 14.7 p -68.67 -34.08 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.18 0.515 . . . . 0.0 109.92 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.474 HD13 HD12 ' A' ' 65' ' ' ILE . 86.2 mt -73.82 -25.9 60.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.291 178.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -53.16 56.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.751 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.1 pp -65.57 -33.62 76.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.605 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.82 -50.58 66.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.179 0.514 . . . . 0.0 110.96 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.9 p -72.43 -29.19 63.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -72.47 -39.62 67.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.388 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.472 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 19.7 ptp -150.09 -57.27 0.18 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -174.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 56' ' ' MET . 10.4 t70 -97.37 131.16 44.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.835 -166.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.4 t80 66.92 87.49 0.12 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.295 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.54 77.52 9.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.804 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.0 ttt -174.23 144.43 0.95 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.1 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.35 142.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.936 0.773 . . . . 0.0 112.305 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 73.3 mmtt 67.98 139.06 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.475 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 91.3 Cg_endo -94.01 -168.46 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.318 2.679 . . . . 0.0 112.368 177.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -73.48 89.11 1.65 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.141 0.496 . . . . 0.0 110.948 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.474 HD12 HD13 ' A' ' 50' ' ' LEU . 69.0 mt -100.94 110.52 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.747 176.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -126.26 7.49 7.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.889 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 m -75.61 -78.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.635 -172.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -176.21 88.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -132.36 -82.32 0.49 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.536 -173.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -128.3 112.79 14.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.881 0.372 . . . . 0.0 110.704 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.634 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 69.7 mtm -92.59 161.29 14.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.186 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.66 141.39 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.516 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.6 mp -109.2 170.51 8.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -176.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.405 ' ND2' HG22 ' A' ' 45' ' ' THR . 75.1 m-20 -110.21 132.15 54.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.013 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.75 -16.94 53.79 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.424 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.49 -179.35 36.95 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.934 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -86.79 5.04 6.01 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.164 2.576 . . . . 0.0 112.824 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.407 HG21 ' OG1' ' A' ' 133' ' ' THR . 21.7 t -120.19 153.84 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 89.4 m-20 65.53 33.44 8.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.873 0.368 . . . . 0.0 110.333 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -65.31 -14.51 60.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.102 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -91.1 -4.67 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.422 0.63 . . . . 0.0 110.553 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -109.5 120.36 42.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.074 0.464 . . . . 0.0 110.897 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.75 108.52 3.62 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.55 ' HB3' HD11 ' A' ' 106' ' ' LEU . 98.0 m-85 -97.19 125.27 41.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.698 0.285 . . . . 0.0 110.735 -176.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.444 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.7 mp -117.12 109.92 29.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.207 0.527 . . . . 0.0 109.891 175.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -94.13 121.01 44.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.322 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -138.55 155.56 48.27 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.461 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.1 m -73.98 164.38 26.7 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 103' ' ' ASP . 14.3 ttmm -88.5 118.1 27.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.072 0.939 . . . . 0.0 112.291 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.4 m -139.48 18.43 2.55 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 169.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -132.6 161.31 34.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.019 -167.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.14 28.14 1.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.603 171.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.51 170.27 13.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.708 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -162.66 79.98 0.5 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.7 m -92.56 -41.42 10.25 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.3 t-160 -169.6 78.38 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.337 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.6 m -115.2 133.86 55.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.102 -172.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.601 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 4.8 t80 -102.11 102.54 13.02 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -81.73 106.27 13.53 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.08 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.55 HG11 ' HE2' ' A' ' 27' ' ' TYR . 16.8 t -91.06 -62.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 46.5 p -119.05 175.71 5.64 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.97 -33.06 64.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 20.5 t70 -106.37 -49.12 3.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.392 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.6 mm -76.2 121.95 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.208 0.528 . . . . 0.0 110.001 -169.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.6 m -122.11 132.45 54.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.758 -175.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 58.6 tp -102.23 112.24 24.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.839 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.664 HG21 ' HB3' ' A' ' 111' ' ' ASP . 15.2 m -106.96 124.3 49.43 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.03 28.35 8.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.881 -175.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 t -146.8 -174.24 4.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.711 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.34 -0.87 25.12 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.091 -176.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.664 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.4 t70 -55.26 -37.7 67.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.258 0.552 . . . . 0.0 110.123 174.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.559 HG23 HD22 ' A' ' 113' ' ' LEU . 36.0 m -55.82 -34.33 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.142 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.559 HD22 HG23 ' A' ' 112' ' ' VAL . 3.5 mm? -62.49 -34.55 77.08 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.446 0.641 . . . . 0.0 110.197 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.37 -25.8 31.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.919 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.0 m -62.3 -57.1 12.62 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.236 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.433 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 11.7 p90 -91.46 3.66 54.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 110.858 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.67 29.18 12.07 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.954 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.4 t -140.62 174.19 10.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -65.05 -39.16 92.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.813 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.7 p -89.76 32.32 0.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.48 -176.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 116' ' ' PHE . . . -58.51 130.46 84.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.993 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.22 140.22 91.07 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.916 2.411 . . . . 0.0 112.308 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.09 -52.87 44.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.723 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -104.75 113.3 26.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.221 -172.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -147.27 133.61 19.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.806 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.525 HG21 ' HG2' ' A' ' 23' ' ' ARG . 32.7 pt -123.99 143.03 38.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.578 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.24 119.35 60.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.227 0.537 . . . . 0.0 110.489 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.6 p -131.07 130.88 43.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.532 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.69 125.63 34.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.014 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . 75.56 178.48 43.2 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.884 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 77.8 m -150.76 173.32 14.33 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.4 m -102.16 116.9 33.63 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 37' ' ' ILE . 78.3 p -111.12 120.83 43.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.994 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -81.01 137.71 36.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.472 . . . . 0.0 110.487 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -71.67 140.23 84.01 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.521 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -36.58 130.25 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.248 3.299 . . . . 0.0 114.716 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 77.37 -34.43 0.2 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.41 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.6 tp60 -60.2 -44.38 95.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -173.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.8 tp -55.82 -35.46 66.39 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.661 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 42.9 tt0 -64.36 -38.92 92.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.148 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -71.26 -39.47 71.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 8.4 mm-40 -57.8 -51.12 70.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.302 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.8 mt -68.75 -33.15 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.564 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.4 91.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.311 . . . . 0.0 111.057 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -86.1 12.64 9.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.09 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 62.32 32.97 16.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.082 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.81 ' HA ' ' HG2' ' A' ' 182' ' ' PRO . 15.9 m-85 -72.14 -28.0 62.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.229 0.538 . . . . 0.0 109.738 172.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.573 ' HZ3' ' HB2' ' A' ' 12' ' ' ALA . 91.0 m95 -134.08 139.41 45.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.695 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.978 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.9 tt -88.2 141.3 28.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.535 ' N ' HD23 ' A' ' 149' ' ' LEU . 59.3 tp -123.09 134.57 54.24 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.696 -175.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.9 p -161.42 164.07 30.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.877 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -71.13 155.78 40.36 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.142 0.496 . . . . 0.0 111.274 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.04 -155.16 0.53 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.935 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.3 t30 65.85 22.9 11.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.76 0.791 . . . . 0.0 109.891 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -88.31 165.72 14.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.883 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 38.0 mt-30 -59.31 -29.09 67.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.052 0.453 . . . . 0.0 110.624 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.664 ' HA ' HG23 ' A' ' 161' ' ' THR . 6.7 m -52.63 -30.48 31.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.262 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.54 -57.18 6.94 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.356 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -127.42 -19.26 4.27 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 41.0 mt-10 -82.74 -9.07 59.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 111.524 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 157' ' ' THR . 1.6 p -65.51 -27.06 68.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.401 0.62 . . . . 0.0 110.246 173.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.0 m -97.77 22.87 8.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.475 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -122.3 -58.59 1.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.073 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.59 ' HG ' ' N ' ' A' ' 165' ' ' ASP . 2.4 pt? -116.41 -63.12 1.49 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.3 -178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.59 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 6.2 t70 -170.64 -175.8 1.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -170.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.545 ' HD3' ' OE2' ' A' ' 169' ' ' GLU . 17.3 mtt180 71.61 155.72 0.15 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 174.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.445 ' HD1' HG23 ' A' ' 168' ' ' VAL . 2.2 p90 -170.04 161.95 8.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.429 173.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.445 HG23 ' HD1' ' A' ' 167' ' ' TRP . 6.8 t 60.01 30.37 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.329 0.585 . . . . 0.0 110.817 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.545 ' OE2' ' HD3' ' A' ' 166' ' ' ARG . 42.0 mt-10 -70.4 -7.21 41.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.037 0.446 . . . . 0.0 110.933 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.477 ' HB1' ' CG1' ' A' ' 11' ' ' ILE . . . -53.79 -39.37 65.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.181 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -81.08 -33.03 33.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.554 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.19 -27.91 61.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 0.0 110.658 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.615 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 1.0 OUTLIER -59.6 -33.05 70.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.196 0.522 . . . . 0.0 110.213 175.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 149' ' ' LEU . 12.8 tp -82.05 -48.73 11.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.473 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 135.87 29.66 0.35 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.228 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 45.9 mm 71.74 -48.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.332 0.653 . . . . 0.0 112.033 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 13.7 m -74.07 89.32 1.95 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.037 0.446 . . . . 0.0 111.112 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.41 142.23 15.63 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 179' ' ' ILE . 4.5 mp -81.47 110.83 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 79.4 mt 63.8 179.77 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.586 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -170.6 86.75 0.52 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.999 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.81 ' HG2' ' HA ' ' A' ' 147' ' ' TYR . 24.2 Cg_endo -94.99 153.6 1.74 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.234 2.623 . . . . 0.0 112.742 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 14' ' ' PRO . . . -132.36 -80.97 0.5 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.774 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.91 -173.72 54.71 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.215 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -129.92 156.33 44.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.078 0.466 . . . . 0.0 111.352 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.03 88.45 2.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.134 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 187' ' ' LEU . 3.0 pp -70.1 145.91 51.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.187 -177.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.213 -179.334 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.424 0.154 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.566 ' HD2' ' HG3' ' A' ' 140' ' ' GLU . 97.1 m-85 -84.56 136.85 33.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 111.112 -177.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.23 -127.4 4.26 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.301 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.35 102.79 7.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.633 0.254 . . . . 0.0 110.974 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.79 -82.8 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 173.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 57.13 107.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 172.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.33 -1.96 79.1 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.565 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.69 ' HD2' ' HB3' ' A' ' 152' ' ' GLU . 37.9 mmtm -95.4 159.85 14.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.478 ' HZ ' ' HG2' ' A' ' 173' ' ' MET . 45.0 p90 -123.79 154.41 39.59 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.511 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.567 HD11 HG21 ' A' ' 40' ' ' ILE . 8.4 pt -114.45 144.56 21.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.758 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.7 mp -110.73 161.41 9.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.405 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 70.51 -176.59 0.2 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.547 0.529 . . . . 0.0 110.784 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 t -174.98 146.0 0.93 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.426 ' HA ' ' CD1' ' A' ' 147' ' ' TYR . 65.6 Cg_endo -73.98 -154.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.022 2.481 . . . . 0.0 111.861 174.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -79.46 49.01 0.95 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.108 0.48 . . . . 0.0 110.646 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.6 tpt -73.64 160.89 30.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.735 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.53 88.17 2.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.04 0.448 . . . . 0.0 110.515 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -75.29 111.64 10.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.22 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.556 ' HG3' ' CD2' ' A' ' 20' ' ' TYR . 9.6 tp10 -76.2 -65.22 0.95 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.242 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.556 ' CD2' ' HG3' ' A' ' 19' ' ' GLU . 66.8 m-85 -140.62 -86.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.7 t80 173.65 -24.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.119 -170.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.83 104.81 3.56 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 70.45 60.07 0.23 Allowed 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.935 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.3 t -97.51 112.01 24.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.228 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.464 HG22 ' HB ' ' A' ' 40' ' ' ILE . 38.6 t 54.76 92.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.076 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.496 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.4 tp -95.02 -57.35 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.496 ' HD1' HG13 ' A' ' 26' ' ' ILE . 6.1 p90 -174.3 175.47 2.63 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.158 0.436 . . . . 0.0 111.637 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.8 mm -94.93 126.61 47.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.816 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.35 -51.24 15.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.753 0.311 . . . . 0.0 111.157 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -159.92 153.83 23.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 0.0 110.846 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -120.6 104.64 10.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -106.59 171.04 7.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.194 -173.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.76 -22.59 65.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.92 0.391 . . . . 0.0 110.999 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -80.69 -39.7 26.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.057 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 170.58 -167.31 40.47 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.605 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.7 m -103.21 121.18 42.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.683 0.277 . . . . 0.0 110.335 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.647 HG13 HG22 ' A' ' 133' ' ' THR . 4.3 mp -98.0 118.74 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.09 153.93 25.37 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.494 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -114.6 88.69 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.728 0.775 . . . . 0.0 110.692 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.581 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -125.1 18.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.113 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.537 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -61.07 -36.17 70.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.382 -176.063 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.6 t30 56.23 66.83 1.1 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 110.582 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 t -169.47 103.41 0.47 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-O 121.545 0.688 . . . . 0.0 111.156 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 5.9 Cg_exo -78.83 158.75 27.8 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.612 2.208 . . . . 0.0 110.286 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.54 HG21 ' ND2' ' A' ' 74' ' ' ASN . 73.6 p -110.38 166.3 11.09 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.549 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -73.87 -30.35 62.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.976 0.417 . . . . 0.0 110.78 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.62 149.99 49.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.261 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.0 m -97.59 150.83 20.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.965 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.676 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.1 p -61.85 -36.62 74.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.71 -35.46 81.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.481 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 8.3 mm-40 -62.04 -39.0 90.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.038 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.1 mt -74.98 -35.6 62.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.941 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 83.2 mt -62.96 -49.46 74.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.497 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.2 p -67.56 -30.34 69.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.857 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 1.7 tpp180 -60.77 -52.24 65.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.6 -177.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.43 ' HG3' ' H ' ' A' ' 57' ' ' ASP . 13.1 ptt? -109.85 -64.85 1.21 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -173.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.43 ' H ' ' HG3' ' A' ' 56' ' ' MET . 35.7 t70 -155.4 136.14 13.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.809 0.338 . . . . 0.0 111.586 -174.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -152.49 139.3 18.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.692 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -91.02 151.42 21.05 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 60.7 mtt -76.41 84.76 3.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.37 0.605 . . . . 0.0 111.365 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.746 ' HB1' ' HA3' ' A' ' 117' ' ' GLY . . . -124.77 1.54 8.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.863 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 31.8 mmmt -129.23 143.84 50.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.856 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.491 ' HB2' HG12 ' A' ' 65' ' ' ILE . 38.5 Cg_exo -62.24 -20.76 71.11 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.174 2.583 . . . . 0.0 113.089 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 70.55 17.28 6.79 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.201 0.6 . . . . 0.0 112.118 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.491 HG12 ' HB2' ' A' ' 63' ' ' PRO . 16.3 pt -81.44 126.56 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -61.57 107.5 0.81 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.38 0.61 . . . . 0.0 111.729 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.5 t -166.39 141.13 4.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.142 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 60.28 91.84 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.656 0.598 . . . . 0.0 111.924 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.09 132.09 37.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.935 0.398 . . . . 0.0 110.388 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -122.57 118.18 27.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.205 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.6 mtt -77.9 152.24 33.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.568 HG21 HD23 ' A' ' 129' ' ' LEU . 13.8 p -106.52 149.38 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.283 174.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.565 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.0 mp -102.42 159.75 15.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.763 0.315 . . . . 0.0 110.333 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.54 ' ND2' HG21 ' A' ' 45' ' ' THR . 35.9 m-20 -101.83 121.75 42.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.29 -23.34 58.99 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.542 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.97 -177.07 36.6 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.397 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.53 -25.94 7.64 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.259 2.639 . . . . 0.0 112.835 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.3 t -86.62 125.93 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.988 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 67.19 31.04 6.92 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.485 0.491 . . . . 0.0 110.855 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -65.97 -21.62 66.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.46 -175.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -82.87 -0.23 47.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.265 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -125.42 142.5 51.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 110.675 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.78 131.88 10.74 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.11 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -112.72 123.1 49.55 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 106' ' ' LEU . 5.2 mp -137.49 120.16 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.913 0.387 . . . . 0.0 111.268 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.1 t -110.51 130.41 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -132.01 149.36 52.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.448 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 p -69.91 150.44 46.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.984 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -65.79 112.86 3.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.532 0.682 . . . . 0.0 110.53 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 92.5 m -157.87 -48.2 0.06 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.68 -165.77 1.41 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.645 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -165.79 134.07 3.05 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.894 ' HB3' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -100.35 -171.03 1.96 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.91 -177.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -118.0 -46.12 2.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.879 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 36.5 p -75.33 -84.32 0.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -168.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -110.6 91.29 3.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 111.571 -172.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.9 m -96.04 104.03 15.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.565 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -102.73 102.62 12.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.015 0.436 . . . . 0.0 109.9 175.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 102' ' ' ASP . 4.8 mtmm -89.76 107.01 18.84 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.58 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -60.55 -53.96 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.424 HG22 HG12 ' A' ' 104' ' ' ILE . 5.8 t -134.53 -176.16 4.12 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.469 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 33.5 t70 -65.3 -33.35 75.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 118.27 0.486 . . . . 0.0 112.285 -170.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -98.15 2.38 48.46 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 101' ' ' THR . 47.0 mm -117.81 123.65 71.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.7 m -124.41 124.99 43.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.993 0.425 . . . . 0.0 111.325 -176.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 85' ' ' ILE . 21.4 tp -101.59 130.45 47.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.021 174.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.7 m -129.16 124.89 35.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.1 p -109.03 28.87 8.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.64 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m -138.08 177.24 8.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.51 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.453 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -63.5 -11.82 43.2 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.304 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.894 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . 0.9 OUTLIER -47.84 -38.02 15.1 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.781 0.433 . . . . 0.0 111.051 175.552 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.424 HG11 HG21 ' A' ' 85' ' ' ILE . 86.5 t -52.58 -40.82 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.376 178.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.554 HD11 HD22 ' A' ' 53' ' ' LEU . 3.8 mm? -62.3 -36.46 82.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.08 -27.24 54.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.05 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 m -56.99 -55.73 30.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.192 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.492 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 20.8 p90 -90.49 26.5 1.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -173.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.746 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -107.67 17.12 36.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.566 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 t -145.5 -179.31 6.58 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.677 -0.308 . . . . 0.0 110.326 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -74.88 -21.74 59.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.678 0.275 . . . . 0.0 111.253 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.9 p -91.96 23.39 3.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.943 0.401 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.492 ' CB ' ' HA ' ' A' ' 116' ' ' PHE . . . -65.69 146.03 99.0 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.232 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.55 133.83 38.7 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.415 2.077 . . . . 0.0 111.452 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.49 -36.48 83.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.997 0.427 . . . . 0.0 110.794 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -136.74 128.1 28.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.075 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.01 140.78 24.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.745 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.5 pt -110.5 132.93 57.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.976 0.417 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.95 126.91 73.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.385 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 80.8 m -140.62 150.0 43.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.005 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.568 HD23 HG21 ' A' ' 72' ' ' VAL . 4.3 mm? -100.32 117.52 34.68 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.51 177.75 50.53 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.904 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 66.4 m -145.83 168.58 20.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.89 0.376 . . . . 0.0 110.432 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.5 m -114.2 119.95 38.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.265 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.647 HG22 HG13 ' A' ' 37' ' ' ILE . 21.5 p -102.03 114.7 29.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.584 0.707 . . . . 0.0 111.69 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.53 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.5 OUTLIER -99.55 135.59 40.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.925 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 10.5 mptt -75.64 136.69 70.81 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.025 -175.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 6.5 Cg_exo -74.86 42.56 0.84 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.647 2.898 . . . . 0.0 114.175 -170.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 55.1 m-70 -156.58 -38.72 0.08 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 171.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.617 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 50.4 tt0 -52.8 -60.72 2.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.906 171.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.53 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 57.4 tp -63.03 -35.88 81.71 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.402 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.566 ' HG3' ' HD2' ' A' ' 2' ' ' PHE . 40.6 tt0 -55.66 -48.75 74.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.893 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 75.5 mt-30 -72.47 -31.5 65.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.114 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 53.7 mm-40 -59.19 -44.17 92.21 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.156 0.503 . . . . 0.0 109.912 175.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.588 HG12 ' HB2' ' A' ' 148' ' ' TRP . 66.7 mt -64.43 -36.78 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.341 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.29 -24.92 67.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.403 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 73.4 mt-30 -78.17 -0.64 29.16 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.903 0.382 . . . . 0.0 110.351 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 70.28 31.28 3.15 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.895 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' TYR . . . . . 0.47 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 59.7 m-85 -100.5 -4.23 29.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.262 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.588 ' HB2' HG12 ' A' ' 143' ' ' ILE . 97.2 m95 -134.48 148.94 50.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.768 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 60.3 mt -126.03 153.35 44.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.852 175.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.1 tp -121.87 134.93 54.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.017 0.437 . . . . 0.0 111.576 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.2 t -149.96 173.13 14.15 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.69 ' HB3' ' HD2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -129.26 154.1 47.15 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.246 -179.026 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' ' 157' ' ' THR . . . -127.21 104.72 8.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.702 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -81.42 88.51 6.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.344 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 70.0 -65.97 0.29 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.828 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.581 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 30.7 mt-30 -56.62 -70.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -170.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.536 ' HB ' ' HB1' ' A' ' 153' ' ' ALA . 3.1 m -54.21 -29.57 46.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -175.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -57.21 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.87 -174.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -128.83 -13.6 4.63 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 31.4 mt-10 -81.71 -52.33 7.27 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.273 174.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.5 m 61.89 113.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 124.397 1.061 . . . . 0.0 111.664 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.511 ' HB3' HD22 ' A' ' 164' ' ' LEU . 18.1 m -70.83 82.44 0.64 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.289 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -81.74 69.61 8.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.638 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 162' ' ' SER . 2.5 pt? -129.35 -31.25 2.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.007 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -115.95 -53.18 2.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.073 0.463 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.724 HH22 ' HG2' ' A' ' 172' ' ' GLU . 36.7 ttp-105 -145.81 171.57 14.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -86.49 -50.67 6.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.119 0.485 . . . . 0.0 110.723 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.09 91.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.702 0.763 . . . . 0.0 110.685 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.543 ' OE2' ' HB3' ' A' ' 166' ' ' ARG . 20.0 mm-40 -94.04 -3.23 51.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.767 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -56.72 -33.26 66.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.581 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -79.51 -27.88 41.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.759 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.724 ' HG2' HH22 ' A' ' 166' ' ' ARG . 23.8 mm-40 -73.29 -23.41 60.28 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.01 0.433 . . . . 0.0 110.669 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.478 ' HG2' ' HZ ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -66.29 -28.47 68.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.732 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.425 ' CD2' HD13 ' A' ' 149' ' ' LEU . 10.4 tp -112.89 -50.5 2.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.198 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 142.4 114.99 1.08 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 77.1 mt -54.49 -44.16 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.816 0.341 . . . . 0.0 111.358 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.0 m -92.68 30.39 1.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.104 0.478 . . . . 0.0 111.126 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.58 97.03 2.24 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.05 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.7 tt -114.39 142.85 25.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.747 0.308 . . . . 0.0 110.382 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.439 HD11 HD21 ' A' ' 149' ' ' LEU . 5.0 mp -88.13 153.44 21.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.68 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 55.42 64.7 5.3 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.033 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -86.27 -9.35 7.2 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.454 2.103 . . . . 0.0 112.043 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -111.18 29.76 7.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.714 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.86 139.27 47.48 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.429 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 185' ' ' ARG . 5.1 tpm_? -78.29 -26.86 47.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.87 0.367 . . . . 0.0 110.417 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -129.1 83.17 2.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.243 0.545 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 94.2 mt -120.36 -37.34 3.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.949 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.248 0.981 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.666 -177.527 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.532 ' HA ' ' CD ' ' A' ' 140' ' ' GLU . 64.5 mtt . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.239 0.066 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 64.73 92.22 0.07 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.66 0.6 . . . . 0.0 110.794 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.92 -72.38 0.6 Allowed Glycine 0 C--N 1.33 0.196 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.652 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -103.57 99.93 9.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.114 0.483 . . . . 0.0 110.399 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -99.98 15.6 26.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.453 0.644 . . . . 0.0 109.752 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.732 HE21 HG13 ' A' ' 100' ' ' VAL . 49.2 tt0 -91.51 131.49 36.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.674 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.8 0.14 59.09 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.684 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.439 ' HB2' HD23 ' A' ' 5' ' ' LEU . 3.3 mptp? -107.8 176.62 5.08 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 43.3 p90 -142.72 152.94 42.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.054 0.454 . . . . 0.0 110.39 173.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 pt -118.19 128.12 75.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.307 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 60.0 mt -86.63 111.92 22.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.168 -175.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -120.78 94.87 4.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.558 173.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 15' ' ' GLU . 5.7 m -145.24 103.51 4.37 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.276 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.48 -28.58 8.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.643 2.229 . . . . 0.0 112.647 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' O ' HG22 ' A' ' 13' ' ' THR . 73.2 mm-40 -107.42 -178.82 3.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.975 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -80.1 103.47 10.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' ' 18' ' ' ASP . 12.3 t70 66.71 -165.59 0.22 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -171.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.43 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 35.3 t70 -125.71 -22.49 4.21 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.983 -0.448 . . . . 0.0 110.802 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -140.87 -85.65 0.19 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.743 -178.414 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.437 ' H ' ' HB3' ' A' ' 19' ' ' GLU . 70.3 t80 177.86 -44.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.609 -173.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 166' ' ' ARG . 0.2 OUTLIER -141.62 29.85 1.72 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -176.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.725 ' HA ' ' NH1' ' A' ' 23' ' ' ARG . 1.9 t70 -100.95 -177.54 3.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.072 -171.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.725 ' NH1' ' HA ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -123.92 85.75 2.46 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.445 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.5 p -121.2 154.6 36.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.818 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t 67.91 96.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 O-C-N 123.815 0.697 . . . . 0.0 111.117 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.642 HG21 HG23 ' A' ' 39' ' ' VAL . 10.6 tp -124.65 -146.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.345 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.561 ' H ' HG13 ' A' ' 26' ' ' ILE . 3.5 p90 -116.63 171.71 7.7 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.427 1.012 . . . . 0.0 111.623 -164.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.53 116.09 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.553 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.8 m -75.51 -45.07 40.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.109 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -140.48 144.86 36.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.86 0.362 . . . . 0.0 110.719 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -128.61 111.96 13.76 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.293 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -114.75 173.36 6.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -71.84 -23.14 61.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.744 0.307 . . . . 0.0 111.112 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -107.45 -27.59 10.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.468 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.82 127.12 3.32 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 119.8 -1.19 . . . . 0.0 113.06 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 133' ' ' THR . 82.1 m -107.39 110.72 22.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.745 HG13 HG22 ' A' ' 133' ' ' THR . 4.0 mp -96.54 114.33 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.843 -172.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -145.71 160.88 28.19 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.642 HG23 HG21 ' A' ' 26' ' ' ILE . 3.0 m -114.75 63.97 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.599 0.714 . . . . 0.0 110.491 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -111.66 15.3 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.544 -175.167 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 43' ' ' THR . 10.4 tp -68.91 -28.25 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.359 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 63.7 87.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.103 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.487 HG22 HG23 ' A' ' 41' ' ' ILE . 4.1 t -168.52 96.84 0.56 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.455 0.645 . . . . 0.0 111.086 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 57.9 Cg_endo -74.84 154.19 43.13 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.059 1.839 . . . . 0.0 111.3 174.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -115.63 152.24 33.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.681 0.277 . . . . 0.0 110.614 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.77 -17.15 62.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.07 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.401 ' O ' HG12 ' A' ' 72' ' ' VAL . 21.4 tp -76.08 160.01 30.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.709 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 14.7 m -119.81 160.11 23.26 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.903 -174.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.571 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.9 p -65.82 -37.92 81.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.046 -175.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.468 HD23 HD12 ' A' ' 53' ' ' LEU . 91.6 mt -66.54 -33.98 76.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.204 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.709 ' OE1' ' HB2' ' A' ' 48' ' ' SER . 3.1 mp0 -61.76 -40.41 95.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.627 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.02 -39.82 63.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.327 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 113' ' ' LEU . 95.1 mt -62.62 -49.14 76.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.978 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.69 HG22 ' HB3' ' A' ' 59' ' ' GLN . 40.1 p -68.11 -30.97 70.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.634 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -60.25 -37.27 79.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.585 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 73.0 mtm -78.53 -83.77 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -169.8 24.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.642 0.734 . . . . 0.0 110.714 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.472 ' CD1' ' HG ' ' A' ' 113' ' ' LEU . 98.9 m-85 -116.33 96.17 5.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.161 -178.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.69 ' HB3' HG22 ' A' ' 54' ' ' THR . 23.5 pt20 -142.14 115.56 8.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.568 0.699 . . . . 0.0 111.221 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 51.9 ttp -138.17 111.74 8.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.747 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.01 93.5 5.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.157 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.447 ' HB3' ' HE2' ' A' ' 62' ' ' LYS . 15.8 ptpt -68.66 142.38 93.9 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.759 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 27.5 Cg_exo -63.29 -16.87 57.19 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.17 2.58 . . . . 0.0 113.126 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -83.61 99.37 10.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.854 HD13 ' H ' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -80.0 15.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.255 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.423 ' O ' ' HB ' ' A' ' 67' ' ' THR . 79.6 m-85 -100.36 148.64 24.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.7 178.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 66' ' ' TYR . 38.3 m 76.98 112.29 0.07 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.983 0.802 . . . . 0.0 110.128 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.46 -174.11 4.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.118 0.485 . . . . 0.0 111.221 -174.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -58.97 153.97 16.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.195 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 48' ' ' SER . 29.6 mm-40 -111.52 127.88 55.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.679 178.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 66.2 mtt -79.87 157.79 26.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.013 0.435 . . . . 0.0 111.47 -176.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 129' ' ' LEU . 9.7 p -107.74 149.87 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.237 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 8.0 mp -107.98 168.39 9.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.0 110.142 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.39 137.07 46.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.537 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -103.09 -9.38 39.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.44 -0.885 . . . . 0.0 113.009 -173.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.11 164.7 12.25 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.95 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.6 -20.91 26.29 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.961 2.441 . . . . 0.0 112.502 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.51 128.38 39.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.972 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 64.66 24.99 13.04 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.44 0.462 . . . . 0.0 110.612 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HA ' ' CA ' ' A' ' 130' ' ' GLY . 53.3 tt0 -65.29 -23.5 67.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.534 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.02 -19.63 62.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.674 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 82' ' ' ARG . 39.1 mtm180 -109.67 143.73 39.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.004 0.431 . . . . 0.0 111.057 -171.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.41 130.76 10.04 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.336 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -111.84 124.22 51.91 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.408 ' O ' HD12 ' A' ' 106' ' ' LEU . 5.4 mp -131.14 115.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.0 111.032 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.01 126.43 67.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.76 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -133.17 161.09 35.37 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.119 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 m -67.52 159.04 30.52 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.444 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 46.1 tttp -72.55 120.13 17.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.188 0.518 . . . . 0.0 110.645 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.1 m -144.99 107.67 4.45 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 173.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -54.31 138.15 39.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.345 0.593 . . . . 0.0 112.199 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -176.71 24.54 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.757 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 67.51 -165.52 0.21 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -167.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -151.56 137.32 17.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.018 0.437 . . . . 0.0 111.262 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 111' ' ' ASP . 30.9 m -89.81 -50.04 6.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.076 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 109' ' ' SER . 50.3 t60 -168.32 88.56 0.24 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.72 176.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 57.8 m -130.9 136.02 48.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.716 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -103.43 116.69 32.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 101' ' ' THR . 0.3 OUTLIER -81.32 122.08 27.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.06 0.457 . . . . 0.0 111.84 -175.037 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.732 HG13 HE21 ' A' ' 6' ' ' GLN . 64.2 t -68.4 -53.01 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 165.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 9.9 t -138.54 -169.67 2.66 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.886 -1.506 . . . . 0.0 107.0 167.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.05 -40.88 60.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 118.9 0.773 . . . . 0.0 110.983 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 6.3 m-20 -76.31 -25.55 54.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.7 mm -118.01 123.1 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 m -131.25 133.62 45.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.036 0.446 . . . . 0.0 111.987 -173.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 85' ' ' ILE . 19.1 tp -96.12 137.27 35.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.991 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.866 HG21 ' HB3' ' A' ' 111' ' ' ASP . 50.9 m -133.51 128.34 35.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.888 0.375 . . . . 0.0 111.164 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.9 p -120.08 25.4 9.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.831 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.515 ' CB ' ' HB3' ' A' ' 96' ' ' HIS . 8.6 t -136.9 -170.56 2.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.619 -174.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.12 -5.29 52.94 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 116.509 -0.314 . . . . 0.0 112.926 -178.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.866 ' HB3' HG21 ' A' ' 107' ' ' THR . 14.6 t70 -55.22 -37.13 66.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.337 0.589 . . . . 0.0 110.483 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.09 -50.1 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.701 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.623 HD11 HD13 ' A' ' 53' ' ' LEU . 3.9 mm? -61.98 -41.02 97.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.854 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.19 -41.89 98.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.386 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 68.2 m -54.15 -68.76 0.16 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.309 -176.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PHE . . . . . 0.434 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 32.2 p90 -86.87 21.97 2.12 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 111.979 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.33 19.12 10.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.896 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 120' ' ' THR . 8.9 t -157.48 -170.48 3.24 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.922 0.361 . . . . 0.0 110.524 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -67.7 -20.9 65.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.0 111.248 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.509 ' H ' HG23 ' A' ' 118' ' ' THR . 16.6 p -98.05 36.07 1.63 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.278 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -75.73 121.95 86.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.438 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.38 131.56 20.6 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.633 2.222 . . . . 0.0 111.295 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.61 -47.26 73.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.326 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -123.11 123.24 40.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.374 0.607 . . . . 0.0 111.897 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -146.13 131.92 19.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.02 175.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.3 pt -105.39 132.77 51.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.902 0.382 . . . . 0.0 110.311 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.83 123.49 71.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.235 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 74.2 m -136.07 142.96 44.41 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.413 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 72' ' ' VAL . 3.9 mm? -93.63 115.49 27.97 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.631 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . 80.89 173.32 47.19 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.841 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 62.8 m -147.06 169.22 19.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.7 m -105.95 116.65 32.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.004 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.745 HG22 HG13 ' A' ' 37' ' ' ILE . 47.7 p -103.66 115.84 31.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.465 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.908 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 1.5 t-105 -78.77 157.49 28.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.749 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 12.9 mmmm -65.37 147.16 98.79 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.378 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.23 113.89 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.443 2.762 . . . . 0.0 112.949 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.509 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 10.9 m-70 66.83 -3.36 0.93 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.534 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 53.3 tt0 -74.82 -25.48 59.04 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.733 -177.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.446 ' O ' HG13 ' A' ' 143' ' ' ILE . 49.1 tp -56.95 -39.24 74.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.885 -175.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.532 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 12.7 pt-20 -66.36 -34.27 77.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.784 0.326 . . . . 0.0 110.76 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 2.6 mp0 -71.33 -38.9 71.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 110.243 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.908 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 32.9 mm-40 -59.54 -43.54 93.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 139' ' ' LEU . 78.7 mt -64.48 -34.07 67.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.803 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.04 -19.01 65.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.335 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 15.5 mt-30 -79.94 -2.47 43.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.723 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 71.05 18.8 5.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.712 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -100.27 3.91 43.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 12' ' ' ALA . 99.8 m95 -134.83 119.86 18.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.83 0.347 . . . . 0.0 110.79 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.521 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 3.9 tt -100.21 113.05 25.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.9 tt -90.19 134.52 34.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 110.632 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.7 m -142.0 152.19 43.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.539 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.29 158.84 24.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.483 0.659 . . . . 0.0 111.618 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.69 -152.57 0.44 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.891 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.0 t30 67.87 65.97 0.37 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.959 0.409 . . . . 0.0 111.233 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -178.6 -89.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.969 174.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -106.4 -55.96 2.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.001 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.8 m -52.12 -29.81 23.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.571 -170.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.34 -53.98 40.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -134.39 15.29 3.76 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.89 -53.36 5.16 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.456 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.6 p -81.31 -75.44 0.28 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.3 m 60.02 -138.42 0.67 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.624 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -77.99 70.84 4.41 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.131 0.491 . . . . 0.0 111.806 -172.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.76 -4.8 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.112 0.482 . . . . 0.0 110.576 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -129.75 -169.55 2.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.47 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 55.5 mtt180 -95.36 -48.53 5.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.675 0.274 . . . . 0.0 111.035 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 -100.99 154.41 18.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.227 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 170' ' ' ALA . 31.9 t -69.45 135.4 28.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.322 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -97.23 -4.76 38.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.462 0.172 . . . . 0.0 111.315 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.588 ' H ' HG12 ' A' ' 168' ' ' VAL . . . -53.1 -42.44 65.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -77.12 -37.41 54.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.025 0.44 . . . . 0.0 110.787 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -75.78 -22.89 55.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.688 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -57.18 -37.26 71.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.84 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.8 tp -89.53 -44.31 10.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.946 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 120.02 0.61 13.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.118 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.8 mp 68.97 -72.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.259 0.624 . . . . 0.0 111.625 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 11.2 t 70.88 160.95 0.22 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.41 0.684 . . . . 0.0 111.029 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -90.93 -6.43 67.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.488 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.583 HG22 HD12 ' A' ' 180' ' ' LEU . 3.2 mp -101.32 131.06 49.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 179' ' ' ILE . 6.3 mp 58.73 68.59 0.81 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.189 0.518 . . . . 0.0 110.752 -168.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -121.72 120.46 28.64 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.227 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 17.3 Cg_exo -66.54 134.24 34.9 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.876 2.384 . . . . 0.0 112.475 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -122.47 142.11 50.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.971 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -95.45 23.52 33.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -97.83 18.83 14.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.043 0.449 . . . . 0.0 110.296 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.35 -57.11 3.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.637 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 98.2 mt -116.27 178.26 4.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.251 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.62 179.07 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.789 0.328 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -131.01 172.67 11.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.543 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.25 -73.55 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.085 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -77.96 145.07 36.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.059 0.457 . . . . 0.0 110.725 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.95 -107.47 0.27 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.268 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 59.36 117.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.905 0.753 . . . . 0.0 112.476 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.413 ' C ' ' HD3' ' A' ' 8' ' ' LYS . . . 84.84 8.16 82.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.676 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.94 ' HD2' ' HB2' ' A' ' 152' ' ' GLU . 22.2 mmtp -112.05 150.81 30.14 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -130.49 163.03 27.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.393 0.616 . . . . 0.0 111.895 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.434 HD12 ' CE3' ' A' ' 148' ' ' TRP . 2.5 pt -127.69 128.36 69.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.396 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.495 HD12 HD22 ' A' ' 174' ' ' LEU . 55.0 mt -96.03 150.58 4.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.804 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 76.19 130.75 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.11 0.881 . . . . 0.0 110.91 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.879 ' HB ' ' HD3' ' A' ' 14' ' ' PRO . 32.7 m -140.83 -60.72 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.016 -177.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.879 ' HD3' ' HB ' ' A' ' 13' ' ' THR . 79.0 Cg_endo -91.21 179.17 1.66 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.287 1.992 . . . . 0.0 112.528 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' A' ' 16' ' ' MET . 14.4 tp10 -103.62 -48.89 3.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.946 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.532 ' HG3' ' HG3' ' A' ' 15' ' ' GLU . 64.4 mtm -132.74 -5.47 3.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.145 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -90.93 80.33 5.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.021 0.439 . . . . 0.0 111.253 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -152.12 137.34 17.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.976 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 42.7 tt0 177.36 158.17 0.37 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.414 ' HB3' ' O ' ' A' ' 19' ' ' GLU . 18.6 t80 76.81 -47.34 0.52 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.108 0.563 . . . . 0.0 111.278 174.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 167' ' ' TRP . 79.9 m-85 51.35 55.46 9.42 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 173.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.409 ' HB2' ' CE2' ' A' ' 20' ' ' TYR . 32.0 t0 -91.1 84.42 5.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.708 HH22 ' HG2' ' A' ' 71' ' ' MET . 62.7 mtm180 59.89 82.15 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.192 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -121.23 117.59 27.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.496 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG13 HG22 ' A' ' 40' ' ' ILE . 58.1 t 69.04 134.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.684 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.49 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.8 tp -134.97 -58.89 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.887 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.49 ' HD1' HG13 ' A' ' 26' ' ' ILE . 1.8 p90 -179.23 177.8 0.75 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.011 0.434 . . . . 0.0 111.805 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.9 mm -94.02 125.31 46.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.217 174.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.5 m -89.93 -41.01 12.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -171.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.47 145.29 35.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.209 0.528 . . . . 0.0 110.804 -176.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -122.48 103.61 8.82 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -112.27 166.38 11.33 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.926 -171.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -79.14 -12.34 59.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.384 0.611 . . . . 0.0 109.766 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -86.68 -36.63 18.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.307 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.82 178.88 48.88 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.13 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 133' ' ' THR . 18.0 m -107.26 118.27 36.27 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.615 HG12 HG22 ' A' ' 133' ' ' THR . 56.8 mt -103.4 113.07 39.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.865 0.364 . . . . 0.0 111.424 -170.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.76 164.95 29.6 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.764 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.32 96.23 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.609 0.719 . . . . 0.0 111.685 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.602 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -129.8 17.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.463 177.666 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 74' ' ' ASN . 9.3 tp -54.89 -30.61 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.602 -172.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' O ' ' HB ' ' A' ' 43' ' ' THR . 49.2 t30 60.71 71.18 0.58 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.47 0.308 . . . . 0.0 111.279 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 14.8 t 178.31 117.64 0.19 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 121.583 0.706 . . . . 0.0 111.425 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 1.2 Cg_endo -85.49 157.3 10.75 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.174 2.583 . . . . 0.0 111.09 171.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 74' ' ' ASN . 10.6 p -96.74 175.72 6.26 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.82 -29.29 40.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 110.526 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.4 tp -68.58 148.49 50.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.604 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.748 ' HB3' ' HG2' ' A' ' 51' ' ' GLU . 17.1 t -104.82 152.86 22.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.618 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -64.44 -31.94 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.068 0.461 . . . . 0.0 109.951 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 65' ' ' ILE . 27.8 mt -75.03 -26.26 59.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.089 0.471 . . . . 0.0 110.321 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.748 ' HG2' ' HB3' ' A' ' 48' ' ' SER . 45.8 mm-40 -64.22 -36.62 84.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.563 176.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.29 -35.18 76.63 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.536 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.16 -39.5 63.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 56' ' ' MET . 20.9 p -70.59 -29.69 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 0.0 110.575 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 tpt85 -61.19 -29.55 69.88 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.932 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 54' ' ' THR . 62.6 mtm 68.61 17.51 8.96 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.765 173.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -93.84 88.8 5.89 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.56 ' CZ ' ' HB2' ' A' ' 62' ' ' LYS . 6.5 p90 -146.14 176.79 9.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.362 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.772 ' HB3' ' HA3' ' A' ' 110' ' ' GLY . 65.1 tt0 -98.64 74.66 2.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.865 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.3 mtp 66.82 167.96 0.23 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.162 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 68.67 101.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.113 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.56 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 27.5 tptp -117.74 89.14 32.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.557 170.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.516 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . 83.9 Cg_endo -95.94 -175.92 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.058 2.506 . . . . 0.0 112.544 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.566 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -89.73 131.76 35.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.315 175.761 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.516 HG21 HD22 ' A' ' 50' ' ' LEU . 7.0 tp -97.67 -30.53 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.466 -177.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.2 t80 64.26 -169.96 0.19 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.732 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.768 HG22 ' H ' ' A' ' 68' ' ' GLN . 1.5 m 65.54 -165.28 0.23 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.768 ' H ' HG22 ' A' ' 67' ' ' THR . 40.5 mt-30 -105.93 -178.26 3.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.166 0.508 . . . . 0.0 111.737 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.95 141.88 31.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.554 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -133.52 124.54 27.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.323 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.708 ' HG2' HH22 ' A' ' 23' ' ' ARG . 0.0 OUTLIER -68.12 133.49 49.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.251 0.548 . . . . 0.0 110.8 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.619 HG23 HG13 ' A' ' 127' ' ' VAL . 11.7 p -82.94 149.91 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.197 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.8 mp -93.55 157.86 15.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.273 0.559 . . . . 0.0 111.935 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.588 ' O ' HG21 ' A' ' 41' ' ' ILE . 3.1 t-20 -101.06 87.24 3.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.968 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.34 -32.39 80.69 Favored Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.844 -169.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.93 173.98 33.22 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.991 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.34 -22.97 12.09 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.741 2.294 . . . . 0.0 113.074 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.484 HG21 ' OG1' ' A' ' 133' ' ' THR . 59.4 t -81.21 117.56 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.378 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 62.79 32.87 15.73 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 123.704 0.628 . . . . 0.0 110.467 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HA ' ' HA3' ' A' ' 130' ' ' GLY . 52.6 tt0 -61.86 -22.15 65.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.719 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -82.21 -1.55 49.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -113.95 140.88 48.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.52 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.09 118.4 6.12 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -100.86 125.96 47.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.21 114.04 44.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 110.328 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.533 HG22 HD13 ' A' ' 106' ' ' LEU . 34.7 t -100.3 122.56 52.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.441 177.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -136.47 160.97 37.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.639 0.257 . . . . 0.0 110.971 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.9 m -73.75 177.7 5.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.608 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -51.62 113.83 1.09 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 110.827 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.0 m -121.54 117.57 27.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 -176.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.8 -152.57 0.39 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.743 0.652 . . . . 0.0 109.327 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -137.33 18.88 2.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.163 0.506 . . . . 0.0 110.645 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.87 168.6 11.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.012 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -175.2 146.07 0.82 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.151 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.443 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 90.6 m -89.87 -56.66 3.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.065 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -158.31 104.7 1.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.1 m -116.98 159.17 22.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.811 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -108.33 116.5 32.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.0 tttm -75.92 102.41 5.56 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.997 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.3 t -81.21 -54.11 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.465 ' OG1' HG12 ' A' ' 104' ' ' ILE . 70.8 p -130.04 -162.78 1.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -86.32 4.76 37.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.932 0.396 . . . . 0.0 110.424 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -134.66 -48.95 0.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.363 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.74 HD12 ' HD2' ' A' ' 159' ' ' PHE . 24.2 mm -68.99 122.01 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.714 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.9 m -123.64 116.8 23.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.073 -174.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.533 HD13 HG22 ' A' ' 86' ' ' VAL . 56.1 tp -96.88 128.84 44.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.073 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.573 HG21 ' HB3' ' A' ' 111' ' ' ASP . 26.6 m -128.89 130.96 47.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.3 p -109.03 -12.21 14.87 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 p -101.5 -172.21 2.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.093 0.473 . . . . 0.0 111.798 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.772 ' HA3' ' HB3' ' A' ' 59' ' ' GLN . . . -74.83 7.48 20.5 Favored Glycine 0 C--O 1.227 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.675 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.573 ' HB3' HG21 ' A' ' 107' ' ' THR . 18.2 t0 -64.43 -28.66 69.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.552 0.692 . . . . 0.0 109.698 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.13 -37.18 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.66 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.507 HD23 ' HA2' ' A' ' 110' ' ' GLY . 4.0 mm? -63.66 -34.68 78.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.803 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -80.17 -27.53 38.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.062 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -60.64 -42.37 96.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -104.45 170.31 7.97 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.224 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.516 ' HA3' ' HB2' ' A' ' 63' ' ' PRO . . . 81.27 11.54 83.31 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.036 -177.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.5 t -127.98 168.27 15.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -77.8 -5.05 49.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.048 0.451 . . . . 0.0 110.789 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 p -113.14 27.73 9.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.019 0.438 . . . . 0.0 110.628 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.47 160.37 25.51 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.721 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.8 146.14 29.57 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.4 2.067 . . . . 0.0 111.954 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.465 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 88.6 mt-10 -58.64 -53.12 61.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.161 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 123' ' ' GLU . 9.9 mtmt -139.32 153.69 47.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.985 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -155.01 134.96 12.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.836 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.443 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 24.8 pt -110.57 133.03 57.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.117 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.619 HG13 HG23 ' A' ' 72' ' ' VAL . 5.7 p -119.77 128.17 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.151 0.5 . . . . 0.0 110.725 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 22.6 p -133.19 135.66 45.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.49 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.409 HD23 HG21 ' A' ' 72' ' ' VAL . 4.0 mm? -87.9 108.85 19.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.841 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 80' ' ' GLN . . . 79.2 174.44 45.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.83 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 63.4 m -144.45 168.9 19.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.0 m -105.6 130.72 53.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.183 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.615 HG22 HG12 ' A' ' 37' ' ' ILE . 66.9 p -118.37 125.55 50.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.514 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 27.1 m-90 -82.88 178.88 7.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 167.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 138' ' ' GLN . 1.5 mptm? -74.74 159.95 81.99 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 168.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.56 111.17 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.968 1.779 . . . . 0.0 111.744 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 74.97 8.69 4.08 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.726 174.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 31.1 tt0 -64.24 -36.27 83.54 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.589 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 143' ' ' ILE . 49.3 tp -53.7 -29.62 39.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.976 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.76 -38.99 92.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.82 0.343 . . . . 0.0 110.569 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -69.53 -31.67 70.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.258 0.551 . . . . 0.0 110.3 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -70.14 -43.76 70.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.177 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.445 HG12 ' HB2' ' A' ' 148' ' ' TRP . 74.3 mt -67.98 -31.51 52.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.21 -22.34 60.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.57 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -71.87 -4.56 28.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.513 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 65.19 23.92 12.31 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.272 0.629 . . . . 0.0 111.97 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -96.84 -36.02 10.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.585 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.477 ' CH2' HG23 ' A' ' 13' ' ' THR . 92.9 m95 -92.26 127.84 37.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.679 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 tt -100.69 110.51 22.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.1 tp -82.6 134.53 35.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.539 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.5 p -152.14 144.12 23.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.097 175.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.94 ' HB2' ' HD2' ' A' ' 8' ' ' LYS . 15.9 pt-20 -113.5 153.82 28.08 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.618 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -115.17 152.79 31.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.177 -174.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -94.87 -59.53 1.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.514 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -168.52 -47.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.142 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -52.93 -45.87 67.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.874 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 173' ' ' MET . 0.2 OUTLIER -56.89 -29.18 62.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.172 -177.201 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.461 HD12 HG13 ' A' ' 104' ' ' ILE . 84.1 mt -89.51 -50.89 5.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -174.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.74 ' HD2' HD12 ' A' ' 104' ' ' ILE . 11.8 m-85 -124.78 -0.2 8.01 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -174.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -89.7 -57.65 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.0 m -82.53 79.87 8.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.2 t -152.05 95.12 2.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.784 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 53.7 t80 64.94 71.89 0.45 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.012 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 165' ' ' ASP . 0.2 OUTLIER -102.69 -59.36 1.72 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 171.586 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.431 ' H ' ' HG ' ' A' ' 164' ' ' LEU . 20.9 t70 178.65 67.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.529 ' HB3' ' HB3' ' A' ' 169' ' ' GLU . 13.0 tpt180 -166.97 140.91 3.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.478 -177.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 50.7 m0 -86.24 -34.6 20.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.276 0.56 . . . . 0.0 110.228 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.412 ' HB ' ' OD1' ' A' ' 171' ' ' ASN . 11.3 m -116.75 46.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.271 -176.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 166' ' ' ARG . 5.4 pt-20 -77.48 -18.75 56.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.502 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.88 -57.42 9.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.086 0.469 . . . . 0.0 111.207 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.412 ' OD1' ' HB ' ' A' ' 168' ' ' VAL . 3.8 p-10 -68.89 -25.53 64.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.416 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.85 -25.15 65.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.256 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.702 ' HG3' HG23 ' A' ' 157' ' ' THR . 1.5 tmt? -58.69 -36.6 74.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.441 0.639 . . . . 0.0 109.418 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 11' ' ' ILE . 11.8 tp -84.43 -38.44 20.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.775 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 93.95 -3.18 70.12 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.487 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 22.6 mt 58.43 71.38 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.362 0.601 . . . . 0.0 110.386 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.7 m -157.76 -178.52 7.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.97 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.25 -88.23 0.94 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.974 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.62 HG12 HD12 ' A' ' 180' ' ' LEU . 17.3 tt -163.95 158.9 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.62 HD12 HG12 ' A' ' 179' ' ' ILE . 6.5 mp 68.06 157.05 0.13 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.317 0.647 . . . . 0.0 111.152 -172.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 52.79 66.8 4.46 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.307 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.88 -20.54 19.6 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.747 2.298 . . . . 0.0 112.24 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -154.54 122.68 5.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.723 ' H ' HD11 ' A' ' 187' ' ' LEU . . . -93.7 -169.73 38.61 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 172.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 185' ' ' ARG . 0.1 OUTLIER -95.18 -50.34 5.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.441 0.621 . . . . 0.0 110.451 -179.631 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -88.84 73.6 8.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.146 0.498 . . . . 0.0 110.717 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . 0.723 HD11 ' H ' ' A' ' 184' ' ' GLY . 85.4 mt -110.83 -35.02 6.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.94 177.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 . . . . . 0 C--O 1.249 1.037 0 O-C-N 123.666 0.604 . . . . 0.0 110.116 -176.518 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.792 0.329 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.48 ' HB3' ' CD2' ' A' ' 150' ' ' LEU . 37.4 p90 -140.21 27.31 2.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.79 57.39 3.05 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 116.011 -0.541 . . . . 0.0 113.003 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -166.6 -55.0 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.0 mt 57.44 -149.9 0.45 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.506 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 64.38 104.88 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.563 0.697 . . . . 0.0 111.154 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.73 -4.0 68.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.667 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -113.49 168.24 9.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 41.6 p90 -134.8 155.91 49.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.025 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.8 pt -129.53 128.03 65.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.23 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 58.6 mt -88.16 132.31 33.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.396 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.467 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -125.7 143.96 50.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.932 176.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 183' ' ' ALA . 7.9 m -63.54 114.68 13.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 123.291 0.369 . . . . 0.0 110.71 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.76 151.23 28.02 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.543 2.162 . . . . 0.0 112.058 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -77.3 -80.5 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 49.9 ttp -166.66 119.4 1.01 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.216 0.532 . . . . 0.0 111.714 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.682 ' HB3' ' HG3' ' A' ' 19' ' ' GLU . 6.3 t70 -148.34 -166.51 2.56 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.669 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 58.3 m-20 -94.14 -43.19 8.59 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.682 ' HG3' ' HB3' ' A' ' 17' ' ' ASP . 35.1 mt-10 44.97 73.39 0.16 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.208 0.943 . . . . 0.0 111.944 173.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.887 ' HA ' ' HD1' ' A' ' 167' ' ' TRP . 32.6 m-85 -109.45 -64.38 1.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 111.435 -176.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -117.0 43.94 2.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.3 0.572 . . . . 0.0 110.524 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.659 ' O ' ' HD2' ' A' ' 23' ' ' ARG . 4.9 t70 -127.71 -174.74 3.27 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.379 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.659 ' HD2' ' O ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -127.53 81.12 2.0 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.354 0.597 . . . . 0.0 110.02 175.748 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.545 HG21 ' HG2' ' A' ' 19' ' ' GLU . 29.6 p -90.2 124.49 34.9 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.795 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t 66.86 87.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.503 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.584 HG13 ' N ' ' A' ' 27' ' ' TYR . 7.0 tp -119.02 -117.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.134 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.584 ' N ' HG13 ' A' ' 26' ' ' ILE . 4.5 p90 -118.62 170.33 9.05 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.835 1.198 . . . . 0.0 113.055 -165.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.1 mm -87.73 121.49 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.528 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.3 m -85.57 -41.12 15.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.956 0.407 . . . . 0.0 111.308 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HB3' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -142.11 151.83 42.67 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -149.65 105.03 3.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.469 0.652 . . . . 0.0 111.487 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -129.78 162.78 27.67 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.46 170.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.58 -24.13 64.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.268 0.556 . . . . 0.0 109.853 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -77.07 -9.76 58.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.933 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 164.45 129.62 1.06 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.777 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 133' ' ' THR . 88.5 m -103.86 117.8 35.2 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.574 HG23 ' HB3' ' A' ' 131' ' ' CYS . 3.8 mp -101.39 118.25 47.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.583 -175.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.94 139.64 7.66 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.794 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.665 HG12 ' HA2' ' A' ' 75' ' ' GLY . 2.4 m -92.1 77.31 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.972 0.891 . . . . 0.0 110.201 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.47 HD12 ' CH2' ' A' ' 148' ' ' TRP . 25.1 pt -126.51 4.83 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.815 -172.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.2 pt -73.39 -18.84 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -175.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.469 ' O ' ' HB ' ' A' ' 43' ' ' THR . 47.1 t-20 64.51 89.13 0.1 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.613 0.571 . . . . 0.0 111.618 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 74' ' ' ASN . 10.0 t 173.85 127.74 0.11 Allowed Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.712 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.57 154.35 9.03 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.653 2.236 . . . . 0.0 110.732 169.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.3 p -88.14 177.53 6.88 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.385 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -84.8 -17.54 37.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.114 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.66 152.76 22.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.791 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 55.7 p -102.05 157.26 17.0 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.644 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.499 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 12.1 p -64.66 -32.78 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.033 0.444 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -70.93 -31.95 68.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.865 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.26 -43.97 96.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.1 pp -76.49 -32.49 58.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.042 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 67.6 mt -65.67 -37.89 87.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.302 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.6 p -78.72 -30.76 46.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.863 0.364 . . . . 0.0 111.072 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -63.83 -48.07 78.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.814 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.6 mmt -82.12 -33.01 29.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.533 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.606 ' OD1' ' HG3' ' A' ' 60' ' ' MET . 11.3 t70 68.02 123.63 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.89 0.852 . . . . 0.0 111.689 -172.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.559 ' HE2' ' HD3' ' A' ' 62' ' ' LYS . 36.6 p90 -113.79 -19.86 11.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.918 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 174.07 -39.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.606 ' HG3' ' OD1' ' A' ' 57' ' ' ASP . 66.6 mtt 63.72 84.49 0.15 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.698 -175.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.53 -42.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.0 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.559 ' HD3' ' HE2' ' A' ' 58' ' ' PHE . 13.5 mptt -58.99 146.77 76.09 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.911 177.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 24.8 Cg_exo -64.18 142.3 79.62 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.182 2.588 . . . . 0.0 113.337 -175.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.8 mtm-85 -125.67 115.7 20.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.704 HD12 ' HB3' ' A' ' 68' ' ' GLN . 4.8 pt -127.52 123.42 61.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.128 0.489 . . . . 0.0 111.127 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -82.01 46.94 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.007 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.2 m -158.24 -57.85 0.07 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 0.0 110.479 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.704 ' HB3' HD12 ' A' ' 65' ' ' ILE . 27.8 tt0 -101.73 53.0 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.64 0.733 . . . . 0.0 109.635 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.81 171.43 8.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.276 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 14.5 mm-40 -116.58 132.43 56.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.186 -178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 58.8 mtm -82.81 151.35 26.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.526 HG23 HG22 ' A' ' 127' ' ' VAL . 11.0 p -95.54 133.75 35.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.977 0.417 . . . . 0.0 110.195 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.579 HD21 ' OD1' ' A' ' 22' ' ' ASP . 13.4 mt -72.29 157.75 37.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.004 0.43 . . . . 0.0 111.666 -176.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.481 ' HB3' HG23 ' A' ' 43' ' ' THR . 7.8 t-20 -98.4 113.16 25.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.254 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.665 ' HA2' HG12 ' A' ' 39' ' ' VAL . . . -79.24 -36.24 27.87 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.06 -178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.81 174.62 28.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.894 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.35 -11.87 27.0 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.887 2.391 . . . . 0.0 113.484 -174.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.44 132.01 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.37 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 65.86 39.26 4.71 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.236 0.335 . . . . 0.0 111.582 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -65.76 -21.66 66.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.91 7.65 43.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.741 0.782 . . . . 0.0 109.834 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.37 140.64 49.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.01 129.66 9.86 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.619 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB3' HD11 ' A' ' 106' ' ' LEU . 21.3 m-85 -115.19 125.03 52.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.71 ' HB ' HG21 ' A' ' 112' ' ' VAL . 4.7 mp -131.26 122.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.554 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.623 HG22 HD13 ' A' ' 106' ' ' LEU . 7.3 t -95.18 131.4 42.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -137.96 160.27 39.78 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.465 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.7 m -63.22 145.5 55.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.237 0.542 . . . . 0.0 111.63 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -63.55 124.28 20.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.331 174.449 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -117.88 -176.54 3.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -174.226 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.752 ' HB2' HG21 ' A' ' 120' ' ' THR . 6.8 m-20 -79.78 -35.53 38.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -172.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.546 ' HE1' ' HA ' ' A' ' 115' ' ' SER . 10.1 p-80 -87.07 175.54 8.05 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.979 -173.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.39 169.18 3.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.759 0.79 . . . . 0.0 112.269 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -153.91 113.98 3.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.718 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.5 m -72.87 -77.36 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.154 -169.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -109.03 83.72 1.8 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.323 0.583 . . . . 0.0 110.844 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.3 m -126.04 151.8 46.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.156 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.32 102.0 12.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -69.95 115.7 9.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.77 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.79 -54.47 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.612 177.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.459 HG23 ' H ' ' A' ' 102' ' ' ASP . 2.3 t -131.19 -54.46 1.04 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.959 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' H ' HG23 ' A' ' 101' ' ' THR . 11.8 t70 173.45 -64.01 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 5.7 m-20 -62.77 -26.83 68.9 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.77 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.9 mm -99.51 122.26 51.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -129.2 114.76 16.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.945 0.402 . . . . 0.0 111.466 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.623 HD13 HG22 ' A' ' 86' ' ' VAL . 21.8 tp -93.99 112.19 23.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.794 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.829 HG21 ' HB3' ' A' ' 111' ' ' ASP . 29.8 m -99.96 127.67 46.13 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.07 0.462 . . . . 0.0 110.907 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.8 p -102.16 23.88 10.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.038 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.496 ' H ' HG22 ' A' ' 107' ' ' THR . 34.2 m -151.38 -177.74 6.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.395 -176.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.81 11.75 5.61 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.341 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.829 ' HB3' HG21 ' A' ' 107' ' ' THR . 14.7 t70 -63.42 -30.23 71.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.853 0.835 . . . . 0.0 109.708 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.71 HG21 ' HB ' ' A' ' 85' ' ' ILE . 40.8 t -54.79 -45.44 74.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.609 174.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.405 ' HG ' ' CB ' ' A' ' 58' ' ' PHE . 3.2 mm? -69.38 -33.8 73.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.612 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.58 -41.39 94.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.967 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.584 ' HB3' ' HD3' ' A' ' 122' ' ' PRO . 49.1 m -59.08 -39.66 82.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.761 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.18 4.66 25.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.996 0.427 . . . . 0.0 111.219 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.29 17.4 28.98 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.975 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.3 t -142.58 179.26 7.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -62.55 -32.33 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.851 0.357 . . . . 0.0 110.959 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.752 HG21 ' HB2' ' A' ' 91' ' ' ASP . 23.4 p -92.49 43.1 1.12 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.848 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -56.89 123.65 60.1 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.765 168.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 115' ' ' SER . 27.0 Cg_endo -61.27 129.52 28.69 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.824 2.349 . . . . 0.0 112.558 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.44 -45.82 92.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.875 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -114.14 142.07 46.69 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.6 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -161.29 143.08 11.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.569 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.03 132.6 69.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.232 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 72' ' ' VAL . 7.3 p -115.01 131.07 68.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.113 0.482 . . . . 0.0 110.993 -176.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 8.9 p -142.98 146.46 33.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.456 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mt -102.33 142.81 32.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.83 179.73 7.41 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.074 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.574 ' HB3' HG23 ' A' ' 37' ' ' ILE . 61.9 m -149.14 162.72 39.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.077 0.465 . . . . 0.0 109.977 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -114.03 117.07 30.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.464 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' THR . 17.9 p -107.66 116.38 31.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.234 0.54 . . . . 0.0 112.004 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.653 ' CD1' ' HB2' ' A' ' 139' ' ' LEU . 0.6 OUTLIER -101.23 151.38 21.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.971 177.086 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 11.4 mptt -105.49 137.33 19.26 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.325 -174.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 7.8 Cg_exo -72.09 92.26 0.73 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.379 2.719 . . . . 0.0 112.818 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' HIS . . . . . 0.462 ' HB3' ' O ' ' A' ' 136' ' ' PRO . 13.6 p80 170.85 -18.66 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.125 176.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.593 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 56.9 tp60 -110.32 -58.88 2.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 171.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.653 ' HB2' ' CD1' ' A' ' 134' ' ' TRP . 53.5 tp -56.89 -53.11 61.71 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -172.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -35.94 77.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -173.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.441 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 11.5 mt-30 -74.94 -36.22 62.14 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.45 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 7.6 mm-40 -65.81 -41.96 91.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.756 0.312 . . . . 0.0 110.305 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 139' ' ' LEU . 71.2 mt -62.19 -42.44 95.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.44 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.68 99.25 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.233 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 41.8 mt-30 -78.8 3.56 16.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.02 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 67.35 37.52 3.53 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 175.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -72.84 -28.41 62.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 164.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' TRP . . . . . 0.47 ' CH2' HD12 ' A' ' 40' ' ' ILE . 74.6 m95 -116.4 149.81 38.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.0 -1.454 . . . . 0.0 108.991 175.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.623 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.0 tt -104.6 110.1 22.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.48 ' CD2' ' HB3' ' A' ' 2' ' ' PHE . 34.0 tp -82.03 135.46 35.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 111.228 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.2 m -143.87 156.04 44.31 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 152' ' ' GLU . 0.7 OUTLIER -98.09 153.74 18.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.385 0.612 . . . . 0.0 111.401 -175.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.18 155.4 40.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.33 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -119.01 -62.36 1.53 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.786 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -161.8 -38.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 44.4 mt-30 -54.85 -56.43 19.58 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.2 m -55.12 -28.17 50.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.424 0.63 . . . . 0.0 111.063 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.8 mt -81.31 -54.57 5.38 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.849 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PHE . . . . . 0.455 ' HZ ' ' HB ' ' A' ' 86' ' ' VAL . 71.1 m-85 -133.51 17.66 3.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -172.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 28.6 tt0 -110.65 -48.36 3.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.268 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.479 ' HA ' HD11 ' A' ' 164' ' ' LEU . 0.8 OUTLIER -90.56 -9.46 47.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.055 0.455 . . . . 0.0 111.185 179.225 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.2 t -60.12 136.65 58.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.112 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 72.1 t80 75.2 -44.29 0.53 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.807 0.843 . . . . 0.0 112.554 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' A' ' 161' ' ' THR . 4.0 pp -81.54 -14.79 56.45 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.583 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -87.44 -161.39 0.69 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -115.52 -135.79 0.35 Allowed 'General case' 0 C--O 1.214 -0.774 0 O-C-N 122.111 -0.368 . . . . 0.0 111.164 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.887 ' HD1' ' HA ' ' A' ' 20' ' ' TYR . 2.2 m-90 -57.92 -89.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -168.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.6 m -111.76 91.98 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.334 0.588 . . . . 0.0 111.535 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 173' ' ' MET . 13.2 pt-20 -71.21 -29.22 64.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.723 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.24 91.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.979 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.58 ' OD1' ' HA ' ' A' ' 176' ' ' ILE . 11.1 t-20 -71.99 -31.99 66.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.399 0.619 . . . . 0.0 109.593 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.61 -21.91 61.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.16 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.484 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 23.6 mmt -58.27 -33.74 69.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.465 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.5 tt -117.02 -52.83 2.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.183 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 157.73 115.97 0.47 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.585 HD12 ' H ' ' A' ' 176' ' ' ILE . 3.1 mp -48.16 108.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 O-C-N 124.105 0.532 . . . . 0.0 110.572 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 39.7 m 74.58 98.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.46 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.81 -139.5 10.65 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.863 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.568 HD13 ' HG ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -106.42 137.38 37.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.678 0.275 . . . . 0.0 110.619 -175.33 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.568 ' HG ' HD13 ' A' ' 179' ' ' ILE . 31.3 mt 61.96 64.34 1.01 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.245 -176.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -111.57 108.61 56.26 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.05 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -89.34 114.04 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.914 2.41 . . . . 0.0 112.704 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.477 ' HA ' HG21 ' A' ' 13' ' ' THR . . . -81.38 -13.35 58.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.483 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -84.73 61.85 4.63 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.788 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 188' ' ' GLU . 50.6 ttt-85 -139.23 91.37 2.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.859 0.362 . . . . 0.0 110.411 176.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -96.93 -47.23 5.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 96.2 mt -136.33 155.9 49.41 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.374 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 185' ' ' ARG . 47.1 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.838 -0.601 . . . . 0.0 109.832 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 . . . . . 0 C--O 1.234 0.237 0 CA-C-O 121.593 0.711 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 91.8 mt -82.25 -3.03 54.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.153 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.605 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -65.1 135.65 55.79 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.88 12.82 83.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.961 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.552 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 43.2 mmtm -112.8 163.4 14.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -140.28 150.45 44.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.04 0.448 . . . . 0.0 110.382 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.523 HD11 HG13 ' A' ' 40' ' ' ILE . 8.4 pt -116.06 129.14 72.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.851 -177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.74 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.0 mp -86.37 103.83 13.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -94.8 -54.37 3.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.426 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.86 -178.163 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 121.708 0.766 . . . . 0.0 112.593 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.409 ' O ' ' HB ' ' A' ' 25' ' ' VAL . 1.1 t -140.45 110.89 6.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.391 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.563 HG13 HG22 ' A' ' 40' ' ' ILE . 90.2 t 73.55 140.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 122.844 0.458 . . . . 0.0 110.918 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.564 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.3 tp -135.19 -58.42 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.564 ' HD1' HG13 ' A' ' 26' ' ' ILE . 20.4 p90 -168.05 171.44 9.62 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.647 0.658 . . . . 0.0 112.134 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.68 133.75 40.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.195 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.8 m -75.97 -52.6 9.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.03 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 6' ' ' GLN . 13.7 pt-20 -161.1 169.91 21.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.131 0.491 . . . . 0.0 111.752 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 37.6 t-80 -134.16 111.03 9.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.636 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -128.25 170.16 13.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.495 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.33 -31.97 73.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.133 0.492 . . . . 0.0 110.85 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -74.57 -18.11 60.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.857 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.31 -177.52 30.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.659 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.0 m -113.27 117.62 32.35 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.665 HG13 HG22 ' A' ' 133' ' ' THR . 3.9 mp -96.28 124.85 49.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.44 164.73 34.65 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.037 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.38 81.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.443 0.64 . . . . 0.0 110.355 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.563 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -133.97 6.65 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.431 -176.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.9 tp -70.59 -35.9 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 120.506 0.193 . . . . 0.0 111.247 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 63.97 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.182 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.495 HG23 ' HB2' ' A' ' 74' ' ' ASN . 4.1 t -161.34 91.52 1.49 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 121.714 0.768 . . . . 0.0 110.062 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 58.6 Cg_endo -72.85 154.56 53.63 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.719 2.279 . . . . 0.0 112.058 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.1 p -114.95 167.98 10.31 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.46 -0.63 47.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 0.0 111.595 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.648 HD21 ' HB3' ' A' ' 52' ' ' LEU . 35.1 tp -92.4 152.38 19.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.9 0.381 . . . . 0.0 110.143 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.721 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 12.8 m -109.08 154.48 22.2 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 7.4 p -61.28 -45.56 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.237 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.594 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 90.3 mt -75.67 -25.82 57.12 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.407 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.721 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.5 OUTLIER -57.36 -53.47 57.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.097 178.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HB3' HD21 ' A' ' 47' ' ' LEU . 3.8 pp -66.66 -36.52 82.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.04 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.69 -51.63 64.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.779 0.323 . . . . 0.0 111.105 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.7 p -72.49 -29.46 63.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.057 0.456 . . . . 0.0 111.186 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -69.61 -37.2 76.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.584 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.471 ' HG3' ' O ' ' A' ' 52' ' ' LEU . 65.2 mtt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.928 0.394 . . . . 0.0 111.918 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.594 ' OD2' ' HB2' ' A' ' 50' ' ' LEU . 6.0 t0 . . . . . 0 C--O 1.233 0.233 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -118.34 137.11 53.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 23.3 mmt -81.93 140.44 34.04 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.353 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.46 HG23 HG13 ' A' ' 127' ' ' VAL . 14.2 p -93.94 137.71 22.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.012 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.1 mp -106.48 155.11 19.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.513 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.495 ' HB2' HG23 ' A' ' 43' ' ' THR . 44.2 m-20 -89.42 127.72 35.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.52 -15.0 69.5 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.178 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.22 175.12 29.8 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.66 -12.19 20.27 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.651 2.234 . . . . 0.0 112.719 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.95 145.38 9.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.514 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 64.9 30.7 11.92 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.504 0.321 . . . . 0.0 111.618 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.644 HE21 ' HA ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -65.78 -9.19 26.18 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.045 0.45 . . . . 0.0 111.314 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.1 -19.99 60.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.303 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -134.77 143.16 46.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 111.413 -171.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.14 122.6 7.28 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.597 ' HB3' HD11 ' A' ' 106' ' ' LEU . 92.9 m-85 -96.97 126.12 41.88 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.631 0.253 . . . . 0.0 110.426 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.47 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.6 mp -111.35 115.16 49.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.189 0.518 . . . . 0.0 110.479 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.426 HG22 HD13 ' A' ' 106' ' ' LEU . 31.2 t -94.24 124.42 46.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.309 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -139.51 166.84 23.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.882 0.373 . . . . 0.0 111.195 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.3 p -93.16 174.12 7.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.064 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.55 ' HG3' ' OD1' ' A' ' 103' ' ' ASP . 21.7 mmtp -57.6 134.81 56.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 172.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.624 ' OG1' ' HA ' ' A' ' 122' ' ' PRO . 81.9 m -155.05 114.68 3.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.663 173.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.3 t70 59.68 -147.89 0.47 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.993 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -126.65 36.25 4.5 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.86 -0.525 . . . . 0.0 112.378 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 94' ' ' PHE . 40.2 mm-40 -90.52 161.0 15.69 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.348 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 27.0 t80 167.59 102.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.789 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.4 m -121.26 -55.05 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.974 0.416 . . . . 0.0 110.913 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.74 ' HB2' ' HB2' ' A' ' 111' ' ' ASP . 9.6 m-70 -127.08 70.98 1.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.418 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' A' ' 94' ' ' PHE . 66.4 m -128.51 139.51 52.28 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.111 0.482 . . . . 0.0 111.036 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -102.91 133.35 48.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.548 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -76.31 113.49 13.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.111 0.481 . . . . 0.0 111.943 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.54 -53.73 9.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 166.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.773 HG22 ' HB ' ' A' ' 104' ' ' ILE . 6.3 t -142.72 -164.05 1.75 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.448 ' O ' ' HE3' ' A' ' 89' ' ' LYS . 10.5 t70 -67.42 -53.29 30.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.572 0.623 . . . . 0.0 111.272 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.55 ' OD1' ' HG3' ' A' ' 89' ' ' LYS . 91.8 m-20 -84.18 -34.26 24.01 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.773 ' HB ' HG22 ' A' ' 101' ' ' THR . 46.8 mm -81.48 121.64 35.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.097 0.475 . . . . 0.0 110.226 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.14 128.96 50.03 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.749 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 84' ' ' PHE . 54.8 tp -96.87 112.43 24.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.242 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.615 ' CG2' ' HB3' ' A' ' 111' ' ' ASP . 10.8 m -118.69 128.43 54.5 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -132.91 -29.67 1.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 t -112.37 104.71 12.87 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.459 -0.497 . . . . 0.0 112.024 -172.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.88 -53.4 2.93 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.74 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 15.4 t0 -56.3 -34.48 66.54 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.89 0.476 . . . . 0.0 112.201 -170.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.652 HG23 HD22 ' A' ' 113' ' ' LEU . 3.7 m -59.2 -34.9 55.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.652 HD22 HG23 ' A' ' 112' ' ' VAL . 2.7 mm? -70.64 -27.29 63.94 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.437 0.637 . . . . 0.0 110.24 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.2 -33.54 56.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.288 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.44 ' HB3' ' HD3' ' A' ' 122' ' ' PRO . 20.2 m -60.82 -67.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.967 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.553 ' HA ' ' HB2' ' A' ' 121' ' ' ALA . 8.4 p90 -79.45 140.18 37.43 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.006 0.431 . . . . 0.0 111.055 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.74 -17.71 9.35 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 t -131.89 178.87 6.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -77.66 1.68 19.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -174.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.6 p -99.8 14.55 29.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.451 0.643 . . . . 0.0 110.828 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -71.52 130.93 86.8 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.473 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.624 ' HA ' ' OG1' ' A' ' 90' ' ' THR . 17.4 Cg_exo -63.95 140.09 71.06 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.542 2.161 . . . . 0.0 111.985 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -55.12 -51.35 66.71 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.152 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.548 ' HB2' ' HE2' ' A' ' 159' ' ' PHE . 67.2 mmtt -128.06 138.22 52.47 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.607 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -154.04 144.33 22.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.492 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 28.8 pt -122.27 144.45 31.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.004 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.46 HG13 HG23 ' A' ' 72' ' ' VAL . 7.4 p -119.39 134.29 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.154 0.502 . . . . 0.0 111.197 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 70.2 m -139.11 131.91 29.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.376 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.6 116.77 23.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.188 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.98 -177.33 50.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.388 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 64.1 m -150.41 169.39 21.55 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.168 0.587 . . . . 0.0 109.434 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.6 m -106.88 139.67 40.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.65 0.262 . . . . 0.0 110.502 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.665 HG22 HG13 ' A' ' 37' ' ' ILE . 27.5 p -117.55 114.22 23.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.037 0.446 . . . . 0.0 110.668 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -83.67 156.2 22.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.263 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.401 ' HB2' ' CB ' ' A' ' 138' ' ' GLN . 72.1 mmtt -58.57 141.47 84.04 Favored Pre-proline 0 C--O 1.237 0.441 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.355 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.97 119.89 7.44 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.746 2.297 . . . . 0.0 112.319 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.476 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 58.4 t60 74.83 -9.19 1.39 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.262 174.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.401 ' CB ' ' HB2' ' A' ' 135' ' ' LYS . 47.3 tt0 -66.68 -51.01 60.99 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.158 -0.339 . . . . 0.0 111.29 -177.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 143' ' ' ILE . 47.7 tp -54.41 -35.93 63.43 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.476 ' OE2' ' HA ' ' A' ' 137' ' ' HIS . 45.3 mt-10 -57.8 -43.26 85.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.061 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 8.5 mt-30 -72.39 -38.1 68.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.478 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.64 -40.56 97.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.583 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 139' ' ' LEU . 76.1 mt -65.77 -33.01 60.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.249 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.07 64.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.059 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 75.2 mt-30 -75.97 -8.17 56.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.389 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 65.65 30.67 10.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.078 -173.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -87.74 -18.29 29.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.592 0.711 . . . . 0.0 109.477 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.413 ' HZ3' ' HB2' ' A' ' 12' ' ' ALA . 93.5 m95 -125.62 137.49 53.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.474 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.74 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 58.0 mt -92.37 108.31 19.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.071 0.462 . . . . 0.0 109.9 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.0 tp -91.45 134.05 34.96 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.927 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.0 t -149.7 148.0 28.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 8' ' ' LYS . 1.7 mp0 -85.5 152.62 23.04 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.928 0.394 . . . . 0.0 110.178 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.35 104.15 13.21 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -80.29 77.01 7.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.8 t30 49.97 -83.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.275 0.985 . . . . 0.0 112.889 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.06 -35.58 80.73 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.545 0.212 . . . . 0.0 110.772 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.0 m -58.58 -30.3 67.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.858 0.361 . . . . 0.0 111.385 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 tt -67.0 -50.23 62.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.985 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.642 ' HB2' HD11 ' A' ' 104' ' ' ILE . 2.4 t80 -112.08 -27.67 8.3 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -169.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -105.44 -54.87 2.41 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.493 -176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.468 0.465 0 O-C-N 124.46 1.1 . . . . 0.0 111.863 -172.236 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 168' ' ' VAL . 17.0 t . . . . . 0 CA--C 1.539 0.519 0 CA-C-O 122.429 1.109 . . . . 0.0 109.054 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.524 ' H ' ' CD ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -60.63 -36.3 78.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.48 -178.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.92 -36.16 80.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.049 0.452 . . . . 0.0 111.096 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.423 ' HB3' HG12 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -79.84 -28.36 40.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.739 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.29 -26.38 38.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.361 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -53.94 -33.77 57.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.273 0.559 . . . . 0.0 111.077 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.99 -39.13 14.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.971 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.232 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.139 179.03 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.7 p30 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 121.452 0.644 . . . . 0.0 110.588 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 6' ' ' GLN . 95.8 mt -130.0 -152.12 0.5 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.965 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 50.8 tt0 67.98 119.25 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.215 0.531 . . . . 0.0 110.792 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.18 19.7 27.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.758 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -134.96 169.79 16.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.499 ' CZ ' ' HG3' ' A' ' 173' ' ' MET . 29.4 p90 -143.85 162.41 36.16 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 175.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 3.3 pt -133.02 128.46 56.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.507 -174.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 4.9 mp -96.24 140.05 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.575 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.32 168.68 19.51 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.827 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 N--CA 1.469 0.477 0 O-C-N 124.136 0.898 . . . . 0.0 113.044 177.295 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.712 ' HA ' ' HE ' ' A' ' 23' ' ' ARG . 1.4 mmp_? . . . . . 0 N--CA 1.467 0.393 0 CA-C-O 120.917 0.389 . . . . 0.0 112.023 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.1 p -146.34 158.71 43.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t 68.24 100.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 O-C-N 123.897 0.748 . . . . 0.0 111.13 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.665 HG13 ' HD1' ' A' ' 27' ' ' TYR . 10.6 tp -129.67 -142.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.32 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.665 ' HD1' HG13 ' A' ' 26' ' ' ILE . 37.1 p90 -117.64 174.55 6.1 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.476 1.034 . . . . 0.0 112.259 -165.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -92.98 125.73 45.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.326 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.3 m -73.0 -59.03 2.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.064 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -145.89 164.21 32.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.409 0.623 . . . . 0.0 111.223 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 45.3 t-80 -118.27 118.87 32.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -114.64 -176.87 3.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.326 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -66.51 -28.84 68.88 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.261 0.553 . . . . 0.0 110.438 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.82 9.52 43.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.835 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.09 -143.63 15.34 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.567 -1.302 . . . . 0.0 113.185 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 133' ' ' THR . 12.4 m -123.97 129.11 50.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.499 0.19 . . . . 0.0 110.94 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.7 HG13 HG22 ' A' ' 133' ' ' THR . 3.5 mp -103.74 114.78 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.272 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -145.82 165.72 28.0 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.557 HG12 ' HA3' ' A' ' 75' ' ' GLY . 3.5 m -113.37 68.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.628 0.728 . . . . 0.0 110.787 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.597 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -115.37 15.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.956 -173.498 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.35 -29.38 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.739 0.304 . . . . 0.0 110.737 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 62.99 85.88 0.12 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.093 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.1 t -179.1 123.11 0.24 Allowed Pre-proline 0 C--O 1.235 0.315 0 CA-C-O 121.358 0.599 . . . . 0.0 111.514 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 71.9 Cg_endo -81.67 155.73 18.33 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.503 2.136 . . . . 0.0 110.733 170.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 p -112.2 161.75 16.22 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.022 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.05 -20.42 63.24 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.494 ' O ' HG12 ' A' ' 72' ' ' VAL . 57.5 tp -67.44 145.07 55.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.609 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.533 ' HB3' ' CG ' ' A' ' 69' ' ' ASP . 17.9 m -101.06 153.33 19.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.16 -176.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.1 p -69.65 -33.97 59.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 69' ' ' ASP . 59.0 mt -73.68 -26.84 60.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.514 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.3 OUTLIER -71.45 -40.24 70.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.091 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.5 pp -74.03 -32.34 63.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.013 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 94.9 mt -65.4 -51.28 61.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.328 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.7 p -67.07 -28.47 68.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.339 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -55.72 -39.52 71.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.158 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 46.2 mtt . . . . . 0 C--N 1.326 -0.413 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.043 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.533 ' CG ' ' HB3' ' A' ' 48' ' ' SER . 25.3 t70 . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -126.86 14.46 7.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.836 -175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 44.2 mtt 63.06 165.89 0.12 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.626 -174.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.501 HG21 HD23 ' A' ' 129' ' ' LEU . 11.7 p -116.0 144.16 24.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.785 172.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.575 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.2 mp -103.8 158.12 16.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.972 0.415 . . . . 0.0 110.355 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.43 127.44 53.29 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.557 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -87.79 -10.06 70.4 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.316 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 131' ' ' CYS . . . 160.2 176.74 32.62 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.502 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 1.7 Cg_endo -85.41 -2.3 9.25 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.131 2.554 . . . . 0.0 113.322 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.49 HG12 HD22 ' A' ' 79' ' ' ASN . 19.7 t -103.3 128.39 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.785 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.49 HD22 HG12 ' A' ' 78' ' ' VAL . 45.7 m-80 62.59 39.18 11.7 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.111 0.564 . . . . 0.0 111.809 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.502 ' NE2' ' HA ' ' A' ' 77' ' ' PRO . 96.2 mt-30 -68.58 -10.37 55.46 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.201 0.524 . . . . 0.0 110.582 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -71.92 -17.61 62.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.292 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 82' ' ' ARG . 41.2 mtt180 -110.07 129.28 55.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.409 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 108' ' ' THR . . . -90.6 112.97 4.17 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.509 ' HB3' HD11 ' A' ' 106' ' ' LEU . 85.9 m-85 -93.53 125.04 37.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.646 0.223 . . . . 0.0 110.553 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.473 HG21 HG11 ' A' ' 112' ' ' VAL . 4.7 mp -123.34 105.56 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.975 0.417 . . . . 0.0 110.091 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 66.0 t -88.14 122.03 39.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.37 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -133.01 163.44 29.23 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.834 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 122' ' ' PRO . 4.9 m -64.33 158.67 22.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.66 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.761 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 1.5 tmtp? -66.48 118.22 9.8 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.944 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.443 ' HB ' ' OG1' ' A' ' 120' ' ' THR . 1.5 p -126.3 -169.3 1.99 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.456 173.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -116.27 155.92 27.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.245 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 75.53 165.94 0.27 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.644 0.59 . . . . 0.0 110.253 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 0.3 OUTLIER 69.41 169.29 0.3 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.349 0.66 . . . . 0.0 111.875 -176.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.522 ' HB3' ' O ' ' A' ' 93' ' ' GLU . 21.3 p90 157.46 117.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 113.98 -1.463 . . . . 0.0 109.307 -173.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.2 m -146.71 -71.19 0.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.394 0.616 . . . . 0.0 109.822 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -120.45 37.39 4.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.0 m -74.26 104.78 5.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.684 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -101.97 118.44 36.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.215 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 102' ' ' ASP . 95.6 mttt -100.0 112.0 24.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.877 0.37 . . . . 0.0 110.814 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.06 -53.67 44.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.1 t -133.26 169.67 16.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 166.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.511 ' HA ' ' HD3' ' A' ' 99' ' ' LYS . 38.7 t70 -61.16 -36.59 80.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 118.872 0.76 . . . . 0.0 111.358 -174.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.761 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 4.1 m-20 -77.26 -7.9 56.71 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.2 mm -121.06 122.37 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.959 0.409 . . . . 0.0 110.027 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 m -121.47 113.74 20.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.422 0.63 . . . . 0.0 111.498 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 84' ' ' PHE . 54.1 tp -94.07 137.7 32.98 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.971 174.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.677 HG21 ' HB3' ' A' ' 111' ' ' ASP . 16.2 m -145.98 137.78 25.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 65.4 p -114.28 12.65 17.7 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.434 ' H ' HG22 ' A' ' 107' ' ' THR . 62.8 p -127.73 -174.73 3.27 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.492 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.36 -7.82 47.75 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.311 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.677 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.5 t70 -50.47 -39.44 48.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.73 . . . . 0.0 110.002 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 107' ' ' THR . 91.7 t -60.63 -49.03 86.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.131 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.89 -35.88 82.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.47 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.09 -46.0 72.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.724 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.416 ' HA ' HG22 ' A' ' 118' ' ' THR . 5.2 p -66.93 -37.93 85.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.746 0.308 . . . . 0.0 110.811 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.508 ' CE1' ' HD2' ' A' ' 122' ' ' PRO . 7.0 m-30 -67.56 -24.14 65.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.083 0.468 . . . . 0.0 110.929 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.99 19.86 52.58 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.404 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.58 ' CG2' HG22 ' A' ' 120' ' ' THR . 4.4 t -142.85 -171.04 3.37 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -82.72 13.0 4.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.58 HG22 ' CG2' ' A' ' 118' ' ' THR . 9.8 t -117.49 20.46 13.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.527 0.679 . . . . 0.0 110.538 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.448 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -68.38 115.1 26.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.969 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.508 ' HD2' ' CE1' ' A' ' 116' ' ' PHE . 11.4 Cg_exo -71.87 143.0 40.17 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.904 2.403 . . . . 0.0 112.156 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.79 -47.19 86.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.929 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.0 mmtt -102.26 124.43 47.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.237 -171.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 48.7 p90 -152.15 141.97 21.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.323 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.4 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 24.3 pt -127.26 135.51 63.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.45 175.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.29 125.97 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.141 0.496 . . . . 0.0 110.798 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.6 m -143.08 136.3 28.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.827 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.501 HD23 HG21 ' A' ' 72' ' ' VAL . 4.2 mm? -89.39 124.46 34.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.843 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.94 174.4 17.52 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.398 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.401 ' C ' ' HA3' ' A' ' 76' ' ' GLY . 61.5 m -144.9 169.01 18.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.9 m -105.89 122.51 46.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.669 0.271 . . . . 0.0 110.716 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.7 HG22 HG13 ' A' ' 37' ' ' ILE . 41.3 p -101.71 116.78 33.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.876 0.37 . . . . 0.0 111.172 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.582 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 3.0 t-105 -78.84 156.99 28.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 12.9 mptt -62.27 137.38 95.92 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.805 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 51.9 Cg_exo -52.66 121.5 9.26 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.216 2.611 . . . . 0.0 112.616 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 75.39 -17.1 0.53 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.357 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.55 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 53.8 tp60 -73.91 -30.89 62.83 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.88 -0.512 . . . . 0.0 111.387 -174.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.486 ' O ' HG13 ' A' ' 143' ' ' ILE . 52.4 tp -54.75 -44.71 73.86 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.89 -33.36 75.82 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.994 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 34.3 tt0 -71.93 -38.37 69.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.582 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 11.2 mm-40 -61.21 -42.21 98.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.229 0.538 . . . . 0.0 109.67 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 139' ' ' LEU . 84.8 mt -60.55 -38.18 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.038 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.74 -17.7 64.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 111.662 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 50.1 mt-30 -85.94 -0.72 56.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.467 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 62.84 24.53 14.6 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 123.713 0.805 . . . . 0.0 112.58 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -88.63 -8.02 55.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.292 0.568 . . . . 0.0 109.542 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -135.22 115.09 12.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.13 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.726 HD11 HD22 ' A' ' 174' ' ' LEU . 4.7 tt -84.84 102.51 13.14 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.7 tp -82.92 134.75 35.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.401 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.7 p -150.23 163.92 37.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.8 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.26 154.24 19.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.282 0.563 . . . . 0.0 111.945 -175.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 154' ' ' ASN . . . -92.56 -160.11 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.653 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 153' ' ' ALA . 17.5 m120 70.91 15.23 6.8 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.61 -177.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -96.18 148.57 22.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.46 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.99 -63.0 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.447 ' HB ' ' SD ' ' A' ' 173' ' ' MET . 24.8 m -51.66 -29.16 16.93 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.0 tt -52.36 -49.13 64.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 111.285 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -123.61 -19.78 5.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.988 -173.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -88.17 -9.65 52.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.847 0.356 . . . . 0.0 111.051 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 157' ' ' THR . 11.1 t . . . . . 0 CA--C 1.533 0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.1 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 171' ' ' ASN . 16.1 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.542 0.211 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.638 ' OE2' ' HA ' ' A' ' 23' ' ' ARG . 1.1 pm0 -91.83 -50.18 5.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.017 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.446 ' N ' ' HG2' ' A' ' 169' ' ' GLU . . . -81.23 -48.74 11.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.795 0.331 . . . . 0.0 111.65 -173.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.558 ' HB2' HG21 ' A' ' 168' ' ' VAL . 1.9 m-20 -60.98 -25.43 66.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.123 0.487 . . . . 0.0 111.129 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -71.59 -21.04 61.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.175 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.499 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 68.7 mmm -65.93 -28.22 68.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.058 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.726 HD22 HD11 ' A' ' 149' ' ' LEU . 12.2 tp -95.79 -44.91 7.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.647 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.883 179.061 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.507 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 59.4 m-20 . . . . . 0 CA--C 1.517 -0.314 0 CA-C-O 120.803 0.335 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.7 mt -136.54 -123.54 0.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.291 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 66.77 119.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.178 0.989 . . . . 0.0 111.814 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.8 5.32 77.97 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.478 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 11.3 mptt -113.24 164.77 13.12 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.44 ' HE1' HD11 ' A' ' 11' ' ' ILE . 36.5 p90 -136.82 159.54 41.54 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.028 0.442 . . . . 0.0 111.062 -176.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.7 pt -128.87 127.89 66.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.248 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.83 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.5 mp -92.99 123.43 45.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.39 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -115.59 101.27 8.71 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.6 m . . . . . 0 C--N 1.319 -0.723 0 CA-C-O 120.929 0.395 . . . . 0.0 111.488 -177.073 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.586 ' HE ' HD23 ' A' ' 73' ' ' LEU . 3.0 tmm_? . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.633 0.73 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.9 t -114.54 143.89 44.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.992 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.816 HG11 HG13 ' A' ' 11' ' ' ILE . 40.2 t 63.55 109.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.809 0.814 . . . . 0.0 112.054 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.857 HG21 HG23 ' A' ' 39' ' ' VAL . 5.6 tp -134.36 -161.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.56 ' H ' HG13 ' A' ' 26' ' ' ILE . 5.0 p90 -117.56 169.67 9.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.975 0.807 . . . . 0.0 111.876 -164.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.18 112.14 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.187 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.3 m -73.89 -46.23 45.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.093 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.691 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 36.4 tt0 -135.77 144.45 45.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.424 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.507 ' CD2' ' HA ' ' A' ' 4' ' ' ASN . 74.8 t60 -146.35 104.67 3.81 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -122.87 174.86 6.89 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.22 -21.79 66.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.389 0.614 . . . . 0.0 109.826 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -70.27 -31.23 68.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.194 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 160.91 -179.93 36.06 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.308 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.1 m -115.64 127.68 55.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.654 0.264 . . . . 0.0 110.623 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.2 mp -112.84 115.92 51.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.415 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.32 163.71 26.0 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.857 HG23 HG21 ' A' ' 26' ' ' ILE . 18.3 m -123.84 36.88 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.501 0.667 . . . . 0.0 110.884 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.713 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -84.97 15.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -169.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 pt -64.62 -25.91 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.59 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.1 t-20 64.85 93.11 0.07 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.416 0.447 . . . . 0.0 111.996 176.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 12.4 t 169.48 137.77 0.06 OUTLIER Pre-proline 0 C--O 1.24 0.569 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.184 175.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.845 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 93.0 Cg_endo -85.18 176.88 5.56 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.728 2.285 . . . . 0.0 111.052 170.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.401 HG22 ' ND2' ' A' ' 74' ' ' ASN . 15.2 p -116.59 176.34 5.16 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.428 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -91.12 5.62 48.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.943 0.877 . . . . 0.0 109.566 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 tp -106.66 156.4 18.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.487 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 10.5 m -100.27 151.49 21.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.7 p -65.54 -33.89 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.8 mt -68.33 -26.62 65.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.621 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 48' ' ' SER . 4.2 mm-40 -63.16 -47.28 83.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.562 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.6 -39.17 88.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.514 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 89.3 mt -64.8 -43.73 92.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.291 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -72.55 -29.09 63.25 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -56.63 -43.45 80.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.046 0.45 . . . . 0.0 110.169 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.8 mtm . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.615 176.945 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 121.16 0.505 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -125.55 123.12 38.4 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.609 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.558 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 1.9 mpt? -76.73 157.75 31.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.849 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.98 140.23 18.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.845 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 10.4 mp -104.39 152.26 22.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.876 0.37 . . . . 0.0 110.581 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.401 ' ND2' HG22 ' A' ' 45' ' ' THR . 57.8 m-20 -85.48 141.99 29.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.589 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.41 -25.39 7.02 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.703 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.83 170.94 30.46 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.974 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.64 -3.17 12.73 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.191 2.594 . . . . 0.0 112.96 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.4 t -102.23 146.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 61.45 42.84 10.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.933 0.397 . . . . 0.0 111.096 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.821 HE21 ' HA ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -65.06 -10.9 33.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -176.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.28 -12.55 56.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.73 0.3 . . . . 0.0 110.75 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -130.27 128.89 42.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.314 0.578 . . . . 0.0 112.068 -167.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.52 125.34 7.99 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.21 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.572 ' HB3' HD11 ' A' ' 106' ' ' LEU . 64.7 m-85 -99.99 126.15 46.13 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.44 HG12 HG11 ' A' ' 112' ' ' VAL . 3.8 mp -114.57 122.41 68.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.118 0.485 . . . . 0.0 110.989 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -101.59 125.23 55.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.533 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -131.18 160.7 34.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.609 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.1 p -71.55 132.78 45.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.08 0.467 . . . . 0.0 109.948 174.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 103' ' ' ASP . 9.2 tmtt? -67.76 122.65 18.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.465 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.8 t -152.65 -12.93 0.17 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.307 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -83.57 159.69 21.58 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.69 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -148.52 104.89 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 65.95 -179.03 0.19 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.68 0.613 . . . . 0.0 110.634 -175.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 70.11 -61.7 0.45 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.224 0.609 . . . . 0.0 111.348 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 111' ' ' ASP . 2.0 p -75.11 133.91 41.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.338 0.59 . . . . 0.0 110.77 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.426 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 29.6 m80 -82.36 61.79 5.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.905 177.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.5 m -85.46 138.39 32.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -100.69 123.32 44.73 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.619 ' HD2' ' HA ' ' A' ' 102' ' ' ASP . 28.8 ttpp -83.68 106.58 15.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.343 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.435 HG11 ' HE2' ' A' ' 27' ' ' TYR . 51.9 t -70.45 -54.01 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.226 0.536 . . . . 0.0 109.87 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 102' ' ' ASP . 2.8 t -124.84 -54.6 1.63 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.562 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.619 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 14.9 t70 -177.1 -72.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.638 ' HA ' ' HB3' ' A' ' 89' ' ' LYS . 6.7 m-20 -77.27 -3.97 42.51 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.041 0.448 . . . . 0.0 111.396 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.683 HG13 HD13 ' A' ' 158' ' ' LEU . 51.6 mm -106.41 122.55 60.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.66 128.32 43.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.238 0.542 . . . . 0.0 111.624 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 84' ' ' PHE . 63.3 tp -102.85 121.22 42.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.45 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.53 HG21 ' HB2' ' A' ' 111' ' ' ASP . 4.2 m -126.82 134.46 50.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.623 0.249 . . . . 0.0 110.435 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -147.34 3.26 0.77 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.237 0.542 . . . . 0.0 111.392 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.504 ' HB2' ' OD1' ' A' ' 111' ' ' ASP . 14.2 m -85.9 15.05 5.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.332 . . . . 0.0 111.667 -174.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.19 -23.37 35.63 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.53 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.563 ' HB3' HG22 ' A' ' 95' ' ' THR . 3.0 m-20 -51.34 -37.65 48.95 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.298 0.639 . . . . 0.0 111.545 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.44 HG11 HG12 ' A' ' 85' ' ' ILE . 60.1 t -47.98 -40.84 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.971 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.544 ' HA ' ' CE2' ' A' ' 116' ' ' PHE . 98.0 mt -62.88 -32.73 74.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.072 0.463 . . . . 0.0 110.933 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.18 -35.87 35.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.54 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.1 m -56.21 -50.34 71.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.811 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.544 ' CE2' ' HA ' ' A' ' 113' ' ' LEU . 40.7 p90 -79.64 11.57 3.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.588 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.92 16.56 13.37 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.855 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 76.7 p -111.63 177.7 4.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.373 . . . . 0.0 110.781 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -83.21 -26.45 30.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.61 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 p -96.88 20.8 10.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.432 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -51.21 136.61 29.62 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.542 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 23.6 Cg_exo -62.16 150.78 85.44 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.028 2.485 . . . . 0.0 112.613 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -59.58 -49.6 77.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.911 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -143.59 146.21 33.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.559 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -152.1 137.52 17.64 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.473 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.13 148.11 16.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.447 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.76 129.45 74.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.191 0.52 . . . . 0.0 110.905 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.436 ' SG ' HG11 ' A' ' 39' ' ' VAL . 5.7 p -126.27 124.75 41.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.398 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 129' ' ' LEU . 1.2 tm? -84.22 119.0 24.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.343 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.81 178.78 27.32 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.539 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.5 m -147.81 171.96 14.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.86 0.362 . . . . 0.0 110.046 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 37.6 m -111.57 121.24 44.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.104 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.8 p -96.76 115.33 27.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.174 0.511 . . . . 0.0 111.364 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -101.35 149.9 23.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.473 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 1.5 mppt? -86.78 130.28 49.34 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.778 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 7.5 Cg_exo -73.32 44.5 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.538 2.825 . . . . 0.0 114.335 -168.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -154.11 -39.23 0.09 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.369 . . . . 0.0 110.545 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.538 ' HA ' ' OE1' ' A' ' 138' ' ' GLN . 5.5 tp60 -75.79 -30.72 59.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.693 -175.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.432 ' O ' HG13 ' A' ' 143' ' ' ILE . 60.1 tp -57.87 -38.83 76.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.013 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.9 -42.12 97.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.041 0.448 . . . . 0.0 110.526 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.569 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 31.0 mm-40 -68.17 -39.24 82.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.437 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.627 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 14.1 mm-40 -62.03 -43.34 99.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.167 0.508 . . . . 0.0 110.486 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 150' ' ' LEU . 77.1 mt -65.26 -39.4 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.096 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.42 73.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.536 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 67.1 mt-30 -78.76 2.95 18.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.372 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 19.1 m120 67.18 15.51 10.04 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.345 0.658 . . . . 0.0 112.265 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.447 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 57.0 m-85 -79.94 -21.79 43.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.35 0.595 . . . . 0.0 109.769 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.627 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 97.5 m95 -127.29 114.82 18.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.707 175.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.83 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 24.7 mt -86.36 103.09 14.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.529 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.5 ' HB2' HD13 ' A' ' 143' ' ' ILE . 60.3 tp -86.87 132.96 33.67 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.345 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.9 m -156.75 152.44 26.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.176 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -91.18 153.99 19.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.111 0.481 . . . . 0.0 110.651 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.52 114.25 28.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.62 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.99 68.09 3.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.226 0.536 . . . . 0.0 109.919 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 16.6 m120 65.5 -80.48 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.021 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -60.6 -42.92 97.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.857 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 11.8 m -54.24 -30.45 50.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.683 HD13 HG13 ' A' ' 104' ' ' ILE . 5.5 tt -62.68 -57.59 10.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.285 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -121.45 -23.13 5.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -170.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -100.2 -61.25 1.39 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.474 0.77 0 C-N-CA 124.184 0.994 . . . . 0.0 112.107 -174.012 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 CA--C 1.535 0.37 0 CA-C-O 120.844 0.354 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -59.91 -5.13 0.88 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.02 -29.27 70.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.896 0.379 . . . . 0.0 110.526 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -80.32 -24.09 40.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.474 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -59.43 -42.42 91.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.383 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -58.9 -31.68 68.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.158 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 7.5 tt -81.65 -46.43 14.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.549 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.411 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.158 -179.158 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 . . . . . 0 C--O 1.232 0.16 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.3 mt -129.4 -170.41 2.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.341 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 68.09 112.18 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.701 0.625 . . . . 0.0 110.892 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.29 3.58 65.04 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 12.6 mptt -106.22 171.24 7.45 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 153' ' ' ALA . 54.9 p90 -140.43 150.73 44.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.803 0.335 . . . . 0.0 110.443 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 pt -109.14 130.75 61.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.226 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.674 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 2.8 mp -76.99 131.41 34.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.099 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 24' ' ' THR . . . -57.66 137.26 56.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.973 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.063 179.707 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 . . . . . 0 CA--C 1.52 -0.183 0 CA-C-O 121.197 0.522 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.565 ' HA ' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -75.17 55.84 0.77 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.021 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 p -173.4 113.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.865 HG22 ' HD1' ' A' ' 27' ' ' TYR . 44.2 mm -120.71 -83.97 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.938 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.865 ' HD1' HG22 ' A' ' 26' ' ' ILE . 9.9 p90 -173.31 170.21 4.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.049 0.452 . . . . 0.0 111.15 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 mm -102.52 121.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.955 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.2 m -76.97 -46.37 24.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.439 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -151.07 159.27 44.61 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 79.2 t60 -148.12 138.2 22.63 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -174.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 t30 77.87 164.84 0.23 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.22 0.95 . . . . 0.0 111.547 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 68.52 -71.61 0.11 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.675 0.79 . . . . 0.0 112.145 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -88.41 -26.08 22.34 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.79 -177.19 20.38 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.109 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' A' ' 134' ' ' TRP . 23.8 m -100.0 101.85 13.05 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 37' ' ' ILE . 4.5 mp -95.22 112.0 26.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.41 157.36 27.23 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.005 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 4.3 m -123.53 93.74 2.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.266 0.555 . . . . 0.0 110.295 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.452 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -128.56 8.15 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.156 -177.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 pt -80.92 -27.61 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.565 ' HB3' ' HA ' ' A' ' 24' ' ' THR . 13.5 t30 38.96 85.98 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.237 0.961 . . . . 0.0 112.84 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 6.6 t -143.66 112.2 5.4 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-O 121.252 0.549 . . . . 0.0 109.95 176.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 4.8 Cg_exo -76.97 152.57 31.93 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.213 1.942 . . . . 0.0 111.318 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 p -124.88 163.15 22.85 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.716 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -82.82 1.06 41.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.191 0.52 . . . . 0.0 110.743 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.68 HD21 HD21 ' A' ' 52' ' ' LEU . 54.7 tp -83.36 144.48 29.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.235 173.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.65 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 14.5 m -104.19 145.66 29.89 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.7 p -63.57 -33.36 61.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.573 HD23 HD12 ' A' ' 53' ' ' LEU . 90.3 mt -66.99 -33.06 74.76 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.571 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.65 ' HG3' ' HB2' ' A' ' 48' ' ' SER . 32.8 mt-10 -61.26 -43.34 99.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.242 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.68 HD21 HD21 ' A' ' 47' ' ' LEU . 96.4 mt -67.91 -33.38 74.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.303 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.573 HD12 HD23 ' A' ' 50' ' ' LEU . 94.0 mt -69.67 -42.07 74.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.9 m -62.22 -39.75 93.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.351 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -58.48 -39.89 81.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.383 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.9 mtt . . . . . 0 C--N 1.325 -0.458 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.123 -178.321 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.539 ' HB3' HD12 ' A' ' 50' ' ' LEU . 1.1 m-20 . . . . . 0 N--CA 1.466 0.327 0 CA-C-O 121.405 0.621 . . . . 0.0 111.953 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -152.18 90.88 1.55 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.1 ptm -71.15 140.48 50.57 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.378 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.731 HG21 HD23 ' A' ' 129' ' ' LEU . 11.0 p -108.21 149.79 11.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.621 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.4 mp -94.29 152.88 18.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.404 . . . . 0.0 110.12 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.74 124.93 34.6 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.38 -26.26 21.35 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.851 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.86 164.47 15.09 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.871 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.68 -18.71 22.04 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.473 2.115 . . . . 0.0 112.627 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.411 HG21 ' OG1' ' A' ' 133' ' ' THR . 42.8 t -90.13 133.34 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.232 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 65.77 27.9 11.05 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 110.205 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.42 -17.7 64.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.044 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.59 -10.69 60.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.501 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -125.43 144.49 50.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.055 0.455 . . . . 0.0 110.436 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.31 120.91 7.03 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -98.74 126.55 44.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.749 0.309 . . . . 0.0 110.233 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.441 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.5 mp -113.07 112.7 41.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.194 0.521 . . . . 0.0 109.987 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.3 t -94.25 114.65 31.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.147 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -116.33 148.93 40.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.53 -174.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 m -82.39 150.25 27.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.974 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 43.8 tttm -70.16 114.0 7.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.836 0.827 . . . . 0.0 111.551 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.523 HG21 ' HG3' ' A' ' 123' ' ' GLU . 3.2 m -135.28 11.58 3.53 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.641 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -160.13 -173.08 3.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.167 -164.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -158.86 27.23 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.666 173.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -103.58 169.3 8.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.386 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.6 p90 176.74 157.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.038 0.446 . . . . 0.0 111.558 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 p -102.83 -37.72 7.73 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 164.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -168.15 91.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.152 169.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.2 m -100.63 167.42 10.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.51 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 12.6 t80 -124.57 98.18 5.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.428 ' HA ' HG23 ' A' ' 105' ' ' THR . 86.3 tttt -73.27 108.37 6.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 -177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.3 -59.03 3.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.95 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 103' ' ' ASP . 58.5 p -117.14 -176.33 2.97 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.417 ' HA ' ' CE ' ' A' ' 99' ' ' LYS . 31.0 t70 -82.22 34.2 0.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.821 0.819 . . . . 0.0 109.701 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.597 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 12.9 t0 -158.12 -67.25 0.09 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.437 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.86 121.93 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.673 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 99' ' ' LYS . 24.0 m -134.6 134.17 40.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.956 -173.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 63.6 tp -84.73 132.82 34.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.137 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.546 ' HB ' HG13 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -136.63 143.84 43.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 107' ' ' THR . 14.6 t -179.88 21.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.949 0.404 . . . . 0.0 111.32 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.0 t -101.22 8.52 42.53 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.613 -0.679 . . . . 0.0 111.207 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.76 -30.03 6.58 Favored Glycine 0 CA--C 1.509 -0.296 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -45.28 -50.39 11.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.411 -0.894 . . . . 0.0 111.407 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.546 HG13 ' HB ' ' A' ' 107' ' ' THR . 17.5 m -47.81 -45.06 11.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.904 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.19 -30.8 69.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.422 . . . . 0.0 110.789 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -77.99 -33.74 51.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.576 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.0 m -60.66 -62.86 1.55 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.403 -174.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -74.3 -2.77 26.53 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.797 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -96.26 3.67 64.19 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.222 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 120' ' ' THR . 12.4 t -138.89 171.82 13.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -82.26 4.92 21.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.661 0.267 . . . . 0.0 111.49 -175.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.457 ' H ' HG23 ' A' ' 118' ' ' THR . 69.2 p -102.97 15.73 28.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.906 0.384 . . . . 0.0 110.816 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -58.17 141.04 82.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.017 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 19.7 Cg_exo -65.16 146.01 85.74 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.763 2.308 . . . . 0.0 111.986 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.523 ' HG3' HG21 ' A' ' 90' ' ' THR . 38.1 mt-10 -65.4 -37.76 87.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.482 -176.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 123' ' ' GLU . 12.1 mtmt -128.41 132.15 48.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.353 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -163.55 147.53 10.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.447 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.1 pt -126.47 143.74 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.979 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.573 HG13 HG23 ' A' ' 72' ' ' VAL . 6.4 p -114.78 129.4 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.054 0.454 . . . . 0.0 110.588 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.8 p -134.73 136.08 42.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.382 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.731 HD23 HG21 ' A' ' 72' ' ' VAL . 4.0 mm? -86.52 120.99 28.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.356 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.76 -179.15 38.35 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.704 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 61.2 m -145.65 167.49 22.98 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 33.9 m -102.4 122.73 44.86 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 36' ' ' THR . 39.5 p -107.46 120.35 41.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.043 0.449 . . . . 0.0 112.162 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.622 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 1.5 m-90 -96.02 144.75 26.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.316 170.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 138' ' ' GLN . 12.0 mptt -65.05 156.02 82.03 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.394 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.1 133.95 40.55 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.144 1.896 . . . . 0.0 110.642 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.454 ' HA ' ' CG ' ' A' ' 140' ' ' GLU . 49.4 m80 63.74 29.5 14.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.242 0.544 . . . . 0.0 111.325 -175.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 55.5 tp60 -106.29 -68.89 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.225 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.506 ' O ' HG13 ' A' ' 143' ' ' ILE . 52.4 tp -63.14 -47.06 84.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.784 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 137' ' ' HIS . 10.9 pt-20 -58.44 -34.21 70.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.63 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -65.77 -51.17 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.726 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -71.85 -29.85 64.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.36 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' A' ' 148' ' ' TRP . 71.5 mt -61.07 -43.59 96.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.44 -30.32 71.1 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.63 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 42.1 mt-30 -81.16 5.46 16.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.365 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 71.93 30.97 2.14 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.309 0.643 . . . . 0.0 112.369 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -93.84 -3.82 51.21 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.165 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.595 ' HB2' HG12 ' A' ' 143' ' ' ILE . 96.0 m95 -139.43 160.64 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.268 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.674 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 3.1 tt -113.08 118.62 35.27 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 8' ' ' LYS . 35.5 tp -105.08 148.58 26.66 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.994 0.425 . . . . 0.0 111.707 -175.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.5 t -159.69 166.84 29.74 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -106.24 154.1 21.21 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.983 -178.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . . . -120.9 151.78 39.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.57 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.41 -61.15 1.78 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.522 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 103' ' ' ASP . 24.8 p-10 -170.8 -59.67 0.02 OUTLIER 'General case' 0 C--O 1.235 0.316 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 45.6 mt-30 -56.94 -41.94 79.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -173.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.463 ' HA ' ' OG1' ' A' ' 161' ' ' THR . 21.4 m -55.56 -32.87 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.37 -51.98 4.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -99.37 -23.34 15.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 39.5 mt-10 -111.83 -25.75 9.29 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -166.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 169' ' ' GLU . 34.0 m . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -174.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 95.6 t . . . . . 0 N--CA 1.468 0.425 0 CA-C-O 121.335 0.588 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.536 ' HG3' HG21 ' A' ' 161' ' ' THR . 0.0 OUTLIER -118.16 -41.19 2.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.842 178.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.77 -43.87 94.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.662 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -76.5 -26.32 55.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 0.0 110.344 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.34 -29.55 66.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.936 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.0 tpt -60.59 -32.65 71.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.116 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.542 HD13 HD21 ' A' ' 149' ' ' LEU . 13.0 tp -77.35 -42.68 35.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.908 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.698 178.878 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 p30 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.236 0.541 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.03 -93.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.205 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 65.15 117.07 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.191 0.52 . . . . 0.0 111.46 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.97 -4.27 74.7 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.391 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 2.3 mptp? -105.58 163.79 12.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.543 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 48.7 p90 -140.7 149.52 42.3 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.221 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.584 HD11 HG13 ' A' ' 40' ' ' ILE . 16.4 pt -98.17 145.01 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.43 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.727 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 45.1 mm -81.68 95.62 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.506 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -102.94 -44.93 5.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.757 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.47 0.57 0 C-N-CA 123.7 0.8 . . . . 0.0 111.224 -177.026 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.93 0.395 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 42' ' ' ASN . 33.6 p -92.48 131.53 37.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.329 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.0 t 74.25 82.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 O-C-N 123.885 0.741 . . . . 0.0 111.28 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.887 HG22 ' H ' ' A' ' 27' ' ' TYR . 16.3 mm -107.76 -166.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.887 ' H ' HG22 ' A' ' 26' ' ' ILE . 7.2 p90 -114.86 175.18 5.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.521 0.6 . . . . 0.0 111.683 -167.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.9 mm -86.13 112.55 22.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.358 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.9 -55.2 28.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.386 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -144.17 127.48 16.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.868 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -108.89 99.68 8.99 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 158.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -112.31 59.72 0.63 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.896 -166.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t70 63.2 -66.76 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.97 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.46 -39.45 11.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.75 147.57 17.07 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.886 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 133' ' ' THR . 26.2 m -133.79 102.73 5.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.494 HG13 HG22 ' A' ' 133' ' ' THR . 4.5 mp -111.02 121.77 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.32 -174.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.46 162.48 29.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.92 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 5.7 m -125.81 91.2 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.27 0.557 . . . . 0.0 110.215 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.584 HG13 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -135.85 16.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.9 pt -80.92 -20.89 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.247 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.408 ' HB3' HG22 ' A' ' 24' ' ' THR . 46.1 m-20 61.15 47.93 6.75 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 167.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t -146.06 133.98 10.54 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.431 -177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 61.9 Cg_endo -73.89 165.44 32.14 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.973 2.449 . . . . 0.0 112.366 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.542 HG22 ' ND2' ' A' ' 74' ' ' ASN . 31.1 p -99.54 -166.2 1.32 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.966 0.413 . . . . 0.0 110.034 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.5 12.37 27.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.885 0.85 . . . . 0.0 108.848 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.9 tp -109.86 146.84 34.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.586 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 19.7 m -95.81 149.2 21.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.676 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.4 p -63.9 -30.47 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.297 0.57 . . . . 0.0 109.998 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.7 mt -75.19 -26.65 59.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.367 177.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.0 OUTLIER -68.67 -40.67 80.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.377 -176.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.668 HD22 HD21 ' A' ' 129' ' ' LEU . 3.9 pp -71.78 -30.51 65.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.064 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 88.5 mt -66.3 -48.42 70.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.323 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.0 p -61.0 -30.24 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.195 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -72.62 -52.8 13.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.4 mtt . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.505 0.193 . . . . 0.0 110.685 -179.404 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 49' ' ' VAL . 30.0 mm-40 -96.38 125.92 41.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.431 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 66.5 mtt -84.43 149.88 25.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.362 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.621 HG21 HD23 ' A' ' 129' ' ' LEU . 12.7 p -100.58 150.23 5.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.725 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 7.0 mp -99.74 164.41 12.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.255 0.55 . . . . 0.0 111.678 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.542 ' ND2' HG22 ' A' ' 45' ' ' THR . 47.9 m-80 -81.84 124.43 29.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.705 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.89 -27.6 37.4 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.601 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.412 ' HA3' ' C ' ' A' ' 131' ' ' CYS . . . 168.98 175.11 38.11 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -86.51 3.24 6.9 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.948 2.432 . . . . 0.0 112.511 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.465 HG12 HD22 ' A' ' 79' ' ' ASN . 21.9 t -109.06 121.25 61.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.238 -175.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.465 HD22 HG12 ' A' ' 78' ' ' VAL . 54.5 m-80 55.83 56.49 6.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.009 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.465 ' O ' HD12 ' A' ' 129' ' ' LEU . 84.3 mt-30 -70.93 -7.5 46.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.682 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.89 -10.02 58.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.262 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -112.26 131.36 55.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.939 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.41 117.75 5.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.807 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.524 ' HB3' HD11 ' A' ' 106' ' ' LEU . 71.9 m-85 -102.6 126.08 49.55 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.413 HG21 HG21 ' A' ' 112' ' ' VAL . 4.4 mp -119.88 107.77 21.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 0.0 110.544 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.717 HG22 HD13 ' A' ' 106' ' ' LEU . 12.5 t -91.8 120.66 41.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -134.9 158.83 43.25 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.441 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.5 t -76.21 167.86 21.1 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.146 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER -76.25 114.76 15.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.831 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.755 HG21 ' HA ' ' A' ' 122' ' ' PRO . 1.5 p -116.3 -2.94 12.01 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.013 172.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 92' ' ' HIS . 17.1 t70 -175.68 -145.79 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.515 ' H ' ' CG ' ' A' ' 91' ' ' ASP . 37.4 m80 -88.48 -159.68 0.58 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.609 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 4.1 mp0 -76.19 169.93 17.26 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -117.48 -161.0 0.8 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.6 m -59.9 -37.45 79.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.623 0.249 . . . . 0.0 111.566 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -152.79 80.98 1.22 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.141 0.496 . . . . 0.0 110.342 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 75.0 m -133.77 143.89 48.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.479 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -102.21 128.41 48.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.293 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.609 ' HD3' ' HG3' ' A' ' 93' ' ' GLU . 5.1 tptm -90.65 110.36 21.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.9 t -81.3 -71.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.054 0.454 . . . . 0.0 110.461 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 t -130.48 67.07 1.49 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.481 0.658 . . . . 0.0 110.758 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' HE2' ' A' ' 99' ' ' LYS . 28.1 t70 66.78 -69.83 0.12 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.412 176.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.624 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 11.0 t70 -77.74 -55.43 5.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.228 0.537 . . . . 0.0 110.019 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.415 HD12 ' CD1' ' A' ' 159' ' ' PHE . 33.0 mm -64.93 122.78 16.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.452 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.1 m -128.75 131.09 47.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.837 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.717 HD13 HG22 ' A' ' 86' ' ' VAL . 55.4 tp -107.75 112.61 25.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.083 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.5 m -96.6 124.77 40.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.414 HG22 ' CD2' ' A' ' 84' ' ' PHE . 60.2 p -107.36 17.1 23.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.1 m -147.7 -177.19 5.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.741 0.305 . . . . 0.0 111.184 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.44 -3.01 23.66 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.391 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -49.31 -32.8 11.77 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.961 0.905 . . . . 0.0 110.999 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.413 HG21 HG21 ' A' ' 85' ' ' ILE . 10.3 p -54.71 -34.68 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.972 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.73 -37.71 79.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.176 0.512 . . . . 0.0 110.492 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.28 -24.03 63.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.723 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -72.29 -18.29 61.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.213 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -97.01 144.93 26.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 0.0 110.767 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.26 -17.76 21.73 Favored Glycine 0 C--N 1.328 0.124 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.822 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 p -92.03 25.78 2.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 74.01 -39.82 0.44 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.607 0.763 . . . . 0.0 111.351 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.9 p -81.17 18.42 1.08 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.46 123.64 67.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.76 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.755 ' HA ' HG21 ' A' ' 90' ' ' THR . 29.7 Cg_endo -64.31 136.26 50.42 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.628 2.219 . . . . 0.0 112.862 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -66.71 -47.65 71.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.136 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -124.39 127.76 48.04 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.178 -174.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -155.9 152.36 28.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.51 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.8 pt -129.45 132.46 66.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.156 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.528 HG13 HG23 ' A' ' 72' ' ' VAL . 6.8 p -112.09 134.59 54.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.193 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 84.0 m -140.24 139.65 35.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.066 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.668 HD21 HD22 ' A' ' 52' ' ' LEU . 4.3 mm? -89.84 118.44 29.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.962 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.47 177.82 44.6 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.057 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.412 ' C ' ' HA3' ' A' ' 76' ' ' GLY . 73.5 m -145.6 171.58 14.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.904 0.383 . . . . 0.0 110.048 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.472 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 19.3 m -100.26 115.59 30.26 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 36' ' ' THR . 44.0 p -108.35 134.74 50.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.774 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.691 ' CD1' ' HB2' ' A' ' 139' ' ' LEU . 1.1 m-90 -119.9 165.02 15.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.302 0.572 . . . . 0.0 110.343 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -91.61 140.73 25.29 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.603 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.36 61.28 4.19 Favored 'Trans proline' 0 N--CA 1.473 0.313 0 C-N-CA 123.269 2.646 . . . . 0.0 113.298 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -167.73 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.592 ' HG3' ' OE2' ' A' ' 142' ' ' GLU . 52.2 tp60 -65.77 -68.36 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.377 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.691 ' HB2' ' CD1' ' A' ' 134' ' ' TRP . 55.8 tp -52.77 -42.02 64.6 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.887 0.375 . . . . 0.0 111.721 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -60.54 -32.85 71.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.078 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.597 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 25.3 mt-30 -72.31 -45.62 59.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.07 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.73 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 1.1 mp0 -54.42 -41.91 69.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.768 0.318 . . . . 0.0 111.199 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 139' ' ' LEU . 86.3 mt -56.91 -42.61 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.147 0.498 . . . . 0.0 110.538 175.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.46 -20.57 63.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.658 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.597 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 38.1 mt-30 -88.82 6.39 39.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.954 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 145' ' ' GLN . 14.0 m120 69.15 13.24 8.65 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.549 0.53 . . . . 0.0 111.233 -178.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -81.6 -21.86 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.714 0.768 . . . . 0.0 109.004 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.73 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 99.3 m95 -133.26 131.18 39.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.861 172.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.727 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 98.8 mt -95.64 155.3 16.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.5 tp -127.61 135.13 49.85 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.776 0.322 . . . . 0.0 111.039 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.1 t -141.04 176.84 8.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 8' ' ' LYS . 33.0 mt-10 -125.69 153.85 43.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.584 0.23 . . . . 0.0 110.882 -175.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.33 124.19 18.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.962 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -89.52 -45.07 9.67 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.103 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -172.65 -60.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.625 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 44.6 mt-30 -53.89 -48.96 69.56 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.347 -172.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.9 m -59.33 -28.35 66.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.855 0.359 . . . . 0.0 111.913 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.22 -53.84 4.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.415 ' CD1' HD12 ' A' ' 104' ' ' ILE . 34.5 m-85 -127.15 12.84 7.17 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -170.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 21.2 tt0 -109.83 -50.93 2.93 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 N--CA 1.445 -0.691 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.188 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.6 t . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 121.395 0.617 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -80.12 -2.28 43.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.491 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.415 ' HB1' HD12 ' A' ' 11' ' ' ILE . . . -51.78 -39.58 58.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -172.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -81.03 -37.16 29.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.084 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.16 -38.35 60.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.011 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 14.6 tpt -63.95 -27.8 69.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.277 0.561 . . . . 0.0 110.328 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.48 -35.31 40.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.132 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.405 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.086 -179.404 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 C--O 1.233 0.226 0 CA-C-O 121.162 0.506 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.455 HD13 HG13 ' A' ' 28' ' ' ILE . 97.3 mt -78.56 -92.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.516 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 39.63 84.52 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.563 0.745 . . . . 0.0 112.421 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.61 -9.57 12.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.461 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.437 ' HG3' ' HG3' ' A' ' 152' ' ' GLU . 10.4 mptt -107.19 172.46 6.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -129.29 143.1 50.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.008 0.432 . . . . 0.0 110.269 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 9.3 pt -107.03 127.33 62.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.224 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.923 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.3 mp -92.63 107.8 19.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.672 -174.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.618 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -91.19 -45.36 8.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.705 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 C--N 1.331 -0.198 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.597 -175.031 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.444 ' HA ' HD21 ' A' ' 42' ' ' ASN . 3.7 p -63.65 83.16 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -173.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.743 HG13 ' HB ' ' A' ' 40' ' ' ILE . 51.7 t 62.24 100.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 O-C-N 123.792 0.683 . . . . 0.0 112.136 173.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.644 ' CG2' HG23 ' A' ' 39' ' ' VAL . 11.3 tp -89.58 -141.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.919 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.557 ' H ' HG13 ' A' ' 26' ' ' ILE . 2.8 p90 -115.75 175.0 5.73 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.718 1.144 . . . . 0.0 112.442 -163.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.455 HG13 HD13 ' A' ' 5' ' ' LEU . 49.8 mm -90.24 120.91 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.823 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.0 m -87.36 -38.21 16.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -171.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.929 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 9.3 tp10 -141.15 155.18 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.84 0.352 . . . . 0.0 110.998 -173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -146.18 104.36 3.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.85 170.09 8.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.317 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -62.76 -22.01 66.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.165 0.507 . . . . 0.0 111.031 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.23 5.61 25.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.108 -173.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.581 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 161.68 161.12 11.48 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.587 -1.292 . . . . 0.0 113.546 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.7 m -108.55 128.72 55.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.929 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.5 mp -106.47 117.69 52.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.746 -173.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.72 165.42 26.85 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.644 HG23 ' CG2' ' A' ' 26' ' ' ILE . 2.5 m -118.74 44.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.518 0.675 . . . . 0.0 110.616 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.743 ' HB ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -95.31 19.04 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.071 -175.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.6 tp -76.83 -31.73 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.658 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.444 HD21 ' HA ' ' A' ' 24' ' ' THR . 3.1 m120 58.07 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.163 0.585 . . . . 0.0 112.226 -175.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -171.15 107.69 0.4 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 121.539 0.685 . . . . 0.0 110.313 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 6.5 Cg_exo -74.42 154.03 45.23 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.595 2.197 . . . . 0.0 111.209 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.3 p -127.73 158.43 37.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.884 0.373 . . . . 0.0 111.231 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.58 10.76 2.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.641 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.9 tp -86.09 146.08 26.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.8 t -99.0 149.57 22.85 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.704 0.288 . . . . 0.0 110.687 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 8.8 p -63.8 -26.02 39.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.25 0.548 . . . . 0.0 109.916 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.38 -27.54 59.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.312 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.25 -31.46 60.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.64 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.2 pp -72.67 -26.08 61.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.149 0.499 . . . . 0.0 109.745 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 113' ' ' LEU . 87.8 mt -75.42 -42.56 53.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.886 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.4 p -68.24 -30.93 70.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -73.55 -11.41 60.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.3 mtt . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 172.107 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.994 0.426 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.495 ' HB2' HG12 ' A' ' 49' ' ' VAL . 25.6 mm-40 -94.16 104.07 16.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.914 -178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 87.8 mtp -78.86 142.75 36.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.633 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 127' ' ' VAL . 12.6 p -98.96 149.66 5.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.183 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.8 mp -99.52 158.97 15.37 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.051 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.54 132.92 44.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 175.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.619 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -91.3 -12.52 59.8 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.353 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.23 174.89 30.59 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.098 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.06 -10.26 15.23 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.171 2.581 . . . . 0.0 112.944 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.07 122.55 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.05 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 64.92 46.52 2.86 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.461 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.428 ' O ' HD12 ' A' ' 129' ' ' LEU . 49.7 mt-30 -67.12 -10.3 48.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.98 -3.01 58.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.91 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -113.21 115.95 29.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.954 0.407 . . . . 0.0 110.69 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.84 115.49 4.99 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -96.5 126.17 41.5 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.21 103.91 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.002 0.429 . . . . 0.0 109.977 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.702 HG22 ' HB3' ' A' ' 106' ' ' LEU . 31.1 t -93.13 124.74 45.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.557 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -135.09 164.61 27.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.864 0.364 . . . . 0.0 111.654 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 124' ' ' LYS . 14.6 m -70.36 160.67 31.86 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.196 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 23.4 tptm -76.72 121.31 23.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.374 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -107.5 -67.04 0.98 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -164.72 -172.1 2.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 171.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.56 93.61 4.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -104.36 -175.9 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.934 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -72.24 97.34 1.97 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.283 -172.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.488 HG22 ' HB3' ' A' ' 111' ' ' ASP . 20.9 p -145.01 142.27 29.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.442 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -88.65 80.68 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 172.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.492 ' HB3' HG22 ' A' ' 105' ' ' THR . 15.7 m -116.46 150.93 37.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.233 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -104.83 139.53 39.46 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -101.57 116.0 31.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.76 -53.65 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 167.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.503 HG22 ' HB ' ' A' ' 104' ' ' ILE . 10.2 t -137.6 -166.18 1.9 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 169.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -83.32 -22.27 32.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 118.566 0.621 . . . . 0.0 111.023 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 28.7 m-20 -101.16 -11.66 19.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.623 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.503 ' HB ' HG22 ' A' ' 101' ' ' THR . 42.1 mm -120.72 122.67 68.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 97' ' ' SER . 29.7 m -145.77 130.6 18.12 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.787 0.327 . . . . 0.0 111.167 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.702 ' HB3' HG22 ' A' ' 86' ' ' VAL . 1.1 pt? -108.21 132.69 53.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.477 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 109' ' ' SER . 50.3 m -96.06 129.36 43.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.105 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 p -107.0 21.13 18.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.031 0.443 . . . . 0.0 111.588 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.473 ' H ' HG22 ' A' ' 107' ' ' THR . 22.7 t -147.0 175.15 10.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.328 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.08 -0.0 49.41 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 113.004 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.488 ' HB3' HG22 ' A' ' 95' ' ' THR . 67.9 m-20 -56.22 -33.43 65.35 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.659 0.742 . . . . 0.0 110.514 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 p -52.25 -33.81 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.232 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.555 HD11 HD22 ' A' ' 53' ' ' LEU . 16.9 mt -73.02 -31.82 64.72 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.849 0.357 . . . . 0.0 111.171 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.21 -36.03 82.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.015 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -79.94 -2.93 45.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.213 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.35 146.54 23.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 111.046 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.42 -24.83 30.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.323 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 p -87.57 -175.5 5.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.787 0.327 . . . . 0.0 110.795 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -75.84 -16.46 60.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.284 0.564 . . . . 0.0 109.758 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.6 p -91.89 8.86 35.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.479 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.457 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -76.91 114.45 39.48 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.686 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 14.0 Cg_exo -69.09 130.17 19.67 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.806 2.338 . . . . 0.0 111.926 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.45 -36.92 85.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.977 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.494 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 13.5 mmtp -103.65 100.54 10.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.465 -171.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 35.2 p90 -138.29 130.9 29.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.047 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.4 pt -116.84 132.86 65.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 72' ' ' VAL . 7.7 p -115.24 129.22 71.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.263 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 84.8 m -136.63 136.6 39.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.479 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 72' ' ' VAL . 4.2 mm? -90.51 114.36 26.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.653 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.27 173.64 42.18 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.533 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.3 m -147.14 169.97 18.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.795 0.331 . . . . 0.0 110.436 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.8 m -105.11 122.5 46.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.246 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.692 HG22 HG13 ' A' ' 37' ' ' ILE . 30.5 p -100.94 123.63 45.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.402 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -105.63 153.44 21.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.183 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -73.94 138.03 76.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.867 0.365 . . . . 0.0 111.262 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.581 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 36.3 Cg_endo -65.52 136.72 47.66 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.872 2.381 . . . . 0.0 111.69 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.714 ' HA ' ' CD ' ' A' ' 140' ' ' GLU . 81.3 m-70 64.98 13.76 8.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.876 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 26.7 tt0 -108.21 -54.68 2.47 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 171.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 143' ' ' ILE . 66.3 tp -57.79 -41.17 81.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.718 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.714 ' CD ' ' HA ' ' A' ' 137' ' ' HIS . 7.0 pt-20 -59.1 -38.15 78.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -76.39 -30.78 57.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.71 0.291 . . . . 0.0 110.806 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 9.5 mm-40 -61.51 -41.5 97.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.0 110.035 175.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.592 ' HA ' ' HB2' ' A' ' 148' ' ' TRP . 76.2 mt -58.61 -40.44 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.629 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.44 65.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.895 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.447 HE21 ' HA ' ' A' ' 142' ' ' GLU . 36.5 mt-30 -82.44 -1.08 49.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.946 -0.115 . . . . 0.0 111.041 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 71.3 11.58 6.74 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.713 0.633 . . . . 0.0 110.126 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -77.1 -24.65 51.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.927 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.618 ' CZ3' ' HB2' ' A' ' 12' ' ' ALA . 95.3 m95 -130.49 138.98 50.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.018 174.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.923 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 98.3 mt -100.91 157.7 16.53 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.8 tp -129.55 134.37 47.71 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.667 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.1 t -154.47 143.28 20.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.465 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.437 ' HG3' ' HG3' ' A' ' 8' ' ' LYS . 4.6 mp0 -73.13 154.63 40.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.44 -26.78 24.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.998 0.427 . . . . 0.0 110.509 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.4 m120 55.59 21.92 4.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.009 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 70.59 -51.47 0.67 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.435 0.694 . . . . 0.0 111.815 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.443 ' HA ' ' CB ' ' A' ' 160' ' ' GLU . 36.2 mt-30 -64.14 -50.02 69.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.098 -173.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.7 m -61.84 -29.45 70.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.109 0.48 . . . . 0.0 110.69 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.38 -57.76 3.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.907 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -120.99 -38.18 2.86 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.443 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 26.3 tt0 -56.87 -58.23 9.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.775 0.321 . . . . 0.0 111.238 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.5 t . . . . . 0 CA--C 1.535 0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.924 -173.155 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.638 0.733 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -104.74 -37.34 7.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.071 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.73 -47.0 83.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.492 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -71.95 -30.9 65.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.791 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 175' ' ' GLY . 31.8 tt0 -68.07 -31.56 71.28 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.683 0.278 . . . . 0.0 110.714 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.502 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 20.1 mmt -58.73 -28.68 66.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.977 0.418 . . . . 0.0 110.858 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.4 tp -96.74 -57.73 2.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.696 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 172' ' ' GLU . . . . . . . . 0 N--CA 1.443 -0.85 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 31' ' ' HIS . 54.7 t30 . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.3 mt -123.89 -83.29 0.65 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.588 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 63.76 152.51 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.776 0.798 . . . . 0.0 111.713 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.37 23.71 70.29 Favored Glycine 0 C--N 1.316 -0.558 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.907 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.556 ' NZ ' ' HG3' ' A' ' 152' ' ' GLU . 71.0 mmtt -110.75 164.83 12.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 29.3 p90 -144.13 153.24 41.94 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 172.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.549 ' O ' HG21 ' A' ' 25' ' ' VAL . 4.5 pt -117.72 127.03 75.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.046 0.451 . . . . 0.0 111.098 -176.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.714 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 53.8 mt -94.41 112.95 28.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.287 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 148' ' ' TRP . . . -158.7 124.1 4.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.318 172.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p . . . . . 0 C--N 1.32 -0.693 0 CA-C-O 121.108 0.48 . . . . 0.0 110.898 -177.65 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HD3' ' HA ' ' A' ' 23' ' ' ARG . 32.9 mmt180 . . . . . 0 C--O 1.233 0.231 0 CA-C-O 121.503 0.668 . . . . 0.0 111.756 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.649 ' O ' HG22 ' A' ' 25' ' ' VAL . 32.0 p -96.61 89.96 5.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.498 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.77 HG12 HD21 ' A' ' 42' ' ' ASN . 1.9 m 62.51 174.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.427 1.091 . . . . 0.0 111.911 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.541 HG13 ' H ' ' A' ' 27' ' ' TYR . 11.1 tp -156.22 -142.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.541 ' H ' HG13 ' A' ' 26' ' ' ILE . 1.1 p90 -109.49 170.08 8.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 119.552 1.069 . . . . 0.0 112.277 -163.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.83 126.87 49.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.617 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 55.6 m -78.49 -59.28 2.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.39 159.89 33.96 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.454 0.645 . . . . 0.0 111.742 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.448 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 49.0 t-80 -144.13 142.0 30.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.355 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.449 ' ND2' ' H ' ' A' ' 33' ' ' ASP . 3.6 t-20 83.88 177.98 0.05 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.553 1.158 . . . . 0.0 109.091 -177.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.449 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 33.3 t70 68.24 -76.2 0.06 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.22 0.608 . . . . 0.0 110.893 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.489 ' HB3' HD11 ' A' ' 37' ' ' ILE . 8.4 t30 -93.18 -34.44 13.61 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.49 -110.11 0.44 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.181 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 133' ' ' THR . 11.0 m -136.32 105.25 5.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 133' ' ' THR . 4.1 mp -98.97 112.02 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.444 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.67 170.22 31.16 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.517 HG23 ' CG2' ' A' ' 26' ' ' ILE . 2.8 m -120.58 76.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.649 0.737 . . . . 0.0 111.004 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.501 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -121.9 20.91 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 -176.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.419 HG23 HG22 ' A' ' 43' ' ' THR . 10.1 tp -73.05 -24.11 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.033 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.77 HD21 HG12 ' A' ' 25' ' ' VAL . 86.6 m-20 53.63 82.87 0.08 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.274 0.63 . . . . 0.0 112.299 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 6.5 t -172.81 113.45 0.36 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.433 0.635 . . . . 0.0 110.881 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 50.9 Cg_endo -71.94 153.92 58.17 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.078 1.852 . . . . 0.0 110.482 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.431 HG22 HD22 ' A' ' 74' ' ' ASN . 11.2 p -96.65 169.93 9.55 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.773 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.33 5.88 11.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.91 161.31 17.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 57.6 p -116.4 160.89 19.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.337 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 12.5 p -67.72 -32.89 58.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.966 0.412 . . . . 0.0 110.361 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.553 HD23 HD12 ' A' ' 53' ' ' LEU . 59.6 mt -73.82 -32.02 63.52 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.993 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -57.46 -53.33 59.38 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.15 -43.83 70.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.237 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.553 HD12 HD23 ' A' ' 50' ' ' LEU . 80.9 mt -62.3 -45.56 92.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.267 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.8 p -73.47 -32.88 64.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.056 0.455 . . . . 0.0 111.314 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -67.74 -34.65 77.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.944 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 47.3 mtt . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.203 178.769 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.266 0.555 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -99.85 129.66 45.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.665 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 91.5 mtp -75.85 136.12 40.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.236 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 129' ' ' LEU . 14.0 p -88.98 141.48 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 7.4 mp -95.98 161.56 13.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.235 0.541 . . . . 0.0 111.099 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.431 HD22 HG22 ' A' ' 45' ' ' THR . 2.0 t-20 -92.37 132.71 36.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.941 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -88.22 -25.37 31.45 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.263 -0.97 . . . . 0.0 111.908 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.42 176.72 27.04 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.93 -17.84 22.12 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.971 2.447 . . . . 0.0 112.67 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.9 t -98.7 143.95 12.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.045 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 m120 62.95 31.76 15.99 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.975 0.51 . . . . 0.0 112.052 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -71.56 -10.12 59.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -80.7 -0.12 36.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.349 . . . . 0.0 110.262 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -122.49 133.77 54.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.607 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.23 110.42 3.63 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.516 ' HB3' HD11 ' A' ' 106' ' ' LEU . 93.7 m-85 -92.35 124.85 36.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.694 0.283 . . . . 0.0 110.322 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 112' ' ' VAL . 2.7 mp -121.56 112.63 36.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.409 0.623 . . . . 0.0 110.224 177.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 66.0 t -90.74 110.96 22.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.198 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -137.28 165.01 27.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.704 0.287 . . . . 0.0 111.569 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.7 p -81.75 159.46 23.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.004 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 90' ' ' THR . 58.5 tttm -87.47 140.73 29.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.931 0.396 . . . . 0.0 110.144 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -95.06 -170.71 2.25 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.417 ' H ' HG22 ' A' ' 90' ' ' THR . 6.7 p-10 -64.2 -35.09 79.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.157 0.503 . . . . 0.0 110.118 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -83.4 163.54 20.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.684 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.44 -172.38 4.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.08 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -132.14 162.72 30.18 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.8 m -80.96 -47.0 14.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.876 0.37 . . . . 0.0 110.515 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.473 ' O ' HG23 ' A' ' 107' ' ' THR . 7.7 t60 -145.28 97.29 2.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.692 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.432 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 66.7 m -135.56 152.72 51.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.044 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -101.66 114.39 28.4 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 102' ' ' ASP . 88.3 tttt -78.14 102.33 7.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 0.0 110.727 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.438 HG11 ' HE2' ' A' ' 27' ' ' TYR . 40.3 t -86.11 -53.83 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.57 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 36.8 p -116.01 176.67 4.99 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 4.8 t70 -86.32 52.32 2.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.264 0.554 . . . . 0.0 110.289 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.557 ' HB3' HD21 ' A' ' 155' ' ' ASN . 28.6 t70 177.65 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.891 178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.503 HG21 HD13 ' A' ' 158' ' ' LEU . 48.1 mm -90.3 124.38 42.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.123 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 97' ' ' SER . 0.5 OUTLIER -121.36 139.14 53.82 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.443 -176.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 84' ' ' PHE . 65.5 tp -101.12 112.41 24.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.274 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 96' ' ' HIS . 18.8 m -99.93 130.33 46.09 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.238 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -114.18 10.88 17.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.074 -174.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.0 m -132.19 -177.46 4.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.254 . . . . 0.0 110.926 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.458 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -70.7 4.85 8.48 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.688 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.454 ' HB3' HG21 ' A' ' 107' ' ' THR . 17.4 t0 -61.13 -29.54 69.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.331 0.586 . . . . 0.0 109.451 174.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.539 HG21 HD13 ' A' ' 85' ' ' ILE . 47.0 t -57.48 -39.42 68.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.732 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.509 HD13 ' CZ ' ' A' ' 116' ' ' PHE . 4.1 mm? -61.6 -32.51 72.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.594 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -81.87 -32.89 30.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.952 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 47.4 m -57.99 -51.93 67.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.415 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.517 ' HA ' ' HB1' ' A' ' 121' ' ' ALA . 10.7 p90 -92.73 8.89 37.35 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.746 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -104.81 37.02 4.01 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.62 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 t -151.47 165.46 34.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -67.81 -22.58 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.133 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 p -104.71 42.3 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.246 0.546 . . . . 0.0 110.832 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.517 ' HB1' ' HA ' ' A' ' 116' ' ' PHE . . . -64.19 140.58 97.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.093 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 12.2 Cg_exo -68.95 124.04 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.337 2.025 . . . . 0.0 111.025 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.66 -28.35 58.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.743 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -105.88 105.36 15.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.061 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 46.4 p90 -157.24 146.3 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.159 0.504 . . . . 0.0 111.587 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.7 142.83 39.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.566 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.18 131.7 66.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.903 0.382 . . . . 0.0 111.11 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 77.6 m -142.98 141.1 31.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.414 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.542 HD23 HG21 ' A' ' 72' ' ' VAL . 4.1 mm? -94.02 119.25 32.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.255 177.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.502 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 78.35 -179.86 51.52 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.476 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.4 m -147.99 169.31 20.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.906 0.384 . . . . 0.0 110.005 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.839 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 30.2 m -106.85 126.96 52.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.779 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 36' ' ' THR . 39.4 p -114.49 119.69 37.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.425 0.631 . . . . 0.0 112.136 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.839 ' HZ3' ' HB3' ' A' ' 132' ' ' SER . 1.3 m-90 -99.94 136.27 40.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.025 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -83.23 147.54 53.84 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.315 -175.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 137' ' ' HIS . 21.6 Cg_exo -66.55 73.82 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.656 2.904 . . . . 0.0 112.736 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 136' ' ' PRO . 17.4 p-80 167.17 -23.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.652 1.181 . . . . 0.0 108.083 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.585 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 63.0 tt0 -84.68 -67.35 0.8 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.51 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 134' ' ' TRP . 51.2 tp -60.52 -44.88 95.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.114 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -61.18 -42.13 98.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.741 -0.208 . . . . 0.0 111.429 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.585 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.6 mp0 -68.44 -35.58 77.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.636 0.255 . . . . 0.0 110.676 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 8.6 mm-40 -64.01 -46.51 84.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.268 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.659 HG12 ' HB2' ' A' ' 148' ' ' TRP . 68.6 mt -62.07 -41.17 90.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.581 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.52 81.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.459 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.585 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 40.6 mt-30 -82.46 7.11 15.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 67.03 37.14 3.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.834 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -83.98 -48.15 10.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.134 0.492 . . . . 0.0 109.893 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.659 ' HB2' HG12 ' A' ' 143' ' ' ILE . 96.7 m95 -107.37 130.18 54.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.486 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.714 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.9 tt -91.21 103.3 15.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 8' ' ' LYS . 55.2 tp -82.66 133.68 35.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.022 0.439 . . . . 0.0 111.198 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.8 m -145.32 172.89 12.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.126 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.556 ' HG3' ' NZ ' ' A' ' 8' ' ' LYS . 5.2 mp0 -96.65 153.44 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.234 0.54 . . . . 0.0 111.791 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -119.72 108.49 14.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.125 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -79.94 49.39 1.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -170.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.557 HD21 ' HB3' ' A' ' 103' ' ' ASP . 0.2 OUTLIER 64.7 -74.22 0.05 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.491 0.716 . . . . 0.0 111.361 175.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -61.47 -25.53 67.3 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.702 0.401 . . . . 0.0 111.132 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.902 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 13.6 m -52.73 -29.66 28.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.028 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.503 HD13 HG21 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -63.12 -44.03 96.76 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -175.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.67 -3.15 2.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -117.64 -37.25 3.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.902 ' HB ' ' HA ' ' A' ' 157' ' ' THR . 9.7 m . . . . . 0 C--N 1.324 -0.5 0 O-C-N 122.404 -0.185 . . . . 0.0 110.893 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.23 0.067 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.402 ' H ' ' HG3' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -57.27 -49.24 76.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.082 -170.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.49 83.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.045 0.45 . . . . 0.0 111.257 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -68.53 -37.54 80.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.305 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -64.02 -28.33 69.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.563 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -55.89 -34.57 65.64 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 110.271 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.0 tp -102.0 -55.09 2.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.157 0.503 . . . . 0.0 110.29 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.985 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.349 -175.896 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 N--CA 1.467 0.377 0 CA-C-O 121.591 0.71 . . . . 0.0 112.611 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 96.8 mt -86.16 -10.99 53.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.128 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -65.98 127.27 31.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.959 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.24 0.84 79.72 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.615 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -115.22 -177.33 3.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.665 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 44.1 p90 -151.24 161.68 42.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 139' ' ' LEU . 16.6 pt -121.32 129.19 75.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.519 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.757 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.6 mp -75.22 107.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.286 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.455 ' H ' HG21 ' A' ' 25' ' ' VAL . . . -79.43 101.05 7.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.8 m . . . . . 0 C--N 1.321 -0.662 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.31 179.691 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 . . . . . 0 C--O 1.234 0.243 0 CA-C-O 121.324 0.583 . . . . 0.0 112.265 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.7 t -118.72 117.42 28.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.503 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.699 HG13 HG22 ' A' ' 40' ' ' ILE . 59.3 t 69.19 153.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.151 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.514 HG13 ' HD1' ' A' ' 27' ' ' TYR . 7.0 tp -136.68 -57.42 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.025 173.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.665 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 6.0 p90 -177.73 175.3 1.37 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 111.639 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 5' ' ' LEU . 50.3 mm -103.86 127.66 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.613 176.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.5 m -81.33 -53.31 6.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.723 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.51 160.82 36.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.512 0.672 . . . . 0.0 112.315 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.531 ' O ' ' HB3' ' A' ' 32' ' ' ASN . 84.3 t60 -164.12 136.23 4.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.58 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 21.7 t-20 86.68 -38.96 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.229 0.956 . . . . 0.0 110.513 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 30.1 t70 -73.74 97.02 2.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 33' ' ' ASP . 28.9 t-20 76.33 -38.99 0.34 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.883 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.03 -141.76 5.73 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.552 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.2 m -125.03 112.75 16.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.066 0.433 . . . . 0.0 110.125 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 37' ' ' ILE . 4.0 mp -110.96 121.15 63.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.07 171.8 31.4 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.057 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.82 91.86 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.555 0.693 . . . . 0.0 110.423 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.699 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -136.4 18.41 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.066 -175.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 tp -64.52 -29.7 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.183 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 58.98 82.47 0.14 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.114 0.483 . . . . 0.0 111.801 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 t -175.82 121.54 0.32 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 65.0 Cg_endo -78.59 153.66 26.82 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.313 2.009 . . . . 0.0 110.735 171.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.1 p -101.59 177.96 4.77 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.065 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -81.56 -17.36 48.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.19 0.519 . . . . 0.0 110.345 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.5 tp -80.28 150.66 29.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.443 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 34.9 t -103.51 151.35 22.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.073 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 14.1 p -65.8 -30.09 48.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.303 0.573 . . . . 0.0 109.692 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.0 mt -74.1 -26.76 60.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.023 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 48' ' ' SER . 5.8 mm-40 -69.83 -44.13 70.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.155 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.3 pp -68.9 -34.26 75.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.706 0.289 . . . . 0.0 110.724 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.0 mt -64.81 -48.85 72.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.34 . . . . 0.0 110.75 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.0 p -69.2 -30.15 68.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.061 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.4 tpt85 -62.51 -30.74 71.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.556 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 81.0 mtp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.556 176.368 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 t0 . . . . . 0 N--CA 1.452 -0.35 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -103.25 115.42 30.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.183 0.516 . . . . 0.0 110.773 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.552 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 55.2 mtt -83.26 125.5 31.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.79 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 129' ' ' LEU . 14.9 p -69.7 144.31 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.832 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 6.7 mp -96.71 157.68 15.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.997 0.427 . . . . 0.0 110.606 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.42 146.78 26.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.398 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -103.84 -27.07 6.47 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.758 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.87 167.66 17.66 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.696 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.25 -17.97 44.85 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 123.058 2.505 . . . . 0.0 113.143 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.446 HG21 ' OG1' ' A' ' 133' ' ' THR . 48.9 t -94.73 132.13 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.813 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 63.36 31.25 15.31 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.593 0.558 . . . . 0.0 110.852 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -12.18 61.44 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.105 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -79.02 -7.98 58.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -127.36 138.63 53.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.044 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.93 132.0 10.89 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.499 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.548 ' HB3' HD11 ' A' ' 106' ' ' LEU . 82.1 m-85 -106.79 126.11 51.87 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.557 HG21 HG11 ' A' ' 112' ' ' VAL . 2.6 mp -119.59 106.28 18.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.394 0.616 . . . . 0.0 110.925 -176.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.68 HG22 HD13 ' A' ' 106' ' ' LEU . 12.1 t -91.57 138.03 20.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.403 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.404 ' HE1' ' OG1' ' A' ' 107' ' ' THR . 52.6 p-80 -149.89 156.34 41.6 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.672 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.5 m -76.09 170.86 15.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.707 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -78.26 116.82 18.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.31 0.576 . . . . 0.0 110.977 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.6 m -140.27 -44.99 0.42 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -95.95 165.82 12.08 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -117.22 14.61 14.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.583 0.706 . . . . 0.0 109.997 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -100.64 163.33 12.39 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.789 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.2 p90 176.18 127.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.254 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 m -97.97 -49.96 4.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.187 0.518 . . . . 0.0 109.806 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.442 ' HB2' ' OG ' ' A' ' 109' ' ' SER . 12.7 m-70 -135.6 102.18 5.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.534 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.1 p -135.94 152.95 51.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.969 -177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -109.6 136.58 48.74 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 170.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 102' ' ' ASP . 87.1 tttt -90.1 105.49 17.84 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.0 t -79.16 -55.49 9.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.7 p -132.59 -175.89 3.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.583 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.426 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 11.5 m-20 -73.95 -13.81 60.94 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.898 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -105.56 -58.68 1.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.302 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.799 HD12 ' HD2' ' A' ' 159' ' ' PHE . 42.1 mm -67.96 122.79 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.117 0.484 . . . . 0.0 110.414 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 m -127.2 124.57 39.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.317 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.68 HD13 HG22 ' A' ' 86' ' ' VAL . 25.8 tp -96.0 115.55 27.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.547 174.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.854 HG21 ' HB2' ' A' ' 111' ' ' ASP . 42.1 m -117.64 126.91 53.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.481 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.6 p -96.8 -10.58 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.487 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.442 ' OG ' ' HB2' ' A' ' 96' ' ' HIS . 38.9 m -95.27 179.62 5.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.636 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.21 5.37 34.83 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.903 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.854 ' HB2' HG21 ' A' ' 107' ' ' THR . 25.7 m-20 -54.88 -40.45 69.75 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.58 ' CG2' ' HB ' ' A' ' 107' ' ' THR . 22.6 t -57.58 -48.98 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.805 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.28 -34.99 75.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.714 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -59.08 -46.66 87.71 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.749 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.4 m -66.2 -44.54 83.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.137 0.494 . . . . 0.0 110.873 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -68.42 -24.18 64.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.428 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -91.31 6.72 80.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.592 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.1 p -128.85 -162.58 1.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.95 0.375 . . . . 0.0 111.331 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.89 0.51 34.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 111.603 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 p -113.83 25.68 10.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.085 0.469 . . . . 0.0 111.331 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -60.26 124.09 76.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.162 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 2.8 Cg_endo -82.19 129.29 5.95 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.41 2.74 . . . . 0.0 111.958 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.54 -35.16 78.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.649 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -104.33 109.02 20.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.903 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 24.6 p90 -153.05 144.09 23.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.808 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.548 HG12 ' HZ ' ' A' ' 159' ' ' PHE . 30.4 pt -136.56 147.67 27.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.183 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.483 HG23 HG13 ' A' ' 85' ' ' ILE . 7.7 p -128.26 131.34 69.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.016 0.436 . . . . 0.0 110.789 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 26.6 p -133.31 144.03 49.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.399 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 72' ' ' VAL . 3.8 mm? -92.05 110.56 21.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.465 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.413 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 83.91 -179.18 52.13 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.777 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.1 m -147.73 169.55 19.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.349 . . . . 0.0 110.101 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.597 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 38.9 m -108.02 125.4 51.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.055 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.446 ' OG1' HG21 ' A' ' 78' ' ' VAL . 18.1 p -107.66 127.37 53.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.217 0.532 . . . . 0.0 111.565 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.597 ' HZ3' ' HB3' ' A' ' 132' ' ' SER . 1.0 OUTLIER -115.43 150.6 36.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.246 175.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.428 ' HD2' ' H ' ' A' ' 135' ' ' LYS . 10.6 mptt -74.17 151.49 88.07 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.054 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.19 129.55 34.83 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.652 2.235 . . . . 0.0 111.867 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 72.2 -6.09 1.61 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.521 0.729 . . . . 0.0 112.299 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 7.4 tp60 -73.29 -57.53 3.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.936 0.398 . . . . 0.0 110.296 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 10' ' ' ILE . 44.3 tp -64.0 -34.52 78.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.198 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.48 -40.89 83.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.368 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.595 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.0 OUTLIER -65.11 -48.1 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.295 177.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 148' ' ' TRP . 50.5 mt-10 -57.43 -40.14 77.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.312 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 139' ' ' LEU . 80.5 mt -62.28 -44.13 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 0.0 110.449 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.91 73.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.007 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 84.3 mt-30 -79.47 6.2 10.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.179 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 65.14 25.31 12.44 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.113 0.565 . . . . 0.0 112.239 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -84.17 -17.8 38.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.13 0.49 . . . . 0.0 109.963 173.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.417 ' CD1' ' HB3' ' A' ' 142' ' ' GLU . 89.5 m95 -135.52 137.5 42.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.22 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.757 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 87.2 mt -94.6 138.05 32.96 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.9 tp -111.51 136.72 50.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.418 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.9 t -156.2 160.68 40.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.274 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -87.37 154.01 21.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.903 0.383 . . . . 0.0 110.439 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.07 -36.5 3.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.836 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 58.3 t30 49.67 -97.9 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.528 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -140.18 -17.52 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.725 0.298 . . . . 0.0 110.539 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.684 ' HA ' ' HB3' ' A' ' 160' ' ' GLU . 2.1 mt-30 -73.62 -72.67 0.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.199 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.3 m -58.15 -29.26 65.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.027 0.441 . . . . 0.0 110.856 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -58.18 7.85 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.106 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.799 ' HD2' HD12 ' A' ' 104' ' ' ILE . 14.3 m-85 -135.05 -39.3 0.77 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.684 ' HB3' ' HA ' ' A' ' 156' ' ' GLN . 21.4 tt0 -62.7 -25.69 68.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.853 -170.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 120.648 0.261 . . . . 0.0 110.394 177.689 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.001 0.429 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -73.05 -11.64 60.63 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.101 0.477 . . . . 0.0 110.104 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.567 ' HB1' ' HE2' ' A' ' 9' ' ' PHE . . . -56.91 -45.94 82.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.554 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -81.34 -27.11 35.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.033 0.444 . . . . 0.0 110.175 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.38 -30.88 71.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.445 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 88.1 mmm -62.37 -28.65 69.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.934 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.61 -49.34 5.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.261 0.553 . . . . 0.0 110.369 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.026 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -176.085 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 94.0 m-20 . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.422 HD21 HD11 ' A' ' 150' ' ' LEU . 81.8 mt 73.58 13.73 4.39 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 175.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -69.33 134.81 49.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 172.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.31 32.21 65.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.313 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -126.21 -177.89 4.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 4.3 p90 -149.55 148.92 29.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.023 0.44 . . . . 0.0 111.082 170.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.504 HG12 HD11 ' A' ' 28' ' ' ILE . 10.2 pt -118.96 128.86 75.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.344 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.678 HD13 HD22 ' A' ' 149' ' ' LEU . 4.3 mp -98.35 136.84 27.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.537 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.5 -174.5 4.25 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.0 m . . . . . 0 CA--C 1.536 0.423 0 CA-C-O 121.497 0.665 . . . . 0.0 111.685 177.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.44 ' CZ ' HD11 ' A' ' 73' ' ' LEU . 49.2 mtm180 . . . . . 0 C--O 1.233 0.217 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -82.1 108.5 15.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.017 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.0 t 74.3 133.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.22 0.608 . . . . 0.0 111.886 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.54 HG23 ' H ' ' A' ' 27' ' ' TYR . 6.3 tp -135.0 -65.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.66 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -177.61 177.43 1.14 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.606 0.639 . . . . 0.0 111.781 -177.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.504 HD11 HG12 ' A' ' 10' ' ' ILE . 34.0 mm -103.22 133.64 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.288 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.9 m -81.23 -59.54 2.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.371 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -165.09 157.52 15.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.185 0.517 . . . . 0.0 111.26 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 4' ' ' ASN . 11.8 t-80 -103.3 132.01 49.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.245 174.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -129.12 172.0 11.85 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.6 -36.5 78.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.931 0.396 . . . . 0.0 111.035 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -72.42 -22.83 61.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.135 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.554 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 156.01 -177.77 32.9 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.131 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 m -97.76 121.6 39.86 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.698 HG13 HG22 ' A' ' 133' ' ' THR . 4.3 mp -88.54 117.45 32.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.253 -175.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.07 151.02 22.68 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.195 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 m -116.67 93.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.512 0.672 . . . . 0.0 110.764 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.434 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -132.95 13.3 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.294 -176.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 pt -79.71 -26.91 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.569 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.4 t30 59.07 91.93 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.76 0.663 . . . . 0.0 112.13 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 43' ' ' THR . 9.2 t -156.72 93.63 2.36 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 122.06 0.933 . . . . 0.0 110.941 175.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 93.9 Cg_endo -81.96 157.49 18.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.665 2.243 . . . . 0.0 111.697 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.8 p -121.6 156.72 32.35 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -12.26 60.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.934 0.397 . . . . 0.0 110.692 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.7 tp -71.36 144.51 49.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.602 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.821 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 59.5 m -105.65 157.6 17.3 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.458 -174.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.1 p -65.89 -34.15 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.925 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.82 -36.78 85.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.936 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.821 ' HG2' ' HB2' ' A' ' 48' ' ' SER . 26.9 mm-40 -58.68 -45.87 88.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.775 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.76 -42.34 97.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.854 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 97.8 mt -65.77 -41.66 91.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.323 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.4 p -71.9 -31.17 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.437 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -63.32 -36.5 83.9 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.813 0.34 . . . . 0.0 110.254 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 C--N 1.329 -0.318 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.057 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -126.86 113.24 16.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.937 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.624 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.8 mtt -82.0 148.64 28.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.235 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.431 HG21 HD23 ' A' ' 129' ' ' LEU . 13.7 p -96.7 147.76 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.134 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 6.6 mp -108.46 155.09 20.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.987 0.422 . . . . 0.0 110.554 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -94.32 121.13 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.72 -23.14 43.57 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.742 -173.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 153.87 174.56 24.18 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.033 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.61 -21.56 14.63 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.767 2.312 . . . . 0.0 113.085 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.408 HG21 ' OG1' ' A' ' 133' ' ' THR . 51.9 t -81.4 131.19 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 60.31 30.89 20.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.127 0.489 . . . . 0.0 110.155 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -59.15 -27.75 65.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.208 -173.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.67 -7.61 56.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.909 0.385 . . . . 0.0 111.224 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.6 mtm-85 -118.14 131.69 56.39 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.126 0.489 . . . . 0.0 111.142 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.56 118.3 5.08 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.358 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.505 ' HB3' HD11 ' A' ' 106' ' ' LEU . 85.9 m-85 -91.99 125.88 36.85 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.506 0.194 . . . . 0.0 110.494 -178.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.673 ' HB ' HG11 ' A' ' 112' ' ' VAL . 4.3 mp -112.94 110.62 32.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.182 0.515 . . . . 0.0 109.646 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 40.6 t -91.86 119.15 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.399 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -129.51 152.38 49.1 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.427 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -62.88 156.36 24.45 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.516 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -74.58 117.94 16.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.532 0.682 . . . . 0.0 110.218 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.6 m -140.41 157.64 45.22 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -64.85 124.71 22.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.688 0.756 . . . . 0.0 110.934 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -173.36 138.61 0.72 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.646 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.35 160.99 14.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -106.06 113.16 26.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.603 0.716 . . . . 0.0 111.67 -173.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.3 m -83.13 -45.09 14.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.477 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.98 37.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -77.66 125.02 28.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.926 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -105.46 136.08 45.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.446 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -86.59 128.85 35.02 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.781 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 72.0 t -70.39 -54.86 16.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -134.79 -48.53 0.75 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.96 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -176.38 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.951 169.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.42 -13.03 60.37 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.101 0.477 . . . . 0.0 111.245 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' ' 100' ' ' VAL . 24.8 mm -105.06 124.24 59.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.0 m -117.36 130.41 56.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.1 0.476 . . . . 0.0 111.538 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 84' ' ' PHE . 67.1 tp -107.79 128.15 54.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.23 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 1.024 HG21 ' HB3' ' A' ' 111' ' ' ASP . 12.1 m -142.58 137.32 30.01 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.129 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 p -120.47 3.21 10.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.391 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.591 ' O ' HG22 ' A' ' 112' ' ' VAL . 15.2 m -109.61 -173.55 2.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.403 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.69 -15.61 13.21 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.907 -0.588 . . . . 0.0 114.541 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 1.024 ' HB3' HG21 ' A' ' 107' ' ' THR . 11.6 t70 -49.43 -46.66 47.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.247 0.523 . . . . 0.0 110.961 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.673 HG11 ' HB ' ' A' ' 85' ' ' ILE . 31.9 m -60.54 -39.61 81.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.634 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.526 HD13 ' CZ ' ' A' ' 116' ' ' PHE . 4.3 mm? -70.84 -42.73 69.78 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.356 0.598 . . . . 0.0 110.059 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.44 -28.47 66.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.019 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 65.5 m -54.34 -57.0 12.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.561 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.526 ' CZ ' HD13 ' A' ' 113' ' ' LEU . 37.8 p90 -84.24 13.38 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.274 0.559 . . . . 0.0 110.914 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -106.1 9.17 42.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.521 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.4 t -137.44 176.32 8.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -79.68 -9.72 59.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.864 0.364 . . . . 0.0 111.085 -173.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 p -104.03 25.96 9.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.332 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -54.34 121.59 32.53 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.199 174.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 17.2 Cg_exo -67.06 145.58 73.93 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.977 2.451 . . . . 0.0 112.464 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.47 -42.97 82.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.489 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -107.89 125.06 51.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.155 -170.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 42.0 p90 -158.44 133.68 8.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.224 176.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 30.7 pt -124.83 147.95 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.245 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.7 p -122.64 129.16 75.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.193 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.6 p -138.99 132.23 29.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.296 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 72' ' ' VAL . 3.5 mm? -80.82 114.09 19.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.391 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.59 178.26 39.84 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.402 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 75.4 m -147.71 172.08 14.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.7 m -111.78 132.37 54.71 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.698 HG22 HG13 ' A' ' 37' ' ' ILE . 34.9 p -112.4 117.02 31.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.003 0.43 . . . . 0.0 111.028 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -94.67 116.91 29.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.127 0.489 . . . . 0.0 110.15 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 4.4 mptp? -60.22 136.44 91.33 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.546 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.554 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 10.2 Cg_exo -72.14 54.92 2.31 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.706 2.937 . . . . 0.0 113.367 -175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -154.91 -55.21 0.1 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.562 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.0 tp60 -63.34 -35.93 82.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.287 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.34 -35.78 74.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.931 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.15 -41.54 94.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.038 0.447 . . . . 0.0 109.831 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.523 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 32.8 mm-40 -64.87 -47.56 77.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.703 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 16.2 mm-40 -54.61 -50.95 66.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.131 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.794 HG12 ' HB2' ' A' ' 148' ' ' TRP . 67.0 mt -68.57 -36.32 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.205 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.35 75.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 21.6 mt-30 -81.95 12.93 3.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.502 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 68.02 24.28 7.9 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.379 0.672 . . . . 0.0 112.318 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -92.59 -5.67 51.13 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.943 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.794 ' HB2' HG12 ' A' ' 143' ' ' ILE . 95.4 m95 -140.48 130.79 25.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.819 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.678 HD22 HD13 ' A' ' 11' ' ' ILE . 6.5 tt -92.96 117.26 29.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.422 HD11 HD21 ' A' ' 5' ' ' LEU . 9.3 tt -95.39 133.85 38.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.974 0.416 . . . . 0.0 110.889 -175.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.472 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 35.5 t -151.52 154.74 37.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.246 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -79.52 156.4 27.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . . . -126.59 -139.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.1 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.4 t30 61.69 53.63 3.19 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.913 0.863 . . . . 0.0 109.483 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -151.48 169.08 22.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.778 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -54.37 -25.74 26.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.951 0.501 . . . . 0.0 112.165 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -53.51 -28.19 29.68 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 122.581 0.352 . . . . 0.0 111.721 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.5 -57.12 7.98 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -127.66 0.06 6.13 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.06 12.33 17.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.329 0.585 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.32 -0.703 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.042 174.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 121.135 0.493 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.22 -7.8 26.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.263 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.406 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -57.66 -34.09 69.0 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -74.22 -43.17 58.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.732 0.301 . . . . 0.0 111.046 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.71 -20.85 45.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.872 0.368 . . . . 0.0 110.402 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 14.9 tpt -64.39 -33.64 76.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.23 0.538 . . . . 0.0 110.069 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.644 HD22 HD21 ' A' ' 149' ' ' LEU . 11.2 tp -83.06 -39.0 21.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.454 0.645 . . . . 0.0 109.336 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.567 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.115 179.211 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.4 t30 . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.855 0.36 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.44 -8.77 37.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.918 -173.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 30' ' ' GLU . 11.1 pt20 -82.61 149.52 27.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.69 4.19 79.8 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.344 -173.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HG3' ' HA ' ' A' ' 152' ' ' GLU . 11.3 mptt -121.87 179.0 4.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.648 ' HZ ' ' HG2' ' A' ' 173' ' ' MET . 2.2 p90 -149.31 139.36 22.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.239 0.542 . . . . 0.0 110.485 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 pt -108.85 127.72 65.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.294 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.79 HD13 HD22 ' A' ' 149' ' ' LEU . 4.5 mp -100.08 129.48 50.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.813 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.04 93.12 2.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.469 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 C--N 1.324 -0.505 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.357 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 121.12 0.486 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.611 ' HB ' ' HA ' ' A' ' 42' ' ' ASN . 44.5 p -94.76 137.09 34.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.21 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.648 HG13 HG22 ' A' ' 40' ' ' ILE . 78.7 t 78.02 119.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 123.838 0.711 . . . . 0.0 111.656 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.5 tp -121.88 -55.64 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.366 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.606 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 2.8 p90 -178.69 172.63 1.37 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.027 0.442 . . . . 0.0 111.395 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.49 130.93 47.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.76 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.7 m -89.32 -42.65 11.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -170.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.524 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 42.0 tt0 -142.02 146.12 35.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 111.105 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -124.8 109.45 13.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.332 0.587 . . . . 0.0 110.529 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -95.06 176.6 6.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.67 -42.14 99.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 118.016 0.371 . . . . 0.0 111.325 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -119.87 4.82 10.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.29 0.567 . . . . 0.0 111.0 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.11 108.44 0.73 Allowed Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.943 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 m -100.34 105.98 17.56 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.676 HG13 HG22 ' A' ' 133' ' ' THR . 4.3 mp -88.75 114.27 26.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.722 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.95 173.9 32.53 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.866 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -121.01 83.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.608 0.718 . . . . 0.0 110.389 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.648 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -134.92 28.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.791 -176.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 43' ' ' THR . 11.0 tp -71.71 -16.71 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.383 -176.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.611 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 53.4 m-80 67.01 72.6 0.36 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.161 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 13.3 t 170.36 143.87 0.1 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HB3' HD23 ' A' ' 73' ' ' LEU . 49.5 Cg_endo -90.81 -170.59 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.957 2.438 . . . . 0.0 110.874 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.3 p -111.78 170.73 7.94 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -88.66 0.99 55.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.351 0.596 . . . . 0.0 110.021 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.17 162.28 13.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.253 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 2.0 m -105.13 158.19 16.75 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.35 -38.36 80.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.803 0.335 . . . . 0.0 110.757 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -65.31 -28.51 69.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -59.87 -44.31 94.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.47 -177.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.435 ' H ' HD12 ' A' ' 52' ' ' LEU . 4.9 mp -73.07 -43.81 61.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 110.176 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.5 mt -58.13 -45.84 86.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.552 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.9 p -73.34 -33.84 65.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.351 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -65.23 -41.95 93.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.796 0.331 . . . . 0.0 110.396 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 83.9 mtp . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.233 178.102 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -128.0 119.81 26.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.741 0.305 . . . . 0.0 110.29 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 89.9 mtp -84.44 131.67 34.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 p -81.7 127.77 39.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.139 0.495 . . . . 0.0 110.701 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 44' ' ' PRO . 87.9 mt -70.33 160.13 32.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.64 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.451 ' H ' ' HA ' ' A' ' 44' ' ' PRO . 7.1 t-20 -98.49 117.81 33.75 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -79.76 -33.06 35.0 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.968 -175.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.51 -176.29 29.17 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.073 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -87.4 5.6 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.157 2.571 . . . . 0.0 113.278 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.47 132.6 57.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 59.1 37.56 24.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 110.494 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -70.01 -10.86 60.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.67 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.29 5.78 29.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.927 0.394 . . . . 0.0 110.819 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -130.95 132.28 44.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.289 0.566 . . . . 0.0 111.66 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.96 118.8 5.03 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.531 ' HB3' HD11 ' A' ' 106' ' ' LEU . 66.0 m-85 -97.79 125.4 42.61 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.669 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.8 mp -112.9 107.85 24.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.277 0.561 . . . . 0.0 109.949 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 106' ' ' LEU . 33.6 t -86.71 115.73 28.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.85 159.49 38.43 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.522 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 22.2 m -70.19 160.8 31.46 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.585 172.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.453 ' HE3' ' O ' ' A' ' 102' ' ' ASP . 13.9 ptpt -70.16 172.49 7.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -171.31 -43.8 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.839 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -154.91 -154.31 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -91.83 176.49 6.5 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.415 ' OE2' ' HA ' ' A' ' 96' ' ' HIS . 5.6 pt-20 -93.7 168.59 10.91 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.507 0.67 . . . . 0.0 111.512 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -122.87 -36.62 2.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.706 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.42 ' HB ' ' OD1' ' A' ' 111' ' ' ASP . 10.0 m -112.94 -63.67 1.41 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.04 174.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.415 ' HA ' ' OE2' ' A' ' 93' ' ' GLU . 6.7 t60 179.45 126.82 0.07 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.095 0.474 . . . . 0.0 111.25 174.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 71.2 m -119.31 143.95 47.09 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.115 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -102.6 110.36 22.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.233 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' A' ' 102' ' ' ASP . 29.2 ttpt -84.42 102.64 12.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.398 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.8 t -69.34 -54.41 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 104' ' ' ILE . 11.3 t -134.58 167.46 20.76 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 170.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.648 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 33.6 m-20 -58.91 -44.54 91.27 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -172.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 88' ' ' SER . 25.6 m-20 -76.99 -28.5 55.11 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -175.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.427 ' H ' HG23 ' A' ' 101' ' ' THR . 43.7 mm -118.29 123.07 71.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.08 0.467 . . . . 0.0 111.183 -175.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.6 m -130.77 136.7 48.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.045 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.639 HD13 HG22 ' A' ' 86' ' ' VAL . 45.5 tp -99.07 125.68 44.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.488 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.956 HG21 ' HB2' ' A' ' 111' ' ' ASP . 17.8 m -135.9 128.96 31.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -136.36 1.48 2.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.216 0.531 . . . . 0.0 110.164 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.419 ' HB2' ' OD1' ' A' ' 111' ' ' ASP . 4.7 m -72.8 -7.67 51.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.782 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.31 -20.7 11.16 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.055 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.956 ' HB2' HG21 ' A' ' 107' ' ' THR . 2.2 m-20 -48.82 -42.97 37.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.12 0.568 . . . . 0.0 111.327 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.695 HG13 ' HB ' ' A' ' 107' ' ' THR . 5.1 m -53.01 -46.58 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.52 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.33 -36.04 74.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 110.499 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -70.66 -24.61 62.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.153 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -77.75 -14.64 59.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.942 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -85.25 132.09 34.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.965 0.412 . . . . 0.0 111.054 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 112.92 -4.21 25.74 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.765 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.8 t -123.26 157.5 33.0 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -66.85 -10.48 48.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.2 p -92.1 19.3 6.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.002 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.39 144.84 97.51 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.183 172.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.49 140.66 92.57 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.764 2.309 . . . . 0.0 112.729 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.524 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 48.5 mt-10 -57.99 -52.81 63.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.219 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HE2' ' HB2' ' A' ' 123' ' ' GLU . 5.4 mtmt -129.33 146.03 51.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.656 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 44.5 p90 -159.62 141.19 12.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.823 0.344 . . . . 0.0 110.692 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.02 144.41 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.827 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.24 129.22 68.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.037 0.446 . . . . 0.0 110.844 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.9 m -129.6 129.39 44.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.261 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.07 108.73 16.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.637 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.543 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 77.74 -176.44 53.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.189 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 83.4 m -147.85 173.48 12.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 0.0 110.191 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.3 m -120.02 116.76 26.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.157 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.676 HG22 HG13 ' A' ' 37' ' ' ILE . 38.3 p -96.32 113.95 25.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.085 0.469 . . . . 0.0 109.923 175.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.582 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -99.64 141.56 32.28 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.917 -178.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -90.28 117.51 68.09 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.396 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.26 55.77 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.523 2.815 . . . . 0.0 112.286 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -146.01 -37.36 0.25 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -87.56 -44.35 11.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.005 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.582 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 59.2 tp -56.92 -40.19 75.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.315 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.09 -33.44 73.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.828 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 71.1 mm-40 -67.25 -52.16 44.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.88 0.371 . . . . 0.0 110.234 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.428 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 0.4 OUTLIER -60.72 -41.57 95.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.717 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.593 HG12 ' HB2' ' A' ' 148' ' ' TRP . 60.3 mt -64.2 -40.71 90.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.721 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.72 71.01 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 111.027 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 37.0 mt-30 -87.26 9.09 21.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.942 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.412 HD22 ' HA ' ' A' ' 146' ' ' ASN . 10.4 m120 64.61 33.54 10.61 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.582 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -94.45 5.12 52.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.211 0.529 . . . . 0.0 110.085 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.593 ' HB2' HG12 ' A' ' 143' ' ' ILE . 92.1 m95 -142.49 123.69 14.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.725 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.79 HD22 HD13 ' A' ' 11' ' ' ILE . 6.0 tt -78.86 110.6 14.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.23 133.37 34.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.055 0.455 . . . . 0.0 111.501 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.8 t -162.25 157.06 22.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.083 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.526 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 8.6 pt-20 -85.12 154.1 22.25 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.76 119.78 39.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.747 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -168.58 -175.87 2.61 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 67.2 t30 75.29 163.67 0.26 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.398 0.679 . . . . 0.0 111.327 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 69.3 mt-30 -62.06 -25.43 67.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.036 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.7 m -51.82 -29.86 20.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.441 -175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.96 -54.53 43.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -125.34 -17.46 5.62 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -171.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 45.9 mt-10 -96.2 1.79 52.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.289 0.566 . . . . 0.0 110.914 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 t . . . . . 0 C--N 1.32 -0.681 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.857 176.337 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.628 HG22 ' H ' ' A' ' 171' ' ' ASN . 6.6 p . . . . . 0 N--CA 1.468 0.455 0 CA-C-O 122.191 0.996 . . . . 0.0 113.512 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.21 -28.05 63.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.883 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.56 -32.95 74.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.162 0.506 . . . . 0.0 110.597 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.628 ' H ' HG22 ' A' ' 168' ' ' VAL . 62.5 t30 -81.37 -32.72 32.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.105 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.78 -24.41 61.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.735 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.648 ' HG2' ' HZ ' ' A' ' 9' ' ' PHE . 13.3 tpt -55.64 -30.34 60.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.498 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.2 tp -97.68 -50.17 4.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.957 0.408 . . . . 0.0 109.915 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.524 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.979 179.102 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.7 t30 . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 120.941 0.401 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.2 tt -90.77 -0.97 57.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.718 0.771 . . . . 0.0 109.066 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.82 136.81 37.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.768 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.07 2.46 80.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.753 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.91 159.53 15.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 151' ' ' SER . 37.6 p90 -125.41 154.0 42.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.9 pt -124.64 128.77 73.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.686 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.8 mp -75.46 119.63 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.501 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.638 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -102.12 155.37 18.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.975 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.541 0.599 0 CA-C-O 121.682 0.753 . . . . 0.0 111.851 178.078 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 . . . . . 0 N--CA 1.45 -0.443 0 CA-C-O 121.249 0.547 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 t -104.32 167.43 9.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.484 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t 50.02 79.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.422 0.629 . . . . 0.0 110.472 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.499 HD11 HD23 ' A' ' 158' ' ' LEU . 4.0 tp -93.31 -61.16 2.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -170.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.42 ' HD1' HG23 ' A' ' 26' ' ' ILE . 2.1 p90 -167.94 174.55 7.35 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.323 0.511 . . . . 0.0 111.688 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -92.09 123.5 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.611 175.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.2 m -78.45 -38.3 41.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.195 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.98 150.25 20.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 0.0 110.306 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -131.49 104.83 7.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -119.53 167.36 12.05 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.804 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -73.22 -12.95 61.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.771 0.319 . . . . 0.0 110.651 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -83.03 -21.74 33.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.458 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.77 176.31 28.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.835 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 133' ' ' THR . 30.0 m -112.66 127.07 56.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.798 0.299 . . . . 0.0 110.779 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 37' ' ' ILE . 4.5 mp -104.42 110.21 29.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.35 165.39 27.47 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.44 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.45 80.11 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.802 0.811 . . . . 0.0 110.213 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -131.68 28.95 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.884 -176.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.516 HG21 ' HB3' ' A' ' 74' ' ' ASN . 11.0 tp -62.01 -25.94 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.46 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.03 61.42 1.61 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.763 177.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.493 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 9.5 t 179.24 132.51 0.24 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.437 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 43' ' ' THR . 2.2 Cg_endo -82.44 178.64 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.65 2.233 . . . . 0.0 111.05 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.478 HG22 HD22 ' A' ' 74' ' ' ASN . 22.7 p -94.05 -169.22 2.03 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.86 20.03 13.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.812 0.815 . . . . 0.0 109.179 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 47' ' ' LEU . 14.1 tp -125.73 170.87 11.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.016 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.7 p -113.8 162.83 15.83 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.603 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.7 p -63.58 -33.6 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.7 mt -67.55 -44.92 77.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.221 0.534 . . . . 0.0 109.994 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -54.88 -42.8 72.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.004 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.508 HD11 HG11 ' A' ' 72' ' ' VAL . 66.2 mt -56.74 -55.09 38.66 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.957 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 67.6 mt -59.84 -43.13 94.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.089 -175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.9 p -80.33 -29.35 38.06 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -61.19 -59.65 4.99 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 C--N 1.332 -0.193 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -175.031 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.467 ' OD2' ' HG2' ' A' ' 70' ' ' GLN . 13.5 t70 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.467 ' HG2' ' OD2' ' A' ' 69' ' ' ASP . 27.1 mm-40 -99.65 125.15 45.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.985 0.421 . . . . 0.0 110.009 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.1 ttp -86.88 146.01 26.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.649 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.586 HG23 HG13 ' A' ' 127' ' ' VAL . 5.1 p -95.88 140.69 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.831 0.348 . . . . 0.0 110.608 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.5 mt -89.72 164.54 14.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.951 0.405 . . . . 0.0 110.875 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.516 ' HB3' HG21 ' A' ' 41' ' ' ILE . 1.6 t-20 -95.0 145.57 24.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -99.99 -36.43 4.2 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.966 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.89 -171.88 35.58 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.16 -14.68 10.67 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.045 2.497 . . . . 0.0 112.936 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.87 139.08 25.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.75 -175.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 66.32 30.11 9.14 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.979 0.512 . . . . 0.0 111.639 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -65.83 -15.07 62.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.044 0.449 . . . . 0.0 111.548 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.06 -2.5 52.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.543 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -129.76 136.0 49.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.38 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.44 126.36 8.66 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.07 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -107.08 125.68 51.36 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.541 HD13 HG21 ' A' ' 112' ' ' VAL . 3.4 mp -118.03 113.66 42.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.931 0.396 . . . . 0.0 110.5 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.519 HG22 HD13 ' A' ' 106' ' ' LEU . 25.2 t -93.1 120.61 42.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.494 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 29.5 p-80 -139.29 161.17 38.08 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.768 -175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.427 ' OG ' ' HE3' ' A' ' 124' ' ' LYS . 47.4 p -83.51 151.16 25.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.961 0.41 . . . . 0.0 111.315 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 89' ' ' LYS . 13.6 ttpt -71.4 127.28 32.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.175 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -129.59 -43.41 1.26 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.649 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -124.83 -15.22 6.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.159 0.504 . . . . 0.0 110.741 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 71.08 80.48 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.856 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 93' ' ' GLU . 1.3 pm0 -75.39 169.03 18.86 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.719 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -168.32 82.2 0.17 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.5 m -111.2 -37.74 5.23 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 161.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -171.12 77.51 0.07 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.903 165.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 p -97.71 134.62 40.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.958 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -103.06 121.2 42.1 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -87.59 115.8 25.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.046 0.451 . . . . 0.0 111.273 -174.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.69 -54.38 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.34 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.5 t -147.73 173.84 12.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.959 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -84.44 59.7 5.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.132 0.491 . . . . 0.0 110.624 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -175.9 -37.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.755 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.808 HG13 HD13 ' A' ' 158' ' ' LEU . 29.6 mm -117.95 129.7 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.687 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 m -127.88 139.37 52.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.052 0.453 . . . . 0.0 111.054 -174.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.519 HD13 HG22 ' A' ' 86' ' ' VAL . 57.3 tp -96.69 137.14 36.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.192 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.416 ' HB ' ' CG2' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -116.95 124.07 48.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.6 p -111.63 18.92 18.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.62 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.4 t -147.18 -178.41 6.2 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.1 4.11 8.95 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -49.75 -36.96 27.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.637 0.775 . . . . 0.0 109.756 172.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.541 HG21 HD13 ' A' ' 85' ' ' ILE . 29.3 t -53.5 -40.46 41.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.165 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.17 -33.19 73.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.393 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -71.28 -44.38 65.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.007 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m -64.22 -42.29 96.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.483 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -85.47 9.69 15.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.357 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.61 33.09 5.98 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.744 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 t -154.71 165.62 35.98 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -64.92 -24.33 67.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.773 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.0 p -88.91 32.02 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.114 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.89 146.0 82.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.854 173.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.494 ' HB3' ' CD2' ' A' ' 87' ' ' HIS . 9.2 Cg_endo -53.16 134.23 55.51 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.322 2.681 . . . . 0.0 113.398 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -62.7 -62.5 1.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.909 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.992 ' HD3' ' HG3' ' A' ' 160' ' ' GLU . 4.3 mtmt -103.69 145.31 30.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.8 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -167.71 140.89 3.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 0.0 111.475 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.03 145.02 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.248 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.586 HG13 HG23 ' A' ' 72' ' ' VAL . 4.6 p -117.06 124.9 73.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.008 0.432 . . . . 0.0 110.833 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 59.3 m -128.24 133.6 48.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.273 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 72' ' ' VAL . 3.7 mm? -89.06 116.56 27.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.399 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.563 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 76.39 -174.69 53.47 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.758 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 68.2 m -149.18 168.15 24.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.8 m -107.73 119.07 38.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.191 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 36' ' ' THR . 11.1 p -101.69 114.83 29.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.301 0.572 . . . . 0.0 111.346 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -84.21 155.54 22.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.95 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -56.4 142.46 68.78 Favored Pre-proline 0 C--O 1.236 0.388 0 O-C-N 123.472 0.483 . . . . 0.0 111.077 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.45 119.18 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.164 2.576 . . . . 0.0 112.659 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 66.74 17.55 10.59 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.595 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.951 HE21 ' HA ' ' A' ' 138' ' ' GLN . 0.0 OUTLIER -98.66 -23.12 15.58 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.636 -178.089 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 36' ' ' THR . 57.6 tp -68.36 -50.33 53.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.529 0.204 . . . . 0.0 110.943 -175.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -60.35 -34.12 73.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.019 0.438 . . . . 0.0 110.789 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -40.08 77.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.4 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -69.69 -37.81 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 110.146 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.76 HG12 ' HB2' ' A' ' 148' ' ' TRP . 82.8 mt -60.34 -38.02 76.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.541 174.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.79 -28.61 69.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.302 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -88.13 4.41 45.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.928 175.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 16.5 m120 68.69 31.95 4.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.225 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -73.25 -30.54 63.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.466 0.65 . . . . 0.0 109.253 169.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.76 ' HB2' HG12 ' A' ' 143' ' ' ILE . 85.8 m95 -132.22 145.64 51.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.698 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 64.1 mt -104.43 118.33 36.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.99 135.6 40.16 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.46 -173.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 8.1 t -150.48 163.68 37.81 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 173.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -86.13 152.49 22.81 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.866 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -114.5 7.02 16.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.716 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -71.65 76.73 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.111 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -176.88 -178.67 0.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -65.11 -19.01 65.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.4 m -52.52 -27.17 15.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.527 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.808 HD13 HG13 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -57.1 -43.0 81.8 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.078 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -133.74 -46.89 0.8 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.992 ' HG3' ' HD3' ' A' ' 124' ' ' LYS . 34.1 mt-10 -85.63 16.97 3.52 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -166.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.317 -0.833 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 172.382 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.38 -28.97 68.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.875 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.13 95.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 110.716 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -81.21 -26.99 35.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.18 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.19 -37.78 72.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.566 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -62.43 -30.18 71.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.669 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.3 tp -79.48 -36.12 39.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.878 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.514 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.864 179.476 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 111.233 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.5 mt -72.02 1.27 7.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.598 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.574 ' NE2' ' HA ' ' A' ' 100' ' ' VAL . 53.6 tt0 -66.08 131.68 46.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.831 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.23 -4.81 77.81 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.67 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 12.1 mptt -109.75 168.88 9.09 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -141.46 152.75 44.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.049 0.452 . . . . 0.0 110.938 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.1 pt -117.37 128.02 74.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.584 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.691 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 45.3 mt -101.3 133.25 45.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.794 -177.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.55 167.58 21.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.384 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 120.688 0.28 . . . . 0.0 110.78 178.952 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 . . . . . 0 N--CA 1.448 -0.572 0 CA-C-O 120.953 0.406 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.0 t -140.73 125.98 18.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.649 -177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.7 t 69.78 130.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.808 0.692 . . . . 0.0 112.106 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.54 HG23 ' H ' ' A' ' 27' ' ' TYR . 7.0 tp -142.8 -64.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.678 176.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.54 ' H ' HG23 ' A' ' 26' ' ' ILE . 1.8 p90 -177.01 177.14 1.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.142 0.428 . . . . 0.0 111.311 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.86 124.22 40.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.759 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.4 m -97.14 -40.45 8.8 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -128.89 147.88 50.86 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -175.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 6' ' ' GLN . 5.7 p80 -131.81 116.66 17.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 0.0 111.072 -177.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.453 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.9 OUTLIER -100.75 -7.85 23.32 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 169.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 72.43 -46.97 0.66 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.702 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -84.6 3.54 36.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 167.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.12 126.55 1.83 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.885 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' A' ' 133' ' ' THR . 22.7 m -101.74 119.68 39.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.584 0.192 . . . . 0.0 110.94 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.803 HG13 HG22 ' A' ' 133' ' ' THR . 4.4 mp -109.08 111.47 36.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.933 0.397 . . . . 0.0 110.392 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.76 162.62 28.54 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.291 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.7 m -114.18 79.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.809 0.814 . . . . 0.0 110.754 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -134.69 18.6 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.907 -178.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 tp -78.57 -21.41 13.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.122 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.4 t30 69.28 93.24 0.08 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.463 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -161.98 122.72 1.55 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.087 176.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.78 155.42 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.803 2.335 . . . . 0.0 110.817 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.622 HG22 HD22 ' A' ' 74' ' ' ASN . 9.2 p -101.1 170.48 8.24 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.679 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -92.49 16.13 12.6 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.55 159.05 31.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.964 -172.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 42.6 t -106.51 154.8 20.34 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.198 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 9.4 p -67.64 -35.13 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.73 -26.74 60.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.381 0.61 . . . . 0.0 109.577 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 12.8 mm-40 -68.46 -47.95 65.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.866 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.5 pp -69.84 -34.11 73.19 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.914 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 62.8 mt -61.6 -52.32 64.86 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.415 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 p -69.6 -28.47 65.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.087 0.47 . . . . 0.0 111.302 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -59.15 -34.76 72.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.601 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 CA--C 1.532 0.259 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.683 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 121.056 0.455 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -98.46 122.57 41.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.255 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttt -79.09 140.91 37.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.474 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.403 HG21 HD23 ' A' ' 129' ' ' LEU . 8.0 p -103.92 140.17 22.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.137 0.494 . . . . 0.0 110.889 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.52 163.7 13.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.314 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.622 HD22 HG22 ' A' ' 45' ' ' THR . 4.1 t-20 -105.3 113.16 26.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -77.31 -25.12 64.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.243 -171.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.21 176.63 26.76 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.5 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -83.52 4.81 6.77 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.118 2.545 . . . . 0.0 113.283 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.451 HG12 HD22 ' A' ' 79' ' ' ASN . 19.2 t -106.62 118.76 54.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.451 HD22 HG12 ' A' ' 78' ' ' VAL . 51.2 m-80 64.7 33.61 10.32 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.374 0.421 . . . . 0.0 110.233 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.591 ' HA ' ' HA3' ' A' ' 130' ' ' GLY . 26.0 tt0 -66.07 -15.96 63.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.374 -175.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -82.51 -7.29 59.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.511 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -109.41 140.7 42.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.055 0.455 . . . . 0.0 111.819 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 130.14 9.58 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.637 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -113.94 124.37 52.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.06 119.36 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.806 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.49 139.62 46.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -148.13 162.72 38.84 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.444 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -74.87 161.5 29.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -81.2 121.76 26.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.024 0.44 . . . . 0.0 110.195 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.517 ' CB ' ' HA ' ' A' ' 122' ' ' PRO . 21.7 m -144.33 -34.15 0.38 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.382 0.61 . . . . 0.0 109.402 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -102.09 179.22 4.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.567 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -120.56 79.85 1.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.399 0.618 . . . . 0.0 110.427 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 4.8 pt-20 -64.62 168.03 6.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.138 173.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -154.12 -29.54 0.12 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 p -46.74 -59.99 2.69 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -173.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -170.36 71.99 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.296 0.57 . . . . 0.0 109.49 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.465 ' HB3' HG21 ' A' ' 105' ' ' THR . 11.3 m -79.83 132.1 36.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.018 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 74.4 t80 -104.11 126.64 51.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.214 177.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.528 ' HE2' ' HA ' ' A' ' 102' ' ' ASP . 13.8 mmmm -72.61 117.72 14.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.519 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.574 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 63.8 t -80.11 -54.68 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 t -131.53 -48.46 0.98 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.528 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 35.9 t70 -178.57 -66.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 172.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.41 -46.18 80.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.0 mm -72.94 123.52 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 97' ' ' SER . 19.1 m -132.79 142.94 49.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.531 -174.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 31.3 tp -96.98 135.67 38.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.117 176.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.436 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 2.6 m -135.01 123.56 23.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.605 0.24 . . . . 0.0 110.681 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.9 p -134.97 -0.42 2.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.821 0.343 . . . . 0.0 111.728 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -92.99 17.33 10.9 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.31 -14.09 66.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.561 174.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.86 -27.61 60.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.884 0.373 . . . . 0.0 110.849 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.436 ' CG1' ' HB ' ' A' ' 107' ' ' THR . 18.6 m -53.53 -32.81 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.926 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.35 -29.55 62.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 111.153 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -85.28 -35.56 21.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.609 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.5 m -58.76 -33.85 70.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.168 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -83.16 11.51 6.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.044 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.04 24.25 3.29 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.986 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 120' ' ' THR . 3.3 p -123.71 14.76 9.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.981 0.39 . . . . 0.0 111.636 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' THR . 0.8 OUTLIER 70.18 -37.16 0.37 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 111.442 -174.409 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.446 ' H ' ' C ' ' A' ' 118' ' ' THR . 16.6 p -78.13 28.04 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.865 0.466 . . . . 0.0 111.781 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.87 134.16 89.73 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.321 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.517 ' HA ' ' CB ' ' A' ' 90' ' ' THR . 9.8 Cg_endo -53.27 140.61 61.84 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.213 2.609 . . . . 0.0 112.771 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.429 ' CB ' ' HE2' ' A' ' 124' ' ' LYS . 66.0 mt-10 -57.28 -52.8 63.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.143 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HE2' ' CB ' ' A' ' 123' ' ' GLU . 5.6 mtmt -128.84 142.98 50.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.029 -176.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -150.3 145.17 26.01 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.876 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.2 pt -114.75 133.4 61.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.36 128.84 74.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.158 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 78.4 m -142.89 150.04 39.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.256 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.403 HD23 HG21 ' A' ' 72' ' ' VAL . 3.8 mm? -97.09 112.98 24.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.899 176.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 80' ' ' GLN . . . 81.48 176.76 51.26 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.716 -178.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.6 m -147.71 173.36 12.84 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.5 m -113.97 121.62 44.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.071 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.803 HG22 HG13 ' A' ' 37' ' ' ILE . 73.7 p -110.25 119.75 40.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.129 0.49 . . . . 0.0 110.773 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -80.27 159.9 25.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.84 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -75.28 138.02 71.74 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.891 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.34 132.39 50.46 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.815 2.343 . . . . 0.0 111.291 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 2.0 t60 79.14 -33.81 0.15 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.926 0.766 . . . . 0.0 111.437 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -59.17 -48.33 82.0 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.504 0.193 . . . . 0.0 111.485 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.8 tp -57.99 -37.43 74.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.129 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -62.03 -43.62 98.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.0 110.22 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.627 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -62.16 -43.58 98.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.894 177.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -63.16 -42.82 99.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.882 0.373 . . . . 0.0 110.712 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 148' ' ' TRP . 83.4 mt -62.35 -39.98 86.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.343 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.35 -28.59 69.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.496 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 60.8 mt-30 -88.75 8.9 26.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.967 177.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.9 m120 66.78 30.72 7.83 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -81.53 -29.24 33.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.275 0.56 . . . . 0.0 109.742 171.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.615 ' HB2' HG12 ' A' ' 143' ' ' ILE . 95.3 m95 -131.01 131.49 44.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.761 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.691 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 44.0 mt -89.99 112.57 24.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.957 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.5 tp -87.04 133.01 33.63 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.653 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 p -161.23 148.83 15.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.106 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 3.3 pm0 -95.47 165.23 12.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.054 0.454 . . . . 0.0 110.893 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.71 -88.13 0.63 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.593 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 53.26 29.77 9.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.779 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -137.29 176.26 8.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -174.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -57.63 -35.93 71.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.602 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -52.83 -29.44 27.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.694 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.49 -56.99 12.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.04 7.41 6.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -169.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -106.24 -19.25 13.76 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.136 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.7 t . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -172.292 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 10.1 m . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 170' ' ' ALA . 1.5 pm0 -63.01 -52.87 61.25 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.619 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 169' ' ' GLU . . . -70.26 -31.65 69.12 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 110.613 -177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -66.98 -42.84 84.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.87 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -74.98 -21.21 59.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.098 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.555 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 14.1 mmt -62.93 -34.41 77.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.242 0.544 . . . . 0.0 109.699 172.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.6 tp -83.52 -40.24 19.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.996 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.623 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.926 177.974 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.455 -0.179 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.1 mt 64.61 -90.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.384 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 31.45 86.54 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.308 1.005 . . . . 0.0 112.96 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 123.83 -0.59 9.22 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.385 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.782 ' HE3' ' HG3' ' A' ' 152' ' ' GLU . 13.6 mptt -105.52 169.16 8.62 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 2.5 p90 -142.45 167.89 21.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.418 HD12 ' CE3' ' A' ' 148' ' ' TRP . 4.8 pt -128.16 128.44 68.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.083 0.468 . . . . 0.0 111.477 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.619 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 4.6 mp -98.36 127.08 51.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.626 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.46 -72.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.083 0.239 . . . . 0.0 110.763 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.7 m . . . . . 0 CA--C 1.531 0.239 0 O-C-N 123.778 0.674 . . . . 0.0 110.958 -178.343 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 120.971 0.415 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.434 ' HA ' ' OD1' ' A' ' 42' ' ' ASN . 4.3 m -65.51 96.05 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.497 -177.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.897 HG12 ' H ' ' A' ' 26' ' ' ILE . 3.1 t 60.79 -170.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.253 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.902 HG21 HG23 ' A' ' 39' ' ' VAL . 10.1 tp -174.13 -147.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.723 ' HD1' HG13 ' A' ' 26' ' ' ILE . 2.6 p90 -120.87 176.33 5.6 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.217 0.917 . . . . 0.0 111.368 -168.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.9 127.95 43.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.416 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.44 -44.76 7.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.937 -176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.796 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.9 tp10 -136.03 156.38 48.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.411 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -140.87 110.18 6.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.184 0.516 . . . . 0.0 110.254 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -113.3 179.95 3.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -76.1 -35.0 59.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.055 0.455 . . . . 0.0 110.488 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.96 -24.27 60.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.975 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 171.63 178.28 41.89 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 119.966 -1.111 . . . . 0.0 112.959 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -103.62 130.38 51.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.796 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 mp -100.87 114.5 40.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.059 0.457 . . . . 0.0 110.89 -174.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.41 178.85 19.29 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.902 HG23 HG21 ' A' ' 26' ' ' ILE . 10.7 m -125.08 33.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.626 0.727 . . . . 0.0 110.316 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.569 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -82.98 20.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.366 -173.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.466 HG23 HG22 ' A' ' 43' ' ' THR . 10.4 tp -67.24 -25.04 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.646 0.26 . . . . 0.0 111.249 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 24' ' ' THR . 4.6 t30 67.16 80.64 0.21 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.409 173.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.466 HG22 HG23 ' A' ' 41' ' ' ILE . 5.1 t -178.2 126.39 0.27 Allowed Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 121.319 0.581 . . . . 0.0 111.877 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.64 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 83.7 Cg_endo -84.33 179.69 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.677 2.251 . . . . 0.0 110.689 169.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 p -119.6 -175.32 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -93.55 9.03 38.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.174 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 tp -125.43 163.95 21.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.84 0.353 . . . . 0.0 110.857 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 10.6 m -107.48 163.21 13.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.295 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.602 ' HB ' HG11 ' A' ' 127' ' ' VAL . 11.3 p -66.15 -35.72 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.744 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.21 -26.44 62.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 110.487 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -35.47 78.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.944 177.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.02 -44.74 91.75 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.064 0.459 . . . . 0.0 109.87 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.582 HD13 HD11 ' A' ' 113' ' ' LEU . 27.3 mt -66.54 -33.48 75.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.655 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.6 m -62.3 -35.35 78.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.086 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -76.05 -60.58 2.27 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.397 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.4 ptt? . . . . . 0 C--O 1.233 0.217 0 C-N-CA 123.114 0.566 . . . . 0.0 110.815 -178.32 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 . . . . . 0 N--CA 1.458 -0.052 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -104.43 112.29 25.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 88.2 mtp -82.26 144.46 30.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.465 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 127' ' ' VAL . 7.3 p -93.97 137.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.886 0.374 . . . . 0.0 110.06 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.64 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.9 mp -102.02 -179.79 4.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.937 0.398 . . . . 0.0 110.341 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -115.41 137.14 52.36 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.405 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -97.04 -23.78 14.25 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.813 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.34 173.76 30.37 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.04 -12.15 16.16 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.023 2.482 . . . . 0.0 112.823 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.4 t -87.73 125.21 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.67 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 59.53 40.28 20.64 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.883 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -70.65 -10.95 60.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.298 0.57 . . . . 0.0 110.524 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.13 -22.69 67.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.155 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -104.15 147.17 27.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.432 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.86 124.34 7.13 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.618 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HB3' HD11 ' A' ' 106' ' ' LEU . 60.5 m-85 -106.12 124.83 50.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.487 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.7 mp -120.23 110.06 27.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.683 HG22 HD13 ' A' ' 106' ' ' LEU . 21.4 t -95.55 124.46 48.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.651 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 125' ' ' PHE . 25.6 p80 -138.29 168.76 19.07 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.804 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.0 t -64.99 168.34 6.6 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.505 ' HG2' ' HA ' ' A' ' 103' ' ' ASP . 12.7 mmmt -51.25 112.9 0.81 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.235 0.541 . . . . 0.0 110.427 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 m -158.74 122.43 3.9 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.68 -150.03 0.45 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.319 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 77.97 13.85 1.64 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.409 1.083 . . . . 0.0 109.701 -169.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -98.35 155.48 17.2 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -147.65 -27.43 0.36 Allowed 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.656 -0.418 . . . . 0.0 112.083 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.2 m -67.1 -55.2 15.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.926 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -169.0 110.28 0.49 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 111.12 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 m -118.74 137.24 53.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.195 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -123.02 137.21 55.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.99 118.46 34.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.313 0.578 . . . . 0.0 110.781 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.82 -54.08 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.169 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 t -134.67 165.53 25.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.26 67.89 6.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.488 0.661 . . . . 0.0 111.177 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 89' ' ' LYS . 24.6 t70 178.92 -31.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.089 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 49.2 mm -105.95 124.42 61.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.248 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.4 m -113.96 128.34 56.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.897 0.379 . . . . 0.0 110.955 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.683 HD13 HG22 ' A' ' 86' ' ' VAL . 54.5 tp -109.31 113.14 25.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.614 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 m -100.01 124.09 44.98 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -109.02 25.78 11.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.314 0.578 . . . . 0.0 111.122 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.9 m -144.8 172.92 12.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.506 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.78 8.42 3.37 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.705 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.56 -17.19 64.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.487 HG11 ' HB ' ' A' ' 85' ' ' ILE . 25.6 m -58.01 -29.63 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.73 174.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.582 HD11 HD13 ' A' ' 53' ' ' LEU . 4.5 mm? -60.78 -31.87 71.21 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.132 0.491 . . . . 0.0 110.464 177.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -78.59 -37.25 42.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.864 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -53.65 -45.07 70.1 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.887 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -97.98 140.84 31.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.782 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.04 2.37 45.37 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.058 -177.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 120' ' ' THR . 9.0 t -115.75 -175.83 2.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -58.87 -34.35 71.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.071 0.463 . . . . 0.0 110.504 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 118' ' ' THR . 21.6 p -112.01 64.03 0.62 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.136 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.03 125.51 85.18 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.192 172.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.07 133.1 24.2 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.538 2.158 . . . . 0.0 112.312 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -61.73 -57.81 10.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.355 0.598 . . . . 0.0 111.702 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.1 mtmm -118.54 127.48 53.66 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 -168.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 87' ' ' HIS . 37.5 p90 -150.62 138.52 19.98 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.819 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.2 pt -116.06 134.14 60.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.834 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.602 HG11 ' HB ' ' A' ' 49' ' ' VAL . 6.5 p -114.17 128.36 71.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.253 0.549 . . . . 0.0 110.702 -177.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 18.2 p -142.23 138.23 31.3 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.187 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.8 mt -89.3 140.14 29.79 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.768 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.89 -175.15 4.02 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.47 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 79.1 m -148.83 173.06 13.67 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.0 p -114.05 122.3 46.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.915 0.388 . . . . 0.0 110.445 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.702 HG22 HG13 ' A' ' 37' ' ' ILE . 25.3 p -98.65 117.01 32.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.042 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.437 ' HZ3' HD11 ' A' ' 40' ' ' ILE . 1.2 t-105 -68.48 148.4 50.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.279 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -69.16 144.91 95.77 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.142 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.91 125.27 18.58 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.274 2.649 . . . . 0.0 113.484 -173.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 2.8 t60 71.59 -8.28 1.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.056 172.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -67.07 -44.75 79.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.343 . . . . 0.0 111.491 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 47.7 tp -57.51 -31.43 66.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.548 -175.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -58.83 -41.11 86.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.301 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.52 -49.66 18.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.849 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 0.3 OUTLIER -54.88 -40.93 70.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.93 -48.16 76.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.856 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.63 -35.98 81.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.828 0.347 . . . . 0.0 111.407 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -87.33 16.08 5.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.891 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 68.14 24.38 7.68 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.511 ' HD2' ' HA ' ' A' ' 142' ' ' GLU . 75.6 m-85 -83.57 -25.48 30.89 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.849 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 94.5 m95 -133.96 132.96 40.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.885 176.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.619 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.8 tt -90.62 115.13 27.5 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.6 tp -93.98 135.55 35.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.764 0.316 . . . . 0.0 111.386 -175.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.5 t -156.21 156.17 33.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.782 ' HG3' ' HE3' ' A' ' 8' ' ' LYS . 7.6 mp0 -70.11 153.54 43.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.61 -3.56 9.82 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -71.97 81.64 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.795 0.807 . . . . 0.0 111.322 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -158.57 165.48 34.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.0 -30.05 32.94 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.1 m -55.76 -30.5 61.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.938 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.49 -53.19 52.06 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.945 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.403 ' CZ ' HG12 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -115.77 -46.07 2.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -65.01 -47.34 77.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.81 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.0 m . . . . . 0 CA--C 1.534 0.358 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.656 179.533 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.3 t . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -4.33 20.76 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.69 -57.32 12.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 111.627 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -75.25 -24.54 57.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -66.02 -22.44 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.19 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 13.7 tpt -55.12 -33.29 62.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.45 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.472 HD22 HD21 ' A' ' 149' ' ' LEU . 12.1 tp -107.79 -51.96 2.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.958 0.409 . . . . 0.0 110.878 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.016 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -175.414 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.636 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 61.2 t30 . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.83 -98.49 0.45 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.466 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 29' ' ' CYS . 56.2 mt-30 61.84 122.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.429 1.109 . . . . 0.0 112.557 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.04 5.77 88.94 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.937 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -93.74 158.18 15.8 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.455 ' HE1' HD11 ' A' ' 11' ' ' ILE . 29.8 p90 -134.52 163.04 30.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.049 0.452 . . . . 0.0 110.924 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 4.2 pt -127.54 128.16 69.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.421 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.668 HG12 ' HA ' ' A' ' 171' ' ' ASN . 4.5 mp -87.92 132.51 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.364 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.32 168.59 26.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.418 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 m . . . . . 0 C--N 1.322 -0.629 0 CA-C-O 120.951 0.405 . . . . 0.0 110.66 178.768 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 . . . . . 0 N--CA 1.449 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.9 p -84.78 -168.13 2.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.417 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.743 HG23 HG22 ' A' ' 40' ' ' ILE . 2.7 p -56.01 136.19 18.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.479 173.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.425 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.2 tp -114.14 -55.41 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.78 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.425 ' HD1' HG13 ' A' ' 26' ' ' ILE . 5.2 p90 -175.45 171.93 2.75 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.212 0.529 . . . . 0.0 111.852 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.0 mm -90.95 126.55 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.754 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 6' ' ' GLN . 43.2 t -81.98 -50.89 8.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.046 -174.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 45.8 mt-10 -136.21 146.59 46.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.963 0.411 . . . . 0.0 111.454 -177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.636 ' CD2' ' HA ' ' A' ' 4' ' ' ASN . 43.2 t60 -137.21 114.05 10.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.088 175.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -116.7 172.31 7.32 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.406 ' HA ' ' CD2' ' A' ' 137' ' ' HIS . 41.0 m-20 -82.23 -20.03 38.5 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 172.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -16.03 24.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.665 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.43 174.46 44.41 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.303 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -149.23 133.58 17.47 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.437 -0.449 . . . . 0.0 110.401 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.75 HG13 HG22 ' A' ' 133' ' ' THR . 4.5 mp -122.87 123.64 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.246 -177.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.41 172.0 24.46 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.044 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.2 97.53 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.394 0.616 . . . . 0.0 110.51 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.743 HG22 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -130.98 24.48 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.195 -176.177 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.885 HG12 ' HB3' ' A' ' 74' ' ' ASN . 10.0 tp -55.81 -39.17 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.447 -173.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.48 25.19 14.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.613 0.365 . . . . 0.0 111.605 175.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.625 HG22 HG13 ' A' ' 41' ' ' ILE . 3.8 t -166.81 148.27 5.46 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 122.076 -0.39 . . . . 0.0 110.144 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 2.3 Cg_endo -81.99 -173.57 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.22 2.613 . . . . 0.0 112.471 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -101.58 -161.23 0.84 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.18 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.86 -7.69 22.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.284 0.564 . . . . 0.0 110.443 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.416 ' O ' HG12 ' A' ' 72' ' ' VAL . 16.4 tp -107.21 171.22 7.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.252 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.822 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 14.7 m -119.65 161.77 20.12 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.106 -0.371 . . . . 0.0 110.342 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 12.8 p -69.39 -35.49 67.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.046 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.0 mt -59.69 -37.61 79.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.084 176.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.822 ' HG2' ' HB2' ' A' ' 48' ' ' SER . 23.2 mm-40 -60.01 -53.18 60.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.445 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' A' ' 56' ' ' MET . 94.5 mt -61.05 -46.78 89.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.663 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 85.1 mt -57.53 -44.67 85.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.299 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.7 p -75.5 -36.35 60.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.259 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.438 ' C ' ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -58.51 -50.82 72.38 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.661 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 52' ' ' LEU . 25.4 ptt? . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.225 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.002 0.43 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.427 ' O ' HG12 ' A' ' 49' ' ' VAL . 25.9 mm-40 -120.07 120.27 35.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.247 0.546 . . . . 0.0 110.304 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 12.4 ttt -88.44 144.05 26.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.407 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.528 HG21 HD23 ' A' ' 129' ' ' LEU . 9.0 p -89.08 137.12 21.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.202 0.525 . . . . 0.0 110.73 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 67.3 mt -80.43 167.84 19.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.216 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.885 ' HB3' HG12 ' A' ' 41' ' ' ILE . 7.1 t-20 -97.64 155.85 16.8 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -109.69 -25.6 5.38 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.455 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.88 174.1 20.19 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.46 -9.18 18.69 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.858 2.372 . . . . 0.0 112.221 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.499 HG12 ' OD1' ' A' ' 79' ' ' ASN . 6.1 t -104.12 139.22 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.269 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.582 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 20.3 m120 56.05 34.5 23.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.442 0.297 . . . . 0.0 111.325 176.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.613 ' HA ' ' CA ' ' A' ' 130' ' ' GLY . 15.7 tt0 -66.54 -13.67 61.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.154 0.502 . . . . 0.0 111.524 -174.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.71 -8.48 57.36 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.735 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -102.25 133.7 46.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.032 0.444 . . . . 0.0 111.228 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.35 124.24 6.37 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.715 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -108.73 123.1 48.48 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.44 HG21 HG21 ' A' ' 112' ' ' VAL . 5.2 mp -139.56 112.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 0.0 110.662 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.8 t -115.29 132.04 65.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.302 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -125.53 152.51 44.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.64 ' HB3' ' HB3' ' A' ' 159' ' ' PHE . 20.1 p -81.38 148.46 29.32 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 87.8 tttt -67.01 114.35 5.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.865 0.841 . . . . 0.0 111.57 -176.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.706 ' HB ' ' HA ' ' A' ' 122' ' ' PRO . 3.5 m -138.55 10.51 2.71 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -140.3 164.6 29.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.031 -168.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -136.44 15.69 3.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.331 0.586 . . . . 0.0 109.74 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -124.87 160.75 28.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.844 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.1 p90 170.44 154.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.188 0.93 . . . . 0.0 109.887 -175.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.4 m -104.08 -45.19 4.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.229 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -151.71 108.32 3.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.834 0.35 . . . . 0.0 110.494 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 p -139.89 150.18 44.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.067 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -102.18 112.12 24.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -90.56 123.68 34.41 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.184 0.516 . . . . 0.0 111.557 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.4 -54.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.2 p -116.43 -165.86 1.1 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -90.03 15.57 9.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.683 0.754 . . . . 0.0 109.349 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 13.2 t70 -131.03 -59.97 0.97 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.251 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.699 HG13 HD13 ' A' ' 158' ' ' LEU . 50.7 mm -72.49 122.15 24.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.126 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.96 133.17 45.57 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.328 0.585 . . . . 0.0 112.383 -176.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 85' ' ' ILE . 31.1 tp -99.77 122.11 42.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.216 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m -102.54 123.86 47.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.822 0.344 . . . . 0.0 110.113 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.6 p -116.53 20.62 14.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.887 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 m -139.67 177.58 7.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.445 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.77 -6.17 49.6 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.518 -0.372 . . . . 0.0 112.262 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.22 -29.38 63.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.207 0.527 . . . . 0.0 110.619 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.454 HG13 HD22 ' A' ' 113' ' ' LEU . 14.8 p -54.63 -34.02 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.714 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.473 HD11 HD22 ' A' ' 53' ' ' LEU . 2.9 mm? -63.57 -35.99 82.32 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.026 0.441 . . . . 0.0 110.356 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.27 -34.54 65.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.88 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.2 m -58.31 -49.46 77.07 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.136 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -99.9 3.73 44.67 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.886 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.13 11.55 65.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.82 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -118.24 164.71 14.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -66.98 -23.01 65.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.898 0.38 . . . . 0.0 110.856 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.9 p -94.07 24.57 4.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.934 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -51.07 136.37 28.42 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.14 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.706 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 31.3 Cg_exo -58.74 145.96 94.16 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.095 2.53 . . . . 0.0 112.339 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.99 -47.93 70.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.242 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -141.8 143.53 33.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.663 -176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -152.03 148.59 27.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.83 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.4 pt -118.71 141.34 38.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.71 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.99 122.8 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.246 0.546 . . . . 0.0 110.495 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 81.3 m -132.81 158.14 43.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.153 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 72' ' ' VAL . 3.4 mm? -112.76 113.21 25.21 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.852 0.358 . . . . 0.0 110.555 175.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.613 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . 101.98 -178.24 26.92 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.556 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 34.8 m -144.43 168.43 20.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.7 m -114.33 116.09 28.4 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.75 HG22 HG13 ' A' ' 37' ' ' ILE . 40.8 p -117.56 143.79 45.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.257 0.551 . . . . 0.0 111.731 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -110.89 177.47 4.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.233 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.542 ' HB3' ' HD2' ' A' ' 136' ' ' PRO . 65.6 mttp -85.17 167.13 27.52 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.221 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 135' ' ' LYS . 90.4 Cg_exo -44.15 105.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.969 2.446 . . . . 0.0 113.507 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 4.4 m-70 65.48 7.62 4.48 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.946 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.561 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.7 tp60 -57.5 -48.1 80.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.105 0.411 . . . . 0.0 111.396 -174.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.504 ' O ' HG13 ' A' ' 143' ' ' ILE . 65.3 tp -57.04 -34.86 68.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.981 0.42 . . . . 0.0 110.993 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -61.89 -46.05 91.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.59 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 13.4 mp0 -73.14 -30.15 63.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.09 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 66.9 mm-40 -60.92 -42.55 98.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.254 0.549 . . . . 0.0 110.013 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.547 HG12 ' HB2' ' A' ' 148' ' ' TRP . 86.0 mt -65.09 -29.73 48.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.586 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.07 -12.7 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.371 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 48.0 mt-30 -88.94 1.18 55.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.418 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 68.69 17.44 8.89 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.607 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -80.34 -18.95 47.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.325 0.583 . . . . 0.0 110.137 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.547 ' HB2' HG12 ' A' ' 143' ' ' ILE . 84.7 m95 -126.1 138.89 53.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.05 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 48.8 mt -106.43 107.59 18.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.073 0.463 . . . . 0.0 110.232 176.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tt -84.73 134.13 34.35 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.286 -174.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.505 ' HB2' HD13 ' A' ' 174' ' ' LEU . 16.1 t -150.07 178.09 9.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.045 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.25 154.14 39.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.254 0.55 . . . . 0.0 111.549 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.81 145.16 32.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.202 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.429 ' N ' HD22 ' A' ' 154' ' ' ASN . 0.9 OUTLIER -88.61 26.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.097 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.8 t30 70.48 -45.66 0.6 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.884 0.874 . . . . 0.0 110.672 -174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -57.93 -43.49 86.32 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 121.185 0.517 . . . . 0.0 109.851 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -28.84 69.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.444 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.699 HD13 HG13 ' A' ' 104' ' ' ILE . 2.8 tt -74.5 -56.57 4.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.112 -173.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.64 ' HB3' ' HB3' ' A' ' 88' ' ' SER . 0.4 OUTLIER -125.27 -23.55 4.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -174.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.29 -51.09 14.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.357 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.541 0.63 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.23 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.546 0.689 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.11 -6.0 47.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.73 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.71 67.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.074 0.464 . . . . 0.0 110.649 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.668 ' HA ' HG12 ' A' ' 11' ' ' ILE . 44.6 t30 -67.87 -39.43 83.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.111 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -79.29 -20.89 46.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.718 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.514 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 2.2 tpt -63.11 -33.6 75.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.462 0.648 . . . . 0.0 109.263 173.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 151' ' ' SER . 13.0 tp -81.0 -45.06 17.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.251 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.579 0 CA-C-N 115.437 -0.802 . . . . 0.0 113.247 175.614 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 121.339 0.59 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.47 HD13 HD23 ' A' ' 139' ' ' LEU . 85.1 mt -74.82 -8.86 57.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.633 -171.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.3 132.82 49.24 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.73 11.7 84.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.774 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.634 ' HG3' ' HA ' ' A' ' 152' ' ' GLU . 13.8 mptt -117.06 172.05 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.481 -0.423 . . . . 0.0 110.145 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 54.9 p90 -144.21 152.94 41.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.587 HD12 ' CE3' ' A' ' 148' ' ' TRP . 17.4 pt -109.79 151.83 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.992 0.425 . . . . 0.0 110.877 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.793 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 40.8 mm -100.66 115.51 42.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.826 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -149.63 147.65 28.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.588 0.232 . . . . 0.0 111.485 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.035 178.376 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HD2' HD21 ' A' ' 73' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -74.82 79.89 2.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.108 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.826 HG21 ' HB3' ' A' ' 12' ' ' ALA . 91.9 t 72.72 132.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.875 174.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.598 HG13 ' HD1' ' A' ' 27' ' ' TYR . 4.6 tp -122.72 -103.65 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.941 174.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.598 ' HD1' HG13 ' A' ' 26' ' ' ILE . 8.8 p90 -129.33 173.8 10.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 120.027 1.285 . . . . 0.0 112.348 -171.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.3 mm -100.49 128.29 52.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.673 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.1 m -79.8 -57.8 3.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.519 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.44 157.75 43.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.268 0.556 . . . . 0.0 111.297 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -133.03 112.06 11.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.666 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 32' ' ' ASN . 0.9 OUTLIER -94.98 163.33 13.36 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 166.138 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.33 -30.9 71.49 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.189 0.519 . . . . 0.0 110.608 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -96.65 -33.98 11.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.718 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.93 123.45 4.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.354 -172.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 133' ' ' THR . 28.4 m -108.78 116.34 31.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 176.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.602 HG13 HG22 ' A' ' 133' ' ' THR . 3.5 mp -104.32 120.13 54.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.834 0.349 . . . . 0.0 110.943 -174.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.46 163.5 29.26 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.913 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.534 HG23 HG23 ' A' ' 26' ' ' ILE . 1.6 m -115.42 88.1 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.668 0.747 . . . . 0.0 110.501 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.548 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -132.27 26.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.061 -175.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.648 HG21 ' O ' ' A' ' 74' ' ' ASN . 10.7 tp -64.74 -36.56 77.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.415 -172.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.522 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.1 t-20 63.38 63.88 0.86 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.126 0.489 . . . . 0.0 110.923 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.551 HG22 HG13 ' A' ' 41' ' ' ILE . 14.3 t 173.37 130.0 0.1 Allowed Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.927 175.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 75.1 Cg_endo -92.97 155.95 2.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.175 2.583 . . . . 0.0 112.038 173.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 74' ' ' ASN . 9.8 p -87.6 -177.99 6.0 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.74 -2.86 46.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.735 0.779 . . . . 0.0 109.458 177.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.437 HD21 HD21 ' A' ' 52' ' ' LEU . 62.2 tp -90.35 158.3 17.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.164 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 11.8 m -114.42 152.88 30.85 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.207 -0.308 . . . . 0.0 110.467 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.615 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.2 p -64.15 -37.62 80.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.043 0.449 . . . . 0.0 110.007 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.38 -34.2 77.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.339 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 48' ' ' SER . 34.1 mt-10 -63.51 -44.0 95.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.518 177.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.497 HD13 HD21 ' A' ' 129' ' ' LEU . 56.4 mt -66.59 -45.93 77.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.75 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 89.3 mt -56.04 -48.97 75.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.072 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -73.1 -31.42 64.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.539 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -68.63 -52.36 32.24 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.81 0.338 . . . . 0.0 111.021 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.9 mtm . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.916 -177.092 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 C--O 1.233 0.185 0 CA-C-O 121.304 0.573 . . . . 0.0 111.716 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -103.21 112.94 26.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.618 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 87.7 mtp -82.3 145.29 30.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.033 0.444 . . . . 0.0 111.397 -171.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.458 HG23 HG22 ' A' ' 127' ' ' VAL . 8.1 p -99.03 143.29 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.369 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 8.0 mp -90.78 164.14 14.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 110.373 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 41' ' ' ILE . 3.6 t-20 -100.27 103.49 14.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.59 -27.8 61.72 Favored Glycine 0 C--N 1.328 0.098 0 O-C-N 123.5 0.5 . . . . 0.0 112.885 -171.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.03 172.19 30.22 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.14 -13.04 28.42 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.333 2.022 . . . . 0.0 111.825 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.74 145.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.468 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.545 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 83.9 m-20 63.96 24.75 13.72 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.222 0.326 . . . . 0.0 111.765 174.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -69.16 -10.89 59.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.702 0.763 . . . . 0.0 110.595 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.0 -13.68 60.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.711 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -113.71 134.54 54.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.981 0.42 . . . . 0.0 110.935 -172.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.57 119.22 5.06 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.755 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -105.84 121.52 44.23 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.436 HG13 HG23 ' A' ' 127' ' ' VAL . 5.1 mp -141.96 117.72 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 95.3 t -112.14 119.82 61.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.431 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -129.5 159.64 35.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -177.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.6 m -82.45 167.68 18.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.119 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.431 ' HE2' ' CE1' ' A' ' 87' ' ' HIS . 4.7 mptp? -119.22 122.02 41.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 t -94.13 -21.11 19.31 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.573 -173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.885 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 2.6 t70 -114.03 -4.78 13.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.56 0.695 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.7 m170 67.29 34.39 4.9 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.07 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.885 ' HG3' ' HB3' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -87.97 165.72 15.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.94 175.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -159.06 116.57 2.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.294 0.568 . . . . 0.0 110.966 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.7 m -88.73 -60.57 1.92 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.97 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.557 ' H ' ' HB2' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -145.24 35.22 1.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.439 179.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 148.48 24.47 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.97 -175.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -102.16 135.68 43.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.565 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -87.3 116.12 25.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.37 -54.04 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 169.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.807 HG22 ' HB ' ' A' ' 104' ' ' ILE . 11.9 t -138.69 -158.43 0.86 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -59.33 -65.18 0.71 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -93.66 -23.96 18.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.751 0.31 . . . . 0.0 111.38 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.807 ' HB ' HG22 ' A' ' 101' ' ' THR . 41.3 mm -86.96 122.46 38.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.987 0.423 . . . . 0.0 110.823 -171.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.1 p -134.16 137.9 44.8 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.981 -175.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.6 tp -91.82 137.66 32.18 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.33 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.818 HG21 ' HB3' ' A' ' 111' ' ' ASP . 25.4 m -138.8 140.04 38.44 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.733 -0.604 . . . . 0.0 111.456 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.4 p -111.6 -29.07 7.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.417 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.5 m -155.55 160.29 40.39 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.689 0.281 . . . . 0.0 111.171 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.82 -82.19 0.41 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.903 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.818 ' HB3' HG21 ' A' ' 107' ' ' THR . 11.2 t70 -51.91 -48.57 64.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.546 0.738 . . . . 0.0 111.629 -173.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.561 HG13 HD22 ' A' ' 113' ' ' LEU . 7.6 p -63.58 -38.64 82.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.988 -176.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.561 HD22 HG13 ' A' ' 112' ' ' VAL . 2.6 mm? -69.46 -33.27 72.67 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.303 0.573 . . . . 0.0 110.0 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -76.35 -28.2 56.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.607 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.6 m -57.48 -62.43 1.79 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.35 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -86.36 27.68 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -172.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.2 20.36 23.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.155 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.6 t -162.93 172.72 14.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -71.54 -19.49 62.16 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.722 0.296 . . . . 0.0 111.471 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.0 p -84.53 18.27 2.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 0.0 110.994 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.41 129.82 93.85 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.341 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.98 139.23 72.42 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.623 2.215 . . . . 0.0 112.195 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -60.71 -48.58 81.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.515 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 159' ' ' PHE . 2.0 mmpp? -101.05 119.09 38.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.937 -168.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 36.9 p90 -154.87 127.93 8.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.289 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.2 pt -109.43 133.54 54.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.082 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.557 HG11 ' HB ' ' A' ' 49' ' ' VAL . 7.5 p -116.44 128.94 73.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.279 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 81.2 m -143.52 151.97 40.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.105 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 52' ' ' LEU . 2.4 mm? -102.45 117.18 34.17 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 174.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . 83.67 -175.85 52.19 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.964 -175.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 19.3 m -148.45 163.69 36.41 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 m -98.37 114.84 27.32 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.602 HG22 HG13 ' A' ' 37' ' ' ILE . 22.6 p -112.5 120.02 40.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.522 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 0.4 OUTLIER -86.23 133.25 33.85 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 136' ' ' PRO . 96.6 mttt -65.0 153.31 89.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.082 -175.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 135' ' ' LYS . 33.5 Cg_exo -28.7 98.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 1 C-N-CA 125.507 4.138 . . . . 0.0 115.233 -171.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 71.58 -2.71 2.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.88 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -62.82 -30.07 71.21 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.47 HD23 HD13 ' A' ' 5' ' ' LEU . 36.2 tp -60.14 -29.16 68.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.604 0.24 . . . . 0.0 111.296 -176.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.99 -38.4 90.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.07 0.462 . . . . 0.0 109.912 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.518 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.9 mp0 -70.43 -37.16 74.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.412 177.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.522 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 74.7 mm-40 -63.41 -43.7 96.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.341 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 139' ' ' LEU . 73.3 mt -68.56 -31.24 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.483 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.26 -24.43 67.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.215 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 39.1 mt-30 -83.7 -0.59 51.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.562 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 62.23 17.24 9.1 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.665 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -87.97 0.78 55.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.415 0.626 . . . . 0.0 109.703 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.587 ' CE3' HD12 ' A' ' 10' ' ' ILE . 99.4 m95 -138.07 122.11 17.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.651 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.793 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 75.8 mt -98.92 145.64 26.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.1 tp -124.49 134.65 52.97 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.138 0.494 . . . . 0.0 111.368 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.0 t -138.38 148.95 45.07 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.432 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.634 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 26.0 mp0 -87.32 153.32 21.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.032 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -115.05 128.71 56.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.123 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -62.4 -63.56 1.2 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.986 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -177.64 -56.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.095 175.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 42.0 mt-30 -62.85 -27.3 69.24 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.808 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.9 m -52.45 -29.06 22.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.134 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.1 mt -65.21 -54.72 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.463 ' HD2' ' HB3' ' A' ' 124' ' ' LYS . 54.1 m-85 -129.83 -14.17 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 44.2 mt-10 -96.41 0.89 51.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.162 0.506 . . . . 0.0 110.877 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.183 175.378 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 173' ' ' MET . 50.2 mt-10 -53.89 -42.99 69.27 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.59 -46.26 66.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.037 0.446 . . . . 0.0 111.276 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -80.44 -36.84 33.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.909 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.18 -29.29 70.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.504 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 169' ' ' GLU . 29.2 mmt -60.64 -29.35 69.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.918 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.425 HD13 HG13 ' A' ' 11' ' ' ILE . 5.2 tt -101.1 -51.66 3.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.925 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.94 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.443 -178.773 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.099 0.476 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.09 8.87 16.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.184 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -70.95 119.77 15.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.391 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.17 7.84 45.73 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.1 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -116.85 175.36 5.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.512 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 26.9 p90 -146.92 140.58 25.75 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 171.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 pt -93.92 131.74 39.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.311 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.978 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 3.4 mp -90.07 114.99 28.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.833 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.573 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -90.71 125.2 35.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.609 174.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-O 120.89 0.376 . . . . 0.0 110.706 -179.706 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.525 ' HG2' HG21 ' A' ' 126' ' ' ILE . 7.1 tpm_? . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 121.235 0.541 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 t -91.91 132.41 36.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.501 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t 71.43 117.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.259 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.916 HG22 ' HD1' ' A' ' 27' ' ' TYR . 9.0 mm -116.17 -95.55 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.326 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.916 ' HD1' HG22 ' A' ' 26' ' ' ILE . 2.1 p90 178.09 -177.4 0.22 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.251 0.22 . . . . 0.0 110.56 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.2 mm -95.25 124.6 47.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.3 m -91.22 -46.46 8.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.722 -173.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.739 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 32.1 mt-10 -131.89 150.57 52.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.372 0.606 . . . . 0.0 112.218 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -132.37 105.95 7.6 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 167.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -109.3 171.05 7.67 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.453 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.53 -26.23 68.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.665 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -111.41 13.01 21.53 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.11 170.59 22.22 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.238 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 133' ' ' THR . 55.1 m -115.21 130.41 56.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.839 HG13 HG22 ' A' ' 133' ' ' THR . 3.8 mp -109.59 119.11 58.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.425 -173.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.01 165.12 28.56 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.121 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.515 HG23 ' HB ' ' A' ' 26' ' ' ILE . 3.3 m -126.99 102.5 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.237 0.541 . . . . 0.0 110.957 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.489 ' N ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -141.79 12.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.166 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 tp -74.55 -33.8 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.204 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 58.96 86.5 0.09 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.798 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 9.0 t -163.04 123.02 1.41 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.257 0.551 . . . . 0.0 111.411 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 2.4 Cg_endo -83.01 173.95 9.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.184 2.589 . . . . 0.0 111.607 176.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.405 HG22 ' ND2' ' A' ' 74' ' ' ASN . 16.6 p -118.17 -171.51 2.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.756 0.312 . . . . 0.0 110.366 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.76 7.11 47.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.387 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -112.12 155.52 23.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.427 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 43.0 m -104.91 157.44 17.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.003 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 14.7 p -68.67 -34.08 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.18 0.515 . . . . 0.0 109.92 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.82 -25.9 60.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.291 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -53.16 56.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.751 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.1 pp -65.57 -33.62 76.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.605 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.82 -50.58 66.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.179 0.514 . . . . 0.0 110.96 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.9 p -72.43 -29.19 63.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -72.47 -39.62 67.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.388 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 19.7 ptp . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -174.77 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.522 -0.122 0 CA-C-O 120.659 0.266 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -128.3 112.79 14.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.881 0.372 . . . . 0.0 110.704 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.634 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 69.7 mtm -92.59 161.29 14.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.186 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.66 141.39 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.516 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.6 mp -109.2 170.51 8.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -176.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.405 ' ND2' HG22 ' A' ' 45' ' ' THR . 75.1 m-20 -110.21 132.15 54.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.013 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.75 -16.94 53.79 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.424 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.49 -179.35 36.95 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.934 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -86.79 5.04 6.01 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.164 2.576 . . . . 0.0 112.824 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.407 HG21 ' OG1' ' A' ' 133' ' ' THR . 21.7 t -120.19 153.84 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.415 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 89.4 m-20 65.53 33.44 8.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.873 0.368 . . . . 0.0 110.333 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -65.31 -14.51 60.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.102 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -91.1 -4.67 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.422 0.63 . . . . 0.0 110.553 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -109.5 120.36 42.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.074 0.464 . . . . 0.0 110.897 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.75 108.52 3.62 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.55 ' HB3' HD11 ' A' ' 106' ' ' LEU . 98.0 m-85 -97.19 125.27 41.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.698 0.285 . . . . 0.0 110.735 -176.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.444 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.7 mp -117.12 109.92 29.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.207 0.527 . . . . 0.0 109.891 175.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -94.13 121.01 44.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.322 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -138.55 155.56 48.27 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.461 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.1 m -73.98 164.38 26.7 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 103' ' ' ASP . 14.3 ttmm -88.5 118.1 27.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.072 0.939 . . . . 0.0 112.291 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.4 m -139.48 18.43 2.55 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 169.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -132.6 161.31 34.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.019 -167.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.14 28.14 1.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.603 171.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.51 170.27 13.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.708 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -162.66 79.98 0.5 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.7 m -92.56 -41.42 10.25 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -169.6 78.38 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.337 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.6 m -115.2 133.86 55.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.102 -172.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.601 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 4.8 t80 -102.11 102.54 13.02 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -81.73 106.27 13.53 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.08 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.55 HG11 ' HE2' ' A' ' 27' ' ' TYR . 16.8 t -91.06 -62.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 46.5 p -119.05 175.71 5.64 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.97 -33.06 64.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 20.5 t70 -106.37 -49.12 3.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.392 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.6 mm -76.2 121.95 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.208 0.528 . . . . 0.0 110.001 -169.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.6 m -122.11 132.45 54.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.758 -175.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 58.6 tp -102.23 112.24 24.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.839 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.664 HG21 ' HB3' ' A' ' 111' ' ' ASP . 15.2 m -106.96 124.3 49.43 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.03 28.35 8.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.881 -175.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 t -146.8 -174.24 4.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.711 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.34 -0.87 25.12 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.091 -176.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.664 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.4 t70 -55.26 -37.7 67.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.258 0.552 . . . . 0.0 110.123 174.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.559 HG23 HD22 ' A' ' 113' ' ' LEU . 36.0 m -55.82 -34.33 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.142 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.559 HD22 HG23 ' A' ' 112' ' ' VAL . 3.5 mm? -62.49 -34.55 77.08 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.446 0.641 . . . . 0.0 110.197 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.37 -25.8 31.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.919 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.0 m -62.3 -57.1 12.62 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.236 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.433 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 11.7 p90 -91.46 3.66 54.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 110.858 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.67 29.18 12.07 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.954 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.4 t -140.62 174.19 10.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -65.05 -39.16 92.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.813 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.7 p -89.76 32.32 0.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.48 -176.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 116' ' ' PHE . . . -58.51 130.46 84.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.993 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.22 140.22 91.07 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.916 2.411 . . . . 0.0 112.308 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.09 -52.87 44.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.723 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -104.75 113.3 26.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.221 -172.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -147.27 133.61 19.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.806 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.525 HG21 ' HG2' ' A' ' 23' ' ' ARG . 32.7 pt -123.99 143.03 38.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.578 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.24 119.35 60.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.227 0.537 . . . . 0.0 110.489 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.6 p -131.07 130.88 43.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.532 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.69 125.63 34.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.014 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . 75.56 178.48 43.2 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.884 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 77.8 m -150.76 173.32 14.33 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.4 m -102.16 116.9 33.63 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 37' ' ' ILE . 78.3 p -111.12 120.83 43.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.994 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -81.01 137.71 36.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.472 . . . . 0.0 110.487 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -71.67 140.23 84.01 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.521 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -36.58 130.25 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.248 3.299 . . . . 0.0 114.716 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.2 t60 77.37 -34.43 0.2 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.41 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.6 tp60 -60.2 -44.38 95.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -173.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.8 tp -55.82 -35.46 66.39 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.661 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -64.36 -38.92 92.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.148 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -71.26 -39.47 71.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 8.4 mm-40 -57.8 -51.12 70.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.302 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.8 mt -68.75 -33.15 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.564 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.4 91.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.311 . . . . 0.0 111.057 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -86.1 12.64 9.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.09 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 62.32 32.97 16.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.082 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.531 ' HD2' ' HA ' ' A' ' 142' ' ' GLU . 15.9 m-85 -72.14 -28.0 62.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.229 0.538 . . . . 0.0 109.738 172.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.573 ' HZ3' ' HB2' ' A' ' 12' ' ' ALA . 91.0 m95 -134.08 139.41 45.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.695 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.978 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.9 tt -88.2 141.3 28.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.535 ' N ' HD23 ' A' ' 149' ' ' LEU . 59.3 tp -123.09 134.57 54.24 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.696 -175.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.9 p -161.42 164.07 30.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.877 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -71.13 155.78 40.36 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.142 0.496 . . . . 0.0 111.274 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.04 -155.16 0.53 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.935 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.3 t30 65.85 22.9 11.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.76 0.791 . . . . 0.0 109.891 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -88.31 165.72 14.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.883 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 38.0 mt-30 -59.31 -29.09 67.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.052 0.453 . . . . 0.0 110.624 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.664 ' HA ' HG23 ' A' ' 161' ' ' THR . 6.7 m -52.63 -30.48 31.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.262 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.54 -57.18 6.94 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.356 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -127.42 -19.26 4.27 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 41.0 mt-10 -82.74 -9.07 59.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 111.524 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 157' ' ' THR . 1.6 p . . . . . 0 C--N 1.324 -0.511 0 CA-C-O 121.401 0.62 . . . . 0.0 110.246 173.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 168' ' ' VAL . 6.8 t . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 121.329 0.585 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.4 -7.21 41.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.037 0.446 . . . . 0.0 110.933 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.477 ' HB1' ' CG1' ' A' ' 11' ' ' ILE . . . -53.79 -39.37 65.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.181 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -81.08 -33.03 33.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.554 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.19 -27.91 61.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 0.0 110.658 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.615 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 1.0 OUTLIER -59.6 -33.05 70.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.196 0.522 . . . . 0.0 110.213 175.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 149' ' ' LEU . 12.8 tp -82.05 -48.73 11.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.473 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.536 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.228 -179.535 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 . . . . . 0 CA--C 1.519 -0.213 0 CA-C-O 120.633 0.254 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.79 -82.8 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 173.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 57.13 107.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 172.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.33 -1.96 79.1 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.565 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.69 ' HD2' ' HB3' ' A' ' 152' ' ' GLU . 37.9 mmtm -95.4 159.85 14.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.478 ' HZ ' ' HG2' ' A' ' 173' ' ' MET . 45.0 p90 -123.79 154.41 39.59 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.511 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.567 HD11 HG21 ' A' ' 40' ' ' ILE . 8.4 pt -114.45 144.56 21.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.758 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.7 mp -110.73 161.41 9.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.405 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 70.51 -176.59 0.2 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.547 0.529 . . . . 0.0 110.784 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 t . . . . . 0 C--N 1.325 -0.486 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.385 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 121.401 0.62 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.3 t -97.51 112.01 24.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.228 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.464 HG22 ' HB ' ' A' ' 40' ' ' ILE . 38.6 t 54.76 92.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.076 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.496 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.4 tp -95.02 -57.35 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.496 ' HD1' HG13 ' A' ' 26' ' ' ILE . 6.1 p90 -174.3 175.47 2.63 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.158 0.436 . . . . 0.0 111.637 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.8 mm -94.93 126.61 47.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.816 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.35 -51.24 15.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.753 0.311 . . . . 0.0 111.157 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -159.92 153.83 23.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 0.0 110.846 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -120.6 104.64 10.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -106.59 171.04 7.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.194 -173.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.76 -22.59 65.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.92 0.391 . . . . 0.0 110.999 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -80.69 -39.7 26.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.057 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 170.58 -167.31 40.47 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.605 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.7 m -103.21 121.18 42.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.683 0.277 . . . . 0.0 110.335 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.647 HG13 HG22 ' A' ' 133' ' ' THR . 4.3 mp -98.0 118.74 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.09 153.93 25.37 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.494 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -114.6 88.69 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.728 0.775 . . . . 0.0 110.692 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.581 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -125.1 18.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.113 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.537 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -61.07 -36.17 70.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.382 -176.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.6 t30 56.23 66.83 1.1 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 110.582 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 t -169.47 103.41 0.47 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-O 121.545 0.688 . . . . 0.0 111.156 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 5.9 Cg_exo -78.83 158.75 27.8 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.612 2.208 . . . . 0.0 110.286 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.54 HG21 ' ND2' ' A' ' 74' ' ' ASN . 73.6 p -110.38 166.3 11.09 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.549 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -73.87 -30.35 62.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.976 0.417 . . . . 0.0 110.78 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.62 149.99 49.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.261 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.0 m -97.59 150.83 20.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.965 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.676 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.1 p -61.85 -36.62 74.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.71 -35.46 81.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.481 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 8.3 mm-40 -62.04 -39.0 90.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.038 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.1 mt -74.98 -35.6 62.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.941 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 83.2 mt -62.96 -49.46 74.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.497 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.2 p -67.56 -30.34 69.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.857 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 1.7 tpp180 -60.77 -52.24 65.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.6 -177.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 13.1 ptt? . . . . . 0 C--N 1.326 -0.42 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -173.428 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.935 0.398 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -122.57 118.18 27.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.205 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.6 mtt -77.9 152.24 33.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.568 HG21 HD23 ' A' ' 129' ' ' LEU . 13.8 p -106.52 149.38 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.283 174.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.565 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.0 mp -102.42 159.75 15.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.763 0.315 . . . . 0.0 110.333 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.54 ' ND2' HG21 ' A' ' 45' ' ' THR . 35.9 m-20 -101.83 121.75 42.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.29 -23.34 58.99 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.542 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.97 -177.07 36.6 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.397 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.53 -25.94 7.64 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.259 2.639 . . . . 0.0 112.835 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.3 t -86.62 125.93 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.988 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 67.19 31.04 6.92 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.485 0.491 . . . . 0.0 110.855 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -65.97 -21.62 66.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.46 -175.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -82.87 -0.23 47.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.265 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -125.42 142.5 51.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 110.675 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.78 131.88 10.74 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.11 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -112.72 123.1 49.55 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 106' ' ' LEU . 5.2 mp -137.49 120.16 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.913 0.387 . . . . 0.0 111.268 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.1 t -110.51 130.41 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -132.01 149.36 52.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.448 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 p -69.91 150.44 46.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.984 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -65.79 112.86 3.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.532 0.682 . . . . 0.0 110.53 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 92.5 m -157.87 -48.2 0.06 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.68 -165.77 1.41 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.645 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -165.79 134.07 3.05 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.894 ' HB3' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -100.35 -171.03 1.96 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.91 -177.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -118.0 -46.12 2.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.879 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 36.5 p -75.33 -84.32 0.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -168.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -110.6 91.29 3.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 111.571 -172.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.9 m -96.04 104.03 15.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.565 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -102.73 102.62 12.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.015 0.436 . . . . 0.0 109.9 175.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 102' ' ' ASP . 4.8 mtmm -89.76 107.01 18.84 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.58 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -60.55 -53.96 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.424 HG22 HG12 ' A' ' 104' ' ' ILE . 5.8 t -134.53 -176.16 4.12 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.469 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 33.5 t70 -65.3 -33.35 75.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 118.27 0.486 . . . . 0.0 112.285 -170.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -98.15 2.38 48.46 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 101' ' ' THR . 47.0 mm -117.81 123.65 71.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.7 m -124.41 124.99 43.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.993 0.425 . . . . 0.0 111.325 -176.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 85' ' ' ILE . 21.4 tp -101.59 130.45 47.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.021 174.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.7 m -129.16 124.89 35.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.1 p -109.03 28.87 8.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.64 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m -138.08 177.24 8.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.51 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.453 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -63.5 -11.82 43.2 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.304 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.894 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . 0.9 OUTLIER -47.84 -38.02 15.1 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.781 0.433 . . . . 0.0 111.051 175.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.424 HG11 HG21 ' A' ' 85' ' ' ILE . 86.5 t -52.58 -40.82 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.376 178.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.554 HD11 HD22 ' A' ' 53' ' ' LEU . 3.8 mm? -62.3 -36.46 82.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.08 -27.24 54.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.05 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 m -56.99 -55.73 30.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.192 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.492 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 20.8 p90 -90.49 26.5 1.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -173.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -107.67 17.12 36.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.566 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 t -145.5 -179.31 6.58 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.677 -0.308 . . . . 0.0 110.326 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -74.88 -21.74 59.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.678 0.275 . . . . 0.0 111.253 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.9 p -91.96 23.39 3.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.943 0.401 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.492 ' CB ' ' HA ' ' A' ' 116' ' ' PHE . . . -65.69 146.03 99.0 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.232 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.55 133.83 38.7 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.415 2.077 . . . . 0.0 111.452 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.49 -36.48 83.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.997 0.427 . . . . 0.0 110.794 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -136.74 128.1 28.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.075 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.01 140.78 24.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.745 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.5 pt -110.5 132.93 57.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.976 0.417 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.95 126.91 73.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.385 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 80.8 m -140.62 150.0 43.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.005 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.568 HD23 HG21 ' A' ' 72' ' ' VAL . 4.3 mm? -100.32 117.52 34.68 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.51 177.75 50.53 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.904 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 66.4 m -145.83 168.58 20.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.89 0.376 . . . . 0.0 110.432 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.5 m -114.2 119.95 38.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.265 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.647 HG22 HG13 ' A' ' 37' ' ' ILE . 21.5 p -102.03 114.7 29.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.584 0.707 . . . . 0.0 111.69 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.53 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.5 OUTLIER -99.55 135.59 40.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.925 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 10.5 mptt -75.64 136.69 70.81 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.025 -175.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 6.5 Cg_exo -74.86 42.56 0.84 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.647 2.898 . . . . 0.0 114.175 -170.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 55.1 m-70 -156.58 -38.72 0.08 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 171.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.617 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 50.4 tt0 -52.8 -60.72 2.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.906 171.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.53 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 57.4 tp -63.03 -35.88 81.71 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.402 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.476 ' HB3' ' HA ' ' A' ' 137' ' ' HIS . 40.6 tt0 -55.66 -48.75 74.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.893 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 23.5 mt-30 -72.47 -31.5 65.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.114 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 53.7 mm-40 -59.19 -44.17 92.21 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.156 0.503 . . . . 0.0 109.912 175.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.588 HG12 ' HB2' ' A' ' 148' ' ' TRP . 66.7 mt -64.43 -36.78 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.341 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.29 -24.92 67.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.403 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 73.4 mt-30 -78.17 -0.64 29.16 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.903 0.382 . . . . 0.0 110.351 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.1 m120 70.28 31.28 3.15 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.895 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . 0.47 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 59.7 m-85 -100.5 -4.23 29.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.262 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.588 ' HB2' HG12 ' A' ' 143' ' ' ILE . 97.2 m95 -134.48 148.94 50.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.768 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 60.3 mt -126.03 153.35 44.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.852 175.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.1 tp -121.87 134.93 54.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.017 0.437 . . . . 0.0 111.576 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.2 t -149.96 173.13 14.15 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.69 ' HB3' ' HD2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -129.26 154.1 47.15 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.246 -179.026 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' ' 157' ' ' THR . . . -127.21 104.72 8.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.702 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -81.42 88.51 6.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.344 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 70.0 -65.97 0.29 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.828 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.581 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 30.7 mt-30 -56.62 -70.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -170.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.536 ' HB ' ' HB1' ' A' ' 153' ' ' ALA . 3.1 m -54.21 -29.57 46.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -175.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -57.21 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.87 -174.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -128.83 -13.6 4.63 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 31.4 mt-10 -81.71 -52.33 7.27 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.273 174.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.5 m . . . . . 0 C--N 1.33 -0.281 0 O-C-N 124.397 1.061 . . . . 0.0 111.664 177.565 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.702 0.763 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -94.04 -3.23 51.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.767 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -56.72 -33.26 66.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.581 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -79.51 -27.88 41.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.759 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -73.29 -23.41 60.28 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.01 0.433 . . . . 0.0 110.669 176.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.478 ' HG2' ' HZ ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -66.29 -28.47 68.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.732 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.425 ' CD2' HD13 ' A' ' 149' ' ' LEU . 10.4 tp -112.89 -50.5 2.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.198 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -176.824 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 121.114 0.483 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -99.98 15.6 26.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.453 0.644 . . . . 0.0 109.752 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.732 HE21 HG13 ' A' ' 100' ' ' VAL . 49.2 tt0 -91.51 131.49 36.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.674 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.8 0.14 59.09 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.684 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.439 ' HB2' HD23 ' A' ' 5' ' ' LEU . 3.3 mptp? -107.8 176.62 5.08 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 43.3 p90 -142.72 152.94 42.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.054 0.454 . . . . 0.0 110.39 173.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 pt -118.19 128.12 75.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.307 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 60.0 mt -86.63 111.92 22.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.168 -175.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -120.78 94.87 4.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.558 173.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.276 -178.605 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.5 p -121.2 154.6 36.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.818 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t 67.91 96.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 O-C-N 123.815 0.697 . . . . 0.0 111.117 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.642 HG21 HG23 ' A' ' 39' ' ' VAL . 10.6 tp -124.65 -146.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.345 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.561 ' H ' HG13 ' A' ' 26' ' ' ILE . 3.5 p90 -116.63 171.71 7.7 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.427 1.012 . . . . 0.0 111.623 -164.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.53 116.09 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.553 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.8 m -75.51 -45.07 40.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.109 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -140.48 144.86 36.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.86 0.362 . . . . 0.0 110.719 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -128.61 111.96 13.76 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.293 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -114.75 173.36 6.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -71.84 -23.14 61.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.744 0.307 . . . . 0.0 111.112 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -107.45 -27.59 10.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.468 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.82 127.12 3.32 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 119.8 -1.19 . . . . 0.0 113.06 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 133' ' ' THR . 82.1 m -107.39 110.72 22.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.745 HG13 HG22 ' A' ' 133' ' ' THR . 4.0 mp -96.54 114.33 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.843 -172.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -145.71 160.88 28.19 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.642 HG23 HG21 ' A' ' 26' ' ' ILE . 3.0 m -114.75 63.97 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.599 0.714 . . . . 0.0 110.491 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -111.66 15.3 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.544 -175.167 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 43' ' ' THR . 10.4 tp -68.91 -28.25 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.359 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 63.7 87.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.103 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.487 HG22 HG23 ' A' ' 41' ' ' ILE . 4.1 t -168.52 96.84 0.56 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.455 0.645 . . . . 0.0 111.086 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 57.9 Cg_endo -74.84 154.19 43.13 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.059 1.839 . . . . 0.0 111.3 174.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -115.63 152.24 33.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.681 0.277 . . . . 0.0 110.614 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.77 -17.15 62.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.07 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.401 ' O ' HG12 ' A' ' 72' ' ' VAL . 21.4 tp -76.08 160.01 30.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.709 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 14.7 m -119.81 160.11 23.26 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.903 -174.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.571 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.9 p -65.82 -37.92 81.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.046 -175.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.468 HD23 HD12 ' A' ' 53' ' ' LEU . 91.6 mt -66.54 -33.98 76.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.204 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.709 ' OE1' ' HB2' ' A' ' 48' ' ' SER . 3.1 mp0 -61.76 -40.41 95.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.627 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.02 -39.82 63.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.327 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 113' ' ' LEU . 95.1 mt -62.62 -49.14 76.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.978 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 40.1 p -68.11 -30.97 70.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.634 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -60.25 -37.27 79.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.585 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 73.0 mtm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 176.993 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.258 0.551 . . . . 0.0 112.195 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 48' ' ' SER . 29.6 mm-40 -111.52 127.88 55.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.679 178.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 66.2 mtt -79.87 157.79 26.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.013 0.435 . . . . 0.0 111.47 -176.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 129' ' ' LEU . 9.7 p -107.74 149.87 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.237 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 8.0 mp -107.98 168.39 9.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.0 110.142 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.39 137.07 46.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.537 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -103.09 -9.38 39.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.44 -0.885 . . . . 0.0 113.009 -173.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.11 164.7 12.25 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.95 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.6 -20.91 26.29 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.961 2.441 . . . . 0.0 112.502 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.51 128.38 39.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.972 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 64.66 24.99 13.04 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.44 0.462 . . . . 0.0 110.612 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HA ' ' CA ' ' A' ' 130' ' ' GLY . 53.3 tt0 -65.29 -23.5 67.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.534 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.02 -19.63 62.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.674 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 82' ' ' ARG . 39.1 mtm180 -109.67 143.73 39.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.004 0.431 . . . . 0.0 111.057 -171.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.41 130.76 10.04 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.336 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -111.84 124.22 51.91 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.408 ' O ' HD12 ' A' ' 106' ' ' LEU . 5.4 mp -131.14 115.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.0 111.032 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.01 126.43 67.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.76 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -133.17 161.09 35.37 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.119 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 m -67.52 159.04 30.52 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.444 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 46.1 tttp -72.55 120.13 17.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.188 0.518 . . . . 0.0 110.645 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.1 m -144.99 107.67 4.45 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 173.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -54.31 138.15 39.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.345 0.593 . . . . 0.0 112.199 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -176.71 24.54 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.757 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 67.51 -165.52 0.21 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -167.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -151.56 137.32 17.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.018 0.437 . . . . 0.0 111.262 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 111' ' ' ASP . 30.9 m -89.81 -50.04 6.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.076 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 109' ' ' SER . 50.3 t60 -168.32 88.56 0.24 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.72 176.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 57.8 m -130.9 136.02 48.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.716 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -103.43 116.69 32.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 101' ' ' THR . 0.3 OUTLIER -81.32 122.08 27.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.06 0.457 . . . . 0.0 111.84 -175.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.732 HG13 HE21 ' A' ' 6' ' ' GLN . 64.2 t -68.4 -53.01 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 165.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 9.9 t -138.54 -169.67 2.66 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.886 -1.506 . . . . 0.0 107.0 167.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.05 -40.88 60.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 118.9 0.773 . . . . 0.0 110.983 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 6.3 m-20 -76.31 -25.55 54.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.7 mm -118.01 123.1 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 m -131.25 133.62 45.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.036 0.446 . . . . 0.0 111.987 -173.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 85' ' ' ILE . 19.1 tp -96.12 137.27 35.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.991 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.866 HG21 ' HB3' ' A' ' 111' ' ' ASP . 50.9 m -133.51 128.34 35.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.888 0.375 . . . . 0.0 111.164 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.9 p -120.08 25.4 9.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.831 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.515 ' CB ' ' HB3' ' A' ' 96' ' ' HIS . 8.6 t -136.9 -170.56 2.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.619 -174.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.12 -5.29 52.94 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 116.509 -0.314 . . . . 0.0 112.926 -178.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.866 ' HB3' HG21 ' A' ' 107' ' ' THR . 14.6 t70 -55.22 -37.13 66.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.337 0.589 . . . . 0.0 110.483 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.09 -50.1 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.701 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.623 HD11 HD13 ' A' ' 53' ' ' LEU . 3.9 mm? -61.98 -41.02 97.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.854 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.19 -41.89 98.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.386 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 68.2 m -54.15 -68.76 0.16 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.309 -176.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . 0.434 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 32.2 p90 -86.87 21.97 2.12 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 111.979 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.33 19.12 10.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.896 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 120' ' ' THR . 8.9 t -157.48 -170.48 3.24 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.922 0.361 . . . . 0.0 110.524 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -67.7 -20.9 65.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.0 111.248 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.509 ' H ' HG23 ' A' ' 118' ' ' THR . 16.6 p -98.05 36.07 1.63 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.278 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -75.73 121.95 86.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.438 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.38 131.56 20.6 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.633 2.222 . . . . 0.0 111.295 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.61 -47.26 73.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.326 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -123.11 123.24 40.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.374 0.607 . . . . 0.0 111.897 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -146.13 131.92 19.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.02 175.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.3 pt -105.39 132.77 51.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.902 0.382 . . . . 0.0 110.311 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.83 123.49 71.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.235 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 74.2 m -136.07 142.96 44.41 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.413 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 72' ' ' VAL . 3.9 mm? -93.63 115.49 27.97 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.631 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . 80.89 173.32 47.19 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.841 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 62.8 m -147.06 169.22 19.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.7 m -105.95 116.65 32.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.004 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.745 HG22 HG13 ' A' ' 37' ' ' ILE . 47.7 p -103.66 115.84 31.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.465 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.908 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 1.5 t-105 -78.77 157.49 28.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.749 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 12.9 mmmm -65.37 147.16 98.79 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.378 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.23 113.89 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.443 2.762 . . . . 0.0 112.949 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.509 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 10.9 m-70 66.83 -3.36 0.93 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.534 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 53.3 tt0 -74.82 -25.48 59.04 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.733 -177.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.446 ' O ' HG13 ' A' ' 143' ' ' ILE . 49.1 tp -56.95 -39.24 74.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.885 -175.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.583 ' HG3' ' NE2' ' A' ' 141' ' ' GLN . 12.7 pt-20 -66.36 -34.27 77.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.784 0.326 . . . . 0.0 110.76 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.583 ' NE2' ' HG3' ' A' ' 140' ' ' GLU . 2.2 mp0 -71.33 -38.9 71.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 110.243 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.908 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 32.9 mm-40 -59.54 -43.54 93.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 139' ' ' LEU . 78.7 mt -64.48 -34.07 67.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.803 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.04 -19.01 65.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.335 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.473 ' NE2' ' HA ' ' A' ' 142' ' ' GLU . 54.2 mt-30 -79.94 -2.47 43.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.723 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 71.05 18.8 5.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.712 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -100.27 3.91 43.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 12' ' ' ALA . 99.8 m95 -134.83 119.86 18.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.83 0.347 . . . . 0.0 110.79 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.521 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 3.9 tt -100.21 113.05 25.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.9 tt -90.19 134.52 34.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 110.632 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.7 m -142.0 152.19 43.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.539 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.29 158.84 24.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.483 0.659 . . . . 0.0 111.618 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.69 -152.57 0.44 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.891 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.0 t30 67.87 65.97 0.37 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.959 0.409 . . . . 0.0 111.233 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -178.6 -89.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.969 174.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -106.4 -55.96 2.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.001 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.8 m -52.12 -29.81 23.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.571 -170.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.34 -53.98 40.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -134.39 15.29 3.76 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.89 -53.36 5.16 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.456 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.6 p . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.426 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 170' ' ' ALA . 31.9 t . . . . . 0 C--O 1.233 0.187 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -97.23 -4.76 38.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.462 0.172 . . . . 0.0 111.315 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.588 ' H ' HG12 ' A' ' 168' ' ' VAL . . . -53.1 -42.44 65.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -77.12 -37.41 54.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.025 0.44 . . . . 0.0 110.787 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -75.78 -22.89 55.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.688 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -57.18 -37.26 71.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.84 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.8 tp -89.53 -44.31 10.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.946 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.118 -179.989 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.234 0.251 0 CA-C-O 121.059 0.457 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.95 -107.47 0.27 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.268 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 59.36 117.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.905 0.753 . . . . 0.0 112.476 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.413 ' C ' ' HD3' ' A' ' 8' ' ' LYS . . . 84.84 8.16 82.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.676 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.94 ' HD2' ' HB2' ' A' ' 152' ' ' GLU . 22.2 mmtp -112.05 150.81 30.14 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -130.49 163.03 27.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.393 0.616 . . . . 0.0 111.895 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.434 HD12 ' CE3' ' A' ' 148' ' ' TRP . 2.5 pt -127.69 128.36 69.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.396 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.495 HD12 HD22 ' A' ' 174' ' ' LEU . 55.0 mt -96.03 150.58 4.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.804 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 76.19 130.75 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.11 0.881 . . . . 0.0 110.91 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.477 HG23 ' CH2' ' A' ' 148' ' ' TRP . 32.7 m . . . . . 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.016 -177.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.708 HH22 ' HG2' ' A' ' 71' ' ' MET . 62.7 mtm180 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.346 0.593 . . . . 0.0 111.192 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -121.23 117.59 27.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.496 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.424 HG13 HG22 ' A' ' 40' ' ' ILE . 58.1 t 69.04 134.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.684 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.49 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.8 tp -134.97 -58.89 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.887 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.49 ' HD1' HG13 ' A' ' 26' ' ' ILE . 1.8 p90 -179.23 177.8 0.75 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.011 0.434 . . . . 0.0 111.805 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.9 mm -94.02 125.31 46.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.217 174.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.5 m -89.93 -41.01 12.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -171.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.47 145.29 35.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.209 0.528 . . . . 0.0 110.804 -176.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -122.48 103.61 8.82 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -112.27 166.38 11.33 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.926 -171.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -79.14 -12.34 59.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.384 0.611 . . . . 0.0 109.766 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -86.68 -36.63 18.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.307 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.82 178.88 48.88 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.13 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 133' ' ' THR . 18.0 m -107.26 118.27 36.27 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.615 HG12 HG22 ' A' ' 133' ' ' THR . 56.8 mt -103.4 113.07 39.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.865 0.364 . . . . 0.0 111.424 -170.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.76 164.95 29.6 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.764 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.32 96.23 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.609 0.719 . . . . 0.0 111.685 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.602 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -129.8 17.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.463 177.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 74' ' ' ASN . 9.3 tp -54.89 -30.61 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.602 -172.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.517 ' O ' ' HB ' ' A' ' 43' ' ' THR . 49.2 t30 60.71 71.18 0.58 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.47 0.308 . . . . 0.0 111.279 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 14.8 t 178.31 117.64 0.19 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 121.583 0.706 . . . . 0.0 111.425 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 1.2 Cg_endo -85.49 157.3 10.75 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.174 2.583 . . . . 0.0 111.09 171.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 74' ' ' ASN . 10.6 p -96.74 175.72 6.26 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.82 -29.29 40.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 110.526 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.4 tp -68.58 148.49 50.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.604 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.748 ' HB3' ' HG2' ' A' ' 51' ' ' GLU . 17.1 t -104.82 152.86 22.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.618 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -64.44 -31.94 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.068 0.461 . . . . 0.0 109.951 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.8 mt -75.03 -26.26 59.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.089 0.471 . . . . 0.0 110.321 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.748 ' HG2' ' HB3' ' A' ' 48' ' ' SER . 45.8 mm-40 -64.22 -36.62 84.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.563 176.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.29 -35.18 76.63 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.536 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.16 -39.5 63.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 56' ' ' MET . 20.9 p -70.59 -29.69 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 0.0 110.575 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 tpt85 -61.19 -29.55 69.88 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.932 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 54' ' ' THR . 62.6 mtm . . . . . 0 N--CA 1.466 0.346 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.765 173.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 120.875 0.369 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -133.52 124.54 27.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.323 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.708 ' HG2' HH22 ' A' ' 23' ' ' ARG . 0.0 OUTLIER -68.12 133.49 49.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.251 0.548 . . . . 0.0 110.8 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.619 HG23 HG13 ' A' ' 127' ' ' VAL . 11.7 p -82.94 149.91 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.197 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.8 mp -93.55 157.86 15.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.273 0.559 . . . . 0.0 111.935 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.588 ' O ' HG21 ' A' ' 41' ' ' ILE . 3.1 t-20 -101.06 87.24 3.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.968 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.34 -32.39 80.69 Favored Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.844 -169.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.93 173.98 33.22 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.991 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.34 -22.97 12.09 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.741 2.294 . . . . 0.0 113.074 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.484 HG21 ' OG1' ' A' ' 133' ' ' THR . 59.4 t -81.21 117.56 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.378 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 62.79 32.87 15.73 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 123.704 0.628 . . . . 0.0 110.467 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HA ' ' HA3' ' A' ' 130' ' ' GLY . 52.6 tt0 -61.86 -22.15 65.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.719 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -82.21 -1.55 49.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -113.95 140.88 48.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.52 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.09 118.4 6.12 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -100.86 125.96 47.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.21 114.04 44.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 110.328 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.533 HG22 HD13 ' A' ' 106' ' ' LEU . 34.7 t -100.3 122.56 52.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.441 177.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -136.47 160.97 37.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.639 0.257 . . . . 0.0 110.971 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.9 m -73.75 177.7 5.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.608 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -51.62 113.83 1.09 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 110.827 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.0 m -121.54 117.57 27.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 -176.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.8 -152.57 0.39 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.743 0.652 . . . . 0.0 109.327 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -137.33 18.88 2.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.163 0.506 . . . . 0.0 110.645 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.87 168.6 11.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.012 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -175.2 146.07 0.82 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.151 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.443 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 90.6 m -89.87 -56.66 3.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.065 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -158.31 104.7 1.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.1 m -116.98 159.17 22.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.811 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -108.33 116.5 32.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.0 tttm -75.92 102.41 5.56 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.997 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.3 t -81.21 -54.11 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.465 ' OG1' HG12 ' A' ' 104' ' ' ILE . 70.8 p -130.04 -162.78 1.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -86.32 4.76 37.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.932 0.396 . . . . 0.0 110.424 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -134.66 -48.95 0.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.363 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.74 HD12 ' HD2' ' A' ' 159' ' ' PHE . 24.2 mm -68.99 122.01 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.714 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.9 m -123.64 116.8 23.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.073 -174.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.533 HD13 HG22 ' A' ' 86' ' ' VAL . 56.1 tp -96.88 128.84 44.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.073 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.573 HG21 ' HB3' ' A' ' 111' ' ' ASP . 26.6 m -128.89 130.96 47.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.3 p -109.03 -12.21 14.87 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 p -101.5 -172.21 2.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.093 0.473 . . . . 0.0 111.798 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.507 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -74.83 7.48 20.5 Favored Glycine 0 C--O 1.227 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.675 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.573 ' HB3' HG21 ' A' ' 107' ' ' THR . 18.2 t0 -64.43 -28.66 69.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.552 0.692 . . . . 0.0 109.698 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.13 -37.18 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.66 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.507 HD23 ' HA2' ' A' ' 110' ' ' GLY . 4.0 mm? -63.66 -34.68 78.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.803 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -80.17 -27.53 38.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.062 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -60.64 -42.37 96.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -104.45 170.31 7.97 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.224 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 81.27 11.54 83.31 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.036 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.5 t -127.98 168.27 15.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -77.8 -5.05 49.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.048 0.451 . . . . 0.0 110.789 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 p -113.14 27.73 9.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.019 0.438 . . . . 0.0 110.628 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.47 160.37 25.51 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.721 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.8 146.14 29.57 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.4 2.067 . . . . 0.0 111.954 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.465 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 88.6 mt-10 -58.64 -53.12 61.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.161 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 123' ' ' GLU . 9.9 mtmt -139.32 153.69 47.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.985 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -155.01 134.96 12.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.836 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.443 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 24.8 pt -110.57 133.03 57.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.117 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.619 HG13 HG23 ' A' ' 72' ' ' VAL . 5.7 p -119.77 128.17 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.151 0.5 . . . . 0.0 110.725 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 22.6 p -133.19 135.66 45.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.49 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.409 HD23 HG21 ' A' ' 72' ' ' VAL . 4.0 mm? -87.9 108.85 19.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.841 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 80' ' ' GLN . . . 79.2 174.44 45.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.83 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 63.4 m -144.45 168.9 19.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.0 m -105.6 130.72 53.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.183 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.615 HG22 HG12 ' A' ' 37' ' ' ILE . 66.9 p -118.37 125.55 50.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.514 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 27.1 m-90 -82.88 178.88 7.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 167.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 138' ' ' GLN . 1.5 mptm? -74.74 159.95 81.99 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 168.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.56 111.17 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.968 1.779 . . . . 0.0 111.744 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 74.97 8.69 4.08 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.726 174.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 31.1 tt0 -64.24 -36.27 83.54 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.589 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 143' ' ' ILE . 49.3 tp -53.7 -29.62 39.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.976 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.76 -38.99 92.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.82 0.343 . . . . 0.0 110.569 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -69.53 -31.67 70.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.258 0.551 . . . . 0.0 110.3 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -70.14 -43.76 70.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.177 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.445 HG12 ' HB2' ' A' ' 148' ' ' TRP . 74.3 mt -67.98 -31.51 52.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.21 -22.34 60.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.57 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -71.87 -4.56 28.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.513 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 65.19 23.92 12.31 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.272 0.629 . . . . 0.0 111.97 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -96.84 -36.02 10.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.585 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.477 ' CH2' HG23 ' A' ' 13' ' ' THR . 92.9 m95 -92.26 127.84 37.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.679 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 tt -100.69 110.51 22.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.1 tp -82.6 134.53 35.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.539 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.5 p -152.14 144.12 23.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.097 175.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.94 ' HB2' ' HD2' ' A' ' 8' ' ' LYS . 15.9 pt-20 -113.5 153.82 28.08 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.618 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -115.17 152.79 31.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.177 -174.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -94.87 -59.53 1.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.514 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -168.52 -47.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.142 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -52.93 -45.87 67.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.874 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 173' ' ' MET . 0.2 OUTLIER -56.89 -29.18 62.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.172 -177.201 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.461 HD12 HG13 ' A' ' 104' ' ' ILE . 84.1 mt -89.51 -50.89 5.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -174.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.74 ' HD2' HD12 ' A' ' 104' ' ' ILE . 11.8 m-85 -124.78 -0.2 8.01 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -174.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -89.7 -57.65 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.201 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.412 ' HB ' ' OD1' ' A' ' 171' ' ' ASN . 11.3 m . . . . . 0 CA--C 1.531 0.215 0 CA-C-O 121.318 0.58 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 169' ' ' GLU . 5.4 pt-20 -77.48 -18.75 56.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.502 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.88 -57.42 9.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.086 0.469 . . . . 0.0 111.207 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.412 ' OD1' ' HB ' ' A' ' 168' ' ' VAL . 3.8 p-10 -68.89 -25.53 64.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.416 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.85 -25.15 65.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.256 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.702 ' HG3' HG23 ' A' ' 157' ' ' THR . 1.5 tmt? -58.69 -36.6 74.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.441 0.639 . . . . 0.0 109.418 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 11' ' ' ILE . 11.8 tp -84.43 -38.44 20.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.775 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.487 179.886 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.7 t30 . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.0 mt 57.44 -149.9 0.45 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.506 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 64.38 104.88 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.563 0.697 . . . . 0.0 111.154 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.73 -4.0 68.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.667 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -113.49 168.24 9.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 41.6 p90 -134.8 155.91 49.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.025 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.8 pt -129.53 128.03 65.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.23 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 58.6 mt -88.16 132.31 33.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.396 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.467 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -125.7 143.96 50.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.932 176.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 C--N 1.324 -0.507 0 O-C-N 123.291 0.369 . . . . 0.0 110.71 178.648 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER . . . . . 0 CA--C 1.519 -0.219 0 CA-C-O 121.354 0.597 . . . . 0.0 110.02 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.4 ' HB ' ' ND2' ' A' ' 42' ' ' ASN . 29.6 p -90.2 124.49 34.9 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.795 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t 66.86 87.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.503 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.584 HG13 ' N ' ' A' ' 27' ' ' TYR . 7.0 tp -119.02 -117.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.134 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.584 ' N ' HG13 ' A' ' 26' ' ' ILE . 4.5 p90 -118.62 170.33 9.05 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.835 1.198 . . . . 0.0 113.055 -165.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.1 mm -87.73 121.49 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.528 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.3 m -85.57 -41.12 15.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.956 0.407 . . . . 0.0 111.308 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HB3' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -142.11 151.83 42.67 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -149.65 105.03 3.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.469 0.652 . . . . 0.0 111.487 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -129.78 162.78 27.67 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.46 170.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.58 -24.13 64.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.268 0.556 . . . . 0.0 109.853 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.07 -9.76 58.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.933 176.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 164.45 129.62 1.06 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.777 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 133' ' ' THR . 88.5 m -103.86 117.8 35.2 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.574 HG23 ' HB3' ' A' ' 131' ' ' CYS . 3.8 mp -101.39 118.25 47.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.583 -175.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.94 139.64 7.66 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.794 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.665 HG12 ' HA2' ' A' ' 75' ' ' GLY . 2.4 m -92.1 77.31 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.972 0.891 . . . . 0.0 110.201 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.47 HD12 ' CH2' ' A' ' 148' ' ' TRP . 25.1 pt -126.51 4.83 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.815 -172.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.2 pt -73.39 -18.84 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -175.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.469 ' O ' ' HB ' ' A' ' 43' ' ' THR . 47.1 t-20 64.51 89.13 0.1 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.613 0.571 . . . . 0.0 111.618 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 74' ' ' ASN . 10.0 t 173.85 127.74 0.11 Allowed Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.712 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.57 154.35 9.03 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.653 2.236 . . . . 0.0 110.732 169.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.3 p -88.14 177.53 6.88 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.385 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -84.8 -17.54 37.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.114 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.66 152.76 22.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.791 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 55.7 p -102.05 157.26 17.0 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.644 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.499 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 12.1 p -64.66 -32.78 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.033 0.444 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -70.93 -31.95 68.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.865 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.26 -43.97 96.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.1 pp -76.49 -32.49 58.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.042 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 67.6 mt -65.67 -37.89 87.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.302 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.6 p -78.72 -30.76 46.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.863 0.364 . . . . 0.0 111.072 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -63.83 -48.07 78.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.814 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.6 mmt . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.533 179.858 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.927 0.394 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.844 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -116.58 132.43 56.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.186 -178.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 58.8 mtm -82.81 151.35 26.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.526 HG23 HG22 ' A' ' 127' ' ' VAL . 11.0 p -95.54 133.75 35.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.977 0.417 . . . . 0.0 110.195 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.4 mt -72.29 157.75 37.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.004 0.43 . . . . 0.0 111.666 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.481 ' HB3' HG23 ' A' ' 43' ' ' THR . 7.8 t-20 -98.4 113.16 25.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.254 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.665 ' HA2' HG12 ' A' ' 39' ' ' VAL . . . -79.24 -36.24 27.87 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.06 -178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.81 174.62 28.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.894 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.35 -11.87 27.0 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.887 2.391 . . . . 0.0 113.484 -174.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.44 132.01 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.37 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 65.86 39.26 4.71 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.236 0.335 . . . . 0.0 111.582 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -65.76 -21.66 66.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.91 7.65 43.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.741 0.782 . . . . 0.0 109.834 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.37 140.64 49.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.01 129.66 9.86 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.619 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB3' HD11 ' A' ' 106' ' ' LEU . 21.3 m-85 -115.19 125.03 52.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.71 ' HB ' HG21 ' A' ' 112' ' ' VAL . 4.7 mp -131.26 122.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.554 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.623 HG22 HD13 ' A' ' 106' ' ' LEU . 7.3 t -95.18 131.4 42.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -137.96 160.27 39.78 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.465 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.7 m -63.22 145.5 55.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.237 0.542 . . . . 0.0 111.63 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -63.55 124.28 20.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.331 174.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -117.88 -176.54 3.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -174.226 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.752 ' HB2' HG21 ' A' ' 120' ' ' THR . 6.8 m-20 -79.78 -35.53 38.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -172.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.546 ' HE1' ' HA ' ' A' ' 115' ' ' SER . 10.1 p-80 -87.07 175.54 8.05 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.979 -173.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.39 169.18 3.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.759 0.79 . . . . 0.0 112.269 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -153.91 113.98 3.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.718 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.5 m -72.87 -77.36 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.154 -169.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -109.03 83.72 1.8 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.323 0.583 . . . . 0.0 110.844 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.3 m -126.04 151.8 46.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.156 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.32 102.0 12.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -69.95 115.7 9.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.77 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.79 -54.47 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.612 177.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.459 HG23 ' H ' ' A' ' 102' ' ' ASP . 2.3 t -131.19 -54.46 1.04 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.959 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.459 ' H ' HG23 ' A' ' 101' ' ' THR . 11.8 t70 173.45 -64.01 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 5.7 m-20 -62.77 -26.83 68.9 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.77 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.9 mm -99.51 122.26 51.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -129.2 114.76 16.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.945 0.402 . . . . 0.0 111.466 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.623 HD13 HG22 ' A' ' 86' ' ' VAL . 21.8 tp -93.99 112.19 23.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.794 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.829 HG21 ' HB3' ' A' ' 111' ' ' ASP . 29.8 m -99.96 127.67 46.13 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.07 0.462 . . . . 0.0 110.907 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.8 p -102.16 23.88 10.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.038 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.496 ' H ' HG22 ' A' ' 107' ' ' THR . 34.2 m -151.38 -177.74 6.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.395 -176.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.81 11.75 5.61 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.341 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.829 ' HB3' HG21 ' A' ' 107' ' ' THR . 14.7 t70 -63.42 -30.23 71.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.853 0.835 . . . . 0.0 109.708 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.71 HG21 ' HB ' ' A' ' 85' ' ' ILE . 40.8 t -54.79 -45.44 74.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.609 174.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.38 -33.8 73.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.612 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.58 -41.39 94.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.967 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.584 ' HB3' ' HD3' ' A' ' 122' ' ' PRO . 49.1 m -59.08 -39.66 82.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.761 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.18 4.66 25.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.996 0.427 . . . . 0.0 111.219 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.29 17.4 28.98 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.975 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.3 t -142.58 179.26 7.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -62.55 -32.33 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.851 0.357 . . . . 0.0 110.959 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.752 HG21 ' HB2' ' A' ' 91' ' ' ASP . 23.4 p -92.49 43.1 1.12 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.848 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -56.89 123.65 60.1 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.765 168.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 115' ' ' SER . 27.0 Cg_endo -61.27 129.52 28.69 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.824 2.349 . . . . 0.0 112.558 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.44 -45.82 92.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.875 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -114.14 142.07 46.69 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.6 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -161.29 143.08 11.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.569 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.03 132.6 69.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.232 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 72' ' ' VAL . 7.3 p -115.01 131.07 68.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.113 0.482 . . . . 0.0 110.993 -176.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 8.9 p -142.98 146.46 33.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.456 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mt -102.33 142.81 32.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.83 179.73 7.41 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.074 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.574 ' HB3' HG23 ' A' ' 37' ' ' ILE . 61.9 m -149.14 162.72 39.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.077 0.465 . . . . 0.0 109.977 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -114.03 117.07 30.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.464 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' THR . 17.9 p -107.66 116.38 31.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.234 0.54 . . . . 0.0 112.004 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.653 ' CD1' ' HB2' ' A' ' 139' ' ' LEU . 0.6 OUTLIER -101.23 151.38 21.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.971 177.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 11.4 mptt -105.49 137.33 19.26 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.325 -174.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 7.8 Cg_exo -72.09 92.26 0.73 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.379 2.719 . . . . 0.0 112.818 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' HIS . . . . . 0.462 ' HB3' ' O ' ' A' ' 136' ' ' PRO . 13.6 p80 170.85 -18.66 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.125 176.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.593 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 56.9 tp60 -110.32 -58.88 2.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 171.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.653 ' HB2' ' CD1' ' A' ' 134' ' ' TRP . 53.5 tp -56.89 -53.11 61.71 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -172.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -35.94 77.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -173.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.441 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 11.5 mt-30 -74.94 -36.22 62.14 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.45 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 7.6 mm-40 -65.81 -41.96 91.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.756 0.312 . . . . 0.0 110.305 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 139' ' ' LEU . 71.2 mt -62.19 -42.44 95.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.44 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.68 99.25 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.233 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 41.8 mt-30 -78.8 3.56 16.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.02 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.35 37.52 3.53 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 175.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -72.84 -28.41 62.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 164.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' TRP . . . . . 0.47 ' CH2' HD12 ' A' ' 40' ' ' ILE . 74.6 m95 -116.4 149.81 38.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.0 -1.454 . . . . 0.0 108.991 175.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.623 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.0 tt -104.6 110.1 22.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 34.0 tp -82.03 135.46 35.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 111.228 -176.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.2 m -143.87 156.04 44.31 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 152' ' ' GLU . 0.7 OUTLIER -98.09 153.74 18.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.385 0.612 . . . . 0.0 111.401 -175.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.18 155.4 40.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.33 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -119.01 -62.36 1.53 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.786 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -161.8 -38.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 44.4 mt-30 -54.85 -56.43 19.58 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.2 m -55.12 -28.17 50.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.424 0.63 . . . . 0.0 111.063 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.8 mt -81.31 -54.57 5.38 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.849 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . 0.455 ' HZ ' ' HB ' ' A' ' 86' ' ' VAL . 71.1 m-85 -133.51 17.66 3.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -172.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 28.6 tt0 -110.65 -48.36 3.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.268 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 121.055 0.455 . . . . 0.0 111.185 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.236 0.343 0 CA-C-O 121.334 0.588 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 173' ' ' MET . 13.2 pt-20 -71.21 -29.22 64.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.723 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.24 91.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.979 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -71.99 -31.99 66.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.399 0.619 . . . . 0.0 109.593 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.61 -21.91 61.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.16 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.484 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 23.6 mmt -58.27 -33.74 69.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.465 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.5 tt -117.02 -52.83 2.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.183 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.089 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -175.194 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.8 mtm . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 61.06 116.26 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 O-C-N 124.093 0.871 . . . . 0.0 112.114 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.94 72.79 0.53 Allowed Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.095 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 69.9 114.83 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.96 0.904 . . . . 0.0 111.425 176.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 31' ' ' HIS . 91.8 mt -82.25 -3.03 54.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.153 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.605 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -65.1 135.65 55.79 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 175.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.88 12.82 83.04 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.961 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.552 ' HD2' ' HG3' ' A' ' 152' ' ' GLU . 43.2 mmtm -112.8 163.4 14.65 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -140.28 150.45 44.06 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.04 0.448 . . . . 0.0 110.382 174.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.523 HD11 HG13 ' A' ' 40' ' ' ILE . 8.4 pt -116.06 129.14 72.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.851 -177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.74 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.0 mp -86.37 103.83 13.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -94.8 -54.37 3.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.426 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.5 m 58.35 82.38 0.23 Allowed Pre-proline 0 CA--C 1.532 0.254 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.86 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -68.18 151.89 76.56 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 122.73 2.287 . . . . 0.0 111.985 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -59.19 -46.16 89.16 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.665 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.3 ttt -168.52 -74.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.212 -0.903 . . . . 0.0 108.571 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 51.49 73.02 0.33 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.401 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 t70 75.64 -49.7 0.62 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.527 0.731 . . . . 0.0 111.934 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -72.32 156.93 38.58 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -124.63 -38.37 2.4 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -176.94 -12.64 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -174.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -93.81 73.16 4.22 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.704 -0.622 . . . . 0.0 111.666 -167.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 71.5 123.74 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.942 -1.027 . . . . 0.0 112.593 174.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.409 ' O ' ' HB ' ' A' ' 25' ' ' VAL . 1.1 t -140.45 110.89 6.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.391 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.563 HG13 HG22 ' A' ' 40' ' ' ILE . 90.2 t 73.55 140.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 122.844 0.458 . . . . 0.0 110.918 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.564 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.3 tp -135.19 -58.42 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.564 ' HD1' HG13 ' A' ' 26' ' ' ILE . 20.4 p90 -168.05 171.44 9.62 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.647 0.658 . . . . 0.0 112.134 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.68 133.75 40.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.195 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 38.8 m -75.97 -52.6 9.91 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.03 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.605 ' HA ' ' HB2' ' A' ' 6' ' ' GLN . 13.7 pt-20 -161.1 169.91 21.46 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.131 0.491 . . . . 0.0 111.752 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 37.6 t-80 -134.16 111.03 9.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.636 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -128.25 170.16 13.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.495 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.33 -31.97 73.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.133 0.492 . . . . 0.0 110.85 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -74.57 -18.11 60.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.857 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.31 -177.52 30.04 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.659 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.0 m -113.27 117.62 32.35 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.665 HG13 HG22 ' A' ' 133' ' ' THR . 3.9 mp -96.28 124.85 49.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.44 164.73 34.65 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.037 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.38 81.65 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.443 0.64 . . . . 0.0 110.355 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.563 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -133.97 6.65 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.431 -176.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 8.9 tp -70.59 -35.9 63.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-O 120.506 0.193 . . . . 0.0 111.247 -176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 63.97 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.182 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.495 HG23 ' HB2' ' A' ' 74' ' ' ASN . 4.1 t -161.34 91.52 1.49 Allowed Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 121.714 0.768 . . . . 0.0 110.062 172.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.468 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 58.6 Cg_endo -72.85 154.56 53.63 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.719 2.279 . . . . 0.0 112.058 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.1 p -114.95 167.98 10.31 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.46 -0.63 47.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.765 0.317 . . . . 0.0 111.595 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.648 HD21 ' HB3' ' A' ' 52' ' ' LEU . 35.1 tp -92.4 152.38 19.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.9 0.381 . . . . 0.0 110.143 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.721 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 12.8 m -109.08 154.48 22.2 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.446 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 7.4 p -61.28 -45.56 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.237 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.594 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 90.3 mt -75.67 -25.82 57.12 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.105 -0.238 . . . . 0.0 110.407 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.721 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.5 OUTLIER -57.36 -53.47 57.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.097 178.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.648 ' HB3' HD21 ' A' ' 47' ' ' LEU . 3.8 pp -66.66 -36.52 82.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.04 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.69 -51.63 64.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.779 0.323 . . . . 0.0 111.105 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.7 p -72.49 -29.46 63.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.057 0.456 . . . . 0.0 111.186 -176.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -69.61 -37.2 76.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.584 -178.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.471 ' HG3' ' O ' ' A' ' 52' ' ' LEU . 65.2 mtt -82.35 -91.69 0.07 Allowed 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.928 0.394 . . . . 0.0 111.918 -176.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -146.76 24.35 1.21 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.938 0.875 . . . . 0.0 110.435 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -122.34 50.25 1.5 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -67.1 -37.63 84.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.611 -171.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.7 ttt -90.77 84.22 5.82 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.261 0.553 . . . . 0.0 110.682 -177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -111.34 -165.59 1.0 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.209 175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 62' ' ' LYS . 13.5 ptmt -125.38 67.05 55.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 178.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -88.77 -14.77 2.84 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.202 1.935 . . . . 0.0 111.5 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 56.86 -163.41 0.17 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.393 -178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.7 pt -82.35 9.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.692 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -67.75 -42.94 81.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.19 177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 m 73.31 -20.22 0.3 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.013 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -66.02 153.45 42.16 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.594 ' OD2' ' HB2' ' A' ' 50' ' ' LEU . 6.0 t0 -139.21 178.69 7.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.174 -174.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -118.34 137.11 53.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 23.3 mmt -81.93 140.44 34.04 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.353 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.46 HG23 HG13 ' A' ' 127' ' ' VAL . 14.2 p -93.94 137.71 22.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.012 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.1 mp -106.48 155.11 19.92 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.513 -177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.495 ' HB2' HG23 ' A' ' 43' ' ' THR . 44.2 m-20 -89.42 127.72 35.86 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.52 -15.0 69.5 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.178 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.22 175.12 29.8 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.66 -12.19 20.27 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.651 2.234 . . . . 0.0 112.719 -178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.9 t -97.95 145.38 9.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.514 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 64.9 30.7 11.92 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 122.504 0.321 . . . . 0.0 111.618 176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.644 HE21 ' HA ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -65.78 -9.19 26.18 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.045 0.45 . . . . 0.0 111.314 -179.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.1 -19.99 60.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.303 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -134.77 143.16 46.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.157 0.503 . . . . 0.0 111.413 -171.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.14 122.6 7.28 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.597 ' HB3' HD11 ' A' ' 106' ' ' LEU . 92.9 m-85 -96.97 126.12 41.88 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.631 0.253 . . . . 0.0 110.426 -176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.47 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.6 mp -111.35 115.16 49.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.189 0.518 . . . . 0.0 110.479 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.426 HG22 HD13 ' A' ' 106' ' ' LEU . 31.2 t -94.24 124.42 46.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.309 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -139.51 166.84 23.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.882 0.373 . . . . 0.0 111.195 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.3 p -93.16 174.12 7.38 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.064 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.55 ' HG3' ' OD1' ' A' ' 103' ' ' ASP . 21.7 mmtp -57.6 134.81 56.47 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.205 172.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.624 ' OG1' ' HA ' ' A' ' 122' ' ' PRO . 81.9 m -155.05 114.68 3.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.663 173.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.3 t70 59.68 -147.89 0.47 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.993 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -126.65 36.25 4.5 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 121.86 -0.525 . . . . 0.0 112.378 -176.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 94' ' ' PHE . 40.2 mm-40 -90.52 161.0 15.69 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.554 -0.459 . . . . 0.0 110.348 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.493 ' HB2' ' O ' ' A' ' 93' ' ' GLU . 27.0 t80 167.59 102.6 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.789 -172.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.4 m -121.26 -55.05 1.97 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.974 0.416 . . . . 0.0 110.913 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.74 ' HB2' ' HB2' ' A' ' 111' ' ' ASP . 9.6 m-70 -127.08 70.98 1.3 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.418 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.411 ' HB2' ' CE2' ' A' ' 94' ' ' PHE . 66.4 m -128.51 139.51 52.28 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.111 0.482 . . . . 0.0 111.036 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -102.91 133.35 48.16 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.548 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -76.31 113.49 13.94 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.111 0.481 . . . . 0.0 111.943 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.54 -53.73 9.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 166.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.773 HG22 ' HB ' ' A' ' 104' ' ' ILE . 6.3 t -142.72 -164.05 1.75 Allowed 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 170.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.448 ' O ' ' HE3' ' A' ' 89' ' ' LYS . 10.5 t70 -67.42 -53.29 30.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 118.572 0.623 . . . . 0.0 111.272 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.55 ' OD1' ' HG3' ' A' ' 89' ' ' LYS . 91.8 m-20 -84.18 -34.26 24.01 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.773 ' HB ' HG22 ' A' ' 101' ' ' THR . 46.8 mm -81.48 121.64 35.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.097 0.475 . . . . 0.0 110.226 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.14 128.96 50.03 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.749 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.597 HD11 ' HB3' ' A' ' 84' ' ' PHE . 54.8 tp -96.87 112.43 24.19 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.242 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.615 ' CG2' ' HB3' ' A' ' 111' ' ' ASP . 10.8 m -118.69 128.43 54.5 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.9 t -132.91 -29.67 1.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 t -112.37 104.71 12.87 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.459 -0.497 . . . . 0.0 112.024 -172.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.88 -53.4 2.93 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 114.767 0.667 . . . . 0.0 114.767 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.74 ' HB2' ' HB2' ' A' ' 96' ' ' HIS . 15.4 t0 -56.3 -34.48 66.54 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 122.89 0.476 . . . . 0.0 112.201 -170.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.652 HG23 HD22 ' A' ' 113' ' ' LEU . 3.7 m -59.2 -34.9 55.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.652 HD22 HG23 ' A' ' 112' ' ' VAL . 2.7 mm? -70.64 -27.29 63.94 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.437 0.637 . . . . 0.0 110.24 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -77.2 -33.54 56.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.288 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.44 ' HB3' ' HD3' ' A' ' 122' ' ' PRO . 20.2 m -60.82 -67.64 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.967 -176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.553 ' HA ' ' HB2' ' A' ' 121' ' ' ALA . 8.4 p90 -79.45 140.18 37.43 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.006 0.431 . . . . 0.0 111.055 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.74 -17.71 9.35 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.154 -0.778 . . . . 0.0 111.154 -175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 7.1 t -131.89 178.87 6.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -77.66 1.68 19.07 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -174.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.6 p -99.8 14.55 29.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.451 0.643 . . . . 0.0 110.828 175.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.553 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -71.52 130.93 86.8 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.473 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.624 ' HA ' ' OG1' ' A' ' 90' ' ' THR . 17.4 Cg_exo -63.95 140.09 71.06 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.542 2.161 . . . . 0.0 111.985 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -55.12 -51.35 66.71 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.152 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.548 ' HB2' ' HE2' ' A' ' 159' ' ' PHE . 67.2 mmtt -128.06 138.22 52.47 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.607 -175.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -154.04 144.33 22.16 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.492 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 28.8 pt -122.27 144.45 31.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.004 177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.46 HG13 HG23 ' A' ' 72' ' ' VAL . 7.4 p -119.39 134.29 63.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.154 0.502 . . . . 0.0 111.197 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 70.2 m -139.11 131.91 29.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.376 176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.6 116.77 23.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.188 178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.98 -177.33 50.31 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.388 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 64.1 m -150.41 169.39 21.55 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.168 0.587 . . . . 0.0 109.434 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.6 m -106.88 139.67 40.93 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.65 0.262 . . . . 0.0 110.502 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.665 HG22 HG13 ' A' ' 37' ' ' ILE . 27.5 p -117.55 114.22 23.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.037 0.446 . . . . 0.0 110.668 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -83.67 156.2 22.78 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.263 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.401 ' HB2' ' CB ' ' A' ' 138' ' ' GLN . 72.1 mmtt -58.57 141.47 84.04 Favored Pre-proline 0 C--O 1.237 0.441 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.355 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.97 119.89 7.44 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.746 2.297 . . . . 0.0 112.319 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.476 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 58.4 t60 74.83 -9.19 1.39 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.262 174.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.401 ' CB ' ' HB2' ' A' ' 135' ' ' LYS . 47.3 tt0 -66.68 -51.01 60.99 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.158 -0.339 . . . . 0.0 111.29 -177.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 143' ' ' ILE . 47.7 tp -54.41 -35.93 63.43 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.811 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.476 ' OE2' ' HA ' ' A' ' 137' ' ' HIS . 45.3 mt-10 -57.8 -43.26 85.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.061 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 8.5 mt-30 -72.39 -38.1 68.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.478 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -62.64 -40.56 97.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.583 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 139' ' ' LEU . 76.1 mt -65.77 -33.01 60.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.249 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.58 -25.07 64.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.059 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 75.2 mt-30 -75.97 -8.17 56.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.389 176.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.456 ' HB3' HD13 ' A' ' 180' ' ' LEU . 44.9 m-80 65.65 30.67 10.3 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.078 -173.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -87.74 -18.29 29.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.592 0.711 . . . . 0.0 109.477 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.413 ' HZ3' ' HB2' ' A' ' 12' ' ' ALA . 93.5 m95 -125.62 137.49 53.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.474 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.74 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 58.0 mt -92.37 108.31 19.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.071 0.462 . . . . 0.0 109.9 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 56.0 tp -91.45 134.05 34.96 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.927 -176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.0 t -149.7 148.0 28.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.552 ' HG3' ' HD2' ' A' ' 8' ' ' LYS . 1.7 mp0 -85.5 152.62 23.04 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.928 0.394 . . . . 0.0 110.178 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -109.35 104.15 13.21 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -80.29 77.01 7.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.896 -175.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.8 t30 49.97 -83.56 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 124.275 0.985 . . . . 0.0 112.889 173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.06 -35.58 80.73 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.545 0.212 . . . . 0.0 110.772 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.0 m -58.58 -30.3 67.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.858 0.361 . . . . 0.0 111.385 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.6 tt -67.0 -50.23 62.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.985 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.642 ' HB2' HD11 ' A' ' 104' ' ' ILE . 2.4 t80 -112.08 -27.67 8.3 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -169.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.499 ' HB3' ' HB2' ' A' ' 163' ' ' TYR . 60.7 mt-10 -105.44 -54.87 2.41 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.493 -176.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.9 t 38.39 88.46 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.46 1.1 . . . . 0.0 111.863 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.8 m 76.29 -37.24 0.29 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.337 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 160' ' ' GLU . 87.2 t80 68.23 93.61 0.08 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.208 0.603 . . . . 0.0 111.925 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.549 ' HG ' ' N ' ' A' ' 165' ' ' ASP . 2.5 pt? -173.6 -55.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.291 173.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.549 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 0.8 OUTLIER 175.47 143.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 175.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.657 ' HB3' ' HB3' ' A' ' 169' ' ' GLU . 2.9 mmt-85 -159.4 145.86 16.52 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.197 0.522 . . . . 0.0 111.759 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -138.17 137.47 37.65 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 171.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 168' ' ' VAL . 17.0 t 68.41 20.11 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 122.429 1.109 . . . . 0.0 109.054 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.657 ' HB3' ' HB3' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -60.63 -36.3 78.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 114.534 -1.212 . . . . 0.0 111.48 -178.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -61.92 -36.16 80.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.049 0.452 . . . . 0.0 111.096 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.423 ' HB3' HG12 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -79.84 -28.36 40.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.739 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -80.29 -26.38 38.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.361 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -53.94 -33.77 57.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.273 0.559 . . . . 0.0 111.077 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.3 tp -87.99 -39.13 14.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.971 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 130.45 46.36 0.15 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.139 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 39.5 mt 55.62 73.94 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 121.655 0.74 . . . . 0.0 110.532 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 15.8 p -99.2 131.59 45.12 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.958 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -124.51 -172.18 13.53 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 174.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 180' ' ' LEU . 45.5 mm 68.77 166.47 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 122.461 0.305 . . . . 0.0 110.607 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.484 ' N ' HG22 ' A' ' 179' ' ' ILE . 93.8 mt 63.01 62.51 1.02 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.149 0.58 . . . . 0.0 111.3 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.908 ' HB3' ' HD3' ' A' ' 182' ' ' PRO . . . 177.55 -59.14 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.253 175.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.908 ' HD3' ' HB3' ' A' ' 181' ' ' ALA . 25.4 Cg_endo -96.63 97.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 122.84 2.36 . . . . 0.0 111.2 173.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -108.96 -36.9 5.97 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.905 0.383 . . . . 0.0 110.209 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 66.9 23.8 72.77 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.528 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.597 ' NH1' ' HB3' ' A' ' 188' ' ' GLU . 51.7 ttp85 -108.47 78.4 1.16 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -89.45 -60.14 2.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.092 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.23 97.04 9.59 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.207 0.527 . . . . 0.0 111.162 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.597 ' HB3' ' NH1' ' A' ' 185' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.855 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.604 ' HA ' ' OE2' ' A' ' 140' ' ' GLU . 27.2 ttt . . . . . 0 N--CA 1.477 0.875 0 CA-C-O 121.149 0.499 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -114.12 -44.17 3.16 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 173.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 75.98 -67.74 2.35 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.84 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -88.76 130.2 35.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.452 0.644 . . . . 0.0 110.588 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' O ' ' HB3' ' A' ' 6' ' ' GLN . 95.8 mt -130.0 -152.12 0.5 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.402 -0.817 . . . . 0.0 108.965 178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.452 ' HB3' ' O ' ' A' ' 5' ' ' LEU . 50.8 tt0 67.98 119.25 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.215 0.531 . . . . 0.0 110.792 -175.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.18 19.7 27.61 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.758 -176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -134.96 169.79 16.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.499 ' CZ ' ' HG3' ' A' ' 173' ' ' MET . 29.4 p90 -143.85 162.41 36.16 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 175.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 3.3 pt -133.02 128.46 56.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.507 -174.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 4.9 mp -96.24 140.05 18.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.575 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.32 168.68 19.51 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 121.214 -0.194 . . . . 0.0 110.827 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.414 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 30.6 p 53.53 96.77 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.477 0 O-C-N 124.136 0.898 . . . . 0.0 113.044 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 181' ' ' ALA . 19.1 Cg_endo -62.65 -28.45 76.87 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.491 2.127 . . . . 0.0 111.482 174.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.88 148.29 50.89 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.298 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.517 ' HB3' ' HB2' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -162.1 149.64 14.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -94.83 96.17 9.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.89 0.376 . . . . 0.0 110.882 -174.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 20' ' ' TYR . 6.1 t70 65.76 173.75 0.22 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.857 -178.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 70.99 -39.7 0.46 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.581 0.752 . . . . 0.0 111.946 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 16' ' ' MET . 41.5 t80 -56.31 -27.64 56.25 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.675 0.79 . . . . 0.0 111.92 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -103.71 17.04 24.96 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.22 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -128.19 61.92 1.44 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.158 0.504 . . . . 0.0 110.296 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.712 ' HA ' ' HE ' ' A' ' 23' ' ' ARG . 1.4 mmp_? 64.16 86.62 0.12 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.023 176.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.1 p -146.34 158.71 43.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.2 t 68.24 100.47 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 O-C-N 123.897 0.748 . . . . 0.0 111.13 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.665 HG13 ' HD1' ' A' ' 27' ' ' TYR . 10.6 tp -129.67 -142.61 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.32 -177.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.665 ' HD1' HG13 ' A' ' 26' ' ' ILE . 37.1 p90 -117.64 174.55 6.1 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.476 1.034 . . . . 0.0 112.259 -165.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.4 mp -92.98 125.73 45.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.326 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 60.3 m -73.0 -59.03 2.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.064 -176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -145.89 164.21 32.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.409 0.623 . . . . 0.0 111.223 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 5' ' ' LEU . 45.3 t-80 -118.27 118.87 32.98 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -114.64 -176.87 3.0 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.326 -170.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -66.51 -28.84 68.88 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.261 0.553 . . . . 0.0 110.438 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.82 9.52 43.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.835 -174.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.09 -143.63 15.34 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.567 -1.302 . . . . 0.0 113.185 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 133' ' ' THR . 12.4 m -123.97 129.11 50.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.499 0.19 . . . . 0.0 110.94 -174.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.7 HG13 HG22 ' A' ' 133' ' ' THR . 3.5 mp -103.74 114.78 44.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.272 -177.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -145.82 165.72 28.0 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.557 HG12 ' HA3' ' A' ' 75' ' ' GLY . 3.5 m -113.37 68.03 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.628 0.728 . . . . 0.0 110.787 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.597 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -115.37 15.93 7.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.956 -173.498 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.0 tp -68.35 -29.38 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.739 0.304 . . . . 0.0 110.737 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 62.99 85.88 0.12 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.093 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.1 t -179.1 123.11 0.24 Allowed Pre-proline 0 C--O 1.235 0.315 0 CA-C-O 121.358 0.599 . . . . 0.0 111.514 175.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 71.9 Cg_endo -81.67 155.73 18.33 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.503 2.136 . . . . 0.0 110.733 170.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.2 p -112.2 161.75 16.22 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.731 -0.387 . . . . 0.0 111.022 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -70.05 -20.42 63.24 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.117 -174.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.494 ' O ' HG12 ' A' ' 72' ' ' VAL . 57.5 tp -67.44 145.07 55.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.609 176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.533 ' HB3' ' CG ' ' A' ' 69' ' ' ASP . 17.9 m -101.06 153.33 19.65 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.16 -176.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.1 p -69.65 -33.97 59.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 69' ' ' ASP . 59.0 mt -73.68 -26.84 60.93 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.514 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 0.3 OUTLIER -71.45 -40.24 70.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.091 179.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.5 pp -74.03 -32.34 63.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.013 -177.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 94.9 mt -65.4 -51.28 61.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.328 177.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.7 p -67.07 -28.47 68.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.339 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -55.72 -39.52 71.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.158 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 46.2 mtt -108.35 -45.34 3.92 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -150.14 -150.47 0.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -170.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.0 t80 77.48 24.52 0.78 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 122.148 0.975 . . . . 0.0 109.72 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -84.18 14.67 4.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.626 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.6 ttm -155.55 150.68 26.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.145 -175.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 74.84 159.6 0.22 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.083 0.864 . . . . 0.0 112.793 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 52.6 mttm 68.35 150.29 0.12 Allowed Pre-proline 0 N--CA 1.466 0.335 0 CA-C-N 114.929 -1.032 . . . . 0.0 113.08 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -73.36 -179.65 4.63 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.011 2.474 . . . . 0.0 112.611 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -86.03 92.89 8.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.056 0.455 . . . . 0.0 111.497 -175.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.9 pt -92.22 87.3 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.561 171.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -58.9 -59.8 4.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.399 -171.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.9 t -133.43 80.29 1.87 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 122.106 0.955 . . . . 0.0 110.283 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -129.91 34.69 4.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.374 1.083 . . . . 0.0 108.236 177.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.533 ' CG ' ' HB3' ' A' ' 48' ' ' SER . 25.3 t70 -80.58 152.68 28.47 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.445 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -126.86 14.46 7.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.836 -175.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 44.2 mtt 63.06 165.89 0.12 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.626 -174.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.501 HG21 HD23 ' A' ' 129' ' ' LEU . 11.7 p -116.0 144.16 24.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.785 172.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.575 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.2 mp -103.8 158.12 16.61 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.972 0.415 . . . . 0.0 110.355 178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -106.43 127.44 53.29 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.557 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -87.79 -10.06 70.4 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.316 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.401 ' HA3' ' C ' ' A' ' 131' ' ' CYS . . . 160.2 176.74 32.62 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.502 ' HA ' ' NE2' ' A' ' 80' ' ' GLN . 1.7 Cg_endo -85.41 -2.3 9.25 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.131 2.554 . . . . 0.0 113.322 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.49 HG12 HD22 ' A' ' 79' ' ' ASN . 19.7 t -103.3 128.39 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.785 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.49 HD22 HG12 ' A' ' 78' ' ' VAL . 45.7 m-80 62.59 39.18 11.7 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.111 0.564 . . . . 0.0 111.809 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.502 ' NE2' ' HA ' ' A' ' 77' ' ' PRO . 96.2 mt-30 -68.58 -10.37 55.46 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.201 0.524 . . . . 0.0 110.582 176.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -71.92 -17.61 62.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.292 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 82' ' ' ARG . 41.2 mtt180 -110.07 129.28 55.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.409 -175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 108' ' ' THR . . . -90.6 112.97 4.17 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 175.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.509 ' HB3' HD11 ' A' ' 106' ' ' LEU . 85.9 m-85 -93.53 125.04 37.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.646 0.223 . . . . 0.0 110.553 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.473 HG21 HG11 ' A' ' 112' ' ' VAL . 4.7 mp -123.34 105.56 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.975 0.417 . . . . 0.0 110.091 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 66.0 t -88.14 122.03 39.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.37 177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -133.01 163.44 29.23 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 121.187 -0.205 . . . . 0.0 110.834 -178.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.461 ' HB2' ' HB3' ' A' ' 122' ' ' PRO . 4.9 m -64.33 158.67 22.88 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.66 -178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.761 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 1.5 tmtp? -66.48 118.22 9.8 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.944 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.443 ' HB ' ' OG1' ' A' ' 120' ' ' THR . 1.5 p -126.3 -169.3 1.99 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.456 173.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -116.27 155.92 27.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.245 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 75.53 165.94 0.27 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.644 0.59 . . . . 0.0 110.253 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 94' ' ' PHE . 0.3 OUTLIER 69.41 169.29 0.3 Allowed 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.349 0.66 . . . . 0.0 111.875 -176.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.522 ' HB3' ' O ' ' A' ' 93' ' ' GLU . 21.3 p90 157.46 117.61 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 113.98 -1.463 . . . . 0.0 109.307 -173.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.2 m -146.71 -71.19 0.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.394 0.616 . . . . 0.0 109.822 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 31.4 m-70 -120.45 37.39 4.28 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.0 m -74.26 104.78 5.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.684 -176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -101.97 118.44 36.91 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.215 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 102' ' ' ASP . 95.6 mttt -100.0 112.0 24.3 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.877 0.37 . . . . 0.0 110.814 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.06 -53.67 44.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.1 t -133.26 169.67 16.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 166.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.511 ' HA ' ' HD3' ' A' ' 99' ' ' LYS . 38.7 t70 -61.16 -36.59 80.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 118.872 0.76 . . . . 0.0 111.358 -174.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.761 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 4.1 m-20 -77.26 -7.9 56.71 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.2 mm -121.06 122.37 67.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.959 0.409 . . . . 0.0 110.027 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.9 m -121.47 113.74 20.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.422 0.63 . . . . 0.0 111.498 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 84' ' ' PHE . 54.1 tp -94.07 137.7 32.98 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.971 174.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.677 HG21 ' HB3' ' A' ' 111' ' ' ASP . 16.2 m -145.98 137.78 25.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 176.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 83' ' ' GLY . 65.4 p -114.28 12.65 17.7 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.434 ' H ' HG22 ' A' ' 107' ' ' THR . 62.8 p -127.73 -174.73 3.27 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.492 -176.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.36 -7.82 47.75 Favored Glycine 0 C--N 1.336 0.569 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.311 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.677 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.5 t70 -50.47 -39.44 48.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.632 0.73 . . . . 0.0 110.002 173.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.557 ' CG2' ' HB ' ' A' ' 107' ' ' THR . 91.7 t -60.63 -49.03 86.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.131 176.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.89 -35.88 82.56 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.47 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -68.09 -46.0 72.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.724 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.416 ' HA ' HG22 ' A' ' 118' ' ' THR . 5.2 p -66.93 -37.93 85.23 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.746 0.308 . . . . 0.0 110.811 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.508 ' CE1' ' HD2' ' A' ' 122' ' ' PRO . 7.0 m-30 -67.56 -24.14 65.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.083 0.468 . . . . 0.0 110.929 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -95.99 19.86 52.58 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.404 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.58 ' CG2' HG22 ' A' ' 120' ' ' THR . 4.4 t -142.85 -171.04 3.37 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -82.72 13.0 4.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -172.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.58 HG22 ' CG2' ' A' ' 118' ' ' THR . 9.8 t -117.49 20.46 13.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.527 0.679 . . . . 0.0 110.538 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.448 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -68.38 115.1 26.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.969 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.508 ' HD2' ' CE1' ' A' ' 116' ' ' PHE . 11.4 Cg_exo -71.87 143.0 40.17 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.904 2.403 . . . . 0.0 112.156 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.79 -47.19 86.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.929 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 162' ' ' SER . 55.0 mmtt -102.26 124.43 47.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.237 -171.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 48.7 p90 -152.15 141.97 21.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.323 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.4 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 24.3 pt -127.26 135.51 63.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.45 175.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.29 125.97 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.141 0.496 . . . . 0.0 110.798 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 85.6 m -143.08 136.3 28.18 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.827 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.501 HD23 HG21 ' A' ' 72' ' ' VAL . 4.2 mm? -89.39 124.46 34.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.843 176.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.94 174.4 17.52 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.619 -0.801 . . . . 0.0 113.398 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.401 ' C ' ' HA3' ' A' ' 76' ' ' GLY . 61.5 m -144.9 169.01 18.89 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 35.9 m -105.89 122.51 46.26 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.669 0.271 . . . . 0.0 110.716 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.7 HG22 HG13 ' A' ' 37' ' ' ILE . 41.3 p -101.71 116.78 33.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.876 0.37 . . . . 0.0 111.172 177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.582 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 3.0 t-105 -78.84 156.99 28.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.177 177.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 12.9 mptt -62.27 137.38 95.92 Favored Pre-proline 0 C--O 1.237 0.414 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.805 -177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 51.9 Cg_exo -52.66 121.5 9.26 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.216 2.611 . . . . 0.0 112.616 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 75.39 -17.1 0.53 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.357 175.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.55 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 53.8 tp60 -73.91 -30.89 62.83 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.88 -0.512 . . . . 0.0 111.387 -174.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.486 ' O ' HG13 ' A' ' 143' ' ' ILE . 52.4 tp -54.75 -44.71 73.86 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.604 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 8.9 pt-20 -64.89 -33.36 75.82 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.981 -0.288 . . . . 0.0 110.994 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 34.3 tt0 -71.93 -38.37 69.88 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 177.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.582 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 11.2 mm-40 -61.21 -42.21 98.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.229 0.538 . . . . 0.0 109.67 175.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 139' ' ' LEU . 84.8 mt -60.55 -38.18 77.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.038 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.74 -17.7 64.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.9 0.381 . . . . 0.0 111.662 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 50.1 mt-30 -85.94 -0.72 56.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.467 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 62.84 24.53 14.6 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 123.713 0.805 . . . . 0.0 112.58 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -88.63 -8.02 55.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.292 0.568 . . . . 0.0 109.542 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -135.22 115.09 12.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.13 177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.726 HD11 HD22 ' A' ' 174' ' ' LEU . 4.7 tt -84.84 102.51 13.14 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.7 tp -82.92 134.75 35.06 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.401 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.7 p -150.23 163.92 37.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.8 177.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.26 154.24 19.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.282 0.563 . . . . 0.0 111.945 -175.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 154' ' ' ASN . . . -92.56 -160.11 0.72 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.653 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 153' ' ' ALA . 17.5 m120 70.91 15.23 6.8 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.61 -177.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -96.18 148.57 22.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.46 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.99 -63.0 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -175.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.447 ' HB ' ' SD ' ' A' ' 173' ' ' MET . 24.8 m -51.66 -29.16 16.93 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 6.0 tt -52.36 -49.13 64.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 111.285 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -123.61 -19.78 5.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.988 -173.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -88.17 -9.65 52.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.847 0.356 . . . . 0.0 111.051 -176.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 157' ' ' THR . 11.1 t -63.16 -12.78 30.34 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.94 0.4 . . . . 0.0 111.1 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.454 ' HB3' ' HD2' ' A' ' 124' ' ' LYS . 22.6 t -74.97 74.7 2.19 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 121.654 0.74 . . . . 0.0 109.482 174.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -157.15 -69.75 0.1 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.503 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 25.4 mt -124.43 -43.16 2.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.353 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.4 t70 63.51 -168.48 0.2 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.767 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.478 ' HG3' ' N ' ' A' ' 167' ' ' TRP . 0.2 OUTLIER -154.94 -38.66 0.09 Allowed 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 121.151 -0.22 . . . . 0.0 111.184 177.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.478 ' N ' ' HG3' ' A' ' 166' ' ' ARG . 2.1 t90 -174.71 -63.44 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.756 0.313 . . . . 0.0 110.517 -172.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.558 HG21 ' HB2' ' A' ' 171' ' ' ASN . 16.1 m -131.65 149.22 32.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.507 -178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.638 ' OE2' ' HA ' ' A' ' 23' ' ' ARG . 1.1 pm0 -91.83 -50.18 5.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.017 -177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.446 ' N ' ' HG2' ' A' ' 169' ' ' GLU . . . -81.23 -48.74 11.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.795 0.331 . . . . 0.0 111.65 -173.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.558 ' HB2' HG21 ' A' ' 168' ' ' VAL . 1.9 m-20 -60.98 -25.43 66.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.123 0.487 . . . . 0.0 111.129 -176.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.446 ' OE1' ' HD3' ' A' ' 166' ' ' ARG . 19.1 tp10 -71.59 -21.04 61.92 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.175 -177.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.499 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 68.7 mmm -65.93 -28.22 68.76 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.058 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.726 HD22 HD11 ' A' ' 149' ' ' LEU . 12.2 tp -95.79 -44.91 7.21 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 123.15 52.56 0.21 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.883 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mp 64.57 94.85 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.076 0.465 . . . . 0.0 110.832 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.612 ' HB3' HD23 ' A' ' 174' ' ' LEU . 11.0 t -177.99 130.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.714 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -128.58 132.42 7.26 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.421 HG22 ' HG ' ' A' ' 180' ' ' LEU . 24.9 mt -113.03 118.73 58.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.964 0.382 . . . . 0.0 111.518 -175.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.421 ' HG ' HG22 ' A' ' 179' ' ' ILE . 80.4 mt 59.73 103.93 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.905 1.076 . . . . 0.0 113.905 168.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.535 ' HB2' ' HD2' ' A' ' 14' ' ' PRO . . . -93.17 129.44 39.3 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.966 173.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 4.3 Cg_exo -76.39 5.24 4.81 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 123.204 2.603 . . . . 0.0 112.272 177.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 64.97 9.36 5.36 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.043 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 109.59 -19.75 28.29 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.186 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -83.88 105.67 14.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.114 0.483 . . . . 0.0 110.552 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -137.73 -45.89 0.54 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.292 177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.46 ' O ' ' HG ' ' A' ' 187' ' ' LEU . 1.6 pt? -139.91 95.51 2.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.692 0.758 . . . . 0.0 110.755 179.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--O 1.249 1.055 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 177.055 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -70.21 116.41 10.54 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.17 -58.15 16.07 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.576 -174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.507 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 59.4 m-20 -131.91 155.57 47.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.803 0.335 . . . . 0.0 110.904 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.7 mt -136.54 -123.54 0.15 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.291 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 66.77 119.97 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 122.178 0.989 . . . . 0.0 111.814 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.8 5.32 77.97 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.478 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 11.3 mptt -113.24 164.77 13.12 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 176.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.44 ' HE1' HD11 ' A' ' 11' ' ' ILE . 36.5 p90 -136.82 159.54 41.54 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.028 0.442 . . . . 0.0 111.062 -176.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.7 pt -128.87 127.89 66.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.248 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.83 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.5 mp -92.99 123.43 45.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.39 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -115.59 101.27 8.71 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 173.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 78.6 m -122.68 98.86 42.66 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-O 120.929 0.395 . . . . 0.0 111.488 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.66 -5.27 13.19 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.998 2.466 . . . . 0.0 110.511 170.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.552 ' OE2' ' HD2' ' A' ' 185' ' ' ARG . 32.5 mt-10 70.22 159.12 0.19 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.336 -179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.454 ' HB3' ' O ' ' A' ' 15' ' ' GLU . 46.8 ttp 70.57 144.75 0.06 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.683 -171.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.569 ' HA ' ' HB3' ' A' ' 20' ' ' TYR . 15.5 t70 -65.45 -99.15 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -176.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.4 t70 52.3 71.12 0.49 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.108 0.48 . . . . 0.0 110.492 -173.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 64.45 43.82 4.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.266 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.569 ' HB3' ' HA ' ' A' ' 17' ' ' ASP . 55.6 t80 -119.16 -38.56 3.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.252 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -59.21 -22.24 60.73 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -172.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -96.33 97.03 9.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.184 0.516 . . . . 0.0 110.162 -171.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.586 ' HE ' HD23 ' A' ' 73' ' ' LEU . 3.0 tmm_? 57.17 86.21 0.07 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.526 -1.216 . . . . 0.0 110.994 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.9 t -114.54 143.89 44.25 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.992 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.816 HG11 HG13 ' A' ' 11' ' ' ILE . 40.2 t 63.55 109.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.809 0.814 . . . . 0.0 112.054 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.857 HG21 HG23 ' A' ' 39' ' ' VAL . 5.6 tp -134.36 -161.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.56 ' H ' HG13 ' A' ' 26' ' ' ILE . 5.0 p90 -117.56 169.67 9.36 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 118.975 0.807 . . . . 0.0 111.876 -164.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.18 112.14 18.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.187 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.3 m -73.89 -46.23 45.92 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.093 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.691 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 36.4 tt0 -135.77 144.45 45.8 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.424 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.507 ' CD2' ' HA ' ' A' ' 4' ' ' ASN . 74.8 t60 -146.35 104.67 3.81 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 173.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -122.87 174.86 6.89 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.22 -21.79 66.31 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.389 0.614 . . . . 0.0 109.826 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -70.27 -31.23 68.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.393 -0.822 . . . . 0.0 111.194 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 160.91 -179.93 36.06 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.308 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.1 m -115.64 127.68 55.37 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.654 0.264 . . . . 0.0 110.623 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.691 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.2 mp -112.84 115.92 51.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.415 -178.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.32 163.71 26.0 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 176.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.857 HG23 HG21 ' A' ' 26' ' ' ILE . 18.3 m -123.84 36.88 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.501 0.667 . . . . 0.0 110.884 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.713 ' HA ' HG22 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -84.97 15.03 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -169.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.9 pt -64.62 -25.91 38.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -175.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.59 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.1 t-20 64.85 93.11 0.07 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.416 0.447 . . . . 0.0 111.996 176.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.59 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 12.4 t 169.48 137.77 0.06 OUTLIER Pre-proline 0 C--O 1.24 0.569 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.184 175.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.845 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 93.0 Cg_endo -85.18 176.88 5.56 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.728 2.285 . . . . 0.0 111.052 170.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.401 HG22 ' ND2' ' A' ' 74' ' ' ASN . 15.2 p -116.59 176.34 5.16 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.428 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -91.12 5.62 48.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.943 0.877 . . . . 0.0 109.566 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.8 tp -106.66 156.4 18.65 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.487 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 10.5 m -100.27 151.49 21.41 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.7 p -65.54 -33.89 66.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.659 HD13 ' HA ' ' A' ' 64' ' ' ARG . 35.8 mt -68.33 -26.62 65.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.621 178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 48' ' ' SER . 4.2 mm-40 -63.16 -47.28 83.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.562 177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.6 -39.17 88.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.514 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 89.3 mt -64.8 -43.73 92.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.291 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.612 HG21 ' HD2' ' A' ' 64' ' ' ARG . 17.8 p -72.55 -29.09 63.25 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -56.63 -43.45 80.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.046 0.45 . . . . 0.0 110.169 177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.8 mtm -87.8 -24.7 23.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.615 176.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.8 t70 73.8 137.27 0.05 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.253 1.021 . . . . 0.0 110.48 -173.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -139.33 -52.08 0.54 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.488 -174.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -145.22 161.12 40.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.723 0.296 . . . . 0.0 110.417 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 50.9 ttp -72.65 124.1 24.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.222 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 62' ' ' LYS . . . 63.13 -113.34 0.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.12 -0.946 . . . . 0.0 112.598 169.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 61' ' ' ALA . 52.1 mttm 67.13 159.66 0.14 Allowed Pre-proline 0 C--O 1.234 0.274 0 O-C-N 123.637 0.586 . . . . 0.0 111.752 -173.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -64.53 111.29 1.61 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.462 2.108 . . . . 0.0 110.785 171.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.659 ' HA ' HD13 ' A' ' 50' ' ' LEU . 47.6 ptt85 -156.14 7.98 0.22 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.948 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 70.7 mt -142.29 -48.5 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.482 ' O ' ' HB ' ' A' ' 67' ' ' THR . 75.8 m-85 -110.42 158.61 18.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.063 176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 66' ' ' TYR . 47.4 m 76.57 151.61 0.12 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -168.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -67.37 112.1 4.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.12 0.486 . . . . 0.0 110.881 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -87.7 -162.16 0.78 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.505 -172.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -125.55 123.12 38.4 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.609 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.558 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 1.9 mpt? -76.73 157.75 31.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.849 177.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.98 140.23 18.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.845 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 10.4 mp -104.39 152.26 22.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.876 0.37 . . . . 0.0 110.581 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.401 ' ND2' HG22 ' A' ' 45' ' ' THR . 57.8 m-20 -85.48 141.99 29.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.589 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.41 -25.39 7.02 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.703 175.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.83 170.94 30.46 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.107 -0.568 . . . . 0.0 111.974 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.64 -3.17 12.73 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.191 2.594 . . . . 0.0 112.96 -178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.4 t -102.23 146.34 10.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 61.45 42.84 10.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.933 0.397 . . . . 0.0 111.096 179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.821 HE21 ' HA ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -65.06 -10.9 33.82 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -176.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -83.28 -12.55 56.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.73 0.3 . . . . 0.0 110.75 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 69.2 mtm-85 -130.27 128.89 42.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.314 0.578 . . . . 0.0 112.068 -167.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.52 125.34 7.99 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.21 174.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.572 ' HB3' HD11 ' A' ' 106' ' ' LEU . 64.7 m-85 -99.99 126.15 46.13 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.44 HG12 HG11 ' A' ' 112' ' ' VAL . 3.8 mp -114.57 122.41 68.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.118 0.485 . . . . 0.0 110.989 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 60.5 t -101.59 125.23 55.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.533 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -131.18 160.7 34.03 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.609 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.1 p -71.55 132.78 45.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.08 0.467 . . . . 0.0 109.948 174.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.638 ' HB3' ' HA ' ' A' ' 103' ' ' ASP . 9.2 tmtt? -67.76 122.65 18.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.465 -175.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.8 t -152.65 -12.93 0.17 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.307 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -83.57 159.69 21.58 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.69 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -148.52 104.89 3.54 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 65.95 -179.03 0.19 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.68 0.613 . . . . 0.0 110.634 -175.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 70.11 -61.7 0.45 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.224 0.609 . . . . 0.0 111.348 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.563 HG22 ' HB3' ' A' ' 111' ' ' ASP . 2.0 p -75.11 133.91 41.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.338 0.59 . . . . 0.0 110.77 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.426 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 29.6 m80 -82.36 61.79 5.72 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.905 177.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 40.5 m -85.46 138.39 32.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.363 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -100.69 123.32 44.73 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.619 ' HD2' ' HA ' ' A' ' 102' ' ' ASP . 28.8 ttpp -83.68 106.58 15.5 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.343 -177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.435 HG11 ' HE2' ' A' ' 27' ' ' TYR . 51.9 t -70.45 -54.01 20.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.226 0.536 . . . . 0.0 109.87 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 102' ' ' ASP . 2.8 t -124.84 -54.6 1.63 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.562 176.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.619 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 14.9 t70 -177.1 -72.37 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.638 ' HA ' ' HB3' ' A' ' 89' ' ' LYS . 6.7 m-20 -77.27 -3.97 42.51 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.041 0.448 . . . . 0.0 111.396 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.683 HG13 HD13 ' A' ' 158' ' ' LEU . 51.6 mm -106.41 122.55 60.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 175.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.66 128.32 43.89 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.238 0.542 . . . . 0.0 111.624 -175.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 84' ' ' PHE . 63.3 tp -102.85 121.22 42.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.45 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.53 HG21 ' HB2' ' A' ' 111' ' ' ASP . 4.2 m -126.82 134.46 50.55 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.623 0.249 . . . . 0.0 110.435 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.1 t -147.34 3.26 0.77 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.237 0.542 . . . . 0.0 111.392 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.504 ' HB2' ' OD1' ' A' ' 111' ' ' ASP . 14.2 m -85.9 15.05 5.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.796 0.332 . . . . 0.0 111.667 -174.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 101.19 -23.37 35.63 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.53 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.563 ' HB3' HG22 ' A' ' 95' ' ' THR . 3.0 m-20 -51.34 -37.65 48.95 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.298 0.639 . . . . 0.0 111.545 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.44 HG11 HG12 ' A' ' 85' ' ' ILE . 60.1 t -47.98 -40.84 9.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.971 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.544 ' HA ' ' CE2' ' A' ' 116' ' ' PHE . 98.0 mt -62.88 -32.73 74.04 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.072 0.463 . . . . 0.0 110.933 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -80.18 -35.87 35.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.54 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 35.1 m -56.21 -50.34 71.51 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.168 -0.923 . . . . 0.0 112.811 -174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.544 ' CE2' ' HA ' ' A' ' 113' ' ' LEU . 40.7 p90 -79.64 11.57 3.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.588 -175.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -116.92 16.56 13.37 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 121.07 -0.586 . . . . 0.0 111.855 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 76.7 p -111.63 177.7 4.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.882 0.373 . . . . 0.0 110.781 -177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -83.21 -26.45 30.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.61 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 p -96.88 20.8 10.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.432 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -51.21 136.61 29.62 Favored Pre-proline 0 C--O 1.235 0.293 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.542 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 23.6 Cg_exo -62.16 150.78 85.44 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.028 2.485 . . . . 0.0 112.613 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -59.58 -49.6 77.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.911 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -143.59 146.21 33.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.559 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -152.1 137.52 17.64 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.473 178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.8 pp -113.13 148.11 16.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.447 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -117.76 129.45 74.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.191 0.52 . . . . 0.0 110.905 -177.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.436 ' SG ' HG11 ' A' ' 39' ' ' VAL . 5.7 p -126.27 124.75 41.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.398 177.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 129' ' ' LEU . 1.2 tm? -84.22 119.0 24.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.343 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 70.81 178.78 27.32 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.539 -175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.5 m -147.81 171.96 14.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.86 0.362 . . . . 0.0 110.046 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 37.6 m -111.57 121.24 44.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.104 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.8 p -96.76 115.33 27.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.174 0.511 . . . . 0.0 111.364 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -101.35 149.9 23.56 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.473 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.492 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 1.5 mppt? -86.78 130.28 49.34 Favored Pre-proline 0 C--N 1.316 -0.87 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.778 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 7.5 Cg_exo -73.32 44.5 0.86 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 123.538 2.825 . . . . 0.0 114.335 -168.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 27.1 p80 -154.11 -39.23 0.09 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.874 0.369 . . . . 0.0 110.545 174.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.538 ' HA ' ' OE1' ' A' ' 138' ' ' GLN . 5.5 tp60 -75.79 -30.72 59.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.693 -175.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.432 ' O ' HG13 ' A' ' 143' ' ' ILE . 60.1 tp -57.87 -38.83 76.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.013 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -60.9 -42.12 97.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.041 0.448 . . . . 0.0 110.526 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.569 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 31.0 mm-40 -68.17 -39.24 82.62 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.437 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.627 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 14.1 mm-40 -62.03 -43.34 99.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.167 0.508 . . . . 0.0 110.486 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 150' ' ' LEU . 77.1 mt -65.26 -39.4 85.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.096 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.97 -32.42 73.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.536 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 67.1 mt-30 -78.76 2.95 18.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.372 178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 19.1 m120 67.18 15.51 10.04 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.345 0.658 . . . . 0.0 112.265 177.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.447 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 57.0 m-85 -79.94 -21.79 43.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.35 0.595 . . . . 0.0 109.769 174.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.627 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 97.5 m95 -127.29 114.82 18.1 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.707 175.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.83 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 24.7 mt -86.36 103.09 14.61 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.529 -178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.5 ' HB2' HD13 ' A' ' 143' ' ' ILE . 60.3 tp -86.87 132.96 33.67 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.345 -177.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 66.9 m -156.75 152.44 26.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.176 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -91.18 153.99 19.63 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.111 0.481 . . . . 0.0 110.651 179.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -101.52 114.25 28.1 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.62 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.99 68.09 3.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.226 0.536 . . . . 0.0 109.919 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 16.6 m120 65.5 -80.48 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 114.861 -1.063 . . . . 0.0 112.021 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -60.6 -42.92 97.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.857 -172.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 11.8 m -54.24 -30.45 50.36 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.683 HD13 HG13 ' A' ' 104' ' ' ILE . 5.5 tt -62.68 -57.59 10.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.285 -174.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -121.45 -23.13 5.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -170.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -100.2 -61.25 1.39 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -175.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 162' ' ' SER . 6.5 t 36.2 83.49 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.184 0.994 . . . . 0.0 112.107 -174.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 161' ' ' THR . 41.5 m 77.48 2.23 3.05 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.314 -174.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 86.6 t80 72.21 -42.17 0.53 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.196 0.998 . . . . 0.0 113.031 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 32.5 mt -50.78 -67.73 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -171.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -161.62 166.55 26.69 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -157.99 136.53 11.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.09 0.472 . . . . 0.0 111.691 -176.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.502 ' HE3' ' H ' ' A' ' 23' ' ' ARG . 95.3 m95 -133.02 -50.54 0.88 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.658 176.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 13.4 p -129.98 -2.71 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.232 -172.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 27.4 mp0 -59.91 -5.13 0.88 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -173.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.02 -29.27 70.69 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.896 0.379 . . . . 0.0 110.526 174.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -80.32 -24.09 40.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.474 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -59.43 -42.42 91.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.383 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -58.9 -31.68 68.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.158 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.744 ' HG ' ' HB ' ' A' ' 179' ' ' ILE . 7.5 tt -81.65 -46.43 14.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.549 -176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . -61.41 -41.7 99.6 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.25 -0.886 . . . . 0.0 113.158 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 78.0 mt -66.6 -48.67 79.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.653 0.263 . . . . 0.0 111.235 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.1 m -76.43 -24.54 53.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.44 56.75 3.55 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.989 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.744 ' HB ' ' HG ' ' A' ' 174' ' ' LEU . 50.9 mm -85.15 132.12 32.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.573 0.225 . . . . 0.0 111.133 -176.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.737 ' HG ' HG22 ' A' ' 179' ' ' ILE . 87.3 mt 67.0 -163.86 0.23 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.271 178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -67.72 114.39 19.68 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.922 0.391 . . . . 0.0 111.758 -177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.32 140.05 21.58 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.54 2.16 . . . . 0.0 112.197 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 62.88 23.41 13.98 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.239 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -94.17 28.69 10.09 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.547 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.552 ' HD2' ' OE2' ' A' ' 15' ' ' GLU . 21.3 ptt180 -92.76 -166.28 1.5 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.3 -75.69 0.5 Allowed 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 121.094 -0.242 . . . . 0.0 111.415 -173.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 74.3 mt 57.14 19.26 4.66 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.343 0.402 . . . . 0.0 111.487 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 119.016 -0.516 . . . . 0.0 110.664 -177.888 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -109.78 44.63 1.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.303 0.573 . . . . 0.0 110.508 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.94 -1.06 77.85 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.789 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -159.61 156.71 28.42 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.3 mt -129.4 -170.41 2.28 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.341 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 68.09 112.18 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.701 0.625 . . . . 0.0 110.892 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.29 3.58 65.04 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -172.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 12.6 mptt -106.22 171.24 7.45 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 153' ' ' ALA . 54.9 p90 -140.43 150.73 44.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.803 0.335 . . . . 0.0 110.443 178.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.8 pt -109.14 130.75 61.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.226 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.674 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 2.8 mp -76.99 131.41 34.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.099 -177.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HB2' ' HB ' ' A' ' 24' ' ' THR . . . -57.66 137.26 56.62 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.973 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p -80.63 110.38 16.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.063 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.559 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 20.2 Cg_exo -65.41 118.84 5.81 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.897 2.398 . . . . 0.0 111.849 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.502 ' HA ' ' H ' ' A' ' 185' ' ' ARG . 7.1 pt-20 -148.58 -16.97 0.32 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -126.86 -54.93 1.4 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.655 0.983 . . . . 0.0 113.655 -167.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -117.06 -64.57 1.29 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.056 0.455 . . . . 0.0 111.619 -168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.479 ' OD2' ' HB2' ' A' ' 20' ' ' TYR . 19.0 t70 -171.74 -45.76 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -172.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.559 ' HG2' ' HA ' ' A' ' 14' ' ' PRO . 0.4 OUTLIER 72.06 1.77 4.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.059 171.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.479 ' HB2' ' OD2' ' A' ' 18' ' ' ASP . 96.7 m-85 -100.19 -27.68 13.39 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 161.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -61.23 -54.2 47.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.386 -1.279 . . . . 0.0 110.713 177.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -92.54 129.04 38.59 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -82.52 59.87 4.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.197 0.522 . . . . 0.0 110.511 -177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.565 ' HA ' ' HB3' ' A' ' 42' ' ' ASN . 0.3 OUTLIER -75.17 55.84 0.77 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.021 -176.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.1 p -173.4 113.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.842 -177.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.865 HG22 ' HD1' ' A' ' 27' ' ' TYR . 44.2 mm -120.71 -83.97 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.938 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.865 ' HD1' HG22 ' A' ' 26' ' ' ILE . 9.9 p90 -173.31 170.21 4.31 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.049 0.452 . . . . 0.0 111.15 176.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 mm -102.52 121.67 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.955 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.2 m -76.97 -46.37 24.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.439 -175.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -151.07 159.27 44.61 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 79.2 t60 -148.12 138.2 22.63 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.678 0.251 . . . . 0.0 111.678 -174.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 t30 77.87 164.84 0.23 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.22 0.95 . . . . 0.0 111.547 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 68.52 -71.61 0.11 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.675 0.79 . . . . 0.0 112.145 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -88.41 -26.08 22.34 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 138.79 -177.19 20.38 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.109 178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' A' ' 134' ' ' TRP . 23.8 m -100.0 101.85 13.05 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 37' ' ' ILE . 4.5 mp -95.22 112.0 26.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.41 157.36 27.23 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.005 179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 4.3 m -123.53 93.74 2.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.266 0.555 . . . . 0.0 110.295 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.452 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -128.56 8.15 2.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.156 -177.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.9 pt -80.92 -27.61 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.927 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.565 ' HB3' ' HA ' ' A' ' 24' ' ' THR . 13.5 t30 38.96 85.98 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 O-C-N 124.237 0.961 . . . . 0.0 112.84 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 6.6 t -143.66 112.2 5.4 Favored Pre-proline 0 C--N 1.315 -0.896 0 CA-C-O 121.252 0.549 . . . . 0.0 109.95 176.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 4.8 Cg_exo -76.97 152.57 31.93 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.213 1.942 . . . . 0.0 111.318 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.6 p -124.88 163.15 22.85 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.716 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -82.82 1.06 41.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.191 0.52 . . . . 0.0 110.743 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.68 HD21 HD21 ' A' ' 52' ' ' LEU . 54.7 tp -83.36 144.48 29.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.235 173.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.65 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 14.5 m -104.19 145.66 29.89 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.7 p -63.57 -33.36 61.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 176.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.573 HD23 HD12 ' A' ' 53' ' ' LEU . 90.3 mt -66.99 -33.06 74.76 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.571 175.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.65 ' HG3' ' HB2' ' A' ' 48' ' ' SER . 32.8 mt-10 -61.26 -43.34 99.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.242 176.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.68 HD21 HD21 ' A' ' 47' ' ' LEU . 96.4 mt -67.91 -33.38 74.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.303 177.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 58' ' ' PHE . 94.0 mt -69.67 -42.07 74.67 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 38.9 m -62.22 -39.75 93.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.351 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -58.48 -39.89 81.21 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.383 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.9 mtt -86.6 -91.89 0.1 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.123 -178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -165.92 77.04 0.24 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.082 0.467 . . . . 0.0 109.807 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.788 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 25.7 t80 -165.2 138.72 4.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.761 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.409 ' HG2' ' HG3' ' A' ' 60' ' ' MET . 8.8 tt0 -139.64 151.29 45.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.38 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.418 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 68.7 mtt 69.98 -149.45 0.11 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.685 0.616 . . . . 0.0 111.168 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.418 ' H ' ' HB3' ' A' ' 60' ' ' MET . . . 71.11 69.0 0.17 Allowed 'General case' 0 N--CA 1.462 0.133 0 O-C-N 123.925 0.765 . . . . 0.0 111.58 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 47.4 mttp 64.58 81.17 0.22 Allowed Pre-proline 0 N--CA 1.462 0.172 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.152 174.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.436 ' O ' ' HA ' ' A' ' 69' ' ' ASP . 38.3 Cg_endo -67.79 -42.68 6.26 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.651 2.234 . . . . 0.0 112.935 -175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.2 tpp180 55.48 85.71 0.06 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.491 0.494 . . . . 0.0 110.491 -178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 65' ' ' ILE . 4.4 mp -81.0 -43.75 20.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -170.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -60.66 -60.32 3.99 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.818 -172.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 t -83.12 114.15 21.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 168.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -41.67 95.48 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -164.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.539 ' HB3' HD12 ' A' ' 50' ' ' LEU . 1.1 m-20 48.07 -108.07 0.23 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.953 177.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -152.18 90.88 1.55 Allowed 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 24.1 ptm -71.15 140.48 50.57 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.378 -177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.731 HG21 HD23 ' A' ' 129' ' ' LEU . 11.0 p -108.21 149.79 11.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.621 -174.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.4 mp -94.29 152.88 18.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.947 0.404 . . . . 0.0 110.12 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.74 124.93 34.6 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 177.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -91.38 -26.26 21.35 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.851 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.86 164.47 15.09 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.871 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.68 -18.71 22.04 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.473 2.115 . . . . 0.0 112.627 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.411 HG21 ' OG1' ' A' ' 133' ' ' THR . 42.8 t -90.13 133.34 32.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.232 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 65.77 27.9 11.05 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.402 0.62 . . . . 0.0 110.205 -178.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -66.42 -17.7 64.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.044 -176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.59 -10.69 60.1 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.355 -0.838 . . . . 0.0 111.501 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -125.43 144.49 50.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.055 0.455 . . . . 0.0 110.436 -177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -99.31 120.91 7.03 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -98.74 126.55 44.39 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.749 0.309 . . . . 0.0 110.233 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.441 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.5 mp -113.07 112.7 41.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.194 0.521 . . . . 0.0 109.987 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.3 t -94.25 114.65 31.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.147 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -116.33 148.93 40.09 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.409 -0.516 . . . . 0.0 111.53 -174.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 37.0 m -82.39 150.25 27.23 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.974 174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 43.8 tttm -70.16 114.0 7.89 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.836 0.827 . . . . 0.0 111.551 -169.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.523 HG21 ' HG3' ' A' ' 123' ' ' GLU . 3.2 m -135.28 11.58 3.53 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.641 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -160.13 -173.08 3.87 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.167 -164.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -158.86 27.23 0.22 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.666 173.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -103.58 169.3 8.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.386 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.6 p90 176.74 157.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.038 0.446 . . . . 0.0 111.558 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.4 p -102.83 -37.72 7.73 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 164.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -168.15 91.94 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.152 169.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 49.2 m -100.63 167.42 10.35 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.51 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.528 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 12.6 t80 -124.57 98.18 5.62 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.428 ' HA ' HG23 ' A' ' 105' ' ' THR . 86.3 tttt -73.27 108.37 6.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 -177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.9 t -83.3 -59.03 3.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.95 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.431 ' C ' ' H ' ' A' ' 103' ' ' ASP . 58.5 p -117.14 -176.33 2.97 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 175.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.417 ' HA ' ' CE ' ' A' ' 99' ' ' LYS . 31.0 t70 -82.22 34.2 0.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.821 0.819 . . . . 0.0 109.701 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.597 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 12.9 t0 -158.12 -67.25 0.09 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.437 179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.86 121.93 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.673 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 99' ' ' LYS . 24.0 m -134.6 134.17 40.97 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.956 -173.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 63.6 tp -84.73 132.82 34.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.137 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.546 ' HB ' HG13 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -136.63 143.84 43.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.919 -179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' A' ' 107' ' ' THR . 14.6 t -179.88 21.84 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.949 0.404 . . . . 0.0 111.32 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 35.0 t -101.22 8.52 42.53 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.613 -0.679 . . . . 0.0 111.207 -174.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.76 -30.03 6.58 Favored Glycine 0 CA--C 1.509 -0.296 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -45.28 -50.39 11.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.411 -0.894 . . . . 0.0 111.407 172.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.546 HG13 ' HB ' ' A' ' 107' ' ' THR . 17.5 m -47.81 -45.06 11.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 114.846 -1.07 . . . . 0.0 112.904 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.19 -30.8 69.98 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.987 0.422 . . . . 0.0 110.789 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -77.99 -33.74 51.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.576 179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.0 m -60.66 -62.86 1.55 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.403 -174.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -74.3 -2.77 26.53 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.762 -0.375 . . . . 0.0 111.797 -173.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -96.26 3.67 64.19 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.222 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.457 HG23 ' H ' ' A' ' 120' ' ' THR . 12.4 t -138.89 171.82 13.77 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -82.26 4.92 21.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.661 0.267 . . . . 0.0 111.49 -175.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.457 ' H ' HG23 ' A' ' 118' ' ' THR . 69.2 p -102.97 15.73 28.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.906 0.384 . . . . 0.0 110.816 176.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -58.17 141.04 82.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.017 174.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 19.7 Cg_exo -65.16 146.01 85.74 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.763 2.308 . . . . 0.0 111.986 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.523 ' HG3' HG21 ' A' ' 90' ' ' THR . 38.1 mt-10 -65.4 -37.76 87.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.482 -176.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 123' ' ' GLU . 12.1 mtmt -128.41 132.15 48.49 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.353 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -163.55 147.53 10.5 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.447 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.1 pt -126.47 143.74 38.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.979 176.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.573 HG13 HG23 ' A' ' 72' ' ' VAL . 6.4 p -114.78 129.4 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.054 0.454 . . . . 0.0 110.588 -179.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.8 p -134.73 136.08 42.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.382 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.731 HD23 HG21 ' A' ' 72' ' ' VAL . 4.0 mm? -86.52 120.99 28.44 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.356 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 72.76 -179.15 38.35 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.704 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 61.2 m -145.65 167.49 22.98 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.481 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 33.9 m -102.4 122.73 44.86 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 36' ' ' THR . 39.5 p -107.46 120.35 41.94 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.043 0.449 . . . . 0.0 112.162 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.622 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 1.5 m-90 -96.02 144.75 26.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.316 170.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 138' ' ' GLN . 12.0 mptt -65.05 156.02 82.03 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.394 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.1 133.95 40.55 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.144 1.896 . . . . 0.0 110.642 172.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.454 ' HA ' ' CG ' ' A' ' 140' ' ' GLU . 49.4 m80 63.74 29.5 14.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.242 0.544 . . . . 0.0 111.325 -175.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 55.5 tp60 -106.29 -68.89 0.85 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.225 173.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.506 ' O ' HG13 ' A' ' 143' ' ' ILE . 52.4 tp -63.14 -47.06 84.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.784 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.454 ' CG ' ' HA ' ' A' ' 137' ' ' HIS . 10.9 pt-20 -58.44 -34.21 70.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.837 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.63 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 0.9 OUTLIER -65.77 -51.17 61.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.726 -179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -71.85 -29.85 64.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.36 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.595 HG12 ' HB2' ' A' ' 148' ' ' TRP . 71.5 mt -61.07 -43.59 96.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 171.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.44 -30.32 71.1 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.945 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.63 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 42.1 mt-30 -81.16 5.46 16.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.365 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 71.93 30.97 2.14 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.309 0.643 . . . . 0.0 112.369 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -93.84 -3.82 51.21 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.165 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.595 ' HB2' HG12 ' A' ' 143' ' ' ILE . 96.0 m95 -139.43 160.64 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.268 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.674 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 3.1 tt -113.08 118.62 35.27 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 8' ' ' LYS . 35.5 tp -105.08 148.58 26.66 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.994 0.425 . . . . 0.0 111.707 -175.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.5 t -159.69 166.84 29.74 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 0.3 OUTLIER -106.24 154.1 21.21 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.983 -178.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . . . -120.9 151.78 39.26 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.57 -177.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.41 -61.15 1.78 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.522 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.469 ' HB3' ' HB3' ' A' ' 103' ' ' ASP . 24.8 p-10 -170.8 -59.67 0.02 OUTLIER 'General case' 0 C--O 1.235 0.316 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 45.6 mt-30 -56.94 -41.94 79.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -173.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.463 ' HA ' ' OG1' ' A' ' 161' ' ' THR . 21.4 m -55.56 -32.87 63.37 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 88.2 mt -93.37 -51.98 4.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -99.37 -23.34 15.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.476 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 39.5 mt-10 -111.83 -25.75 9.29 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -166.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.536 HG21 ' HG3' ' A' ' 169' ' ' GLU . 34.0 m -46.47 -42.46 15.51 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -174.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.3 m -58.83 -19.52 42.21 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -86.93 -52.68 5.32 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.641 0.238 . . . . 0.0 111.641 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 164' ' ' LEU . 1.3 pt? -83.96 -35.87 23.67 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -173.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -99.45 -171.83 2.14 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -119.09 -57.11 2.04 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 121.242 -0.183 . . . . 0.0 110.781 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.454 ' CE3' HG23 ' A' ' 168' ' ' VAL . 2.2 t90 -166.74 140.76 3.96 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -175.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.454 HG23 ' CE3' ' A' ' 167' ' ' TRP . 95.6 t 69.82 90.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 O-C-N 123.786 0.679 . . . . 0.0 111.118 -178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.536 ' HG3' HG21 ' A' ' 161' ' ' THR . 0.0 OUTLIER -118.16 -41.19 2.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.842 178.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.77 -43.87 94.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.662 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -76.5 -26.32 55.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.13 0.49 . . . . 0.0 110.344 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -70.34 -29.55 66.27 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.936 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.0 tpt -60.59 -32.65 71.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.116 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.542 HD13 HD21 ' A' ' 149' ' ' LEU . 13.0 tp -77.35 -42.68 35.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.908 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 112.93 -18.41 21.82 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.698 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 25.3 mt 63.87 81.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 123.046 0.538 . . . . 0.0 111.195 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.9 t -122.58 -46.76 2.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.515 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -157.99 121.52 1.07 Allowed Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.552 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 12.8 tt -114.28 134.08 58.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.04 0.447 . . . . 0.0 110.338 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 92.7 mt -91.09 114.24 26.71 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.405 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -159.89 100.57 1.46 Allowed Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.421 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -77.86 108.75 2.59 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.903 2.402 . . . . 0.0 111.615 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 62.75 58.4 1.59 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.316 0.579 . . . . 0.0 110.305 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -96.15 143.64 16.81 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.613 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.502 ' H ' ' HA ' ' A' ' 15' ' ' GLU . 18.5 mmt180 -128.4 98.28 5.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.144 0.497 . . . . 0.0 111.545 -177.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -100.67 12.55 37.19 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.373 -0.83 . . . . 0.0 108.819 171.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -158.85 166.81 31.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.799 -178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.516 -0.754 . . . . 0.0 110.342 178.182 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.581 ' HB3' ' HB3' ' A' ' 140' ' ' GLU . 15.5 tpt . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 120.769 0.318 . . . . 0.0 110.59 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -87.93 -21.87 24.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.862 0.363 . . . . 0.0 110.597 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.16 -150.59 17.52 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.865 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -90.47 105.55 17.89 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.236 0.541 . . . . 0.0 110.765 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.03 -93.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.205 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 65.15 117.07 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.191 0.52 . . . . 0.0 111.46 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.97 -4.27 74.7 Favored Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.391 -177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 152' ' ' GLU . 2.3 mptp? -105.58 163.79 12.39 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.543 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 48.7 p90 -140.7 149.52 42.3 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.221 -178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.584 HD11 HG13 ' A' ' 40' ' ' ILE . 16.4 pt -98.17 145.01 10.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.43 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.727 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 45.1 mm -81.68 95.62 3.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.506 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -102.94 -44.93 5.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.757 179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.638 ' HB ' ' HD2' ' A' ' 14' ' ' PRO . 52.0 p 56.3 -179.95 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.57 0 C-N-CA 123.7 0.8 . . . . 0.0 111.224 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.638 ' HD2' ' HB ' ' A' ' 13' ' ' THR . 27.4 Cg_exo -64.0 -57.79 0.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 121.321 1.347 . . . . 0.0 110.499 169.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 176.0 72.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 54.2 ttp 74.05 -54.67 0.68 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.095 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -145.62 -166.39 2.43 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 69.42 -166.23 0.17 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.534 0.734 . . . . 0.0 111.59 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 14' ' ' PRO . 6.1 tp10 64.36 -92.43 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -173.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 173.14 -96.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.62 0.768 . . . . 0.0 111.038 167.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -173.82 15.07 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.717 0.294 . . . . 0.0 111.383 -174.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -105.43 110.37 22.7 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -168.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 66.98 16.89 10.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.933 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.408 HG22 ' HB3' ' A' ' 42' ' ' ASN . 33.6 p -92.48 131.53 37.55 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.329 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.0 t 74.25 82.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 O-C-N 123.885 0.741 . . . . 0.0 111.28 177.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.887 HG22 ' H ' ' A' ' 27' ' ' TYR . 16.3 mm -107.76 -166.85 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.887 ' H ' HG22 ' A' ' 26' ' ' ILE . 7.2 p90 -114.86 175.18 5.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.521 0.6 . . . . 0.0 111.683 -167.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.9 mm -86.13 112.55 22.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.358 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.9 -55.2 28.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.386 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -144.17 127.48 16.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.868 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -108.89 99.68 8.99 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 158.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -112.31 59.72 0.63 Allowed 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.896 -166.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t70 63.2 -66.76 0.09 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.97 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.46 -39.45 11.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -102.75 147.57 17.07 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.886 -175.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.634 ' O ' ' HA ' ' A' ' 133' ' ' THR . 26.2 m -133.79 102.73 5.56 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.494 HG13 HG22 ' A' ' 133' ' ' THR . 4.5 mp -111.02 121.77 64.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.32 -174.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.46 162.48 29.3 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.92 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' O ' ' HB ' ' A' ' 26' ' ' ILE . 5.7 m -125.81 91.2 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.27 0.557 . . . . 0.0 110.215 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.584 HG13 HD11 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -135.85 16.34 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.9 pt -80.92 -20.89 11.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.247 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.408 ' HB3' HG22 ' A' ' 24' ' ' THR . 46.1 m-20 61.15 47.93 6.75 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 167.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.0 t -146.06 133.98 10.54 Favored Pre-proline 0 C--N 1.325 -0.487 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.431 -177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 61.9 Cg_endo -73.89 165.44 32.14 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.973 2.449 . . . . 0.0 112.366 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.542 HG22 ' ND2' ' A' ' 74' ' ' ASN . 31.1 p -99.54 -166.2 1.32 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.966 0.413 . . . . 0.0 110.034 176.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.5 12.37 27.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.885 0.85 . . . . 0.0 108.848 171.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 37.9 tp -109.86 146.84 34.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.586 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 19.7 m -95.81 149.2 21.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.676 177.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.523 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 14.4 p -63.9 -30.47 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.297 0.57 . . . . 0.0 109.998 178.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 63' ' ' PRO . 86.7 mt -75.19 -26.65 59.19 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.367 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 48' ' ' SER . 1.0 OUTLIER -68.67 -40.67 80.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.377 -176.29 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.668 HD22 HD21 ' A' ' 129' ' ' LEU . 3.9 pp -71.78 -30.51 65.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.064 177.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 88.5 mt -66.3 -48.42 70.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.323 176.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.0 p -61.0 -30.24 70.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.195 178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -72.62 -52.8 13.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.4 mtt -90.91 -92.46 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.505 0.193 . . . . 0.0 110.685 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -136.92 146.24 45.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.574 ' HB2' ' HG2' ' A' ' 63' ' ' PRO . 12.3 p90 -129.21 -30.86 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -172.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 69.56 128.02 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.135 0.493 . . . . 0.0 111.316 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.417 ' HB3' ' H ' ' A' ' 61' ' ' ALA . 68.4 mtt 59.73 -156.81 0.34 Allowed 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.687 -178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.417 ' H ' ' HB3' ' A' ' 60' ' ' MET . . . -115.68 38.39 3.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.239 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -53.94 36.06 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.823 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.699 ' HB3' ' HB3' ' A' ' 50' ' ' LEU . 12.3 Cg_exo -72.32 79.25 1.8 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.178 1.919 . . . . 0.0 111.251 174.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -135.39 -2.31 2.49 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.595 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 72.9 mt -126.83 120.78 56.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.695 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -102.41 173.56 6.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.916 175.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 31.1 m 77.05 -47.51 0.52 Allowed 'General case' 0 C--O 1.234 0.273 0 O-C-N 123.784 0.677 . . . . 0.0 110.376 -178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -102.61 34.12 2.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 122.243 1.021 . . . . 0.0 108.766 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -93.13 158.64 15.67 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.818 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.402 ' O ' HG12 ' A' ' 49' ' ' VAL . 30.0 mm-40 -96.38 125.92 41.21 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.431 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 66.5 mtt -84.43 149.88 25.69 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.362 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.621 HG21 HD23 ' A' ' 129' ' ' LEU . 12.7 p -100.58 150.23 5.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.49 . . . . 0.0 109.725 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.659 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 7.0 mp -99.74 164.41 12.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.255 0.55 . . . . 0.0 111.678 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.542 ' ND2' HG22 ' A' ' 45' ' ' THR . 47.9 m-80 -81.84 124.43 29.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.705 177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.89 -27.6 37.4 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.13 -1.033 . . . . 0.0 110.601 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.412 ' HA3' ' C ' ' A' ' 131' ' ' CYS . . . 168.98 175.11 38.11 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -86.51 3.24 6.9 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.948 2.432 . . . . 0.0 112.511 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.465 HG12 HD22 ' A' ' 79' ' ' ASN . 21.9 t -109.06 121.25 61.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.238 -175.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.465 HD22 HG12 ' A' ' 78' ' ' VAL . 54.5 m-80 55.83 56.49 6.02 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.009 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.465 ' O ' HD12 ' A' ' 129' ' ' LEU . 84.3 mt-30 -70.93 -7.5 46.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.682 177.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -70.89 -10.02 58.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.262 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -112.26 131.36 55.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.939 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -96.41 117.75 5.8 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.807 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.524 ' HB3' HD11 ' A' ' 106' ' ' LEU . 71.9 m-85 -102.6 126.08 49.55 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.413 HG21 HG21 ' A' ' 112' ' ' VAL . 4.4 mp -119.88 107.77 21.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 0.0 110.544 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.717 HG22 HD13 ' A' ' 106' ' ' LEU . 12.5 t -91.8 120.66 41.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -134.9 158.83 43.25 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.441 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.5 t -76.21 167.86 21.1 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.146 178.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.624 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 1.0 OUTLIER -76.25 114.76 15.28 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.831 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.755 HG21 ' HA ' ' A' ' 122' ' ' PRO . 1.5 p -116.3 -2.94 12.01 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.013 172.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 92' ' ' HIS . 17.1 t70 -175.68 -145.79 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.515 ' H ' ' CG ' ' A' ' 91' ' ' ASP . 37.4 m80 -88.48 -159.68 0.58 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.609 ' HG3' ' HD3' ' A' ' 99' ' ' LYS . 4.1 mp0 -76.19 169.93 17.26 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 173.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -117.48 -161.0 0.8 Allowed 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 60.6 m -59.9 -37.45 79.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.623 0.249 . . . . 0.0 111.566 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -152.79 80.98 1.22 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.141 0.496 . . . . 0.0 110.342 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 75.0 m -133.77 143.89 48.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.479 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -102.21 128.41 48.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.293 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.609 ' HD3' ' HG3' ' A' ' 93' ' ' GLU . 5.1 tptm -90.65 110.36 21.52 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.9 t -81.3 -71.76 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.054 0.454 . . . . 0.0 110.461 -177.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.2 t -130.48 67.07 1.49 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.481 0.658 . . . . 0.0 110.758 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' HE2' ' A' ' 99' ' ' LYS . 28.1 t70 66.78 -69.83 0.12 Allowed 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.412 176.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.624 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 11.0 t70 -77.74 -55.43 5.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.228 0.537 . . . . 0.0 110.019 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.415 HD12 ' CD1' ' A' ' 159' ' ' PHE . 33.0 mm -64.93 122.78 16.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.452 -176.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.1 m -128.75 131.09 47.84 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.837 -176.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.717 HD13 HG22 ' A' ' 86' ' ' VAL . 55.4 tp -107.75 112.61 25.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.083 -177.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.5 m -96.6 124.77 40.69 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.414 HG22 ' CD2' ' A' ' 84' ' ' PHE . 60.2 p -107.36 17.1 23.23 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -172.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.1 m -147.7 -177.19 5.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.741 0.305 . . . . 0.0 111.184 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.44 -3.01 23.66 Favored Glycine 0 C--N 1.335 0.51 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.391 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -49.31 -32.8 11.77 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.961 0.905 . . . . 0.0 110.999 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.413 HG21 HG21 ' A' ' 85' ' ' ILE . 10.3 p -54.71 -34.68 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 114.812 -1.086 . . . . 0.0 111.972 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 92.3 mt -68.73 -37.71 79.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.176 0.512 . . . . 0.0 110.492 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -69.28 -24.03 63.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.723 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.5 m -72.29 -18.29 61.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.213 175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -97.01 144.93 26.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.78 0.324 . . . . 0.0 110.767 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 83.26 -17.76 21.73 Favored Glycine 0 C--N 1.328 0.124 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.822 178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.8 p -92.03 25.78 2.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.659 0.244 . . . . 0.0 111.659 -175.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 74.01 -39.82 0.44 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.607 0.763 . . . . 0.0 111.351 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.9 p -81.17 18.42 1.08 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.46 123.64 67.6 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.76 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.755 ' HA ' HG21 ' A' ' 90' ' ' THR . 29.7 Cg_endo -64.31 136.26 50.42 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.628 2.219 . . . . 0.0 112.862 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -66.71 -47.65 71.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.136 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 41.1 mtmt -124.39 127.76 48.04 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.178 -174.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -155.9 152.36 28.19 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.51 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.8 pt -129.45 132.46 66.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.156 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.528 HG13 HG23 ' A' ' 72' ' ' VAL . 6.8 p -112.09 134.59 54.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.193 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 84.0 m -140.24 139.65 35.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.066 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.668 HD21 HD22 ' A' ' 52' ' ' LEU . 4.3 mm? -89.84 118.44 29.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.262 -0.427 . . . . 0.0 109.962 178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.47 177.82 44.6 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.057 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.412 ' C ' ' HA3' ' A' ' 76' ' ' GLY . 73.5 m -145.6 171.58 14.49 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.904 0.383 . . . . 0.0 110.048 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.472 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 19.3 m -100.26 115.59 30.26 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 36' ' ' THR . 44.0 p -108.35 134.74 50.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.774 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.691 ' CD1' ' HB2' ' A' ' 139' ' ' LEU . 1.1 m-90 -119.9 165.02 15.17 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.302 0.572 . . . . 0.0 110.343 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -91.61 140.73 25.29 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.603 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.36 61.28 4.19 Favored 'Trans proline' 0 N--CA 1.473 0.313 0 C-N-CA 123.269 2.646 . . . . 0.0 113.298 -173.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -167.73 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.592 ' HG3' ' OE2' ' A' ' 142' ' ' GLU . 52.2 tp60 -65.77 -68.36 0.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.377 -174.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.691 ' HB2' ' CD1' ' A' ' 134' ' ' TRP . 55.8 tp -52.77 -42.02 64.6 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.887 0.375 . . . . 0.0 111.721 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.581 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 50.7 mt-10 -60.54 -32.85 71.88 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.078 -179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.597 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 25.3 mt-30 -72.31 -45.62 59.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.07 175.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.73 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 1.1 mp0 -54.42 -41.91 69.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.768 0.318 . . . . 0.0 111.199 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 139' ' ' LEU . 86.3 mt -56.91 -42.61 78.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.147 0.498 . . . . 0.0 110.538 175.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -69.46 -20.57 63.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.658 -178.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.597 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 38.1 mt-30 -88.82 6.39 39.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.954 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 145' ' ' GLN . 14.0 m120 69.15 13.24 8.65 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.549 0.53 . . . . 0.0 111.233 -178.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -81.6 -21.86 38.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.714 0.768 . . . . 0.0 109.004 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.73 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 99.3 m95 -133.26 131.18 39.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.861 172.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.727 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 98.8 mt -95.64 155.3 16.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.5 tp -127.61 135.13 49.85 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.776 0.322 . . . . 0.0 111.039 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.1 t -141.04 176.84 8.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 8' ' ' LYS . 33.0 mt-10 -125.69 153.85 43.27 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.584 0.23 . . . . 0.0 110.882 -175.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -139.33 124.19 18.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.962 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -89.52 -45.07 9.67 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.103 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -172.65 -60.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.625 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 44.6 mt-30 -53.89 -48.96 69.56 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.347 -172.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.9 m -59.33 -28.35 66.74 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.855 0.359 . . . . 0.0 111.913 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 96.6 mt -89.22 -53.84 4.38 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.415 ' CD1' HD12 ' A' ' 104' ' ' ILE . 34.5 m-85 -127.15 12.84 7.17 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -170.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 21.2 tt0 -109.83 -50.93 2.93 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 170.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.7 p -99.61 143.23 30.08 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 9.3 t -171.7 -149.45 0.06 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -56.72 -18.45 12.51 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.859 0.463 . . . . 0.0 111.772 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.433 ' H ' ' HG ' ' A' ' 164' ' ' LEU . 2.8 pp -88.39 -4.5 58.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.767 -177.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 166' ' ' ARG . 10.5 t70 -138.74 -144.32 0.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.63 ' HD2' ' HG2' ' A' ' 169' ' ' GLU . 31.8 ttm180 -51.63 124.49 12.4 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.219 0.607 . . . . 0.0 111.762 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -73.29 102.48 3.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.105 -176.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 47.6 t 62.22 89.6 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 123.761 0.663 . . . . 0.0 111.481 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.63 ' HG2' ' HD2' ' A' ' 166' ' ' ARG . 49.5 mt-10 -80.12 -2.28 43.82 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.491 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.415 ' HB1' HD12 ' A' ' 11' ' ' ILE . . . -51.78 -39.58 58.88 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -172.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -81.03 -37.16 29.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.811 0.339 . . . . 0.0 111.084 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.16 -38.35 60.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.011 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 14.6 tpt -63.95 -27.8 69.38 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.277 0.561 . . . . 0.0 110.328 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 9.5 tp -79.48 -35.31 40.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.132 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 119.08 8.0 9.83 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.086 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 52.7 mt 59.77 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.556 0.693 . . . . 0.0 111.084 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 18.6 t -149.53 109.8 4.17 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.315 -0.857 . . . . 0.0 108.914 177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -99.75 100.77 2.27 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.733 -175.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.475 HG22 HD12 ' A' ' 180' ' ' LEU . 4.1 mp -102.79 114.84 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.475 HD12 HG22 ' A' ' 179' ' ' ILE . 6.3 mp 63.12 -170.6 0.18 Allowed 'General case' 0 N--CA 1.465 0.292 0 O-C-N 123.726 0.641 . . . . 0.0 111.565 -174.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -125.49 128.37 24.69 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.149 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 32.1 Cg_exo -61.68 166.8 11.14 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.024 2.483 . . . . 0.0 112.455 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.98 108.59 0.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.301 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.6 137.79 27.84 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.482 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 79.1 mtm180 -75.27 93.73 2.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.827 0.346 . . . . 0.0 110.636 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -129.78 81.82 2.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.194 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 95.8 mt -135.62 166.06 24.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.342 -177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 . . . . . 0 C--O 1.25 1.107 0 O-C-N 123.482 0.489 . . . . 0.0 110.376 179.178 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 111.401 0.149 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 70.5 -74.44 0.08 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.219 0.608 . . . . 0.0 111.021 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.74 -105.57 1.76 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.418 -0.42 . . . . 0.0 113.776 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -80.61 105.09 11.6 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.162 0.506 . . . . 0.0 111.809 -174.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.455 HD13 HG13 ' A' ' 28' ' ' ILE . 97.3 mt -78.56 -92.3 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.516 172.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 39.63 84.52 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.563 0.745 . . . . 0.0 112.421 176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.61 -9.57 12.87 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.461 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' HG3' ' HG3' ' A' ' 152' ' ' GLU . 10.4 mptt -107.19 172.46 6.81 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -129.29 143.1 50.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.008 0.432 . . . . 0.0 110.269 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 9.3 pt -107.03 127.33 62.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.224 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.923 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 4.3 mp -92.63 107.8 19.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.672 -174.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.618 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -91.19 -45.36 8.69 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.705 176.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.764 HG21 HG12 ' A' ' 179' ' ' ILE . 18.2 m 63.1 80.47 0.24 Allowed Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.597 -175.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -84.02 16.23 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.865 2.377 . . . . 0.0 112.117 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 65.64 16.87 10.7 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.703 -177.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.0 ttt -84.93 113.32 21.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.909 177.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 18' ' ' ASP . 19.0 t70 -103.55 27.32 7.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.99 -169.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.923 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . 2.2 t70 68.66 129.2 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.494 0.664 . . . . 0.0 111.544 -175.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -93.26 -41.82 9.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.74 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -160.19 -36.02 0.05 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.754 0.311 . . . . 0.0 110.985 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -153.16 37.45 0.48 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.716 0.769 . . . . 0.0 109.199 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.923 ' HB3' ' HA ' ' A' ' 18' ' ' ASP . 30.8 t70 -88.22 120.77 29.89 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.302 -176.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -89.22 112.14 23.1 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.444 ' HA ' HD21 ' A' ' 42' ' ' ASN . 3.7 p -63.65 83.16 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -173.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.743 HG13 ' HB ' ' A' ' 40' ' ' ILE . 51.7 t 62.24 100.73 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 O-C-N 123.792 0.683 . . . . 0.0 112.136 173.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.644 ' CG2' HG23 ' A' ' 39' ' ' VAL . 11.3 tp -89.58 -141.02 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.919 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.557 ' H ' HG13 ' A' ' 26' ' ' ILE . 2.8 p90 -115.75 175.0 5.73 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 119.718 1.144 . . . . 0.0 112.442 -163.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.455 HG13 HD13 ' A' ' 5' ' ' LEU . 49.8 mm -90.24 120.91 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.823 176.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.0 m -87.36 -38.21 16.4 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -171.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.929 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 9.3 tp10 -141.15 155.18 46.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.84 0.352 . . . . 0.0 110.998 -173.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -146.18 104.36 3.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.85 170.09 8.15 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.317 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -62.76 -22.01 66.26 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.165 0.507 . . . . 0.0 111.031 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.23 5.61 25.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.108 -173.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.581 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 161.68 161.12 11.48 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 119.587 -1.292 . . . . 0.0 113.546 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 49.7 m -108.55 128.72 55.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.929 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.5 mp -106.47 117.69 52.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.746 -173.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.72 165.42 26.85 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.644 HG23 ' CG2' ' A' ' 26' ' ' ILE . 2.5 m -118.74 44.33 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.518 0.675 . . . . 0.0 110.616 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.743 ' HB ' HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -95.31 19.04 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.071 -175.309 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.6 tp -76.83 -31.73 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.658 -175.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.444 HD21 ' HA ' ' A' ' 24' ' ' THR . 3.1 m120 58.07 98.1 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.163 0.585 . . . . 0.0 112.226 -175.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.9 t -171.15 107.69 0.4 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 121.539 0.685 . . . . 0.0 110.313 173.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.546 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 6.5 Cg_exo -74.42 154.03 45.23 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.595 2.197 . . . . 0.0 111.209 176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.3 p -127.73 158.43 37.65 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.884 0.373 . . . . 0.0 111.231 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.58 10.76 2.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.641 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 48.9 tp -86.09 146.08 26.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.8 t -99.0 149.57 22.85 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 120.704 0.288 . . . . 0.0 110.687 -177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.592 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 8.8 p -63.8 -26.02 39.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.25 0.548 . . . . 0.0 109.916 175.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.554 ' HB3' HE22 ' A' ' 59' ' ' GLN . 91.8 mt -75.38 -27.54 59.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.312 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -75.25 -31.46 60.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.64 -177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.592 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.2 pp -72.67 -26.08 61.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.149 0.499 . . . . 0.0 109.745 176.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.555 HD22 HD11 ' A' ' 113' ' ' LEU . 87.8 mt -75.42 -42.56 53.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.886 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.4 p -68.24 -30.93 70.09 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -73.55 -11.41 60.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.82 0.343 . . . . 0.0 110.851 178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.3 mtt -91.89 -84.6 0.26 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 172.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.4 t70 179.7 25.37 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.542 0.687 . . . . 0.0 109.597 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.709 ' HB3' HD12 ' A' ' 113' ' ' LEU . 96.6 m-85 -132.81 166.88 21.25 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.03 -170.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.554 HE22 ' HB3' ' A' ' 50' ' ' LEU . 2.0 mm-40 -155.99 175.67 13.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.864 175.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 42.5 ttp 67.94 101.47 0.05 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 111.486 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' A' ' 53' ' ' LEU . . . -122.41 -50.46 2.0 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.373 177.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 57.2 mtpt -131.89 154.4 81.73 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.204 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 12.1 Cg_exo -71.89 43.75 0.59 Allowed 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.851 2.367 . . . . 0.0 112.433 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.41 ' HB3' ' HG3' ' A' ' 68' ' ' GLN . 0.4 OUTLIER -113.3 87.4 2.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 46.7 mt -86.55 85.98 2.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -171.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.7 t80 71.18 -42.57 0.54 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 168.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.0 t -56.87 -27.42 60.47 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.084 0.469 . . . . 0.0 111.426 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.41 ' HG3' ' HB3' ' A' ' 64' ' ' ARG . 11.1 pt20 -144.42 86.52 1.83 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.582 0.706 . . . . 0.0 109.59 174.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -65.98 140.24 58.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.239 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.495 ' HB2' HG12 ' A' ' 49' ' ' VAL . 25.6 mm-40 -94.16 104.07 16.09 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.914 -178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 87.8 mtp -78.86 142.75 36.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.633 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 127' ' ' VAL . 12.6 p -98.96 149.66 5.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.183 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.546 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.8 mp -99.52 158.97 15.37 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.051 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -99.54 132.92 44.55 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 175.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.619 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -91.3 -12.52 59.8 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.353 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.23 174.89 30.59 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.098 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.06 -10.26 15.23 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 123.171 2.581 . . . . 0.0 112.944 -177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.07 122.55 42.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.05 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 64.92 46.52 2.86 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.461 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.428 ' O ' HD12 ' A' ' 129' ' ' LEU . 49.7 mt-30 -67.12 -10.3 48.68 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.98 -3.01 58.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.91 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 86.9 mtt-85 -113.21 115.95 29.02 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.954 0.407 . . . . 0.0 110.69 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.84 115.49 4.99 Favored Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -96.5 126.17 41.5 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 -177.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.21 103.91 16.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.002 0.429 . . . . 0.0 109.977 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.702 HG22 ' HB3' ' A' ' 106' ' ' LEU . 31.1 t -93.13 124.74 45.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.557 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -135.09 164.61 27.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.864 0.364 . . . . 0.0 111.654 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 124' ' ' LYS . 14.6 m -70.36 160.67 31.86 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.196 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 23.4 tptm -76.72 121.31 23.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.374 176.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -107.5 -67.04 0.98 Allowed 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 169.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -164.72 -172.1 2.52 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 171.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.56 93.61 4.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -104.36 -175.9 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.934 168.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -72.24 97.34 1.97 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.283 -172.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.488 HG22 ' HB3' ' A' ' 111' ' ' ASP . 20.9 p -145.01 142.27 29.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.442 178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -88.65 80.68 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 172.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.492 ' HB3' HG22 ' A' ' 105' ' ' THR . 15.7 m -116.46 150.93 37.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.233 -175.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -104.83 139.53 39.46 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -101.57 116.0 31.77 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.76 -53.65 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 167.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.503 HG22 ' HB ' ' A' ' 104' ' ' ILE . 10.2 t -137.6 -166.18 1.9 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 169.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -83.32 -22.27 32.95 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 118.566 0.621 . . . . 0.0 111.023 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 28.7 m-20 -101.16 -11.66 19.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.623 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.503 ' HB ' HG22 ' A' ' 101' ' ' THR . 42.1 mm -120.72 122.67 68.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 97' ' ' SER . 29.7 m -145.77 130.6 18.12 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.787 0.327 . . . . 0.0 111.167 -174.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.702 ' HB3' HG22 ' A' ' 86' ' ' VAL . 1.1 pt? -108.21 132.69 53.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.477 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 109' ' ' SER . 50.3 m -96.06 129.36 43.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.105 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 p -107.0 21.13 18.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.031 0.443 . . . . 0.0 111.588 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.473 ' H ' HG22 ' A' ' 107' ' ' THR . 22.7 t -147.0 175.15 10.9 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.328 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.08 -0.0 49.41 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 113.004 -176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.488 ' HB3' HG22 ' A' ' 95' ' ' THR . 67.9 m-20 -56.22 -33.43 65.35 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.659 0.742 . . . . 0.0 110.514 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 p -52.25 -33.81 17.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.232 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.709 HD12 ' HB3' ' A' ' 58' ' ' PHE . 16.9 mt -73.02 -31.82 64.72 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.849 0.357 . . . . 0.0 111.171 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -64.21 -36.03 82.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.015 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.3 m -79.94 -2.93 45.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.213 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -94.35 146.54 23.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 111.046 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.42 -24.83 30.33 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.323 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 p -87.57 -175.5 5.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.787 0.327 . . . . 0.0 110.795 -178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -75.84 -16.46 60.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.284 0.564 . . . . 0.0 109.758 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.6 p -91.89 8.86 35.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.479 -177.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.457 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -76.91 114.45 39.48 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.686 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 14.0 Cg_exo -69.09 130.17 19.67 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.806 2.338 . . . . 0.0 111.926 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -64.45 -36.92 85.73 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.977 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.494 ' HB2' ' OG ' ' A' ' 88' ' ' SER . 13.5 mmtp -103.65 100.54 10.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.465 -171.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 35.2 p90 -138.29 130.9 29.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.047 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.4 pt -116.84 132.86 65.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 72' ' ' VAL . 7.7 p -115.24 129.22 71.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.263 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 84.8 m -136.63 136.6 39.29 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.479 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 72' ' ' VAL . 4.2 mm? -90.51 114.36 26.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.653 176.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.27 173.64 42.18 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.533 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.3 m -147.14 169.97 18.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.795 0.331 . . . . 0.0 110.436 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.8 m -105.11 122.5 46.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.246 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.692 HG22 HG13 ' A' ' 37' ' ' ILE . 30.5 p -100.94 123.63 45.42 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.402 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -105.63 153.44 21.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.183 174.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -73.94 138.03 76.27 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-O 120.867 0.365 . . . . 0.0 111.262 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.581 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 36.3 Cg_endo -65.52 136.72 47.66 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.872 2.381 . . . . 0.0 111.69 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.714 ' HA ' ' CD ' ' A' ' 140' ' ' GLU . 81.3 m-70 64.98 13.76 8.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.876 -178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 26.7 tt0 -108.21 -54.68 2.47 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 171.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 143' ' ' ILE . 66.3 tp -57.79 -41.17 81.53 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.718 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.714 ' CD ' ' HA ' ' A' ' 137' ' ' HIS . 7.0 pt-20 -59.1 -38.15 78.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.867 0.365 . . . . 0.0 111.046 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -76.39 -30.78 57.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.71 0.291 . . . . 0.0 110.806 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 9.5 mm-40 -61.51 -41.5 97.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.051 0.453 . . . . 0.0 110.035 175.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.592 ' HA ' ' HB2' ' A' ' 148' ' ' TRP . 76.2 mt -58.61 -40.44 79.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.629 175.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.25 -19.44 65.38 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.895 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.447 HE21 ' HA ' ' A' ' 142' ' ' GLU . 36.5 mt-30 -82.44 -1.08 49.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.946 -0.115 . . . . 0.0 111.041 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 71.3 11.58 6.74 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 123.713 0.633 . . . . 0.0 110.126 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -77.1 -24.65 51.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.927 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.618 ' CZ3' ' HB2' ' A' ' 12' ' ' ALA . 95.3 m95 -130.49 138.98 50.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.018 174.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.923 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 98.3 mt -100.91 157.7 16.53 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 173.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.8 tp -129.55 134.37 47.71 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 120.686 -0.405 . . . . 0.0 111.667 -177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.1 t -154.47 143.28 20.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.465 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.437 ' HG3' ' HG3' ' A' ' 8' ' ' LYS . 4.6 mp0 -73.13 154.63 40.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -86.44 -26.78 24.52 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.998 0.427 . . . . 0.0 110.509 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 17.4 m120 55.59 21.92 4.86 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.151 -0.931 . . . . 0.0 112.009 178.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 70.59 -51.47 0.67 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.435 0.694 . . . . 0.0 111.815 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.443 ' HA ' ' CB ' ' A' ' 160' ' ' GLU . 36.2 mt-30 -64.14 -50.02 69.86 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.098 -173.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.7 m -61.84 -29.45 70.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.109 0.48 . . . . 0.0 110.69 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.38 -57.76 3.94 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.907 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -120.99 -38.18 2.86 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.443 ' CB ' ' HA ' ' A' ' 156' ' ' GLN . 26.3 tt0 -56.87 -58.23 9.06 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.775 0.321 . . . . 0.0 111.238 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 8.5 t -63.44 -13.95 45.56 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.924 -173.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 m -78.75 43.63 0.5 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.802 0.334 . . . . 0.0 111.154 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -79.77 -41.46 26.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.876 0.369 . . . . 0.0 111.239 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 53.1 mt -95.69 -81.89 0.39 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.328 -168.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -173.25 -27.2 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.664 -168.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.412 ' HD3' ' OE1' ' A' ' 172' ' ' GLU . 32.1 ttm180 -44.08 114.55 0.68 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -97.55 -178.98 4.31 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.19 168.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.8 t 60.98 68.04 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.638 0.733 . . . . 0.0 109.867 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -104.74 -37.34 7.1 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.071 -178.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -57.73 -47.0 83.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.492 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -71.95 -30.9 65.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.791 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 175' ' ' GLY . 31.8 tt0 -68.07 -31.56 71.28 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.683 0.278 . . . . 0.0 110.714 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.502 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 20.1 mmt -58.73 -28.68 66.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.977 0.418 . . . . 0.0 110.858 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.4 tp -96.74 -57.73 2.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.696 177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 172' ' ' GLU . . . -170.43 -110.81 0.24 Allowed Glycine 0 N--CA 1.443 -0.85 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 175' ' ' GLY . 5.3 mm -160.49 -60.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.254 0.622 . . . . 0.0 109.904 176.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 19.8 m -99.68 123.01 43.53 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.806 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.44 ' O ' ' HB ' ' A' ' 179' ' ' ILE . . . 154.93 -100.74 0.2 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.4 177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.764 HG12 HG21 ' A' ' 13' ' ' THR . 2.0 mp 70.6 132.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-O 121.394 0.616 . . . . 0.0 110.382 -176.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.544 HD13 HD21 ' A' ' 149' ' ' LEU . 5.9 mp -72.86 97.84 2.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.588 -177.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -124.44 102.65 32.87 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.209 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.04 -37.13 94.05 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.037 2.491 . . . . 0.0 112.466 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 50.57 58.95 4.95 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.505 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -157.61 -138.9 2.6 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.413 ' HG3' ' H ' ' A' ' 185' ' ' ARG . 0.0 OUTLIER -76.53 77.13 3.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.57 0.7 . . . . 0.0 111.501 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -120.89 30.48 6.86 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.198 176.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 187' ' ' LEU . 2.4 pt? -118.86 173.43 6.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.606 -174.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.498 -0.763 . . . . 0.0 109.099 179.354 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.707 0.289 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -165.01 160.22 18.77 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.551 174.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.41 -127.78 4.35 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.99 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 31' ' ' HIS . 54.7 t30 -82.35 146.76 29.21 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.3 mt -123.89 -83.29 0.65 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.588 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 63.76 152.51 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 CA-C-O 121.776 0.798 . . . . 0.0 111.713 -176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.37 23.71 70.29 Favored Glycine 0 C--N 1.316 -0.558 0 CA-C-N 115.093 -0.958 . . . . 0.0 111.907 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.556 ' NZ ' ' HG3' ' A' ' 152' ' ' GLU . 71.0 mmtt -110.75 164.83 12.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 29.3 p90 -144.13 153.24 41.94 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 172.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.549 ' O ' HG21 ' A' ' 25' ' ' VAL . 4.5 pt -117.72 127.03 75.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.046 0.451 . . . . 0.0 111.098 -176.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.714 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 53.8 mt -94.41 112.95 28.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.287 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 148' ' ' TRP . . . -158.7 124.1 4.35 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.318 172.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.478 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 19.1 p -90.61 107.88 23.36 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-O 121.108 0.48 . . . . 0.0 110.898 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.502 ' HG2' HD22 ' A' ' 42' ' ' ASN . 6.3 Cg_exo -73.52 89.18 0.97 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.184 2.59 . . . . 0.0 112.861 -173.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 67.78 -0.98 1.8 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.835 171.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 66.7 mtm 50.23 49.45 20.5 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.19 0.519 . . . . 0.0 110.464 -176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.578 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 3.0 t70 -78.85 -169.69 1.87 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.698 -172.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -67.32 -55.07 15.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.84 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.513 ' HB2' ' HD2' ' A' ' 44' ' ' PRO . 8.6 pt-20 -82.73 38.95 0.59 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.535 0.683 . . . . 0.0 110.873 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.578 ' HB3' ' O ' ' A' ' 17' ' ' ASP . 0.4 OUTLIER -116.75 -33.09 4.93 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.425 -174.005 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -58.8 -26.65 64.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.091 -0.959 . . . . 0.0 113.442 -173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 6.4 t70 -105.44 100.43 10.01 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.483 ' HD3' ' HA ' ' A' ' 23' ' ' ARG . 32.9 mmt180 79.04 103.49 0.07 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.59 1.181 . . . . 0.0 111.756 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.649 ' O ' HG22 ' A' ' 25' ' ' VAL . 32.0 p -96.61 89.96 5.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.498 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.77 HG12 HD21 ' A' ' 42' ' ' ASN . 1.9 m 62.51 174.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.427 1.091 . . . . 0.0 111.911 -178.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.541 HG13 ' H ' ' A' ' 27' ' ' TYR . 11.1 tp -156.22 -142.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.541 ' H ' HG13 ' A' ' 26' ' ' ILE . 1.1 p90 -109.49 170.08 8.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 119.552 1.069 . . . . 0.0 112.277 -163.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.83 126.87 49.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.617 175.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 55.6 m -78.49 -59.28 2.85 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.052 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -128.39 159.89 33.96 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.454 0.645 . . . . 0.0 111.742 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.448 ' HB3' ' OD1' ' A' ' 4' ' ' ASN . 49.0 t-80 -144.13 142.0 30.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.355 177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.449 ' ND2' ' H ' ' A' ' 33' ' ' ASP . 3.6 t-20 83.88 177.98 0.05 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.553 1.158 . . . . 0.0 109.091 -177.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.449 ' H ' ' ND2' ' A' ' 32' ' ' ASN . 33.3 t70 68.24 -76.2 0.06 Allowed 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.22 0.608 . . . . 0.0 110.893 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.489 ' HB3' HD11 ' A' ' 37' ' ' ILE . 8.4 t30 -93.18 -34.44 13.61 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.49 -110.11 0.44 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.181 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 133' ' ' THR . 11.0 m -136.32 105.25 5.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 175.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.581 HG13 HG22 ' A' ' 133' ' ' THR . 4.1 mp -98.97 112.02 30.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.444 -174.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.67 170.22 31.16 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.517 HG23 ' CG2' ' A' ' 26' ' ' ILE . 2.8 m -120.58 76.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.649 0.737 . . . . 0.0 111.004 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.501 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -121.9 20.91 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.836 -176.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.419 HG23 HG22 ' A' ' 43' ' ' THR . 10.1 tp -73.05 -24.11 20.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.033 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.77 HD21 HG12 ' A' ' 25' ' ' VAL . 86.6 m-20 53.63 82.87 0.08 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.274 0.63 . . . . 0.0 112.299 178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 6.5 t -172.81 113.45 0.36 Allowed Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.433 0.635 . . . . 0.0 110.881 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.614 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 50.9 Cg_endo -71.94 153.92 58.17 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.078 1.852 . . . . 0.0 110.482 171.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.431 HG22 HD22 ' A' ' 74' ' ' ASN . 11.2 p -96.65 169.93 9.55 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.773 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -79.33 5.88 11.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.971 0.415 . . . . 0.0 110.571 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.9 tp -113.91 161.31 17.79 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.286 -175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 57.6 p -116.4 160.89 19.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.337 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.479 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 12.5 p -67.72 -32.89 58.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.966 0.412 . . . . 0.0 110.361 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.553 HD23 HD12 ' A' ' 53' ' ' LEU . 59.6 mt -73.82 -32.02 63.52 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.993 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' HB2' ' OG ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -57.46 -53.33 59.38 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 176.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 81.7 mt -54.15 -43.83 70.9 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.237 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.553 HD12 HD23 ' A' ' 50' ' ' LEU . 80.9 mt -62.3 -45.56 92.68 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.267 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.8 p -73.47 -32.88 64.57 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.056 0.455 . . . . 0.0 111.314 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -67.74 -34.65 77.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.944 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 47.3 mtt -106.56 1.01 24.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.203 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.4 t70 62.08 100.03 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 123.911 0.757 . . . . 0.0 111.05 -177.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -81.69 155.01 25.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.808 -174.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -61.37 130.27 45.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.888 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 3.9 mtt -76.25 88.88 3.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.392 0.615 . . . . 0.0 111.578 -175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.47 10.13 2.71 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.651 174.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -153.34 133.06 7.32 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.005 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -58.51 163.16 11.06 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.983 2.456 . . . . 0.0 112.711 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.44 ' O ' ' HB ' ' A' ' 65' ' ' ILE . 9.7 tpt180 -64.49 -61.37 2.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.488 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' HB ' ' O ' ' A' ' 64' ' ' ARG . 2.0 mp 68.76 108.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 121.412 0.625 . . . . 0.0 110.068 -172.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -101.35 126.13 48.07 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.524 -175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.4 m 64.59 36.47 8.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.845 0.831 . . . . 0.0 111.677 173.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.428 ' HB3' ' CG2' ' A' ' 65' ' ' ILE . 7.7 tt0 -140.46 34.39 1.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 122.233 1.015 . . . . 0.0 108.286 171.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -74.01 146.62 43.64 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.971 -174.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -99.85 129.66 45.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.665 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.576 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 91.5 mtp -75.85 136.12 40.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.236 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.542 HG21 HD23 ' A' ' 129' ' ' LEU . 14.0 p -88.98 141.48 14.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 7.4 mp -95.98 161.56 13.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.235 0.541 . . . . 0.0 111.099 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.431 HD22 HG22 ' A' ' 45' ' ' THR . 2.0 t-20 -92.37 132.71 36.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.941 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -88.22 -25.37 31.45 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.263 -0.97 . . . . 0.0 111.908 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.42 176.72 27.04 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.93 -17.84 22.12 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.971 2.447 . . . . 0.0 112.67 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.9 t -98.7 143.95 12.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.045 -175.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 m120 62.95 31.76 15.99 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.975 0.51 . . . . 0.0 112.052 174.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -71.56 -10.12 59.28 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -80.7 -0.12 36.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.832 0.349 . . . . 0.0 110.262 178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 79.7 mtt85 -122.49 133.77 54.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.607 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.23 110.42 3.63 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.516 ' HB3' HD11 ' A' ' 106' ' ' LEU . 93.7 m-85 -92.35 124.85 36.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.694 0.283 . . . . 0.0 110.322 -177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 112' ' ' VAL . 2.7 mp -121.56 112.63 36.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.409 0.623 . . . . 0.0 110.224 177.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 66.0 t -90.74 110.96 22.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.198 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -137.28 165.01 27.18 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.704 0.287 . . . . 0.0 111.569 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.7 p -81.75 159.46 23.85 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.004 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 90' ' ' THR . 58.5 tttm -87.47 140.73 29.23 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.931 0.396 . . . . 0.0 110.144 177.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -95.06 -170.71 2.25 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 176.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.417 ' H ' HG22 ' A' ' 90' ' ' THR . 6.7 p-10 -64.2 -35.09 79.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.157 0.503 . . . . 0.0 110.118 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -83.4 163.54 20.5 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.684 178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -85.44 -172.38 4.11 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.08 176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -132.14 162.72 30.18 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.8 m -80.96 -47.0 14.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.876 0.37 . . . . 0.0 110.515 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.473 ' O ' HG23 ' A' ' 107' ' ' THR . 7.7 t60 -145.28 97.29 2.98 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.692 177.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.432 ' HB3' ' HB ' ' A' ' 105' ' ' THR . 66.7 m -135.56 152.72 51.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.044 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -101.66 114.39 28.4 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 102' ' ' ASP . 88.3 tttt -78.14 102.33 7.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.976 0.417 . . . . 0.0 110.727 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.438 HG11 ' HE2' ' A' ' 27' ' ' TYR . 40.3 t -86.11 -53.83 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.57 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 36.8 p -116.01 176.67 4.99 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.542 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 4.8 t70 -86.32 52.32 2.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.264 0.554 . . . . 0.0 110.289 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.557 ' HB3' HD21 ' A' ' 155' ' ' ASN . 28.6 t70 177.65 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.891 178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.503 HG21 HD13 ' A' ' 158' ' ' LEU . 48.1 mm -90.3 124.38 42.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.123 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 97' ' ' SER . 0.5 OUTLIER -121.36 139.14 53.82 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.443 -176.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' A' ' 84' ' ' PHE . 65.5 tp -101.12 112.41 24.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.274 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 96' ' ' HIS . 18.8 m -99.93 130.33 46.09 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.238 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.9 p -114.18 10.88 17.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.074 -174.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 16.0 m -132.19 -177.46 4.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.634 0.254 . . . . 0.0 110.926 -174.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.458 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -70.7 4.85 8.48 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 116.102 -0.499 . . . . 0.0 112.688 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.454 ' HB3' HG21 ' A' ' 107' ' ' THR . 17.4 t0 -61.13 -29.54 69.83 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.331 0.586 . . . . 0.0 109.451 174.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.539 HG21 HD13 ' A' ' 85' ' ' ILE . 47.0 t -57.48 -39.42 68.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.732 176.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.509 HD13 ' CZ ' ' A' ' 116' ' ' PHE . 4.1 mm? -61.6 -32.51 72.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.594 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -81.87 -32.89 30.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.952 178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 47.4 m -57.99 -51.93 67.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.415 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.517 ' HA ' ' HB1' ' A' ' 121' ' ' ALA . 10.7 p90 -92.73 8.89 37.35 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.746 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -104.81 37.02 4.01 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.62 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.0 t -151.47 165.46 34.1 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -67.81 -22.58 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.972 0.415 . . . . 0.0 111.133 -177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 p -104.71 42.3 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.246 0.546 . . . . 0.0 110.832 177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.517 ' HB1' ' HA ' ' A' ' 116' ' ' PHE . . . -64.19 140.58 97.95 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.093 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 12.2 Cg_exo -68.95 124.04 11.0 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.337 2.025 . . . . 0.0 111.025 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -75.66 -28.35 58.7 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.743 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -105.88 105.36 15.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.061 -173.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 46.4 p90 -157.24 146.3 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.159 0.504 . . . . 0.0 111.587 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 27.9 pt -123.7 142.83 39.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.566 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 p -115.18 131.7 66.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.903 0.382 . . . . 0.0 111.11 -176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 77.6 m -142.98 141.1 31.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.414 178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.542 HD23 HG21 ' A' ' 72' ' ' VAL . 4.1 mm? -94.02 119.25 32.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.255 177.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.502 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 78.35 -179.86 51.52 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.476 -177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 73.4 m -147.99 169.31 20.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.906 0.384 . . . . 0.0 110.005 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.839 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 30.2 m -106.85 126.96 52.98 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.779 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.596 ' HA ' ' O ' ' A' ' 36' ' ' THR . 39.4 p -114.49 119.69 37.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.425 0.631 . . . . 0.0 112.136 -177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.839 ' HZ3' ' HB3' ' A' ' 132' ' ' SER . 1.3 m-90 -99.94 136.27 40.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.025 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.433 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -83.23 147.54 53.84 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.315 -175.245 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 137' ' ' HIS . 21.6 Cg_exo -66.55 73.82 0.4 Allowed 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.656 2.904 . . . . 0.0 112.736 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.484 ' HB3' ' O ' ' A' ' 136' ' ' PRO . 17.4 p-80 167.17 -23.87 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.652 1.181 . . . . 0.0 108.083 178.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.585 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 63.0 tt0 -84.68 -67.35 0.8 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.51 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 134' ' ' TRP . 51.2 tp -60.52 -44.88 95.55 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.114 -174.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -61.18 -42.13 98.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.741 -0.208 . . . . 0.0 111.429 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.585 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.6 mp0 -68.44 -35.58 77.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.636 0.255 . . . . 0.0 110.676 178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.585 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 8.6 mm-40 -64.01 -46.51 84.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.841 0.353 . . . . 0.0 110.268 176.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.659 HG12 ' HB2' ' A' ' 148' ' ' TRP . 68.6 mt -62.07 -41.17 90.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.581 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -62.05 -36.52 81.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.459 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.585 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 40.6 mt-30 -82.46 7.11 15.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.907 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 67.03 37.14 3.91 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.834 177.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -83.98 -48.15 10.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.134 0.492 . . . . 0.0 109.893 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.659 ' HB2' HG12 ' A' ' 143' ' ' ILE . 96.7 m95 -107.37 130.18 54.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.486 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.927 ' HG ' ' HG ' ' A' ' 180' ' ' LEU . 4.9 tt -91.21 103.3 15.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 8' ' ' LYS . 55.2 tp -82.66 133.68 35.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.022 0.439 . . . . 0.0 111.198 -177.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.8 m -145.32 172.89 12.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.126 177.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.556 ' HG3' ' NZ ' ' A' ' 8' ' ' LYS . 5.2 mp0 -96.65 153.44 17.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.234 0.54 . . . . 0.0 111.791 -175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -119.72 108.49 14.49 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.125 172.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -79.94 49.39 1.07 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -170.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.557 HD21 ' HB3' ' A' ' 103' ' ' ASP . 0.2 OUTLIER 64.7 -74.22 0.05 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.491 0.716 . . . . 0.0 111.361 175.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -61.47 -25.53 67.3 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.702 0.401 . . . . 0.0 111.132 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.902 ' HA ' ' HB ' ' A' ' 161' ' ' THR . 13.6 m -52.73 -29.66 28.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.028 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.503 HD13 HG21 ' A' ' 104' ' ' ILE . 0.6 OUTLIER -63.12 -44.03 96.76 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -175.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.67 -3.15 2.95 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -117.64 -37.25 3.5 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.902 ' HB ' ' HA ' ' A' ' 157' ' ' THR . 9.7 m -94.33 112.53 24.33 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 122.404 -0.185 . . . . 0.0 110.893 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.1 t 66.65 90.31 0.09 Allowed 'General case' 0 N--CA 1.461 0.105 0 O-C-N 123.748 0.655 . . . . 0.0 110.336 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -71.45 -57.49 4.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.626 -175.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.54 ' HG ' ' N ' ' A' ' 165' ' ' ASP . 2.1 pt? -161.9 -66.31 0.05 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.695 -0.229 . . . . 0.0 110.996 173.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.54 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 13.9 m-20 61.1 -68.28 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.392 0.677 . . . . 0.0 112.108 -176.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -121.48 179.97 4.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.676 0.274 . . . . 0.0 110.452 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -87.76 24.38 1.75 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.107 0.479 . . . . 0.0 111.224 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.5 m -137.57 36.36 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.365 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.402 ' H ' ' HG3' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -57.27 -49.24 76.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.152 -0.931 . . . . 0.0 113.082 -170.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.17 -37.49 83.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.045 0.45 . . . . 0.0 111.257 -178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' ' 176' ' ' ILE . 2.7 t-20 -68.53 -37.54 80.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.305 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -64.02 -28.33 69.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.563 -178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -55.89 -34.57 65.64 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.988 0.423 . . . . 0.0 110.271 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.0 tp -102.0 -55.09 2.56 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.157 0.503 . . . . 0.0 110.29 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 151.14 117.15 0.77 Allowed Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.349 -175.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.4 ' HA ' ' OD1' ' A' ' 171' ' ' ASN . 56.8 mt -55.99 -50.88 66.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.052 0.453 . . . . 0.0 110.512 177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.6 t -86.74 104.22 15.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.832 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -171.53 -90.79 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.903 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 71.6 mt 72.7 139.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.203 0.525 . . . . 0.0 111.513 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.927 ' HG ' ' HG ' ' A' ' 149' ' ' LEU . 80.4 mt -72.44 124.3 24.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.352 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 57.59 70.75 1.23 Allowed Pre-proline 0 C--N 1.33 -0.246 0 O-C-N 124.024 0.827 . . . . 0.0 111.921 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.8 15.61 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.532 2.155 . . . . 0.0 112.15 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -120.46 104.29 9.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.576 -178.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 167.44 130.87 1.21 Allowed Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 185' ' ' ARG . 50.0 mtt85 -84.77 -91.71 0.09 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.087 0.47 . . . . 0.0 110.409 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -173.1 66.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.543 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.558 ' O ' HD12 ' A' ' 187' ' ' LEU . 2.5 pp -76.83 118.51 19.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.757 0.789 . . . . 0.0 110.29 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.001 -175.61 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptt? . . . . . 0 N--CA 1.481 1.086 0 CA-C-O 121.62 0.724 . . . . 0.0 111.002 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -97.02 152.09 19.08 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.054 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.77 66.59 2.41 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.287 -0.482 . . . . 0.0 113.642 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 68.8 119.47 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.591 0.71 . . . . 0.0 112.611 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.459 ' O ' ' HB ' ' A' ' 28' ' ' ILE . 96.8 mt -86.16 -10.99 53.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.128 176.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -65.98 127.27 31.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.959 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.24 0.84 79.72 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.615 -177.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -115.22 -177.33 3.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.665 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 44.1 p90 -151.24 161.68 42.28 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 173.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.516 HD13 HD21 ' A' ' 139' ' ' LEU . 16.6 pt -121.32 129.19 75.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.519 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.757 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.6 mp -75.22 107.42 5.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.286 -177.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.455 ' H ' HG21 ' A' ' 25' ' ' VAL . . . -79.43 101.05 7.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.574 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 20.8 m -105.0 107.73 59.52 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.31 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -71.61 -76.52 0.01 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.56 2.173 . . . . 0.0 112.108 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 185' ' ' ARG . 33.2 tt0 -153.15 84.37 1.2 Allowed 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 67.2 mtt 65.19 -75.97 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.297 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -158.83 159.19 34.8 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -166.15 -83.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.49 17.55 10.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.131 0.967 . . . . 0.0 108.841 167.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -55.91 -35.06 66.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 113.606 -1.633 . . . . 0.0 111.539 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 167' ' ' TRP . 73.7 t80 -65.39 -20.52 66.42 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.093 -176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -97.81 80.35 2.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.013 0.435 . . . . 0.0 110.935 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.5 mtm180 60.79 86.95 0.09 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.265 -0.879 . . . . 0.0 112.265 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.7 t -118.72 117.42 28.86 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.503 -177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.699 HG13 HG22 ' A' ' 40' ' ' ILE . 59.3 t 69.19 153.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.151 173.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.514 HG13 ' HD1' ' A' ' 27' ' ' TYR . 7.0 tp -136.68 -57.42 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.025 173.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.665 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 6.0 p90 -177.73 175.3 1.37 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.108 0.48 . . . . 0.0 111.639 177.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 5' ' ' LEU . 50.3 mm -103.86 127.66 57.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.613 176.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.5 m -81.33 -53.31 6.43 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.723 -173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -134.51 160.82 36.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.512 0.672 . . . . 0.0 112.315 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.531 ' O ' ' HB3' ' A' ' 32' ' ' ASN . 84.3 t60 -164.12 136.23 4.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.58 178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 31' ' ' HIS . 21.7 t-20 86.68 -38.96 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 O-C-N 124.229 0.956 . . . . 0.0 110.513 176.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 34' ' ' ASN . 30.1 t70 -73.74 97.02 2.62 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.426 ' HB3' ' O ' ' A' ' 33' ' ' ASP . 28.9 t-20 76.33 -38.99 0.34 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.883 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.03 -141.76 5.73 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.552 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.2 m -125.03 112.75 16.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 117.066 0.433 . . . . 0.0 110.125 176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 37' ' ' ILE . 4.0 mp -110.96 121.15 63.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.444 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.07 171.8 31.4 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.057 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.82 91.86 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.555 0.693 . . . . 0.0 110.423 177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.699 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -136.4 18.41 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.066 -175.426 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 tp -64.52 -29.7 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.183 -177.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 58.98 82.47 0.14 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.114 0.483 . . . . 0.0 111.801 177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 t -175.82 121.54 0.32 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.8 176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 65.0 Cg_endo -78.59 153.66 26.82 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.313 2.009 . . . . 0.0 110.735 171.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.1 p -101.59 177.96 4.77 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.065 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -81.56 -17.36 48.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.19 0.519 . . . . 0.0 110.345 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.5 tp -80.28 150.66 29.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.443 -177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.552 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 34.9 t -103.51 151.35 22.96 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.073 -178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.506 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 14.1 p -65.8 -30.09 48.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.303 0.573 . . . . 0.0 109.692 177.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.0 mt -74.1 -26.76 60.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.023 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 48' ' ' SER . 5.8 mm-40 -69.83 -44.13 70.59 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.155 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.3 pp -68.9 -34.26 75.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.706 0.289 . . . . 0.0 110.724 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 58' ' ' PHE . 87.0 mt -64.81 -48.85 72.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.815 0.34 . . . . 0.0 110.75 177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.0 p -69.2 -30.15 68.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.061 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 36.4 tpt85 -62.51 -30.74 71.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.556 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 81.0 mtp -83.72 -92.56 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.556 176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -161.52 30.46 0.13 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.755 0.788 . . . . 0.0 110.659 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 88.8 m-85 -107.91 108.66 19.91 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.26 176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 -137.39 4.78 2.67 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -173.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 86.4 mtp -147.69 162.73 38.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.683 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 78.07 134.09 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 O-C-N 124.486 1.116 . . . . 0.0 112.804 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.573 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 11.4 mmpt? 60.72 72.92 0.66 Allowed Pre-proline 0 N--CA 1.466 0.361 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.779 174.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -95.8 122.07 0.27 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.205 2.604 . . . . 0.0 113.118 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -82.11 57.97 3.77 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 173.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.555 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 40.9 mt 62.96 -88.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.502 -173.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.555 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 21.4 p90 164.3 -24.17 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.55 -30.29 61.69 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.866 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -76.29 91.19 3.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.344 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -96.41 115.93 28.23 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.658 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -103.25 115.42 30.53 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.183 0.516 . . . . 0.0 110.773 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.552 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 55.2 mtt -83.26 125.5 31.66 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.79 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 129' ' ' LEU . 14.9 p -69.7 144.31 14.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.832 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 6.7 mp -96.71 157.68 15.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.997 0.427 . . . . 0.0 110.606 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.42 146.78 26.8 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.398 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -103.84 -27.07 6.47 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.758 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 155.87 167.66 17.66 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.696 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.25 -17.97 44.85 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 123.058 2.505 . . . . 0.0 113.143 -176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.446 HG21 ' OG1' ' A' ' 133' ' ' THR . 48.9 t -94.73 132.13 39.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.843 -0.162 . . . . 0.0 110.813 -177.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 63.36 31.25 15.31 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.593 0.558 . . . . 0.0 110.852 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -12.18 61.44 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.105 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -79.02 -7.98 58.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -127.36 138.63 53.06 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.044 -173.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.93 132.0 10.89 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.499 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.548 ' HB3' HD11 ' A' ' 106' ' ' LEU . 82.1 m-85 -106.79 126.11 51.87 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.557 HG21 HG11 ' A' ' 112' ' ' VAL . 2.6 mp -119.59 106.28 18.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.394 0.616 . . . . 0.0 110.925 -176.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.68 HG22 HD13 ' A' ' 106' ' ' LEU . 12.1 t -91.57 138.03 20.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.403 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.404 ' HE1' ' OG1' ' A' ' 107' ' ' THR . 52.6 p-80 -149.89 156.34 41.6 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.672 -178.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.5 m -76.09 170.86 15.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.707 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.2 tppt? -78.26 116.82 18.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.31 0.576 . . . . 0.0 110.977 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 20.6 m -140.27 -44.99 0.42 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 174.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -95.95 165.82 12.08 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -117.22 14.61 14.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.583 0.706 . . . . 0.0 109.997 -176.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -100.64 163.33 12.39 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.789 -178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.2 p90 176.18 127.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.254 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 25.1 m -97.97 -49.96 4.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.187 0.518 . . . . 0.0 109.806 174.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.442 ' HB2' ' OG ' ' A' ' 109' ' ' SER . 12.7 m-70 -135.6 102.18 5.03 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.534 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 22.1 p -135.94 152.95 51.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.969 -177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -109.6 136.58 48.74 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 170.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 102' ' ' ASP . 87.1 tttt -90.1 105.49 17.84 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.041 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.0 t -79.16 -55.49 9.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 172.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 29.7 p -132.59 -175.89 3.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.142 -0.935 . . . . 0.0 108.583 171.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.426 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 11.5 m-20 -73.95 -13.81 60.94 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.983 -0.287 . . . . 0.0 110.898 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -105.56 -58.68 1.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.302 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.799 HD12 ' HD2' ' A' ' 159' ' ' PHE . 42.1 mm -67.96 122.79 19.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.117 0.484 . . . . 0.0 110.414 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 m -127.2 124.57 39.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.317 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.68 HD13 HG22 ' A' ' 86' ' ' VAL . 25.8 tp -96.0 115.55 27.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.547 174.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.854 HG21 ' HB2' ' A' ' 111' ' ' ASP . 42.1 m -117.64 126.91 53.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.481 -177.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 16.6 p -96.8 -10.58 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.487 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.442 ' OG ' ' HB2' ' A' ' 96' ' ' HIS . 38.9 m -95.27 179.62 5.12 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.636 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.21 5.37 34.83 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.903 -175.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.854 ' HB2' HG21 ' A' ' 107' ' ' THR . 25.7 m-20 -54.88 -40.45 69.75 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.58 ' CG2' ' HB ' ' A' ' 107' ' ' THR . 22.6 t -57.58 -48.98 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.805 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.28 -34.99 75.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.714 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -59.08 -46.66 87.71 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.749 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.4 m -66.2 -44.54 83.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.137 0.494 . . . . 0.0 110.873 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -68.42 -24.18 64.72 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.428 -172.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -91.31 6.72 80.94 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.592 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.1 p -128.85 -162.58 1.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.95 0.375 . . . . 0.0 111.331 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.89 0.51 34.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.797 0.332 . . . . 0.0 111.603 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 p -113.83 25.68 10.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.085 0.469 . . . . 0.0 111.331 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -60.26 124.09 76.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.162 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 2.8 Cg_endo -82.19 129.29 5.95 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.41 2.74 . . . . 0.0 111.958 177.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.54 -35.16 78.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.649 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 40.6 mmtt -104.33 109.02 20.7 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.903 -172.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 24.6 p90 -153.05 144.09 23.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.791 0.329 . . . . 0.0 110.808 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.548 HG12 ' HZ ' ' A' ' 159' ' ' PHE . 30.4 pt -136.56 147.67 27.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.183 176.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.483 HG23 HG13 ' A' ' 85' ' ' ILE . 7.7 p -128.26 131.34 69.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.016 0.436 . . . . 0.0 110.789 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 26.6 p -133.31 144.03 49.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.399 177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 72' ' ' VAL . 3.8 mm? -92.05 110.56 21.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.465 178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.413 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 83.91 -179.18 52.13 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.777 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.1 m -147.73 169.55 19.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.349 . . . . 0.0 110.101 176.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.597 ' HB3' ' HZ3' ' A' ' 134' ' ' TRP . 38.9 m -108.02 125.4 51.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.055 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.446 ' OG1' HG21 ' A' ' 78' ' ' VAL . 18.1 p -107.66 127.37 53.6 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.217 0.532 . . . . 0.0 111.565 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.597 ' HZ3' ' HB3' ' A' ' 132' ' ' SER . 1.0 OUTLIER -115.43 150.6 36.17 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.246 175.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.428 ' HD2' ' H ' ' A' ' 135' ' ' LYS . 10.6 mptt -74.17 151.49 88.07 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.054 178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.19 129.55 34.83 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.652 2.235 . . . . 0.0 111.867 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 72.2 -6.09 1.61 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.521 0.729 . . . . 0.0 112.299 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 7.4 tp60 -73.29 -57.53 3.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.936 0.398 . . . . 0.0 110.296 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 10' ' ' ILE . 44.3 tp -64.0 -34.52 78.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.198 178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.48 -40.89 83.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.368 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.595 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.0 OUTLIER -65.11 -48.1 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.295 177.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.417 ' HB3' ' CD1' ' A' ' 148' ' ' TRP . 50.5 mt-10 -57.43 -40.14 77.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.312 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 139' ' ' LEU . 80.5 mt -62.28 -44.13 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.875 0.369 . . . . 0.0 110.449 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.29 -31.91 73.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.007 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 84.3 mt-30 -79.47 6.2 10.91 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.179 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 65.14 25.31 12.44 Favored 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 123.113 0.565 . . . . 0.0 112.239 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -84.17 -17.8 38.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.13 0.49 . . . . 0.0 109.963 173.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.417 ' CD1' ' HB3' ' A' ' 142' ' ' GLU . 89.5 m95 -135.52 137.5 42.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.22 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.757 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 87.2 mt -94.6 138.05 32.96 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 174.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.9 tp -111.51 136.72 50.29 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.418 -173.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 30.9 t -156.2 160.68 40.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.274 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -87.37 154.01 21.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.903 0.383 . . . . 0.0 110.439 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -118.07 -36.5 3.59 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.836 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 58.3 t30 49.67 -97.9 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.528 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -140.18 -17.52 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.725 0.298 . . . . 0.0 110.539 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.684 ' HA ' ' HB3' ' A' ' 160' ' ' GLU . 2.1 mt-30 -73.62 -72.67 0.25 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.199 -175.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.3 m -58.15 -29.26 65.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.027 0.441 . . . . 0.0 110.856 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.49 -58.18 7.85 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.106 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.799 ' HD2' HD12 ' A' ' 104' ' ' ILE . 14.3 m-85 -135.05 -39.3 0.77 Allowed 'General case' 0 C--O 1.232 0.161 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.684 ' HB3' ' HA ' ' A' ' 156' ' ' GLN . 21.4 tt0 -62.7 -25.69 68.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.853 -170.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.5 t -59.04 -33.81 71.19 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.648 0.261 . . . . 0.0 110.394 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.9 m 55.87 91.32 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 174.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 70.2 105.55 0.06 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.87 176.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.901 HD22 ' H ' ' A' ' 164' ' ' LEU . 0.1 OUTLIER -71.31 -71.85 0.24 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 36.4 t70 69.16 -6.89 0.86 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.8 174.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 169' ' ' GLU . 25.8 ptt180 -101.2 -162.94 0.97 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.948 175.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.439 ' HA ' ' CE1' ' A' ' 21' ' ' PHE . 8.7 m-90 -62.14 -92.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.96 0.41 . . . . 0.0 110.686 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.41 ' H ' ' HB2' ' A' ' 167' ' ' TRP . 1.3 m -151.59 104.61 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.658 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 166' ' ' ARG . 8.5 pt-20 -73.05 -11.64 60.63 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.101 0.477 . . . . 0.0 110.104 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.567 ' HB1' ' HE2' ' A' ' 9' ' ' PHE . . . -56.91 -45.94 82.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.554 175.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -81.34 -27.11 35.09 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.033 0.444 . . . . 0.0 110.175 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.38 -30.88 71.91 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.445 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 88.1 mmm -62.37 -28.65 69.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.934 177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.9 tp -95.61 -49.34 5.43 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.261 0.553 . . . . 0.0 110.369 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 151.28 118.65 0.83 Allowed Glycine 0 N--CA 1.441 -1.026 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -176.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 64.1 mt -56.57 94.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.411 0.625 . . . . 0.0 111.212 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 24.7 t -177.53 -171.96 0.34 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.314 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -147.3 -109.01 0.55 Allowed Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.992 HG22 HD12 ' A' ' 180' ' ' LEU . 42.0 mm 73.0 146.62 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.114 0.566 . . . . 0.0 111.555 175.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.992 HD12 HG22 ' A' ' 179' ' ' ILE . 5.5 mp 63.13 63.29 0.93 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.132 -171.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -148.96 106.53 3.41 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.893 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.86 108.3 1.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.51 2.14 . . . . 0.0 112.258 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.6 105.67 1.01 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.193 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 141.57 67.84 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.553 ' NH2' ' HA ' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -77.34 85.95 3.75 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.075 0.464 . . . . 0.0 110.441 -176.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -94.35 -51.04 4.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.998 -178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.857 ' HG ' ' H ' ' A' ' 188' ' ' GLU . 0.6 OUTLIER -107.75 -80.92 0.57 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.33 -174.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.857 ' H ' ' HG ' ' A' ' 187' ' ' LEU . 5.2 tp10 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.267 -0.873 . . . . 0.0 109.206 -177.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -105.92 -60.82 1.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.052 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 61.31 56.41 23.71 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.072 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 94.0 m-20 74.7 -33.36 0.24 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.49 0.716 . . . . 0.0 112.402 177.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.422 HD21 HD11 ' A' ' 150' ' ' LEU . 81.8 mt 73.58 13.73 4.39 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 175.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -69.33 134.81 49.55 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 172.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.31 32.21 65.43 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.313 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -126.21 -177.89 4.12 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 174.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.66 ' HB3' ' HA ' ' A' ' 27' ' ' TYR . 4.3 p90 -149.55 148.92 29.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.023 0.44 . . . . 0.0 111.082 170.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.504 HG12 HD11 ' A' ' 28' ' ' ILE . 10.2 pt -118.96 128.86 75.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.344 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.678 HD13 HD22 ' A' ' 149' ' ' LEU . 4.3 mp -98.35 136.84 27.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.537 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -143.5 -174.5 4.25 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.484 HG21 ' HB2' ' A' ' 17' ' ' ASP . 41.0 m 64.45 82.38 0.21 Allowed Pre-proline 0 CA--C 1.536 0.423 0 CA-C-O 121.497 0.665 . . . . 0.0 111.685 177.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -97.25 9.11 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.846 2.364 . . . . 0.0 114.054 -177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HG3' ' HG3' ' A' ' 16' ' ' MET . 9.1 pt-20 -173.27 -41.27 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.414 ' O ' HG23 ' A' ' 13' ' ' THR . 88.0 mtp -112.59 100.62 8.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.039 -175.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.484 ' HB2' HG21 ' A' ' 13' ' ' THR . 34.0 t70 -111.95 158.79 19.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 175.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -80.25 -30.51 38.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.887 0.375 . . . . 0.0 110.38 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 20' ' ' TYR . 1.5 tm-20 -103.28 -91.14 0.36 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 19' ' ' GLU . 49.0 t80 166.21 -55.32 0.0 OUTLIER 'General case' 0 N--CA 1.461 0.098 0 O-C-N 123.982 0.801 . . . . 0.0 110.384 176.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.556 ' HE1' ' HB3' ' A' ' 167' ' ' TRP . 88.0 t80 -143.78 -12.6 0.66 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -172.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.429 ' HB3' ' HG3' ' A' ' 19' ' ' GLU . 36.9 t70 -84.25 79.66 9.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.379 0.609 . . . . 0.0 110.905 -170.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.44 ' CZ ' HD11 ' A' ' 73' ' ' LEU . 49.2 mtm180 74.48 45.85 0.17 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.605 -1.18 . . . . 0.0 112.675 172.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.8 m -82.1 108.5 15.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.017 175.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 98.0 t 74.3 133.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.22 0.608 . . . . 0.0 111.886 177.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.54 HG23 ' H ' ' A' ' 27' ' ' TYR . 6.3 tp -135.0 -65.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.66 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -177.61 177.43 1.14 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 118.606 0.639 . . . . 0.0 111.781 -177.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.504 HD11 HG12 ' A' ' 10' ' ' ILE . 34.0 mm -103.22 133.64 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.288 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.9 m -81.23 -59.54 2.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.371 -174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -165.09 157.52 15.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.185 0.517 . . . . 0.0 111.26 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 4' ' ' ASN . 11.8 t-80 -103.3 132.01 49.9 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.245 174.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -129.12 172.0 11.85 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -60.6 -36.5 78.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.931 0.396 . . . . 0.0 111.035 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -72.42 -22.83 61.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.135 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.554 ' HA2' ' HD3' ' A' ' 136' ' ' PRO . . . 156.01 -177.77 32.9 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.131 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 m -97.76 121.6 39.86 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.078 -0.342 . . . . 0.0 110.078 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.698 HG13 HG22 ' A' ' 133' ' ' THR . 4.3 mp -88.54 117.45 32.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.253 -175.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -155.07 151.02 22.68 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.195 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.5 m -116.67 93.43 2.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.512 0.672 . . . . 0.0 110.764 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.434 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -132.95 13.3 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.294 -176.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.3 pt -79.71 -26.91 12.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.569 -177.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.4 t30 59.07 91.93 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 123.76 0.663 . . . . 0.0 112.13 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 43' ' ' THR . 9.2 t -156.72 93.63 2.36 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 122.06 0.933 . . . . 0.0 110.941 175.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 93.9 Cg_endo -81.96 157.49 18.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.665 2.243 . . . . 0.0 111.697 175.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.8 p -121.6 156.72 32.35 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.91 -12.26 60.61 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.934 0.397 . . . . 0.0 110.692 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 53.7 tp -71.36 144.51 49.84 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.602 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.821 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 59.5 m -105.65 157.6 17.3 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.458 -174.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 9.1 p -65.89 -34.15 68.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.925 176.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.8 mt -64.82 -36.78 85.43 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.936 176.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.821 ' HG2' ' HB2' ' A' ' 48' ' ' SER . 26.9 mm-40 -58.68 -45.87 88.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.775 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.1 mt -60.76 -42.34 97.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.854 176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 97.8 mt -65.77 -41.66 91.78 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.323 -178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.856 HG22 ' HG2' ' A' ' 59' ' ' GLN . 21.4 p -71.9 -31.17 66.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.437 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -63.32 -36.5 83.9 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-O 120.813 0.34 . . . . 0.0 110.254 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.518 ' O ' ' HB2' ' A' ' 57' ' ' ASP . 65.6 mtt -71.66 -85.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 56' ' ' MET . 3.3 t70 171.36 33.21 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 O-C-N 123.922 0.764 . . . . 0.0 109.666 171.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 53' ' ' LEU . 96.9 m-85 -116.24 87.66 2.73 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.332 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.856 ' HG2' HG22 ' A' ' 54' ' ' THR . 78.3 mt-30 -96.98 82.2 3.19 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.006 0.431 . . . . 0.0 110.093 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 71.0 mtm -136.6 -170.74 2.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.523 -178.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.25 -76.57 0.05 Allowed 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.849 0.718 . . . . 0.0 111.172 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 5.2 mptp? -116.26 115.79 40.06 Favored Pre-proline 0 C--N 1.325 -0.488 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 176.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 23.2 Cg_exo -63.82 92.44 0.17 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.068 2.512 . . . . 0.0 112.754 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 59.0 mtp180 51.88 72.07 0.41 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.411 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 60.9 mt 72.98 -68.35 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.958 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.0 t80 59.79 36.91 22.17 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.04 0.448 . . . . 0.0 110.45 178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.9 m 70.04 3.86 4.55 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.234 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -119.93 67.58 0.82 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.869 -177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -77.85 131.91 37.76 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -126.86 113.24 16.3 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.937 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.624 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 61.8 mtt -82.0 148.64 28.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.235 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.431 HG21 HD23 ' A' ' 129' ' ' LEU . 13.7 p -96.7 147.76 5.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.134 -178.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 6.6 mp -108.46 155.09 20.98 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.987 0.422 . . . . 0.0 110.554 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -94.32 121.13 35.52 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 174.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.72 -23.14 43.57 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.742 -173.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.528 ' O ' ' HG2' ' A' ' 80' ' ' GLN . . . 153.87 174.56 24.18 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.033 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.61 -21.56 14.63 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.767 2.312 . . . . 0.0 113.085 -177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.408 HG21 ' OG1' ' A' ' 133' ' ' THR . 51.9 t -81.4 131.19 34.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 60.31 30.89 20.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.127 0.489 . . . . 0.0 110.155 -177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.528 ' HG2' ' O ' ' A' ' 76' ' ' GLY . 0.0 OUTLIER -59.15 -27.75 65.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.208 -173.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -77.67 -7.61 56.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.909 0.385 . . . . 0.0 111.224 -175.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.6 mtm-85 -118.14 131.69 56.39 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.126 0.489 . . . . 0.0 111.142 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.56 118.3 5.08 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.358 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.505 ' HB3' HD11 ' A' ' 106' ' ' LEU . 85.9 m-85 -91.99 125.88 36.85 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.506 0.194 . . . . 0.0 110.494 -178.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.673 ' HB ' HG11 ' A' ' 112' ' ' VAL . 4.3 mp -112.94 110.62 32.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.182 0.515 . . . . 0.0 109.646 174.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 40.6 t -91.86 119.15 38.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.399 177.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.5 p80 -129.51 152.38 49.1 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.427 -178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.6 m -62.88 156.36 24.45 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.516 177.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -74.58 117.94 16.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.532 0.682 . . . . 0.0 110.218 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.6 m -140.41 157.64 45.22 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -64.85 124.71 22.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.688 0.756 . . . . 0.0 110.934 -175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.0 t-80 -173.36 138.61 0.72 Allowed 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.646 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -63.35 160.99 14.85 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -106.06 113.16 26.53 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.603 0.716 . . . . 0.0 111.67 -173.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.3 m -83.13 -45.09 14.35 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.477 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -173.98 37.43 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -178.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -77.66 125.02 28.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.249 -1.341 . . . . 0.0 110.926 -172.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -105.46 136.08 45.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.446 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -86.59 128.85 35.02 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.347 -0.541 . . . . 0.0 110.781 178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.443 ' HB ' ' HB ' ' A' ' 104' ' ' ILE . 72.0 t -70.39 -54.86 16.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 172.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 t -134.79 -48.53 0.75 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.083 -0.962 . . . . 0.0 108.96 172.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -176.38 -63.11 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.951 169.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.42 -13.03 60.37 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.101 0.477 . . . . 0.0 111.245 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.443 ' HB ' ' HB ' ' A' ' 100' ' ' VAL . 24.8 mm -105.06 124.24 59.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 12.0 m -117.36 130.41 56.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.1 0.476 . . . . 0.0 111.538 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 84' ' ' PHE . 67.1 tp -107.79 128.15 54.33 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.23 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 1.024 HG21 ' HB3' ' A' ' 111' ' ' ASP . 12.1 m -142.58 137.32 30.01 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.129 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.8 p -120.47 3.21 10.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.391 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.591 ' O ' HG22 ' A' ' 112' ' ' VAL . 15.2 m -109.61 -173.55 2.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.403 -176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -56.69 -15.61 13.21 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.907 -0.588 . . . . 0.0 114.541 -175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 1.024 ' HB3' HG21 ' A' ' 107' ' ' THR . 11.6 t70 -49.43 -46.66 47.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 117.247 0.523 . . . . 0.0 110.961 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.673 HG11 ' HB ' ' A' ' 85' ' ' ILE . 31.9 m -60.54 -39.61 81.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.634 -178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.526 HD13 ' CZ ' ' A' ' 116' ' ' PHE . 4.3 mm? -70.84 -42.73 69.78 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.356 0.598 . . . . 0.0 110.059 177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -69.44 -28.47 66.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.019 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 65.5 m -54.34 -57.0 12.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.561 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.526 ' CZ ' HD13 ' A' ' 113' ' ' LEU . 37.8 p90 -84.24 13.38 5.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.274 0.559 . . . . 0.0 110.914 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -106.1 9.17 42.7 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.521 175.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.4 t -137.44 176.32 8.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -79.68 -9.72 59.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.864 0.364 . . . . 0.0 111.085 -173.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.6 p -104.03 25.96 9.32 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.332 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 116' ' ' PHE . . . -54.34 121.59 32.53 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.199 174.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 121' ' ' ALA . 17.2 Cg_exo -67.06 145.58 73.93 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.977 2.451 . . . . 0.0 112.464 -179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.47 -42.97 82.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.489 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -107.89 125.06 51.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.155 -170.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 42.0 p90 -158.44 133.68 8.62 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.224 176.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 30.7 pt -124.83 147.95 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.245 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.7 p -122.64 129.16 75.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.138 0.494 . . . . 0.0 111.193 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.6 p -138.99 132.23 29.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.296 177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 72' ' ' VAL . 3.5 mm? -80.82 114.09 19.47 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.391 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.59 178.26 39.84 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.402 -176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 75.4 m -147.71 172.08 14.65 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 49.7 m -111.78 132.37 54.71 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.698 HG22 HG13 ' A' ' 37' ' ' ILE . 34.9 p -112.4 117.02 31.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.003 0.43 . . . . 0.0 111.028 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -94.67 116.91 29.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.127 0.489 . . . . 0.0 110.15 177.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 4.4 mptp? -60.22 136.44 91.33 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.546 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.554 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 10.2 Cg_exo -72.14 54.92 2.31 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.706 2.937 . . . . 0.0 113.367 -175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 64.3 t-80 -154.91 -55.21 0.1 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.562 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.0 tp60 -63.34 -35.93 82.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.287 178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 43.5 tp -59.34 -35.78 74.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.931 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.15 -41.54 94.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.038 0.447 . . . . 0.0 109.831 177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.523 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 32.8 mm-40 -64.87 -47.56 77.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.703 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 16.2 mm-40 -54.61 -50.95 66.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.131 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.794 HG12 ' HB2' ' A' ' 148' ' ' TRP . 67.0 mt -68.57 -36.32 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.205 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.35 75.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 111.024 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 21.6 mt-30 -81.95 12.93 3.64 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.502 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 68.02 24.28 7.9 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.379 0.672 . . . . 0.0 112.318 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -92.59 -5.67 51.13 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.943 -178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.794 ' HB2' HG12 ' A' ' 143' ' ' ILE . 95.4 m95 -140.48 130.79 25.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.819 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.678 HD22 HD13 ' A' ' 11' ' ' ILE . 6.5 tt -92.96 117.26 29.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.422 HD11 HD21 ' A' ' 5' ' ' LEU . 9.3 tt -95.39 133.85 38.86 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.974 0.416 . . . . 0.0 110.889 -175.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.472 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 35.5 t -151.52 154.74 37.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.246 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -79.52 156.4 27.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.478 ' HB2' ' CD2' ' A' ' 9' ' ' PHE . . . -126.59 -139.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.1 176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.4 t30 61.69 53.63 3.19 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.913 0.863 . . . . 0.0 109.483 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -151.48 169.08 22.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.778 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -54.37 -25.74 26.14 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 122.951 0.501 . . . . 0.0 112.165 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -53.51 -28.19 29.68 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 122.581 0.352 . . . . 0.0 111.721 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.5 -57.12 7.98 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -127.66 0.06 6.13 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -175.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.06 12.33 17.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.329 0.585 . . . . 0.0 110.911 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.41 156.4 1.24 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.774 -1.103 . . . . 0.0 112.042 174.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 17.6 t -74.19 147.74 42.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.371 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -108.29 2.5 22.68 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.823 0.344 . . . . 0.0 110.823 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.7 pp -118.05 -12.48 10.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.837 -176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 166' ' ' ARG . 19.5 t70 -157.2 158.37 36.1 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.464 ' HD3' ' HA ' ' A' ' 166' ' ' ARG . 66.4 mmt-85 73.5 101.66 0.07 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.966 0.791 . . . . 0.0 112.597 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.556 ' HB3' ' HE1' ' A' ' 21' ' ' PHE . 10.5 p90 -84.81 89.38 7.52 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.685 174.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.3 t 65.79 95.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.603 -177.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -67.22 -7.8 26.7 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.263 -175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.406 ' HB1' HD11 ' A' ' 11' ' ' ILE . . . -57.66 -34.09 69.0 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -174.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -74.22 -43.17 58.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.732 0.301 . . . . 0.0 111.046 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -79.71 -20.85 45.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.872 0.368 . . . . 0.0 110.402 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 14.9 tpt -64.39 -33.64 76.32 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.23 0.538 . . . . 0.0 110.069 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.644 HD22 HD21 ' A' ' 149' ' ' LEU . 11.2 tp -83.06 -39.0 21.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.454 0.645 . . . . 0.0 109.336 176.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 120.65 -6.2 11.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.115 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 67.0 mt 67.74 -78.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 123.277 0.631 . . . . 0.0 111.161 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 17.1 m 69.48 -58.73 0.51 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.608 0.763 . . . . 0.0 111.821 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 161.15 121.13 0.57 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 9.6 tp -62.67 134.28 28.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.238 0.542 . . . . 0.0 111.117 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 88.1 mt -88.51 99.95 12.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.969 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -125.19 122.56 25.26 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.459 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 23.2 Cg_exo -64.84 138.81 59.59 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.795 2.33 . . . . 0.0 111.728 177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -87.62 84.83 7.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.104 0.478 . . . . 0.0 110.535 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.482 ' HA3' ' CD2' ' A' ' 187' ' ' LEU . . . -160.16 144.62 10.23 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -118.72 119.95 35.95 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 121.062 -0.255 . . . . 0.0 111.385 -174.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 67.87 22.57 8.66 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.195 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.482 ' CD2' ' HA3' ' A' ' 184' ' ' GLY . 2.0 pp -86.23 154.18 21.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.044 0.449 . . . . 0.0 111.652 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 C--O 1.247 0.972 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.682 175.817 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.88 0.371 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -103.67 -36.65 7.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.483 -171.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 79.58 -71.34 2.71 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.602 -175.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -129.22 111.33 12.79 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.855 0.36 . . . . 0.0 110.034 176.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.44 -8.77 37.62 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.918 -173.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 30' ' ' GLU . 11.1 pt20 -82.61 149.52 27.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.69 4.19 79.8 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.344 -173.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HG3' ' HA ' ' A' ' 152' ' ' GLU . 11.3 mptt -121.87 179.0 4.64 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 176.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.648 ' HZ ' ' HG2' ' A' ' 173' ' ' MET . 2.2 p90 -149.31 139.36 22.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.239 0.542 . . . . 0.0 110.485 176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.4 pt -108.85 127.72 65.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.294 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.79 HD13 HD22 ' A' ' 149' ' ' LEU . 4.5 mp -100.08 129.48 50.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.813 -175.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.04 93.12 2.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.469 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.4 t -73.49 124.24 90.21 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 175.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -52.09 -70.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.033 2.489 . . . . 0.0 112.847 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -132.15 -75.55 0.51 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.869 0.366 . . . . 0.0 111.272 178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 53.6 ttp -148.19 164.11 34.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.444 -171.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 29.7 t70 72.34 117.82 0.05 OUTLIER 'General case' 0 C--O 1.237 0.406 0 O-C-N 124.056 0.847 . . . . 0.0 110.299 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 19' ' ' GLU . 33.3 m-20 -97.93 -146.59 0.31 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.121 -170.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 22' ' ' ASP . 25.6 mt-10 -56.38 -81.64 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.49 -171.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 166' ' ' ARG . 32.0 t80 70.85 -64.48 0.37 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.625 0.77 . . . . 0.0 110.214 -178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -153.01 11.9 0.48 Allowed 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.051 175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.54 ' OD2' ' HG3' ' A' ' 44' ' ' PRO . 12.4 t0 -133.68 94.34 3.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.411 -177.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.454 ' HG2' ' HB3' ' A' ' 19' ' ' GLU . 32.3 mtp180 -101.26 105.74 16.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.12 0.486 . . . . 0.0 110.636 -172.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.611 ' HB ' ' HA ' ' A' ' 42' ' ' ASN . 44.5 p -94.76 137.09 34.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.21 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.648 HG13 HG22 ' A' ' 40' ' ' ILE . 78.7 t 78.02 119.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 123.838 0.711 . . . . 0.0 111.656 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.5 tp -121.88 -55.64 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.366 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.606 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 2.8 p90 -178.69 172.63 1.37 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.027 0.442 . . . . 0.0 111.395 177.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.7 mp -99.49 130.93 47.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.76 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 56.7 m -89.32 -42.65 11.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -170.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.524 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 42.0 tt0 -142.02 146.12 35.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.988 0.423 . . . . 0.0 111.105 -175.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -124.8 109.45 13.09 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.332 0.587 . . . . 0.0 110.529 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -95.06 176.6 6.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 170.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -62.67 -42.14 99.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 118.016 0.371 . . . . 0.0 111.325 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -119.87 4.82 10.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.29 0.567 . . . . 0.0 111.0 -177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -134.11 108.44 0.73 Allowed Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.181 -1.009 . . . . 0.0 112.943 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.9 m -100.34 105.98 17.56 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.676 HG13 HG22 ' A' ' 133' ' ' THR . 4.3 mp -88.75 114.27 26.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.722 -175.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.95 173.9 32.53 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.866 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -121.01 83.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.608 0.718 . . . . 0.0 110.389 177.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.648 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -134.92 28.68 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.791 -176.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.459 HG23 HG22 ' A' ' 43' ' ' THR . 11.0 tp -71.71 -16.71 19.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.383 -176.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.611 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 53.4 m-80 67.01 72.6 0.36 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.161 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 13.3 t 170.36 143.87 0.1 OUTLIER Pre-proline 0 C--N 1.332 -0.183 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.556 ' HB3' HD23 ' A' ' 73' ' ' LEU . 49.5 Cg_endo -90.81 -170.59 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.957 2.438 . . . . 0.0 110.874 170.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.3 p -111.78 170.73 7.94 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 169.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -88.66 0.99 55.87 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.351 0.596 . . . . 0.0 110.021 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.17 162.28 13.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.253 -174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 2.0 m -105.13 158.19 16.75 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.1 p -62.35 -38.36 80.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.803 0.335 . . . . 0.0 110.757 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 74.1 mt -65.31 -28.51 69.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.044 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 48' ' ' SER . 0.3 OUTLIER -59.87 -44.31 94.24 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.47 -177.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.435 ' H ' HD12 ' A' ' 52' ' ' LEU . 4.9 mp -73.07 -43.81 61.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 110.176 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.73 ' HB3' ' HB3' ' A' ' 58' ' ' PHE . 97.5 mt -58.13 -45.84 86.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.552 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 29.9 p -73.34 -33.84 65.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.351 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -65.23 -41.95 93.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.796 0.331 . . . . 0.0 110.396 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 83.9 mtp -79.18 -87.88 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.233 178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -175.31 98.76 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.208 175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.73 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 29.9 t80 -155.75 81.51 1.02 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.377 0.608 . . . . 0.0 109.558 175.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -110.34 -7.32 14.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.623 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.4 ttm -105.02 92.53 4.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.69 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -161.14 -106.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.152 176.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -141.05 99.46 6.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -73.94 104.73 1.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.781 2.321 . . . . 0.0 111.722 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.573 ' HG3' ' HD2' ' A' ' 66' ' ' TYR . 0.9 OUTLIER -101.2 -28.47 12.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.578 -179.238 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.0 mp 53.53 96.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.506 0.722 . . . . 0.0 112.511 176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.573 ' HD2' ' HG3' ' A' ' 64' ' ' ARG . 63.8 m-85 -135.72 154.31 51.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.257 175.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.8 t -67.86 -36.96 81.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.197 0.522 . . . . 0.0 110.312 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -125.22 94.7 4.24 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 174.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -85.32 -102.68 0.06 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.026 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -128.0 119.81 26.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.741 0.305 . . . . 0.0 110.29 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.515 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 89.9 mtp -84.44 131.67 34.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 5.8 p -81.7 127.77 39.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.139 0.495 . . . . 0.0 110.701 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 44' ' ' PRO . 87.9 mt -70.33 160.13 32.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.64 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.451 ' H ' ' HA ' ' A' ' 44' ' ' PRO . 7.1 t-20 -98.49 117.81 33.75 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.543 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -79.76 -33.06 35.0 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.968 -175.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 150.51 -176.29 29.17 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.073 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -87.4 5.6 5.54 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.157 2.571 . . . . 0.0 113.278 -177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.47 132.6 57.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 59.1 37.56 24.13 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 110.494 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -70.01 -10.86 60.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.67 -173.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -85.29 5.78 29.01 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.927 0.394 . . . . 0.0 110.819 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -130.95 132.28 44.97 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 121.289 0.566 . . . . 0.0 111.66 -176.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -86.96 118.8 5.03 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.531 ' HB3' HD11 ' A' ' 106' ' ' LEU . 66.0 m-85 -97.79 125.4 42.61 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.669 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.8 mp -112.9 107.85 24.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.277 0.561 . . . . 0.0 109.949 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 106' ' ' LEU . 33.6 t -86.71 115.73 28.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -131.85 159.49 38.43 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.522 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 22.2 m -70.19 160.8 31.46 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.585 172.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.453 ' HE3' ' O ' ' A' ' 102' ' ' ASP . 13.9 ptpt -70.16 172.49 7.97 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.4 t -171.31 -43.8 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.839 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -154.91 -154.31 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -91.83 176.49 6.5 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.415 ' OE2' ' HA ' ' A' ' 96' ' ' HIS . 5.6 pt-20 -93.7 168.59 10.91 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.507 0.67 . . . . 0.0 111.512 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -122.87 -36.62 2.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.706 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.42 ' HB ' ' OD1' ' A' ' 111' ' ' ASP . 10.0 m -112.94 -63.67 1.41 Allowed 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.04 174.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.415 ' HA ' ' OE2' ' A' ' 93' ' ' GLU . 6.7 t60 179.45 126.82 0.07 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.095 0.474 . . . . 0.0 111.25 174.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 71.2 m -119.31 143.95 47.09 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.115 174.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -102.6 110.36 22.28 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.233 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.648 ' HD2' ' HA ' ' A' ' 102' ' ' ASP . 29.2 ttpt -84.42 102.64 12.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.398 -178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.8 t -69.34 -54.41 19.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 104' ' ' ILE . 11.3 t -134.58 167.46 20.76 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 170.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.648 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 33.6 m-20 -58.91 -44.54 91.27 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -172.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 88' ' ' SER . 25.6 m-20 -76.99 -28.5 55.11 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -175.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.427 ' H ' HG23 ' A' ' 101' ' ' THR . 43.7 mm -118.29 123.07 71.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.08 0.467 . . . . 0.0 111.183 -175.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.6 m -130.77 136.7 48.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.045 -174.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.639 HD13 HG22 ' A' ' 86' ' ' VAL . 45.5 tp -99.07 125.68 44.63 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.488 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.956 HG21 ' HB2' ' A' ' 111' ' ' ASP . 17.8 m -135.9 128.96 31.54 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.884 0.373 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -136.36 1.48 2.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.216 0.531 . . . . 0.0 110.164 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.419 ' HB2' ' OD1' ' A' ' 111' ' ' ASP . 4.7 m -72.8 -7.67 51.84 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.782 -176.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 117.31 -20.7 11.16 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.055 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.956 ' HB2' HG21 ' A' ' 107' ' ' THR . 2.2 m-20 -48.82 -42.97 37.86 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.12 0.568 . . . . 0.0 111.327 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.695 HG13 ' HB ' ' A' ' 107' ' ' THR . 5.1 m -53.01 -46.58 54.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.52 -177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.33 -36.04 74.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.114 0.483 . . . . 0.0 110.499 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -70.66 -24.61 62.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.153 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 43.2 m -77.75 -14.64 59.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.942 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -85.25 132.09 34.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.965 0.412 . . . . 0.0 111.054 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 112.92 -4.21 25.74 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.765 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.8 t -123.26 157.5 33.0 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -66.85 -10.48 48.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 43.2 p -92.1 19.3 6.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.002 176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.39 144.84 97.51 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.183 172.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -60.49 140.66 92.57 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.764 2.309 . . . . 0.0 112.729 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.524 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 48.5 mt-10 -57.99 -52.81 63.99 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.219 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HE2' ' HB2' ' A' ' 123' ' ' GLU . 5.4 mtmt -129.33 146.03 51.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.355 -0.838 . . . . 0.0 109.656 -178.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 44.5 p90 -159.62 141.19 12.97 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.823 0.344 . . . . 0.0 110.692 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 37.6 pt -123.02 144.41 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.827 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.24 129.22 68.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.037 0.446 . . . . 0.0 110.844 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 62.9 m -129.6 129.39 44.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.261 178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -83.07 108.73 16.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.637 178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.543 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 77.74 -176.44 53.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.189 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 83.4 m -147.85 173.48 12.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.902 0.382 . . . . 0.0 110.191 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 51.3 m -120.02 116.76 26.39 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.157 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.676 HG22 HG13 ' A' ' 37' ' ' ILE . 38.3 p -96.32 113.95 25.58 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.085 0.469 . . . . 0.0 109.923 175.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.582 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.2 OUTLIER -99.64 141.56 32.28 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.917 -178.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.414 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 0.8 OUTLIER -90.28 117.51 68.09 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.396 -179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.26 55.77 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.523 2.815 . . . . 0.0 112.286 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -146.01 -37.36 0.25 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -87.56 -44.35 11.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.005 171.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.582 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 59.2 tp -56.92 -40.19 75.87 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.315 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -61.09 -33.44 73.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.828 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.562 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 71.1 mm-40 -67.25 -52.16 44.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.88 0.371 . . . . 0.0 110.234 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.428 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 0.4 OUTLIER -60.72 -41.57 95.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.717 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.593 HG12 ' HB2' ' A' ' 148' ' ' TRP . 60.3 mt -64.2 -40.71 90.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.721 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.74 -30.72 71.01 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.902 0.382 . . . . 0.0 111.027 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 37.0 mt-30 -87.26 9.09 21.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.942 177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.412 HD22 ' HA ' ' A' ' 146' ' ' ASN . 10.4 m120 64.61 33.54 10.61 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.582 174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -94.45 5.12 52.76 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.211 0.529 . . . . 0.0 110.085 173.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.593 ' HB2' HG12 ' A' ' 143' ' ' ILE . 92.1 m95 -142.49 123.69 14.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.725 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.79 HD22 HD13 ' A' ' 11' ' ' ILE . 6.0 tt -78.86 110.6 14.19 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 57.2 tp -90.23 133.37 34.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.055 0.455 . . . . 0.0 111.501 -176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.8 t -162.25 157.06 22.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.083 176.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.526 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 8.6 pt-20 -85.12 154.1 22.25 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -100.76 119.78 39.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.747 -176.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -168.58 -175.87 2.61 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 67.2 t30 75.29 163.67 0.26 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.398 0.679 . . . . 0.0 111.327 177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 69.3 mt-30 -62.06 -25.43 67.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.036 -175.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 24.7 m -51.82 -29.86 20.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.441 -175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.96 -54.53 43.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -125.34 -17.46 5.62 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -171.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 45.9 mt-10 -96.2 1.79 52.5 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.289 0.566 . . . . 0.0 110.914 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 4.6 t -59.4 136.75 58.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.857 176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 42.0 m -97.8 150.06 21.67 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.638 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -109.1 107.68 18.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.848 0.356 . . . . 0.0 110.953 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 165' ' ' ASP . 3.3 pp -128.51 -36.52 1.87 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.285 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.469 ' OD2' ' HD3' ' A' ' 166' ' ' ARG . 33.9 t70 -167.79 -105.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.554 ' HB3' ' HA ' ' A' ' 20' ' ' TYR . 0.2 OUTLIER -164.88 137.82 4.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.783 0.802 . . . . 0.0 112.558 173.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -152.35 83.52 1.25 Allowed 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 166.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.628 HG22 ' H ' ' A' ' 171' ' ' ASN . 6.6 p -37.7 95.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 124.625 1.203 . . . . 0.0 113.512 -163.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -71.21 -28.05 63.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.883 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -64.56 -32.95 74.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.162 0.506 . . . . 0.0 110.597 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.628 ' H ' HG22 ' A' ' 168' ' ' VAL . 62.5 t30 -81.37 -32.72 32.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.105 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.78 -24.41 61.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.735 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.648 ' HG2' ' HZ ' ' A' ' 9' ' ' PHE . 13.3 tpt -55.64 -30.34 60.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.498 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.2 tp -97.68 -50.17 4.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.957 0.408 . . . . 0.0 109.915 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 147.39 38.06 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.979 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 3.9 mp 62.29 94.47 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.086 0.469 . . . . 0.0 110.119 -176.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.8 t 66.31 -176.83 0.19 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.889 -174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.61 -92.04 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.904 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.621 HG12 ' HG ' ' A' ' 180' ' ' LEU . 10.8 tt -141.78 130.86 23.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.621 ' HG ' HG12 ' A' ' 179' ' ' ILE . 52.6 mt 52.1 62.45 2.69 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.79 0.681 . . . . 0.0 111.553 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -165.6 88.06 0.95 Allowed Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -93.34 -3.71 3.15 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.003 2.469 . . . . 0.0 112.072 172.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 61.6 -86.66 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.5 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -171.61 32.86 0.14 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -120.84 120.98 37.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.723 0.297 . . . . 0.0 110.399 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -131.43 88.39 2.58 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 80.6 mt -106.83 -3.25 20.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.89 -175.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.664 -0.684 . . . . 0.0 110.307 178.773 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtm . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 61.15 95.33 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 O-C-N 123.881 0.738 . . . . 0.0 111.042 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.78 -68.91 1.5 Allowed Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.813 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -94.56 99.11 11.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.941 0.401 . . . . 0.0 109.957 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 5' ' ' LEU . 1.2 tt -90.77 -0.97 57.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.718 0.771 . . . . 0.0 109.066 178.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -78.82 136.81 37.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.768 176.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.07 2.46 80.68 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 111.753 -178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -101.91 159.53 15.27 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 151' ' ' SER . 37.6 p90 -125.41 154.0 42.59 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 174.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.549 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.9 pt -124.64 128.77 73.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.686 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.8 mp -75.46 119.63 23.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.501 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.638 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -102.12 155.37 18.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.975 176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.429 ' N ' ' HD3' ' A' ' 14' ' ' PRO . 7.1 t -147.08 69.22 11.74 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-O 121.682 0.753 . . . . 0.0 111.851 178.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 13' ' ' THR . 13.5 Cg_endo -96.09 129.25 0.38 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.31 2.673 . . . . 0.0 111.169 170.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.21 101.62 1.92 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.093 0.473 . . . . 0.0 111.673 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.523 ' HG2' ' H ' ' A' ' 18' ' ' ASP . 46.9 ttp -131.33 140.99 49.84 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 174.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -90.88 0.39 57.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.316 0.579 . . . . 0.0 111.182 -174.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.523 ' H ' ' HG2' ' A' ' 16' ' ' MET . 36.1 t70 -123.61 151.92 42.46 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 70.26 106.21 0.06 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.947 0.779 . . . . 0.0 110.088 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -154.62 -57.34 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.586 -174.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -82.4 -5.99 59.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -171.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -99.98 172.7 7.06 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -93.94 85.41 4.75 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.249 0.547 . . . . 0.0 111.351 -174.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.6 t -104.32 167.43 9.76 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.484 176.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.1 t 50.02 79.58 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.422 0.629 . . . . 0.0 110.472 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.499 HD11 HD23 ' A' ' 158' ' ' LEU . 4.0 tp -93.31 -61.16 2.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -170.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.42 ' HD1' HG23 ' A' ' 26' ' ' ILE . 2.1 p90 -167.94 174.55 7.35 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 118.323 0.511 . . . . 0.0 111.688 -175.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -92.09 123.5 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.611 175.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.2 m -78.45 -38.3 41.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.195 -173.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -158.98 150.25 20.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 0.0 110.306 176.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -131.49 104.83 7.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -119.53 167.36 12.05 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.804 -175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -73.22 -12.95 61.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.771 0.319 . . . . 0.0 110.651 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -83.03 -21.74 33.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.458 175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 156.77 176.31 28.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.102 -0.57 . . . . 0.0 111.835 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 133' ' ' THR . 30.0 m -112.66 127.07 56.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.798 0.299 . . . . 0.0 110.779 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.411 HD12 ' N ' ' A' ' 37' ' ' ILE . 4.5 mp -104.42 110.21 29.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.35 165.39 27.47 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.288 -0.958 . . . . 0.0 112.44 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -119.45 80.11 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.802 0.811 . . . . 0.0 110.213 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.439 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -131.68 28.95 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.884 -176.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.516 HG21 ' HB3' ' A' ' 74' ' ' ASN . 11.0 tp -62.01 -25.94 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.46 -175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.03 61.42 1.61 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.763 177.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.493 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 9.5 t 179.24 132.51 0.24 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.437 176.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 43' ' ' THR . 2.2 Cg_endo -82.44 178.64 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.65 2.233 . . . . 0.0 111.05 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.478 HG22 HD22 ' A' ' 74' ' ' ASN . 22.7 p -94.05 -169.22 2.03 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 174.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -117.86 20.03 13.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.812 0.815 . . . . 0.0 109.179 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 47' ' ' LEU . 14.1 tp -125.73 170.87 11.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.016 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.7 p -113.8 162.83 15.83 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.603 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.7 p -63.58 -33.6 62.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 62' ' ' LYS . 53.7 mt -67.55 -44.92 77.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.221 0.534 . . . . 0.0 109.994 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -54.88 -42.8 72.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.004 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.508 HD11 HG11 ' A' ' 72' ' ' VAL . 66.2 mt -56.74 -55.09 38.66 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.957 -178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.525 ' O ' ' HB3' ' A' ' 58' ' ' PHE . 67.6 mt -59.84 -43.13 94.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.089 -175.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.59 HG21 ' HB3' ' A' ' 64' ' ' ARG . 18.9 p -80.33 -29.35 38.06 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -176.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -61.19 -59.65 4.99 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -164.71 -23.92 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -92.19 27.05 2.3 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.596 0.712 . . . . 0.0 111.54 -171.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 42.7 t80 -162.93 -104.39 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.481 172.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.476 ' HG3' ' O ' ' A' ' 58' ' ' PHE . 74.2 mt-30 -162.87 -90.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.233 0.54 . . . . 0.0 109.777 -177.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 27.4 ttt -172.23 118.7 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.256 -0.883 . . . . 0.0 108.934 178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.27 -54.55 0.23 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.168 0.509 . . . . 0.0 109.974 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.601 ' HB3' HD22 ' A' ' 50' ' ' LEU . 4.0 mptp? -87.81 151.17 49.52 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.976 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.82 109.12 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.887 2.392 . . . . 0.0 113.134 -177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.59 ' HB3' HG21 ' A' ' 54' ' ' THR . 36.8 ptt180 -79.38 4.75 14.43 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.133 0.492 . . . . 0.0 110.933 177.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.1 tt -76.12 -23.35 15.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.822 174.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -98.69 97.54 8.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.363 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 25.3 p -77.71 -36.02 51.43 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 175.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -94.09 105.56 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.642 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.467 ' OD2' ' HG2' ' A' ' 70' ' ' GLN . 13.5 t70 -156.54 -105.19 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.467 ' HG2' ' OD2' ' A' ' 69' ' ' ASP . 27.1 mm-40 -99.65 125.15 45.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.985 0.421 . . . . 0.0 110.009 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 50.1 ttp -86.88 146.01 26.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.649 -176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.586 HG23 HG13 ' A' ' 127' ' ' VAL . 5.1 p -95.88 140.69 16.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.831 0.348 . . . . 0.0 110.608 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.5 mt -89.72 164.54 14.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.951 0.405 . . . . 0.0 110.875 -178.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.516 ' HB3' HG21 ' A' ' 41' ' ' ILE . 1.6 t-20 -95.0 145.57 24.85 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -99.99 -36.43 4.2 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.966 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.89 -171.88 35.58 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 111.772 -0.531 . . . . 0.0 111.772 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.16 -14.68 10.67 Favored 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.045 2.497 . . . . 0.0 112.936 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.4 t -103.87 139.08 25.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.75 -175.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 66.32 30.11 9.14 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 122.979 0.512 . . . . 0.0 111.639 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -65.83 -15.07 62.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.044 0.449 . . . . 0.0 111.548 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -82.06 -2.5 52.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.543 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -129.76 136.0 49.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.38 -175.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.44 126.36 8.66 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.07 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -107.08 125.68 51.36 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.541 HD13 HG21 ' A' ' 112' ' ' VAL . 3.4 mp -118.03 113.66 42.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.931 0.396 . . . . 0.0 110.5 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.519 HG22 HD13 ' A' ' 106' ' ' LEU . 25.2 t -93.1 120.61 42.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.494 ' CD2' ' HB3' ' A' ' 122' ' ' PRO . 29.5 p-80 -139.29 161.17 38.08 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.626 -0.43 . . . . 0.0 110.768 -175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.427 ' OG ' ' HE3' ' A' ' 124' ' ' LYS . 47.4 p -83.51 151.16 25.55 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.961 0.41 . . . . 0.0 111.315 -178.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 89' ' ' LYS . 13.6 ttpt -71.4 127.28 32.06 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.175 177.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.2 t -129.59 -43.41 1.26 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.649 175.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -124.83 -15.22 6.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.159 0.504 . . . . 0.0 110.741 179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 71.08 80.48 0.16 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.856 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 93' ' ' GLU . 1.3 pm0 -75.39 169.03 18.86 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.719 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -168.32 82.2 0.17 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 16.5 m -111.2 -37.74 5.23 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 161.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -171.12 77.51 0.07 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.903 165.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.7 p -97.71 134.62 40.65 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.958 -178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -103.06 121.2 42.1 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -87.59 115.8 25.27 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.046 0.451 . . . . 0.0 111.273 -174.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.69 -54.38 8.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.34 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.5 t -147.73 173.84 12.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.959 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -84.44 59.7 5.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.132 0.491 . . . . 0.0 110.624 -174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -175.9 -37.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.755 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.808 HG13 HD13 ' A' ' 158' ' ' LEU . 29.6 mm -117.95 129.7 73.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.687 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 20.3 m -127.88 139.37 52.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.052 0.453 . . . . 0.0 111.054 -174.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.519 HD13 HG22 ' A' ' 86' ' ' VAL . 57.3 tp -96.69 137.14 36.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.192 -179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.416 ' HB ' ' CG2' ' A' ' 112' ' ' VAL . 0.0 OUTLIER -116.95 124.07 48.5 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 176.376 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 41.6 p -111.63 18.92 18.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.62 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.4 t -147.18 -178.41 6.2 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -175.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.1 4.11 8.95 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -49.75 -36.96 27.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.637 0.775 . . . . 0.0 109.756 172.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.541 HG21 HD13 ' A' ' 85' ' ' ILE . 29.3 t -53.5 -40.46 41.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.165 178.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.17 -33.19 73.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.393 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -71.28 -44.38 65.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.007 177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.6 m -64.22 -42.29 96.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.483 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -85.47 9.69 15.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.357 -178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.61 33.09 5.98 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.744 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.6 t -154.71 165.62 35.98 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -64.92 -24.33 67.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.902 0.382 . . . . 0.0 110.773 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.0 p -88.91 32.02 0.83 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.114 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.89 146.0 82.85 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.854 173.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.494 ' HB3' ' CD2' ' A' ' 87' ' ' HIS . 9.2 Cg_endo -53.16 134.23 55.51 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.322 2.681 . . . . 0.0 113.398 -177.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -62.7 -62.5 1.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.909 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.992 ' HD3' ' HG3' ' A' ' 160' ' ' GLU . 4.3 mtmt -103.69 145.31 30.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.8 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -167.71 140.89 3.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 0.0 111.475 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.4 pt -133.03 145.02 34.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.74 -0.663 . . . . 0.0 109.248 172.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.586 HG13 HG23 ' A' ' 72' ' ' VAL . 4.6 p -117.06 124.9 73.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.008 0.432 . . . . 0.0 110.833 -178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 59.3 m -128.24 133.6 48.84 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.273 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.508 HD23 HG21 ' A' ' 72' ' ' VAL . 3.7 mm? -89.06 116.56 27.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.399 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.563 ' O ' ' HA3' ' A' ' 75' ' ' GLY . . . 76.39 -174.69 53.47 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.758 -176.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 68.2 m -149.18 168.15 24.03 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.8 m -107.73 119.07 38.42 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.191 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.586 ' HA ' ' O ' ' A' ' 36' ' ' THR . 11.1 p -101.69 114.83 29.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.301 0.572 . . . . 0.0 111.346 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -84.21 155.54 22.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.95 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -56.4 142.46 68.78 Favored Pre-proline 0 C--O 1.236 0.388 0 O-C-N 123.472 0.483 . . . . 0.0 111.077 177.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -55.45 119.18 6.13 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.164 2.576 . . . . 0.0 112.659 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 66.74 17.55 10.59 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.595 174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.951 HE21 ' HA ' ' A' ' 138' ' ' GLN . 0.0 OUTLIER -98.66 -23.12 15.58 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.636 -178.089 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.48 HD22 HG21 ' A' ' 36' ' ' THR . 57.6 tp -68.36 -50.33 53.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.529 0.204 . . . . 0.0 110.943 -175.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -60.35 -34.12 73.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.019 0.438 . . . . 0.0 110.789 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -40.08 77.49 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.4 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -69.69 -37.81 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 110.146 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.76 HG12 ' HB2' ' A' ' 148' ' ' TRP . 82.8 mt -60.34 -38.02 76.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.934 0.397 . . . . 0.0 110.541 174.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -63.79 -28.61 69.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.302 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -88.13 4.41 45.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.585 -0.279 . . . . 0.0 110.928 175.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 16.5 m120 68.69 31.95 4.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.225 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -73.25 -30.54 63.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.466 0.65 . . . . 0.0 109.253 169.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.76 ' HB2' HG12 ' A' ' 143' ' ' ILE . 85.8 m95 -132.22 145.64 51.47 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.698 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.556 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 64.1 mt -104.43 118.33 36.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tt -98.99 135.6 40.16 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.46 -173.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 8.1 t -150.48 163.68 37.81 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 173.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -86.13 152.49 22.81 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.866 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -114.5 7.02 16.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.716 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -71.65 76.73 0.83 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.111 -176.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -176.88 -178.67 0.87 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -65.11 -19.01 65.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.4 m -52.52 -27.17 15.37 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.527 176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.808 HD13 HG13 ' A' ' 104' ' ' ILE . 1.0 OUTLIER -57.1 -43.0 81.8 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.078 179.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -133.74 -46.89 0.8 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.992 ' HG3' ' HD3' ' A' ' 124' ' ' LYS . 34.1 mt-10 -85.63 16.97 3.52 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 -166.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.6 m -55.96 162.48 1.85 Allowed 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 172.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.9 p -47.18 110.06 0.26 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.443 0.639 . . . . 0.0 112.497 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -77.17 -17.21 58.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.252 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.5 -20.12 57.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.776 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -177.31 122.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.926 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -98.71 -37.53 9.45 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.037 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 30.9 t90 55.96 -100.71 0.11 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.684 -174.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 21.4 t -141.22 75.95 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.38 -28.97 68.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.875 -175.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.13 95.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.92 0.391 . . . . 0.0 110.716 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.543 HD21 HG23 ' A' ' 176' ' ' ILE . 62.3 t30 -81.21 -26.99 35.49 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.18 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -71.19 -37.78 72.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.566 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -62.43 -30.18 71.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.669 176.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.3 tp -79.48 -36.12 39.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.878 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 103.87 8.93 38.56 Favored Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.864 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.543 HG23 HD21 ' A' ' 171' ' ' ASN . 13.9 mt 54.12 64.21 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 121.431 0.634 . . . . 0.0 110.63 -178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 22.8 t -158.98 124.3 4.26 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.135 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.78 177.13 43.66 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.746 178.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.735 HG12 HD12 ' A' ' 180' ' ' LEU . 14.8 tt -95.76 158.59 3.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.735 HD12 HG12 ' A' ' 179' ' ' ILE . 6.6 mp 65.28 87.67 0.11 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.476 0.655 . . . . 0.0 110.983 -173.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.416 ' HB1' ' HD2' ' A' ' 182' ' ' PRO . . . -93.24 159.74 34.75 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.907 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.416 ' HD2' ' HB1' ' A' ' 181' ' ' ALA . 26.3 Cg_endo -62.89 90.19 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.525 2.15 . . . . 0.0 112.504 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -131.39 -77.96 0.52 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.728 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.8 -79.07 1.72 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.871 -0.681 . . . . 0.0 113.345 173.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 185' ' ' ARG . 8.7 ptp85 -162.14 151.45 15.82 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.438 0.162 . . . . 0.0 111.438 -172.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . 45.37 73.83 0.15 Allowed 'General case' 0 N--CA 1.465 0.282 0 O-C-N 124.295 0.997 . . . . 0.0 113.049 174.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.9 mt -102.54 108.54 19.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.608 176.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 118.3 -0.857 . . . . 0.0 109.539 176.218 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 4.3 tpt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.533 ' HB3' HD21 ' A' ' 5' ' ' LEU . 19.8 m-30 -76.6 93.86 3.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.188 174.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.54 163.78 12.47 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.679 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 57.64 40.6 26.51 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 111.233 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.533 HD21 ' HB3' ' A' ' 2' ' ' PHE . 93.5 mt -72.02 1.27 7.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.598 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.574 ' NE2' ' HA ' ' A' ' 100' ' ' VAL . 53.6 tt0 -66.08 131.68 46.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.831 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.23 -4.81 77.81 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.67 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 152' ' ' GLU . 12.1 mptt -109.75 168.88 9.09 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 176.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -141.46 152.75 44.49 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.049 0.452 . . . . 0.0 110.938 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.443 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 6.1 pt -117.37 128.02 74.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.584 -179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.691 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 45.3 mt -101.3 133.25 45.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.794 -177.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.424 ' O ' ' HD3' ' A' ' 14' ' ' PRO . . . -136.55 167.58 21.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.384 177.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.8 p -97.62 107.61 40.56 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.688 0.28 . . . . 0.0 110.78 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 12' ' ' ALA . 89.3 Cg_endo -90.56 169.81 3.82 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.022 2.481 . . . . 0.0 112.454 179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.8 mp0 -96.43 128.64 43.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.1 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 26.5 mmt 72.48 125.37 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 O-C-N 124.21 0.944 . . . . 0.0 111.656 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -94.17 150.75 20.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.166 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -157.24 156.93 33.36 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.606 ' CD ' ' H ' ' A' ' 20' ' ' TYR . 2.8 tm-20 61.17 -150.31 0.4 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.606 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 91.7 m-85 -110.85 -40.56 4.5 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 172.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -176.19 -34.87 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.29 175.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.41 85.27 1.99 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 178.67 -30.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.2 -176.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.0 t -140.73 125.98 18.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.649 -177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.7 t 69.78 130.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 123.808 0.692 . . . . 0.0 112.106 175.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.54 HG23 ' H ' ' A' ' 27' ' ' TYR . 7.0 tp -142.8 -64.0 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.678 176.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.54 ' H ' HG23 ' A' ' 26' ' ' ILE . 1.8 p90 -177.01 177.14 1.31 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 118.142 0.428 . . . . 0.0 111.311 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.86 124.22 40.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.759 177.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.4 m -97.14 -40.45 8.8 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.577 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 0.3 OUTLIER -128.89 147.88 50.86 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -175.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.506 ' HB3' ' HB2' ' A' ' 6' ' ' GLN . 5.7 p80 -131.81 116.66 17.53 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.536 0.684 . . . . 0.0 111.072 -177.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.453 ' N ' HD22 ' A' ' 32' ' ' ASN . 0.9 OUTLIER -100.75 -7.85 23.32 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 169.756 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 72.43 -46.97 0.66 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 114.439 -1.255 . . . . 0.0 110.702 177.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -84.6 3.54 36.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 167.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.12 126.55 1.83 Allowed Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.885 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.552 ' O ' ' HA ' ' A' ' 133' ' ' THR . 22.7 m -101.74 119.68 39.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.584 0.192 . . . . 0.0 110.94 -178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.803 HG13 HG22 ' A' ' 133' ' ' THR . 4.4 mp -109.08 111.47 36.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.933 0.397 . . . . 0.0 110.392 -179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.76 162.62 28.54 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.291 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.7 m -114.18 79.92 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.809 0.814 . . . . 0.0 110.754 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.406 HD13 ' H ' ' A' ' 40' ' ' ILE . 0.2 OUTLIER -134.69 18.6 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.907 -178.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 10.6 tp -78.57 -21.41 13.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.122 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.4 t30 69.28 93.24 0.08 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.463 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.536 ' HB ' ' HB3' ' A' ' 74' ' ' ASN . 0.2 OUTLIER -161.98 122.72 1.55 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.087 176.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.78 155.42 4.13 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.803 2.335 . . . . 0.0 110.817 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.622 HG22 HD22 ' A' ' 74' ' ' ASN . 9.2 p -101.1 170.48 8.24 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.679 178.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -92.49 16.13 12.6 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.6 tp -124.55 159.05 31.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.964 -172.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 51' ' ' GLU . 42.6 t -106.51 154.8 20.34 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.198 176.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 9.4 p -67.64 -35.13 71.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 178.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.0 mt -73.73 -26.74 60.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.381 0.61 . . . . 0.0 109.577 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 48' ' ' SER . 12.8 mm-40 -68.46 -47.95 65.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.866 176.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.5 pp -69.84 -34.11 73.19 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.914 -178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 58' ' ' PHE . 62.8 mt -61.6 -52.32 64.86 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.415 177.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.5 p -69.6 -28.47 65.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.087 0.47 . . . . 0.0 111.302 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -59.15 -34.76 72.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.601 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -146.88 -23.71 0.41 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -134.53 -152.28 0.47 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -169.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.531 ' HB2' ' HB3' ' A' ' 53' ' ' LEU . 81.2 t80 76.9 -32.54 0.19 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.164 0.586 . . . . 0.0 111.887 172.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 67.37 -83.64 0.03 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 123.139 0.575 . . . . 0.0 110.44 178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 52.8 ttp 179.08 84.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.044 175.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.4 -20.84 18.15 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -143.32 154.42 60.64 Favored Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.684 175.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -63.1 153.36 74.33 Favored 'Trans proline' 0 C--O 1.235 0.343 0 C-N-CA 122.372 2.048 . . . . 0.0 111.501 173.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -77.8 73.26 4.37 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.24 0.543 . . . . 0.0 110.852 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 6.5 tp -141.2 115.79 5.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.721 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -141.09 95.15 2.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.366 0.603 . . . . 0.0 111.325 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.9 p -81.88 -61.47 1.91 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.364 177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -98.11 85.9 3.58 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 174.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.9 163.93 14.21 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.97 -175.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -98.46 122.57 41.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.255 -178.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 25.2 ttt -79.09 140.91 37.74 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.474 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.403 HG21 HD23 ' A' ' 129' ' ' LEU . 8.0 p -103.92 140.17 22.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 121.137 0.494 . . . . 0.0 110.889 -177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.3 mt -93.52 163.7 13.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.314 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.622 HD22 HG22 ' A' ' 45' ' ' THR . 4.1 t-20 -105.3 113.16 26.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.451 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -77.31 -25.12 64.27 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.864 -0.684 . . . . 0.0 113.243 -171.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.21 176.63 26.76 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.5 178.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -83.52 4.81 6.77 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.118 2.545 . . . . 0.0 113.283 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.451 HG12 HD22 ' A' ' 79' ' ' ASN . 19.2 t -106.62 118.76 54.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.451 HD22 HG12 ' A' ' 78' ' ' VAL . 51.2 m-80 64.7 33.61 10.32 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.374 0.421 . . . . 0.0 110.233 -176.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.591 ' HA ' ' HA3' ' A' ' 130' ' ' GLY . 26.0 tt0 -66.07 -15.96 63.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.374 -175.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -82.51 -7.29 59.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.511 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -109.41 140.7 42.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.055 0.455 . . . . 0.0 111.819 -174.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.02 130.14 9.58 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.637 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -113.94 124.37 52.01 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.0 mp -131.06 119.36 44.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.902 0.382 . . . . 0.0 110.806 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.49 139.62 46.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -148.13 162.72 38.84 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.444 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.6 m -74.87 161.5 29.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.3 tptt -81.2 121.76 26.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.024 0.44 . . . . 0.0 110.195 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.517 ' CB ' ' HA ' ' A' ' 122' ' ' PRO . 21.7 m -144.33 -34.15 0.38 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.382 0.61 . . . . 0.0 109.402 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -102.09 179.22 4.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.567 174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -120.56 79.85 1.54 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.399 0.618 . . . . 0.0 110.427 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 93' ' ' GLU . 4.8 pt-20 -64.62 168.03 6.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.138 173.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -154.12 -29.54 0.12 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 10.8 p -46.74 -59.99 2.69 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -173.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -170.36 71.99 0.06 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.296 0.57 . . . . 0.0 109.49 176.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.465 ' HB3' HG21 ' A' ' 105' ' ' THR . 11.3 m -79.83 132.1 36.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.018 -177.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 74.4 t80 -104.11 126.64 51.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.214 177.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.528 ' HE2' ' HA ' ' A' ' 102' ' ' ASP . 13.8 mmmm -72.61 117.72 14.64 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.519 -178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.574 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 63.8 t -80.11 -54.68 10.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 172.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 t -131.53 -48.46 0.98 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.528 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 35.9 t70 -178.57 -66.77 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 172.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.41 -46.18 80.99 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.0 mm -72.94 123.52 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.465 HG21 ' HB3' ' A' ' 97' ' ' SER . 19.1 m -132.79 142.94 49.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.531 -174.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 31.3 tp -96.98 135.67 38.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.117 176.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.436 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 2.6 m -135.01 123.56 23.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.605 0.24 . . . . 0.0 110.681 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 11.9 p -134.97 -0.42 2.79 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.821 0.343 . . . . 0.0 111.728 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.8 m -92.99 17.33 10.9 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.31 -14.09 66.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.561 174.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.86 -27.61 60.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.884 0.373 . . . . 0.0 110.849 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.436 ' CG1' ' HB ' ' A' ' 107' ' ' THR . 18.6 m -53.53 -32.81 21.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.926 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 90.2 mt -73.35 -29.55 62.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.884 0.373 . . . . 0.0 111.153 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -85.28 -35.56 21.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.609 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.5 m -58.76 -33.85 70.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.168 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -83.16 11.51 6.37 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.044 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.04 24.25 3.29 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.13 -1.033 . . . . 0.0 112.986 -179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.446 ' C ' ' H ' ' A' ' 120' ' ' THR . 3.3 p -123.71 14.76 9.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.981 0.39 . . . . 0.0 111.636 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 118' ' ' THR . 0.8 OUTLIER 70.18 -37.16 0.37 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.512 0.725 . . . . 0.0 111.442 -174.409 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.446 ' H ' ' C ' ' A' ' 118' ' ' THR . 16.6 p -78.13 28.04 0.19 Allowed 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 122.865 0.466 . . . . 0.0 111.781 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.87 134.16 89.73 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.321 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.517 ' HA ' ' CB ' ' A' ' 90' ' ' THR . 9.8 Cg_endo -53.27 140.61 61.84 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.213 2.609 . . . . 0.0 112.771 -178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.429 ' CB ' ' HE2' ' A' ' 124' ' ' LYS . 66.0 mt-10 -57.28 -52.8 63.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.143 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.429 ' HE2' ' CB ' ' A' ' 123' ' ' GLU . 5.6 mtmt -128.84 142.98 50.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.029 -176.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -150.3 145.17 26.01 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.876 -178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 35.2 pt -114.75 133.4 61.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.36 128.84 74.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.158 178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 78.4 m -142.89 150.04 39.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.256 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.403 HD23 HG21 ' A' ' 72' ' ' VAL . 3.8 mm? -97.09 112.98 24.51 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.899 176.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 80' ' ' GLN . . . 81.48 176.76 51.26 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.716 -178.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 80.6 m -147.71 173.36 12.84 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.5 m -113.97 121.62 44.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.071 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.803 HG22 HG13 ' A' ' 37' ' ' ILE . 73.7 p -110.25 119.75 40.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.129 0.49 . . . . 0.0 110.773 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -80.27 159.9 25.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.84 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -75.28 138.02 71.74 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.891 175.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.34 132.39 50.46 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.815 2.343 . . . . 0.0 111.291 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 2.0 t60 79.14 -33.81 0.15 Allowed 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.926 0.766 . . . . 0.0 111.437 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -59.17 -48.33 82.0 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.504 0.193 . . . . 0.0 111.485 -177.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 59.8 tp -57.99 -37.43 74.22 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.129 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 1' ' ' MET . 48.5 tt0 -62.03 -43.62 98.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.111 0.481 . . . . 0.0 110.22 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.627 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 0.7 OUTLIER -62.16 -43.58 98.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.894 177.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -63.16 -42.82 99.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.882 0.373 . . . . 0.0 110.712 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.615 HG12 ' HB2' ' A' ' 148' ' ' TRP . 83.4 mt -62.35 -39.98 86.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.343 176.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.35 -28.59 69.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.496 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 60.8 mt-30 -88.75 8.9 26.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.967 177.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 7.9 m120 66.78 30.72 7.83 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -81.53 -29.24 33.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.275 0.56 . . . . 0.0 109.742 171.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.615 ' HB2' HG12 ' A' ' 143' ' ' ILE . 95.3 m95 -131.01 131.49 44.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.761 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.691 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 44.0 mt -89.99 112.57 24.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.957 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 59.5 tp -87.04 133.01 33.63 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.653 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.0 p -161.23 148.83 15.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.106 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 3.3 pm0 -95.47 165.23 12.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.054 0.454 . . . . 0.0 110.893 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.71 -88.13 0.63 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.593 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 53.26 29.77 9.0 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.779 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -137.29 176.26 8.87 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -174.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -57.63 -35.93 71.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.602 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -52.83 -29.44 27.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.694 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.49 -56.99 12.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.356 -177.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.04 7.41 6.6 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -169.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -106.24 -19.25 13.76 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.136 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 10.7 t -63.59 -24.15 67.68 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -172.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 20.1 m -72.52 85.23 1.14 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.837 0.351 . . . . 0.0 111.079 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.502 ' HB3' ' H ' ' A' ' 164' ' ' LEU . 7.1 m-85 -133.96 -157.05 0.78 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.517 176.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.502 ' H ' ' HB3' ' A' ' 163' ' ' TYR . 3.5 pp -63.24 -27.27 69.23 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.117 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.431 ' N ' HD12 ' A' ' 164' ' ' LEU . 38.8 t70 -140.52 148.86 41.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.574 ' HB2' ' OE2' ' A' ' 169' ' ' GLU . 5.0 ptt180 -153.93 -97.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.843 -174.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.488 ' H ' ' HG3' ' A' ' 166' ' ' ARG . 19.5 t90 79.32 -53.63 0.43 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 165.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 10.1 m -129.48 29.64 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -170.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.574 ' OE2' ' HB2' ' A' ' 166' ' ' ARG . 1.5 pm0 -63.01 -52.87 61.25 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.619 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.426 ' H ' ' HG2' ' A' ' 169' ' ' GLU . . . -70.26 -31.65 69.12 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-O 120.944 0.402 . . . . 0.0 110.613 -177.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -66.98 -42.84 84.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.87 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -74.98 -21.21 59.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.098 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.555 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 14.1 mmt -62.93 -34.41 77.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.242 0.544 . . . . 0.0 109.699 172.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 12.6 tp -83.52 -40.24 19.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.421 -0.809 . . . . 0.0 108.996 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.57 22.6 50.06 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.926 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 15.1 mt 51.42 50.06 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 121.796 0.807 . . . . 0.0 109.871 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 13.3 t -88.18 -167.29 1.83 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.171 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -69.74 90.36 0.31 Allowed Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.595 -178.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.406 HD12 HD11 ' A' ' 149' ' ' LEU . 4.9 tt -96.04 125.61 48.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.023 0.44 . . . . 0.0 110.597 177.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 6.0 mp -82.48 77.41 9.26 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.252 0.549 . . . . 0.0 110.336 177.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -166.3 113.57 0.74 Allowed Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.485 177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.84 83.18 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.915 2.41 . . . . 0.0 112.041 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -98.19 -66.3 0.91 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.331 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 166.1 168.31 28.08 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 121.063 -0.589 . . . . 0.0 111.963 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 76.0 mtm180 -136.03 33.07 2.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.954 0.407 . . . . 0.0 110.641 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -103.27 8.55 38.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.758 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 187' ' ' LEU . 1.8 pt? -152.34 120.79 6.38 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.151 0.5 . . . . 0.0 111.69 -176.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 . . . . . 0 C--O 1.252 1.217 0 CA-C-O 117.965 -1.017 . . . . 0.0 108.834 172.63 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tmm? . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.489 ' HE2' ' HG2' ' A' ' 140' ' ' GLU . 27.1 p90 -114.67 119.12 35.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.263 0.554 . . . . 0.0 111.634 -177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -117.61 -82.29 0.87 Allowed Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 174.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -104.76 -14.57 15.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.1 mt 64.61 -90.49 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.384 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 31.45 86.54 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 124.308 1.005 . . . . 0.0 112.96 -173.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 123.83 -0.59 9.22 Favored Glycine 0 C--N 1.314 -0.646 0 CA-C-N 114.684 -1.144 . . . . 0.0 112.385 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.782 ' HE3' ' HG3' ' A' ' 152' ' ' GLU . 13.6 mptt -105.52 169.16 8.62 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 175.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 2.5 p90 -142.45 167.89 21.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.418 HD12 ' CE3' ' A' ' 148' ' ' TRP . 4.8 pt -128.16 128.44 68.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.083 0.468 . . . . 0.0 111.477 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.619 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 4.6 mp -98.36 127.08 51.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.626 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.46 -72.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.083 0.239 . . . . 0.0 110.763 176.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 25.7 m 67.13 95.9 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.239 0 O-C-N 123.778 0.674 . . . . 0.0 110.958 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.26 -48.78 19.68 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.796 2.331 . . . . 0.0 112.407 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.654 ' HG2' ' HG2' ' A' ' 16' ' ' MET . 43.6 tt0 -170.77 -81.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.064 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.654 ' HG2' ' HG2' ' A' ' 15' ' ' GLU . 25.7 ptt? -175.08 -168.29 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.552 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -125.83 -74.3 0.61 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 175.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -119.94 -56.93 1.99 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 170.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 16' ' ' MET . 33.4 mt-10 -84.65 179.09 7.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.141 170.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -95.68 -66.49 0.91 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.566 -172.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -128.41 74.65 1.57 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.211 0.529 . . . . 0.0 110.855 -170.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -111.78 98.71 7.59 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 171.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.445 ' HD3' ' NE1' ' A' ' 167' ' ' TRP . 0.8 OUTLIER 62.5 69.69 0.6 Allowed 'General case' 0 C--N 1.33 -0.242 0 O-C-N 123.724 0.64 . . . . 0.0 110.3 -172.789 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.434 ' HA ' ' OD1' ' A' ' 42' ' ' ASN . 4.3 m -65.51 96.05 0.24 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.497 -177.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.897 HG12 ' H ' ' A' ' 26' ' ' ILE . 3.1 t 60.79 -170.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.253 178.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.902 HG21 HG23 ' A' ' 39' ' ' VAL . 10.1 tp -174.13 -147.74 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.723 ' HD1' HG13 ' A' ' 26' ' ' ILE . 2.6 p90 -120.87 176.33 5.6 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.217 0.917 . . . . 0.0 111.368 -168.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.4 mm -91.9 127.95 43.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.416 178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.7 m -96.44 -44.76 7.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.937 -176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.796 ' HB3' ' HB ' ' A' ' 37' ' ' ILE . 8.9 tp10 -136.03 156.38 48.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.916 0.388 . . . . 0.0 110.411 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -140.87 110.18 6.26 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.184 0.516 . . . . 0.0 110.254 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -113.3 179.95 3.81 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -76.1 -35.0 59.51 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.055 0.455 . . . . 0.0 110.488 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.96 -24.27 60.77 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.975 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 171.63 178.28 41.89 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 119.966 -1.111 . . . . 0.0 112.959 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 16.9 m -103.62 130.38 51.06 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.796 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 3.9 mp -100.87 114.5 40.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.059 0.457 . . . . 0.0 110.89 -174.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -139.41 178.85 19.29 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.902 HG23 HG21 ' A' ' 26' ' ' ILE . 10.7 m -125.08 33.88 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.626 0.727 . . . . 0.0 110.316 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.569 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -82.98 20.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.366 -173.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.466 HG23 HG22 ' A' ' 43' ' ' THR . 10.4 tp -67.24 -25.04 32.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.646 0.26 . . . . 0.0 111.249 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.434 ' OD1' ' HA ' ' A' ' 24' ' ' THR . 4.6 t30 67.16 80.64 0.21 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.409 173.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.466 HG22 HG23 ' A' ' 41' ' ' ILE . 5.1 t -178.2 126.39 0.27 Allowed Pre-proline 0 C--O 1.233 0.221 0 CA-C-O 121.319 0.581 . . . . 0.0 111.877 178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.64 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 83.7 Cg_endo -84.33 179.69 4.39 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.677 2.251 . . . . 0.0 110.689 169.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 p -119.6 -175.32 2.93 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 177.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -93.55 9.03 38.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.174 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 tp -125.43 163.95 21.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.84 0.353 . . . . 0.0 110.857 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 10.6 m -107.48 163.21 13.25 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.295 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.602 ' HB ' HG11 ' A' ' 127' ' ' VAL . 11.3 p -66.15 -35.72 75.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.744 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.648 HD12 ' HD3' ' A' ' 64' ' ' ARG . 81.2 mt -72.21 -26.44 62.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 110.487 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.15 -35.47 78.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.944 177.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.6 mt -59.02 -44.74 91.75 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.064 0.459 . . . . 0.0 109.87 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.582 HD13 HD11 ' A' ' 113' ' ' LEU . 27.3 mt -66.54 -33.48 75.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.655 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 98.6 m -62.3 -35.35 78.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.086 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 37.7 mtm180 -76.05 -60.58 2.27 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.397 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 24.4 ptt? 168.86 -24.99 0.0 OUTLIER 'General case' 0 C--O 1.233 0.217 0 C-N-CA 123.114 0.566 . . . . 0.0 110.815 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -61.41 125.96 25.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.334 -174.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.587 ' O ' ' HB2' ' A' ' 59' ' ' GLN . 43.1 m-85 64.41 44.36 4.21 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.586 178.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.587 ' HB2' ' O ' ' A' ' 58' ' ' PHE . 1.8 mp0 82.22 154.81 0.11 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.69 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.46 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 25.7 ttt -111.66 145.26 39.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -166.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 77.88 108.71 0.08 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.219 168.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.573 ' HE3' ' HA ' ' A' ' 62' ' ' LYS . 1.7 tpmt? -155.38 85.42 3.43 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -62.34 138.89 74.13 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.224 2.616 . . . . 0.0 113.213 -174.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.648 ' HD3' HD12 ' A' ' 50' ' ' LEU . 50.7 ptt85 -139.41 173.23 11.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.533 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.2 pt -117.88 -175.5 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.357 176.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 69.55 168.18 0.29 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 123.938 0.773 . . . . 0.0 111.041 -179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.6 m -67.63 -45.64 74.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.267 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.06 162.23 34.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.106 178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -132.09 -97.53 0.31 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -104.43 112.29 25.29 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 88.2 mtp -82.26 144.46 30.62 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.465 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 127' ' ' VAL . 7.3 p -93.97 137.57 22.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.886 0.374 . . . . 0.0 110.06 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.64 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.9 mp -102.02 -179.79 4.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.937 0.398 . . . . 0.0 110.341 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -115.41 137.14 52.36 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -97.04 -23.78 14.25 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.721 -0.752 . . . . 0.0 111.813 179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.34 173.76 30.37 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -78.04 -12.15 16.16 Favored 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 123.023 2.482 . . . . 0.0 112.823 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.4 t -87.73 125.21 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.67 -176.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 22.2 m-20 59.53 40.28 20.64 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.883 178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -70.65 -10.95 60.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.298 0.57 . . . . 0.0 110.524 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.13 -22.69 67.03 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.155 172.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -104.15 147.17 27.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.432 -175.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -109.86 124.34 7.13 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.618 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.512 ' HB3' HD11 ' A' ' 106' ' ' LEU . 60.5 m-85 -106.12 124.83 50.2 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.487 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.7 mp -120.23 110.06 27.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.683 HG22 HD13 ' A' ' 106' ' ' LEU . 21.4 t -95.55 124.46 48.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.651 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 125' ' ' PHE . 25.6 p80 -138.29 168.76 19.07 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.804 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 42.0 t -64.99 168.34 6.6 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.505 ' HG2' ' HA ' ' A' ' 103' ' ' ASP . 12.7 mmmt -51.25 112.9 0.81 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.235 0.541 . . . . 0.0 110.427 177.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.1 m -158.74 122.43 3.9 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.68 -150.03 0.45 Allowed 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.319 -176.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 77.97 13.85 1.64 Allowed 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.409 1.083 . . . . 0.0 109.701 -169.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -98.35 155.48 17.2 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 173.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -147.65 -27.43 0.36 Allowed 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.656 -0.418 . . . . 0.0 112.083 -169.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 86.2 m -67.1 -55.2 15.25 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.191 -0.204 . . . . 0.0 110.926 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -169.0 110.28 0.49 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.657 0.265 . . . . 0.0 111.12 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 21.8 m -118.74 137.24 53.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.195 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.0 t80 -123.02 137.21 55.01 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.99 118.46 34.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.313 0.578 . . . . 0.0 110.781 178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.82 -54.08 16.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.169 176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 t -134.67 165.53 25.02 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 173.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -80.26 67.89 6.24 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.488 0.661 . . . . 0.0 111.177 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.505 ' HA ' ' HG2' ' A' ' 89' ' ' LYS . 24.6 t70 178.92 -31.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.089 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 49.2 mm -105.95 124.42 61.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.248 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.4 m -113.96 128.34 56.35 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.897 0.379 . . . . 0.0 110.955 -176.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.683 HD13 HG22 ' A' ' 86' ' ' VAL . 54.5 tp -109.31 113.14 25.72 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.614 179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.7 m -100.01 124.09 44.98 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 1.4 m -109.02 25.78 11.4 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.314 0.578 . . . . 0.0 111.122 -173.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.9 m -144.8 172.92 12.34 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.506 -178.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.78 8.42 3.37 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 116.322 -0.399 . . . . 0.0 112.705 177.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.56 -17.19 64.68 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.487 HG11 ' HB ' ' A' ' 85' ' ' ILE . 25.6 m -58.01 -29.63 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.73 174.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.582 HD11 HD13 ' A' ' 53' ' ' LEU . 4.5 mm? -60.78 -31.87 71.21 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.132 0.491 . . . . 0.0 110.464 177.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -78.59 -37.25 42.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.864 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.4 m -53.65 -45.07 70.1 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.887 -177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -97.98 140.84 31.72 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.782 177.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.04 2.37 45.37 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.058 -177.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 120' ' ' THR . 9.0 t -115.75 -175.83 2.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -58.87 -34.35 71.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.071 0.463 . . . . 0.0 110.504 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.422 ' H ' HG23 ' A' ' 118' ' ' THR . 21.6 p -112.01 64.03 0.62 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.136 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.03 125.51 85.18 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.192 172.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.07 133.1 24.2 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.538 2.158 . . . . 0.0 112.312 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -61.73 -57.81 10.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.355 0.598 . . . . 0.0 111.702 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.1 mtmm -118.54 127.48 53.66 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.248 -168.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 87' ' ' HIS . 37.5 p90 -150.62 138.52 19.98 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.819 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.2 pt -116.06 134.14 60.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.834 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.602 HG11 ' HB ' ' A' ' 49' ' ' VAL . 6.5 p -114.17 128.36 71.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 121.253 0.549 . . . . 0.0 110.702 -177.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 18.2 p -142.23 138.23 31.3 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.187 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.8 mt -89.3 140.14 29.79 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.768 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 59.89 -175.15 4.02 Favored Glycine 0 CA--C 1.523 0.571 0 CA-C-N 115.617 -0.72 . . . . 0.0 113.47 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 79.1 m -148.83 173.06 13.67 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 31.0 p -114.05 122.3 46.46 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.915 0.388 . . . . 0.0 110.445 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.702 HG22 HG13 ' A' ' 37' ' ' ILE . 25.3 p -98.65 117.01 32.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.042 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.437 ' HZ3' HD11 ' A' ' 40' ' ' ILE . 1.2 t-105 -68.48 148.4 50.64 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.279 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -69.16 144.91 95.77 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.142 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.91 125.27 18.58 Favored 'Trans proline' 0 CA--C 1.529 0.251 0 C-N-CA 123.274 2.649 . . . . 0.0 113.484 -173.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 2.8 t60 71.59 -8.28 1.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.056 172.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -67.07 -44.75 79.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.343 . . . . 0.0 111.491 -175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 47.7 tp -57.51 -31.43 66.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.548 -175.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.489 ' HG2' ' HE2' ' A' ' 2' ' ' PHE . 48.7 mt-10 -58.83 -41.11 86.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.301 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -75.52 -49.66 18.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.924 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.849 ' HB3' ' HD1' ' A' ' 148' ' ' TRP . 0.3 OUTLIER -54.88 -40.93 70.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.139 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 71.9 mt -67.93 -48.16 76.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.856 178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.63 -35.98 81.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.828 0.347 . . . . 0.0 111.407 -176.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -87.33 16.08 5.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.891 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 68.14 24.38 7.68 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 170.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.511 ' HD2' ' HA ' ' A' ' 142' ' ' GLU . 75.6 m-85 -83.57 -25.48 30.89 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 173.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.849 ' HD1' ' HB3' ' A' ' 142' ' ' GLU . 94.5 m95 -133.96 132.96 40.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.885 176.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.619 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.8 tt -90.62 115.13 27.5 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.436 ' CD2' ' HB3' ' A' ' 2' ' ' PHE . 55.6 tp -93.98 135.55 35.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.764 0.316 . . . . 0.0 111.386 -175.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.5 t -156.21 156.17 33.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.782 ' HG3' ' HE3' ' A' ' 8' ' ' LYS . 7.6 mp0 -70.11 153.54 43.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -120.61 -3.56 9.82 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -71.97 81.64 0.93 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.795 0.807 . . . . 0.0 111.322 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -158.57 165.48 34.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -53.0 -30.05 32.94 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.1 m -55.76 -30.5 61.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.938 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.2 tt -64.49 -53.19 52.06 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.945 -175.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.403 ' CZ ' HG12 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -115.77 -46.07 2.86 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -174.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 162' ' ' SER . 25.5 tt0 -65.01 -47.34 77.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.81 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 20.0 m 72.76 -27.03 0.18 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.656 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 160' ' ' GLU . 48.2 m 64.74 100.35 0.04 OUTLIER 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.347 0.594 . . . . 0.0 109.624 -173.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -67.3 91.48 0.25 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.331 -170.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.1 pp -160.07 -33.14 0.06 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.07 178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 166' ' ' ARG . 17.0 t70 -109.39 -170.15 1.6 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.511 ' HB3' ' CE3' ' A' ' 167' ' ' TRP . 26.1 mmt180 -119.23 -78.66 0.59 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.808 0.337 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.511 ' CE3' ' HB3' ' A' ' 166' ' ' ARG . 16.2 m-90 -146.89 26.77 1.1 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.115 -177.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 45.3 t -102.99 -38.44 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -171.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.11 -4.33 20.76 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -171.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.69 -57.32 12.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.994 0.426 . . . . 0.0 111.627 -178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.503 ' ND2' HG13 ' A' ' 176' ' ' ILE . 4.4 p-10 -75.25 -24.54 57.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -177.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -66.02 -22.44 66.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.19 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 13.7 tpt -55.12 -33.29 62.73 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.45 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.472 HD22 HD21 ' A' ' 149' ' ' LEU . 12.1 tp -107.79 -51.96 2.83 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.958 0.409 . . . . 0.0 110.878 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 156.54 115.85 0.5 Allowed Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 176' ' ' ILE . 4.4 mp -48.83 -56.95 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 O-C-N 123.889 0.405 . . . . 0.0 110.86 -178.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 20.7 m 71.65 -45.68 0.62 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.317 0.647 . . . . 0.0 111.901 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 139.54 -69.8 0.47 Allowed Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 10.5 tp -169.62 148.05 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 97.6 mt -80.72 83.75 6.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.042 0.449 . . . . 0.0 110.065 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -159.13 156.7 26.75 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.229 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -67.58 -8.79 23.32 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.863 2.375 . . . . 0.0 112.91 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . 63.93 -164.58 0.25 Allowed 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.449 0.468 . . . . 0.0 111.266 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.45 51.61 7.22 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.715 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 63.12 67.04 0.69 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.364 0.602 . . . . 0.0 109.883 -176.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -101.0 69.11 1.29 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.029 -176.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 4.2 mp -114.25 146.69 40.1 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.946 175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.707 179.176 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.582 ' HA ' ' CD ' ' A' ' 140' ' ' GLU . 89.5 mtp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.786 0.327 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -119.38 131.99 55.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.305 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.01 -58.88 10.19 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.824 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.636 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 61.2 t30 -149.37 154.81 39.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 175.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.0 mt -118.83 -98.49 0.45 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.466 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 29' ' ' CYS . 56.2 mt-30 61.84 122.49 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 122.429 1.109 . . . . 0.0 112.557 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.04 5.77 88.94 Favored Glycine 0 C--N 1.316 -0.576 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.937 -177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -93.74 158.18 15.8 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.455 ' HE1' HD11 ' A' ' 11' ' ' ILE . 29.8 p90 -134.52 163.04 30.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.049 0.452 . . . . 0.0 110.924 179.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 149' ' ' LEU . 4.2 pt -127.54 128.16 69.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.421 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.668 HG12 ' HA ' ' A' ' 171' ' ' ASN . 4.5 mp -87.92 132.51 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.364 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.32 168.59 26.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.418 177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.0 m -122.17 99.12 43.76 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.951 0.405 . . . . 0.0 110.66 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.35 174.58 10.49 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.054 2.503 . . . . 0.0 111.462 176.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -69.27 112.31 5.76 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.219 0.533 . . . . 0.0 109.997 177.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 21.1 ptp -79.11 159.97 27.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.296 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -160.52 -57.74 0.06 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.379 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 66.17 115.8 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.906 0.754 . . . . 0.0 112.03 172.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -124.21 -46.49 1.93 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -145.38 -89.08 0.1 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.7 p90 -116.85 39.12 3.28 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.389 0.614 . . . . 0.0 110.092 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -49.68 125.43 11.56 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.604 -1.18 . . . . 0.0 111.655 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -110.61 120.82 43.65 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.0 110.089 -178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 46.9 p -84.78 -168.13 2.08 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.417 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.743 HG23 HG22 ' A' ' 40' ' ' ILE . 2.7 p -56.01 136.19 18.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.479 173.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.425 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.2 tp -114.14 -55.41 4.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.78 -178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.425 ' HD1' HG13 ' A' ' 26' ' ' ILE . 5.2 p90 -175.45 171.93 2.75 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.212 0.529 . . . . 0.0 111.852 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 50.0 mm -90.95 126.55 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.754 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 6' ' ' GLN . 43.2 t -81.98 -50.89 8.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.046 -174.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.508 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 45.8 mt-10 -136.21 146.59 46.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.963 0.411 . . . . 0.0 111.454 -177.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.636 ' CD2' ' HA ' ' A' ' 4' ' ' ASN . 43.2 t60 -137.21 114.05 10.49 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.088 175.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -116.7 172.31 7.32 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.406 ' HA ' ' CD2' ' A' ' 137' ' ' HIS . 41.0 m-20 -82.23 -20.03 38.5 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 172.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.49 -16.03 24.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.665 -178.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.43 174.46 44.41 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.303 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -149.23 133.58 17.47 Favored 'General case' 0 C--N 1.323 -0.562 0 O-C-N 122.437 -0.449 . . . . 0.0 110.401 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.75 HG13 HG22 ' A' ' 133' ' ' THR . 4.5 mp -122.87 123.64 68.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.246 -177.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -142.41 172.0 24.46 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.044 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.2 97.53 3.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.394 0.616 . . . . 0.0 110.51 177.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.743 HG22 HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -130.98 24.48 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.195 -176.177 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.885 HG12 ' HB3' ' A' ' 74' ' ' ASN . 10.0 tp -55.81 -39.17 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.447 -173.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 t30 63.48 25.19 14.38 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.613 0.365 . . . . 0.0 111.605 175.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.625 HG22 HG13 ' A' ' 41' ' ' ILE . 3.8 t -166.81 148.27 5.46 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 122.076 -0.39 . . . . 0.0 110.144 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.553 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 2.3 Cg_endo -81.99 -173.57 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.22 2.613 . . . . 0.0 112.471 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.4 p -101.58 -161.23 0.84 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.18 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -101.86 -7.69 22.27 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.284 0.564 . . . . 0.0 110.443 177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.416 ' O ' HG12 ' A' ' 72' ' ' VAL . 16.4 tp -107.21 171.22 7.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.252 -175.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.822 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 14.7 m -119.65 161.77 20.12 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.106 -0.371 . . . . 0.0 110.342 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.517 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 12.8 p -69.39 -35.49 67.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.046 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.567 HD11 ' O ' ' A' ' 68' ' ' GLN . 65.0 mt -59.69 -37.61 79.28 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.084 176.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.822 ' HG2' ' HB2' ' A' ' 48' ' ' SER . 23.2 mm-40 -60.01 -53.18 60.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.445 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.403 ' O ' ' HG2' ' A' ' 56' ' ' MET . 94.5 mt -61.05 -46.78 89.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.663 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 85.1 mt -57.53 -44.67 85.29 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.299 -177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 15.7 p -75.5 -36.35 60.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.259 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.438 ' C ' ' HD2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -58.51 -50.82 72.38 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.661 -179.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 52' ' ' LEU . 25.4 ptt? -86.54 -6.19 58.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.225 -177.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 t70 60.59 97.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.0 0.905 . . . . 0.0 111.092 -174.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.662 ' O ' ' HG2' ' A' ' 59' ' ' GLN . 3.7 p90 -93.55 22.4 5.43 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.359 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.662 ' HG2' ' O ' ' A' ' 58' ' ' PHE . 16.6 pt20 65.17 100.42 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.581 1.152 . . . . 0.0 109.005 -164.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 92.4 mtp -73.21 98.58 2.65 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.403 -172.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -138.79 159.74 41.39 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.653 177.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 64' ' ' ARG . 67.9 mttm 59.33 95.73 0.05 OUTLIER Pre-proline 0 N--CA 1.463 0.216 0 O-C-N 123.807 0.692 . . . . 0.0 111.809 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.74 -1.1 10.29 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 123.033 2.489 . . . . 0.0 112.548 178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.474 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 0.9 OUTLIER 69.39 164.61 0.25 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.513 0.673 . . . . 0.0 111.278 -179.122 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' A' ' 66' ' ' TYR . 68.4 mt -105.16 117.59 51.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.266 173.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 65' ' ' ILE . 80.2 t80 74.31 143.11 0.07 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 124.126 0.891 . . . . 0.0 109.796 -172.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 67' ' ' THR . 12.2 t -57.69 110.41 0.89 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.841 0.829 . . . . 0.0 111.217 -176.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.567 ' O ' HD11 ' A' ' 50' ' ' LEU . 36.2 tt0 -97.89 75.13 2.36 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.981 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -79.51 108.33 12.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.05 177.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.427 ' O ' HG12 ' A' ' 49' ' ' VAL . 25.9 mm-40 -120.07 120.27 35.78 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.247 0.546 . . . . 0.0 110.304 177.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.456 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 12.4 ttt -88.44 144.05 26.61 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.407 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.528 HG21 HD23 ' A' ' 129' ' ' LEU . 9.0 p -89.08 137.12 21.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 CA-C-O 121.202 0.525 . . . . 0.0 110.73 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 67.3 mt -80.43 167.84 19.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.216 -178.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.885 ' HB3' HG12 ' A' ' 41' ' ' ILE . 7.1 t-20 -97.64 155.85 16.8 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 130' ' ' GLY . . . -109.69 -25.6 5.38 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.477 -0.868 . . . . 0.0 111.455 176.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 148.88 174.1 20.19 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.46 -9.18 18.69 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.858 2.372 . . . . 0.0 112.221 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.499 HG12 ' OD1' ' A' ' 79' ' ' ASN . 6.1 t -104.12 139.22 25.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.269 -178.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.582 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 20.3 m120 56.05 34.5 23.88 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.442 0.297 . . . . 0.0 111.325 176.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.613 ' HA ' ' CA ' ' A' ' 130' ' ' GLY . 15.7 tt0 -66.54 -13.67 61.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.154 0.502 . . . . 0.0 111.524 -174.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -76.71 -8.48 57.36 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.735 177.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -102.25 133.7 46.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.032 0.444 . . . . 0.0 111.228 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.35 124.24 6.37 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.715 176.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -108.73 123.1 48.48 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.44 HG21 HG21 ' A' ' 112' ' ' VAL . 5.2 mp -139.56 112.95 6.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.726 0.298 . . . . 0.0 110.662 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 76.8 t -115.29 132.04 65.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.302 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -125.53 152.51 44.92 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.64 ' HB3' ' HB3' ' A' ' 159' ' ' PHE . 20.1 p -81.38 148.46 29.32 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 173.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.474 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 87.8 tttt -67.01 114.35 5.73 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.865 0.841 . . . . 0.0 111.57 -176.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.706 ' HB ' ' HA ' ' A' ' 122' ' ' PRO . 3.5 m -138.55 10.51 2.71 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 173.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -140.3 164.6 29.65 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.118 -1.855 . . . . 0.0 110.031 -168.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -136.44 15.69 3.19 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.331 0.586 . . . . 0.0 109.74 177.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -124.87 160.75 28.08 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.844 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 53.1 p90 170.44 154.13 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.188 0.93 . . . . 0.0 109.887 -175.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 21.4 m -104.08 -45.19 4.8 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.229 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -151.71 108.32 3.48 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.834 0.35 . . . . 0.0 110.494 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.6 p -139.89 150.18 44.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.067 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -102.18 112.12 24.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -90.56 123.68 34.41 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.184 0.516 . . . . 0.0 111.557 -174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.4 -54.46 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 174.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 51.2 p -116.43 -165.86 1.1 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 170.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -90.03 15.57 9.86 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.683 0.754 . . . . 0.0 109.349 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.474 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 13.2 t70 -131.03 -59.97 0.97 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.251 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.699 HG13 HD13 ' A' ' 158' ' ' LEU . 50.7 mm -72.49 122.15 24.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.126 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.96 133.17 45.57 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.328 0.585 . . . . 0.0 112.383 -176.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 85' ' ' ILE . 31.1 tp -99.77 122.11 42.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.216 176.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.3 m -102.54 123.86 47.05 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.822 0.344 . . . . 0.0 110.113 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.6 p -116.53 20.62 14.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.887 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.8 m -139.67 177.58 7.84 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.445 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.77 -6.17 49.6 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.518 -0.372 . . . . 0.0 112.262 -178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -57.22 -29.38 63.69 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.207 0.527 . . . . 0.0 110.619 175.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.454 HG13 HD22 ' A' ' 113' ' ' LEU . 14.8 p -54.63 -34.02 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.714 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.552 ' HG ' ' HB2' ' A' ' 58' ' ' PHE . 2.9 mm? -63.57 -35.99 82.32 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.026 0.441 . . . . 0.0 110.356 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -73.27 -34.54 65.86 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.88 178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.2 m -58.31 -49.46 77.07 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.136 -176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -99.9 3.73 44.67 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.886 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -97.13 11.55 65.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.82 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.9 t -118.24 164.71 14.77 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -66.98 -23.01 65.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.898 0.38 . . . . 0.0 110.856 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.9 p -94.07 24.57 4.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.934 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . . . -51.07 136.37 28.42 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.14 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.706 ' HA ' ' HB ' ' A' ' 90' ' ' THR . 31.3 Cg_exo -58.74 145.96 94.16 Favored 'Trans proline' 0 C--O 1.234 0.318 0 C-N-CA 123.095 2.53 . . . . 0.0 112.339 -178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.99 -47.93 70.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.242 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -141.8 143.53 33.48 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.663 -176.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -152.03 148.59 27.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.83 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.4 pt -118.71 141.34 38.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.71 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.99 122.8 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.246 0.546 . . . . 0.0 110.495 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 81.3 m -132.81 158.14 43.23 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.153 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 72' ' ' VAL . 3.4 mm? -112.76 113.21 25.21 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.852 0.358 . . . . 0.0 110.555 175.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.613 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . 101.98 -178.24 26.92 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.556 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 34.8 m -144.43 168.43 20.13 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 36.7 m -114.33 116.09 28.4 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.75 HG22 HG13 ' A' ' 37' ' ' ILE . 40.8 p -117.56 143.79 45.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.257 0.551 . . . . 0.0 111.731 -177.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 22.6 m-90 -110.89 177.47 4.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.233 175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.542 ' HB3' ' HD2' ' A' ' 136' ' ' PRO . 65.6 mttp -85.17 167.13 27.52 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.221 175.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' A' ' 135' ' ' LYS . 90.4 Cg_exo -44.15 105.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.969 2.446 . . . . 0.0 113.507 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.406 ' CD2' ' HA ' ' A' ' 33' ' ' ASP . 4.4 m-70 65.48 7.62 4.48 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.946 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.561 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.7 tp60 -57.5 -48.1 80.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 118.105 0.411 . . . . 0.0 111.396 -174.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.504 ' O ' HG13 ' A' ' 143' ' ' ILE . 65.3 tp -57.04 -34.86 68.64 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.981 0.42 . . . . 0.0 110.993 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.582 ' CD ' ' HA ' ' A' ' 1' ' ' MET . 39.6 tt0 -61.89 -46.05 91.1 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.59 -178.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 13.4 mp0 -73.14 -30.15 63.4 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.09 177.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 66.9 mm-40 -60.92 -42.55 98.33 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 121.254 0.549 . . . . 0.0 110.013 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.547 HG12 ' HB2' ' A' ' 148' ' ' TRP . 86.0 mt -65.09 -29.73 48.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.586 177.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.07 -12.7 61.8 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.371 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.477 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 48.0 mt-30 -88.94 1.18 55.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.418 177.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 68.69 17.44 8.89 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.607 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -80.34 -18.95 47.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.325 0.583 . . . . 0.0 110.137 173.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.547 ' HB2' HG12 ' A' ' 143' ' ' ILE . 84.7 m95 -126.1 138.89 53.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.05 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.585 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 48.8 mt -106.43 107.59 18.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.073 0.463 . . . . 0.0 110.232 176.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.4 tt -84.73 134.13 34.35 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.286 -174.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.505 ' HB2' HD13 ' A' ' 174' ' ' LEU . 16.1 t -150.07 178.09 9.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.045 176.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -123.25 154.14 39.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.254 0.55 . . . . 0.0 111.549 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.81 145.16 32.44 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.202 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.429 ' N ' HD22 ' A' ' 154' ' ' ASN . 0.9 OUTLIER -88.61 26.21 1.54 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.097 179.366 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 4.8 t30 70.48 -45.66 0.6 Allowed 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.884 0.874 . . . . 0.0 110.672 -174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -57.93 -43.49 86.32 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 121.185 0.517 . . . . 0.0 109.851 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -28.84 69.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.444 179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.699 HD13 HG13 ' A' ' 104' ' ' ILE . 2.8 tt -74.5 -56.57 4.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.112 -173.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.64 ' HB3' ' HB3' ' A' ' 88' ' ' SER . 0.4 OUTLIER -125.27 -23.55 4.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 -174.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.29 -51.09 14.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.357 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.595 HG22 ' H ' ' A' ' 162' ' ' SER . 0.2 OUTLIER 59.74 -158.81 0.31 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.23 172.351 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.595 ' H ' HG22 ' A' ' 161' ' ' THR . 21.4 t -101.52 -14.4 17.5 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.87 -175.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 162' ' ' SER . 18.6 m-85 73.45 147.53 0.09 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.089 -175.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.6 mt 75.21 -46.49 0.59 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.01 0.924 . . . . 0.0 108.798 -168.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 58.95 96.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 114.508 -1.224 . . . . 0.0 111.723 170.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -87.61 -40.97 13.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.189 -174.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -157.89 -171.19 3.43 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.673 -177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 12.6 m -89.9 98.89 8.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.546 0.689 . . . . 0.0 110.863 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.11 -6.0 47.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.73 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -55.97 -35.71 67.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.074 0.464 . . . . 0.0 110.649 175.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.668 ' HA ' HG12 ' A' ' 11' ' ' ILE . 44.6 t30 -67.87 -39.43 83.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.111 178.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.455 ' HA ' HG13 ' A' ' 176' ' ' ILE . 36.0 tt0 -79.29 -20.89 46.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.718 -178.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.514 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 2.2 tpt -63.11 -33.6 75.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.462 0.648 . . . . 0.0 109.263 173.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 151' ' ' SER . 13.0 tp -81.0 -45.06 17.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.251 173.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 135.18 7.5 1.97 Allowed Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.437 -0.802 . . . . 0.0 113.247 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.455 HG13 ' HA ' ' A' ' 172' ' ' GLU . 55.6 mt 63.17 94.24 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-O 121.323 0.582 . . . . 0.0 111.299 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 7.0 t -115.76 165.74 12.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.355 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -84.24 152.77 28.47 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.143 -179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 8.7 tt -73.13 128.91 36.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.033 0.444 . . . . 0.0 111.127 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.1 mp -93.69 134.4 36.04 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.199 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 53.22 68.02 3.29 Favored Pre-proline 0 N--CA 1.466 0.335 0 O-C-N 123.673 0.608 . . . . 0.0 111.259 -176.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.52 -4.93 13.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.705 2.27 . . . . 0.0 113.459 -173.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -140.51 148.3 40.86 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.587 0.232 . . . . 0.0 110.812 -177.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 156.04 -81.73 0.16 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.569 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -146.81 130.96 17.36 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -86.35 43.16 1.04 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.567 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 6.5 mp 54.29 36.6 25.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.411 0.624 . . . . 0.0 110.45 -177.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 . . . . . 0 C--O 1.249 1.057 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.464 -177.627 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tmm? . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 64.58 21.34 12.41 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 169.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 66.0 35.02 90.09 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.074 176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 69.52 122.4 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.185 0.594 . . . . 0.0 110.607 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.47 HD13 HD23 ' A' ' 139' ' ' LEU . 85.1 mt -74.82 -8.86 57.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.652 -0.703 . . . . 0.0 112.633 -171.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -66.3 132.82 49.24 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.73 11.7 84.38 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.774 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.634 ' HG3' ' HA ' ' A' ' 152' ' ' GLU . 13.8 mptt -117.06 172.05 7.53 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.481 -0.423 . . . . 0.0 110.145 176.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 54.9 p90 -144.21 152.94 41.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.266 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.587 HD12 ' CE3' ' A' ' 148' ' ' TRP . 17.4 pt -109.79 151.83 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.992 0.425 . . . . 0.0 110.877 -178.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.793 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 40.8 mm -100.66 115.51 42.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.826 ' HB3' HG21 ' A' ' 25' ' ' VAL . . . -149.63 147.65 28.37 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.588 0.232 . . . . 0.0 111.485 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.1 m 58.31 81.29 0.26 Allowed Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.035 178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -84.31 -14.09 7.15 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.16 1.906 . . . . 0.0 111.843 175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.8 mm-40 -129.68 121.34 26.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.404 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.7 tpt -139.1 112.79 8.39 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -86.89 -35.83 18.75 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -170.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 33.0 t0 -71.47 -73.11 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.544 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . 1.1 mp0 -85.45 94.63 9.04 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 169.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -65.59 -32.61 74.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.012 0.435 . . . . 0.0 111.652 -172.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -125.24 64.53 1.15 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.681 0.753 . . . . 0.0 110.175 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.544 ' HB2' ' HB3' ' A' ' 19' ' ' GLU . 29.3 t70 -90.72 168.04 12.05 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.761 174.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HD2' HD21 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -79.97 78.51 6.59 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.7 p -74.82 79.89 2.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.108 -173.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.826 HG21 ' HB3' ' A' ' 12' ' ' ALA . 91.9 t 72.72 132.73 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.875 174.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.598 HG13 ' HD1' ' A' ' 27' ' ' TYR . 4.6 tp -122.72 -103.65 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 118.802 -0.618 . . . . 0.0 110.941 174.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.598 ' HD1' HG13 ' A' ' 26' ' ' ILE . 8.8 p90 -129.33 173.8 10.19 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 120.027 1.285 . . . . 0.0 112.348 -171.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.3 mm -100.49 128.29 52.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.673 176.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 58.1 m -79.8 -57.8 3.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.519 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -146.44 157.75 43.8 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.268 0.556 . . . . 0.0 111.297 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -133.03 112.06 11.5 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.666 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 32' ' ' ASN . 0.9 OUTLIER -94.98 163.33 13.36 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 166.138 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -62.33 -30.9 71.49 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.189 0.519 . . . . 0.0 110.608 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -96.65 -33.98 11.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.718 179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -126.93 123.45 4.66 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.354 -172.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.562 ' O ' ' HA ' ' A' ' 133' ' ' THR . 28.4 m -108.78 116.34 31.8 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 176.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.602 HG13 HG22 ' A' ' 133' ' ' THR . 3.5 mp -104.32 120.13 54.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.834 0.349 . . . . 0.0 110.943 -174.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.46 163.5 29.26 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.913 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.534 HG23 HG23 ' A' ' 26' ' ' ILE . 1.6 m -115.42 88.1 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.668 0.747 . . . . 0.0 110.501 177.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.548 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -132.27 26.98 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.061 -175.689 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.648 HG21 ' O ' ' A' ' 74' ' ' ASN . 10.7 tp -64.74 -36.56 77.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.415 -172.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.522 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.1 t-20 63.38 63.88 0.86 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.126 0.489 . . . . 0.0 110.923 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.551 HG22 HG13 ' A' ' 41' ' ' ILE . 14.3 t 173.37 130.0 0.1 Allowed Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.927 175.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.551 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 75.1 Cg_endo -92.97 155.95 2.7 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.175 2.583 . . . . 0.0 112.038 173.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 74' ' ' ASN . 9.8 p -87.6 -177.99 6.0 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -95.74 -2.86 46.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.735 0.779 . . . . 0.0 109.458 177.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.437 HD21 HD21 ' A' ' 52' ' ' LEU . 62.2 tp -90.35 158.3 17.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.164 -177.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 11.8 m -114.42 152.88 30.85 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.207 -0.308 . . . . 0.0 110.467 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.615 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.2 p -64.15 -37.62 80.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.043 0.449 . . . . 0.0 110.007 177.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.5 mt -63.38 -34.2 77.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.339 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 48' ' ' SER . 34.1 mt-10 -63.51 -44.0 95.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.518 177.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.497 HD13 HD21 ' A' ' 129' ' ' LEU . 56.4 mt -66.59 -45.93 77.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.75 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 89.3 mt -56.04 -48.97 75.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.072 -178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.8 p -73.1 -31.42 64.32 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.539 -178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -68.63 -52.36 32.24 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.81 0.338 . . . . 0.0 111.021 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.9 mtm -84.05 -90.85 0.09 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.916 -177.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -164.17 142.28 7.14 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.219 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.426 ' HA ' ' HG ' ' A' ' 113' ' ' LEU . 43.2 p90 -137.51 21.61 2.93 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.731 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 58' ' ' PHE . 1.6 mp0 67.5 112.84 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.297 -170.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.424 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 17.1 ttt -67.82 164.04 20.49 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.444 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 60' ' ' MET . . . 77.31 4.68 3.18 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.656 0.783 . . . . 0.0 111.261 -175.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -96.0 127.5 40.68 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.08 130.61 26.16 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.639 2.226 . . . . 0.0 112.65 -178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 0.6 OUTLIER -143.25 154.02 43.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.907 178.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 32.8 pt -118.68 178.75 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.0 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.414 ' O ' ' HB ' ' A' ' 67' ' ' THR . 75.9 t80 -132.66 81.88 1.97 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.761 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 66' ' ' TYR . 14.7 t 178.57 162.87 0.72 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.365 179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 56.21 73.21 0.45 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.574 0.702 . . . . 0.0 110.226 -178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -70.71 128.77 37.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.716 -173.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -103.21 112.94 26.04 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 172.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.618 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 87.7 mtp -82.3 145.29 30.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.033 0.444 . . . . 0.0 111.397 -171.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.458 HG23 HG22 ' A' ' 127' ' ' VAL . 8.1 p -99.03 143.29 13.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.369 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 8.0 mp -90.78 164.14 14.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.955 0.407 . . . . 0.0 110.373 177.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 41' ' ' ILE . 3.6 t-20 -100.27 103.49 14.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.59 -27.8 61.72 Favored Glycine 0 C--N 1.328 0.098 0 O-C-N 123.5 0.5 . . . . 0.0 112.885 -171.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.03 172.19 30.22 Favored Glycine 0 N--CA 1.442 -0.9 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.14 -13.04 28.42 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.333 2.022 . . . . 0.0 111.825 177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.74 145.37 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.468 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.545 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 83.9 m-20 63.96 24.75 13.72 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.222 0.326 . . . . 0.0 111.765 174.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -69.16 -10.89 59.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.702 0.763 . . . . 0.0 110.595 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.0 -13.68 60.23 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.711 176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 50.0 mtm180 -113.71 134.54 54.69 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.981 0.42 . . . . 0.0 110.935 -172.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.57 119.22 5.06 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.755 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -105.84 121.52 44.23 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.436 HG13 HG23 ' A' ' 127' ' ' VAL . 5.1 mp -141.96 117.72 6.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 178.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 125' ' ' PHE . 95.3 t -112.14 119.82 61.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.431 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 0.1 OUTLIER -129.5 159.64 35.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.925 -177.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.6 m -82.45 167.68 18.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.119 174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.431 ' HE2' ' CE1' ' A' ' 87' ' ' HIS . 4.7 mptp? -119.22 122.02 41.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 t -94.13 -21.11 19.31 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 121.011 -0.275 . . . . 0.0 111.573 -173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.885 ' HB3' ' HG3' ' A' ' 93' ' ' GLU . 2.6 t70 -114.03 -4.78 13.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.56 0.695 . . . . 0.0 109.499 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.7 m170 67.29 34.39 4.9 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.07 -177.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.885 ' HG3' ' HB3' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -87.97 165.72 15.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.94 175.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -159.06 116.57 2.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.294 0.568 . . . . 0.0 110.966 176.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 38.7 m -88.73 -60.57 1.92 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.97 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.557 ' H ' ' HB2' ' A' ' 111' ' ' ASP . 0.1 OUTLIER -145.24 35.22 1.09 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.439 179.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.06 148.48 24.47 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.97 -175.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -102.16 135.68 43.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.565 -178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -87.3 116.12 25.18 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -172.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.9 t -95.37 -54.04 7.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 169.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.807 HG22 ' HB ' ' A' ' 104' ' ' ILE . 11.9 t -138.69 -158.43 0.86 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -59.33 -65.18 0.71 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 -174.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -93.66 -23.96 18.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.751 0.31 . . . . 0.0 111.38 -175.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.807 ' HB ' HG22 ' A' ' 101' ' ' THR . 41.3 mm -86.96 122.46 38.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.987 0.423 . . . . 0.0 110.823 -171.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.1 p -134.16 137.9 44.8 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.981 -175.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.6 tp -91.82 137.66 32.18 Favored 'General case' 0 C--O 1.218 -0.591 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.33 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.818 HG21 ' HB3' ' A' ' 111' ' ' ASP . 25.4 m -138.8 140.04 38.44 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 121.733 -0.604 . . . . 0.0 111.456 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 34.4 p -111.6 -29.07 7.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.417 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.5 m -155.55 160.29 40.39 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.689 0.281 . . . . 0.0 111.171 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.82 -82.19 0.41 Allowed Glycine 0 CA--C 1.521 0.444 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.903 176.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.818 ' HB3' HG21 ' A' ' 107' ' ' THR . 11.2 t70 -51.91 -48.57 64.12 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.546 0.738 . . . . 0.0 111.629 -173.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.561 HG13 HD22 ' A' ' 113' ' ' LEU . 7.6 p -63.58 -38.64 82.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.988 -176.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.561 HD22 HG13 ' A' ' 112' ' ' VAL . 2.6 mm? -69.46 -33.27 72.67 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.303 0.573 . . . . 0.0 110.0 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -76.35 -28.2 56.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.607 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 58.6 m -57.48 -62.43 1.79 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.639 -0.71 . . . . 0.0 112.35 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -86.36 27.68 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -172.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -111.2 20.36 23.7 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.155 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.6 t -162.93 172.72 14.65 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -71.54 -19.49 62.16 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.722 0.296 . . . . 0.0 111.471 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.0 p -84.53 18.27 2.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.056 0.455 . . . . 0.0 110.994 178.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.41 129.82 93.85 Favored Pre-proline 0 N--CA 1.452 -0.349 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.341 174.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -62.98 139.23 72.42 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.623 2.215 . . . . 0.0 112.195 178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -60.71 -48.58 81.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.515 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 159' ' ' PHE . 2.0 mmpp? -101.05 119.09 38.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.937 -168.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.43 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 36.9 p90 -154.87 127.93 8.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.289 175.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 34.2 pt -109.43 133.54 54.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.082 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.557 HG11 ' HB ' ' A' ' 49' ' ' VAL . 7.5 p -116.44 128.94 73.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.279 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 81.2 m -143.52 151.97 40.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.105 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 52' ' ' LEU . 2.4 mm? -102.45 117.18 34.17 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 174.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.545 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . 83.67 -175.85 52.19 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.964 -175.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 19.3 m -148.45 163.69 36.41 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.9 m -98.37 114.84 27.32 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 175.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.602 HG22 HG13 ' A' ' 37' ' ' ILE . 22.6 p -112.5 120.02 40.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.568 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.522 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 0.4 OUTLIER -86.23 133.25 33.85 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 177.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 136' ' ' PRO . 96.6 mttt -65.0 153.31 89.16 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.082 -175.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 135' ' ' LYS . 33.5 Cg_exo -28.7 98.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.68 1 C-N-CA 125.507 4.138 . . . . 0.0 115.233 -171.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 71.58 -2.71 2.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.88 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -62.82 -30.07 71.21 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.47 HD23 HD13 ' A' ' 5' ' ' LEU . 36.2 tp -60.14 -29.16 68.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.604 0.24 . . . . 0.0 111.296 -176.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.99 -38.4 90.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.07 0.462 . . . . 0.0 109.912 178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.518 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 1.9 mp0 -70.43 -37.16 74.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.412 177.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.522 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 74.7 mm-40 -63.41 -43.7 96.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.341 177.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 139' ' ' LEU . 73.3 mt -68.56 -31.24 50.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.483 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.26 -24.43 67.32 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.215 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.518 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 39.1 mt-30 -83.7 -0.59 51.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.562 176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 62.23 17.24 9.1 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.665 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -87.97 0.78 55.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.415 0.626 . . . . 0.0 109.703 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.587 ' CE3' HD12 ' A' ' 10' ' ' ILE . 99.4 m95 -138.07 122.11 17.9 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.651 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.793 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 75.8 mt -98.92 145.64 26.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.1 tp -124.49 134.65 52.97 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.138 0.494 . . . . 0.0 111.368 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 31.0 t -138.38 148.95 45.07 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.432 175.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.634 ' HA ' ' HG3' ' A' ' 8' ' ' LYS . 26.0 mp0 -87.32 153.32 21.56 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.032 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -115.05 128.71 56.41 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.123 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -62.4 -63.56 1.2 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.986 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -177.64 -56.24 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.095 175.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 42.0 mt-30 -62.85 -27.3 69.24 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.955 0.407 . . . . 0.0 110.808 178.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.9 m -52.45 -29.06 22.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.134 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 82.1 mt -65.21 -54.72 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.463 ' HD2' ' HB3' ' A' ' 124' ' ' LYS . 54.1 m-85 -129.83 -14.17 4.06 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -173.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 44.2 mt-10 -96.41 0.89 51.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.162 0.506 . . . . 0.0 110.877 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 14.5 t -66.41 150.93 48.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.183 175.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.711 ' HB2' ' HA ' ' A' ' 167' ' ' TRP . 22.6 t 67.19 4.41 3.65 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.201 0.6 . . . . 0.0 112.12 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -79.73 -14.11 58.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.975 0.417 . . . . 0.0 110.121 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' A' ' 165' ' ' ASP . 2.2 pp -135.48 -4.95 2.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.852 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.44 ' HB2' HD12 ' A' ' 164' ' ' LEU . 5.6 t70 -153.3 -156.37 0.69 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 121.117 -0.233 . . . . 0.0 110.38 -175.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.549 ' O ' ' HG3' ' A' ' 169' ' ' GLU . 26.6 mmm180 -66.84 155.49 38.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.825 0.345 . . . . 0.0 111.275 -176.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.711 ' HA ' ' HB2' ' A' ' 162' ' ' SER . 5.2 t-105 -76.42 -17.61 59.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.517 0.675 . . . . 0.0 110.69 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 31.5 m -91.96 20.59 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.512 -172.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.613 ' O ' ' HG2' ' A' ' 173' ' ' MET . 50.2 mt-10 -53.89 -42.99 69.27 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.59 -46.26 66.87 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.037 0.446 . . . . 0.0 111.276 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.444 ' OD1' HG13 ' A' ' 176' ' ' ILE . 20.5 t-20 -80.44 -36.84 33.03 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.909 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -64.18 -29.29 70.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.504 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.613 ' HG2' ' O ' ' A' ' 169' ' ' GLU . 29.2 mmt -60.64 -29.35 69.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.918 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.425 HD13 HG13 ' A' ' 11' ' ' ILE . 5.2 tt -101.1 -51.66 3.47 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.925 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 151.35 117.41 0.77 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.443 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.576 ' H ' HD12 ' A' ' 176' ' ' ILE . 4.4 mp -63.93 -44.46 97.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.509 0.671 . . . . 0.0 109.319 174.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 43.1 t -92.87 103.55 15.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.08 -0.963 . . . . 0.0 109.718 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 157.19 -140.27 7.01 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 54.0 mt 69.85 119.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 121.462 0.648 . . . . 0.0 111.511 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 5.4 mp -82.88 64.88 7.73 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.334 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -134.01 113.59 12.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.679 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -61.38 153.36 66.34 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.857 2.371 . . . . 0.0 112.004 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -77.89 66.38 3.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.346 0.593 . . . . 0.0 110.843 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 146.88 52.76 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.474 HH22 ' HB1' ' A' ' 12' ' ' ALA . 27.3 ptt180 -74.6 95.48 2.82 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.282 0.563 . . . . 0.0 111.219 -177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -87.98 75.82 8.71 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.258 0.551 . . . . 0.0 109.729 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 98.0 mt -77.23 84.91 3.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.862 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 . . . . . 0 C--O 1.245 0.838 0 CA-C-O 118.381 -0.818 . . . . 0.0 109.922 176.222 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.547 ' HA ' ' HB2' ' A' ' 140' ' ' GLU . 2.0 mpt? . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 66.92 -59.24 0.38 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.508 0.723 . . . . 0.0 111.093 -172.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 166.14 -152.46 21.62 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -76.16 107.84 8.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.099 0.476 . . . . 0.0 110.096 175.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.09 8.87 16.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.184 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -70.95 119.77 15.56 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.391 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.17 7.84 45.73 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.1 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -116.85 175.36 5.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.512 ' CB ' ' HA ' ' A' ' 27' ' ' TYR . 26.9 p90 -146.92 140.58 25.75 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 171.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 pt -93.92 131.74 39.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.311 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.978 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 3.4 mp -90.07 114.99 28.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.833 -175.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.573 ' HB2' ' HZ3' ' A' ' 148' ' ' TRP . . . -90.71 125.2 35.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.609 174.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.3 m -119.29 90.57 42.36 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.89 0.376 . . . . 0.0 110.706 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 87.5 Cg_endo -93.94 177.93 1.09 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.135 2.557 . . . . 0.0 112.658 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -120.91 10.52 10.87 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.347 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -85.55 -76.74 0.32 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.951 -176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -166.54 129.27 1.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.949 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -115.57 152.96 32.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.51 ' HG3' ' HB3' ' A' ' 22' ' ' ASP . 3.3 mm-40 -91.31 164.89 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.194 0.521 . . . . 0.0 112.024 -172.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -122.28 -38.56 2.67 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.802 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.6 t80 -102.25 -38.06 7.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.732 -176.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' HB3' ' HG3' ' A' ' 19' ' ' GLU . 3.2 t70 -73.39 169.48 17.07 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.125 -0.488 . . . . 0.0 109.832 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.525 ' HG2' HG21 ' A' ' 126' ' ' ILE . 7.1 tpm_? -87.6 83.36 7.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.235 0.541 . . . . 0.0 110.858 -172.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.2 t -91.91 132.41 36.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.501 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.5 t 71.43 117.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.259 178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.916 HG22 ' HD1' ' A' ' 27' ' ' TYR . 9.0 mm -116.17 -95.55 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.326 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.916 ' HD1' HG22 ' A' ' 26' ' ' ILE . 2.1 p90 178.09 -177.4 0.22 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 122.251 0.22 . . . . 0.0 110.56 178.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.2 mm -95.25 124.6 47.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 79.3 m -91.22 -46.46 8.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.722 -173.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.739 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 32.1 mt-10 -131.89 150.57 52.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.372 0.606 . . . . 0.0 112.218 -176.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -132.37 105.95 7.6 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 167.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -109.3 171.05 7.67 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.453 -175.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -62.53 -26.23 68.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.665 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -111.41 13.01 21.53 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 157.11 170.59 22.22 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 119.619 -1.277 . . . . 0.0 113.238 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 133' ' ' THR . 55.1 m -115.21 130.41 56.91 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.839 HG13 HG22 ' A' ' 133' ' ' THR . 3.8 mp -109.59 119.11 58.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.425 -173.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.01 165.12 28.56 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.121 178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.515 HG23 ' HB ' ' A' ' 26' ' ' ILE . 3.3 m -126.99 102.5 9.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.237 0.541 . . . . 0.0 110.957 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.489 ' N ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -141.79 12.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.166 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.1 tp -74.55 -33.8 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.204 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 60.8 m-20 58.96 86.5 0.09 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.798 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 9.0 t -163.04 123.02 1.41 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.257 0.551 . . . . 0.0 111.411 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.516 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 2.4 Cg_endo -83.01 173.95 9.73 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.184 2.589 . . . . 0.0 111.607 176.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.405 HG22 ' ND2' ' A' ' 74' ' ' ASN . 16.6 p -118.17 -171.51 2.08 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.756 0.312 . . . . 0.0 110.366 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -96.76 7.11 47.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.387 178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.5 tp -112.12 155.52 23.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.427 -176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.634 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 43.0 m -104.91 157.44 17.21 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.003 176.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.436 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 14.7 p -68.67 -34.08 63.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.18 0.515 . . . . 0.0 109.92 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.474 HD13 HD12 ' A' ' 65' ' ' ILE . 86.2 mt -73.82 -25.9 60.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.291 178.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -53.16 56.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.751 178.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.1 pp -65.57 -33.62 76.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.605 -175.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 97.4 mt -64.82 -50.58 66.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.179 0.514 . . . . 0.0 110.96 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.9 p -72.43 -29.19 63.49 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 28.5 ttt85 -72.47 -39.62 67.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.388 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.472 ' HG3' ' N ' ' A' ' 57' ' ' ASP . 19.7 ptp -150.09 -57.27 0.18 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -174.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 56' ' ' MET . 10.4 t70 -97.37 131.16 44.3 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.835 -166.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.4 t80 66.92 87.49 0.12 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.295 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.54 77.52 9.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.804 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 26.0 ttt -174.23 144.43 0.95 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.1 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 72.35 142.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.936 0.773 . . . . 0.0 112.305 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 73.3 mmtt 67.98 139.06 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.389 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.475 178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 91.3 Cg_endo -94.01 -168.46 0.17 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.318 2.679 . . . . 0.0 112.368 177.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -73.48 89.11 1.65 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.141 0.496 . . . . 0.0 110.948 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.474 HD12 HD13 ' A' ' 50' ' ' LEU . 69.0 mt -100.94 110.52 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.747 176.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -126.26 7.49 7.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.889 -173.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 m -75.61 -78.9 0.1 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.635 -172.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -176.21 88.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -132.36 -82.32 0.49 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.536 -173.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -128.3 112.79 14.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.881 0.372 . . . . 0.0 110.704 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.634 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 69.7 mtm -92.59 161.29 14.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.186 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -104.66 141.39 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.516 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 6.6 mp -109.2 170.51 8.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.812 0.339 . . . . 0.0 110.82 -176.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.405 ' ND2' HG22 ' A' ' 45' ' ' THR . 75.1 m-20 -110.21 132.15 54.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.013 176.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.75 -16.94 53.79 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.424 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 161.49 -179.35 36.95 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.934 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -86.79 5.04 6.01 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.164 2.576 . . . . 0.0 112.824 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.407 HG21 ' OG1' ' A' ' 133' ' ' THR . 21.7 t -120.19 153.84 23.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 89.4 m-20 65.53 33.44 8.66 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.873 0.368 . . . . 0.0 110.333 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -65.31 -14.51 60.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.102 -174.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -91.1 -4.67 56.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.422 0.63 . . . . 0.0 110.553 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -109.5 120.36 42.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.074 0.464 . . . . 0.0 110.897 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.75 108.52 3.62 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.55 ' HB3' HD11 ' A' ' 106' ' ' LEU . 98.0 m-85 -97.19 125.27 41.6 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.698 0.285 . . . . 0.0 110.735 -176.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.444 ' HB ' HG11 ' A' ' 112' ' ' VAL . 3.7 mp -117.12 109.92 29.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.207 0.527 . . . . 0.0 109.891 175.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -94.13 121.01 44.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.322 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -138.55 155.56 48.27 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.461 -177.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 28.1 m -73.98 164.38 26.7 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 103' ' ' ASP . 14.3 ttmm -88.5 118.1 27.91 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 122.072 0.939 . . . . 0.0 112.291 -176.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.4 m -139.48 18.43 2.55 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 169.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -132.6 161.31 34.2 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.205 -1.816 . . . . 0.0 111.019 -167.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.14 28.14 1.39 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.603 171.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.51 170.27 13.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.708 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -162.66 79.98 0.5 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.7 m -92.56 -41.42 10.25 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 8.9 t60 -169.6 78.38 0.1 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.337 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 11.6 m -115.2 133.86 55.66 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.102 -172.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.601 ' HB3' ' HB3' ' A' ' 106' ' ' LEU . 4.8 t80 -102.11 102.54 13.02 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -81.73 106.27 13.53 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.08 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.55 HG11 ' HE2' ' A' ' 27' ' ' TYR . 16.8 t -91.06 -62.71 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 46.5 p -119.05 175.71 5.64 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 174.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -55.97 -33.06 64.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 20.5 t70 -106.37 -49.12 3.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.392 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 25.6 mm -76.2 121.95 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 CA-C-O 121.208 0.528 . . . . 0.0 110.001 -169.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.6 m -122.11 132.45 54.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.758 -175.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 98' ' ' TYR . 58.6 tp -102.23 112.24 24.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.839 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.664 HG21 ' HB3' ' A' ' 111' ' ' ASP . 15.2 m -106.96 124.3 49.43 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 176.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.03 28.35 8.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.881 -175.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.0 t -146.8 -174.24 4.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.711 -177.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.34 -0.87 25.12 Favored Glycine 0 C--N 1.337 0.607 0 CA-C-N 116.192 -0.458 . . . . 0.0 113.091 -176.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.664 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.4 t70 -55.26 -37.7 67.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.258 0.552 . . . . 0.0 110.123 174.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.559 HG23 HD22 ' A' ' 113' ' ' LEU . 36.0 m -55.82 -34.33 36.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.142 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.559 HD22 HG23 ' A' ' 112' ' ' VAL . 3.5 mm? -62.49 -34.55 77.08 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.446 0.641 . . . . 0.0 110.197 178.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -83.37 -25.8 31.07 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.919 -179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.0 m -62.3 -57.1 12.62 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.236 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.433 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 11.7 p90 -91.46 3.66 54.42 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.014 0.435 . . . . 0.0 110.858 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -98.67 29.18 12.07 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.954 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.4 t -140.62 174.19 10.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -65.05 -39.16 92.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.813 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.7 p -89.76 32.32 0.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.48 -176.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.433 ' CB ' ' HA ' ' A' ' 116' ' ' PHE . . . -58.51 130.46 84.8 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.993 176.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.22 140.22 91.07 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.916 2.411 . . . . 0.0 112.308 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.09 -52.87 44.68 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.723 179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -104.75 113.3 26.79 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.221 -172.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -147.27 133.61 19.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.806 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.525 HG21 ' HG2' ' A' ' 23' ' ' ARG . 32.7 pt -123.99 143.03 38.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.578 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.24 119.35 60.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.227 0.537 . . . . 0.0 110.489 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 9.6 p -131.07 130.88 43.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.532 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.69 125.63 34.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.014 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 79' ' ' ASN . . . 75.56 178.48 43.2 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.884 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 77.8 m -150.76 173.32 14.33 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 18.4 m -102.16 116.9 33.63 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.839 HG22 HG13 ' A' ' 37' ' ' ILE . 78.3 p -111.12 120.83 43.64 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.994 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . . . . . . . . . 2.1 m-90 -81.01 137.71 36.06 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.092 0.472 . . . . 0.0 110.487 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -71.67 140.23 84.01 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.521 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -36.58 130.25 0.44 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 124.248 3.299 . . . . 0.0 114.716 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 6.2 t60 77.37 -34.43 0.2 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.768 -1.105 . . . . 0.0 112.41 174.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 60.6 tp60 -60.2 -44.38 95.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -173.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 44.8 tp -55.82 -35.46 66.39 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.661 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 1' ' ' MET . 42.9 tt0 -64.36 -38.92 92.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 110.148 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -71.26 -39.47 71.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.633 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.558 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 8.4 mm-40 -57.8 -51.12 70.87 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.302 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.8 mt -68.75 -33.15 58.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.564 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.61 -39.4 91.11 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.754 0.311 . . . . 0.0 111.057 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -86.1 12.64 9.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.09 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 62.32 32.97 16.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.082 176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.81 ' HA ' ' HG2' ' A' ' 182' ' ' PRO . 15.9 m-85 -72.14 -28.0 62.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.229 0.538 . . . . 0.0 109.738 172.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.573 ' HZ3' ' HB2' ' A' ' 12' ' ' ALA . 91.0 m95 -134.08 139.41 45.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.695 -177.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.978 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.9 tt -88.2 141.3 28.67 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.535 ' N ' HD23 ' A' ' 149' ' ' LEU . 59.3 tp -123.09 134.57 54.24 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.696 -175.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 25.9 p -161.42 164.07 30.1 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.877 175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -71.13 155.78 40.36 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.142 0.496 . . . . 0.0 111.274 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -106.04 -155.16 0.53 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.935 -175.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.3 t30 65.85 22.9 11.39 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.76 0.791 . . . . 0.0 109.891 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -88.31 165.72 14.8 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.25 -0.886 . . . . 0.0 108.883 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 160' ' ' GLU . 38.0 mt-30 -59.31 -29.09 67.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.052 0.453 . . . . 0.0 110.624 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.664 ' HA ' HG23 ' A' ' 161' ' ' THR . 6.7 m -52.63 -30.48 31.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.262 -179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.54 -57.18 6.94 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.356 -175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -127.42 -19.26 4.27 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 156' ' ' GLN . 41.0 mt-10 -82.74 -9.07 59.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.828 0.347 . . . . 0.0 111.524 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 157' ' ' THR . 1.6 p -65.51 -27.06 68.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.401 0.62 . . . . 0.0 110.246 173.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.0 m -97.77 22.87 8.56 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.475 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -122.3 -58.59 1.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.073 -175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.59 ' HG ' ' N ' ' A' ' 165' ' ' ASP . 2.4 pt? -116.41 -63.12 1.49 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 120.368 -0.533 . . . . 0.0 112.3 -178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.59 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 6.2 t70 -170.64 -175.8 1.93 Allowed 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -170.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.545 ' HD3' ' OE2' ' A' ' 169' ' ' GLU . 17.3 mtt180 71.61 155.72 0.15 Allowed 'General case' 0 C--O 1.234 0.25 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 174.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.445 ' HD1' HG23 ' A' ' 168' ' ' VAL . 2.2 p90 -170.04 161.95 8.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.153 -1.385 . . . . 0.0 108.429 173.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.445 HG23 ' HD1' ' A' ' 167' ' ' TRP . 6.8 t 60.01 30.37 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 121.329 0.585 . . . . 0.0 110.817 -178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.545 ' OE2' ' HD3' ' A' ' 166' ' ' ARG . 42.0 mt-10 -70.4 -7.21 41.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.037 0.446 . . . . 0.0 110.933 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.477 ' HB1' ' CG1' ' A' ' 11' ' ' ILE . . . -53.79 -39.37 65.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.378 -0.828 . . . . 0.0 112.181 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -81.08 -33.03 33.67 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.554 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.19 -27.91 61.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.756 0.312 . . . . 0.0 110.658 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.615 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 1.0 OUTLIER -59.6 -33.05 70.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.196 0.522 . . . . 0.0 110.213 175.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.741 HD13 HD21 ' A' ' 149' ' ' LEU . 12.8 tp -82.05 -48.73 11.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.473 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 135.87 29.66 0.35 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.268 -0.878 . . . . 0.0 112.228 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 45.9 mm 71.74 -48.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 123.332 0.653 . . . . 0.0 112.033 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 13.7 m -74.07 89.32 1.95 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.037 0.446 . . . . 0.0 111.112 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.41 142.23 15.63 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.457 ' H ' HD12 ' A' ' 179' ' ' ILE . 4.5 mp -81.47 110.83 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 79.4 mt 63.8 179.77 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.586 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -170.6 86.75 0.52 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.999 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.81 ' HG2' ' HA ' ' A' ' 147' ' ' TYR . 24.2 Cg_endo -94.99 153.6 1.74 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.234 2.623 . . . . 0.0 112.742 178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 14' ' ' PRO . . . -132.36 -80.97 0.5 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.774 177.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 80.91 -173.72 54.71 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.215 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 16.9 mtt180 -129.92 156.33 44.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.078 0.466 . . . . 0.0 111.352 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -126.03 88.45 2.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.134 178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 187' ' ' LEU . 3.0 pp -70.1 145.91 51.29 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.187 -177.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.511 -0.757 . . . . 0.0 110.213 -179.334 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.424 0.154 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.566 ' HD2' ' HG3' ' A' ' 140' ' ' GLU . 97.1 m-85 -84.56 136.85 33.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.061 0.458 . . . . 0.0 111.112 -177.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.23 -127.4 4.26 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.301 -178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -78.35 102.79 7.9 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.633 0.254 . . . . 0.0 110.974 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.7 mt -72.79 -82.8 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 173.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 57.13 107.9 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 172.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.33 -1.96 79.1 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.565 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.69 ' HD2' ' HB3' ' A' ' 152' ' ' GLU . 37.9 mmtm -95.4 159.85 14.81 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.478 ' HZ ' ' HG2' ' A' ' 173' ' ' MET . 45.0 p90 -123.79 154.41 39.59 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.511 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.567 HD11 HG21 ' A' ' 40' ' ' ILE . 8.4 pt -114.45 144.56 21.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.758 -178.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 149' ' ' LEU . 3.7 mp -110.73 161.41 9.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.405 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 70.51 -176.59 0.2 Allowed 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.547 0.529 . . . . 0.0 110.784 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.5 t -174.98 146.0 0.93 Allowed Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.426 ' HA ' ' CD1' ' A' ' 147' ' ' TYR . 65.6 Cg_endo -73.98 -154.47 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.022 2.481 . . . . 0.0 111.861 174.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -79.46 49.01 0.95 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.108 0.48 . . . . 0.0 110.646 178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.6 tpt -73.64 160.89 30.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.735 -179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -74.53 88.17 2.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.04 0.448 . . . . 0.0 110.515 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -75.29 111.64 10.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.22 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.556 ' HG3' ' CD2' ' A' ' 20' ' ' TYR . 9.6 tp10 -76.2 -65.22 0.95 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.242 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.556 ' CD2' ' HG3' ' A' ' 19' ' ' GLU . 66.8 m-85 -140.62 -86.0 0.2 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.7 t80 173.65 -24.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.119 -170.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.83 104.81 3.56 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 70.45 60.07 0.23 Allowed 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.935 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.3 t -97.51 112.01 24.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.228 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.464 HG22 ' HB ' ' A' ' 40' ' ' ILE . 38.6 t 54.76 92.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.076 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.496 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.4 tp -95.02 -57.35 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -175.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.496 ' HD1' HG13 ' A' ' 26' ' ' ILE . 6.1 p90 -174.3 175.47 2.63 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.158 0.436 . . . . 0.0 111.637 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 46.8 mm -94.93 126.61 47.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.816 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.35 -51.24 15.69 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.753 0.311 . . . . 0.0 111.157 -175.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -159.92 153.83 23.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 0.0 110.846 -175.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -120.6 104.64 10.1 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 171.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -106.59 171.04 7.57 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.194 -173.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.76 -22.59 65.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.92 0.391 . . . . 0.0 110.999 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -80.69 -39.7 26.69 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.057 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 170.58 -167.31 40.47 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.605 -178.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.7 m -103.21 121.18 42.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.683 0.277 . . . . 0.0 110.335 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.647 HG13 HG22 ' A' ' 133' ' ' THR . 4.3 mp -98.0 118.74 45.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.09 153.93 25.37 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.494 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 m -114.6 88.69 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.728 0.775 . . . . 0.0 110.692 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.581 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -125.1 18.01 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.113 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.537 ' H ' HD13 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -61.07 -36.17 70.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.382 -176.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 37.6 t30 56.23 66.83 1.1 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.223 0.535 . . . . 0.0 110.582 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 t -169.47 103.41 0.47 Allowed Pre-proline 0 N--CA 1.45 -0.451 0 CA-C-O 121.545 0.688 . . . . 0.0 111.156 177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.565 ' HA ' ' HG ' ' A' ' 73' ' ' LEU . 5.9 Cg_exo -78.83 158.75 27.8 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.612 2.208 . . . . 0.0 110.286 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.54 HG21 ' ND2' ' A' ' 74' ' ' ASN . 73.6 p -110.38 166.3 11.09 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.549 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -73.87 -30.35 62.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.976 0.417 . . . . 0.0 110.78 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.5 tp -66.62 149.99 49.67 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.261 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.0 m -97.59 150.83 20.7 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.965 -175.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.676 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 7.1 p -61.85 -36.62 74.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 176.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.71 -35.46 81.12 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.481 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 55' ' ' ARG . 8.3 mm-40 -62.04 -39.0 90.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.038 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.1 mt -74.98 -35.6 62.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.941 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 83.2 mt -62.96 -49.46 74.64 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.497 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 36.2 p -67.56 -30.34 69.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.857 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.443 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 1.7 tpp180 -60.77 -52.24 65.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.6 -177.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.43 ' HG3' ' H ' ' A' ' 57' ' ' ASP . 13.1 ptt? -109.85 -64.85 1.21 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -173.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.43 ' H ' ' HG3' ' A' ' 56' ' ' MET . 35.7 t70 -155.4 136.14 13.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.809 0.338 . . . . 0.0 111.586 -174.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -152.49 139.3 18.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.692 176.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -91.02 151.42 21.05 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 60.7 mtt -76.41 84.76 3.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.37 0.605 . . . . 0.0 111.365 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.746 ' HB1' ' HA3' ' A' ' 117' ' ' GLY . . . -124.77 1.54 8.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.863 174.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 31.8 mmmt -129.23 143.84 50.4 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.856 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.491 ' HB2' HG12 ' A' ' 65' ' ' ILE . 38.5 Cg_exo -62.24 -20.76 71.11 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.174 2.583 . . . . 0.0 113.089 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 88.0 mtm-85 70.55 17.28 6.79 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.201 0.6 . . . . 0.0 112.118 175.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.491 HG12 ' HB2' ' A' ' 63' ' ' PRO . 16.3 pt -81.44 126.56 39.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 172.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -61.57 107.5 0.81 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.38 0.61 . . . . 0.0 111.729 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.5 t -166.39 141.13 4.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.142 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 60.28 91.84 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.656 0.598 . . . . 0.0 111.924 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -78.09 132.09 37.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.935 0.398 . . . . 0.0 110.388 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -122.57 118.18 27.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.205 -178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 56.6 mtt -77.9 152.24 33.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 -179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.568 HG21 HD23 ' A' ' 129' ' ' LEU . 13.8 p -106.52 149.38 10.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.283 174.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.565 ' HG ' ' HA ' ' A' ' 44' ' ' PRO . 7.0 mp -102.42 159.75 15.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.763 0.315 . . . . 0.0 110.333 177.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.54 ' ND2' HG21 ' A' ' 45' ' ' THR . 35.9 m-20 -101.83 121.75 42.69 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 175.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.29 -23.34 58.99 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.542 -174.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 159.97 -177.07 36.6 Favored Glycine 0 N--CA 1.444 -0.777 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.397 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -77.53 -25.94 7.64 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.259 2.639 . . . . 0.0 112.835 -178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.3 t -86.62 125.93 40.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.988 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 67.19 31.04 6.92 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.485 0.491 . . . . 0.0 110.855 177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -65.97 -21.62 66.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.46 -175.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -82.87 -0.23 47.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.265 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.5 mtm180 -125.42 142.5 51.47 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.963 0.411 . . . . 0.0 110.675 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.78 131.88 10.74 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.11 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -112.72 123.1 49.55 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 106' ' ' LEU . 5.2 mp -137.49 120.16 20.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-O 120.913 0.387 . . . . 0.0 111.268 -177.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.1 t -110.51 130.41 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -132.01 149.36 52.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.448 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 p -69.91 150.44 46.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.984 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -65.79 112.86 3.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.532 0.682 . . . . 0.0 110.53 -178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 92.5 m -157.87 -48.2 0.06 Allowed 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -92.68 -165.77 1.41 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.645 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -165.79 134.07 3.05 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.894 ' HB3' ' HB3' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -100.35 -171.03 1.96 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.91 -177.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -118.0 -46.12 2.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.879 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 36.5 p -75.33 -84.32 0.05 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -168.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -110.6 91.29 3.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.847 0.356 . . . . 0.0 111.571 -172.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.9 m -96.04 104.03 15.95 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.565 175.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -102.73 102.62 12.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.015 0.436 . . . . 0.0 109.9 175.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 102' ' ' ASP . 4.8 mtmm -89.76 107.01 18.84 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.58 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.4 t -60.55 -53.96 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.424 HG22 HG12 ' A' ' 104' ' ' ILE . 5.8 t -134.53 -176.16 4.12 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 167.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.469 ' HA ' ' HE2' ' A' ' 99' ' ' LYS . 33.5 t70 -65.3 -33.35 75.76 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 118.27 0.486 . . . . 0.0 112.285 -170.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -98.15 2.38 48.46 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.424 HG12 HG22 ' A' ' 101' ' ' THR . 47.0 mm -117.81 123.65 71.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.7 m -124.41 124.99 43.54 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.993 0.425 . . . . 0.0 111.325 -176.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.429 HD12 ' O ' ' A' ' 85' ' ' ILE . 21.4 tp -101.59 130.45 47.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.021 174.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.7 m -129.16 124.89 35.81 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.1 p -109.03 28.87 8.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.64 -176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 70.9 m -138.08 177.24 8.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.51 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.453 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -63.5 -11.82 43.2 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.989 -0.55 . . . . 0.0 113.304 -177.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.894 ' HB3' ' HB3' ' A' ' 93' ' ' GLU . 0.9 OUTLIER -47.84 -38.02 15.1 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.781 0.433 . . . . 0.0 111.051 175.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.424 HG11 HG21 ' A' ' 85' ' ' ILE . 86.5 t -52.58 -40.82 35.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.376 178.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.554 HD11 HD22 ' A' ' 53' ' ' LEU . 3.8 mm? -62.3 -36.46 82.17 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -77.08 -27.24 54.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.05 -177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 70.2 m -56.99 -55.73 30.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.192 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.492 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 20.8 p90 -90.49 26.5 1.96 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -173.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.746 ' HA3' ' HB1' ' A' ' 61' ' ' ALA . . . -107.67 17.12 36.52 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.566 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 t -145.5 -179.31 6.58 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.677 -0.308 . . . . 0.0 110.326 -175.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -74.88 -21.74 59.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.678 0.275 . . . . 0.0 111.253 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.9 p -91.96 23.39 3.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.943 0.401 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.492 ' CB ' ' HA ' ' A' ' 116' ' ' PHE . . . -65.69 146.03 99.0 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.232 178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -64.55 133.83 38.7 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.415 2.077 . . . . 0.0 111.452 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.49 -36.48 83.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.997 0.427 . . . . 0.0 110.794 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 25.8 mtmt -136.74 128.1 28.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.075 -177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -148.01 140.78 24.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.745 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 26.5 pt -110.5 132.93 57.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 120.976 0.417 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.7 p -115.95 126.91 73.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.385 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 80.8 m -140.62 150.0 43.02 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.005 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.568 HD23 HG21 ' A' ' 72' ' ' VAL . 4.3 mm? -100.32 117.52 34.68 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 79.51 177.75 50.53 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.904 -177.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 66.4 m -145.83 168.58 20.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.89 0.376 . . . . 0.0 110.432 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 50.5 m -114.2 119.95 38.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.265 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.647 HG22 HG13 ' A' ' 37' ' ' ILE . 21.5 p -102.03 114.7 29.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.584 0.707 . . . . 0.0 111.69 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.53 ' HD1' ' HB2' ' A' ' 139' ' ' LEU . 0.5 OUTLIER -99.55 135.59 40.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.925 179.27 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.61 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 10.5 mptt -75.64 136.69 70.81 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.025 -175.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 6.5 Cg_exo -74.86 42.56 0.84 Allowed 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.647 2.898 . . . . 0.0 114.175 -170.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.476 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 55.1 m-70 -156.58 -38.72 0.08 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 171.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.617 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 50.4 tt0 -52.8 -60.72 2.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.906 171.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.53 ' HB2' ' HD1' ' A' ' 134' ' ' TRP . 57.4 tp -63.03 -35.88 81.71 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.402 179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.566 ' HG3' ' HD2' ' A' ' 2' ' ' PHE . 40.6 tt0 -55.66 -48.75 74.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.893 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 23.5 mt-30 -72.47 -31.5 65.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.114 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 53.7 mm-40 -59.19 -44.17 92.21 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.156 0.503 . . . . 0.0 109.912 175.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.588 HG12 ' HB2' ' A' ' 148' ' ' TRP . 66.7 mt -64.43 -36.78 78.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.341 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.29 -24.92 67.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.403 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.582 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 73.4 mt-30 -78.17 -0.64 29.16 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.903 0.382 . . . . 0.0 110.351 176.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.1 m120 70.28 31.28 3.15 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.895 177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . 0.47 ' HD2' ' HB2' ' A' ' 145' ' ' GLN . 59.7 m-85 -100.5 -4.23 29.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.262 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.588 ' HB2' HG12 ' A' ' 143' ' ' ILE . 97.2 m95 -134.48 148.94 50.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.768 -179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 11' ' ' ILE . 60.3 mt -126.03 153.35 44.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.852 175.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 60.1 tp -121.87 134.93 54.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.017 0.437 . . . . 0.0 111.576 -176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.2 t -149.96 173.13 14.15 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.69 ' HB3' ' HD2' ' A' ' 8' ' ' LYS . 0.7 OUTLIER -129.26 154.1 47.15 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.48 -0.488 . . . . 0.0 111.246 -179.026 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.536 ' HB1' ' HB ' ' A' ' 157' ' ' THR . . . -127.21 104.72 8.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.702 -178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -81.42 88.51 6.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.344 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 70.0 -65.97 0.29 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.69 -0.687 . . . . 0.0 112.828 176.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.581 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 30.7 mt-30 -56.62 -70.03 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -170.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.536 ' HB ' ' HB1' ' A' ' 153' ' ' ALA . 3.1 m -54.21 -29.57 46.74 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -175.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.61 -57.21 4.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.87 -174.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -128.83 -13.6 4.63 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -172.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 31.4 mt-10 -81.71 -52.33 7.27 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.273 174.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.5 m 61.89 113.75 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 O-C-N 124.397 1.061 . . . . 0.0 111.664 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.511 ' HB3' HD22 ' A' ' 164' ' ' LEU . 18.1 m -70.83 82.44 0.64 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.289 -178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -81.74 69.61 8.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.638 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.511 HD22 ' HB3' ' A' ' 162' ' ' SER . 2.5 pt? -129.35 -31.25 2.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.007 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -115.95 -53.18 2.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.073 0.463 . . . . 0.0 110.503 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.724 HH22 ' HG2' ' A' ' 172' ' ' GLU . 36.7 ttp-105 -145.81 171.57 14.58 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 8.6 m0 -86.49 -50.67 6.69 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.119 0.485 . . . . 0.0 110.723 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 4.3 p -88.09 91.04 3.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.702 0.763 . . . . 0.0 110.685 -178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.543 ' OE2' ' HB3' ' A' ' 166' ' ' ARG . 20.0 mm-40 -94.04 -3.23 51.68 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.767 178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -56.72 -33.26 66.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.581 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -79.51 -27.88 41.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.759 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.724 ' HG2' HH22 ' A' ' 166' ' ' ARG . 23.8 mm-40 -73.29 -23.41 60.28 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.01 0.433 . . . . 0.0 110.669 176.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.478 ' HG2' ' HZ ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -66.29 -28.47 68.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.732 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.425 ' CD2' HD13 ' A' ' 149' ' ' LEU . 10.4 tp -112.89 -50.5 2.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.198 -176.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 142.4 114.99 1.08 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 77.1 mt -54.49 -44.16 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.816 0.341 . . . . 0.0 111.358 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 55.0 m -92.68 30.39 1.56 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.104 0.478 . . . . 0.0 111.126 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -87.58 97.03 2.24 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.05 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.7 tt -114.39 142.85 25.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.747 0.308 . . . . 0.0 110.382 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.439 HD11 HD21 ' A' ' 149' ' ' LEU . 5.0 mp -88.13 153.44 21.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.68 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 55.42 64.7 5.3 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.033 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -86.27 -9.35 7.2 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.454 2.103 . . . . 0.0 112.043 177.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -111.18 29.76 7.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.714 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -57.86 139.27 47.48 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.429 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.448 ' HA ' ' NE ' ' A' ' 185' ' ' ARG . 5.1 tpm_? -78.29 -26.86 47.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.87 0.367 . . . . 0.0 110.417 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -129.1 83.17 2.13 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.243 0.545 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 94.2 mt -120.36 -37.34 3.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.949 178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.248 0.981 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.666 -177.527 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.532 ' HA ' ' CD ' ' A' ' 140' ' ' GLU . 64.5 mtt . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 120.239 0.066 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 64.73 92.22 0.07 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.66 0.6 . . . . 0.0 110.794 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -57.92 -72.38 0.6 Allowed Glycine 0 C--N 1.33 0.196 0 CA-C-N 115.563 -0.744 . . . . 0.0 112.652 -178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -103.57 99.93 9.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.114 0.483 . . . . 0.0 110.399 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.439 HD23 ' HB2' ' A' ' 8' ' ' LYS . 0.5 OUTLIER -99.98 15.6 26.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.453 0.644 . . . . 0.0 109.752 178.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.732 HE21 HG13 ' A' ' 100' ' ' VAL . 49.2 tt0 -91.51 131.49 36.92 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.674 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.8 0.14 59.09 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.684 -173.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.439 ' HB2' HD23 ' A' ' 5' ' ' LEU . 3.3 mptp? -107.8 176.62 5.08 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 43.3 p90 -142.72 152.94 42.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.054 0.454 . . . . 0.0 110.39 173.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.9 pt -118.19 128.12 75.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.307 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 60.0 mt -86.63 111.92 22.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.168 -175.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -120.78 94.87 4.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.558 173.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 15' ' ' GLU . 5.7 m -145.24 103.51 4.37 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.276 -178.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.48 -28.58 8.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.643 2.229 . . . . 0.0 112.647 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.447 ' O ' HG22 ' A' ' 13' ' ' THR . 73.2 mm-40 -107.42 -178.82 3.74 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.975 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -80.1 103.47 10.0 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.43 ' CG ' ' H ' ' A' ' 18' ' ' ASP . 12.3 t70 66.71 -165.59 0.22 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -171.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.43 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 35.3 t70 -125.71 -22.49 4.21 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.983 -0.448 . . . . 0.0 110.802 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' HB3' ' H ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER -140.87 -85.65 0.19 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.743 -178.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.437 ' H ' ' HB3' ' A' ' 19' ' ' GLU . 70.3 t80 177.86 -44.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.609 -173.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 166' ' ' ARG . 0.2 OUTLIER -141.62 29.85 1.72 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -176.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.725 ' HA ' ' NH1' ' A' ' 23' ' ' ARG . 1.9 t70 -100.95 -177.54 3.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.072 -171.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.725 ' NH1' ' HA ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -123.92 85.75 2.46 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -177.445 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.5 p -121.2 154.6 36.04 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.818 -174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t 67.91 96.53 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 O-C-N 123.815 0.697 . . . . 0.0 111.117 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.642 HG21 HG23 ' A' ' 39' ' ' VAL . 10.6 tp -124.65 -146.74 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.345 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.561 ' H ' HG13 ' A' ' 26' ' ' ILE . 3.5 p90 -116.63 171.71 7.7 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.427 1.012 . . . . 0.0 111.623 -164.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.2 mm -87.53 116.09 29.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.553 177.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.8 m -75.51 -45.07 40.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.109 -173.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -140.48 144.86 36.27 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.86 0.362 . . . . 0.0 110.719 176.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -128.61 111.96 13.76 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.293 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -114.75 173.36 6.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -71.84 -23.14 61.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.744 0.307 . . . . 0.0 111.112 -177.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -107.45 -27.59 10.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.468 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.82 127.12 3.32 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 119.8 -1.19 . . . . 0.0 113.06 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 133' ' ' THR . 82.1 m -107.39 110.72 22.77 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 173.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.745 HG13 HG22 ' A' ' 133' ' ' THR . 4.0 mp -96.54 114.33 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.843 -172.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -145.71 160.88 28.19 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 174.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.642 HG23 HG21 ' A' ' 26' ' ' ILE . 3.0 m -114.75 63.97 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.599 0.714 . . . . 0.0 110.491 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.644 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -111.66 15.3 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.544 -175.167 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.487 HG23 HG22 ' A' ' 43' ' ' THR . 10.4 tp -68.91 -28.25 38.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.359 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 63.7 87.74 0.11 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.103 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.487 HG22 HG23 ' A' ' 41' ' ' ILE . 4.1 t -168.52 96.84 0.56 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.455 0.645 . . . . 0.0 111.086 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 57.9 Cg_endo -74.84 154.19 43.13 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.059 1.839 . . . . 0.0 111.3 174.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -115.63 152.24 33.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.681 0.277 . . . . 0.0 110.614 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.77 -17.15 62.2 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.07 -175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.401 ' O ' HG12 ' A' ' 72' ' ' VAL . 21.4 tp -76.08 160.01 30.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 174.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.709 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 14.7 m -119.81 160.11 23.26 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.903 -174.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.571 ' O ' ' HG ' ' A' ' 53' ' ' LEU . 11.9 p -65.82 -37.92 81.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.046 -175.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.468 HD23 HD12 ' A' ' 53' ' ' LEU . 91.6 mt -66.54 -33.98 76.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.063 0.459 . . . . 0.0 110.204 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.709 ' OE1' ' HB2' ' A' ' 48' ' ' SER . 3.1 mp0 -61.76 -40.41 95.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.627 176.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.7 mt -74.02 -39.82 63.33 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.327 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 113' ' ' LEU . 95.1 mt -62.62 -49.14 76.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.978 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.69 HG22 ' HB3' ' A' ' 59' ' ' GLN . 40.1 p -68.11 -30.97 70.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.634 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.9 ttt180 -60.25 -37.27 79.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.585 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 73.0 mtm -78.53 -83.77 0.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 176.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -169.8 24.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.642 0.734 . . . . 0.0 110.714 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.472 ' CD1' ' HG ' ' A' ' 113' ' ' LEU . 98.9 m-85 -116.33 96.17 5.41 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.161 -178.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.69 ' HB3' HG22 ' A' ' 54' ' ' THR . 23.5 pt20 -142.14 115.56 8.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.568 0.699 . . . . 0.0 111.221 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 51.9 ttp -138.17 111.74 8.17 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.747 177.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.01 93.5 5.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.157 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 62' ' ' LYS . 15.8 ptpt -68.66 142.38 93.9 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.759 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 27.5 Cg_exo -63.29 -16.87 57.19 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.17 2.58 . . . . 0.0 113.126 -176.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -83.61 99.37 10.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.854 ' H ' HD13 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -80.0 15.11 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.255 -179.707 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.423 ' O ' ' HB ' ' A' ' 67' ' ' THR . 79.6 m-85 -100.36 148.64 24.48 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.7 178.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 66' ' ' TYR . 38.3 m 76.98 112.29 0.07 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.983 0.802 . . . . 0.0 110.128 -175.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.46 -174.11 4.76 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.118 0.485 . . . . 0.0 111.221 -174.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -58.97 153.97 16.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.195 -178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 48' ' ' SER . 29.6 mm-40 -111.52 127.88 55.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.679 178.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 66.2 mtt -79.87 157.79 26.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.013 0.435 . . . . 0.0 111.47 -176.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 HD23 ' A' ' 129' ' ' LEU . 9.7 p -107.74 149.87 10.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.237 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 8.0 mp -107.98 168.39 9.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.848 0.356 . . . . 0.0 110.142 176.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.39 137.07 46.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.537 ' HA3' HG12 ' A' ' 39' ' ' VAL . . . -103.09 -9.38 39.54 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.44 -0.885 . . . . 0.0 113.009 -173.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 151.11 164.7 12.25 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.95 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.6 -20.91 26.29 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.961 2.441 . . . . 0.0 112.502 -178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -85.51 128.38 39.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.312 -0.403 . . . . 0.0 109.972 -178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 64.66 24.99 13.04 Favored 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.44 0.462 . . . . 0.0 110.612 -178.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.631 ' HA ' ' CA ' ' A' ' 130' ' ' GLY . 53.3 tt0 -65.29 -23.5 67.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.534 -173.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -71.02 -19.63 62.49 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.674 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 82' ' ' ARG . 39.1 mtm180 -109.67 143.73 39.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.004 0.431 . . . . 0.0 111.057 -171.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.41 130.76 10.04 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.336 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -111.84 124.22 51.91 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.408 ' O ' HD12 ' A' ' 106' ' ' LEU . 5.4 mp -131.14 115.58 30.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.907 0.384 . . . . 0.0 111.032 -177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.0 t -110.01 126.43 67.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.76 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -133.17 161.09 35.37 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.119 -176.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 m -67.52 159.04 30.52 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.444 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 46.1 tttp -72.55 120.13 17.73 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.188 0.518 . . . . 0.0 110.645 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.1 m -144.99 107.67 4.45 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 173.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -54.31 138.15 39.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.345 0.593 . . . . 0.0 112.199 -175.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -176.71 24.54 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.757 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 67.51 -165.52 0.21 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -167.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -151.56 137.32 17.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.018 0.437 . . . . 0.0 111.262 178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 111' ' ' ASP . 30.9 m -89.81 -50.04 6.28 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.076 175.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 109' ' ' SER . 50.3 t60 -168.32 88.56 0.24 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.72 176.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 57.8 m -130.9 136.02 48.23 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.716 -178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -103.43 116.69 32.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 101' ' ' THR . 0.3 OUTLIER -81.32 122.08 27.01 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.06 0.457 . . . . 0.0 111.84 -175.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.732 HG13 HE21 ' A' ' 6' ' ' GLN . 64.2 t -68.4 -53.01 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 165.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 99' ' ' LYS . 9.9 t -138.54 -169.67 2.66 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.886 -1.506 . . . . 0.0 107.0 167.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.05 -40.88 60.04 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 118.9 0.773 . . . . 0.0 110.983 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 6.3 m-20 -76.31 -25.55 54.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -177.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.7 mm -118.01 123.1 71.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.3 m -131.25 133.62 45.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.036 0.446 . . . . 0.0 111.987 -173.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 85' ' ' ILE . 19.1 tp -96.12 137.27 35.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.991 176.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.866 HG21 ' HB3' ' A' ' 111' ' ' ASP . 50.9 m -133.51 128.34 35.13 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.888 0.375 . . . . 0.0 111.164 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 10.9 p -120.08 25.4 9.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.831 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.515 ' CB ' ' HB3' ' A' ' 96' ' ' HIS . 8.6 t -136.9 -170.56 2.73 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.619 -174.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.12 -5.29 52.94 Favored Glycine 0 C--N 1.335 0.48 0 CA-C-N 116.509 -0.314 . . . . 0.0 112.926 -178.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.866 ' HB3' HG21 ' A' ' 107' ' ' THR . 14.6 t70 -55.22 -37.13 66.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.337 0.589 . . . . 0.0 110.483 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.7 t -54.09 -50.1 56.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.701 176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.623 HD11 HD13 ' A' ' 53' ' ' LEU . 3.9 mm? -61.98 -41.02 97.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.854 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -62.19 -41.89 98.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.386 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 121' ' ' ALA . 68.2 m -54.15 -68.76 0.16 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.307 -0.861 . . . . 0.0 112.309 -176.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . 0.434 ' HA ' ' CB ' ' A' ' 121' ' ' ALA . 32.2 p90 -86.87 21.97 2.12 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.909 0.385 . . . . 0.0 111.979 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.33 19.12 10.89 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.896 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.509 HG23 ' H ' ' A' ' 120' ' ' THR . 8.9 t -157.48 -170.48 3.24 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.922 0.361 . . . . 0.0 110.524 -176.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -67.7 -20.9 65.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.106 0.479 . . . . 0.0 111.248 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.509 ' H ' HG23 ' A' ' 118' ' ' THR . 16.6 p -98.05 36.07 1.63 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.278 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -75.73 121.95 86.1 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.438 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.38 131.56 20.6 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.633 2.222 . . . . 0.0 111.295 174.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.61 -47.26 73.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.326 -178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.8 mtmt -123.11 123.24 40.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.374 0.607 . . . . 0.0 111.897 -169.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -146.13 131.92 19.02 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.02 175.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.3 pt -105.39 132.77 51.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.902 0.382 . . . . 0.0 110.311 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.8 p -115.83 123.49 71.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.235 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 73' ' ' LEU . 74.2 m -136.07 142.96 44.41 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.413 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.463 HD23 HG21 ' A' ' 72' ' ' VAL . 3.9 mm? -93.63 115.49 27.97 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 174.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.631 ' CA ' ' HA ' ' A' ' 80' ' ' GLN . . . 80.89 173.32 47.19 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.841 -177.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 62.8 m -147.06 169.22 19.7 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.7 m -105.95 116.65 32.3 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.004 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.745 HG22 HG13 ' A' ' 37' ' ' ILE . 47.7 p -103.66 115.84 31.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.465 178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.908 ' HE1' ' HG3' ' A' ' 142' ' ' GLU . 1.5 t-105 -78.77 157.49 28.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.749 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 12.9 mmmm -65.37 147.16 98.79 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.378 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.23 113.89 1.62 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.443 2.762 . . . . 0.0 112.949 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.509 ' O ' ' HG2' ' A' ' 140' ' ' GLU . 10.9 m-70 66.83 -3.36 0.93 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.534 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 53.3 tt0 -74.82 -25.48 59.04 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.733 -177.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.446 ' O ' HG13 ' A' ' 143' ' ' ILE . 49.1 tp -56.95 -39.24 74.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.885 -175.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.583 ' HG3' ' NE2' ' A' ' 141' ' ' GLN . 12.7 pt-20 -66.36 -34.27 77.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.784 0.326 . . . . 0.0 110.76 -179.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.583 ' NE2' ' HG3' ' A' ' 140' ' ' GLU . 2.2 mp0 -71.33 -38.9 71.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 110.243 174.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.908 ' HG3' ' HE1' ' A' ' 134' ' ' TRP . 32.9 mm-40 -59.54 -43.54 93.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 139' ' ' LEU . 78.7 mt -64.48 -34.07 67.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.803 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.04 -19.01 65.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.335 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.473 ' NE2' ' HA ' ' A' ' 142' ' ' GLU . 54.2 mt-30 -79.94 -2.47 43.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.723 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 71.05 18.8 5.79 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.712 178.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -100.27 3.91 43.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.525 ' CZ3' ' HB2' ' A' ' 12' ' ' ALA . 99.8 m95 -134.83 119.86 18.64 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.83 0.347 . . . . 0.0 110.79 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.521 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 3.9 tt -100.21 113.05 25.42 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 8.9 tt -90.19 134.52 34.23 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.061 0.458 . . . . 0.0 110.632 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.7 m -142.0 152.19 43.19 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.539 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -81.29 158.84 24.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.483 0.659 . . . . 0.0 111.618 -178.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -150.69 -152.57 0.44 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.891 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.0 t30 67.87 65.97 0.37 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.959 0.409 . . . . 0.0 111.233 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -178.6 -89.08 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.969 174.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -106.4 -55.96 2.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.001 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.8 m -52.12 -29.81 23.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.571 -170.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.34 -53.98 40.25 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -134.39 15.29 3.76 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.89 -53.36 5.16 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 119.956 -0.697 . . . . 0.0 110.456 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 28.6 p -81.31 -75.44 0.28 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.3 m 60.02 -138.42 0.67 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.624 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -77.99 70.84 4.41 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.131 0.491 . . . . 0.0 111.806 -172.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.0 pp -119.76 -4.8 10.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.112 0.482 . . . . 0.0 110.576 173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -129.75 -169.55 2.14 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.47 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . 55.5 mtt180 -95.36 -48.53 5.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.675 0.274 . . . . 0.0 111.035 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . . . . . . . . . 19.7 m-90 -100.99 154.41 18.72 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.227 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 170' ' ' ALA . 31.9 t -69.45 135.4 28.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.322 -179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -97.23 -4.76 38.34 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.462 0.172 . . . . 0.0 111.315 -175.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.588 ' H ' HG12 ' A' ' 168' ' ' VAL . . . -53.1 -42.44 65.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -77.12 -37.41 54.24 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.025 0.44 . . . . 0.0 110.787 -178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -75.78 -22.89 55.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.688 -176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -57.18 -37.26 71.88 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.84 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.8 tp -89.53 -44.31 10.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.946 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 120.02 0.61 13.13 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.118 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 4.8 mp 68.97 -72.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.259 0.624 . . . . 0.0 111.625 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 11.2 t 70.88 160.95 0.22 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.41 0.684 . . . . 0.0 111.029 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -90.93 -6.43 67.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.488 -178.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.583 HG22 HD12 ' A' ' 180' ' ' LEU . 3.2 mp -101.32 131.06 49.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.583 HD12 HG22 ' A' ' 179' ' ' ILE . 6.3 mp 58.73 68.59 0.81 Allowed 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.189 0.518 . . . . 0.0 110.752 -168.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 182' ' ' PRO . . . -121.72 120.46 28.64 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.227 179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 181' ' ' ALA . 17.3 Cg_exo -66.54 134.24 34.9 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.876 2.384 . . . . 0.0 112.475 -178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -122.47 142.11 50.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.971 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -95.45 23.52 33.37 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.47 -176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -97.83 18.83 14.88 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.043 0.449 . . . . 0.0 110.296 -178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -83.35 -57.11 3.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.637 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 98.2 mt -116.27 178.26 4.39 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.251 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.62 179.07 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.789 0.328 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -131.01 172.67 11.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.543 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -135.25 -73.55 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.085 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -77.96 145.07 36.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.059 0.457 . . . . 0.0 110.725 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.6 mt -130.95 -107.47 0.27 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.268 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 59.36 117.08 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.905 0.753 . . . . 0.0 112.476 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.413 ' C ' ' HD3' ' A' ' 8' ' ' LYS . . . 84.84 8.16 82.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.676 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.94 ' HD2' ' HB2' ' A' ' 152' ' ' GLU . 22.2 mmtp -112.05 150.81 30.14 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -130.49 163.03 27.9 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.393 0.616 . . . . 0.0 111.895 -173.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.434 HD12 ' CE3' ' A' ' 148' ' ' TRP . 2.5 pt -127.69 128.36 69.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.396 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.495 HD12 HD22 ' A' ' 174' ' ' LEU . 55.0 mt -96.03 150.58 4.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.804 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 76.19 130.75 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.11 0.881 . . . . 0.0 110.91 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.879 ' HB ' ' HD3' ' A' ' 14' ' ' PRO . 32.7 m -140.83 -60.72 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.016 -177.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.879 ' HD3' ' HB ' ' A' ' 13' ' ' THR . 79.0 Cg_endo -91.21 179.17 1.66 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.287 1.992 . . . . 0.0 112.528 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.532 ' HG3' ' HG3' ' A' ' 16' ' ' MET . 14.4 tp10 -103.62 -48.89 3.82 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.946 177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.532 ' HG3' ' HG3' ' A' ' 15' ' ' GLU . 64.4 mtm -132.74 -5.47 3.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.145 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -90.93 80.33 5.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.021 0.439 . . . . 0.0 111.253 -175.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -152.12 137.34 17.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.976 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 20' ' ' TYR . 42.7 tt0 177.36 158.17 0.37 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.414 ' HB3' ' O ' ' A' ' 19' ' ' GLU . 18.6 t80 76.81 -47.34 0.52 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.108 0.563 . . . . 0.0 111.278 174.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 167' ' ' TRP . 79.9 m-85 51.35 55.46 9.42 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 173.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.409 ' HB2' ' CE2' ' A' ' 20' ' ' TYR . 32.0 t0 -91.1 84.42 5.7 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.708 HH22 ' HG2' ' A' ' 71' ' ' MET . 62.7 mtm180 59.89 82.15 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.192 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.0 t -121.23 117.59 27.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.496 -175.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG13 HG22 ' A' ' 40' ' ' ILE . 58.1 t 69.04 134.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.684 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.49 HG13 ' HD1' ' A' ' 27' ' ' TYR . 6.8 tp -134.97 -58.89 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.887 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.49 ' HD1' HG13 ' A' ' 26' ' ' ILE . 1.8 p90 -179.23 177.8 0.75 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.011 0.434 . . . . 0.0 111.805 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.9 mm -94.02 125.31 46.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.217 174.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.5 m -89.93 -41.01 12.01 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -171.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.47 145.29 35.04 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.209 0.528 . . . . 0.0 110.804 -176.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -122.48 103.61 8.82 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 171.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -112.27 166.38 11.33 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.926 -171.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -79.14 -12.34 59.99 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.384 0.611 . . . . 0.0 109.766 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -86.68 -36.63 18.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.307 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -178.82 178.88 48.88 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.13 -178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 133' ' ' THR . 18.0 m -107.26 118.27 36.27 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.615 HG12 HG22 ' A' ' 133' ' ' THR . 56.8 mt -103.4 113.07 39.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.865 0.364 . . . . 0.0 111.424 -170.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.76 164.95 29.6 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.764 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.32 96.23 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.609 0.719 . . . . 0.0 111.685 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.602 ' H ' HD13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -129.8 17.25 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.463 177.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 74' ' ' ASN . 9.3 tp -54.89 -30.61 23.34 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.602 -172.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.517 ' O ' ' HB ' ' A' ' 43' ' ' THR . 49.2 t30 60.71 71.18 0.58 Allowed 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 122.47 0.308 . . . . 0.0 111.279 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 42' ' ' ASN . 14.8 t 178.31 117.64 0.19 Allowed Pre-proline 0 CA--C 1.537 0.468 0 CA-C-O 121.583 0.706 . . . . 0.0 111.425 176.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 73' ' ' LEU . 1.2 Cg_endo -85.49 157.3 10.75 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.174 2.583 . . . . 0.0 111.09 171.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.483 HG22 ' HB2' ' A' ' 74' ' ' ASN . 10.6 p -96.74 175.72 6.26 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -79.82 -29.29 40.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.098 0.475 . . . . 0.0 110.526 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 38.4 tp -68.58 148.49 50.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.604 -176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.748 ' HB3' ' HG2' ' A' ' 51' ' ' GLU . 17.1 t -104.82 152.86 22.08 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.618 -176.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.6 p -64.44 -31.94 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 121.068 0.461 . . . . 0.0 109.951 177.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 65' ' ' ILE . 27.8 mt -75.03 -26.26 59.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.089 0.471 . . . . 0.0 110.321 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.748 ' HG2' ' HB3' ' A' ' 48' ' ' SER . 45.8 mm-40 -64.22 -36.62 84.67 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.563 176.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.29 -35.18 76.63 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.536 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 87.7 mt -74.16 -39.5 63.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.046 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 56' ' ' MET . 20.9 p -70.59 -29.69 66.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 0.0 110.575 177.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.0 tpt85 -61.19 -29.55 69.88 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.932 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 54' ' ' THR . 62.6 mtm 68.61 17.51 8.96 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.765 173.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -93.84 88.8 5.89 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.56 ' CZ ' ' HB2' ' A' ' 62' ' ' LYS . 6.5 p90 -146.14 176.79 9.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.362 -178.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.772 ' HB3' ' HA3' ' A' ' 110' ' ' GLY . 65.1 tt0 -98.64 74.66 2.11 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.865 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 84.3 mtp 66.82 167.96 0.23 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.162 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 68.67 101.29 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.124 -0.944 . . . . 0.0 113.113 174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.56 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 27.5 tptp -117.74 89.14 32.4 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.557 170.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.516 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . 83.9 Cg_endo -95.94 -175.92 0.33 Allowed 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.058 2.506 . . . . 0.0 112.544 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.566 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 0.0 OUTLIER -89.73 131.76 35.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.315 175.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.516 HG21 HD22 ' A' ' 50' ' ' LEU . 7.0 tp -97.67 -30.53 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.466 -177.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.2 t80 64.26 -169.96 0.19 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.732 -177.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.768 HG22 ' H ' ' A' ' 68' ' ' GLN . 1.5 m 65.54 -165.28 0.23 Allowed 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.768 ' H ' HG22 ' A' ' 67' ' ' THR . 40.5 mt-30 -105.93 -178.26 3.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.166 0.508 . . . . 0.0 111.737 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -82.95 141.88 31.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.554 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -133.52 124.54 27.14 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.323 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.708 ' HG2' HH22 ' A' ' 23' ' ' ARG . 0.0 OUTLIER -68.12 133.49 49.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.251 0.548 . . . . 0.0 110.8 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.619 HG23 HG13 ' A' ' 127' ' ' VAL . 11.7 p -82.94 149.91 4.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.197 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 44' ' ' PRO . 5.8 mp -93.55 157.86 15.98 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.273 0.559 . . . . 0.0 111.935 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.588 ' O ' HG21 ' A' ' 41' ' ' ILE . 3.1 t-20 -101.06 87.24 3.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.968 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.34 -32.39 80.69 Favored Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.844 -169.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 163.93 173.98 33.22 Favored Glycine 0 N--CA 1.443 -0.897 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.991 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.34 -22.97 12.09 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.741 2.294 . . . . 0.0 113.074 -177.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.484 HG21 ' OG1' ' A' ' 133' ' ' THR . 59.4 t -81.21 117.56 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.378 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 62.79 32.87 15.73 Favored 'General case' 0 CA--C 1.517 -0.302 0 O-C-N 123.704 0.628 . . . . 0.0 110.467 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HA ' ' HA3' ' A' ' 130' ' ' GLY . 52.6 tt0 -61.86 -22.15 65.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.719 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -82.21 -1.55 49.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -113.95 140.88 48.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.52 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -102.09 118.4 6.12 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -100.86 125.96 47.44 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.21 114.04 44.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-O 121.124 0.488 . . . . 0.0 110.328 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.533 HG22 HD13 ' A' ' 106' ' ' LEU . 34.7 t -100.3 122.56 52.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.441 177.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -136.47 160.97 37.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.639 0.257 . . . . 0.0 110.971 -176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.9 m -73.75 177.7 5.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.608 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -51.62 113.83 1.09 Allowed 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 121.002 0.429 . . . . 0.0 110.827 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 4.0 m -121.54 117.57 27.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 -176.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.8 -152.57 0.39 Allowed 'General case' 0 CA--C 1.532 0.273 0 O-C-N 123.743 0.652 . . . . 0.0 109.327 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -137.33 18.88 2.94 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.163 0.506 . . . . 0.0 110.645 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -121.87 168.6 11.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.012 174.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -175.2 146.07 0.82 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.151 -176.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.443 ' H ' ' CG ' ' A' ' 111' ' ' ASP . 90.6 m -89.87 -56.66 3.15 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.065 175.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -158.31 104.7 1.86 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 50.1 m -116.98 159.17 22.91 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.811 177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -108.33 116.5 32.09 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.0 tttm -75.92 102.41 5.56 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.997 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 56.3 t -81.21 -54.11 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.465 ' OG1' HG12 ' A' ' 104' ' ' ILE . 70.8 p -130.04 -162.78 1.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 173.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -86.32 4.76 37.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.932 0.396 . . . . 0.0 110.424 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -134.66 -48.95 0.76 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.363 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.74 HD12 ' HD2' ' A' ' 159' ' ' PHE . 24.2 mm -68.99 122.01 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.714 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.9 m -123.64 116.8 23.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.073 -174.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.533 HD13 HG22 ' A' ' 86' ' ' VAL . 56.1 tp -96.88 128.84 44.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.073 176.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.573 HG21 ' HB3' ' A' ' 111' ' ' ASP . 26.6 m -128.89 130.96 47.52 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 27.3 p -109.03 -12.21 14.87 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 p -101.5 -172.21 2.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.093 0.473 . . . . 0.0 111.798 -176.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.772 ' HA3' ' HB3' ' A' ' 59' ' ' GLN . . . -74.83 7.48 20.5 Favored Glycine 0 C--O 1.227 -0.334 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.675 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.573 ' HB3' HG21 ' A' ' 107' ' ' THR . 18.2 t0 -64.43 -28.66 69.83 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.552 0.692 . . . . 0.0 109.698 176.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.6 t -56.13 -37.18 48.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.66 174.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.507 HD23 ' HA2' ' A' ' 110' ' ' GLY . 4.0 mm? -63.66 -34.68 78.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.803 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -80.17 -27.53 38.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.062 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -60.64 -42.37 96.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.613 -178.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -104.45 170.31 7.97 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.224 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.516 ' HA3' ' HB2' ' A' ' 63' ' ' PRO . . . 81.27 11.54 83.31 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.036 -177.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.5 t -127.98 168.27 15.51 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -77.8 -5.05 49.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.048 0.451 . . . . 0.0 110.789 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.7 p -113.14 27.73 9.37 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.019 0.438 . . . . 0.0 110.628 175.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.47 160.37 25.51 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.721 -178.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -75.8 146.14 29.57 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.4 2.067 . . . . 0.0 111.954 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.465 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 88.6 mt-10 -58.64 -53.12 61.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.161 176.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 123' ' ' GLU . 9.9 mtmt -139.32 153.69 47.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.985 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -155.01 134.96 12.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.836 176.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.443 ' CG1' ' HB ' ' A' ' 86' ' ' VAL . 24.8 pt -110.57 133.03 57.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.117 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.619 HG13 HG23 ' A' ' 72' ' ' VAL . 5.7 p -119.77 128.17 75.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.151 0.5 . . . . 0.0 110.725 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 22.6 p -133.19 135.66 45.2 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.49 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.409 HD23 HG21 ' A' ' 72' ' ' VAL . 4.0 mm? -87.9 108.85 19.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.077 -0.511 . . . . 0.0 109.841 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 80' ' ' GLN . . . 79.2 174.44 45.64 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.83 -177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 63.4 m -144.45 168.9 19.01 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 177.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 40.0 m -105.6 130.72 53.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.183 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.615 HG22 HG12 ' A' ' 37' ' ' ILE . 66.9 p -118.37 125.55 50.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.514 ' HB2' ' HB ' ' A' ' 36' ' ' THR . 27.1 m-90 -82.88 178.88 7.96 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 167.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 138' ' ' GLN . 1.5 mptm? -74.74 159.95 81.99 Favored Pre-proline 0 C--N 1.315 -0.902 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 168.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.56 111.17 0.57 Allowed 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.968 1.779 . . . . 0.0 111.744 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 74.97 8.69 4.08 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.726 174.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 135' ' ' LYS . 31.1 tt0 -64.24 -36.27 83.54 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.589 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.423 ' O ' HG13 ' A' ' 143' ' ' ILE . 49.3 tp -53.7 -29.62 39.95 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.976 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -62.76 -38.99 92.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.82 0.343 . . . . 0.0 110.569 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -69.53 -31.67 70.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.258 0.551 . . . . 0.0 110.3 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -70.14 -43.76 70.27 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.177 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.445 HG12 ' HB2' ' A' ' 148' ' ' TRP . 74.3 mt -67.98 -31.51 52.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -59.21 -22.34 60.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.57 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -71.87 -4.56 28.77 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.513 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 65.19 23.92 12.31 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.272 0.629 . . . . 0.0 111.97 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -96.84 -36.02 10.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.585 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.477 ' CH2' HG23 ' A' ' 13' ' ' THR . 92.9 m95 -92.26 127.84 37.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.679 -178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.3 tt -100.69 110.51 22.64 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.119 -0.696 . . . . 0.0 109.119 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 62.1 tp -82.6 134.53 35.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.539 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.5 p -152.14 144.12 23.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.097 175.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.94 ' HB2' ' HD2' ' A' ' 8' ' ' LYS . 15.9 pt-20 -113.5 153.82 28.08 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.618 -176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -115.17 152.79 31.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.177 -174.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -94.87 -59.53 1.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.514 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -168.52 -47.98 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.142 -179.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -52.93 -45.87 67.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.744 -1.116 . . . . 0.0 111.874 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.702 HG23 ' HG3' ' A' ' 173' ' ' MET . 0.2 OUTLIER -56.89 -29.18 62.76 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.172 -177.201 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.461 HD12 HG13 ' A' ' 104' ' ' ILE . 84.1 mt -89.51 -50.89 5.83 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -174.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.74 ' HD2' HD12 ' A' ' 104' ' ' ILE . 11.8 m-85 -124.78 -0.2 8.01 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -174.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -89.7 -57.65 2.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 170.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 91.0 m -82.53 79.87 8.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 170.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.2 t -152.05 95.12 2.03 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.784 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 53.7 t80 64.94 71.89 0.45 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.012 175.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 165' ' ' ASP . 0.2 OUTLIER -102.69 -59.36 1.72 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 171.586 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.431 ' H ' ' HG ' ' A' ' 164' ' ' LEU . 20.9 t70 178.65 67.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.529 ' HB3' ' HB3' ' A' ' 169' ' ' GLU . 13.0 tpt180 -166.97 140.91 3.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.478 -177.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 50.7 m0 -86.24 -34.6 20.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.276 0.56 . . . . 0.0 110.228 177.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.412 ' HB ' ' OD1' ' A' ' 171' ' ' ASN . 11.3 m -116.75 46.48 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.271 -176.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 166' ' ' ARG . 5.4 pt-20 -77.48 -18.75 56.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.502 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -63.88 -57.42 9.89 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.086 0.469 . . . . 0.0 111.207 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.412 ' OD1' ' HB ' ' A' ' 168' ' ' VAL . 3.8 p-10 -68.89 -25.53 64.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.416 -178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.85 -25.15 65.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.256 -178.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.702 ' HG3' HG23 ' A' ' 157' ' ' THR . 1.5 tmt? -58.69 -36.6 74.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.441 0.639 . . . . 0.0 109.418 176.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.495 HD22 HD12 ' A' ' 11' ' ' ILE . 11.8 tp -84.43 -38.44 20.2 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.775 179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 93.95 -3.18 70.12 Favored Glycine 0 N--CA 1.452 -0.26 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.487 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 22.6 mt 58.43 71.38 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.362 0.601 . . . . 0.0 110.386 -177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.7 m -157.76 -178.52 7.38 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.97 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 97.25 -88.23 0.94 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.974 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.62 HG12 HD12 ' A' ' 180' ' ' LEU . 17.3 tt -163.95 158.9 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.62 HD12 HG12 ' A' ' 179' ' ' ILE . 6.5 mp 68.06 157.05 0.13 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.317 0.647 . . . . 0.0 111.152 -172.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 52.79 66.8 4.46 Favored Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.307 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.88 -20.54 19.6 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.747 2.298 . . . . 0.0 112.24 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -154.54 122.68 5.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.929 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.723 ' H ' HD11 ' A' ' 187' ' ' LEU . . . -93.7 -169.73 38.61 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 172.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.508 ' HA ' ' NE ' ' A' ' 185' ' ' ARG . 0.1 OUTLIER -95.18 -50.34 5.1 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 117.441 0.621 . . . . 0.0 110.451 -179.631 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -88.84 73.6 8.39 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.146 0.498 . . . . 0.0 110.717 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . 0.723 HD11 ' H ' ' A' ' 184' ' ' GLY . 85.4 mt -110.83 -35.02 6.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.94 177.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 . . . . . 0 C--O 1.249 1.037 0 O-C-N 123.666 0.604 . . . . 0.0 110.116 -176.518 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 N--CA 1.481 1.094 0 CA-C-O 120.792 0.329 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.48 ' HB3' ' CD2' ' A' ' 150' ' ' LEU . 37.4 p90 -140.21 27.31 2.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.79 57.39 3.05 Favored Glycine 0 CA--C 1.519 0.288 0 CA-C-N 116.011 -0.541 . . . . 0.0 113.003 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -166.6 -55.0 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.0 mt 57.44 -149.9 0.45 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.506 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 64.38 104.88 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.563 0.697 . . . . 0.0 111.154 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.73 -4.0 68.44 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.667 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 55.1 mmtt -113.49 168.24 9.92 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' HB2' ' O ' ' A' ' 26' ' ' ILE . 41.6 p90 -134.8 155.91 49.79 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 119.713 -0.795 . . . . 0.0 112.025 -174.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.8 pt -129.53 128.03 65.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.23 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' A' ' 149' ' ' LEU . 58.6 mt -88.16 132.31 33.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.396 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.467 ' HB2' ' CZ3' ' A' ' 148' ' ' TRP . . . -125.7 143.96 50.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.932 176.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 183' ' ' ALA . 7.9 m -63.54 114.68 13.97 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 123.291 0.369 . . . . 0.0 110.71 178.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.76 151.23 28.02 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.543 2.162 . . . . 0.0 112.058 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -77.3 -80.5 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 49.9 ttp -166.66 119.4 1.01 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.216 0.532 . . . . 0.0 111.714 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.682 ' HB3' ' HG3' ' A' ' 19' ' ' GLU . 6.3 t70 -148.34 -166.51 2.56 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 169.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.669 ' HB3' ' CE2' ' A' ' 20' ' ' TYR . 58.3 m-20 -94.14 -43.19 8.59 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.682 ' HG3' ' HB3' ' A' ' 17' ' ' ASP . 35.1 mt-10 44.97 73.39 0.16 Allowed 'General case' 0 N--CA 1.467 0.378 0 O-C-N 124.208 0.943 . . . . 0.0 111.944 173.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.887 ' HA ' ' HD1' ' A' ' 167' ' ' TRP . 32.6 m-85 -109.45 -64.38 1.25 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.895 0.379 . . . . 0.0 111.435 -176.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -117.0 43.94 2.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.3 0.572 . . . . 0.0 110.524 -175.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.659 ' O ' ' HD2' ' A' ' 23' ' ' ARG . 4.9 t70 -127.71 -174.74 3.27 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.379 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.659 ' HD2' ' O ' ' A' ' 22' ' ' ASP . 0.5 OUTLIER -127.53 81.12 2.0 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.354 0.597 . . . . 0.0 110.02 175.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.545 HG21 ' HG2' ' A' ' 19' ' ' GLU . 29.6 p -90.2 124.49 34.9 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.795 -177.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t 66.86 87.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.503 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.584 HG13 ' N ' ' A' ' 27' ' ' TYR . 7.0 tp -119.02 -117.13 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-O 118.938 -0.553 . . . . 0.0 111.134 -178.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.584 ' N ' HG13 ' A' ' 26' ' ' ILE . 4.5 p90 -118.62 170.33 9.05 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.835 1.198 . . . . 0.0 113.055 -165.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.1 mm -87.73 121.49 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.528 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 52.3 m -85.57 -41.12 15.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.956 0.407 . . . . 0.0 111.308 -174.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HB3' HD13 ' A' ' 37' ' ' ILE . 0.1 OUTLIER -142.11 151.83 42.67 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -149.65 105.03 3.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.469 0.652 . . . . 0.0 111.487 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -129.78 162.78 27.67 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.46 170.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -68.58 -24.13 64.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.268 0.556 . . . . 0.0 109.853 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.07 -9.76 58.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.933 176.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 164.45 129.62 1.06 Allowed Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.777 178.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 133' ' ' THR . 88.5 m -103.86 117.8 35.2 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 174.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.574 HG23 ' HB3' ' A' ' 131' ' ' CYS . 3.8 mp -101.39 118.25 47.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.583 -175.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.94 139.64 7.66 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.794 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.665 HG12 ' HA2' ' A' ' 75' ' ' GLY . 2.4 m -92.1 77.31 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.972 0.891 . . . . 0.0 110.201 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.47 HD12 ' CH2' ' A' ' 148' ' ' TRP . 25.1 pt -126.51 4.83 3.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.815 -172.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.2 pt -73.39 -18.84 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -175.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.469 ' O ' ' HB ' ' A' ' 43' ' ' THR . 47.1 t-20 64.51 89.13 0.1 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 123.613 0.571 . . . . 0.0 111.618 177.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.481 HG23 ' HB3' ' A' ' 74' ' ' ASN . 10.0 t 173.85 127.74 0.11 Allowed Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.712 174.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -86.57 154.35 9.03 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.653 2.236 . . . . 0.0 110.732 169.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.3 p -88.14 177.53 6.88 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.385 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -84.8 -17.54 37.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.114 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.0 tp -86.66 152.76 22.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.791 -175.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 71' ' ' MET . 55.7 p -102.05 157.26 17.0 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.644 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.499 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 12.1 p -64.66 -32.78 59.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.033 0.444 . . . . 0.0 110.145 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.6 mt -70.93 -31.95 68.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.865 -179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -63.26 -43.97 96.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.827 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 4.1 pp -76.49 -32.49 58.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.042 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 49' ' ' VAL . 67.6 mt -65.67 -37.89 87.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.302 178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.6 p -78.72 -30.76 46.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.863 0.364 . . . . 0.0 111.072 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 75.7 ttt180 -63.83 -48.07 78.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.814 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.6 mmt -82.12 -33.01 29.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.533 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.606 ' OD1' ' HG3' ' A' ' 60' ' ' MET . 11.3 t70 68.02 123.63 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.89 0.852 . . . . 0.0 111.689 -172.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.559 ' HE2' ' HD3' ' A' ' 62' ' ' LYS . 36.6 p90 -113.79 -19.86 11.35 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.967 -1.015 . . . . 0.0 110.918 -178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 174.07 -39.91 0.01 OUTLIER 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 -169.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.606 ' HG3' ' OD1' ' A' ' 57' ' ' ASP . 66.6 mtt 63.72 84.49 0.15 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.698 -175.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -164.53 -42.73 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.0 -178.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.559 ' HD3' ' HE2' ' A' ' 58' ' ' PHE . 13.5 mptt -58.99 146.77 76.09 Favored Pre-proline 0 C--O 1.234 0.286 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.911 177.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 24.8 Cg_exo -64.18 142.3 79.62 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 123.182 2.588 . . . . 0.0 113.337 -175.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 4.8 mtm-85 -125.67 115.7 20.51 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.704 HD12 ' HB3' ' A' ' 68' ' ' GLN . 4.8 pt -127.52 123.42 61.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.128 0.489 . . . . 0.0 111.127 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -82.01 46.94 1.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.007 -175.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.2 m -158.24 -57.85 0.07 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.112 0.482 . . . . 0.0 110.479 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.704 ' HB3' HD12 ' A' ' 65' ' ' ILE . 27.8 tt0 -101.73 53.0 0.82 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.64 0.733 . . . . 0.0 109.635 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -96.81 171.43 8.52 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.276 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.844 HE21 ' HA ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -116.58 132.43 56.68 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.186 -178.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 48' ' ' SER . 58.8 mtm -82.81 151.35 26.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.042 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.526 HG23 HG22 ' A' ' 127' ' ' VAL . 11.0 p -95.54 133.75 35.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.977 0.417 . . . . 0.0 110.195 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.579 HD21 ' OD1' ' A' ' 22' ' ' ASP . 13.4 mt -72.29 157.75 37.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.004 0.43 . . . . 0.0 111.666 -176.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.481 ' HB3' HG23 ' A' ' 43' ' ' THR . 7.8 t-20 -98.4 113.16 25.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.254 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.665 ' HA2' HG12 ' A' ' 39' ' ' VAL . . . -79.24 -36.24 27.87 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.06 -178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.81 174.62 28.76 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.187 -0.53 . . . . 0.0 111.894 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.35 -11.87 27.0 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.887 2.391 . . . . 0.0 113.484 -174.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.44 132.01 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.37 -178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 65.86 39.26 4.71 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 123.236 0.335 . . . . 0.0 111.582 177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -65.76 -21.66 66.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -92.91 7.65 43.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.741 0.782 . . . . 0.0 109.834 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.37 140.64 49.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.01 129.66 9.86 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.619 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.53 ' HB3' HD11 ' A' ' 106' ' ' LEU . 21.3 m-85 -115.19 125.03 52.91 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.71 ' HB ' HG21 ' A' ' 112' ' ' VAL . 4.7 mp -131.26 122.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.116 0.484 . . . . 0.0 110.554 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.623 HG22 HD13 ' A' ' 106' ' ' LEU . 7.3 t -95.18 131.4 42.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 31.7 p-80 -137.96 160.27 39.78 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 121.09 -0.244 . . . . 0.0 110.465 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.7 m -63.22 145.5 55.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.237 0.542 . . . . 0.0 111.63 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 103' ' ' ASP . 0.7 OUTLIER -63.55 124.28 20.96 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.331 174.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -117.88 -176.54 3.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -174.226 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.752 ' HB2' HG21 ' A' ' 120' ' ' THR . 6.8 m-20 -79.78 -35.53 38.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -172.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.546 ' HE1' ' HA ' ' A' ' 115' ' ' SER . 10.1 p-80 -87.07 175.54 8.05 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.979 -173.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.39 169.18 3.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.759 0.79 . . . . 0.0 112.269 -177.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -153.91 113.98 3.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.718 174.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 37.5 m -72.87 -77.36 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.154 -169.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 24.3 t-80 -109.03 83.72 1.8 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.323 0.583 . . . . 0.0 110.844 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 68.3 m -126.04 151.8 46.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.156 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.32 102.0 12.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -69.95 115.7 9.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.77 -177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 44.0 t -73.79 -54.47 15.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.612 177.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.459 HG23 ' H ' ' A' ' 102' ' ' ASP . 2.3 t -131.19 -54.46 1.04 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.959 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' H ' HG23 ' A' ' 101' ' ' THR . 11.8 t70 173.45 -64.01 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 173.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 89' ' ' LYS . 5.7 m-20 -62.77 -26.83 68.9 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.77 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.9 mm -99.51 122.26 51.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 19.6 m -129.2 114.76 16.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.945 0.402 . . . . 0.0 111.466 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.623 HD13 HG22 ' A' ' 86' ' ' VAL . 21.8 tp -93.99 112.19 23.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.794 176.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.829 HG21 ' HB3' ' A' ' 111' ' ' ASP . 29.8 m -99.96 127.67 46.13 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.07 0.462 . . . . 0.0 110.907 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.8 p -102.16 23.88 10.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.038 -175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.496 ' H ' HG22 ' A' ' 107' ' ' THR . 34.2 m -151.38 -177.74 6.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.395 -176.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.81 11.75 5.61 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.334 -0.46 . . . . 0.0 113.341 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.829 ' HB3' HG21 ' A' ' 107' ' ' THR . 14.7 t70 -63.42 -30.23 71.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.853 0.835 . . . . 0.0 109.708 178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.71 HG21 ' HB ' ' A' ' 85' ' ' ILE . 40.8 t -54.79 -45.44 74.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.609 174.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.405 ' HG ' ' CB ' ' A' ' 58' ' ' PHE . 3.2 mm? -69.38 -33.8 73.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.612 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -60.58 -41.39 94.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.967 173.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.584 ' HB3' ' HD3' ' A' ' 122' ' ' PRO . 49.1 m -59.08 -39.66 82.83 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.761 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -83.18 4.66 25.74 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.996 0.427 . . . . 0.0 111.219 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -110.29 17.4 28.98 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.9 -0.667 . . . . 0.0 111.975 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.3 t -142.58 179.26 7.08 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -62.55 -32.33 73.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.851 0.357 . . . . 0.0 110.959 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.752 HG21 ' HB2' ' A' ' 91' ' ' ASP . 23.4 p -92.49 43.1 1.12 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.848 -177.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 115' ' ' SER . . . -56.89 123.65 60.1 Favored Pre-proline 0 C--O 1.235 0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.765 168.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.584 ' HD3' ' HB3' ' A' ' 115' ' ' SER . 27.0 Cg_endo -61.27 129.52 28.69 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.824 2.349 . . . . 0.0 112.558 -175.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.44 -45.82 92.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.875 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.7 mmtt -114.14 142.07 46.69 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.6 -176.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -161.29 143.08 11.83 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.569 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.2 pt -127.03 132.6 69.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.232 174.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.526 HG22 HG23 ' A' ' 72' ' ' VAL . 7.3 p -115.01 131.07 68.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.113 0.482 . . . . 0.0 110.993 -176.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 8.9 p -142.98 146.46 33.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.456 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.2 mt -102.33 142.81 32.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 176.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 64.83 179.73 7.41 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.074 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.574 ' HB3' HG23 ' A' ' 37' ' ' ILE . 61.9 m -149.14 162.72 39.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.077 0.465 . . . . 0.0 109.977 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.9 t -114.03 117.07 30.28 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.464 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 36' ' ' THR . 17.9 p -107.66 116.38 31.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.234 0.54 . . . . 0.0 112.004 -177.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.653 ' CD1' ' HB2' ' A' ' 139' ' ' LEU . 0.6 OUTLIER -101.23 151.38 21.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.971 177.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 135' ' ' LYS . 11.4 mptt -105.49 137.33 19.26 Favored Pre-proline 0 C--O 1.238 0.459 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.325 -174.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 135' ' ' LYS . 7.8 Cg_exo -72.09 92.26 0.73 Allowed 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.379 2.719 . . . . 0.0 112.818 -179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' HIS . . . . . 0.462 ' HB3' ' O ' ' A' ' 136' ' ' PRO . 13.6 p80 170.85 -18.66 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.125 176.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.593 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 56.9 tp60 -110.32 -58.88 2.02 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.266 171.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.653 ' HB2' ' CD1' ' A' ' 134' ' ' TRP . 53.5 tp -56.89 -53.11 61.71 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -172.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.6 -35.94 77.34 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -173.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.441 ' O ' ' HG3' ' A' ' 145' ' ' GLN . 11.5 mt-30 -74.94 -36.22 62.14 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.024 -0.271 . . . . 0.0 111.45 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' A' ' 138' ' ' GLN . 7.6 mm-40 -65.81 -41.96 91.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.756 0.312 . . . . 0.0 110.305 178.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 139' ' ' LEU . 71.2 mt -62.19 -42.44 95.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.44 176.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.68 99.25 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.233 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 141' ' ' GLN . 41.8 mt-30 -78.8 3.56 16.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.02 178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 67.35 37.52 3.53 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 175.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -72.84 -28.41 62.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 164.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' TRP . . . . . 0.47 ' CH2' HD12 ' A' ' 40' ' ' ILE . 74.6 m95 -116.4 149.81 38.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.0 -1.454 . . . . 0.0 108.991 175.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.623 ' HB3' ' HB ' ' A' ' 11' ' ' ILE . 4.0 tt -104.6 110.1 22.26 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.48 ' CD2' ' HB3' ' A' ' 2' ' ' PHE . 34.0 tp -82.03 135.46 35.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.779 0.323 . . . . 0.0 111.228 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.2 m -143.87 156.04 44.31 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.414 ' CD ' ' H ' ' A' ' 152' ' ' GLU . 0.7 OUTLIER -98.09 153.74 18.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.385 0.612 . . . . 0.0 111.401 -175.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -149.18 155.4 40.59 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.33 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -119.01 -62.36 1.53 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.786 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -161.8 -38.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 160' ' ' GLU . 44.4 mt-30 -54.85 -56.43 19.58 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.2 m -55.12 -28.17 50.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.424 0.63 . . . . 0.0 111.063 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 71.8 mt -81.31 -54.57 5.38 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.849 -176.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . 0.455 ' HZ ' ' HB ' ' A' ' 86' ' ' VAL . 71.1 m-85 -133.51 17.66 3.97 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -172.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 156' ' ' GLN . 28.6 tt0 -110.65 -48.36 3.15 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.268 175.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.479 ' HA ' HD11 ' A' ' 164' ' ' LEU . 0.8 OUTLIER -90.56 -9.46 47.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.055 0.455 . . . . 0.0 111.185 179.225 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.2 t -60.12 136.65 58.09 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.112 -177.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 72.1 t80 75.2 -44.29 0.53 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.807 0.843 . . . . 0.0 112.554 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' A' ' 161' ' ' THR . 4.0 pp -81.54 -14.79 56.45 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.583 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -87.44 -161.39 0.69 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 173.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -115.52 -135.79 0.35 Allowed 'General case' 0 C--O 1.214 -0.774 0 O-C-N 122.111 -0.368 . . . . 0.0 111.164 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.887 ' HD1' ' HA ' ' A' ' 20' ' ' TYR . 2.2 m-90 -57.92 -89.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -168.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 3.6 m -111.76 91.98 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.334 0.588 . . . . 0.0 111.535 -175.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 173' ' ' MET . 13.2 pt-20 -71.21 -29.22 64.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.723 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -59.08 -44.24 91.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.979 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.58 ' OD1' ' HA ' ' A' ' 176' ' ' ILE . 11.1 t-20 -71.99 -31.99 66.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.399 0.619 . . . . 0.0 109.593 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.61 -21.91 61.79 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.16 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.484 ' HA ' ' CE ' ' A' ' 173' ' ' MET . 23.6 mmt -58.27 -33.74 69.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.465 -179.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.5 tt -117.02 -52.83 2.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.183 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLY . . . . . . . . . . . . . . . 157.73 115.97 0.47 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.585 ' H ' HD12 ' A' ' 176' ' ' ILE . 3.1 mp -48.16 108.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.396 0 O-C-N 124.105 0.532 . . . . 0.0 110.572 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 39.7 m 74.58 98.57 0.07 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.328 -1.306 . . . . 0.0 110.46 -175.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -101.81 -139.5 10.65 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.863 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.568 HD13 ' HG ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -106.42 137.38 37.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.678 0.275 . . . . 0.0 110.619 -175.33 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.568 ' HG ' HD13 ' A' ' 179' ' ' ILE . 31.3 mt 61.96 64.34 1.01 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.245 -176.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -111.57 108.61 56.26 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.05 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -89.34 114.04 0.62 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.914 2.41 . . . . 0.0 112.704 -178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.477 ' HA ' HG21 ' A' ' 13' ' ' THR . . . -81.38 -13.35 58.41 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.483 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -84.73 61.85 4.63 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.788 -177.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 188' ' ' GLU . 50.6 ttt-85 -139.23 91.37 2.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.859 0.362 . . . . 0.0 110.411 176.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -96.93 -47.23 5.91 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.596 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 96.2 mt -136.33 155.9 49.41 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.374 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 185' ' ' ARG . 47.1 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.838 -0.601 . . . . 0.0 109.832 179.332 . . . . . . . . 1 1 . 1 stop_ save_